Minnesota 2023-2024 Regular Session

Minnesota House Bill HF100 Compare Versions

OldNewDifferences
11 1.1 A bill for an act​
22 1.2 relating to cannabis; establishing the Office of Cannabis Management; establishing​
3-1.3 an advisory council; requiring reports relating to cannabis use and sales; legalizing​
3+1.3 advisory councils; requiring reports relating to cannabis use and sales; legalizing​
44 1.4 and limiting the possession and use of cannabis and certain hemp products by​
55 1.5 adults; providing for the licensing, inspection, and regulation of cannabis businesses​
6-1.6 and hemp businesses; establishing licensing fees; requiring testing of cannabis​
7-1.7 flower, cannabis products, and certain hemp products; requiring labeling of cannabis​
8-1.8 flower, cannabis products, and certain hemp products; limiting the advertisement​
9-1.9 of cannabis flower, cannabis products, cannabis businesses, and hemp businesses;​
10-1.10 providing for the cultivation of cannabis in private residences; transferring​
11-1.11 regulatory authority for the medical cannabis program; providing for Tribal medical
12-1.12 programs; taxing the sale of cannabis flower, cannabis products, and certain hemp​
13-1.13 products; establishing grant and loan programs; clarifying the prohibition on​
14-1.14 operating a motor vehicle while under the influence of certain products and​
15-1.15 chemicals; amending criminal penalties; establishing expungement procedures for​
16-1.16 certain individuals; requiring reports on expungements; providing for expungement​
17-1.17 of certain evictions; clarifying the rights of landlords and tenants regarding use of​
18-1.18 certain forms of cannabis; establishing labor standards for the use of cannabis​
19-1.19 flower, cannabis products, and certain hemp products by employees and testing​
20-1.20 of employees; providing for the temporary regulation of certain edible cannabinoid
21-1.21 products; providing for professional licensing protections; providing for local​
22-1.22 registration of certain cannabis businesses operating retail establishments; amending​
23-1.23 the scheduling of marijuana and tetrahydrocannabinols; classifying data; making​
24-1.24 miscellaneous cannabis-related and hemp-related changes and additions; making​
25-1.25 clarifying and technical changes; requiring reports; transferring money;​
26-1.26 appropriating money; amending Minnesota Statutes 2022, sections 13.411, by​
27-1.27 adding a subdivision; 13.871, by adding a subdivision; 18K.02, subdivision 5;
28-1.28 34A.01, subdivision 4; 97B.065, subdivision 1; 144.99, subdivision 1; 144A.4791,​
29-1.29 subdivision 14; 151.72; 152.01, subdivision 9, by adding subdivisions; 152.02,​
30-1.30 subdivisions 2, 4; 152.021, subdivisions 1, 2; 152.022, subdivisions 1, 2; 152.023,​
31-1.31 subdivisions 1, 2; 152.024, subdivision 1; 152.025, subdivisions 1, 2; 152.11,
32-1.32 subdivision 2; 152.22, by adding subdivisions; 152.29, subdivision 4, by adding
33-1.33 a subdivision; 152.30; 152.32; 152.33, subdivision 1; 152.35; 169A.03, by adding
34-1.34 subdivisions; 169A.20, subdivision 1; 169A.31, subdivision 1; 169A.51,​
35-1.35 subdivisions 1, 4; 169A.72; 175.45, subdivision 1; 181.938, subdivision 2; 181.950,
36-1.36 subdivisions 2, 4, 5, 8, 13, by adding a subdivision; 181.951, subdivisions 4, 5, 6,​
37-1.37 by adding subdivisions; 181.952, by adding a subdivision; 181.953; 181.954;
38-1.38 181.955; 181.957, subdivision 1; 192A.555; 244.05, subdivision 2; 245C.08,
6+1.6 and hemp businesses; requiring testing of cannabis flower, cannabis products, and
7+1.7 certain hemp products; requiring labeling of cannabis flower, cannabis products,
8+1.8 and certain hemp products; limiting the advertisement of cannabis flower, cannabis
9+1.9 products, and cannabis businesses, and hemp businesses; providing for the
10+1.10 cultivation of cannabis in private residences; transferring regulatory authority for
11+1.11 the medical cannabis program; taxing the sale of cannabis flower, cannabis
12+1.12 products, and certain hemp products; establishing grant and loan programs;
13+1.13 clarifying the prohibition on operating a motor vehicle while under the influence
14+1.14 of certain products and chemicals; amending criminal penalties; establishing
15+1.15 expungement procedures for certain individuals; requiring reports on expungements;
16+1.16 providing for expungement of certain evictions; clarifying the rights of landlords
17+1.17 and tenants regarding use of certain forms of cannabis; establishing labor standards
18+1.18 for the use of cannabis flower, cannabis products, and certain hemp products by
19+1.19 employees and testing of employees; providing for the temporary regulation of
20+1.20 certain edible cannabinoid products; providing for professional licensing
21+1.21 protections; providing for local registration of certain cannabis businesses and
22+1.22 hemp businesses operating retail establishments; amending the scheduling of
23+1.23 marijuana and tetrahydrocannabinols; classifying data; making miscellaneous
24+1.24 cannabis-related changes and additions; making clarifying and technical changes;
25+1.25 appropriating money; amending Minnesota Statutes 2022, sections 13.411, by
26+1.26 adding a subdivision; 13.871, by adding a subdivision; 34A.01, subdivision 4;
27+1.27 144.99, subdivision 1; 144A.4791, subdivision 14; 151.72; 152.01, by adding​
28+1.28 subdivisions; 152.02, subdivisions 2, 4; 152.021, subdivisions 1, 2; 152.022,​
29+1.29 subdivisions 1, 2; 152.023, subdivisions 1, 2; 152.024, subdivision 1; 152.025,​
30+1.30 subdivisions 1, 2; 152.11, subdivision 2; 152.22, by adding subdivisions; 152.29,​
31+1.31 subdivision 4, by adding a subdivision; 152.30; 152.32; 152.33, subdivision 1;​
32+1.32 169A.03, by adding subdivisions; 169A.20, subdivision 1; 169A.31, subdivision
33+1.33 1; 169A.51, subdivisions 1, 4; 169A.72; 175.45, subdivision 1; 181.938, subdivision
34+1.34 2; 181.950, subdivisions 2, 4, 5, 8, 13, by adding a subdivision; 181.951,​
35+1.35 subdivisions 4, 5, 6, by adding subdivisions; 181.952, by adding a subdivision;​
36+1.36 181.953; 181.954; 181.955; 181.957, subdivision 1; 244.05, subdivision 2; 245C.08,​
37+1.37 subdivision 1; 256.01, subdivision 18c; 256B.0625, subdivision 13d; 256D.024,
38+1.38 subdivisions 1, 3; 256J.26, subdivisions 1, 3; 270B.12, by adding a subdivision;​
3939 1​
40-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​
41-State of Minnesota​
40+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​
41+213​
42+Printed​
43+Page No.​State of Minnesota​
4244 This Document can be made available​
4345 in alternative formats upon request​
4446 HOUSE OF REPRESENTATIVES​
4547 H. F. No. 100​
4648 NINETY-THIRD SESSION​
4749 Authored by Stephenson; Hanson, J.; Hortman; Long; Gomez and others​01/05/2023​
4850 The bill was read for the first time and referred to the Committee on Commerce Finance and Policy​
4951 Adoption of Report: Amended and re-referred to the Committee on Judiciary Finance and Civil Law​01/17/2023​
5052 Adoption of Report: Amended and re-referred to the Committee on Environment and Natural Resources Finance and Policy​01/23/2023​
5153 Adoption of Report: Re-referred to the Committee on Labor and Industry Finance and Policy​01/25/2023​
5254 Adoption of Report: Amended and re-referred to the Committee on State and Local Government Finance and Policy​01/30/2023​
5355 Adoption of Report: Re-referred to the Committee on Agriculture Finance and Policy​02/01/2023​
5456 Adoption of Report: Amended and re-referred to the Committee on Workforce Development Finance and Policy​02/06/2023​
5557 Adoption of Report: Amended and re-referred to the Committee on Human Services Policy​02/09/2023​
5658 Adoption of Report: Amended and re-referred to the Committee on Education Finance​02/15/2023​
5759 Adoption of Report: Re-referred to the Committee on Health Finance and Policy​02/20/2023​
5860 Adoption of Report: Re-referred to the Committee on Public Safety Finance and Policy​02/27/2023​
5961 Adoption of Report: Amended and re-referred to the Committee on Economic Development Finance and Policy​03/06/2023​
6062 Adoption of Report: Re-referred to the Committee on Transportation Finance and Policy​03/09/2023​
6163 Adoption of Report: Re-referred to the Committee on Commerce Finance and Policy​03/15/2023​
6264 Adoption of Report: Amended and re-referred to the Committee on Taxes​03/27/2023​
6365 Adoption of Report: Amended and re-referred to the Committee on Ways and Means​04/04/2023​
64-Adoption of Report: Placed on the General Register as Amended and Read for the Second Time​04/19/2023​
65-Calendar for the Day, Amended; Read Third Time as Amended; Bill was laid on the Table as Amended​04/24/2023​
66-Bill was taken from the Table as Amended; Passed by the House and trasmitted to the Senate to include Floor Amendments​04/25/2023​
67-Returned to the House as Amended by the Senate, House refused to concur and a Conference Committee was appointed​05/01/2023​
68-Conference Committee Report Adopted; Read Third Time as Amended by Conference and Repassed​05/18/2023​ 2.1 subdivision 1; 256.01, subdivision 18c; 256B.0625, subdivision 13d; 256D.024,​
69-2.2 subdivisions 1, 3; 256J.26, subdivisions 1, 3; 270B.12, by adding a subdivision;​
70-2.3 270C.19, by adding a subdivision; 273.13, subdivision 24; 275.025, subdivision​
71-2.4 2; 290.0132, subdivision 29; 290.0134, subdivision 19; 297A.61, subdivision 3;​
72-2.5 297A.67, subdivisions 2, 7, by adding a subdivision; 297A.70, subdivisions 2, 4,​
73-2.6 18; 297A.85; 297D.01; 297D.04; 297D.06; 297D.07; 297D.08; 297D.085; 297D.09,​
74-2.7 subdivision 1a; 297D.10; 297D.11; 340A.402, subdivision 1; 340A.412, subdivision​
75-2.8 14; 360.0752, subdivision 2; 461.12, by adding a subdivision; 484.014, subdivision​
76-2.9 3; 504B.171, subdivision 1; 609.135, subdivision 1; 609.2111; 609.2112,​
77-2.10 subdivision 1; 609.2113, subdivisions 1, 2, 3; 609.2114, subdivisions 1, 2;​
78-2.11 609.5311, subdivision 1; 609.5314, subdivision 1; 609.5316, subdivision 2;​
79-2.12 609A.01; 609B.425, subdivision 2; 609B.435, subdivision 2; 624.712, by adding​
80-2.13 subdivisions; 624.713, subdivision 1; 624.714, subdivision 6; 624.7142, subdivision​
81-2.14 1; 624.7151; proposing coding for new law in Minnesota Statutes, chapters 3;​
82-2.15 116J; 116L; 120B; 144; 152; 169A; 270C; 289A; 295; 340A; 477A; 504B; 609A;​
83-2.16 624; proposing coding for new law as Minnesota Statutes, chapter 342; repealing​
84-2.17 Minnesota Statutes 2022, sections 151.72; 152.027, subdivisions 3, 4; 152.21;​
85-2.18 152.22, subdivisions 1, 2, 3, 4, 5, 5a, 5b, 6, 7, 8, 9, 10, 11, 12, 13, 14; 152.23;​
86-2.19 152.24; 152.25, subdivisions 1, 1a, 1b, 1c, 2, 3, 4; 152.26; 152.261; 152.27,​
87-2.20 subdivisions 1, 2, 3, 4, 5, 6, 7; 152.28, subdivisions 1, 2, 3; 152.29, subdivisions​
88-2.21 1, 2, 3, 3a, 4; 152.291; 152.30; 152.31; 152.32, subdivisions 1, 2, 3; 152.33,​
89-2.22 subdivisions 1, 1a, 2, 3, 4, 5, 6; 152.34; 152.35; 152.36, subdivisions 1, 1a, 2, 3,​
90-2.23 4, 5; 152.37.​
91-2.24BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:​
92-2.25 ARTICLE 1​
93-2.26 REGULATION OF ADULT-USE CANNABIS​
94-2.27 Section 1. [342.01] DEFINITIONS.​
95-2.28 Subdivision 1.Terms.For the purposes of this chapter, the following terms have the​
96-2.29meanings given them.​
97-2.30 Subd. 2.Adult-use cannabis concentrate."Adult-use cannabis concentrate" means​
98-2.31cannabis concentrate that is approved for sale by the office or is substantially similar to a​
99-2.32product approved by the office. Adult-use cannabis concentrate does not include any​
100-2.33artificially derived cannabinoid.​
101-2.34 Subd. 3.Adult-use cannabis flower."Adult-use cannabis flower" means cannabis​
102-2.35flower that is approved for sale by the office or is substantially similar to a product approved​
103-2.36by the office. Adult-use cannabis flower does not include medical cannabis flower, hemp​
104-2.37plant parts, or hemp-derived consumer products.​
105-2.38 Subd. 4.Adult-use cannabis product."Adult-use cannabis product" means a cannabis​
106-2.39product that is approved for sale by the office or is substantially similar to a product approved​
107-2.40by the office. Adult-use cannabis product includes edible cannabis products but does not​
108-2.41include medical cannabinoid products or lower-potency hemp edibles.​
66+Adoption of Report: Placed on the General Register as Amended​04/19/2023​
67+Read for the Second Time​
68+Calendar for the Day, Amended​04/24/2023​
69+Read Third Time as Amended​
70+Bill was laid on the Table as Amended​ 2.1 273.13, subdivision 24; 275.025, subdivision 2; 290.0132, subdivision 29; 290.0134,​
71+2.2 subdivision 19; 297A.61, subdivision 3; 297A.67, subdivisions 2, 7; 297A.70,​
72+2.3 subdivisions 2, 4, 18; 297A.85; 297D.01; 297D.04; 297D.06; 297D.07; 297D.08;​
73+2.4 297D.085; 297D.09, subdivision 1a; 297D.10; 297D.11; 340A.412, subdivision​
74+2.5 14; 484.014, subdivision 3; 504B.171, subdivision 1; 609.2112, subdivision 1;​
75+2.6 609.2113, subdivisions 1, 2, 3; 609.2114, subdivisions 1, 2; 609.5311, subdivision​
76+2.7 1; 609.5314, subdivision 1; 609.5316, subdivision 2; 609A.01; 609A.03,​
77+2.8 subdivisions 5, 9; 609B.425, subdivision 2; 609B.435, subdivision 2; 624.712, by​
78+2.9 adding subdivisions; 624.713, subdivision 1; 624.714, subdivision 6; 624.7142,​
79+2.10 subdivision 1; 624.7151; proposing coding for new law in Minnesota Statutes,​
80+2.11 chapters 3; 116J; 116L; 120B; 144; 152; 169A; 270C; 289A; 295; 340A; 504B;​
81+2.12 609A; 624; proposing coding for new law as Minnesota Statutes, chapter 342;​
82+2.13 repealing Minnesota Statutes 2022, sections 151.72; 152.027, subdivisions 3, 4;​
83+2.14 152.21; 152.22, subdivisions 1, 2, 3, 4, 5, 5a, 5b, 6, 7, 8, 9, 10, 11, 12, 13, 14;​
84+2.15 152.23; 152.24; 152.25, subdivisions 1, 1a, 1b, 1c, 2, 3, 4; 152.26; 152.261; 152.27,​
85+2.16 subdivisions 1, 2, 3, 4, 5, 6, 7; 152.28, subdivisions 1, 2, 3; 152.29, subdivisions​
86+2.17 1, 2, 3, 3a, 4; 152.30; 152.31; 152.32, subdivisions 1, 2, 3; 152.33, subdivisions​
87+2.18 1, 1a, 2, 3, 4, 5, 6; 152.34; 152.35; 152.36, subdivisions 1, 1a, 2, 3, 4, 5; 152.37.​
88+2.19BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:​
89+2.20 ARTICLE 1​
90+2.21 REGULATION OF ADULT-USE CANNABIS​
91+2.22 Section 1. [342.01] DEFINITIONS.​
92+2.23 Subdivision 1.Terms.For the purposes of this chapter, the following terms have the​
93+2.24meanings given them.​
94+2.25 Subd. 2.Adult-use cannabis concentrate."Adult-use cannabis concentrate" means​
95+2.26cannabis concentrate that is approved for sale by the office or is substantially similar to a​
96+2.27product approved by the office. Adult-use cannabis concentrate does not include any​
97+2.28artificially derived cannabinoid.​
98+2.29 Subd. 3.Adult-use cannabis flower."Adult-use cannabis flower" means cannabis​
99+2.30flower that is approved for sale by the office or is substantially similar to a product approved​
100+2.31by the office. Adult-use cannabis flower does not include medical cannabis flower.​
101+2.32 Subd. 4.Adult-use cannabis product."Adult-use cannabis product" means a cannabis​
102+2.33product that is approved for sale by the office or is substantially similar to a product approved​
103+2.34by the office. Adult-use cannabis product does not include medical cannabinoid product.​
104+2.35 Subd. 5.Advertisement."Advertisement" means any written or oral statement,​
105+2.36illustration, or depiction that is intended to promote sales of cannabis flower, cannabis​
106+2.37products, lower-potency hemp edibles, hemp-derived consumer products, or sales at a​
107+2.38specific cannabis business and includes any newspaper, radio, internet and electronic media,​
108+2.39or television promotion; the distribution of fliers and circulars; and the display of window​
109109 2​Article 1 Section 1.​
110-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 3.1 Subd. 5.Advertisement."Advertisement" means any written or oral statement,​
111-3.2illustration, or depiction that is intended to promote sales of cannabis flower, cannabis​
112-3.3products, lower-potency hemp edibles, hemp-derived consumer products, or sales at a​
113-3.4specific cannabis business or hemp business and includes any newspaper, radio, internet​
114-3.5and electronic media, or television promotion; the distribution of fliers and circulars; and​
115-3.6the display of window and interior signs in a cannabis business. Advertisement does not​
116-3.7include a fixed outdoor sign that meets the requirements in section 342.64, subdivision 2,​
117-3.8paragraph (b).​
118-3.9 Subd. 6.Artificially derived cannabinoid."Artificially derived cannabinoid" means a​
119-3.10cannabinoid extracted from a cannabis plant, cannabis flower, hemp plant, or hemp plant​
120-3.11parts with a chemical makeup that is changed after extraction to create a different cannabinoid​
121-3.12or other chemical compound by applying a catalyst other than heat or light. Artificially​
122-3.13derived cannabinoid includes but is not limited to any tetrahydrocannabinol created from​
123-3.14cannabidiol but does not include cannabis concentrate, cannabis products, hemp concentrate,​
124-3.15lower-potency hemp edibles, or hemp-derived consumer products.​
125-3.16 Subd. 7.Batch."Batch" means:​
126-3.17 (1) a specific quantity of cannabis plants that are cultivated from the same seed or plant​
127-3.18stock, are cultivated together, are intended to be harvested together, and receive an identical​
128-3.19propagation and cultivation treatment;​
129-3.20 (2) a specific quantity of cannabis flower that is harvested together; is uniform and​
130-3.21intended to meet specifications for identity, strength, purity, and composition; and receives​
131-3.22identical sorting, drying, curing, and storage treatment; or​
132-3.23 (3) a specific quantity of a specific cannabis product, lower-potency hemp edible,​
133-3.24artificially derived cannabinoid, hemp-derived consumer product, or hemp-derived topical​
134-3.25product that is manufactured at the same time and using the same methods, equipment, and​
135-3.26ingredients that is uniform and intended to meet specifications for identity, strength, purity,​
136-3.27and composition, and that is manufactured, packaged, and labeled according to a single​
137-3.28batch production record executed and documented.​
138-3.29 Subd. 8.Batch number."Batch number" means a unique numeric or alphanumeric​
139-3.30identifier assigned to a batch of cannabis plants, cannabis flower, cannabis products,​
140-3.31lower-potency hemp edibles, artificially derived cannabinoid, hemp-derived consumer​
141-3.32products, or hemp-derived topical products.​
142-3.33 Subd. 9.Bona fide labor organization."Bona fide labor organization" means a labor​
143-3.34union that represents or is actively seeking to represent cannabis workers.​
110+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 3.1and interior signs in a cannabis business. Advertisement does not include a fixed outdoor​
111+3.2sign that meets the requirements in section 342.64, subdivision 2, paragraph (b).​
112+3.3 Subd. 6.Artificially derived cannabinoid."Artificially derived cannabinoid" means a​
113+3.4cannabinoid extracted from a cannabis plant, cannabis flower, hemp plant, or hemp plant​
114+3.5parts with a chemical makeup that is changed after extraction to create a different cannabinoid​
115+3.6or other chemical compound by applying a catalyst other than heat or light. Artificially​
116+3.7derived cannabinoid includes but is not limited to any tetrahydrocannabinol created from​
117+3.8cannabidiol but does not include cannabis concentrate, cannabis products, hemp concentrate,​
118+3.9lower-potency hemp edibles, or hemp-derived consumer products.​
119+3.10 Subd. 7.Batch."Batch" means:​
120+3.11 (1) a specific quantity of cannabis plants that are cultivated from the same seed or plant​
121+3.12stock, are cultivated together, are intended to be harvested together, and receive an identical​
122+3.13propagation and cultivation treatment;​
123+3.14 (2) a specific quantity of cannabis flower that is harvested together; is uniform and​
124+3.15intended to meet specifications for identity, strength, purity, and composition; and receives​
125+3.16identical sorting, drying, curing, and storage treatment; or​
126+3.17 (3) a specific quantity of a specific cannabis product, lower-potency hemp edible,​
127+3.18artificially derived cannabinoid, hemp-derived consumer product, or hemp-derived topical​
128+3.19product that is manufactured at the same time and using the same methods, equipment, and​
129+3.20ingredients that is uniform and intended to meet specifications for identity, strength, purity,​
130+3.21and composition, and that is manufactured, packaged, and labeled according to a single​
131+3.22batch production record executed and documented during the same cycle of manufacture​
132+3.23and produced by a continuous process.​
133+3.24 Subd. 8.Batch number."Batch number" means a unique numeric or alphanumeric​
134+3.25identifier assigned to a batch of cannabis plants, cannabis flower, cannabis products,​
135+3.26lower-potency hemp edibles, artificially derived cannabinoid, hemp-derived consumer​
136+3.27products, or hemp-derived topical products.​
137+3.28 Subd. 9.Bona fide labor organization."Bona fide labor organization" means a labor​
138+3.29union that represents or is actively seeking to represent cannabis workers.​
139+3.30 Subd. 10.Cannabinoid."Cannabinoid" means any of the chemical constituents of hemp​
140+3.31plants or cannabis plants that are naturally occurring, biologically active, and act on the​
141+3.32cannabinoid receptors of the brain. Cannabinoid includes but is not limited to​
142+3.33tetrahydrocannabinol and cannabidiol.​
144143 3​Article 1 Section 1.​
145-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 4.1 Subd. 10.Cannabinoid."Cannabinoid" means any of the chemical constituents of hemp​
146-4.2plants or cannabis plants that are naturally occurring, biologically active, and act on the​
147-4.3cannabinoid receptors of the brain. Cannabinoid includes but is not limited to​
148-4.4tetrahydrocannabinol and cannabidiol.​
149-4.5 Subd. 11.Cannabinoid extraction."Cannabinoid extraction" means the process of​
150-4.6extracting cannabis concentrate from cannabis plants or cannabis flower using heat, pressure,​
151-4.7water, lipids, gases, solvents, or other chemicals or chemical processes, but does not include​
152-4.8the process of extracting concentrate from hemp plants or hemp plant parts or the process​
153-4.9of creating any artificially derived cannabinoid.​
154-4.10 Subd. 12.Cannabinoid product."Cannabinoid product" means a cannabis product, a​
155-4.11hemp-derived consumer product, or a lower-potency hemp edible.​
156-4.12 Subd. 13.Cannabinoid profile."Cannabinoid profile" means the amounts of each​
157-4.13cannabinoid that the office requires to be identified in testing and labeling, including but​
158-4.14not limited to delta-9 tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, and​
159-4.15cannabidiolic acid in cannabis flower, a cannabis product, a batch of artificially derived​
160-4.16cannabinoid, a lower-potency hemp edible, a hemp-derived consumer product, or a​
161-4.17hemp-derived topical product expressed as percentages measured by weight and, in the case​
162-4.18of cannabis products, lower-potency hemp edibles, and hemp-derived consumer products,​
163-4.19expressed as milligrams in each serving and package.​
164-4.20 Subd. 14.Cannabis business."Cannabis business" means any of the following licensed​
165-4.21under this chapter:​
166-4.22 (1) cannabis microbusiness;​
167-4.23 (2) cannabis mezzobusiness;​
168-4.24 (3) cannabis cultivator;​
169-4.25 (4) cannabis manufacturer;​
170-4.26 (5) cannabis retailer;​
171-4.27 (6) cannabis wholesaler;​
172-4.28 (7) cannabis transporter;​
173-4.29 (8) cannabis testing facility;​
174-4.30 (9) cannabis event organizer;​
175-4.31 (10) cannabis delivery service;​
144+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 4.1 Subd. 11.Cannabinoid extraction."Cannabinoid extraction" means the process of​
145+4.2extracting cannabis concentrate from cannabis plants or cannabis flower using heat, pressure,​
146+4.3water, lipids, gases, solvents, or other chemicals or chemical processes, but does not include​
147+4.4the process of extracting concentrate from hemp plants or hemp plant parts or the process​
148+4.5of creating any artificially derived cannabinoid.​
149+4.6 Subd. 12.Cannabinoid profile."Cannabinoid profile" means the amounts of each​
150+4.7cannabinoid that the office requires to be identified in testing and labeling, including but​
151+4.8not limited to delta-9 tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol,​
152+4.9cannabidiolic acid, and cannabigerol in cannabis flower, a cannabis product, a batch of​
153+4.10artificially derived cannabinoid, a lower-potency hemp edible, a hemp-derived consumer​
154+4.11product, or a hemp-derived topical product expressed as percentages measured by weight​
155+4.12and, in the case of cannabis products, lower-potency hemp edibles, and hemp-derived​
156+4.13consumer products, expressed as milligrams in each serving and package.​
157+4.14 Subd. 13.Cannabis business."Cannabis business" means any of the following licensed​
158+4.15under this chapter:​
159+4.16 (1) cannabis microbusiness;​
160+4.17 (2) cannabis mezzobusiness;​
161+4.18 (3) cannabis cultivator;​
162+4.19 (4) cannabis manufacturer;​
163+4.20 (5) cannabis retailer;​
164+4.21 (6) cannabis wholesaler;​
165+4.22 (7) cannabis transporter;​
166+4.23 (8) cannabis testing facility;​
167+4.24 (9) cannabis event organizer;​
168+4.25 (10) cannabis delivery service;​
169+4.26 (11) medical cannabis cultivator;​
170+4.27 (12) medical cannabis processor; and​
171+4.28 (13) medical cannabis retailer.​
172+4.29 Subd. 14.Cannabis concentrate.(a) "Cannabis concentrate" means:​
173+4.30 (1) the extracts and resins of a cannabis plant or cannabis flower;​
176174 4​Article 1 Section 1.​
177-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 5.1 (11) medical cannabis cultivator;​
178-5.2 (12) medical cannabis processor;​
179-5.3 (13) medical cannabis retailer; and​
180-5.4 (14) medical cannabis combination business.​
181-5.5 Subd. 15.Cannabis concentrate.(a) "Cannabis concentrate" means:​
182-5.6 (1) the extracts and resins of a cannabis plant or cannabis flower;​
183-5.7 (2) the extracts or resins of a cannabis plant or cannabis flower that are refined to increase​
184-5.8the presence of targeted cannabinoids; or​
185-5.9 (3) a product that is produced by refining extracts or resins of a cannabis plant or cannabis​
186-5.10flower and is intended to be consumed by combustion or vaporization of the product and​
187-5.11inhalation of smoke, aerosol, or vapor from the product.​
188-5.12 (b) Cannabis concentrate does not include hemp concentrate, artificially derived​
189-5.13cannabinoid, or hemp-derived consumer products.​
190-5.14 Subd. 16.Cannabis flower."Cannabis flower" means the harvested flower, bud, leaves,​
191-5.15and stems of a cannabis plant. Cannabis flower includes adult-use cannabis flower and​
192-5.16medical cannabis flower. Cannabis flower does not include cannabis seed, hemp plant parts,​
193-5.17or hemp-derived consumer products.​
194-5.18 Subd. 17.Cannabis industry."Cannabis industry" means every item, product, person,​
195-5.19process, action, business, or other thing related to cannabis flower and cannabis products​
196-5.20and subject to regulation under this chapter.​
197-5.21 Subd. 18.Cannabis paraphernalia."Cannabis paraphernalia" means all equipment,​
198-5.22products, and materials of any kind that are knowingly or intentionally used primarily in:​
199-5.23 (1) manufacturing cannabis products;​
200-5.24 (2) ingesting, inhaling, or otherwise introducing cannabis flower or cannabis products​
201-5.25into the human body; and​
202-5.26 (3) testing the strength, effectiveness, or purity of cannabis flower, cannabis products,​
203-5.27lower-potency hemp edibles, or hemp-derived consumer products.​
204-5.28 Subd. 19.Cannabis plant."Cannabis plant" means all parts of the plant of the genus​
205-5.29Cannabis that is growing or has not been harvested and has a delta-9 tetrahydrocannabinol​
206-5.30concentration of more than 0.3 percent on a dry weight basis.​
207-5.31 Subd. 20.Cannabis product.(a) "Cannabis product" means any of the following:​
175+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 5.1 (2) the extracts or resins of a cannabis plant or cannabis flower that are refined to increase​
176+5.2the presence of targeted cannabinoids; or​
177+5.3 (3) a product that is produced by refining extracts or resins of a cannabis plant or cannabis​
178+5.4flower and is intended to be consumed by combustion or vaporization of the product and​
179+5.5inhalation of smoke, aerosol, or vapor from the product.​
180+5.6 (b) Cannabis concentrate does not include hemp concentrate, artificially derived​
181+5.7cannabinoid, or hemp-derived consumer products.​
182+5.8 Subd. 15.Cannabis flower."Cannabis flower" means the harvested flower, bud, leaves,​
183+5.9and stems of a cannabis plant. Cannabis flower includes adult-use cannabis flower and​
184+5.10medical cannabis flower. Cannabis flower does not include cannabis seed, hemp plant parts,​
185+5.11or hemp-derived consumer products.​
186+5.12 Subd. 16.Cannabis industry."Cannabis industry" means every item, product, person,​
187+5.13process, action, business, or other thing related to cannabis flower and cannabis products​
188+5.14and subject to regulation under this chapter.​
189+5.15 Subd. 17.Cannabis paraphernalia."Cannabis paraphernalia" means all equipment,​
190+5.16products, and materials of any kind that are knowingly or intentionally used primarily in:​
191+5.17 (1) cultivating or harvesting cannabis plants or cannabis flower;​
192+5.18 (2) manufacturing cannabis products;​
193+5.19 (3) ingesting, inhaling, or otherwise introducing cannabis flower or cannabis products​
194+5.20into the human body; and​
195+5.21 (4) testing the strength, effectiveness, or purity of cannabis flower, cannabis products,​
196+5.22lower-potency hemp edibles, or hemp-derived consumer products.​
197+5.23 Subd. 18.Cannabis plant."Cannabis plant" means all parts of the plant of the genus​
198+5.24Cannabis that is growing or has not been harvested and has a delta-9 tetrahydrocannabinol​
199+5.25concentration of more than 0.3 percent on a dry weight basis.​
200+5.26 Subd. 19.Cannabis product.(a) "Cannabis product" means any of the following:​
201+5.27 (1) cannabis concentrate;​
202+5.28 (2) a product infused with cannabinoids, including but not limited to tetrahydrocannabinol,​
203+5.29extracted or derived from cannabis plants or cannabis flower; or​
204+5.30 (3) any other product that contains cannabis concentrate.​
208205 5​Article 1 Section 1.​
209-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 6.1 (1) cannabis concentrate;​
210-6.2 (2) a product infused with cannabinoids, including but not limited to tetrahydrocannabinol,​
211-6.3extracted or derived from cannabis plants or cannabis flower; or​
212-6.4 (3) any other product that contains cannabis concentrate.​
213-6.5 (b) Cannabis product includes adult-use cannabis products, including but not limited to​
214-6.6edible cannabis products and medical cannabinoid products. Cannabis product does not​
215-6.7include cannabis flower, artificially derived cannabinoid, lower-potency hemp edibles,​
216-6.8hemp-derived consumer products, or hemp-derived topical products.​
217-6.9 Subd. 21.Cannabis prohibition."Cannabis prohibition" means the system of state and​
218-6.10federal laws that prevented establishment of a legal market and instead established petty​
219-6.11offenses and criminal offenses punishable by fines, imprisonment, or both for the cultivation,​
220-6.12possession, and sale of all parts of the plant of any species of the genus Cannabis, including​
221-6.13all agronomical varieties, whether growing or not; the seeds thereof; the resin extracted​
222-6.14from any part of such plant; and every compound, manufacture, salt, derivative, mixture,​
223-6.15or preparation of such plant, its seeds, or resin.​
224-6.16 Subd. 22.Cannabis seed."Cannabis seed" means the viable seed of the plant of the​
225-6.17genus Cannabis that is reasonably expected to grow into a cannabis plant. Cannabis seed​
226-6.18does not include hemp seed.​
227-6.19 Subd. 23.Cannabis worker."Cannabis worker" means any individual employed by a​
228-6.20cannabis business and any individual who is a contractor of a cannabis business whose​
229-6.21scope of work involves the handling of cannabis plants, cannabis flower, or cannabis​
230-6.22products.​
231-6.23 Subd. 24.Child-resistant."Child-resistant" means packaging that meets the poison​
232-6.24prevention packaging standards in Code of Federal Regulations, title 16, section 1700.15.​
233-6.25 Subd. 25.Cooperative."Cooperative" means an association conducting business on a​
234-6.26cooperative plan that is organized or is subject to chapter 308A or 308B.​
235-6.27 Subd. 26.Council."Council" means the Cannabis Advisory Council.​
236-6.28 Subd. 27.Cultivation."Cultivation" means any activity involving the planting, growing,​
237-6.29harvesting, drying, curing, grading, or trimming of cannabis plants, cannabis flower, hemp​
238-6.30plants, or hemp plant parts.​
206+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 6.1 (b) Cannabis product includes adult-use cannabis products, including but not limited to​
207+6.2edible cannabis products and medical cannabinoid products. Cannabis product does not​
208+6.3include cannabis flower, artificially derived cannabinoid, lower-potency edible hemp edibles,​
209+6.4hemp-derived consumer products, or hemp-derived topical products.​
210+6.5 Subd. 20.Cannabis prohibition."Cannabis prohibition" means the system of state and​
211+6.6federal laws that prevented establishment of a legal market and instead established petty​
212+6.7offenses and criminal offenses punishable by fines, imprisonment, or both for the cultivation,​
213+6.8possession, and sale of all parts of the plant of any species of the genus Cannabis, including​
214+6.9all agronomical varieties, whether growing or not; the seeds thereof; the resin extracted​
215+6.10from any part of such plant; and every compound, manufacture, salt, derivative, mixture,​
216+6.11or preparation of such plant, its seeds, or resin.​
217+6.12 Subd. 21.Cannabis seed."Cannabis seed" means the viable seed of the plant of the​
218+6.13genus Cannabis that is reasonably expected to grow into a cannabis plant. Cannabis seed​
219+6.14does not include hemp seed.​
220+6.15 Subd. 22.Cannabis worker."Cannabis worker" means any individual employed by a​
221+6.16cannabis business and any individual who is a contractor of a cannabis business whose​
222+6.17scope of work involves the handling of cannabis plants, cannabis flower, or cannabis​
223+6.18products.​
224+6.19 Subd. 23.Child-resistant."Child-resistant" means packaging that meets the poison​
225+6.20prevention packaging standards in Code of Federal Regulations, title 16, section 1700.15.​
226+6.21 Subd. 24.Cooperative."Cooperative" means an association conducting business on a​
227+6.22cooperative plan that is organized or is subject to chapter 308A or 308B.​
228+6.23 Subd. 25.Council."Council" means the Cannabis Advisory Council.​
229+6.24 Subd. 26.Cultivation."Cultivation" means any activity involving the planting, growing,​
230+6.25harvesting, drying, curing, grading, or trimming of cannabis plants, cannabis flower, hemp​
231+6.26plants, or hemp plant parts.​
232+6.27 Subd. 27.Division of Medical Cannabis."Division of Medical Cannabis" means a​
233+6.28division housed in the Office of Cannabis Management that operates the medical cannabis​
234+6.29program.​
235+6.30 Subd. 28.Division of Social Equity"Division of Social Equity" means a division housed​
236+6.31in the Office of Cannabis Management that promotes development, stability, and safety in​
237+6.32communities that have experienced a disproportionate, negative impact from cannabis​
238+6.33prohibition.​
239239 6​Article 1 Section 1.​
240-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 7.1 Subd. 28.Division of Medical Cannabis."Division of Medical Cannabis" means a​
241-7.2division housed in the Office of Cannabis Management that operates the medical cannabis​
242-7.3program.​
243-7.4 Subd. 29.Division of Social Equity"Division of Social Equity" means a division housed​
244-7.5in the Office of Cannabis Management that promotes development, stability, and safety in​
245-7.6communities that have experienced a disproportionate, negative impact from cannabis​
246-7.7prohibition and usage.​
247-7.8 Subd. 30.Drug."Drug" has the meaning given in section 151.01, subdivision 5.​
248-7.9 Subd. 31.Edible cannabis product."Edible cannabis product" means any product that​
249-7.10is intended to be eaten or consumed as a beverage by humans; contains a cannabinoid other​
250-7.11than an artificially derived cannabinoid in combination with food ingredients; is not a drug;​
251-7.12and is a type of product approved for sale by the office, or is substantially similar to a product​
252-7.13approved by the office including but not limited to products that resemble nonalcoholic​
253-7.14beverages, candy, and baked goods. Edible cannabis product does not include lower-potency​
254-7.15hemp edibles.​
255-7.16 Subd. 32.Health care practitioner."Health care practitioner" means a​
256-7.17Minnesota-licensed doctor of medicine, a Minnesota-licensed physician assistant acting​
257-7.18within the scope of authorized practice, or a Minnesota-licensed advanced practice registered​
258-7.19nurse who has an active license in good standing and the primary responsibility for the care​
259-7.20and treatment of the qualifying medical condition of an individual diagnosed with a qualifying​
260-7.21medical condition.​
261-7.22 Subd. 33.Health record."Health record" has the meaning given in section 144.291,​
262-7.23subdivision 2.​
263-7.24 Subd. 34.Hemp business.(a) "Hemp business" means either of the following licensed​
264-7.25under this chapter:​
265-7.26 (1) lower-potency hemp edible manufacturer; or​
266-7.27 (2) lower-potency hemp edible retailer.​
267-7.28 (b) Hemp business does not include a person or entity licensed under chapter 18K to​
268-7.29grow industrial hemp for commercial or research purposes or to process industrial hemp​
269-7.30for commercial purposes.​
270-7.31 Subd. 35.Hemp concentrate.(a) "Hemp concentrate" means:​
271-7.32 (1) the extracts and resins of a hemp plant or hemp plant parts;​
240+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 7.1 Subd. 29.Edible cannabis product."Edible cannabis product" means any product that​
241+7.2is intended to be eaten or consumed as a beverage by humans; contains a cannabinoid other​
242+7.3than an artificially derived cannabinoid in combination with food ingredients; is not a drug;​
243+7.4and is a type of product approved for sale by the office, or is substantially similar to a product​
244+7.5approved by the office including but not limited to products that resemble nonalcoholic​
245+7.6beverages, candy, and baked goods. Edible cannabis product does not include lower-potency​
246+7.7hemp edibles.​
247+7.8 Subd. 30.Health care practitioner."Health care practitioner" means a​
248+7.9Minnesota-licensed doctor of medicine, a Minnesota-licensed physician assistant acting​
249+7.10within the scope of authorized practice, or a Minnesota-licensed advanced practice registered​
250+7.11nurse who has an active license in good standing and the primary responsibility for the care​
251+7.12and treatment of the qualifying medical condition of an individual diagnosed with a qualifying​
252+7.13medical condition.​
253+7.14 Subd. 31.Health record."Health record" has the meaning given in section 144.291,​
254+7.15subdivision 2.​
255+7.16 Subd. 32.Hemp business.(a) "Hemp business" means either of the following licensed​
256+7.17under this chapter:​
257+7.18 (1) lower-potency hemp edible manufacturer; or​
258+7.19 (2) lower-potency hemp edible retailer.​
259+7.20 (b) Hemp business does not include a person or entity licensed under chapter 18K to​
260+7.21grow industrial hemp for commercial or research purposes or to process industrial hemp​
261+7.22for commercial purposes.​
262+7.23 Subd. 33.Hemp concentrate.(a) "Hemp concentrate" means:​
263+7.24 (1) the extracts and resins of a hemp plant or hemp plant parts;​
264+7.25 (2) the extracts or resins of a hemp plant or hemp plant parts that are refined to increase​
265+7.26the presence of targeted cannabinoids; or​
266+7.27 (3) a product that is produced by refining extracts or resins of a hemp plant or hemp​
267+7.28plant parts and is intended to be consumed by combustion or vaporization of the product​
268+7.29and inhalation of smoke, aerosol, or vapor from the product.​
269+7.30 (b) Hemp concentrate does not include artificially derived cannabinoids, lower-potency​
270+7.31hemp edibles, hemp-derived consumer products, or hemp-derived topical products.​
272271 7​Article 1 Section 1.​
273-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 8.1 (2) the extracts or resins of a hemp plant or hemp plant parts that are refined to increase​
274-8.2the presence of targeted cannabinoids; or​
275-8.3 (3) a product that is produced by refining extracts or resins of a hemp plant or hemp​
276-8.4plant parts and is intended to be consumed by combustion or vaporization of the product​
277-8.5and inhalation of smoke, aerosol, or vapor from the product.​
278-8.6 (b) Hemp concentrate does not include artificially derived cannabinoids, lower-potency​
279-8.7hemp edibles, hemp-derived consumer products, or hemp-derived topical products.​
280-8.8 Subd. 36.Hemp consumer industry."Hemp consumer industry" means every item,​
281-8.9product, person, process, action, business, or other thing related to artificially derived​
282-8.10cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products and​
283-8.11subject to regulation under this chapter.​
284-8.12 Subd. 37.Hemp-derived consumer product.(a) "Hemp-derived consumer product"​
285-8.13means a product intended for human or animal consumption, does not contain cannabis​
286-8.14flower or cannabis concentrate, and:​
287-8.15 (1) contains or consists of hemp plant parts; or​
288-8.16 (2) contains hemp concentrate or artificially derived cannabinoids in combination with​
289-8.17other ingredients.​
290-8.18 (b) Hemp-derived consumer product does not include artificially derived cannabinoids,​
291-8.19lower-potency hemp edibles, hemp-derived topical products, hemp fiber products, or hemp​
292-8.20grain.​
293-8.21 Subd. 38.Hemp-derived topical product."Hemp-derived topical product" means a​
294-8.22product intended for human or animal consumption that contains hemp concentrate, is​
295-8.23intended for application externally to a part of the body of a human or animal, and does not​
296-8.24contain cannabis flower or cannabis concentrate.​
297-8.25 Subd. 39.Hemp fiber product."Hemp fiber product" means an intermediate or finished​
298-8.26product made from the fiber of hemp plant parts that is not intended for human or animal​
299-8.27consumption. Hemp fiber product includes but is not limited to cordage, paper, fuel, textiles,​
300-8.28bedding, insulation, construction materials, compost materials, and industrial materials.​
301-8.29 Subd. 40.Hemp grain."Hemp grain" means the harvested seeds of the hemp plant​
302-8.30intended for consumption as a food or part of a food product. Hemp grain includes oils​
303-8.31pressed or extracted from harvested hemp seeds.​
272+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 8.1 Subd. 34.Hemp consumer industry."Hemp consumer industry" means every item,​
273+8.2product, person, process, action, business, or other thing related to artificially derived​
274+8.3cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products and​
275+8.4subject to regulation under this chapter.​
276+8.5 Subd. 35.Hemp-derived consumer product.(a) "Hemp-derived consumer product"​
277+8.6means a product intended for human or animal consumption, does not contain cannabis​
278+8.7flower or cannabis concentrate, and:​
279+8.8 (1) contains or consists of hemp plant parts; or​
280+8.9 (2) contains hemp concentrate or artificially derived cannabinoids in combination with​
281+8.10other ingredients.​
282+8.11 (b) Hemp-derived consumer product does not include artificially derived cannabinoids,​
283+8.12lower-potency hemp edibles, hemp-derived topical products, hemp fiber products, or hemp​
284+8.13grain.​
285+8.14 Subd. 36.Hemp-derived topical product."Hemp-derived topical product" means a​
286+8.15product intended for human or animal consumption that contains hemp concentrate, is​
287+8.16intended for application externally to a part of the body of a human or animal, and does not​
288+8.17contain cannabis flower or cannabis concentrate.​
289+8.18 Subd. 37.Hemp fiber product."Hemp fiber product" means an intermediate or finished​
290+8.19product made from the fiber of hemp plant parts that is not intended for human or animal​
291+8.20consumption. Hemp fiber product includes but is not limited to cordage, paper, fuel, textiles,​
292+8.21bedding, insulation, construction materials, compost materials, and industrial materials.​
293+8.22 Subd. 38.Hemp grain."Hemp grain" means the harvested seeds of the hemp plant​
294+8.23intended for consumption as a food or part of a food product. Hemp grain includes oils​
295+8.24pressed or extracted from harvested hemp seeds.​
296+8.25 Subd. 39.Hemp plant."Hemp plant" means all parts of the plant of the genus Cannabis​
297+8.26that is growing or has not been harvested and has a delta-9 tetrahydrocannabinol​
298+8.27concentration of no more than 0.3 percent on a dry weight basis.​
299+8.28 Subd. 40.Hemp plant parts."Hemp plant parts" means any part of the harvested hemp​
300+8.29plant, including the flower, bud, leaves, stems, and stalk, but does not include derivatives,​
301+8.30extracts, cannabinoids, isomers, acids, salts, and salts of isomers that are separated from​
302+8.31the plant. Hemp plant parts does not include hemp fiber products, hemp grain, or hemp​
303+8.32seed.​
304304 8​Article 1 Section 1.​
305-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 9.1 Subd. 41.Hemp plant."Hemp plant" means all parts of the plant of the genus Cannabis​
306-9.2that is growing or has not been harvested and has a delta-9 tetrahydrocannabinol​
307-9.3concentration of no more than 0.3 percent on a dry weight basis.​
308-9.4 Subd. 42.Hemp plant parts."Hemp plant parts" means any part of the harvested hemp​
309-9.5plant, including the flower, bud, leaves, stems, and stalk, but does not include derivatives,​
310-9.6extracts, cannabinoids, isomers, acids, salts, and salts of isomers that are separated from​
311-9.7the plant. Hemp plant parts does not include hemp fiber products, hemp grain, or hemp​
312-9.8seed.​
313-9.9 Subd. 43.Hemp seed."Hemp seed" means the viable seed of the plant of the genus​
314-9.10Cannabis that is intended to be planted and is reasonably expected to grow into a hemp​
315-9.11plant. Hemp seed does not include cannabis seed or hemp grain.​
316-9.12 Subd. 44.Hemp worker."Hemp worker" means any individual employed by a hemp​
317-9.13business and any individual who is a contractor of a hemp business whose scope of work​
318-9.14involves the handling of artificially derived cannabinoids, hemp concentrate, lower-potency​
319-9.15hemp edibles, or hemp-derived consumer products.​
320-9.16 Subd. 45.Industrial hemp."Industrial hemp" has the meaning given in section 18K.02,​
321-9.17subdivision 3.​
322-9.18 Subd. 46.Intoxicating cannabinoid."Intoxicating cannabinoid" means a cannabinoid,​
323-9.19including an artificially derived cannabinoid, that when introduced into the human body​
324-9.20impairs the central nervous system or impairs the human audio, visual, or mental processes.​
325-9.21Intoxicating cannabinoid includes but is not limited to any tetrahydrocannabinol.​
326-9.22 Subd. 47.Labor peace agreement."Labor peace agreement" means an agreement​
327-9.23between a cannabis business and a bona fide labor organization that protects the state's​
328-9.24interests by, at minimum, prohibiting the labor organization from engaging in picketing,​
329-9.25work stoppages, or boycotts against the cannabis business.​
330-9.26 Subd. 48.License holder."License holder" means a person, cooperative, or business​
331-9.27that holds any of the following licenses:​
332-9.28 (1) cannabis microbusiness;​
333-9.29 (2) cannabis mezzobusiness;​
334-9.30 (3) cannabis cultivator;​
335-9.31 (4) cannabis manufacturer;​
336-9.32 (5) cannabis retailer;​
305+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 9.1 Subd. 41.Hemp seed."Hemp seed" means the viable seed of the plant of the genus​
306+9.2Cannabis that is intended to be planted and is reasonably expected to grow into a hemp​
307+9.3plant. Hemp seed does not include cannabis seed or hemp grain.​
308+9.4 Subd. 42.Hemp worker."Hemp worker" means any individual employed by a hemp​
309+9.5business and any individual who is a contractor of a hemp business whose scope of work​
310+9.6involves the handling of artificially derived cannabinoids, lower-potency hemp edibles, or​
311+9.7hemp-derived consumer products.​
312+9.8 Subd. 43.Industrial hemp."Industrial hemp" has the meaning given in section 18K.02,​
313+9.9subdivision 3.​
314+9.10 Subd. 44.Intoxicating cannabinoid."Intoxicating cannabinoid" means a cannabinoid,​
315+9.11including an artificially derived cannabinoid, that when introduced into the human body​
316+9.12impairs the central nervous system or impairs the human audio, visual, or mental processes.​
317+9.13Intoxicating cannabinoid includes but is not limited to any tetrahydrocannabinol.​
318+9.14 Subd. 45.Labor peace agreement."Labor peace agreement" means an agreement​
319+9.15between a cannabis business and a bona fide labor organization that protects the state's​
320+9.16interests by, at minimum, prohibiting the labor organization from engaging in picketing,​
321+9.17work stoppages, or boycotts against the cannabis business. This type of agreement shall not​
322+9.18mandate a particular method of election or certification of the bona fide labor organization.​
323+9.19 Subd. 46.License holder."License holder" means a person, cooperative, or business​
324+9.20that holds any of the following licenses:​
325+9.21 (1) cannabis microbusiness;​
326+9.22 (2) cannabis mezzobusiness;​
327+9.23 (3) cannabis cultivator;​
328+9.24 (4) cannabis manufacturer;​
329+9.25 (5) cannabis retailer;​
330+9.26 (6) cannabis wholesaler;​
331+9.27 (7) cannabis transporter;​
332+9.28 (8) cannabis testing facility;​
333+9.29 (9) cannabis event organizer;​
334+9.30 (10) cannabis delivery service;​
335+9.31 (11) lower-potency hemp edible manufacturer;​
337336 9​Article 1 Section 1.​
338-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 10.1 (6) cannabis wholesaler;​
339-10.2 (7) cannabis transporter;​
340-10.3 (8) cannabis testing facility;​
341-10.4 (9) cannabis event organizer;​
342-10.5 (10) cannabis delivery service;​
343-10.6 (11) lower-potency hemp edible manufacturer;​
344-10.7 (12) lower-potency hemp edible retailer;​
345-10.8 (13) medical cannabis cultivator;​
346-10.9 (14) medical cannabis processor;​
347-10.10 (15) medical cannabis retailer; or​
348-10.11 (16) medical cannabis combination business.​
349-10.12 Subd. 49.Local unit of government."Local unit of government" means a home rule​
350-10.13charter or statutory city, county, town, or other political subdivision.​
351-10.14 Subd. 50.Lower-potency hemp edible."Lower-potency hemp edible" means any​
352-10.15product that:​
353-10.16 (1) is intended to be eaten or consumed as a beverage by humans;​
354-10.17 (2) contains hemp concentrate or an artificially derived cannabinoid, in combination​
355-10.18with food ingredients;​
356-10.19 (3) is not a drug;​
357-10.20 (4) consists of servings that contain no more than five milligrams of delta-9​
358-10.21tetrahydrocannabinol, 25 milligrams of cannabidiol, 25 milligrams of cannabigerol, or any​
359-10.22combination of those cannabinoids that does not exceed the identified amounts;​
360-10.23 (5) does not contain more than a combined total of 0.5 milligrams of all other​
361-10.24cannabinoids per serving;​
362-10.25 (6) does not contain an artificially derived cannabinoid other than delta-9​
363-10.26tetrahydrocannabinol;​
364-10.27 (7) does not contain a cannabinoid derived from cannabis plants or cannabis flower; and​
337+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 10.1 (12) lower-potency hemp edible retailer;​
338+10.2 (13) medical cannabis cultivator;​
339+10.3 (14) medical cannabis processor; or​
340+10.4 (15) medical cannabis retailer.​
341+10.5 Subd. 47.Local unit of government."Local unit of government" means a home rule​
342+10.6charter or statutory city, county, town, or other political subdivision.​
343+10.7 Subd. 48.Lower-potency hemp edible."Lower-potency hemp edible" means any​
344+10.8product that:​
345+10.9 (1) is intended to be eaten or consumed as a beverage by humans;​
346+10.10 (2) contains hemp concentrate or an artificially derived cannabinoid, in combination​
347+10.11with food ingredients;​
348+10.12 (3) is not a drug;​
349+10.13 (4) consists of servings that contain no more than five milligrams of delta-9​
350+10.14tetrahydrocannabinol, 25 milligrams of cannabidiol, 25 milligrams of cannabigerol, or any​
351+10.15combination of those cannabinoids that does not exceed the identified amounts;​
352+10.16 (5) does not contain more than a combined total of 0.5 milligrams of all other​
353+10.17cannabinoids per serving;​
354+10.18 (6) does not contain an artificially derived cannabinoid other than delta-9​
355+10.19tetrahydrocannabinol;​
356+10.20 (7) does not contain a cannabinoid derived from cannabis plants or cannabis flower; and​
357+10.21 (8) is a type of product approved for sale by the office or is substantially similar to a​
358+10.22product approved by the office, including but not limited to products that resemble​
359+10.23nonalcoholic beverages, candy, and baked goods.​
360+10.24 Subd. 49.Matrix barcode."Matrix barcode" means a code that stores data in a​
361+10.25two-dimensional array of geometrically shaped dark and light cells capable of being read​
362+10.26by the camera on a smartphone or other mobile device.​
363+10.27 Subd. 50.Medical cannabinoid product.(a) "Medical cannabinoid product" means a​
364+10.28product that:​
365+10.29 (1) consists of or contains cannabis concentrate or hemp concentrate or is infused with​
366+10.30cannabinoids, including but not limited to artificially derived cannabinoids; and​
365367 10​Article 1 Section 1.​
366-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 11.1 (8) is a type of product approved for sale by the office or is substantially similar to a​
367-11.2product approved by the office, including but not limited to products that resemble
368-11.3nonalcoholic beverages, candy, and baked goods.
369-11.4 Subd. 51.Matrix barcode."Matrix barcode" means a code that stores data in a
370-11.5two-dimensional array of geometrically shaped dark and light cells capable of being read
371-11.6by the camera on a smartphone or other mobile device.
372-11.7 Subd. 52.Medical cannabinoid product.(a) "Medical cannabinoid product" means a
373-11.8product that:
374-11.9 (1) consists of or contains cannabis concentrate or hemp concentrate or is infused with
375-11.10cannabinoids, including but not limited to artificially derived cannabinoids; and​
376-11.11 (2) is provided to a patient enrolled in the registry program; a registered designated
377-11.12caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a cannabis retailer
378-11.13or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical
379-11.14condition.​
380-11.15 (b) A medical cannabinoid product must be in the form of:
381-11.16 (1) liquid, including but not limited to oil;
382-11.17 (2) pill;
383-11.18 (3) liquid or oil for use with a vaporized delivery method;​
384-11.19 (4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;
385-11.20 (5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and​
386-11.21sublingual tablets;
387-11.22 (6) edible products in the form of gummies and chews;​
388-11.23 (7) topical formulation; or​
389-11.24 (8) any allowable form or delivery method approved by the office.​
390-11.25 (c) Medical cannabinoid product does not include adult-use cannabis products or
391-11.26hemp-derived consumer products.​
392-11.27 Subd. 53.Medical cannabis business."Medical cannabis business" means an entity
393-11.28licensed under this chapter to engage in one or more of the following:
394-11.29 (1) the cultivation of cannabis plants for medical cannabis flower;
395-11.30 (2) the manufacture of medical cannabinoid products; and
368+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 11.1 (2) is provided to a patient enrolled in the registry program; a registered designated
369+11.2caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a cannabis retailer
370+11.3or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical
371+11.4condition.​
372+11.5 (b) A medical cannabinoid product must be in the form of:
373+11.6 (1) liquid, including but not limited to oil;
374+11.7 (2) pill;
375+11.8 (3) liquid or oil for use with a vaporized delivery method;
376+11.9 (4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;
377+11.10 (5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and​
378+11.11sublingual tablets;​
379+11.12 (6) edible products in the form of gummies and chews;
380+11.13 (7) topical formulation; or​
381+11.14 (8) any allowable form or delivery method approved by the office.​
382+11.15 (c) Medical cannabinoid product does not include adult-use cannabis products.
383+11.16 Subd. 51.Medical cannabis business."Medical cannabis business" means an entity
384+11.17licensed under this chapter to engage in one or more of the following:
385+11.18 (1) the cultivation of cannabis plants for medical cannabis flower;​
386+11.19 (2) the manufacture of medical cannabinoid products; and​
387+11.20 (3) the retail sale of medical cannabis flower and medical cannabinoid products.
388+11.21 Subd. 52.Medical cannabis flower."Medical cannabis flower" means cannabis flower
389+11.22provided to a patient enrolled in the registry program; a registered designated caregiver; or
390+11.23a parent, legal guardian, or spouse of an enrolled patient by a cannabis retailer or medical
391+11.24cannabis business to treat or alleviate the symptoms of a qualifying medical condition.​
392+11.25Medical cannabis flower does not include adult-use cannabis flower.
393+11.26 Subd. 53.Medical cannabis paraphernalia."Medical cannabis paraphernalia" means
394+11.27a delivery device, related supply, or educational material used by a patient enrolled in the
395+11.28registry program to administer medical cannabis and medical cannabinoid products.
396+11.29 Subd. 54.Nonintoxicating cannabinoid."Nonintoxicating cannabinoid" means a
397+11.30cannabinoid that when introduced into the human body does not impair the central nervous
396398 11​Article 1 Section 1.​
397-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 12.1 (3) the retail sale of medical cannabis flower and medical cannabinoid products.​
398-12.2 Subd. 54.Medical cannabis flower."Medical cannabis flower" means cannabis flower​
399-12.3provided to a patient enrolled in the registry program; a registered designated caregiver; or​
400-12.4a parent, legal guardian, or spouse of an enrolled patient by a cannabis retailer or medical​
401-12.5cannabis business to treat or alleviate the symptoms of a qualifying medical condition.​
402-12.6Medical cannabis flower does not include adult-use cannabis flower.​
403-12.7 Subd. 55.Medical cannabis paraphernalia."Medical cannabis paraphernalia" means​
404-12.8a delivery device, related supply, or educational material used by a patient enrolled in the​
405-12.9registry program to administer medical cannabis and medical cannabinoid products.​
406-12.10 Subd. 56.Nonintoxicating cannabinoid."Nonintoxicating cannabinoid" means a​
407-12.11cannabinoid that when introduced into the human body does not impair the central nervous​
408-12.12system and does not impair the human audio, visual, or mental processes. Nonintoxicating​
409-12.13cannabinoid includes but is not limited to cannabidiol and cannabigerol but does not include​
410-12.14any artificially derived cannabinoid.​
411-12.15 Subd. 57.Office."Office" means the Office of Cannabis Management.​
412-12.16 Subd. 58.Outdoor advertisement."Outdoor advertisement" means an advertisement​
413-12.17that is located outdoors or can be seen or heard by an individual who is outdoors and includes​
414-12.18billboards; advertisements on benches; advertisements at transit stations or transit shelters;​
415-12.19advertisements on the exterior or interior of buses, taxis, light rail transit, or business vehicles;​
416-12.20and print signs that do not meet the requirements in section 342.64, subdivision 2, paragraph​
417-12.21(b), but that are placed or located on the exterior property of a cannabis business.​
418-12.22 Subd. 59.Patient."Patient" means a Minnesota resident who has been diagnosed with​
419-12.23a qualifying medical condition by a health care practitioner and who has met all other​
420-12.24requirements for patients under this chapter to participate in the registry program.​
421-12.25 Subd. 60.Patient registry number."Patient registry number" means a unique​
422-12.26identification number assigned by the Division of Medical Cannabis to a patient enrolled​
423-12.27in the registry program.​
424-12.28 Subd. 61.Plant canopy."Plant canopy" means the surface area within a cultivation​
425-12.29facility that is used at any time to cultivate mature, flowering cannabis plants. For multiple​
426-12.30tier cultivation, each tier of cultivation surface area contributes to the total plant canopy​
427-12.31calculation. Calculation of the area of the plant canopy does not include the surface area​
428-12.32within the cultivation facility that is used to cultivate immature cannabis plants and seedlings.​
399+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 12.1system and does not impair the human audio, visual, or mental processes. Nonintoxicating​
400+12.2cannabinoid includes but is not limited to cannabidiol and cannabigerol but does not include​
401+12.3any artificially derived cannabinoid.​
402+12.4 Subd. 55.Office."Office" means the Office of Cannabis Management.​
403+12.5 Subd. 56.Outdoor advertisement."Outdoor advertisement" means an advertisement​
404+12.6that is located outdoors or can be seen or heard by an individual who is outdoors and includes​
405+12.7billboards; advertisements on benches; advertisements at transit stations or transit shelters;​
406+12.8advertisements on the exterior or interior of buses, taxis, light rail transit, or business vehicles;​
407+12.9and print signs that do not meet the requirements in section 342.64, subdivision 2, paragraph​
408+12.10(b), but that are placed or located on the exterior property of a cannabis business.​
409+12.11 Subd. 57.Patient."Patient" means a Minnesota resident who has been diagnosed with​
410+12.12a qualifying medical condition by a health care practitioner and who has met all other​
411+12.13requirements for patients under this chapter to participate in the registry program.​
412+12.14 Subd. 58.Patient registry number."Patient registry number" means a unique​
413+12.15identification number assigned by the Division of Medical Cannabis to a patient enrolled​
414+12.16in the registry program.​
415+12.17 Subd. 59.Qualifying medical condition."Qualifying medical condition" means a​
416+12.18diagnosis of any of the following conditions:​
417+12.19 (1) Alzheimer's disease;​
418+12.20 (2) autism spectrum disorder that meets the requirements of the fifth edition of the​
419+12.21Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric​
420+12.22Association;​
421+12.23 (3) cancer, if the underlying condition or treatment produces one or more of the following:​
422+12.24 (i) severe or chronic pain;​
423+12.25 (ii) nausea or severe vomiting; or​
424+12.26 (iii) cachexia or severe wasting;​
425+12.27 (4) chronic motor or vocal tic disorder;​
426+12.28 (5) chronic pain;​
427+12.29 (6) glaucoma;​
428+12.30 (7) human immunodeficiency virus or acquired immune deficiency syndrome;​
429+12.31 (8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);​
429430 12​Article 1 Section 1.​
430-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 13.1 Subd. 62.Propagule."Propagule" means seeds, clones, transplants, and any other
431-13.2propagative industrial hemp material.
432-13.3 Subd. 63.Qualifying medical condition."Qualifying medical condition" means a
433-13.4diagnosis of any of the following conditions:
434-13.5 (1) Alzheimer's disease;​
435-13.6 (2) autism spectrum disorder that meets the requirements of the fifth edition of the
436-13.7Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric
437-13.8Association;​
438-13.9 (3) cancer, if the underlying condition or treatment produces one or more of the following:
439-13.10 (i) severe or chronic pain;​
440-13.11 (ii) nausea or severe vomiting; or
441-13.12 (iii) cachexia or severe wasting;
442-13.13 (4) chronic motor or vocal tic disorder;
443-13.14 (5) chronic pain;​
444-13.15 (6) glaucoma;​
445-13.16 (7) human immunodeficiency virus or acquired immune deficiency syndrome;
446-13.17 (8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);
447-13.18 (9) obstructive sleep apnea;
448-13.19 (10) post-traumatic stress disorder;
449-13.20 (11) Tourette's syndrome;​
450-13.21 (12) amyotrophic lateral sclerosis;
451-13.22 (13) seizures, including those characteristic of epilepsy;​
452-13.23 (14) severe and persistent muscle spasms, including those characteristic of multiple
453-13.24sclerosis;
454-13.25 (15) inflammatory bowel disease, including Crohn's disease;
455-13.26 (16) irritable bowel syndrome;
456-13.27 (17) obsessive-compulsive disorder;
457-13.28 (18) sickle cell disease;
431+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 13.1 (9) obstructive sleep apnea;
432+13.2 (10) post-traumatic stress disorder;
433+13.3 (11) Tourette's syndrome;
434+13.4 (12) amyotrophic lateral sclerosis;
435+13.5 (13) seizures, including those characteristic of epilepsy;​
436+13.6 (14) severe and persistent muscle spasms, including those characteristic of multiple
437+13.7sclerosis;
438+13.8 (15) inflammatory bowel disease, including Crohn's disease;​
439+13.9 (16) irritable bowel syndrome;
440+13.10 (17) obsessive-compulsive disorder;​
441+13.11 (18) sickle cell disease;​
442+13.12 (19) terminal illness, with a probable life expectancy of under one year, if the illness or​
443+13.13its treatment produces one or more of the following:
444+13.14 (i) severe or chronic pain;​
445+13.15 (ii) nausea or severe vomiting; or
446+13.16 (iii) cachexia or severe wasting; or
447+13.17 (20) any other medical condition or its treatment approved by the office.​
448+13.18 Subd. 60.Registered designated caregiver."Registered designated caregiver" means
449+13.19an individual who:
450+13.20 (1) is at least 18 years old;​
451+13.21 (2) is not disqualified for a criminal offense according to rules adopted pursuant to
452+13.22section 342.15, subdivision 2;​
453+13.23 (3) has been approved by the Division of Medical Cannabis to assist a patient with
454+13.24obtaining medical cannabis flower and medical cannabinoid products from a cannabis
455+13.25retailer or medical cannabis retailer and with administering medical cannabis flower and
456+13.26medical cannabinoid products; and
457+13.27 (4) is authorized by the Division of Medical Cannabis to assist a patient with the use of
458+13.28medical cannabis flower and medical cannabinoid products.
458459 13​Article 1 Section 1.​
459-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 14.1 (19) terminal illness, with a probable life expectancy of under one year, if the illness or​
460-14.2its treatment produces one or more of the following:​
461-14.3 (i) severe or chronic pain;​
462-14.4 (ii) nausea or severe vomiting; or​
463-14.5 (iii) cachexia or severe wasting; or​
464-14.6 (20) any other medical condition or its treatment approved by the office.​
465-14.7 Subd. 64.Registered designated caregiver."Registered designated caregiver" means​
466-14.8an individual who:​
467-14.9 (1) is at least 18 years old;​
468-14.10 (2) is not disqualified for a criminal offense according to rules adopted pursuant to​
469-14.11section 342.15, subdivision 2;​
470-14.12 (3) has been approved by the Division of Medical Cannabis to assist a patient with​
471-14.13obtaining medical cannabis flower and medical cannabinoid products from a cannabis​
472-14.14retailer or medical cannabis retailer and with administering medical cannabis flower and​
473-14.15medical cannabinoid products; and​
474-14.16 (4) is authorized by the Division of Medical Cannabis to assist a patient with the use of​
475-14.17medical cannabis flower and medical cannabinoid products.​
476-14.18 Subd. 65.Registry or registry program."Registry" or "registry program" means the​
477-14.19patient registry established under this chapter listing patients authorized to obtain medical​
478-14.20cannabis flower, medical cannabinoid products, and medical cannabis paraphernalia from​
479-14.21cannabis retailers and medical cannabis retailers and administer medical cannabis flower​
480-14.22and medical cannabinoid products.​
481-14.23 Subd. 66.Registry verification."Registry verification" means the verification provided​
482-14.24by the Division of Medical Cannabis that a patient is enrolled in the registry program and​
483-14.25that includes the patient's name, patient registry number, and, if applicable, the name of the​
484-14.26patient's registered designated caregiver or parent, legal guardian, or spouse.​
485-14.27 Subd. 67.Restricted area."Restricted area" means an area where cannabis flower or​
486-14.28cannabis products are cultivated, manufactured, or stored by a cannabis business.​
487-14.29 Subd. 68.Statewide monitoring system."Statewide monitoring system" means the​
488-14.30system for integrated cannabis tracking, inventory, and verification established or adopted​
489-14.31by the office.​
460+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 14.1 Subd. 61.Registry or registry program."Registry" or "registry program" means the​
461+14.2patient registry established under this chapter listing patients authorized to obtain medical​
462+14.3cannabis flower, medical cannabinoid products, and medical cannabis paraphernalia from​
463+14.4cannabis retailers and medical cannabis retailers and administer medical cannabis flower​
464+14.5and medical cannabinoid products.​
465+14.6 Subd. 62.Registry verification."Registry verification" means the verification provided​
466+14.7by the Division of Medical Cannabis that a patient is enrolled in the registry program and​
467+14.8that includes the patient's name, patient registry number, and, if applicable, the name of the​
468+14.9patient's registered designated caregiver or parent, legal guardian, or spouse.​
469+14.10 Subd. 63.Restricted area."Restricted area" means an area where cannabis flower or​
470+14.11cannabis products are cultivated, manufactured, or stored by a cannabis business.​
471+14.12 Subd. 64.Statewide monitoring system."Statewide monitoring system" means the​
472+14.13system for integrated cannabis tracking, inventory, and verification established or adopted​
473+14.14by the office.​
474+14.15 Subd. 65.Synthetic cannabinoid."Synthetic cannabinoid" means a substance with a​
475+14.16similar chemical structure and pharmacological activity to a cannabinoid but is not extracted​
476+14.17or derived from cannabis plants, cannabis flower, hemp plants, or hemp plant parts and is​
477+14.18instead created or produced by chemical or biochemical synthesis.​
478+14.19 Subd. 66.Veteran."Veteran" means an individual who satisfies the requirements in​
479+14.20section 197.447.​
480+14.21 Subd. 67.Visiting designated caregiver."Visiting designated caregiver" means an​
481+14.22individual who is authorized under a visiting patient's jurisdiction of residence to assist the​
482+14.23visiting patient with the use of medical cannabis flower and medical cannabinoid products.​
483+14.24To be considered a visiting designated caregiver, the individual must possess a valid​
484+14.25verification card or its equivalent that is issued by the visiting patient's jurisdiction of​
485+14.26residence and that verifies that the individual is authorized to assist the visiting patient with​
486+14.27the administration of medical cannabis flower and medical cannabinoid products under the​
487+14.28laws or regulations of the visiting patient's jurisdiction of residence.​
488+14.29 Subd. 68.Visiting patient."Visiting patient" means an individual who is not a Minnesota​
489+14.30resident and who possesses a valid registration verification card or its equivalent that is​
490+14.31issued under the laws or regulations of another state, district, commonwealth, or territory​
491+14.32of the United States verifying that the individual is enrolled in or authorized to participate​
492+14.33in that jurisdiction's medical cannabis or medical marijuana program.​
490493 14​Article 1 Section 1.​
491-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 15.1 Subd. 69.Synthetic cannabinoid."Synthetic cannabinoid" means a substance with a​
492-15.2similar chemical structure and pharmacological activity to a cannabinoid but is not extracted
493-15.3or derived from cannabis plants, cannabis flower, hemp plants, or hemp plant parts and is​
494-15.4instead created or produced by chemical or biochemical synthesis.​
495-15.5 Subd. 70.Veteran."Veteran" means an individual who satisfies the requirements in
496-15.6section 197.447.​
497-15.7 Subd. 71.Visiting patient."Visiting patient" means an individual who is not a Minnesota
498-15.8resident and who possesses a valid registration verification card or its equivalent that is
499-15.9issued under the laws or regulations of another state, district, commonwealth, or territory
500-15.10of the United States verifying that the individual is enrolled in or authorized to participate
501-15.11in that jurisdiction's medical cannabis or medical marijuana program.
502-15.12 Subd. 72.Volatile solvent."Volatile solvent" means any solvent that is or produces a
503-15.13flammable gas or vapor that, when present in the air in sufficient quantities, will create
504-15.14explosive or ignitable mixtures. Volatile solvent includes but is not limited to butane, hexane,
505-15.15and propane.
506-15.16Sec. 2. [342.02] OFFICE OF CANNABIS MANAGEMENT .​
507-15.17 Subdivision 1.Establishment.The Office of Cannabis Management is created with the​
508-15.18powers and duties established by law. In making rules, establishing policy, and exercising
509-15.19its regulatory authority over the cannabis industry and hemp consumer industry, the office
510-15.20must:
511-15.21 (1) promote the public health and welfare;​
512-15.22 (2) protect public safety;
513-15.23 (3) eliminate the illicit market for cannabis flower and cannabis products;​
514-15.24 (4) meet the market demand for cannabis flower and cannabis products;
515-15.25 (5) promote a craft industry for cannabis flower and cannabis products; and
516-15.26 (6) prioritize growth and recovery in communities that have experienced a
517-15.27disproportionate, negative impact from cannabis prohibition.
518-15.28 Subd. 2.Powers and duties.(a) The office has the following powers and duties:
519-15.29 (1) to develop, maintain, and enforce an organized system of regulation for the cannabis
520-15.30industry and hemp consumer industry;
494+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 15.1 Subd. 69.Volatile solvent."Volatile solvent" means any solvent that is or produces a​
495+15.2flammable gas or vapor that, when present in the air in sufficient quantities, will create
496+15.3explosive or ignitable mixtures. Volatile solvent includes but is not limited to butane, hexane,
497+15.4and propane.​
498+15.5 Sec. 2. [342.02] OFFICE OF CANNABIS MANAGEMENT .
499+15.6 Subdivision 1.Establishment.The Office of Cannabis Management is created with the
500+15.7powers and duties established by law. In making rules, establishing policy, and exercising
501+15.8its regulatory authority over the cannabis industry and hemp consumer industry, the office
502+15.9must:
503+15.10 (1) promote the public health and welfare;
504+15.11 (2) protect public safety;
505+15.12 (3) eliminate the illicit market for cannabis flower and cannabis products;
506+15.13 (4) meet the market demand for cannabis flower and cannabis products;
507+15.14 (5) promote a craft industry for cannabis flower and cannabis products; and
508+15.15 (6) prioritize growth and recovery in communities that have experienced a
509+15.16disproportionate, negative impact from cannabis prohibition.​
510+15.17 Subd. 2.Powers and duties.The office has the following powers and duties:
511+15.18 (1) to develop, maintain, and enforce an organized system of regulation for the cannabis
512+15.19industry and hemp consumer industry;
513+15.20 (2) to establish programming, services, and notification to protect, maintain, and improve
514+15.21the health of citizens;​
515+15.22 (3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency
516+15.23hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;​
517+15.24 (4) to establish and regularly update standards for product testing, packaging, and​
518+15.25labeling;​
519+15.26 (5) to promote economic growth with an emphasis on growth in areas that experienced​
520+15.27a disproportionate, negative impact from cannabis prohibition;
521+15.28 (6) to issue and renew licenses;
522+15.29 (7) to require fingerprints from individuals determined to be subject to fingerprinting,​
523+15.30including the submission of fingerprints to the Federal Bureau of Investigation where
521524 15​Article 1 Sec. 2.​
522-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 16.1 (2) to establish programming, services, and notification to protect, maintain, and improve​
523-16.2the health of citizens;​
524-16.3 (3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency​
525-16.4hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;​
526-16.5 (4) to establish and regularly update standards for product manufacturing, testing,​
527-16.6packaging, and labeling, including requirements for an expiration, sell-by, or best-used-by​
528-16.7date;​
529-16.8 (5) to promote economic growth with an emphasis on growth in areas that experienced​
530-16.9a disproportionate, negative impact from cannabis prohibition;​
531-16.10 (6) to issue and renew licenses;​
532-16.11 (7) to require fingerprints from individuals determined to be subject to fingerprinting,​
533-16.12including the submission of fingerprints to the Federal Bureau of Investigation where​
534-16.13required by law and to obtain criminal conviction data for individuals seeking a license​
535-16.14from the office on the individual's behalf or as a cooperative member or director, manager,​
536-16.15or general partner of a business entity;​
537-16.16 (8) to receive reports required by this chapter and inspect the premises, records, books,​
538-16.17and other documents of license holders to ensure compliance with all applicable laws and​
539-16.18rules;​
540-16.19 (9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations​
541-16.20pursuant to the office's authority;​
542-16.21 (10) to impose and collect civil and administrative penalties as provided in this chapter;​
543-16.22 (11) to publish such information as may be deemed necessary for the welfare of cannabis​
544-16.23businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety​
545-16.24of citizens;​
546-16.25 (12) to make loans and grants in aid to the extent that appropriations are made available​
547-16.26for that purpose;​
548-16.27 (13) to authorize research and studies on cannabis flower, cannabis products, artificially​
549-16.28derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the​
550-16.29cannabis industry, and the hemp consumer industry;​
551-16.30 (14) to provide reports as required by law;​
552-16.31 (15) to develop a warning label regarding the effects of the use of cannabis flower and​
553-16.32cannabis products by persons 25 years of age or younger;​
525+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 16.1required by law and to obtain criminal conviction data for individuals seeking a license​
526+16.2from the office on the individual's behalf or as a cooperative member or director, manager,​
527+16.3or general partner of a business entity;​
528+16.4 (8) to receive reports required by this chapter and inspect the premises, records, books,​
529+16.5and other documents of license holders to ensure compliance with all applicable laws and​
530+16.6rules;​
531+16.7 (9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations​
532+16.8pursuant to the office's authority;​
533+16.9 (10) to impose and collect civil and administrative penalties as provided in this chapter;​
534+16.10 (11) to publish such information as may be deemed necessary for the welfare of cannabis​
535+16.11businesses, cannabis workers, hemp businesses, hemp workers, and the health and safety​
536+16.12of citizens;​
537+16.13 (12) to make loans and grants in aid to the extent that appropriations are made available​
538+16.14for that purpose;​
539+16.15 (13) to authorize research and studies on cannabis flower, cannabis products, artificially​
540+16.16derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the​
541+16.17cannabis industry, and the hemp consumer industry;​
542+16.18 (14) to provide reports as required by law;​
543+16.19 (15) to establish limits on the potency of cannabis flower and cannabis products that can​
544+16.20be sold to customers by licensed cannabis retailers and licensed cannabis microbusinesses​
545+16.21with an endorsement to sell cannabis flower and cannabis products to customers; and​
546+16.22 (16) to exercise other powers and authority and perform other duties required by law.​
547+16.23 Subd. 3.Medical cannabis program.The powers and duties of the Department of​
548+16.24Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections​
549+16.25152.22 to 152.37, are transferred to the Office of Cannabis Management under section​
550+16.2615.039. State employees shall not be displaced by the transfer of duties from the Department​
551+16.27of Health medical cannabis program to the Office of Cannabis Management under this​
552+16.28subdivision.​
553+16.29 Subd. 4.Interagency agreements.(a) The office and the commissioner of agriculture​
554+16.30shall enter into interagency agreements to ensure that edible cannabis products and​
555+16.31lower-potency hemp edibles are handled, manufactured, and inspected in a manner that is​
554556 16​Article 1 Sec. 2.​
555-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 17.1 (16) to determine, based on a review of medical and scientific literature, whether it is
556-17.2appropriate to require additional health and safety warnings containing information that is
557-17.3both supported by credible science and helpful to consumers in considering potential health
558-17.4risks from the use of cannabis flower, cannabis products, lower-potency hemp edibles, and​
559-17.5hemp-derived consumer products, including but not limited to warnings regarding any risks
560-17.6associated with use by pregnant or breastfeeding individuals, or by individuals planning to
561-17.7become pregnant, and the effects that use has on brain development for individuals under
562-17.8the age of 25;
563-17.9 (17) to establish limits on the potency of cannabis flower and cannabis products that can
564-17.10be sold to customers by licensed cannabis retailers, licensed cannabis microbusinesses, and
565-17.11licensed cannabis mezzobusinesses with an endorsement to sell cannabis flower and cannabis
566-17.12products to customers;
567-17.13 (18) to establish rules authorizing an increase in plant canopy limits and outdoor
568-17.14cultivation limits to meet market demand and limiting cannabis manufacturing consistent
569-17.15with the goals identified in subdivision 1; and
570-17.16 (19) to exercise other powers and authority and perform other duties required by law.
571-17.17 (b) In addition to the powers and duties in paragraph (a), the office has the following
572-17.18powers and duties until January 1, 2027:
573-17.19 (1) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis
574-17.20products that can be sold to customers by licensed cannabis retailers, licensed cannabis
575-17.21microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell
576-17.22adult-use cannabis flower and adult-use cannabis products to customers; and
577-17.23 (2) to permit, upon application to the office in the form prescribed by the director of the
578-17.24office, a licensee under this chapter to perform any activity if such permission is substantially
579-17.25necessary for the licensee to perform any other activity permitted by the applicant's license
580-17.26and is not otherwise prohibited by law.
581-17.27 Subd. 3.Medical cannabis program.(a) The powers and duties of the Department of
582-17.28Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections
583-17.29152.22 to 152.37, are transferred to the Office of Cannabis Management under section
584-17.3015.039.
585-17.31 (b) The following protections shall apply to employees who are transferred from the
586-17.32Department of Health to the Office of Cannabis Management:
557+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 17.1consistent with the relevant food safety requirements in chapters 28A, 31, and 34A and
558+17.2associated rules.
559+17.3 (b) The office may cooperate and enter into other agreements with the commissioner of
560+17.4agriculture and may cooperate and enter into agreements with the commissioners and​
561+17.5directors of other state agencies and departments to promote the beneficial interests of the
562+17.6state.
563+17.7 Subd. 5.Rulemaking.The office may adopt rules to implement any provisions in this
564+17.8chapter. Rules for which notice is published in the State Register before July 1, 2025, may
565+17.9be adopted using the expedited rulemaking process in section 14.389.
566+17.10 Subd. 6.Director.(a) The governor shall appoint a director of the office with the advice
567+17.11and consent of the senate. The director must be in the unclassified service and must serve
568+17.12at the pleasure of the governor.
569+17.13 (b) The salary of the director must not exceed the salary limit established under section
570+17.1415A.0815, subdivision 3.
571+17.15 (c) Four years prior to being nominated to serve as director, while serving as the director,
572+17.16and within four years after terminating service, the director is prohibited from having a
573+17.17direct or an indirect financial interest in a cannabis business or hemp business licensed under
574+17.18this chapter. The director is permanently prohibited from registering as a lobbyist after
575+17.19terminating service.
576+17.20 (d) The director must not have been a member of the Minnesota legislature, held a
577+17.21constitutional office, registered as a lobbyist, or served as a director of a statewide agency
578+17.22for at least four years before appointment.
579+17.23 (e) No later than June 15, 2023, the governor shall appoint an advisory committee to
580+17.24consult with during the hiring process for the director. The advisory committee shall be
581+17.25comprised of:
582+17.26 (1) two members of the house of representatives, one appointed by the majority party
583+17.27and one by the minority party;
584+17.28 (2) two members of the senate, one appointed by the majority party and one by the
585+17.29minority party;
586+17.30 (3) an expert in cannabis policy;
587+17.31 (4) an expert in economic equity;
588+17.32 (5) an expert in cannabis science;
587589 17​Article 1 Sec. 2.​
588-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 18.1 (1) the employment status and job classification of a transferred employee shall not be​
589-18.2altered as a result of the transfer;​
590-18.3 (2) transferred employees who were represented by an exclusive representative prior to​
591-18.4the transfer shall continue to be represented by the same exclusive representative after the​
592-18.5transfer;​
593-18.6 (3) the applicable collective bargaining agreements with exclusive representatives shall​
594-18.7continue in full force and effect for such transferred employees after the transfer;​
595-18.8 (4) the state must meet and negotiate with the exclusive representatives of the transferred​
596-18.9employees about any proposed changes affecting or relating to the transferred employees'​
597-18.10terms and conditions of employment to the extent such changes are not addressed in the​
598-18.11applicable collective bargaining agreement; and​
599-18.12 (5) for an employee in a temporary unclassified position transferred to the Office of​
600-18.13Cannabis Management, the total length of time that the employee has served in the​
601-18.14appointment shall include all time served in the appointment and the transferring agency​
602-18.15and the time served in the appointment at the Office of Cannabis Management. An employee​
603-18.16in a temporary unclassified position who was hired by a transferring agency through an​
604-18.17open competitive selection process in accordance with a policy enacted by Minnesota​
605-18.18Management and Budget shall be considered to have been hired through such process after​
606-18.19the transfer.​
607-18.20 Subd. 4.Interagency agreements.(a) The office and the commissioner of agriculture​
608-18.21shall enter into interagency agreements to ensure that edible cannabis products and​
609-18.22lower-potency hemp edibles are handled, manufactured, and inspected in a manner that is​
610-18.23consistent with the relevant food safety requirements in chapters 28A, 31, and 34A and​
611-18.24associated rules.​
612-18.25 (b) The office may cooperate and enter into other agreements with the commissioner of​
613-18.26agriculture and may cooperate and enter into agreements with the commissioners and​
614-18.27directors of other state agencies and departments to promote the beneficial interests of the​
615-18.28state.​
616-18.29 Subd. 5.Rulemaking.The office may adopt rules to implement any provisions in this​
617-18.30chapter. Rules for which notice is published in the State Register before July 1, 2025, may​
618-18.31be adopted using the expedited rulemaking process in section 14.389.​
590+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 18.1 (6) an expert in restorative justice;​
591+18.2 (7) an expert in harm reduction;​
592+18.3 (8) an expert on race, equity, and inclusion;​
593+18.4 (9) a medical cannabis patient;​
594+18.5 (10) an individual who has been justice involved for the sale of cannabis; and​
595+18.6 (11) an individual with experience in implementing an adult use legalization program.​
596+18.7 (f) While serving on the search committee, members may not:​
597+18.8 (1) have a financial interest in a cannabis business or hemp business;​
598+18.9 (2) be a director or officer of a pharmaceutical company; or​
599+18.10 (3) be a registered lobbyist.​
600+18.11 (g) Members of the advisory committee are not eligible for reimbursement.​
601+18.12 (h) The governor shall designate a chair of the committee who shall convene the first​
602+18.13meeting. The committee may elect other officers as needed. Meetings of the committee are​
603+18.14subject to chapter 13D.​
604+18.15 (i) The commissioner of agriculture shall provide space and support for the advisory​
605+18.16committee. The advisory committee expires on August 1, 2023.​
606+18.17 Subd. 7.Employees.(a) The office may employ other personnel in the classified service​
607+18.18necessary to carry out the duties in this chapter.​
608+18.19 (b) Upon request by the office, a prospective employee of the office must submit a​
609+18.20completed criminal history records check consent form, a full set of classifiable fingerprints,​
610+18.21and the required fees to the office. Upon receipt of this information, the office must submit​
611+18.22the completed criminal history records check consent form, full set of classifiable fingerprints,​
612+18.23and required fees to the Bureau of Criminal Apprehension. After receiving this information,​
613+18.24the bureau must conduct a Minnesota criminal history records check of the prospective​
614+18.25employee. The bureau may exchange a prospective employee's fingerprints with the Federal​
615+18.26Bureau of Investigation to obtain the prospective employee's national criminal history record​
616+18.27information. The bureau must return the results of the Minnesota and federal criminal history​
617+18.28records checks to the director to determine if the prospective employee is disqualified under​
618+18.29rules adopted pursuant to section 342.15.​
619619 18​Article 1 Sec. 2.​
620-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 19.1 Subd. 6.Director.(a) The governor shall appoint a director of the office with the advice
621-19.2and consent of the senate. The director must be in the unclassified service and must serve
622-19.3at the pleasure of the governor.​
623-19.4 (b) The salary of the director must not exceed the salary limit established under section
624-19.515A.0815, subdivision 3.
625-19.6 Subd. 7.Employees.(a) The office may employ other personnel in the classified service
626-19.7necessary to carry out the duties in this chapter.
627-19.8 (b) Upon request by the office, a prospective employee of the office must submit a
628-19.9completed criminal history records check consent form, a full set of classifiable fingerprints,
629-19.10and the required fees to the office. Upon receipt of this information, the office must submit
630-19.11the completed criminal history records check consent form, full set of classifiable fingerprints,
631-19.12and required fees to the Bureau of Criminal Apprehension. After receiving this information,
632-19.13the bureau must conduct a Minnesota criminal history records check of the prospective
633-19.14employee. The bureau may exchange a prospective employee's fingerprints with the Federal
634-19.15Bureau of Investigation to obtain the prospective employee's national criminal history record
635-19.16information. The bureau must return the results of the Minnesota and federal criminal history
636-19.17records checks to the director to determine if the prospective employee is disqualified under
637-19.18rules adopted pursuant to section 342.15.
638-19.19 Subd. 8.Division of Social Equity.The office must establish a Division of Social Equity.
639-19.20At a minimum, the division must:
640-19.21 (1) engage with the community and administer grants to communities that experienced
641-19.22a disproportionate, negative impact from cannabis prohibition and usage in order to promote
642-19.23economic development, improve social determinants of health, provide services to prevent
643-19.24violence, support early intervention programs for youth and families, and promote community
644-19.25stability and safety;​
645-19.26 (2) act as an ombudsperson for the office to provide information, investigate complaints
646-19.27under this chapter, and provide or facilitate dispute resolutions; and
647-19.28 (3) report to the office on the status of complaints and social equity in the cannabis
648-19.29industry.
649-19.30 EFFECTIVE DATE.This section is effective July 1, 2023, except for subdivision 3,
650-19.31which is effective March 1, 2025.​
651-19Article 1 Sec. 2.
652-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 20.1 Sec. 3. [342.03] CANNABIS ADVISORY COUNCIL.
653-20.2 Subdivision 1.Membership.The Cannabis Advisory Council is created consisting of
654-20.3the following members:
655-20.4 (1) the director of the Office of Cannabis Management or a designee;​
656-20.5 (2) the commissioner of employment and economic development or a designee;
657-20.6 (3) the commissioner of revenue or a designee;​
658-20.7 (4) the commissioner of health or a designee;​
659-20.8 (5) the commissioner of human services or a designee;​
660-20.9 (6) the commissioner of public safety or a designee;
661-20.10 (7) the commissioner of human rights or a designee;​
662-20.11 (8) the commissioner of labor or a designee;​
663-20.12 (9) the commissioner of agriculture or a designee;
664-20.13 (10) the commissioner of the Pollution Control Agency or a designee;​
665-20.14 (11) the superintendent of the Bureau of Criminal Apprehension or a designee;
666-20.15 (12) the colonel of the State Patrol or a designee;​
667-20.16 (13) the director of the Office of Traffic Safety in the Department of Public Safety or a
668-20.17designee;​
669-20.18 (14) a representative from the League of Minnesota Cities appointed by the league;​
670-20.19 (15) a representative from the Association of Minnesota Counties appointed by the​
671-20.20association;​
672-20.21 (16) an expert in minority business development appointed by the governor;
673-20.22 (17) an expert in economic development strategies for under-resourced communities
674-20.23appointed by the governor;​
675-20.24 (18) an expert in farming or representing the interests of farmers appointed by the
676-20.25governor;
677-20.26 (19) an expert representing the interests of cannabis workers appointed by the governor;​
678-20.27 (20) an expert representing the interests of employers appointed by the governor;​
679-20.28 (21) an expert in municipal law enforcement with advanced training in impairment
680-20.29detection and evaluation appointed by the governor;
620+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 19.1 (c) While employed by the office and within two years after terminating employment,
621+19.2an employee may not have a direct or an indirect financial interest in a cannabis business
622+19.3licensed under this chapter.​
623+19.4 Subd. 8.Division of Social Equity.The office must establish a Division of Social Equity.
624+19.5At a minimum, the division must:
625+19.6 (1) administer grants to communities that experienced a disproportionate, negative impact
626+19.7from cannabis prohibition in order to promote economic development, provide services to
627+19.8prevent violence, support early intervention programs for youth and families, and promote
628+19.9community stability and safety;
629+19.10 (2) act as an ombudsperson for the office to provide information, investigate complaints
630+19.11under this chapter, and provide or facilitate dispute resolutions; and
631+19.12 (3) report to the office on the status of complaints and social equity in the cannabis
632+19.13industry.
633+19.14 EFFECTIVE DATE.This section is effective July 1, 2023, except for subdivision 2,
634+19.15paragraphs (e), (f), (g), (h), and (i), which are effective the day following final enactment,
635+19.16and subdivision 3, which is effective January 1, 2024.​
636+19.17Sec. 3. [342.03] CANNABIS ADVISORY COUNCIL.
637+19.18 Subdivision 1.Membership.(a) The Cannabis Advisory Council is created consisting
638+19.19of the following members:
639+19.20 (1) the director of the Office of Cannabis Management or a designee;
640+19.21 (2) the commissioner of employment and economic development or a designee;
641+19.22 (3) the commissioner of revenue or a designee;
642+19.23 (4) the commissioner of health or a designee;
643+19.24 (5) the commissioner of public safety or a designee;
644+19.25 (6) the commissioner of human rights or a designee;​
645+19.26 (7) the commissioner of labor or a designee;
646+19.27 (8) the commissioner of agriculture or a designee;​
647+19.28 (9) the commissioner of the Pollution Control Agency or a designee;
648+19.29 (10) the superintendent of the Bureau of Criminal Apprehension or a designee;
649+19.30 (11) a representative from the League of Minnesota Cities appointed by the league;
650+19​Article 1 Sec. 3.​
651+REVISOR BD H0100-11HF100 ELEVENTH ENGROSSMENT​ 20.1 (12) a representative from the Association of Minnesota Counties appointed by the
652+20.2association;
653+20.3 (13) an expert in minority business development appointed by the governor;
654+20.4 (14) an expert in economic development strategies for under-resourced communities
655+20.5appointed by the governor;​
656+20.6 (15) an expert in farming or representing the interests of farmers appointed by the
657+20.7governor;​
658+20.8 (16) an expert representing the interests of cannabis workers appointed by the governor;​
659+20.9 (17) an expert representing the interests of employers appointed by the governor;​
660+20.10 (18) an expert in municipal law enforcement with advanced training in impairment
661+20.11detection and evaluation appointed by the governor;​
662+20.12 (19) an expert in social welfare or social justice appointed by the governor;​
663+20.13 (20) an expert in criminal justice reform to mitigate the disproportionate impact of drug
664+20.14prosecutions on communities of color appointed by the governor;​
665+20.15 (21) an expert in the prevention and treatment of substance use disorders appointed by
666+20.16the governor;​
667+20.17 (22) an expert in minority business ownership appointed by the governor;
668+20.18 (23) an expert in women-owned businesses appointed by the governor;​
669+20.19 (24) an expert in cannabis retailing appointed by the governor;​
670+20.20 (25) an expert in cannabis product manufacturing appointed by the governor;
671+20.21 (26) an expert in laboratory sciences and toxicology appointed by the governor;​
672+20.22 (27) an expert in providing legal services to cannabis businesses appointed by the​
673+20.23governor;
674+20.24 (28) an expert in cannabis cultivation appointed by the governor;​
675+20.25 (29) two patient advocates, one who is a patient enrolled in the medical cannabis program
676+20.26and one patient with experience in the mental health system or substance use disorder
677+20.27treatment system appointed by the governor;​
678+20.28 (30) a veteran appointed by the governor;​
679+20.29 (31) one member of each of the following federally recognized Tribes, designated by
680+20.30the elected Tribal president or chairperson of the governing bodies of:
681681 20​Article 1 Sec. 3.​
682-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 21.1 (22) an expert in social welfare or social justice appointed by the governor;​
683-21.2 (23) an expert in criminal justice reform to mitigate the disproportionate impact of drug
684-21.3prosecutions on communities of color appointed by the governor;​
685-21.4 (24) an expert in prevention, treatment, and recovery related to substance use disorders
686-21.5appointed by the governor;​
687-21.6 (25) an expert in minority business ownership appointed by the governor;​
688-21.7 (26) an expert in women-owned businesses appointed by the governor;​
689-21.8 (27) an expert in cannabis retailing appointed by the governor;​
690-21.9 (28) an expert in cannabis product manufacturing appointed by the governor;​
691-21.10 (29) an expert in laboratory sciences and toxicology appointed by the governor;​
692-21.11 (30) an expert in providing legal services to cannabis businesses appointed by the
693-21.12governor;
694-21.13 (31) an expert in cannabis cultivation appointed by the governor;
695-21.14 (32) an expert in pediatric medicine appointed by the governor;
696-21.15 (33) an expert in adult medicine appointed by the governor;
697-21.16 (34) three patient advocates, one who is a patient enrolled in the medical cannabis
698-21.17program; one who is a parent or caregiver of a patient in the medical cannabis program;
699-21.18and one patient with experience in the mental health system or substance use disorder
700-21.19treatment system appointed by the governor;
701-21.20 (35) two licensed mental health professionals appointed by the governor;
702-21.21 (36) a veteran appointed by the governor;
703-21.22 (37) one member of each of the following federally recognized Tribes, designated by
704-21.23the elected Tribal president or chairperson of the governing bodies of:
705-21.24 (i) the Fond du Lac Band;
706-21.25 (ii) the Grand Portage Band;
707-21.26 (iii) the Mille Lacs Band;
708-21.27 (iv) the White Earth Band;
709-21.28 (v) the Bois Forte Band;​
710-21.29 (vi) the Leech Lake Band;​
682+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 21.1 (i) the Fond du Lac Band;​
683+21.2 (ii) the Grand Portage Band;
684+21.3 (iii) the Mille Lacs Band;​
685+21.4 (iv) the White Earth Band;
686+21.5 (v) the Bois Forte Band;​
687+21.6 (vi) the Leech Lake Band;​
688+21.7 (vii) the Red Lake Nation;​
689+21.8 (viii) the Upper Sioux Community;​
690+21.9 (ix) the Lower Sioux Indian Community;​
691+21.10 (x) the Shakopee Mdewakanton Sioux Community; and
692+21.11 (xi) the Prairie Island Indian Community; and
693+21.12 (32) a representative from the Local Public Health Association of Minnesota appointed
694+21.13by the association.
695+21.14 (b) Four years before being nominated to serve on the Cannabis Advisory Council, while
696+21.15serving on the Cannabis Advisory Council, and within four years after terminating service,
697+21.16a council member shall not serve as a lobbyist, as defined under section 10A.01, subdivision
698+21.1721.
699+21.18 Subd. 2.Terms; compensation; removal; vacancy; expiration.The membership terms,
700+21.19compensation, removal of members appointed by the governor, and filling of vacancies of
701+21.20members are provided in section 15.059. Notwithstanding section 15.059, subdivision 6,
702+21.21the advisory council shall not expire.
703+21.22 Subd. 3.Officers; meetings.(a) The director of the Office of Cannabis Management
704+21.23or the director's designee must chair the Cannabis Advisory Council. The advisory council
705+21.24must elect a vice-chair and may elect other officers as necessary.
706+21.25 (b) The advisory council shall meet quarterly or upon the call of the chair.
707+21.26 (c) Meetings of the advisory council are subject to chapter 13D.
708+21.27 Subd. 4.Duties.(a) The duties of the advisory council shall include:
709+21.28 (1) reviewing national cannabis policy;​
710+21.29 (2) examining the effectiveness of state cannabis policy;​
711711 21​Article 1 Sec. 3.​
712-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 22.1 (vii) the Red Lake Nation;​
713-22.2 (viii) the Upper Sioux Community;​
714-22.3 (ix) the Lower Sioux Indian Community;​
715-22.4 (x) the Shakopee Mdewakanton Sioux Community; and​
716-22.5 (xi) the Prairie Island Indian Community; and​
717-22.6 (38) a representative from the Local Public Health Association of Minnesota appointed​
718-22.7by the association.​
719-22.8 Subd. 2.Terms; compensation; removal; vacancy; expiration.The membership terms,​
720-22.9compensation, removal of members appointed by the governor, and filling of vacancies of​
721-22.10members are provided in section 15.059. Notwithstanding section 15.059, subdivision 6,​
722-22.11the advisory council shall not expire.​
723-22.12 Subd. 3.Officers; meetings.(a) The director of the Office of Cannabis Management​
724-22.13or the director's designee must chair the Cannabis Advisory Council. The advisory council​
725-22.14must elect a vice-chair and may elect other officers as necessary.​
726-22.15 (b) The advisory council shall meet quarterly or upon the call of the chair.​
727-22.16 (c) Meetings of the advisory council are subject to chapter 13D.​
728-22.17 Subd. 4.Duties.(a) The duties of the advisory council shall include:​
729-22.18 (1) reviewing national cannabis policy;​
730-22.19 (2) examining the effectiveness of state cannabis policy;​
731-22.20 (3) reviewing developments in the cannabis industry and hemp consumer industry;​
732-22.21 (4) reviewing developments in the study of cannabis flower, cannabis products, artificially​
733-22.22derived cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products;​
734-22.23 (5) taking public testimony; and​
735-22.24 (6) making recommendations to the Office of Cannabis Management.​
736-22.25 (b) At its discretion, the advisory council may examine other related issues consistent​
737-22.26with this section.​
738-22.27Sec. 4. [342.04] STUDIES; REPORTS.​
739-22.28 (a) The office shall conduct a study to determine the expected size and growth of the​
740-22.29regulated cannabis industry and hemp consumer industry, including an estimate of the​
712+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 22.1 (3) reviewing developments in the cannabis industry;​
713+22.2 (4) reviewing developments in the study of cannabis flower, cannabis products, artificially​
714+22.3derived cannabinoids, lower-potency edible products, and hemp-derived consumer products;​
715+22.4 (5) taking public testimony; and​
716+22.5 (6) making recommendations to the Office of Cannabis Management.​
717+22.6 (b) At its discretion, the advisory council may examine other related issues consistent​
718+22.7with this section.​
719+22.8 Sec. 4. [342.04] STUDIES; REPORTS.​
720+22.9 (a) The office shall conduct a study to determine the expected size and growth of the​
721+22.10regulated cannabis industry, including an estimate of the demand for cannabis flower and​
722+22.11cannabis products, the number and geographic distribution of cannabis businesses needed​
723+22.12to meet that demand, and the anticipated business from residents of other states.​
724+22.13 (b) The office shall conduct a study to determine the size of the illicit cannabis market,​
725+22.14the sources of illicit cannabis flower and illicit cannabis products in the state, the locations​
726+22.15of citations issued and arrests made for cannabis offenses, and the subareas, such as census​
727+22.16tracts or neighborhoods, that experience a disproportionately large amount of cannabis​
728+22.17enforcement.​
729+22.18 (c) The office shall conduct a study on impaired driving to determine the number of​
730+22.19accidents involving one or more drivers who admitted to using cannabis flower, cannabis​
731+22.20products, lower-potency hemp edibles, or hemp-derived consumer products, or who tested​
732+22.21positive for cannabis or tetrahydrocannabinol, the number of arrests of individuals for​
733+22.22impaired driving in which the individual tested positive for cannabis or tetrahydrocannabinol,​
734+22.23and the number of convictions for driving under the influence of cannabis flower, cannabis​
735+22.24products, lower-potency hemp edibles, hemp-derived consumer products, or​
736+22.25tetrahydrocannabinol.​
737+22.26 (d) The office shall provide preliminary reports on the studies conducted pursuant to​
738+22.27paragraphs (a) to (c) to the legislature by January 15, 2024, and shall provide final reports​
739+22.28to the legislature by January 15, 2025. Each report may be consolidated with other annual​
740+22.29reports that the office is required to submit.​
741+22.30 (e) The office shall conduct a study on the state's mental health system and substance​
742+22.31use disorder treatment system to determine the rates at which individuals access those​
743+22.32systems. At a minimum, the report shall include information about the number of people​
741744 22​Article 1 Sec. 4.​
742-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 23.1demand for cannabis flower and cannabis products, the number and geographic distribution​
743-23.2of cannabis businesses needed to meet that demand, and the anticipated business from​
744-23.3residents of other states.​
745-23.4 (b) The office shall conduct a study to determine the size of the illicit cannabis market,​
746-23.5the sources of illicit cannabis flower and illicit cannabis products in the state, the locations​
747-23.6of citations issued and arrests made for cannabis offenses, and the subareas, such as census​
748-23.7tracts or neighborhoods, that experience a disproportionately large amount of cannabis​
749-23.8enforcement.​
750-23.9 (c) The office shall conduct a study on impaired driving to determine:​
751-23.10 (1) the number of accidents involving one or more drivers who admitted to using cannabis​
752-23.11flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products,​
753-23.12or who tested positive for cannabis or tetrahydrocannabinol;​
754-23.13 (2) the number of arrests of individuals for impaired driving in which the individual​
755-23.14tested positive for cannabis or tetrahydrocannabinol; and​
756-23.15 (3) the number of convictions for driving under the influence of cannabis flower, cannabis​
757-23.16products, lower-potency hemp edibles, hemp-derived consumer products, or​
758-23.17tetrahydrocannabinol.​
759-23.18 (d) The office shall provide preliminary reports on the studies conducted pursuant to​
760-23.19paragraphs (a) to (c) to the legislature by January 15, 2024, and shall provide final reports​
761-23.20to the legislature by January 15, 2025. The reports may be consolidated into a single report​
762-23.21by the office.​
763-23.22 (e) The office shall collect existing data from the Department of Human Services,​
764-23.23Department of Health, Minnesota state courts, and hospitals licensed under chapter 144 on​
765-23.24the utilization of mental health and substance use disorder services, emergency room visits,​
766-23.25and commitments to identify any increase in the services provided or any increase in the​
767-23.26number of visits or commitments. The office shall also obtain summary data from existing​
768-23.27first episode psychosis programs on the number of persons served by the programs and​
769-23.28number of persons on the waiting list. All information collected by the office under this​
770-23.29paragraph shall be included in the report required under paragraph (f).​
771-23.30 (f) The office shall conduct an annual market analysis on the status of the regulated​
772-23.31cannabis industry and submit a report of the findings. The office shall submit the report by​
773-23.32January 15, 2025, and each January 15 thereafter and the report may be combined with the​
774-23.33annual report submitted by the office. The process of completing the market analysis must​
745+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 23.1admitted to emergency rooms for treatment of a mental illness or substance use disorder,​
746+23.2ordered by a court to participate in mental health or substance use programming, and who​
747+23.3voluntarily agreed to accept mental health or substance use treatment or admission to a​
748+23.4state-operated treatment program or treatment facility. The report must include summary​
749+23.5data disaggregated by the month of admission or order; age, race, and sex of the individuals;​
750+23.6whether the admission or order was for a mental illness or substance use disorder; and, to​
751+23.7the extent known, the substance of abuse that resulted in the admission or order. Data must​
752+23.8be obtained, retained, and reported in a way that prevents the unauthorized release of private​
753+23.9data on individuals as defined in section 13.02. The office shall submit the report by January​
754+23.1015, 2027, and the report may be combined with the annual report submitted by the office.​
755+23.11 (f) The office shall conduct an annual market analysis on the status of the regulated​
756+23.12cannabis industry and submit a report of the findings. The office shall submit the report by​
757+23.13January 15 of each year and the report may be combined with the annual report submitted​
758+23.14by the office. The process of completing the market analysis must include holding public​
759+23.15meetings to solicit the input of consumers, market stakeholders, and potential new applicants​
760+23.16and must include an assessment as to whether the office has issued the necessary number​
761+23.17of licenses in order to:​
762+23.18 (1) ensure the sufficient supply of cannabis flower and cannabis products to meet demand;​
763+23.19 (2) provide market stability;​
764+23.20 (3) ensure a competitive market; and​
765+23.21 (4) limit the sale of unregulated cannabis flower and cannabis products.​
766+23.22 (g) The office shall submit an annual report to the legislature by January 15, 2024, and​
767+23.23each January 15 thereafter. The annual report shall include but not be limited to the following:​
768+23.24 (1) the status of the regulated cannabis industry;​
769+23.25 (2) the status of the illicit cannabis market;​
770+23.26 (3) the number of accidents, arrests, and convictions involving drivers who admitted to​
771+23.27using cannabis flower, cannabis products, lower-potency hemp products, or hemp-derived​
772+23.28consumer products, or who tested positive for cannabis or tetrahydrocannabinol;​
773+23.29 (4) the change in potency, if any, of cannabis flower and cannabis products available​
774+23.30through the regulated market;​
775775 23​Article 1 Sec. 4.​
776-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 24.1include holding public meetings to solicit the input of consumers, market stakeholders, and​
777-24.2potential new applicants and must include an assessment as to whether the office has issued​
778-24.3the necessary number of licenses in order to:​
779-24.4 (1) ensure the sufficient supply of cannabis flower and cannabis products to meet demand;​
780-24.5 (2) provide market stability;​
781-24.6 (3) ensure a competitive market; and​
782-24.7 (4) limit the sale of unregulated cannabis flower and cannabis products.​
783-24.8 (g) The office shall submit an annual report to the legislature by January 15, 2024, and​
784-24.9each January 15 thereafter. The annual report shall include but not be limited to the following:​
785-24.10 (1) the status of the regulated cannabis industry;​
786-24.11 (2) the status of the illicit cannabis market and hemp consumer industry;​
787-24.12 (3) the number of accidents, arrests, and convictions involving drivers who admitted to​
788-24.13using cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
789-24.14consumer products or who tested positive for cannabis or tetrahydrocannabinol;​
790-24.15 (4) the change in potency, if any, of cannabis flower and cannabis products available​
791-24.16through the regulated market;​
792-24.17 (5) progress on providing opportunities to individuals and communities that experienced​
793-24.18a disproportionate, negative impact from cannabis prohibition, including but not limited to​
794-24.19providing relief from criminal convictions and increasing economic opportunities;​
795-24.20 (6) the status of racial and geographic diversity in the cannabis industry;​
796-24.21 (7) proposed legislative changes, including but not limited to recommendations to​
797-24.22streamline licensing systems and related administrative processes;​
798-24.23 (8) information on the adverse effects of second-hand smoke from any cannabis flower,​
799-24.24cannabis products, and hemp-derived consumer products that are consumed by the​
800-24.25combustion or vaporization of the product and the inhalation of smoke, aerosol, or vapor​
801-24.26from the product; and​
802-24.27 (9) recommendations for the levels of funding for:​
803-24.28 (i) a coordinated education program to address and raise public awareness about the top​
804-24.29three adverse health effects, as determined by the commissioner of health, associated with​
805-24.30the use of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
806-24.31consumer products by individuals under 21 years of age;​
776+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 24.1 (5) progress on providing opportunities to individuals and communities that experienced​
777+24.2a disproportionate, negative impact from cannabis prohibition, including but not limited to​
778+24.3providing relief from criminal convictions and increasing economic opportunities;​
779+24.4 (6) the status of racial and geographic diversity in the cannabis industry;​
780+24.5 (7) proposed legislative changes;​
781+24.6 (8) information on the adverse effects of second-hand smoke from any cannabis flower,​
782+24.7cannabis products, and hemp-derived consumer products that are consumed by combustion​
783+24.8or vaporization of the product and inhalation of smoke, aerosol, or vapor from the product;​
784+24.9and​
785+24.10 (9) recommendations for levels of funding for:​
786+24.11 (i) a coordinated education program to address and raise public awareness about the top​
787+24.12three adverse health effects, as determined by the commissioner of health, associated with​
788+24.13the use of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
789+24.14consumer products by individuals under 21 years of age;​
790+24.15 (ii) a coordinated education program to educate pregnant women, breastfeeding women,​
791+24.16and women who may become pregnant on the adverse health effects of cannabis flower,​
792+24.17cannabis products, lower-potency hemp edibles, or hemp-derived consumer products;​
793+24.18 (iii) training, technical assistance, and educational materials for home visiting programs​
794+24.19and Tribal home visiting programs regarding safe and unsafe use of cannabis flower, cannabis​
795+24.20products, lower-potency hemp edibles, or hemp-derived consumer products in homes with​
796+24.21infants and young children;​
797+24.22 (iv) model programs to educate middle school and high school students on the health​
798+24.23effects on children and adolescents of the use of cannabis flower, cannabis products,​
799+24.24lower-potency hemp edibles, hemp-derived consumer products, and other intoxicating or​
800+24.25controlled substances;​
801+24.26 (v) grants issued through the CanTrain, CanNavigate, CanStartup, and CanGrow​
802+24.27programs;​
803+24.28 (vi) grants to organizations for community development in social equity communities​
804+24.29through the CanRenew program;​
805+24.30 (vii) training of peace officers and law enforcement agencies on changes to laws involving​
806+24.31cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
807+24.32products, and the law's impact on searches and seizures;​
807808 24​Article 1 Sec. 4.​
808-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 25.1 (ii) a coordinated education program to educate pregnant individuals, breastfeeding​
809-25.2individuals, and individuals who may become pregnant on the adverse health effects of​
810-25.3cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
811-25.4products;​
812-25.5 (iii) training, technical assistance, and educational materials for home visiting programs,​
813-25.6Tribal home visiting programs, and child welfare workers regarding safe and unsafe use of​
814-25.7cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
815-25.8products in homes with infants and young children;​
816-25.9 (iv) model programs to educate middle school and high school students on the health​
817-25.10effects on children and adolescents of the use of cannabis flower, cannabis products,​
818-25.11lower-potency hemp edibles, hemp-derived consumer products, and other intoxicating or​
819-25.12controlled substances;​
820-25.13 (v) grants issued through the CanTrain, CanNavigate, CanStartup, and CanGrow​
821-25.14programs;​
822-25.15 (vi) grants to organizations for community development in social equity communities​
823-25.16through the CanRenew program;​
824-25.17 (vii) training of peace officers and law enforcement agencies on changes to laws involving​
825-25.18cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
826-25.19products and the law's impact on searches and seizures;​
827-25.20 (viii) training of peace officers to increase the number of drug recognition experts;​
828-25.21 (ix) training of peace officers on the cultural uses of sage and distinguishing use of sage​
829-25.22from the use of cannabis flower, including whether the Board of Peace Officer Standards​
830-25.23and Training should approve or develop training materials;​
831-25.24 (x) the retirement and replacement of drug detection canines; and​
832-25.25 (xi) the Department of Human Services and county social service agencies to address​
833-25.26any increase in demand for services.​
834-25.27 (g) In developing the recommended funding levels under paragraph (f), clause (9), items​
835-25.28(vii) to (xi), the office shall consult with local law enforcement agencies, the Minnesota​
836-25.29Chiefs of Police Association, the Minnesota Sheriff's Association, the League of Minnesota​
837-25.30Cities, the Association of Minnesota Counties, and county social services agencies.​
838-25​Article 1 Sec. 4.​
839-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 26.1 Sec. 5. [342.05] STATEWIDE MONITORING SYSTEM.​
840-26.2 Subdivision 1.Statewide monitoring.The office must contract with an outside vendor​
841-26.3to establish a statewide monitoring system for integrated cannabis tracking, inventory, and​
842-26.4verification to track all cannabis plants, cannabis flower, and cannabis products from seed,​
843-26.5immature plant, or creation until disposal or sale to a patient or customer.​
844-26.6 Subd. 2.Data submission requirements.The monitoring system must allow cannabis​
845-26.7businesses to submit monitoring data to the office through the use of monitoring system​
846-26.8software commonly used within the cannabis industry and may also permit cannabis​
847-26.9businesses to submit monitoring data through manual data entry with approval from the​
848-26.10office.​
849-26.11Sec. 6. [342.06] APPROVAL OF CANNABIS FLOWER, PRODUCTS, AND​
850-26.12CANNABINOIDS.​
851-26.13 (a) For the purposes of this section, "product category" means a type of product that​
852-26.14may be sold in different sizes, distinct packaging, or at various prices but is still created​
853-26.15using the same manufacturing or agricultural processes. A new or additional stock keeping​
854-26.16unit (SKU) or Universal Product Code (UPC) shall not prevent a product from being​
855-26.17considered the same type as another unit. All other terms have the meanings provided in​
856-26.18section 342.01.​
857-26.19 (b) The office shall approve product categories of cannabis flower, cannabis products,​
858-26.20lower-potency hemp edibles, and hemp-derived consumer products for retail sale.​
859-26.21 (c) The office may establish limits on the total THC of cannabis flower, cannabis products,​
860-26.22and hemp-derived consumer products. As used in this paragraph, "total THC" means the​
861-26.23sum of the percentage by weight of tetrahydrocannabinolic acid multiplied by 0.877 plus​
862-26.24the percentage by weight of all tetrahydrocannabinols.​
863-26.25 (d) The office shall not approve any cannabis product, lower-potency hemp edible, or​
864-26.26hemp-derived consumer product that:​
865-26.27 (1) is or appears to be a lollipop or ice cream;​
866-26.28 (2) bears the likeness or contains characteristics of a real or fictional person, animal, or​
867-26.29fruit;​
868-26.30 (3) is modeled after a type or brand of products primarily consumed by or marketed to​
869-26.31children;​
870-26​Article 1 Sec. 6.​
871-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 27.1 (4) is substantively similar to a meat food product; poultry food product as defined in​
872-27.2section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision​
873-27.37;​
874-27.4 (5) contains a synthetic cannabinoid;​
875-27.5 (6) is made by applying a cannabinoid, including but not limited to an artificially derived​
876-27.6cannabinoid, to a finished food product that does not contain cannabinoids and is sold to​
877-27.7consumers, including but not limited to a candy or snack food; or​
878-27.8 (7) if the product is an edible cannabis product or lower-potency hemp edible, contains​
879-27.9an ingredient, other than a cannabinoid, that is not approved by the United States Food and​
880-27.10Drug Administration for use in food.​
881-27.11Sec. 7. [342.07] AGRICULTURAL AND FOOD SAFETY PRACTICES;​
882-27.12RULEMAKING.​
883-27.13 Subdivision 1.Plant propagation standards.In consultation with the commissioner​
884-27.14of agriculture, the office by rule must establish certification, testing, and labeling​
885-27.15requirements for the methods used to grow new cannabis plants or hemp plants, including​
886-27.16but not limited to growth from seed, clone, cutting, or tissue culture.​
887-27.17 Subd. 2.Agricultural best practices.In consultation with the commissioner of​
888-27.18agriculture and representatives from the University of Minnesota Extension Service, the​
889-27.19office shall establish best practices for:​
890-27.20 (1) the cultivation and preparation of cannabis plants; and​
891-27.21 (2) the use of pesticides, fertilizers, soil amendments, and plant amendments in relation​
892-27.22to growing cannabis plants.​
893-27.23 Subd. 3.Edible cannabinoid product handler endorsement.(a) Any person seeking​
894-27.24to manufacture, process, sell, handle, or store an edible cannabis product or lower-potency​
895-27.25hemp edible, other than an edible cannabis product or lower-potency hemp edible that has​
896-27.26been placed in its final packaging, must first obtain an edible cannabinoid product handler​
897-27.27endorsement.​
898-27.28 (b) In consultation with the commissioner of agriculture, the office shall establish an​
899-27.29edible cannabinoid product handler endorsement.​
900-27.30 (c) The office must regulate edible cannabinoid product handlers and assess penalties​
901-27.31in the same manner provided for food handlers under chapters 28A, 31, and 34A and​
902-27.32associated rules, with the following exceptions:​
809+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 25.1 (viii) training of peace officers to increase the number of drug recognition experts;​
810+25.2 (ix) training of peace officers on the cultural uses of sage and distinguishing use of sage​
811+25.3from the use of cannabis flower, including whether the Board of Peace Officer Standards​
812+25.4and Training should approve or develop training materials;​
813+25.5 (x) the retirement and replacement of drug detection dogs; and​
814+25.6 (xi) the Department of Human Services and county social service agencies to address​
815+25.7any increase in demand for services.​
816+25.8 (h) In developing the recommended funding levels under paragraph (g), clause (9), items​
817+25.9(vii) to (xi), the office shall consult with local law enforcement agencies, the Minnesota​
818+25.10Chiefs of Police Association, the Minnesota Sheriff's Association, the League of Minnesota​
819+25.11Cities, the Association of Minnesota Counties, and county social services agencies.​
820+25.12Sec. 5. [342.05] STATEWIDE MONITORING SYSTEM.​
821+25.13 Subdivision 1.Statewide monitoring.The office must contract with an outside vendor​
822+25.14to establish a statewide monitoring system for integrated cannabis tracking, inventory, and​
823+25.15verification to track all cannabis plants, cannabis flower, and cannabis products from seed,​
824+25.16immature plant, or creation until disposal or sale to a patient or customer.​
825+25.17 Subd. 2.Data submission requirements.The monitoring system must allow cannabis​
826+25.18businesses to submit monitoring data to the office through the use of monitoring system​
827+25.19software commonly used within the cannabis industry and may also permit cannabis​
828+25.20businesses to submit monitoring data through manual data entry with approval from the​
829+25.21office.​
830+25.22Sec. 6. [342.06] APPROVAL OF CANNABIS FLOWER, PRODUCTS, AND​
831+25.23CANNABINOIDS.​
832+25.24 (a) The office shall approve types of cannabis flower, cannabis products, lower-potency​
833+25.25hemp edibles, and hemp-derived consumer products for retail sale.​
834+25.26 (b) The office may establish limits on the total THC of cannabis flower, cannabis​
835+25.27products, and hemp-derived consumer products. As used in this paragraph, "total THC"​
836+25.28means the sum of the percentage by weight of tetrahydrocannabinolic acid multiplied by​
837+25.290.877 plus the percentage by weight of all tetrahydrocannabinols.​
838+25.30 (c) The office shall not approve any cannabis product, lower-potency hemp edible, or​
839+25.31hemp-derived consumer product that:​
840+25​Article 1 Sec. 6.​
841+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 26.1 (1) is or appears to be a lollipop or ice cream;​
842+26.2 (2) bears the likeness or contains characteristics of a real or fictional person, animal, or​
843+26.3fruit;​
844+26.4 (3) is modeled after a type or brand of products primarily consumed by or marketed to​
845+26.5children;​
846+26.6 (4) contains a synthetic cannabinoid;​
847+26.7 (5) is made by applying a cannabinoid, including but not limited to an artificially derived​
848+26.8cannabinoid, to a finished food product that does not contain cannabinoids and is sold to​
849+26.9consumers, including but not limited to a candy or snack food; or​
850+26.10 (6) if the product is an edible cannabis product or lower-potency hemp edible, contains​
851+26.11an ingredient, other than a cannabinoid, that is not approved by the United States Food and​
852+26.12Drug Administration for use in food.​
853+26.13 (d) The office must not approve any cannabis flower, cannabis product, or hemp-derived​
854+26.14consumer product that:​
855+26.15 (1) is intended to be consumed by combustion or vaporization of the product and​
856+26.16inhalation of smoke, aerosol, or vapor from the product; and​
857+26.17 (2) imparts a taste or smell, other than the taste or smell of cannabis flower, that is​
858+26.18distinguishable by an ordinary person before or during consumption of the product.​
859+26.19 (e) The office may adopt rules to limit or prohibit ingredients in or additives to cannabis​
860+26.20flower, cannabis products, or hemp-derived consumer products to ensure compliance with​
861+26.21the limitations in paragraph (d).​
862+26.22Sec. 7. [342.07] AGRICULTURAL AND FOOD SAFETY PRACTICES;​
863+26.23RULEMAKING.​
864+26.24 Subdivision 1.Plant propagation standards.In consultation with the commissioner​
865+26.25of agriculture, the office by rule must establish certification, testing, and labeling​
866+26.26requirements for the methods used to grow new cannabis plants or hemp plants, including​
867+26.27but not limited to growth from seed, clone, cutting, or tissue culture. The requirements must​
868+26.28prohibit the cultivation of cannabis plants derived from genetic engineering, as defined in​
869+26.29section 18F.02, subdivision 4.​
870+26.30 Subd. 2.Agricultural best practices.In consultation with the commissioner of​
871+26.31agriculture and representatives from the University of Minnesota Extension Service, the​
872+26.32office shall establish best practices for:​
873+26​Article 1 Sec. 7.​
874+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 27.1 (1) the cultivation and preparation of cannabis plants; and​
875+27.2 (2) the use of pesticides, fertilizers, soil amendments, and plant amendments in relation​
876+27.3to growing cannabis plants.​
877+27.4 Subd. 3.Edible cannabinoid product handler endorsement.(a) Any person seeking​
878+27.5to manufacture, process, sell, handle, or store an edible cannabis product or lower-potency​
879+27.6hemp edible, other than an edible cannabis product or lower-potency hemp edible that has​
880+27.7been placed in its final packaging, must first obtain an edible cannabinoid product handler​
881+27.8endorsement.​
882+27.9 (b) In consultation with the commissioner of agriculture, the office shall establish an​
883+27.10edible cannabinoid product handler endorsement.​
884+27.11 (c) The office must regulate edible cannabinoid product handlers and assess penalties​
885+27.12in the same manner provided for food handlers under chapters 28A, 31, and 34A and​
886+27.13associated rules, with the following exceptions:​
887+27.14 (1) the office must issue an edible cannabinoid product handler endorsement, rather than​
888+27.15a license;​
889+27.16 (2) eligibility for an edible cannabinoid product handler endorsement is limited to persons​
890+27.17who possess a valid license issued by the office;​
891+27.18 (3) the office may not charge a fee for issuing or renewing the endorsement;​
892+27.19 (4) the office must align the term and renewal period for edible cannabinoid product​
893+27.20handler endorsements with the term and renewal period of the license issued by the office;​
894+27.21and​
895+27.22 (5) an edible cannabis product or lower-potency hemp edible must not be considered​
896+27.23adulterated solely because the product contains tetrahydrocannabinol, cannabis concentrate,​
897+27.24hemp concentrate, artificially derived cannabinoids, or any other material extracted or​
898+27.25derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant parts.​
899+27.26 (d) The edible cannabinoid product handler endorsement must prohibit the manufacture​
900+27.27of edible cannabis products at the same premises where food is manufactured, except for​
901+27.28the limited production of edible products produced solely for product development, sampling,​
902+27.29or testing. This limitation does not apply to the manufacture of lower-potency hemp edibles.​
903903 27​Article 1 Sec. 7.​
904-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 28.1 (1) the office must issue an edible cannabinoid product handler endorsement, rather than​
905-28.2a license;​
906-28.3 (2) eligibility for an edible cannabinoid product handler endorsement is limited to persons​
907-28.4who possess a valid license issued by the office;​
908-28.5 (3) the office may not charge a fee for issuing or renewing the endorsement;​
909-28.6 (4) the office must align the term and renewal period for edible cannabinoid product​
910-28.7handler endorsements with the term and renewal period of the license issued by the office;​
911-28.8and​
912-28.9 (5) an edible cannabis product or lower-potency hemp edible must not be considered​
913-28.10adulterated solely because the product or edible contains tetrahydrocannabinol, cannabis​
914-28.11concentrate, hemp concentrate, artificially derived cannabinoids, or any other material​
915-28.12extracted or derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant​
916-28.13parts.​
917-28.14 (d) The edible cannabinoid product handler endorsement must prohibit the manufacture​
918-28.15of edible cannabis products at the same premises where food is manufactured, except for​
919-28.16the limited production of edible products produced solely for product development, sampling,​
920-28.17or testing. This limitation does not apply to the manufacture of lower-potency hemp edibles.​
921-28.18Sec. 8. [342.08] ESTABLISHMENT OF ENVIRONMENT AL STANDARDS.​
922-28.19 Subdivision 1.Water standards.In consultation with the commissioner of the Pollution​
923-28.20Control Agency, the office by rule must establish appropriate water standards for cannabis​
924-28.21businesses.​
925-28.22 Subd. 2.Energy use.In consultation with the commissioner of commerce, the office​
926-28.23by rule must establish appropriate energy standards for cannabis businesses.​
927-28.24 Subd. 3.Solid waste.In consultation with the commissioner of the Pollution Control​
928-28.25Agency, the office by rule must establish appropriate solid waste standards for the disposal​
929-28.26of:​
930-28.27 (1) cannabis flower and cannabis products;​
931-28.28 (2) packaging;​
932-28.29 (3) recyclable materials, including minimum requirements for the use of recyclable​
933-28.30materials; and​
934-28.31 (4) other solid waste.​
935-28​Article 1 Sec. 8.​
936-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 29.1 Subd. 4.Odor.The office by rule must establish appropriate standards and requirements​
937-29.2to limit odors produced by cannabis businesses.​
938-29.3 Subd. 5.Applicability; federal, state, and local laws.A cannabis business must comply​
939-29.4with all applicable federal, state, and local laws related to the subjects of subdivisions 1 to​
940-29.54.​
941-29.6 Subd. 6.Rulemaking.(a) The office may only adopt a rule under this section if the rule​
942-29.7is consistent with and at least as stringent as applicable state and federal laws related to the​
943-29.8subjects of subdivisions 1 to 4.​
944-29.9 (b) The office must coordinate and consult with a department or agency of the state​
945-29.10regarding the development and implementation of a rule under this section if the department​
946-29.11or agency has expertise or a regulatory interest in the subject matter of the rule.​
947-29.12Sec. 9. [342.09] PERSONAL ADULT USE OF CANNABIS.​
948-29.13 Subdivision 1.Personal adult use, possession, and transportation of cannabis flower​
949-29.14and cannabinoid products.(a) An individual 21 years of age or older may:​
950-29.15 (1) use, possess, or transport cannabis paraphernalia;​
951-29.16 (2) possess or transport two ounces or less of adult-use cannabis flower in a public place;​
952-29.17 (3) possess two pounds or less of adult-use cannabis flower in the individual's private​
953-29.18residence;​
954-29.19 (4) possess or transport eight grams or less of adult-use cannabis concentrate;​
955-29.20 (5) possess or transport edible cannabis products or lower-potency hemp edibles infused​
956-29.21with a combined total of 800 milligrams or less of tetrahydrocannabinol;​
957-29.22 (6) give for no remuneration to an individual who is at least 21 years of age:​
958-29.23 (i) two ounces or less of adult-use cannabis flower;​
959-29.24 (ii) eight grams or less of adult-use cannabis concentrate; or​
960-29.25 (iii) an edible cannabis product or lower-potency hemp edible infused with 800 milligrams​
961-29.26or less of tetrahydrocannabinol; and​
962-29.27 (7) use adult-use cannabis flower and adult-use cannabis products in the following​
963-29.28locations:​
964-29.29 (i) a private residence, including the individual's curtilage or yard;​
904+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 28.1 Sec. 8. [342.08] ESTABLISHMENT OF ENVIRONMENT AL STANDARDS.​
905+28.2 Subdivision 1.Water standards.In consultation with the commissioner of the Pollution​
906+28.3Control Agency, the office by rule must establish appropriate water standards for cannabis​
907+28.4businesses.​
908+28.5 Subd. 2.Energy use.In consultation with the commissioner of commerce, the office​
909+28.6by rule must establish appropriate energy standards for cannabis businesses.​
910+28.7 Subd. 3.Solid waste.In consultation with the commissioner of the Pollution Control​
911+28.8Agency, the office by rule must establish appropriate solid waste standards for the disposal​
912+28.9of:​
913+28.10 (1) cannabis flower and cannabis products;​
914+28.11 (2) packaging;​
915+28.12 (3) recyclable materials, including minimum requirements for the use of recyclable​
916+28.13materials; and​
917+28.14 (4) other solid waste.​
918+28.15 Subd. 4.Odor.The office by rule must establish appropriate standards and requirements​
919+28.16to limit odors produced by cannabis businesses.​
920+28.17 Subd. 5.Applicability; federal, state, and local laws.A cannabis business must comply​
921+28.18with all applicable federal, state, and local laws related to the subjects of subdivisions 1 to​
922+28.194.​
923+28.20 Subd. 6.Rulemaking.(a) The office may only adopt a rule under this section if the rule​
924+28.21is consistent with and at least as stringent as applicable state and federal laws related to the​
925+28.22subjects of subdivisions 1 to 4.​
926+28.23 (b) The office must coordinate and consult with a department or agency of the state​
927+28.24regarding the development and implementation of a rule under this section if the department​
928+28.25or agency has expertise or a regulatory interest in the subject matter of the rule.​
929+28.26Sec. 9. [342.09] PERSONAL ADULT USE OF CANNABIS.​
930+28.27 Subdivision 1.Personal adult use, possession, and transportation of cannabis flower​
931+28.28and cannabinoid products.(a) An individual 21 years of age or older may:​
932+28.29 (1) use, possess, or transport cannabis paraphernalia;​
933+28.30 (2) possess or transport two ounces or less of adult-use cannabis flower in a public place;​
934+28​Article 1 Sec. 9.​
935+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 29.1 (3) possess 1.5 pounds or less of adult-use cannabis flower in the individual's private​
936+29.2residence;​
937+29.3 (4) possess or transport eight grams or less of adult-use cannabis concentrate;​
938+29.4 (5) possess or transport edible cannabis products and lower-potency hemp edibles infused​
939+29.5with a combined total of 800 milligrams or less of tetrahydrocannabinol;​
940+29.6 (6) give for no remuneration two ounces or less of adult-use cannabis flower, eight grams​
941+29.7or less of adult-use cannabis concentrate, or edible cannabis products and lower-potency​
942+29.8hemp edibles infused with 800 milligrams or less of tetrahydrocannabinol to an individual​
943+29.9who is at least 21 years of age; and​
944+29.10 (7) use adult-use cannabis flower and adult-use cannabis products in the following​
945+29.11locations:​
946+29.12 (i) a private residence, including the individual's curtilage or yard;​
947+29.13 (ii) on private property, not generally accessible by the public, unless the individual is​
948+29.14explicitly prohibited from consuming cannabis flower, cannabis products, lower-potency​
949+29.15hemp edibles, or hemp-derived consumer products on the property by the owner of the​
950+29.16property; or​
951+29.17 (iii) on the premises of an establishment or event licensed to permit on-site consumption.​
952+29.18 (b) Except as provided in paragraph (c), an individual may not:​
953+29.19 (1) use, possess, or transport cannabis flower, cannabis products, lower-potency hemp​
954+29.20edibles, or hemp-derived consumer products if the individual is under 21 years of age;​
955+29.21 (2) use cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
956+29.22consumer products in a motor vehicle as defined in section 169A.03, subdivision 15;​
957+29.23 (3) use cannabis flower, cannabis products, or hemp-derived consumer products in a​
958+29.24manner that involves the inhalation of smoke, aerosol, or vapor at any location where​
959+29.25smoking is prohibited under section 144.414;​
960+29.26 (4) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or​
961+29.27hemp-derived consumer products in a public school, as defined in section 120A.05,​
962+29.28subdivisions 9, 11, and 13, or in a charter school governed by chapter 124E, including all​
963+29.29facilities, whether owned, rented, or leased, and all vehicles that a school district owns,​
964+29.30leases, rents, contracts for, or controls;​
965+29.31 (5) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or​
966+29.32hemp-derived consumer products in a state correctional facility;​
965967 29​Article 1 Sec. 9.​
966-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 30.1 (ii) on private property, not generally accessible by the public, unless the individual is​
967-30.2explicitly prohibited from consuming cannabis flower, cannabis products, lower-potency​
968-30.3hemp edibles, or hemp-derived consumer products on the property by the owner of the​
969-30.4property; or​
970-30.5 (iii) on the premises of an establishment or event licensed to permit on-site consumption.​
971-30.6 (b) Except as provided in paragraph (c), an individual may not:​
972-30.7 (1) use, possess, or transport cannabis flower, cannabis products, lower-potency hemp​
973-30.8edibles, or hemp-derived consumer products if the individual is under 21 years of age;​
974-30.9 (2) use cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
975-30.10consumer products in a motor vehicle as defined in section 169A.03, subdivision 15;​
976-30.11 (3) use cannabis flower, cannabis products, or hemp-derived consumer products in a​
977-30.12manner that involves the inhalation of smoke, aerosol, or vapor at any location where​
978-30.13smoking is prohibited under section 144.414;​
979-30.14 (4) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or​
980-30.15hemp-derived consumer products in a public school, as defined in section 120A.05,​
981-30.16subdivisions 9, 11, and 13, or in a charter school governed by chapter 124E, including all​
982-30.17facilities, whether owned, rented, or leased, and all vehicles that a school district owns,​
983-30.18leases, rents, contracts for, or controls;​
984-30.19 (5) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or​
985-30.20hemp-derived consumer products in a state correctional facility;​
986-30.21 (6) operate a motor vehicle while under the influence of cannabis flower, cannabis​
987-30.22products, lower-potency hemp edibles, or hemp-derived consumer products;​
988-30.23 (7) give for no remuneration cannabis flower, cannabis products, lower-potency hemp​
989-30.24edibles, or hemp-derived consumer products to an individual under 21 years of age;​
990-30.25 (8) give for no remuneration cannabis flower or cannabis products as a sample or​
991-30.26promotional gift if the giver is in the business of selling goods or services; or​
992-30.27 (9) vaporize or smoke cannabis flower, cannabis products, artificially derived​
993-30.28cannabinoids, or hemp-derived consumer products in any location where the smoke, aerosol,​
994-30.29or vapor would be inhaled by a minor.​
995-30.30 (c) The prohibitions under paragraph (b), clauses (1) to (4), do not apply to use other​
996-30.31than by smoking or by a vaporized delivery method, possession, or transportation of medical​
968+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 30.1 (6) operate a motor vehicle while under the influence of cannabis flower, cannabis​
969+30.2products, lower-potency hemp edibles, or hemp-derived consumer products;​
970+30.3 (7) give for no remuneration cannabis flower, cannabis products, lower-potency hemp​
971+30.4edibles, or hemp-derived consumer products to an individual under 21 years of age; or​
972+30.5 (8) give for no remuneration cannabis flower or cannabis products as a sample or​
973+30.6promotional gift if the giver is in the business of selling goods or services.​
974+30.7 (c) The prohibitions under paragraph (b), clauses (1) to (4), do not apply to use other​
975+30.8than by smoking or by a vaporized delivery method, possession, or transportation of medical​
976+30.9cannabis flower or medical cannabinoid products by a patient; a registered designated​
977+30.10caregiver; or a parent, legal guardian, or spouse of a patient.​
978+30.11 (d) A proprietor of a family or group family day care program must disclose to parents​
979+30.12or guardians of children cared for on the premises of the family or group family day care​
980+30.13program, if the proprietor permits the smoking or use of cannabis flower, cannabis products,​
981+30.14lower-potency hemp edibles, or hemp-derived consumer products on the premises outside​
982+30.15of its hours of operation. Disclosure must include posting on the premises a conspicuous​
983+30.16written notice and orally informing parents or guardians.​
984+30.17 Subd. 2.Home cultivation of cannabis for personal adult use.Up to eight cannabis​
985+30.18plants, with no more than four being mature, flowering plants may be grown at a single​
986+30.19residence, including the curtilage or yard, without a license to cultivate cannabis issued​
987+30.20under this chapter provided that cultivation takes place at the primary residence of an​
988+30.21individual 21 years of age or older and in an enclosed, locked space that is not open to public​
989+30.22view.​
990+30.23 Subd. 3.Home extraction of cannabis concentrate by use of volatile solvent​
991+30.24prohibited.No person may use a volatile solvent to separate or extract cannabis concentrate​
992+30.25or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis​
993+30.26manufacturer, medical cannabis processor, or lower-potency hemp edible manufacturer​
994+30.27license issued under this chapter.​
995+30.28 Subd. 4.Sale of cannabis flower and products prohibited.No person may sell cannabis​
996+30.29flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products​
997+30.30without a license issued under this chapter that authorizes the sale.​
998+30.31 Subd. 5.Importation of hemp-derived products.No person may import lower-potency​
999+30.32hemp edibles or hemp-derived consumer products that are manufactured outside the​
1000+30.33boundaries of the state of Minnesota with the intent to sell the products to consumers within​
9971001 30​Article 1 Sec. 9.​
998-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 31.1cannabis flower or medical cannabinoid products by a patient; a registered designated​
999-31.2caregiver; or a parent, legal guardian, or spouse of a patient.​
1000-31.3 (d) A proprietor of a family or group family day care program must disclose to parents​
1001-31.4or guardians of children cared for on the premises of the family or group family day care​
1002-31.5program, if the proprietor permits the smoking or use of cannabis flower, cannabis products,​
1003-31.6lower-potency hemp edibles, or hemp-derived consumer products on the premises outside​
1004-31.7of its hours of operation. Disclosure must include posting on the premises a conspicuous​
1005-31.8written notice and orally informing parents or guardians. Cannabis flower or cannabis​
1006-31.9products must be inaccessible to children and stored away from food products.​
1007-31.10 Subd. 2.Home cultivation of cannabis for personal adult use.Up to eight cannabis​
1008-31.11plants, with no more than four being mature, flowering plants may be grown at a single​
1009-31.12residence, including the curtilage or yard, without a license to cultivate cannabis issued​
1010-31.13under this chapter provided that cultivation takes place at the primary residence of an​
1011-31.14individual 21 years of age or older and in an enclosed, locked space that is not open to public​
1012-31.15view.​
1013-31.16 Subd. 3.Home extraction of cannabis concentrate by use of volatile solvent​
1014-31.17prohibited.No person may use a volatile solvent to separate or extract cannabis concentrate​
1015-31.18or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis​
1016-31.19manufacturer, medical cannabis processor, or lower-potency hemp edible manufacturer​
1017-31.20license issued under this chapter.​
1018-31.21 Subd. 4.Sale of cannabis flower and products prohibited.No person may sell cannabis​
1019-31.22flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products​
1020-31.23without a license issued under this chapter that authorizes the sale.​
1021-31.24 Subd. 5.Importation of hemp-derived products.No person may import lower-potency​
1022-31.25hemp edibles or hemp-derived consumer products that are manufactured outside the​
1023-31.26boundaries of the state of Minnesota with the intent to sell the edibles or products to​
1024-31.27consumers within the state or to any other person or business that intends to sell the edibles​
1025-31.28or products to consumers within the state without a license issued under this chapter that​
1026-31.29authorizes the importation of such edibles or products. This subdivision does not apply to​
1027-31.30edibles or products lawfully purchased for personal use.​
1028-31.31 Subd. 6.Violations; penalties.(a) In addition to penalties listed in this subdivision, a​
1029-31.32person who violates the provisions of this chapter is subject to any applicable criminal​
1030-31.33penalty.​
1002+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 31.1the state or to any other person or business that intends to sell the products to consumers​
1003+31.2within the state without a license issued under this chapter that authorizes the importation​
1004+31.3of such products. This subdivision does not apply to products lawfully purchased for personal​
1005+31.4use.​
1006+31.5 Subd. 6.Violations; penalties.(a) In addition to penalties listed in this subdivision, a​
1007+31.6person who violates the provisions of this chapter is subject to any applicable criminal​
1008+31.7penalty.​
1009+31.8 (b) The office may assess the following civil penalties on a person who sells cannabis​
1010+31.9flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products​
1011+31.10without a license issued under this chapter that authorizes the sale:​
1012+31.11 (1) if the person sells up to two ounces of cannabis flower, up to $3,000 or three times​
1013+31.12the retail market value of the cannabis flower, whichever is greater;​
1014+31.13 (2) if the person sells more than two ounces but not more than eight ounces of cannabis​
1015+31.14flower, up to $10,000 or three times the retail market value of the cannabis flower, whichever​
1016+31.15is greater;​
1017+31.16 (3) if the person sells more than eight ounces but not more than one pound of cannabis​
1018+31.17flower, up to $25,000 or three times the retail market value of the cannabis flower, whichever​
1019+31.18is greater;​
1020+31.19 (4) if the person sells more than one pound but not more than five pounds of cannabis​
1021+31.20flower, up to $50,000 or three times the retail market value of the cannabis flower, whichever​
1022+31.21is greater;​
1023+31.22 (5) if the person sells more than five pounds but not more than 25 pounds of cannabis​
1024+31.23flower, up to $100,000 or three times the retail market value of the cannabis flower,​
1025+31.24whichever is greater;​
1026+31.25 (6) if the person sells more than 25 pounds but not more than 50 pounds of cannabis​
1027+31.26flower, up to $250,000 or three times the retail market value of the cannabis flower,​
1028+31.27whichever is greater; and​
1029+31.28 (7) if the person sells more than 50 pounds of cannabis flower, up to $1,000,000 or three​
1030+31.29times the retail market value of the cannabis flower, whichever is greater.​
1031+31.30 (c) The office may assess the following civil penalties on a person who sells cannabis​
1032+31.31concentrate without a license issued under this chapter that authorizes the sale:​
10311033 31​Article 1 Sec. 9.​
1032-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 32.1 (b) The office may assess the following civil penalties on a person who sells cannabis​
1033-32.2flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products​
1034-32.3without a license issued under this chapter that authorizes the sale:​
1035-32.4 (1) if the person sells up to two ounces of cannabis flower, up to $3,000 or three times​
1036-32.5the retail market value of the cannabis flower, whichever is greater;​
1037-32.6 (2) if the person sells more than two ounces but not more than eight ounces of cannabis​
1038-32.7flower, up to $10,000 or three times the retail market value of the cannabis flower, whichever​
1039-32.8is greater;​
1040-32.9 (3) if the person sells more than eight ounces but not more than one pound of cannabis​
1041-32.10flower, up to $25,000 or three times the retail market value of the cannabis flower, whichever​
1042-32.11is greater;​
1043-32.12 (4) if the person sells more than one pound but not more than five pounds of cannabis​
1044-32.13flower, up to $50,000 or three times the retail market value of the cannabis flower, whichever​
1045-32.14is greater;​
1046-32.15 (5) if the person sells more than five pounds but not more than 25 pounds of cannabis​
1047-32.16flower, up to $100,000 or three times the retail market value of the cannabis flower,​
1048-32.17whichever is greater;​
1049-32.18 (6) if the person sells more than 25 pounds but not more than 50 pounds of cannabis​
1050-32.19flower, up to $250,000 or three times the retail market value of the cannabis flower,​
1051-32.20whichever is greater; and​
1052-32.21 (7) if the person sells more than 50 pounds of cannabis flower, up to $1,000,000 or three​
1053-32.22times the retail market value of the cannabis flower, whichever is greater.​
1054-32.23 (c) The office may assess the following civil penalties on a person who sells cannabis​
1055-32.24concentrate without a license issued under this chapter that authorizes the sale:​
1056-32.25 (1) if the person sells up to eight grams of cannabis concentrate, up to $3,000 or three​
1057-32.26times the retail market value of the cannabis concentrate, whichever is greater;​
1058-32.27 (2) if the person sells more than eight grams but not more than 40 grams of cannabis​
1059-32.28concentrate, up to $10,000 or three times the retail market value of the cannabis concentrate,​
1060-32.29whichever is greater;​
1061-32.30 (3) if the person sells more than 40 grams but not more than 80 grams of cannabis​
1062-32.31concentrate, up to $25,000 or three times the retail market value of the cannabis concentrate,​
1063-32.32whichever is greater;​
1034+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 32.1 (1) if the person sells up to eight grams of cannabis concentrate, up to $3,000 or three​
1035+32.2times the retail market value of the cannabis concentrate, whichever is greater;​
1036+32.3 (2) if the person sells more than eight grams but not more than 40 grams of cannabis​
1037+32.4concentrate, up to $10,000 or three times the retail market value of the cannabis concentrate,​
1038+32.5whichever is greater;​
1039+32.6 (3) if the person sells more than 40 grams but not more than 80 grams of cannabis​
1040+32.7concentrate, up to $25,000 or three times the retail market value of the cannabis concentrate,​
1041+32.8whichever is greater;​
1042+32.9 (4) if the person sells more than 80 grams but not more than 400 grams of cannabis​
1043+32.10concentrate, up to $50,000 or three times the retail market value of the cannabis concentrate,​
1044+32.11whichever is greater;​
1045+32.12 (5) if the person sells more than 400 grams but not more than two kilograms of cannabis​
1046+32.13concentrate, up to $100,000 or three times the retail market value of the cannabis concentrate,​
1047+32.14whichever is greater;​
1048+32.15 (6) if the person sells more than two kilograms but not more than four kilograms of​
1049+32.16cannabis concentrate, up to $250,000 or three times the retail market value of the cannabis​
1050+32.17concentrate, whichever is greater; and​
1051+32.18 (7) if the person sells more than four kilograms of cannabis concentrate, up to $1,000,000​
1052+32.19or three times the retail market value of the cannabis concentrate, whichever is greater.​
1053+32.20 (d) The office may assess the following civil penalties on a person who imports or sells​
1054+32.21products infused with tetrahydrocannabinol without a license issued under this chapter that​
1055+32.22authorizes the importation or sale:​
1056+32.23 (1) if the person imports or sells products infused with up to 800 milligrams of​
1057+32.24tetrahydrocannabinol, up to $3,000 or three times the retail market value of the infused​
1058+32.25product, whichever is greater;​
1059+32.26 (2) if the person imports or sells products infused with a total of more than 800 milligrams​
1060+32.27but not more than four grams of tetrahydrocannabinol, up to $10,000 or three times the​
1061+32.28retail market value of the infused product, whichever is greater;​
1062+32.29 (3) if the person imports or sells products infused with a total of more than four grams​
1063+32.30but not more than eight grams of tetrahydrocannabinol, up to $25,000 or three times the​
1064+32.31retail market value of the infused product, whichever is greater;​
10641065 32​Article 1 Sec. 9.​
1065-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 33.1 (4) if the person sells more than 80 grams but not more than 400 grams of cannabis​
1066-33.2concentrate, up to $50,000 or three times the retail market value of the cannabis concentrate,​
1067-33.3whichever is greater;​
1068-33.4 (5) if the person sells more than 400 grams but not more than two kilograms of cannabis​
1069-33.5concentrate, up to $100,000 or three times the retail market value of the cannabis concentrate,​
1070-33.6whichever is greater;​
1071-33.7 (6) if the person sells more than two kilograms but not more than four kilograms of​
1072-33.8cannabis concentrate, up to $250,000 or three times the retail market value of the cannabis​
1073-33.9concentrate, whichever is greater; and​
1074-33.10 (7) if the person sells more than four kilograms of cannabis concentrate, up to $1,000,000​
1075-33.11or three times the retail market value of the cannabis concentrate, whichever is greater.​
1076-33.12 (d) The office may assess the following civil penalties on a person who imports or sells​
1077-33.13products infused with tetrahydrocannabinol without a license issued under this chapter that​
1078-33.14authorizes the importation or sale:​
1079-33.15 (1) if the person imports or sells products infused with up to 800 milligrams of​
1080-33.16tetrahydrocannabinol, up to $3,000 or three times the retail market value of the infused​
1081-33.17product, whichever is greater;​
1082-33.18 (2) if the person imports or sells products infused with a total of more than 800 milligrams​
1083-33.19but not more than four grams of tetrahydrocannabinol, up to $10,000 or three times the​
1084-33.20retail market value of the infused product, whichever is greater;​
1085-33.21 (3) if the person imports or sells products infused with a total of more than four grams​
1086-33.22but not more than eight grams of tetrahydrocannabinol, up to $25,000 or three times the​
1087-33.23retail market value of the infused product, whichever is greater;​
1088-33.24 (4) if the person imports or sells products infused with a total of more than eight grams​
1089-33.25but not more than 40 grams of tetrahydrocannabinol, up to $50,000 or three times the retail​
1090-33.26market value of the infused product, whichever is greater;​
1091-33.27 (5) if the person imports or sells products infused with a total of more than 40 grams​
1092-33.28but not more than 200 grams of tetrahydrocannabinol, up to $100,000 or three times the​
1093-33.29retail market value of the infused product, whichever is greater;​
1094-33.30 (6) if the person imports or sells products infused with a total of more than 200 grams​
1095-33.31but not more than 400 grams of tetrahydrocannabinol, up to $250,000 or three times the​
1096-33.32retail market value of the infused product, whichever is greater; and​
1097-33​Article 1 Sec. 9.​
1098-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 34.1 (7) if the person imports or sells products infused with a total of more than 400 grams​
1099-34.2of tetrahydrocannabinol, up to $1,000,000 or three times the retail market value of the​
1100-34.3infused product, whichever is greater.​
1101-34.4 (e) The office may assess a civil penalty of up to $500 for each plant grown in excess​
1102-34.5of the limit on a person who grows more than eight cannabis plants or more than four mature,​
1103-34.6flowering plants, without a license to cultivate cannabis issued under this chapter.​
1104-34.7 Sec. 10. [342.10] LICENSES; TYPES.​
1105-34.8 The office shall issue the following types of license:​
1106-34.9 (1) cannabis microbusiness;​
1107-34.10 (2) cannabis mezzobusiness;​
1108-34.11 (3) cannabis cultivator;​
1109-34.12 (4) cannabis manufacturer;​
1110-34.13 (5) cannabis retailer;​
1111-34.14 (6) cannabis wholesaler;​
1112-34.15 (7) cannabis transporter;​
1113-34.16 (8) cannabis testing facility;​
1114-34.17 (9) cannabis event organizer;​
1115-34.18 (10) cannabis delivery service;​
1116-34.19 (11) lower-potency hemp edible manufacturer;​
1117-34.20 (12) lower-potency hemp edible retailer;​
1118-34.21 (13) medical cannabis cultivator;​
1119-34.22 (14) medical cannabis processor;​
1120-34.23 (15) medical cannabis retailer; or​
1121-34.24 (16) medical cannabis combination business.​
1122-34.25Sec. 11. [342.11] LICENSES; FEES.​
1123-34.26 (a) The office shall require the payment of application fees, initial licensing fees, and​
1124-34.27renewal licensing fees as provided in this section. The initial license fee shall include the​
1125-34.28fee for initial issuance of the license and the first annual renewal. The renewal fee shall be​
1066+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 33.1 (4) if the person imports or sells products infused with a total of more than eight grams​
1067+33.2but not more than 40 grams of tetrahydrocannabinol, up to $50,000 or three times the retail​
1068+33.3market value of the infused product, whichever is greater;​
1069+33.4 (5) if the person imports or sells products infused with a total of more than 40 grams​
1070+33.5but not more than 200 grams of tetrahydrocannabinol, up to $100,000 or three times the​
1071+33.6retail market value of the infused product, whichever is greater;​
1072+33.7 (6) if the person imports or sells products infused with a total of more than 200 grams​
1073+33.8but not more than 400 grams of tetrahydrocannabinol, up to $250,000 or three times the​
1074+33.9retail market value of the infused product, whichever is greater; and​
1075+33.10 (7) if the person imports or sells products infused with a total of more than 400 grams​
1076+33.11of tetrahydrocannabinol, up to $1,000,000 or three times the retail market value of the​
1077+33.12infused product, whichever is greater.​
1078+33.13 (e) The office may assess a civil penalty of up to $500 for each plant grown in excess​
1079+33.14of the limit on a person who grows more than eight cannabis plants or more than four mature,​
1080+33.15flowering plants, without a license to cultivate cannabis issued under this chapter.​
1081+33.16Sec. 10. [342.10] LICENSES; TYPES.​
1082+33.17 The office shall issue the following types of license:​
1083+33.18 (1) cannabis microbusiness;​
1084+33.19 (2) cannabis mezzobusiness;​
1085+33.20 (3) cannabis cultivator;​
1086+33.21 (4) cannabis manufacturer;​
1087+33.22 (5) cannabis retailer;​
1088+33.23 (6) cannabis wholesaler;​
1089+33.24 (7) cannabis transporter;​
1090+33.25 (8) cannabis testing facility;​
1091+33.26 (9) cannabis event organizer;​
1092+33.27 (10) cannabis delivery service;​
1093+33.28 (11) lower-potency hemp edible manufacturer;​
1094+33.29 (12) lower-potency hemp edible retailer;​
1095+33​Article 1 Sec. 10.​
1096+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 34.1 (13) medical cannabis cultivator;​
1097+34.2 (14) medical cannabis processor; or​
1098+34.3 (15) medical cannabis retailer.​
1099+34.4 Sec. 11. [342.11] LICENSES; FEES.​
1100+34.5 (a) The office shall require the payment of application fees, initial licensing fees, and​
1101+34.6renewal licensing fees as provided in this section. The initial license fee shall include the​
1102+34.7fee for initial issuance of the license and the first annual renewal. The renewal fee shall be​
1103+34.8charged at the time of the second renewal and each subsequent annual renewal thereafter.​
1104+34.9Nothing in this section prohibits a local unit of government from charging the retailer​
1105+34.10registration fee established in section 342.22. Application fees, initial licensing fees, and​
1106+34.11renewal licensing fees are nonrefundable.​
1107+34.12 (b) Application and licensing fees shall be as follows:​
1108+34.13 (1) for a cannabis microbusiness:​
1109+34.14 (i) an application fee of $500;​
1110+34.15 (ii) an initial license fee of $0; and​
1111+34.16 (iii) a renewal license fee of $2,000;​
1112+34.17 (2) for a cannabis mezzobusiness:​
1113+34.18 (i) an application fee of $5,000;​
1114+34.19 (ii) an initial license fee of $5,000; and​
1115+34.20 (iii) a renewal license fee of $10,000;​
1116+34.21 (3) for a cannabis cultivator:​
1117+34.22 (i) an application fee of $10,000;​
1118+34.23 (ii) an initial license fee of $20,000; and​
1119+34.24 (iii) a renewal license fee of $30,000;​
1120+34.25 (4) for a cannabis manufacturer:​
1121+34.26 (i) an application fee of $10,000;​
1122+34.27 (ii) an initial license fee of $10,000; and​
1123+34.28 (iii) a renewal license fee of $20,000;​
11261124 34​Article 1 Sec. 11.​
1127-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 35.1charged at the time of the second renewal and each subsequent annual renewal thereafter.​
1128-35.2Nothing in this section prohibits a local unit of government from charging the retailer​
1129-35.3registration fee established in section 342.22. Application fees, initial licensing fees, and​
1130-35.4renewal licensing fees are nonrefundable.​
1131-35.5 (b) Application and licensing fees shall be as follows:​
1132-35.6 (1) for a cannabis microbusiness:​
1133-35.7 (i) an application fee of $500;​
1134-35.8 (ii) an initial license fee of $0; and​
1135-35.9 (iii) a renewal license fee of $2,000;​
1136-35.10 (2) for a cannabis mezzobusiness:​
1137-35.11 (i) an application fee of $5,000;​
1138-35.12 (ii) an initial license fee of $5,000; and​
1139-35.13 (iii) a renewal license fee of $10,000;​
1140-35.14 (3) for a cannabis cultivator:​
1141-35.15 (i) an application fee of $10,000;​
1142-35.16 (ii) an initial license fee of $20,000; and​
1143-35.17 (iii) a renewal license fee of $30,000;​
1144-35.18 (4) for a cannabis manufacturer:​
1145-35.19 (i) an application fee of $10,000;​
1146-35.20 (ii) an initial license fee of $10,000; and​
1147-35.21 (iii) a renewal license fee of $20,000;​
1148-35.22 (5) for a cannabis retailer:​
1149-35.23 (i) an application fee of $2,500;​
1150-35.24 (ii) an initial license fee of $2,500; and​
1151-35.25 (iii) a renewal license fee of $5,000;​
1152-35.26 (6) for a cannabis wholesaler:​
1153-35.27 (i) an application fee of $5,000;​
1154-35.28 (ii) an initial license fee of $5,000; and​
1125+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 35.1 (5) for a cannabis retailer:​
1126+35.2 (i) an application fee of $2,500;​
1127+35.3 (ii) an initial license fee of $2,500; and​
1128+35.4 (iii) a renewal license fee of $5,000;​
1129+35.5 (6) for a cannabis wholesaler:​
1130+35.6 (i) an application fee of $5,000;​
1131+35.7 (ii) an initial license fee of $5,000; and​
1132+35.8 (iii) a renewal license fee of $10,000;​
1133+35.9 (7) for a cannabis transporter:​
1134+35.10 (i) an application fee of $250;​
1135+35.11 (ii) an initial license fee of $500; and​
1136+35.12 (iii) a renewal license fee of $1,000;​
1137+35.13 (8) for a cannabis testing facility:​
1138+35.14 (i) an application fee of $250;​
1139+35.15 (ii) an initial license fee of $0; and​
1140+35.16 (iii) a renewal license fee of $0;​
1141+35.17 (9) for a cannabis delivery service:​
1142+35.18 (i) an application fee of $250;​
1143+35.19 (ii) an initial license fee of $500; and​
1144+35.20 (iii) a renewal license fee of $1,000;​
1145+35.21 (10) for a cannabis event organizer:​
1146+35.22 (i) an application fee of $750; and​
1147+35.23 (ii) an initial license fee of $750;​
1148+35.24 (11) for a lower-potency hemp edible manufacturer:​
1149+35.25 (i) an application fee of $250;​
1150+35.26 (ii) an initial license fee of $500; and​
1151+35.27 (iii) a renewal license fee of $500;​
11551152 35​Article 1 Sec. 11.​
1156-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 36.1 (iii) a renewal license fee of $10,000;​
1157-36.2 (7) for a cannabis transporter:​
1158-36.3 (i) an application fee of $250;​
1159-36.4 (ii) an initial license fee of $500; and​
1160-36.5 (iii) a renewal license fee of $1,000;​
1161-36.6 (8) for a cannabis testing facility:​
1162-36.7 (i) an application fee of $5,000;​
1163-36.8 (ii) an initial license fee of $5,000; and​
1164-36.9 (iii) a renewal license fee of $10,000;​
1165-36.10 (9) for a cannabis delivery service:​
1166-36.11 (i) an application fee of $250;​
1167-36.12 (ii) an initial license fee of $500; and​
1168-36.13 (iii) a renewal license fee of $1,000;​
1169-36.14 (10) for a cannabis event organizer:​
1170-36.15 (i) an application fee of $750; and​
1171-36.16 (ii) an initial license fee of $750;​
1172-36.17 (11) for a lower-potency hemp edible manufacturer:​
1173-36.18 (i) an application fee of $250;​
1174-36.19 (ii) an initial license fee of $1,000; and​
1175-36.20 (iii) a renewal license fee of $1,000;​
1176-36.21 (12) for a lower-potency hemp edible retailer:​
1177-36.22 (i) an application fee of $250 per retail location;​
1178-36.23 (ii) an initial license fee of $250 per retail location; and​
1179-36.24 (iii) a renewal license fee of $250 per retail location;​
1180-36.25 (13) for a medical cannabis cultivator:​
1181-36.26 (i) an application fee of $250;​
1182-36.27 (ii) an initial license fee of $0; and​
1183-36​Article 1 Sec. 11.​
1184-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 37.1 (iii) a renewal license fee of $0;​
1185-37.2 (14) for a medical cannabis processor:​
1186-37.3 (i) an application fee of $250;​
1187-37.4 (ii) an initial license fee of $0; and​
1188-37.5 (iii) a renewal license fee of $0;​
1189-37.6 (15) for a medical cannabis retailer:​
1190-37.7 (i) an application fee of $250;​
1191-37.8 (ii) an initial license fee of $0; and​
1192-37.9 (iii) a renewal license fee of $0; and​
1193-37.10 (16) for a medical cannabis combination business:​
1194-37.11 (i) an application fee of $10,000;​
1195-37.12 (ii) an initial license fee of $20,000; and​
1196-37.13 (iii) a renewal license fee of $70,000.​
1197-37.14Sec. 12. [342.12] LICENSES; TRANSFERS; ADJUSTMENTS.​
1198-37.15 (a) Licenses issued under this chapter may be freely transferred subject to the prior​
1199-37.16written approval of the office, which approval may be given or withheld in the office's sole​
1200-37.17discretion, provided that a social equity applicant may only transfer the applicant's license​
1201-37.18to another social equity applicant. A new license must be obtained when:​
1202-37.19 (1) the form of the licensee's legal business structure converts or changes to a different​
1203-37.20type of legal business structure; or​
1204-37.21 (2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency,​
1205-37.22or receivership proceedings; merges with another legal organization; or assigns all or​
1206-37.23substantially all of its assets for the benefit of creditors.​
1207-37.24 (b) Transfers between social equity applicants must be reviewed by the Division of​
1208-37.25Social Equity.​
1209-37.26 (c) Licenses must be renewed annually.​
1210-37.27 (d) License holders may petition the office to adjust the tier of a license issued within a​
1211-37.28license category provided that the license holder meets all applicable requirements.​
1212-37​Article 1 Sec. 12.​
1213-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 38.1 (e) The office by rule may permit relocation of a licensed cannabis business, adopt​
1214-38.2requirements for the submission of a license relocation application, establish standards for​
1215-38.3the approval of a relocation application, and charge a fee not to exceed $250 for reviewing​
1216-38.4and processing applications. Relocation of a licensed premises pursuant to this paragraph​
1217-38.5does not extend or otherwise modify the license term of the license subject to relocation.​
1218-38.6 Sec. 13. [342.13] LOCAL CONTROL.​
1219-38.7 (a) A local unit of government may not prohibit the possession, transportation, or use​
1220-38.8of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
1221-38.9consumer products authorized under this chapter.​
1222-38.10 (b) Except as provided in section 342.22, a local unit of government may not prohibit​
1223-38.11the establishment or operation of a cannabis business licensed under this chapter.​
1224-38.12 (c) A local unit of government may adopt reasonable restrictions on the time, place, and​
1225-38.13manner of the operation of a cannabis business provided that such restrictions do not prohibit​
1226-38.14the establishment or operation of cannabis businesses. A local unit of government may​
1227-38.15prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a​
1228-38.16day care, residential treatment facility, or an attraction within a public park that is regularly​
1229-38.17used by minors, including a playground or athletic field.​
1230-38.18 (d) The office shall work with local units of government to:​
1231-38.19 (1) develop model ordinances for reasonable restrictions on the time, place, and manner​
1232-38.20of the operation of a cannabis business;​
1233-38.21 (2) develop standardized forms and procedures for the issuance of a retail registration​
1234-38.22pursuant to section 342.22; and​
1235-38.23 (3) develop model policies and procedures for the performance of compliance checks​
1236-38.24required under section 342.22.​
1237-38.25 (e) If a local unit of government is conducting studies or has authorized a study to be​
1238-38.26conducted or has held or has scheduled a hearing for the purpose of considering adoption​
1239-38.27or amendment of reasonable restrictions on the time, place, and manner of the operation of​
1240-38.28a cannabis business, the governing body of the local unit of government may adopt an​
1241-38.29interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting​
1242-38.30the planning process and the health, safety, and welfare of its citizens. Before adopting the​
1243-38.31interim ordinance, the governing body must hold a public hearing. The interim ordinance​
1244-38.32may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction​
1245-38.33or a portion thereof until January 1, 2025.​
1153+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 36.1 (12) for a lower-potency hemp retailer:​
1154+36.2 (i) an application fee of $250;​
1155+36.3 (ii) an initial license fee of $500; and​
1156+36.4 (iii) a renewal license fee of $500;​
1157+36.5 (13) for a medical cannabis cultivator:​
1158+36.6 (i) an application fee of $250;​
1159+36.7 (ii) an initial license fee of $0; and​
1160+36.8 (iii) a renewal license fee of $0;​
1161+36.9 (14) for a medical cannabis processor:​
1162+36.10 (i) an application fee of $250;​
1163+36.11 (ii) an initial license fee of $0; and​
1164+36.12 (iii) a renewal license fee of $0; and​
1165+36.13 (15) for a medical cannabis retailer:​
1166+36.14 (i) an application fee of $250;​
1167+36.15 (ii) an initial license fee of $0; and​
1168+36.16 (iii) a renewal license fee of $0.​
1169+36.17Sec. 12. [342.12] LICENSES; TRANSFERS; ADJUSTMENTS.​
1170+36.18 (a) Licenses issued under this chapter may not be transferred. A new license must be​
1171+36.19obtained when:​
1172+36.20 (1) the form of the licensee's legal business structure converts or changes to a different​
1173+36.21type of legal business structure;​
1174+36.22 (2) the licensee dissolves, consolidates, or merges with another legal organization;​
1175+36.23 (3) within the previous 24 months, 50 percent or more of the licensee is transferred by​
1176+36.24a single transaction or multiple transactions to:​
1177+36.25 (i) another person or legal organization; or​
1178+36.26 (ii) a person or legal organization who had less than a five percent ownership interest​
1179+36.27in the licensee at the time of the first transaction; or​
1180+36​Article 1 Sec. 12.​
1181+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 37.1 (4) any other event or combination of events that results in a substitution, elimination,​
1182+37.2or withdrawal of the licensee's responsibility for the operation of the licensee.​
1183+37.3 (b) Licenses must be renewed annually.​
1184+37.4 (c) License holders may petition the office to adjust the tier of a license issued within a​
1185+37.5license category provided that the license holder meets all applicable requirements.​
1186+37.6 (d) The office by rule may permit relocation of a licensed cannabis business, adopt​
1187+37.7requirements for the submission of a license relocation application, establish standards for​
1188+37.8the approval of a relocation application, and charge a fee not to exceed $250 for reviewing​
1189+37.9and processing relocation applications. Relocation of a licensed premises pursuant to this​
1190+37.10paragraph does not extend or otherwise modify the license term of the license subject to​
1191+37.11relocation.​
1192+37.12Sec. 13. [342.13] LOCAL CONTROL.​
1193+37.13 (a) A local unit of government may not prohibit the possession, transportation, or use​
1194+37.14of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
1195+37.15consumer products authorized under this chapter.​
1196+37.16 (b) Except as provided in section 342.22, a local unit of government may not prohibit​
1197+37.17the establishment or operation of a cannabis business or hemp business licensed under this​
1198+37.18chapter.​
1199+37.19 (c) A local unit of government may adopt reasonable restrictions on the time, place, and​
1200+37.20manner of the operation of a cannabis business or hemp business provided that such​
1201+37.21restrictions do not prohibit the establishment or operation of cannabis businesses or hemp​
1202+37.22businesses. A local unit of government may prohibit the operation of a cannabis business​
1203+37.23within 1,000 feet of a school, day care, the Capitol or Capitol grounds, or a public park that​
1204+37.24includes a playground, athletic field, or other attraction regularly used by minors.​
1205+37.25 (d) The office shall work with local units of government to:​
1206+37.26 (1) develop model ordinances for reasonable restrictions on the time, place, and manner​
1207+37.27of the operation of a cannabis business or hemp business;​
1208+37.28 (2) develop standardized forms and procedures for the issuance of a retail registration​
1209+37.29pursuant to section 342.22; and​
1210+37.30 (3) develop model policies and procedures for the performance of compliance checks​
1211+37.31required under section 342.22.​
1212+37​Article 1 Sec. 13.​
1213+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 38.1 (e) If a local unit of government is conducting studies or has authorized a study to be​
1214+38.2conducted or has held or has scheduled a hearing for the purpose of considering adoption​
1215+38.3or amendment of reasonable restrictions on the time, place, and manner of the operation of​
1216+38.4a cannabis business, the governing body of the local unit of government may adopt an​
1217+38.5interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting​
1218+38.6the planning process and the health, safety, and welfare of its citizens. Before adopting the​
1219+38.7interim ordinance, the governing body must hold a public hearing. The interim ordinance​
1220+38.8may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction​
1221+38.9or a portion thereof until January 1, 2025.​
1222+38.10 (f) Within 30 days of receiving a copy of an application from the office, a local unit of​
1223+38.11government shall certify on a form provided by the office whether a proposed cannabis​
1224+38.12business or hemp business complies with local zoning ordinances and, if applicable, whether​
1225+38.13the proposed business complies with the state fire code and building code.​
1226+38.14 (g) Upon receipt of an application for a license issued under this chapter, the office shall​
1227+38.15contact the local unit of government in which the business would be located and provide​
1228+38.16the local unit of government with 30 days in which to provide input on the application. The​
1229+38.17local unit of government may provide the office with any additional information it believes​
1230+38.18is relevant to the office's decision on whether to issue a license, including but not limited​
1231+38.19to identifying concerns about the proposed location of a cannabis business or hemp business,​
1232+38.20or sharing public information about an applicant.​
1233+38.21 (h) The office by rule shall establish an expedited complaint process to receive, review,​
1234+38.22and respond to complaints made by a local unit of government about a cannabis business​
1235+38.23or hemp business. Complaints may include alleged violations of local ordinances or other​
1236+38.24alleged violations. At a minimum, the expedited complaint process shall require the office​
1237+38.25to provide an initial response to the complaint within seven days and perform any necessary​
1238+38.26inspections within 30 days. Nothing in this paragraphs prohibits a local unit of government​
1239+38.27from enforcing a local ordinance. If a local unit of government notifies the office that a​
1240+38.28cannabis business or hemp business other than a cannabis retailer, cannabis microbusiness​
1241+38.29with a retail operations endorsement, cannabis mezzobusiness, lower-potency hemp edible​
1242+38.30retailer, or medical cannabis retailer poses an immediate threat to the health or safety of the​
1243+38.31public, the office must respond within 24 hours and may take any action described in section​
1244+38.32342.19 or 342.21.​
1245+38.33 (i) Notwithstanding the foregoing provisions, the state shall not issue a license to any​
1246+38.34cannabis business to operate in the Indian Country, as defined in United States Code, title​
12461247 38​Article 1 Sec. 13.​
1247-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 39.1 (f) Within 30 days of receiving a copy of an application from the office, a local unit of​
1248-39.2government shall certify on a form provided by the office whether a proposed cannabis​
1249-39.3business complies with local zoning ordinances and, if applicable, whether the proposed​
1250-39.4business complies with the state fire code and building code. The office may not issue a​
1251-39.5license if a cannabis business does not meet local zoning and land use laws.​
1252-39.6 (g) Upon receipt of an application for a license issued under this chapter, the office shall​
1253-39.7contact the local unit of government in which the business would be located and provide​
1254-39.8the local unit of government with 30 days in which to provide input on the application. The​
1255-39.9local unit of government may provide the office with any additional information it believes​
1256-39.10is relevant to the office's decision on whether to issue a license, including but not limited​
1257-39.11to identifying concerns about the proposed location of a cannabis business, or sharing public​
1258-39.12information about an applicant.​
1259-39.13 (h) The office by rule shall establish an expedited complaint process to receive, review,​
1260-39.14and respond to complaints made by a local unit of government about a cannabis business.​
1261-39.15Complaints may include alleged violations of local ordinances or other alleged violations.​
1262-39.16At a minimum, the expedited complaint process shall require the office to provide an initial​
1263-39.17response to the complaint within seven days and perform any necessary inspections within​
1264-39.1830 days. Nothing in this paragraph prohibits a local unit of government from enforcing a​
1265-39.19local ordinance. If a local unit of government notifies the office that a cannabis business​
1266-39.20other than a cannabis retailer, cannabis microbusiness with a retail operations endorsement,​
1267-39.21cannabis mezzobusiness, lower-potency hemp edible retailer, medical cannabis retailer, or​
1268-39.22medical cannabis combination business poses an immediate threat to the health or safety​
1269-39.23of the public, the office must respond within one business day and may take any action​
1270-39.24described in section 342.19 or 342.21.​
1271-39.25 (i) A local government unit that issues cannabis retailer registration under section 342.22​
1272-39.26may, by ordinance, limit the number of licensed cannabis retailers, cannabis mezzobusinesses​
1273-39.27with a retail operations endorsement, and cannabis microbusinesses with a retail operations​
1274-39.28endorsement to no fewer than one registration for every 12,500 residents.​
1275-39.29 (j) If a county has one active registration for every 12,500 residents, a city or town within​
1276-39.30the county is not obligated to register a cannabis business.​
1277-39.31 (k) Nothing in this section shall prohibit a local government unit from allowing licensed​
1278-39.32cannabis retailers in excess of the minimums set in paragraph (i).​
1279-39.33 (l) Notwithstanding the foregoing provisions, the state shall not issue a license to any​
1280-39.34cannabis business to operate in Indian country, as defined in United States Code, title 18,​
1281-39​Article 1 Sec. 13.​
1282-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 40.1section 1151, of a Minnesota Tribal government without the consent of the Tribal​
1283-40.2government.​
1284-40.3 Sec. 14. [342.14] CANNABIS LICENSE APPLICATION AND RENEWAL.​
1285-40.4 Subdivision 1.Application; contents.(a) The office by rule shall establish forms and​
1286-40.5procedures for the processing of cannabis licenses issued under this chapter. At a minimum,​
1287-40.6any application to obtain or renew a cannabis license shall include the following information,​
1288-40.7if applicable:​
1289-40.8 (1) the name, address, and date of birth of the applicant;​
1290-40.9 (2) the disclosure of ownership and control required under paragraph (b);​
1291-40.10 (3) the disclosure of whether the applicant or, if the applicant is a business, any officer,​
1292-40.11director, manager, and general partner of the business has ever filed for bankruptcy;​
1293-40.12 (4) the address and legal property description of the business;​
1294-40.13 (5) a general description of the location or locations that the applicant plans to operate,​
1295-40.14including the planned square feet of planned space for cultivation, wholesaling, and retailing,​
1296-40.15as applicable;​
1297-40.16 (6) a copy of the security plan;​
1298-40.17 (7) proof of trade name registration;​
1299-40.18 (8) a copy of the applicant's business plan showing the expected size of the business;​
1300-40.19anticipated growth; the methods of record keeping; the knowledge and experience of the​
1301-40.20applicant and any officer, director, manager, and general partner of the business; the​
1302-40.21environmental plan; and other relevant financial and operational components;​
1303-40.22 (9) an attestation signed by a bona fide labor organization stating that the applicant has​
1304-40.23entered into a labor peace agreement;​
1305-40.24 (10) certification that the applicant will comply with the requirements of this chapter​
1306-40.25relating to the ownership and operation of a cannabis business;​
1307-40.26 (11) identification of one or more controlling persons or managerial employees as agents​
1308-40.27who shall be responsible for dealing with the office on all matters; and​
1309-40.28 (12) a statement that the applicant agrees to respond to the office's supplemental requests​
1310-40.29for information.​
1248+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 39.125, section 1151, of a Minnesota Tribal government without the consent of the Tribal​
1249+39.2government.​
1250+39.3 Sec. 14. [342.14] CANNABIS LICENSE APPLICATION AND RENEWAL.​
1251+39.4 Subdivision 1.Application; contents.(a) The office by rule shall establish forms and​
1252+39.5procedures for the processing of cannabis licenses issued under this chapter. At a minimum,​
1253+39.6any application to obtain or renew a cannabis license shall include the following information,​
1254+39.7if applicable:​
1255+39.8 (1) the name, address, and date of birth of the applicant;​
1256+39.9 (2) the disclosure of ownership and control required under paragraph (b);​
1257+39.10 (3) the disclosure of whether the applicant or, if the applicant is a business, any officer,​
1258+39.11director, manager, and general partner of the business has ever filed for bankruptcy;​
1259+39.12 (4) the address and legal property description of the business;​
1260+39.13 (5) documentation showing legal possession of the premises where the business will​
1261+39.14operate;​
1262+39.15 (6) a diagram of the premises, including a security drawing;​
1263+39.16 (7) a copy of the security plan;​
1264+39.17 (8) proof of trade name registration;​
1265+39.18 (9) a copy of the applicant's business plan showing the expected size of the business;​
1266+39.19anticipated growth; the methods of record keeping; the knowledge and experience of the​
1267+39.20applicant and any officer, director, manager, and general partner of the business; the​
1268+39.21environmental plan; and other relevant financial and operational components;​
1269+39.22 (10) an attestation signed by a bona fide labor organization stating that the applicant has​
1270+39.23entered into a labor peace agreement;​
1271+39.24 (11) certification that the applicant will comply with the requirements of this chapter​
1272+39.25relating to the ownership and operation of a cannabis business;​
1273+39.26 (12) identification of one or more controlling persons or managerial employees as agents​
1274+39.27who shall be responsible for dealing with the office on all matters; and​
1275+39.28 (13) a statement that the applicant agrees to respond to the office's supplemental requests​
1276+39.29for information.​
1277+39​Article 1 Sec. 14.​
1278+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 40.1 (b) An applicant must file and update as necessary a disclosure of ownership and control.​
1279+40.2The office by rule shall establish the contents and form of the disclosure. Except as provided​
1280+40.3in paragraph (f), the disclosure shall, at a minimum, include the following:​
1281+40.4 (1) the management structure, ownership, and control of the applicant or license holder,​
1282+40.5including the name of each cooperative member, officer, director, manager, general partner​
1283+40.6or business entity; the office or position held by each person; each person's percentage​
1284+40.7ownership interest, if any; and, if the business has a parent company, the name of each​
1285+40.8owner, board member, and officer of the parent company and the owner's, board member's,​
1286+40.9or officer's percentage ownership interest in the parent company and the cannabis business;​
1287+40.10 (2) a statement from the applicant and, if the applicant is a business, from every officer,​
1288+40.11director, manager, and general partner of the business, indicating whether that person has​
1289+40.12previously held, or currently holds, an ownership interest in a cannabis business in Minnesota,​
1290+40.13any other state or territory of the United States, or any other country;​
1291+40.14 (3) if the applicant is a corporation, copies of its articles of incorporation and bylaws​
1292+40.15and any amendments to its articles of incorporation or bylaws;​
1293+40.16 (4) copies of any partnership agreement, operating agreement, or shareholder agreement;​
1294+40.17 (5) copies of any promissory notes, security instruments, or other similar agreements;​
1295+40.18 (6) explanation detailing the funding sources used to finance the business;​
1296+40.19 (7) a list of operating and investment accounts for the business, including any applicable​
1297+40.20financial institution and account number; and​
1298+40.21 (8) a list of each outstanding loan and financial obligation obtained for use in the business,​
1299+40.22including the loan amount, loan terms, and name and address of the creditor.​
1300+40.23 (c) An application may include:​
1301+40.24 (1) proof that the applicant is a social equity applicant;​
1302+40.25 (2) a description of the training and education that will be provided to any employee;​
1303+40.26or​
1304+40.27 (3) a copy of business policies governing operations to ensure compliance with this​
1305+40.28chapter.​
1306+40.29 (d) Commitments made by an applicant in its application, including but not limited to​
1307+40.30the maintenance of a labor peace agreement, shall be an ongoing material condition of​
1308+40.31maintaining and renewing the license.​
13111309 40​Article 1 Sec. 14.​
1312-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 41.1 (b) An applicant must file and update as necessary a disclosure of ownership and control.​
1313-41.2The office by rule shall establish the contents and form of the disclosure. Except as provided​
1314-41.3in paragraph (f), the disclosure shall, at a minimum, include the following:​
1315-41.4 (1) the management structure, ownership, and control of the applicant or license holder,​
1316-41.5including the name of each cooperative member, officer, director, manager, general partner​
1317-41.6or business entity; the office or position held by each person; each person's percentage​
1318-41.7ownership interest, if any; and, if the business has a parent company, the name of each​
1319-41.8owner, board member, and officer of the parent company and the owner's, board member's,​
1320-41.9or officer's percentage ownership interest in the parent company and the cannabis business;​
1321-41.10 (2) a statement from the applicant and, if the applicant is a business, from every officer,​
1322-41.11director, manager, and general partner of the business, indicating whether that person has​
1323-41.12previously held, or currently holds, an ownership interest in a cannabis business in Minnesota,​
1324-41.13any other state or territory of the United States, or any other country;​
1325-41.14 (3) if the applicant is a corporation, copies of the applicant's articles of incorporation​
1326-41.15and bylaws and any amendments to the applicant's articles of incorporation or bylaws;​
1327-41.16 (4) copies of any partnership agreement, operating agreement, or shareholder agreement;​
1328-41.17 (5) copies of any promissory notes, security instruments, or other similar agreements;​
1329-41.18 (6) an explanation detailing the funding sources used to finance the business;​
1330-41.19 (7) a list of operating and investment accounts for the business, including any applicable​
1331-41.20financial institution and account number; and​
1332-41.21 (8) a list of each outstanding loan and financial obligation obtained for use in the business,​
1333-41.22including the loan amount, loan terms, and name and address of the creditor.​
1334-41.23 (c) An application may include:​
1335-41.24 (1) proof that the applicant is a social equity applicant;​
1336-41.25 (2) a description of the training and education that will be provided to any employee;​
1337-41.26or​
1338-41.27 (3) a copy of business policies governing operations to ensure compliance with this​
1339-41.28chapter.​
1340-41.29 (d) Commitments made by an applicant in its application, including but not limited to​
1341-41.30the maintenance of a labor peace agreement, shall be an ongoing material condition of​
1342-41.31maintaining and renewing the license.​
1343-41​Article 1 Sec. 14.​
1344-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 42.1 (e) An application on behalf of a corporation or association shall be signed by at least​
1345-42.2two officers or managing agents of that entity.​
1346-42.3 (f) The office may, by rule, establish exceptions to the disclosures required under​
1347-42.4paragraph (b) for members of a cooperative who hold less than a five percent ownership​
1348-42.5interest in the cooperative.​
1349-42.6 Subd. 2.Application; process.(a) An applicant must submit all required information​
1350-42.7to the office on the forms and in the manner prescribed by the office.​
1351-42.8 (b) If the office receives an application that fails to provide the required information,​
1352-42.9the office shall issue a deficiency notice to the applicant. The applicant shall have ten​
1353-42.10business days from the date of the deficiency notice to submit the required information.​
1354-42.11 (c) Failure by an applicant to submit all required information will result in the application​
1355-42.12being rejected.​
1356-42.13 (d) Upon receipt of a completed application and fee, the office shall forward a copy of​
1357-42.14the application to the local unit of government in which the business operates or intends to​
1358-42.15operate with a form for certification as to whether a proposed cannabis business complies​
1359-42.16with local zoning ordinances and, if applicable, whether the proposed business complies​
1360-42.17with the state fire code and building code.​
1361-42.18 (e) Within 90 days of receiving a completed application and the results of any required​
1362-42.19criminal history check, the office shall issue the appropriate license or send the applicant a​
1363-42.20notice of rejection setting forth specific reasons that the office did not approve the application.​
1364-42.21Sec. 15. [342.15] ADULT-USE CANNABIS BUSINESS; CRIMINAL HISTORY​
1365-42.22CHECK AND DISQUALIFICATIONS.​
1366-42.23 Subdivision 1.Criminal history check.(a) Upon request by the office, every license​
1367-42.24applicant or, in the case of a business entity, every cooperative member or director, manager,​
1368-42.25and general partner of the business entity, for a cannabis business license, or in the case of​
1369-42.26a business entity, every cooperative member or director, manager, and general partner of​
1370-42.27the business entity, and prospective cannabis worker must submit a completed criminal​
1371-42.28history records check consent form, a full set of classifiable fingerprints, and the required​
1372-42.29fees to the office. Upon receipt of this information, the office must submit the completed​
1373-42.30criminal history records check consent form, full set of classifiable fingerprints, and required​
1374-42.31fees to the Bureau of Criminal Apprehension. After receiving this information, the bureau​
1375-42.32must conduct a Minnesota criminal history records check of the license applicant or​
1376-42.33prospective cannabis worker. The bureau may exchange a license applicant's or prospective​
1377-42​Article 1 Sec. 15.​
1378-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 43.1cannabis worker's fingerprints with the Federal Bureau of Investigation to obtain the license​
1379-43.2applicant's or prospective cannabis worker's national criminal history record information.​
1380-43.3The bureau must return the results of the Minnesota and federal criminal history records​
1381-43.4checks to the office to determine if the license applicant or prospective cannabis worker is​
1382-43.5disqualified under rules adopted pursuant to this section.​
1383-43.6 (b) The office may, by rule, establish exceptions to the requirement under paragraph (a)​
1384-43.7for members of a cooperative who hold less than a five percent ownership interest in the​
1385-43.8cooperative.​
1386-43.9 Subd. 2.Criminal offenses; disqualifications.The office may by rule determine whether​
1387-43.10any felony convictions shall disqualify a person from holding or receiving a cannabis​
1388-43.11business license issued under this chapter or working for a cannabis business, and the length​
1389-43.12of any such disqualification. In adopting rules pursuant to this subdivision, the office shall​
1390-43.13not disqualify a person for a violation of section 152.025.​
1391-43.14 Subd. 3.Risk of harm; set aside.The office may set aside a disqualification under​
1392-43.15subdivision 2 if the office finds that the person has submitted sufficient information to​
1393-43.16demonstrate that the person does not pose a risk of harm to any person served by the​
1394-43.17applicant, license holder, or other entities as provided in this chapter.​
1395-43.18 Subd. 4.Exception.The background check requirements and disqualifications under​
1396-43.19this section do not apply to an applicant for a hemp business license or to hemp workers.​
1397-43.20Sec. 16. [342.16] CANNABIS BUSINESSES; GENERAL OWNERSHIP​
1398-43.21DISQUALIFICATIONS AND REQUIREMENTS.​
1399-43.22 (a) A license holder or applicant must meet each of the following requirements, if​
1400-43.23applicable, to hold or receive a cannabis license issued under this chapter:​
1401-43.24 (1) be at least 21 years of age;​
1402-43.25 (2) have completed an application for licensure or application for renewal;​
1403-43.26 (3) have paid the applicable application fee and license fee;​
1404-43.27 (4) if the applicant or license holder is a business entity, be incorporated in the state or​
1405-43.28otherwise formed or organized under the laws of the state;​
1406-43.29 (5) not be employed by the office or any state agency with regulatory authority under​
1407-43.30this chapter or the rules adopted pursuant to this chapter;​
1408-43.31 (6) not be a licensed peace officer, as defined in section 626.84, subdivision 1, paragraph​
1409-43.32(c);​
1410-43​Article 1 Sec. 16.​
1411-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 44.1 (7) never have had a license previously issued under this chapter revoked;​
1412-44.2 (8) have filed any previously required tax returns for a cannabis business;​
1413-44.3 (9) have paid and remitted any business taxes, gross receipts taxes, interest, or penalties​
1414-44.4due relating to the operation of a cannabis business;​
1415-44.5 (10) have fully and truthfully complied with all information requests of the office relating​
1416-44.6to license application and renewal;​
1417-44.7 (11) not be disqualified under section 342.15;​
1418-44.8 (12) not employ an individual who is disqualified from working for a cannabis business​
1419-44.9under this chapter; and​
1420-44.10 (13) meet the ownership and operational requirements for the type of license and, if​
1421-44.11applicable, endorsement sought or held.​
1422-44.12 (b) A health care practitioner who certifies qualifying medical conditions for patients is​
1423-44.13prohibited from:​
1424-44.14 (1) holding a direct or indirect economic interest in a cannabis business;​
1425-44.15 (2) serving as a cooperative member, director, manager, general partner, or employee​
1426-44.16of a cannabis business; or​
1427-44.17 (3) advertising with a cannabis business in any way.​
1428-44.18 (c) If the license holder or applicant is a business entity, every officer, director, manager,​
1429-44.19and general partner of the business entity must meet each of the requirements of this section.​
1430-44.20 (d) The ownership disqualifications and requirements under this section do not apply to​
1431-44.21a hemp business license holder or applicant.​
1432-44.22Sec. 17. [342.17] SOCIAL EQUITY APPLICANTS.​
1433-44.23 (a) An applicant qualifies as a social equity applicant if the applicant:​
1434-44.24 (1) was convicted of an offense involving the possession or sale of cannabis or marijuana​
1435-44.25prior to May 1, 2023;​
1436-44.26 (2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense​
1437-44.27involving the possession or sale of cannabis or marijuana prior to May 1, 2023;​
1438-44.28 (3) was a dependent of an individual who was convicted of an offense involving the​
1439-44.29possession or sale of cannabis or marijuana prior to May 1, 2023;​
1440-44​Article 1 Sec. 17.​
1441-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 45.1 (4) is a service-disabled veteran, current or former member of the national guard, or any​
1442-45.2military veteran or current or former member of the national guard who lost honorable status​
1443-45.3due to an offense involving the possession or sale of marijuana;​
1444-45.4 (5) has been a resident for the last five years of one or more subareas, such as census​
1445-45.5tracts or neighborhoods, that experienced a disproportionately large amount of cannabis​
1446-45.6enforcement as determined by the study conducted by the office pursuant to section 342.04,​
1447-45.7paragraph (b), and reported in the preliminary report, final report, or both;​
1448-45.8 (6) is an emerging farmer as defined in section 17.055, subdivision 1; or​
1449-45.9 (7) has been a resident for the last five years of one or more census tracts where, as​
1450-45.10reported in the most recently completed decennial census published by the United States​
1451-45.11Bureau of the Census, either:​
1452-45.12 (i) the poverty rate was 20 percent or more; or​
1453-45.13 (ii) the median family income did not exceed 80 percent of statewide median family​
1454-45.14income or, if in a metropolitan area, did not exceed the greater of 80 percent of the statewide​
1455-45.15median family income or 80 percent of the median family income for that metropolitan​
1456-45.16area.​
1457-45.17 (b) The qualifications described in paragraph (a) apply to each individual applicant or,​
1458-45.18in the case of a business entity, every cooperative member or director, manager, and general​
1459-45.19partner of the business entity.​
1460-45.20Sec. 18. [342.18] LICENSE SELECTION CRITERIA.​
1461-45.21 Subdivision 1.Market stability.The office shall issue the necessary number of licenses​
1462-45.22in order to ensure the sufficient supply of cannabis flower and cannabis products to meet​
1463-45.23demand, provide market stability, ensure a competitive market, and limit the sale of​
1464-45.24unregulated cannabis flower and cannabis products.​
1465-45.25 Subd. 2.Vertical integration prohibited; exceptions.(a) Except as otherwise provided​
1466-45.26in this subdivision, the office shall not issue licenses to a single applicant that would result​
1467-45.27in the applicant being vertically integrated in violation of the provisions of this chapter.​
1468-45.28 (b) Nothing in this section prohibits or limits the issuance of microbusiness licenses or​
1469-45.29mezzobusiness licenses, or the issuance of both lower-potency hemp edible manufacturer​
1470-45.30and lower-potency hemp edible retailer licenses to the same person or entity.​
1471-45.31 Subd. 3.Application score; license priority.(a) The office shall award points to each​
1472-45.32completed application for a license to operate a cannabis business in the following categories:​
1473-45​Article 1 Sec. 18.​
1474-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 46.1 (1) status as a social equity applicant or as an applicant who is substantially similar to​
1475-46.2a social equity applicant as described in paragraph (c);​
1476-46.3 (2) status as a veteran or retired national guard applicant who does not meet the definition​
1477-46.4of social equity applicant;​
1478-46.5 (3) security and record keeping;​
1479-46.6 (4) employee training plan;​
1480-46.7 (5) business plan and financial situation;​
1481-46.8 (6) labor and employment practices;​
1482-46.9 (7) knowledge and experience; and​
1483-46.10 (8) environmental plan.​
1484-46.11 (b) The office may award additional points to an application if the license holder would​
1485-46.12expand service to an underrepresented market, including but not limited to participation in​
1486-46.13the medical cannabis program.​
1487-46.14 (c) The office shall establish application materials permitting individual applicants to​
1488-46.15demonstrate the impact that cannabis prohibition has had on that applicant, including but​
1489-46.16not limited to the arrest or imprisonment of the applicant or a member of the applicant's​
1490-46.17immediate family, and the office may award points to such applicants in the same manner​
1491-46.18as points are awarded to social equity applicants.​
1492-46.19 (d) The office shall establish policies and guidelines, which must be made available to​
1493-46.20the public, regarding the number of points available in each category and the basis for​
1494-46.21awarding those points. Status as a social equity applicant must account for at least 20 percent​
1495-46.22of the total available points. In determining the number of points to award to a cooperative​
1496-46.23or business applying as a social equity applicant, the office shall consider the number or​
1497-46.24ownership percentage of cooperative members, officers, directors, managers, and general​
1498-46.25partners who qualify as social equity applicants.​
1499-46.26 (e) Consistent with the goals identified in subdivision 1, the office shall issue licenses​
1500-46.27in each license category, giving priority to applicants who receive the highest score under​
1501-46.28paragraphs (a) and (b). If there are insufficient licenses available for entities that receive​
1502-46.29identical scores, the office shall utilize a lottery to randomly select license recipients from​
1503-46.30among those entities.​
1504-46​Article 1 Sec. 18.​
1505-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 47.1 Sec. 19. [342.19] INSPECTION; LICENSE VIOLATIONS; PENALTIES.​
1506-47.2 Subdivision 1.Authority to inspect.(a) In order to carry out the purposes of this chapter,​
1507-47.3the office, upon presenting appropriate credentials to the owner, operator, or agent in charge,​
1508-47.4is authorized to:​
1509-47.5 (1) enter any cannabis business or hemp business without delay and at reasonable times;​
1510-47.6 (2) inspect and investigate during regular working hours and at other reasonable times,​
1511-47.7within reasonable limits and in a reasonable manner, any cannabis business or hemp business​
1512-47.8and all relevant conditions, equipment, records, and materials therein; and​
1513-47.9 (3) question privately any employer, owner, operator, agent, or employee of a cannabis​
1514-47.10business or hemp business.​
1515-47.11 (b) An employer, owner, operator, agent, or employee must not refuse the office entry​
1516-47.12or otherwise deter or prohibit the office from taking action under paragraph (a).​
1517-47.13 Subd. 2.Powers of office.(a) In making inspections and investigations under this chapter,​
1518-47.14the office shall have the power to administer oaths, certify as to official acts, take and cause​
1519-47.15to be taken depositions of witnesses, issue subpoenas, and compel the attendance of witnesses​
1520-47.16and production of papers, books, documents, records, and testimony. In case of failure of​
1521-47.17any person to comply with any subpoena lawfully issued, or on the refusal of any witness​
1522-47.18to produce evidence or to testify to any matter regarding which the person may be lawfully​
1523-47.19interrogated, the district court shall, upon application of the office, compel obedience​
1524-47.20proceedings for contempt, as in the case of disobedience of the requirements of a subpoena​
1525-47.21issued by the court or a refusal to testify therein.​
1526-47.22 (b) If the office finds probable cause to believe that any cannabis plant, cannabis flower,​
1527-47.23cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or​
1528-47.24hemp-derived consumer product is being distributed in violation of this chapter or rules​
1529-47.25adopted under this chapter, the office shall affix to the item a tag, withdrawal from​
1530-47.26distribution order, or other appropriate marking providing notice that the cannabis plant,​
1531-47.27cannabis flower, cannabis product, artificially derived cannabinoid, lower-potency hemp​
1532-47.28edible, or hemp-derived consumer product is, or is suspected of being, distributed in violation​
1533-47.29of this chapter, and has been detained or embargoed, and warning all persons not to remove​
1534-47.30or dispose of the item by sale or otherwise until permission for removal or disposal is given​
1535-47.31by the office or the court. It is unlawful for a person to remove or dispose of detained or​
1536-47.32embargoed cannabis plant, cannabis flower, cannabis product, artificially derived​
1537-47.33cannabinoid, lower-potency hemp edible, or hemp-derived consumer product by sale or​
1310+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 41.1 (e) An application on behalf of a corporation or association shall be signed by at least​
1311+41.2two officers or managing agents of that entity.​
1312+41.3 (f) The office may, by rule, establish exceptions to the disclosures required under​
1313+41.4paragraph (b) for members of a cooperative who hold less than a five percent ownership​
1314+41.5interest in the cooperative.​
1315+41.6 Subd. 2.Application; process.(a) An applicant must submit all required information​
1316+41.7to the office on the forms and in the manner prescribed by the office.​
1317+41.8 (b) If the office receives an application that fails to provide the required information,​
1318+41.9the office shall issue a deficiency notice to the applicant. The applicant shall have ten​
1319+41.10business days from the date of the deficiency notice to submit the required information.​
1320+41.11 (c) Failure by an applicant to submit all required information will result in the application​
1321+41.12being rejected.​
1322+41.13 (d) Upon receipt of a completed application and fee, the office shall forward a copy of​
1323+41.14the application to the local unit of government in which the business operates or intends to​
1324+41.15operate with a form for certification as to whether a proposed cannabis business or hemp​
1325+41.16business complies with local zoning ordinances and, if applicable, whether the proposed​
1326+41.17business complies with the state fire code and building code.​
1327+41.18 (e) Within 90 days of receiving a completed application and the results of any required​
1328+41.19criminal history check, the office shall issue the appropriate license or send the applicant a​
1329+41.20notice of rejection setting forth specific reasons that the office did not approve the application.​
1330+41.21Sec. 15. [342.15] ADULT-USE CANNABIS BUSINESS; CRIMINAL HISTORY​
1331+41.22CHECK AND DISQUALIFICATIONS.​
1332+41.23 Subdivision 1.Criminal history check.(a) Upon request by the office, every applicant​
1333+41.24for a cannabis business license and prospective cannabis worker must submit a completed​
1334+41.25criminal history records check consent form, a full set of classifiable fingerprints, and the​
1335+41.26required fees to the office. Upon receipt of this information, the office must submit the​
1336+41.27completed criminal history records check consent form, full set of classifiable fingerprints,​
1337+41.28and required fees to the Bureau of Criminal Apprehension. After receiving this information,​
1338+41.29the bureau must conduct a Minnesota criminal history records check of the license applicant​
1339+41.30or prospective cannabis worker. The bureau may exchange a license applicant's or prospective​
1340+41.31cannabis worker's fingerprints with the Federal Bureau of Investigation to obtain the license​
1341+41.32applicant's or prospective cannabis worker's national criminal history record information.​
1342+41.33The bureau must return the results of the Minnesota and federal criminal history records​
1343+41​Article 1 Sec. 15.​
1344+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 42.1checks to the director to determine if the license applicant or prospective cannabis worker​
1345+42.2is disqualified under rules adopted pursuant to this section.​
1346+42.3 (b) The office may, by rule, establish exceptions to the requirement under paragraph (a)​
1347+42.4for members of a cooperative who hold less than a five percent ownership interest in the​
1348+42.5cooperative.​
1349+42.6 Subd. 2.Criminal offenses; disqualifications.The office may by rule determine whether​
1350+42.7any felony convictions shall disqualify a person from holding or receiving a cannabis​
1351+42.8business license issued under this chapter or working for a cannabis business, and the length​
1352+42.9of any such disqualification. In adopting rules pursuant to this subdivision, the office shall​
1353+42.10not disqualify a person for a violation of section 152.025.​
1354+42.11 Subd. 3.Risk of harm; set aside.The office may set aside a disqualification under​
1355+42.12subdivision 2 if the office finds that the person has submitted sufficient information to​
1356+42.13demonstrate that the person does not pose a risk of harm to any person served by the​
1357+42.14applicant, license holder, or other entities as provided in this chapter.​
1358+42.15 Subd. 4.Exception.The background check requirements and disqualifications under​
1359+42.16this section do not apply to an applicant for a hemp business license or to hemp workers.​
1360+42.17Sec. 16. [342.16] CANNABIS BUSINESSES; GENERAL OWNERSHIP​
1361+42.18DISQUALIFICATIONS AND REQUIREMENTS.​
1362+42.19 (a) A license holder or applicant must meet each of the following requirements, if​
1363+42.20applicable, to hold or receive a cannabis license issued under this chapter:​
1364+42.21 (1) be at least 21 years of age;​
1365+42.22 (2) have completed an application for licensure or application for renewal;​
1366+42.23 (3) have paid the applicable application fee and license fee;​
1367+42.24 (4) reside in the state;​
1368+42.25 (5) if the applicant or license holder is a business entity, be incorporated in the state or​
1369+42.26otherwise formed or organized under the laws of the state;​
1370+42.27 (6) if the applicant or license holder is a business entity, at least 75 percent of the business​
1371+42.28must be owned by Minnesota residents;​
1372+42.29 (7) not be employed by the office or any state agency with regulatory authority under​
1373+42.30this chapter or the rules adopted pursuant to this chapter;​
1374+42​Article 1 Sec. 16.​
1375+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 43.1 (8) not be a licensed peace officer, as defined in section 626.84, subdivision 1, paragraph​
1376+43.2(c);​
1377+43.3 (9) never have had a license previously issued under this chapter revoked;​
1378+43.4 (10) have filed any previously required tax returns for a cannabis business;​
1379+43.5 (11) have paid and remitted any business taxes, gross receipts taxes, interest, or penalties​
1380+43.6due relating to the operation of a cannabis business;​
1381+43.7 (12) have fully and truthfully complied with all information requests of the office relating​
1382+43.8to license application and renewal;​
1383+43.9 (13) not be disqualified under section 342.15;​
1384+43.10 (14) not employ an individual who is disqualified from working for a cannabis business​
1385+43.11under this chapter; and​
1386+43.12 (15) meet the ownership and operational requirements for the type of license and, if​
1387+43.13applicable, endorsement sought or held.​
1388+43.14 (b) A health care practitioner who certifies qualifying medical conditions for patients is​
1389+43.15prohibited from:​
1390+43.16 (1) holding a direct or indirect economic interest in a cannabis business;​
1391+43.17 (2) serving as a cooperative member, director, manager, general partner, or employee​
1392+43.18of a cannabis business; or​
1393+43.19 (3) advertising with a cannabis business in any way.​
1394+43.20 (c) If the license holder or applicant is a business entity, every officer, director, manager,​
1395+43.21and general partner of the business entity must meet each of the requirements of this section.​
1396+43.22 (d) The ownership disqualifications and requirements under this section do not apply to​
1397+43.23a hemp business license holder or applicant.​
1398+43.24Sec. 17. [342.17] SOCIAL EQUITY APPLICANTS.​
1399+43.25 An individual qualifies as a social equity applicant if the individual is:​
1400+43.26 (1) convicted of a cannabis-related offense prior to the effective date of this chapter, or​
1401+43.27had a parent, guardian, child, spouse, or dependent, or was a dependent of an individual​
1402+43.28who, prior to the effective date of this chapter, was convicted of a cannabis-related offense;​
1403+43.29 (2) a service-disabled veteran and national guard as well as any military veteran or​
1404+43.30national guard who lost honorable status due to a cannabis-related offense;​
1405+43​Article 1 Sec. 17.​
1406+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 44.1 (3) a resident for the last five years of one or more communities disproportionately​
1407+44.2impacted by cannabis enforcement as determined by the study conducted by the office​
1408+44.3pursuant to section 342.04, paragraph (b), and reported in the preliminary report, final report,​
1409+44.4or both;​
1410+44.5 (4) socially disadvantaged farmers or ranchers as defined by United States Code, title​
1411+44.67, section 2003(e)(2); or​
1412+44.7 (5) a resident for the last five years of one or more census tracts where, as reported in​
1413+44.8the most recently completed decennial census published by the United States Bureau of the​
1414+44.9Census, either:​
1415+44.10 (i) the poverty rate was 20 percent or more; or​
1416+44.11 (ii) the median family income did not exceed 80 percent of statewide median family​
1417+44.12income or, if in a metropolitan area, did not exceed the greater of 80 percent of the statewide​
1418+44.13median family income or 80 percent of the median family income for that metropolitan​
1419+44.14area.​
1420+44.15Sec. 18. [342.18] LICENSE SELECTION CRITERIA.​
1421+44.16 Subdivision 1.Market stability.The office shall issue the necessary number of licenses​
1422+44.17in order to ensure the sufficient supply of cannabis flower and cannabis products to meet​
1423+44.18demand, provide market stability, ensure a competitive market, and limit the sale of​
1424+44.19unregulated cannabis flower and cannabis products.​
1425+44.20 Subd. 2.Vertical integration prohibited; exceptions.(a) Except as otherwise provided​
1426+44.21in this subdivision, the office shall not issue licenses to a single applicant that would result​
1427+44.22in the applicant being vertically integrated in violation of the provisions of this chapter.​
1428+44.23 (b) Nothing in this section prohibits or limits the issuance of microbusiness licenses or​
1429+44.24mezzobusiness licenses, or the issuance of both lower-potency hemp edible manufacturer​
1430+44.25and lower-potency hemp edible retailer licenses to the same person or entity.​
1431+44.26 Subd. 3.Application score; license priority.(a) The office shall award points to each​
1432+44.27completed application for a license to operate a cannabis business in the following categories:​
1433+44.28 (1) status as a social equity applicant or as an applicant who is substantially similar to​
1434+44.29a social equity applicant as described in paragraph (c);​
1435+44.30 (2) status as a veteran or retired national guard applicant who does not meet the definition​
1436+44.31of social equity applicant;​
1437+44.32 (3) security and record keeping;​
1438+44​Article 1 Sec. 18.​
1439+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 45.1 (4) employee training plan;​
1440+45.2 (5) business plan and financial situation;​
1441+45.3 (6) labor and employment practices;​
1442+45.4 (7) knowledge and experience; and​
1443+45.5 (8) environmental plan.​
1444+45.6 (b) The office may award additional points to an application if the license holder would​
1445+45.7expand service to an underrepresented market including but not limited to participation in​
1446+45.8the medical cannabis program.​
1447+45.9 (c) The office shall establish application materials permitting individual applicants to​
1448+45.10demonstrate the impact that cannabis prohibition has had on that applicant including but​
1449+45.11not limited to the arrest or imprisonment of the applicant or a member of the applicant's​
1450+45.12immediate family, and the office may award points to such applicants in the same manner​
1451+45.13as points are awarded to social equity applicants.​
1452+45.14 (d) The office shall establish policies and guidelines, which shall be made available to​
1453+45.15the public, regarding the number of points available in each category and the basis for​
1454+45.16awarding those points. Status as a social equity applicant must account for at least 20 percent​
1455+45.17of the total available points. In determining the number of points to award to a cooperative​
1456+45.18or business applying as a social equity applicant, the office shall consider the number or​
1457+45.19ownership percentage of cooperative members, officers, directors, managers, and general​
1458+45.20partners who qualify as social equity applicants.​
1459+45.21 (e) Consistent with the goals identified in subdivision 1, the office shall issue licenses​
1460+45.22in each license category, giving priority to applicants who receive the highest score under​
1461+45.23paragraphs (a) and (b). If there are insufficient licenses available for entities that receive​
1462+45.24identical scores, the office shall utilize a lottery to randomly select license recipients from​
1463+45.25among those entities.​
1464+45.26Sec. 19. [342.19] INSPECTION; LICENSE VIOLATIONS; PENALTIES.​
1465+45.27 Subdivision 1.Authority to inspect.(a) In order to carry out the purposes of this chapter,​
1466+45.28the office, upon presenting appropriate credentials to the owner, operator, or agent in charge,​
1467+45.29is authorized to:​
1468+45.30 (1) enter any cannabis business or hemp business without delay and at reasonable times;​
1469+45​Article 1 Sec. 19.​
1470+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 46.1 (2) inspect and investigate during regular working hours and at other reasonable times,​
1471+46.2within reasonable limits and in a reasonable manner, any cannabis business or hemp business​
1472+46.3and all relevant conditions, equipment, records, and materials therein; and​
1473+46.4 (3) question privately any employer, owner, operator, agent, or employee of a cannabis​
1474+46.5business or hemp business.​
1475+46.6 (b) An employer, owner, operator, agent, or employee must not refuse the office entry​
1476+46.7or otherwise deter or prohibit the office from taking action under paragraph (a).​
1477+46.8 Subd. 2.Powers of office.(a) In making inspections and investigations under this chapter,​
1478+46.9the office shall have the power to administer oaths, certify as to official acts, take and cause​
1479+46.10to be taken depositions of witnesses, issue subpoenas, and compel the attendance of witnesses​
1480+46.11and production of papers, books, documents, records, and testimony. In case of failure of​
1481+46.12any person to comply with any subpoena lawfully issued, or on the refusal of any witness​
1482+46.13to produce evidence or to testify to any matter regarding which the person may be lawfully​
1483+46.14interrogated, the district court shall, upon application of the office, compel obedience​
1484+46.15proceedings for contempt, as in the case of disobedience of the requirements of a subpoena​
1485+46.16issued by the court or a refusal to testify therein.​
1486+46.17 (b) If the office finds probable cause to believe that any cannabis plant, cannabis flower,​
1487+46.18cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or​
1488+46.19hemp-derived consumer product is being distributed in violation of this chapter or rules​
1489+46.20adopted under this chapter, the office shall affix to the item a tag, withdrawal from​
1490+46.21distribution order, or other appropriate marking providing notice that the cannabis plant,​
1491+46.22cannabis flower, cannabis product, artificially derived cannabinoid, lower-potency hemp​
1492+46.23edible, or hemp-derived consumer product is, or is suspected of being, distributed in violation​
1493+46.24of this chapter, and has been detained or embargoed, and warning all persons not to remove​
1494+46.25or dispose of the item by sale or otherwise until permission for removal or disposal is given​
1495+46.26by the office or the court. It is unlawful for a person to remove or dispose of detained or​
1496+46.27embargoed cannabis plant, cannabis flower, cannabis product, artificially derived​
1497+46.28cannabinoid, lower-potency hemp edible, or hemp-derived consumer product by sale or​
1498+46.29otherwise without the office's or a court's permission and each transaction is a separate​
1499+46.30violation of this section.​
1500+46.31 (c) If any cannabis plant, cannabis flower, cannabis product, artificially derived​
1501+46.32cannabinoid, lower-potency hemp edible, or hemp-derived consumer product has been​
1502+46.33found by the office to be in violation of this chapter, the office shall petition the district​
1503+46.34court in the county in which the item is detained or embargoed for an order and decree for​
1504+46​Article 1 Sec. 19.​
1505+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 47.1the condemnation of the item. The office shall release the cannabis plant, cannabis flower,​
1506+47.2cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or​
1507+47.3hemp-derived consumer product when this chapter and rules adopted under this chapter​
1508+47.4have been complied with or the item is found not to be in violation of this chapter or rules​
1509+47.5adopted under this chapter.​
1510+47.6 (d) If the court finds that detained or embargoed cannabis plant, cannabis flower, cannabis​
1511+47.7product, artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived​
1512+47.8consumer product is in violation of this chapter or rules adopted under this chapter, the​
1513+47.9following remedies are available:​
1514+47.10 (1) after entering a decree, the cannabis plant, cannabis flower, cannabis product,​
1515+47.11artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer​
1516+47.12product may be destroyed at the expense of the claimant under the supervision of the office,​
1517+47.13and all court costs, fees, storage, and other proper expenses must be assessed against the​
1518+47.14claimant of the cannabis plant, cannabis flower, cannabis product, artificially derived​
1519+47.15cannabinoid, lower-potency hemp edible, or hemp-derived consumer product or the claimant's​
1520+47.16agent; and​
1521+47.17 (2) if the violation can be corrected by proper labeling or processing of the cannabis​
1522+47.18plant, cannabis flower, cannabis product, artificially derived cannabinoid, lower-potency​
1523+47.19hemp edible, or hemp-derived consumer product, the court, after entry of the decree and​
1524+47.20after costs, fees, and expenses have been paid, and a good and sufficient bond conditioned​
1525+47.21that the cannabis plant, cannabis flower, cannabis product, artificially derived cannabinoid,​
1526+47.22lower-potency hemp edible, or hemp-derived consumer product must be properly labeled​
1527+47.23or processed has been executed, may by order direct that the cannabis plant, cannabis flower,​
1528+47.24cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or​
1529+47.25hemp-derived consumer product be delivered to the claimant for proper labeling or processing​
1530+47.26under the supervision of the office. The office's supervision expenses must be paid by the​
1531+47.27claimant. The cannabis plant, cannabis flower, cannabis product, artificially derived​
1532+47.28cannabinoid, lower-potency hemp edible, or hemp-derived consumer product must be​
1533+47.29returned to the claimant and the bond must be discharged on representation to the court by​
1534+47.30the office that the cannabis plant, cannabis flower, cannabis product, artificially derived​
1535+47.31cannabinoid, lower-potency hemp edible, or hemp-derived consumer product is no longer​
1536+47.32in violation and that the office's supervision expenses have been paid.​
1537+47.33 (e) If the office finds in any room, building, piece of equipment, vehicle of transportation,​
1538+47.34or other structure any cannabis plant, cannabis flower, cannabis product, artificially derived​
1539+47.35cannabinoid, lower-potency hemp edible, or hemp-derived consumer product that is unsound​
15381540 47​Article 1 Sec. 19.​
1539-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 48.1otherwise without the office's or a court's permission and each transaction is a separate​
1540-48.2violation of this section.​
1541-48.3 (c) If any cannabis plant, cannabis flower, cannabis product, artificially derived​
1542-48.4cannabinoid, lower-potency hemp edible, or hemp-derived consumer product has been​
1543-48.5found by the office to be in violation of this chapter, the office shall petition the district​
1544-48.6court in the county in which the item is detained or embargoed for an order and decree for​
1545-48.7the condemnation of the item. The office shall release the cannabis plant, cannabis flower,​
1546-48.8cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or​
1547-48.9hemp-derived consumer product when this chapter and rules adopted under this chapter​
1548-48.10have been complied with or the item is found not to be in violation of this chapter or rules​
1549-48.11adopted under this chapter.​
1550-48.12 (d) If the court finds that the detained or embargoed cannabis plant, cannabis flower,​
1551-48.13cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or​
1552-48.14hemp-derived consumer product is in violation of this chapter or rules adopted under this​
1553-48.15chapter, the following remedies are available:​
1554-48.16 (1) after entering a decree, the cannabis plant, cannabis flower, cannabis product,​
1555-48.17artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer​
1556-48.18product may be destroyed at the expense of the claimant under the supervision of the office,​
1557-48.19and all court costs, fees, storage, and other proper expenses must be assessed against the​
1558-48.20claimant of the cannabis plant, cannabis flower, cannabis product, artificially derived​
1559-48.21cannabinoid, lower-potency hemp edible, or hemp-derived consumer product or the claimant's​
1560-48.22agent; and​
1561-48.23 (2) if the violation can be corrected by proper labeling or processing of the cannabis​
1562-48.24plant, cannabis flower, cannabis product, artificially derived cannabinoid, lower-potency​
1563-48.25hemp edible, or hemp-derived consumer product, the court, after entry of the decree and​
1564-48.26after costs, fees, and expenses have been paid, and a good and sufficient bond conditioned​
1565-48.27that the cannabis plant, cannabis flower, cannabis product, artificially derived cannabinoid,​
1566-48.28lower-potency hemp edible, or hemp-derived consumer product must be properly labeled​
1567-48.29or processed has been executed, may by order direct that the cannabis plant, cannabis flower,​
1568-48.30cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or​
1569-48.31hemp-derived consumer product be delivered to the claimant for proper labeling or processing​
1570-48.32under the supervision of the office. The office's supervision expenses must be paid by the​
1571-48.33claimant. The cannabis plant, cannabis flower, cannabis product, artificially derived​
1572-48.34cannabinoid, lower-potency hemp edible, or hemp-derived consumer product must be​
1573-48.35returned to the claimant and the bond must be discharged on representation to the court by​
1541+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 48.1or contains any filthy, decomposed, or putrid substance, or that may be poisonous or​
1542+48.2deleterious to health or otherwise unsafe, the office shall condemn or destroy the item or​
1543+48.3in any other manner render the item as unsalable, and no one has any cause of action against​
1544+48.4the office on account of the office's action.​
1545+48.5 (f) The office may enter into an agreement with the commissioner of agriculture to​
1546+48.6analyze and examine samples or other articles furnished by the office for the purpose of​
1547+48.7determining whether the sample or article violates this chapter or rules adopted under this​
1548+48.8chapter. A copy of the examination or analysis report for any such article, duly authenticated​
1549+48.9under oath by the laboratory analyst making the determination or examination, shall be​
1550+48.10prima facie evidence in all courts of the matters and facts contained in the report.​
1551+48.11 Subd. 3.Aiding of inspection.Subject to rules issued by the office, a representative of​
1552+48.12a cannabis business or hemp business shall be given an opportunity to accompany the office​
1553+48.13during the physical inspection of any cannabis business or hemp business for the purpose​
1554+48.14of aiding such inspection.​
1555+48.15 Subd. 4.Complaints and reports; priority of inspection.(a) The office may conduct​
1556+48.16inspections of any licensed cannabis business or hemp business at any time to ensure​
1557+48.17compliance with the ownership and operation requirements of this chapter.​
1558+48.18 (b) Any person may report a suspected violation of a safety or health standard. If upon​
1559+48.19receipt of such notification the office determines that there are reasonable grounds to believe​
1560+48.20that such violation or danger exists, the office shall make a special inspection as soon as​
1561+48.21practicable to determine if such danger or violation exists.​
1562+48.22 (c) The office shall prioritize inspections of cannabis businesses and hemp businesses​
1563+48.23where there are reasonable grounds to believe that a violation poses imminent danger to the​
1564+48.24public or customers. Inspections must take place within 24 hours of the receipt of a credible​
1565+48.25report.​
1566+48.26 (d) The office shall promptly inspect cannabis businesses and hemp businesses that are​
1567+48.27the subject of complaint by a local unit of government.​
1568+48.28 Subd. 5.Violations; administrative orders and penalties.(a) The office may issue an​
1569+48.29administrative order to any licensed cannabis business or hemp business that the office​
1570+48.30determines has committed a violation of this chapter or rules adopted pursuant to this chapter.​
1571+48.31The administrative order may require the business to correct the violation or to cease and​
1572+48.32desist from committing the violation. The order must state the deficiencies that constitute​
1573+48.33the violation and the time by which the violation must be corrected. If the business believes​
1574+48.34that the information in the administrative order is in error, the business may ask the office​
15741575 48​Article 1 Sec. 19.​
1575-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 49.1the office that the cannabis plant, cannabis flower, cannabis product, artificially derived​
1576-49.2cannabinoid, lower-potency hemp edible, or hemp-derived consumer product is no longer​
1577-49.3in violation and that the office's supervision expenses have been paid.​
1578-49.4 (e) If the office finds in any room, building, piece of equipment, vehicle of transportation,​
1579-49.5or other structure any cannabis plant, cannabis flower, cannabis product, artificially derived​
1580-49.6cannabinoid, lower-potency hemp edible, or hemp-derived consumer product that is unsound​
1581-49.7or contains any filthy, decomposed, or putrid substance, or that may be poisonous or​
1582-49.8deleterious to health or otherwise unsafe, the office shall condemn or destroy the item or​
1583-49.9in any other manner render the item as unsalable, and no one has any cause of action against​
1584-49.10the office on account of the office's action.​
1585-49.11 (f) The office may enter into an agreement with the commissioner of agriculture to​
1586-49.12analyze and examine samples or other articles furnished by the office for the purpose of​
1587-49.13determining whether the sample or article violates this chapter or rules adopted under this​
1588-49.14chapter. A copy of the examination or analysis report for any such article, duly authenticated​
1589-49.15under oath by the laboratory analyst making the determination or examination, shall be​
1590-49.16prima facie evidence in all courts of the matters and facts contained in the report.​
1591-49.17 Subd. 3.Aiding of inspection.Subject to rules issued by the office, a representative of​
1592-49.18a cannabis business or hemp business shall be given an opportunity to accompany the office​
1593-49.19during the physical inspection of any cannabis business or hemp business for the purpose​
1594-49.20of aiding such inspection.​
1595-49.21 Subd. 4.Complaints and reports; priority of inspection.(a) The office may conduct​
1596-49.22inspections of any licensed cannabis business or hemp business at any time to ensure​
1597-49.23compliance with the ownership and operation requirements of this chapter.​
1598-49.24 (b) Any person may report a suspected violation of a safety or health standard. If upon​
1599-49.25receipt of such notification the office determines that there are reasonable grounds to believe​
1600-49.26that such violation or danger exists, the office shall make a special inspection as soon as​
1601-49.27practicable to determine if such danger or violation exists.​
1602-49.28 (c) The office shall prioritize inspections of cannabis businesses and hemp businesses​
1603-49.29where there are reasonable grounds to believe that a violation poses imminent danger to the​
1604-49.30public or customers. Inspections must take place within one business day of the receipt of​
1605-49.31a credible report.​
1606-49.32 (d) The office shall promptly inspect cannabis businesses and hemp businesses that are​
1607-49.33the subject of complaint by a local unit of government.​
1608-49​Article 1 Sec. 19.​
1609-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 50.1 Subd. 5.Violations; administrative orders and penalties.(a) The office may issue an​
1610-50.2administrative order to any licensed cannabis business or hemp business that the office​
1611-50.3determines has committed a violation of this chapter or rules adopted pursuant to this chapter.​
1612-50.4The administrative order may require the business to correct the violation or to cease and​
1613-50.5desist from committing the violation. The order must state the deficiencies that constitute​
1614-50.6the violation and the time by which the violation must be corrected. If the business believes​
1615-50.7that the information in the administrative order is in error, the business may ask the office​
1616-50.8to consider the parts of the order that are alleged to be in error. The request must be in​
1617-50.9writing, delivered to the office by certified mail within seven days after receipt of the order,​
1618-50.10and provide documentation to support the allegation of error. The office must respond to a​
1619-50.11request for reconsideration within 15 days after receiving the request. A request for​
1620-50.12reconsideration does not stay the correction order unless the office issues a supplemental​
1621-50.13order granting additional time. The office's disposition of a request for reconsideration is​
1622-50.14final.​
1623-50.15 (b) For each violation of this chapter or rules adopted pursuant to this chapter, the office​
1624-50.16may issue to each cannabis business or hemp business a monetary penalty of up to $10,000,​
1625-50.17an amount that deprives the business of any economic advantage gained by the violation,​
1626-50.18or both.​
1627-50.19 (c) An administrative penalty may be recovered in a civil action in the name of the state​
1628-50.20brought in the district court of the county where the violation is alleged to have occurred​
1629-50.21or the district court where the office is housed.​
1630-50.22 (d) In addition to penalties listed in this subdivision, a person or business who violates​
1631-50.23the provisions of this chapter is subject to any applicable criminal penalty.​
1632-50.24Sec. 20. [342.20] DATA PRACTICES.​
1633-50.25 Subdivision 1.Not public data.The following data collected, created, or maintained​
1634-50.26by the office are classified as nonpublic data, as defined by section 13.02, subdivision 9, or​
1635-50.27as private data on individuals, as defined by section 13.02, subdivision 12:​
1636-50.28 (1) application data submitted by an applicant for a cannabis business license or hemp​
1637-50.29business license, other than the data listed in subdivision 2;​
1638-50.30 (2) the identity of a complainant who has made a report concerning a license holder or​
1639-50.31an applicant that appears in inactive investigative data unless the complainant consents to​
1640-50.32the disclosure;​
1576+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 49.1to consider the parts of the order that are alleged to be in error. The request must be in​
1577+49.2writing, delivered to the office by certified mail within seven days after receipt of the order,​
1578+49.3and provide documentation to support the allegation of error. The office must respond to a​
1579+49.4request for reconsideration within 15 days after receiving the request. A request for​
1580+49.5reconsideration does not stay the correction order unless the office issues a supplemental​
1581+49.6order granting additional time. The office's disposition of a request for reconsideration is​
1582+49.7final.​
1583+49.8 (b) For each violation of this chapter or rules adopted pursuant to this chapter, the office​
1584+49.9may issue to each cannabis business or hemp business a monetary penalty of up to $10,000,​
1585+49.10an amount that deprives the business of any economic advantage gained by the violation,​
1586+49.11or both.​
1587+49.12 (c) An administrative penalty may be recovered in a civil action in the name of the state​
1588+49.13brought in the district court of the county where the violation is alleged to have occurred​
1589+49.14or the district court where the office is housed.​
1590+49.15 (d) In addition to penalties listed in this subdivision, a person or business who violates​
1591+49.16the provisions of this chapter is subject to any applicable criminal penalty.​
1592+49.17Sec. 20. [342.20] DATA PRACTICES.​
1593+49.18 Subdivision 1.Not public data.The following data collected, created, or maintained​
1594+49.19by the office are classified as nonpublic data, as defined by section 13.02, subdivision 9, or​
1595+49.20as private data on individuals, as defined by section 13.02, subdivision 12:​
1596+49.21 (1) application data submitted by an applicant for a cannabis business license or hemp​
1597+49.22business license, other than the data listed in subdivision 2;​
1598+49.23 (2) the identity of a complainant who has made a report concerning a license holder or​
1599+49.24applicant that appears in inactive complaint data unless the complainant consents to the​
1600+49.25disclosure;​
1601+49.26 (3) the nature or content of unsubstantiated complaints when the information is not​
1602+49.27maintained in anticipation of legal action;​
1603+49.28 (4) the record of any disciplinary proceeding except as limited by subdivision 9;​
1604+49.29 (5) data identifying retail or wholesale customers of a cannabis business or hemp business;​
1605+49.30and​
1606+49.31 (6) data identifying cannabis workers or hemp workers.​
1607+49​Article 1 Sec. 20.​
1608+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 50.1 Subd. 2.Public data on license applicants.(a) The following application data submitted​
1609+50.2by an applicant for a cannabis business license or hemp business license are public data:​
1610+50.3 (1) the applicant's name and designated address;​
1611+50.4 (2) data disclosing the ownership and control of the applicant;​
1612+50.5 (3) proof of trade name registration;​
1613+50.6 (4) data showing the legal possession of the premises where the business will operate;​
1614+50.7 (5) data describing whether volatile chemicals will be used in any methods of extraction​
1615+50.8or concentration;​
1616+50.9 (6) environmental plans;​
1617+50.10 (7) the type and number of other cannabis business licenses or hemp business licenses​
1618+50.11held by the applicant; and​
1619+50.12 (8) the name, address, location, dates, and hours of where any proposed cannabis event​
1620+50.13will take place.​
1621+50.14 (b) Scoring and other data generated by the office in its review of an applicant for a​
1622+50.15cannabis business license or hemp business license are public data.​
1623+50.16 Subd. 3.Public application data on license holders.Once an applicant for a cannabis​
1624+50.17business license or hemp business license becomes a license holder, all of the application​
1625+50.18data that the license holder had previously submitted to the office are public data except​
1626+50.19that the following data remain classified as nonpublic data or private data on individuals:​
1627+50.20 (1) data identifying retail or wholesale customers of a cannabis business or hemp business;​
1628+50.21 (2) data identifying cannabis workers or hemp workers;​
1629+50.22 (3) tax returns, bank account statements, and other financial account information;​
1630+50.23 (4) business plans; and​
1631+50.24 (5) security information and trade secret information, as defined by section 13.37.​
1632+50.25 Subd. 4.Public disciplinary data.Minutes, orders for hearings, findings of fact,​
1633+50.26conclusions of law, and specification of the final disciplinary action contained in the record​
1634+50.27of the disciplinary action are classified as public data. If there is a public hearing concerning​
1635+50.28the disciplinary action, the entire record concerning the disciplinary action is public data.​
1636+50.29If the license holder and the office agree to resolve a complaint without a hearing, the​
1637+50.30agreement and the specific reasons for the agreement are public data.​
16411638 50​Article 1 Sec. 20.​
1642-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 51.1 (3) data identifying retail or wholesale customers of a cannabis business or hemp business;​
1643-51.2and​
1644-51.3 (4) data identifying cannabis workers or hemp workers.​
1645-51.4 Subd. 2.Public data on license applicants.(a) The following application data submitted​
1646-51.5by an applicant for a cannabis business license or hemp business license are public data:​
1647-51.6 (1) the applicant's name and designated address;​
1648-51.7 (2) data disclosing the ownership and control of the applicant;​
1649-51.8 (3) proof of trade name registration;​
1650-51.9 (4) data showing the legal possession of the premises where the business will operate;​
1651-51.10 (5) data describing whether volatile chemicals will be used in any methods of extraction​
1652-51.11or concentration;​
1653-51.12 (6) environmental plans;​
1654-51.13 (7) the type and number of other cannabis business licenses or hemp business licenses​
1655-51.14held by the applicant; and​
1656-51.15 (8) the name, address, location, dates, and hours of where any proposed cannabis event​
1657-51.16will take place.​
1658-51.17 (b) Scoring and other data generated by the office in its review of an applicant for a​
1659-51.18cannabis business license or hemp business license are public data.​
1660-51.19 Subd. 3.Public application data on license holders.Once an applicant for a cannabis​
1661-51.20business license or hemp business license becomes a license holder, all of the application​
1662-51.21data that the license holder had previously submitted to the office are public data except​
1663-51.22that the following data remain classified as nonpublic data or private data on individuals:​
1664-51.23 (1) data identifying retail or wholesale customers of a cannabis business or hemp business;​
1665-51.24 (2) data identifying cannabis workers or hemp workers;​
1666-51.25 (3) tax returns, bank account statements, and other financial account information;​
1667-51.26 (4) business plans; and​
1668-51.27 (5) data classified as nonpublic data or private data on individuals by chapter 13 or other​
1669-51.28applicable law.​
1670-51.29 Subd. 4.Civil investigative data.Data collected or maintained by the office as part of​
1671-51.30an active investigation undertaken for the purpose of the commencement or defense of a​
1672-51​Article 1 Sec. 20.​
1673-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 52.1pending civil legal action, or that are retained in anticipation of a pending civil legal action,​
1674-52.2must be subject to section 13.39.​
1675-52.3 Subd. 5.Data practices administration.(a) The office must establish written procedures​
1676-52.4to ensure that only individuals authorized by law may enter, update, or access data maintained​
1677-52.5by the office and classified as nonpublic or private data on individuals. An authorized​
1678-52.6individual's ability to enter, update, or access not public data must correspond to the official​
1679-52.7duties or training level of the individual and to the statutory authorization granting access​
1680-52.8for that purpose. All queries and responses, and all actions in which not public data are​
1681-52.9entered, updated, accessed, shared, or disseminated, must be recorded in a data audit trail.​
1682-52.10Data contained in the audit trail have the same classification as the underlying data tracked​
1683-52.11by the audit trail.​
1684-52.12 (b) The office must not share data classified as nonpublic or private data on individuals​
1685-52.13under this section or other data identifying an individual applicant or license holder with​
1686-52.14any federal agency, federal department, or federal entity unless specifically ordered to do​
1687-52.15so by a state or federal court.​
1688-52.16 (c) The office must arrange for an independent audit to verify compliance with this​
1689-52.17section. The audit must be completed annually for the first two years following establishment​
1690-52.18of the office and biennially thereafter. The results of the audit are public. No later than 30​
1691-52.19days following completion of the audit, the office must provide a report summarizing the​
1692-52.20audit results to the chairs and ranking minority members of the committees and divisions​
1693-52.21of the house of representatives and the senate with jurisdiction over commerce and data​
1694-52.22practices, and the Legislative Commission on Data Practices and Personal Data Privacy.​
1695-52.23The report must be submitted as required under section 3.195, except that printed copies​
1696-52.24are not required.​
1697-52.25Sec. 21. [342.21] LICENSE SUSPENSION OR REVOCATION; HEARING.​
1698-52.26 Subdivision 1.License revocation and nonrenewal.The office may revoke or not​
1699-52.27renew a license when the office has cause to believe that a cannabis business or hemp​
1700-52.28business has violated an ownership or operational requirement in this chapter or rules adopted​
1701-52.29pursuant to this chapter. The office must notify the license holder in writing, specifying the​
1702-52.30grounds for revocation or nonrenewal and fixing a time of at least 20 days thereafter for a​
1703-52.31hearing on the matter.​
1704-52.32 Subd. 2.Hearing; written findings.(a) Before the office revokes or does not renew a​
1705-52.33license, the office must provide the license holder with a statement of the complaints made​
1706-52.34against the license holder, and the office must hold a hearing to determine whether the office​
1707-52​Article 1 Sec. 21.​
1708-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 53.1should revoke the license or deny renewal of the license. The license holder shall receive​
1709-53.2notice at least 20 days before the date of the hearing and notice may be served either by​
1710-53.3certified mail addressed to the address of the license holder as shown in the license​
1711-53.4application or in the manner provided by law for the service of a summons. At the time and​
1712-53.5place fixed for the hearing, the office, or any office employee or agent authorized by the​
1713-53.6office to conduct the hearing, shall receive evidence, administer oaths, and examine witnesses.​
1714-53.7 (b) After the hearing held pursuant to paragraph (a), or upon the failure of the license​
1715-53.8holder to appear at the hearing, the office must take action as is deemed advisable and issue​
1716-53.9written findings that the office must mail to the license holder. An action of the office under​
1717-53.10this paragraph is subject to judicial review pursuant to chapter 14.​
1718-53.11 Subd. 3.Temporary suspension.The office may temporarily, without hearing, suspend​
1719-53.12the license and operating privilege of any business licensed under this chapter for up to 90​
1720-53.13days if continuing the operation of the business would threaten the health or safety of any​
1721-53.14person. The office may extend the period for an additional 90 days if the office notified the​
1722-53.15business that the office intends to revoke or not renew a license and the hearing required​
1723-53.16under subdivision 2 has not taken place.​
1724-53.17Sec. 22. [342.22] RETAILERS; LOCAL REGISTRATION AND ENFORCEMENT .​
1725-53.18 Subdivision 1.Registration required.Before making retail sales to customers or patients,​
1726-53.19a cannabis microbusiness with a retail operations endorsement, cannabis mezzobusiness​
1727-53.20with a retail operations endorsement, cannabis retailer, medical cannabis retailer, medical​
1728-53.21cannabis combination business, or lower-potency hemp edible retailer must register with​
1729-53.22the city, town, or county in which the retail establishment is located. A county may issue a​
1730-53.23registration in cases where a city or town has provided consent for the county to issue the​
1731-53.24registration for the jurisdiction.​
1732-53.25 Subd. 2.Registration fee.(a) A local unit of government may impose an initial retail​
1733-53.26registration fee of $500 or up to half the amount of the applicable initial license fee under​
1734-53.27section 342.11, whichever is less. The local unit of government may also impose a renewal​
1735-53.28retail registration fee of $1,000 or up to half the amount of the applicable renewal license​
1736-53.29fee under section 342.11, whichever is less. The initial registration fee shall include the fee​
1737-53.30for initial registration and the first annual renewal. Any renewal fee imposed by the local​
1738-53.31unit of government shall be charged at the time of the second renewal and each subsequent​
1739-53.32annual renewal thereafter.​
1740-53.33 (b) The local unit of government may not charge an application fee.​
1639+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 51.1 Subd. 5.Data practices administration.(a) The office must establish written procedures​
1640+51.2to ensure that only individuals authorized by law may enter, update, or access data maintained​
1641+51.3by the office and classified as nonpublic or private data on individuals. An authorized​
1642+51.4individual's ability to enter, update, or access not public data must correspond to the official​
1643+51.5duties or training level of the individual and to the statutory authorization granting access​
1644+51.6for that purpose. All queries and responses, and all actions in which not public data are​
1645+51.7entered, updated, accessed, shared, or disseminated, must be recorded in a data audit trail.​
1646+51.8Data contained in the audit trail have the same classification as the underlying data tracked​
1647+51.9by the audit trail.​
1648+51.10 (b) The office must not share data classified as nonpublic or private data on individuals​
1649+51.11under this section or other data identifying an individual applicant or license holder with​
1650+51.12any federal agency, federal department, or federal entity unless specifically ordered to do​
1651+51.13so by a state or federal court.​
1652+51.14 (c) The office must arrange for an independent audit to verify compliance with this​
1653+51.15section. The audit must be completed annually for the first two years following establishment​
1654+51.16of the office and biennially thereafter. The results of the audit are public. No later than 30​
1655+51.17days following completion of the audit, the office must provide a report summarizing the​
1656+51.18audit results to the chairs and ranking minority members of the committees and divisions​
1657+51.19of the house of representatives and the senate with jurisdiction over commerce and data​
1658+51.20practices, and the Legislative Commission on Data Practices and Personal Data Privacy.​
1659+51.21The report must be submitted as required under section 3.195, except that printed copies​
1660+51.22are not required.​
1661+51.23Sec. 21. [342.21] LICENSE SUSPENSION OR REVOCATION; HEARING.​
1662+51.24 Subdivision 1.License revocation and nonrenewal.The office may revoke or not​
1663+51.25renew a license when the office has cause to believe that a cannabis business or hemp​
1664+51.26business has violated an ownership or operational requirement in this chapter or rules adopted​
1665+51.27pursuant to this chapter. The office must notify the license holder in writing, specifying the​
1666+51.28grounds for revocation or nonrenewal and fixing a time of at least 20 days thereafter for a​
1667+51.29hearing on the matter.​
1668+51.30 Subd. 2.Hearing; written findings.(a) Before the office revokes or does not renew a​
1669+51.31license, the office must provide the license holder with a statement of the complaints made​
1670+51.32against the license holder, and the office must hold a hearing to determine whether the office​
1671+51.33should revoke the license or deny renewal of the license. The license holder shall receive​
1672+51.34notice at least 20 days before the date of the hearing and notice may be served either by​
1673+51​Article 1 Sec. 21.​
1674+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 52.1certified mail addressed to the address of the license holder as shown in the license​
1675+52.2application or in the manner provided by law for the service of a summons. At the time and​
1676+52.3place fixed for the hearing, the office, or any office employee or agent authorized by the​
1677+52.4office to conduct the hearing, shall receive evidence, administer oaths, and examine witnesses.​
1678+52.5 (b) After the hearing held pursuant to paragraph (a), or upon the failure of the license​
1679+52.6holder to appear at the hearing, the office must take action as is deemed advisable and issue​
1680+52.7written findings that the office must mail to the license holder. An action of the office under​
1681+52.8this paragraph is subject to judicial review pursuant to chapter 14.​
1682+52.9 Subd. 3.Temporary suspension.The office may temporarily, without hearing, suspend​
1683+52.10the license and operating privilege of any business licensed under this chapter for up to 90​
1684+52.11days if continuing the operation of the business would threaten the health or safety of any​
1685+52.12person. The office may extend the period for an additional 90 days if the office notified the​
1686+52.13business that the office intends to revoke or not renew a license and the hearing required​
1687+52.14under subdivision 2 has not taken place.​
1688+52.15Sec. 22. [342.22] RETAILERS; LOCAL REGISTRATION AND ENFORCEMENT .​
1689+52.16 Subdivision 1.Registration required.Before making retail sales to customers or patients,​
1690+52.17a cannabis microbusiness with a retail operations endorsement, cannabis mezzobusiness​
1691+52.18with a retail operations endorsement, cannabis retailer, medical cannabis retailer, or​
1692+52.19lower-potency hemp edible retailer must register with the local unit of government in which​
1693+52.20the retail establishment is located.​
1694+52.21 Subd. 2.Registration fee.(a) A local unit of government may impose an initial retail​
1695+52.22registration fee of up to half the amount of the applicable initial license fee under section​
1696+52.23342.11. The local unit of government may also impose a renewal retail registration fee of​
1697+52.24up to half the amount of the applicable renewal license fee under section 342.11. The initial​
1698+52.25license fee shall include the fee for initial registration and the first annual renewal. Any​
1699+52.26renewal fee imposed by the local unit of government shall be charged at the time of the​
1700+52.27second renewal and each subsequent annual renewal thereafter.​
1701+52.28 (b) The local unit of government may not charge an application fee.​
1702+52.29 (c) A cannabis business with a cannabis retailer license and a medical cannabis retailer​
1703+52.30license for the same location may only be charged a single registration fee.​
1704+52.31 (d) Registration fees are nonrefundable.​
1705+52.32 Subd. 3.Issuance of registration.(a) A local unit of government shall issue a retail​
1706+52.33registration to a cannabis microbusiness with a retail operations endorsement, cannabis​
1707+52​Article 1 Sec. 22.​
1708+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 53.1mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis​
1709+53.2retailer, or lower-potency hemp edible retailer that:​
1710+53.3 (1) has a valid license issued by the office;​
1711+53.4 (2) has paid the registration fee or renewal fee pursuant to subdivision 2;​
1712+53.5 (3) is found to be in compliance with the requirements of this chapter at any preliminary​
1713+53.6compliance check that the local unit of government performs; and​
1714+53.7 (4) if applicable, is current on all property taxes and assessments at the location where​
1715+53.8the retail establishment is located.​
1716+53.9 (b) Before issuing a retail registration, the local unit of government may conduct a​
1717+53.10preliminary compliance check to ensure that the cannabis business or hemp business is in​
1718+53.11compliance with the applicable operation requirements and the limits on the types of cannabis​
1719+53.12flower, cannabinoid products, and hemp-derived consumer products that may be sold.​
1720+53.13 (c) A local unit of government shall renew the retail registration of a cannabis business​
1721+53.14or hemp business when the office renews the license of the cannabis business or hemp​
1722+53.15business.​
1723+53.16 (d) A retail registration issued under this section may not be transferred.​
1724+53.17 Subd. 4.Compliance checks.(a) A local unit of government shall conduct compliance​
1725+53.18checks of every cannabis business and hemp business with a retail registration issued by​
1726+53.19the local unit of government. The checks shall assess compliance with age verification​
1727+53.20requirements; the applicable operation requirements; and the applicable limits on the types​
1728+53.21of cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived​
1729+53.22consumer products being sold.​
1730+53.23 (b) The local unit of government must conduct unannounced age verification compliance​
1731+53.24checks at least once each calendar year. Age verification compliance checks must involve​
1732+53.25persons at least 17 years of age, but under the age of 21, who, with the prior written consent​
1733+53.26of a parent or guardian if the person is under the age of 18, attempt to purchase cannabis​
1734+53.27flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products​
1735+53.28under the direct supervision of a law enforcement officer or an employee of the local unit​
1736+53.29of government.​
1737+53.30 (c) Checks to ensure compliance with the applicable operation requirements and the​
1738+53.31limits on the types of cannabis flower, cannabis products, lower-potency hemp edibles, and​
1739+53.32hemp-derived consumer products that may be sold must be performed at least once each​
17411740 53​Article 1 Sec. 22.​
1742-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 54.1 (c) A cannabis business with a cannabis retailer license and a medical cannabis retailer​
1743-54.2license for the same location may only be charged a single registration fee.​
1744-54.3 (d) Registration fees are nonrefundable.​
1745-54.4 Subd. 3.Issuance of registration.(a) A local unit of government shall issue a retail​
1746-54.5registration to a cannabis microbusiness with a retail operations endorsement, cannabis​
1747-54.6mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis​
1748-54.7retailer, or lower-potency hemp edible retailer that:​
1749-54.8 (1) has a valid license issued by the office;​
1750-54.9 (2) has paid the registration fee or renewal fee pursuant to subdivision 2;​
1751-54.10 (3) is found to be in compliance with the requirements of this chapter at any preliminary​
1752-54.11compliance check that the local unit of government performs; and​
1753-54.12 (4) if applicable, is current on all property taxes and assessments at the location where​
1754-54.13the retail establishment is located.​
1755-54.14 (b) Before issuing a retail registration, the local unit of government may conduct a​
1756-54.15preliminary compliance check to ensure that the cannabis business or hemp business is in​
1757-54.16compliance with the applicable operation requirements and the limits on the types of cannabis​
1758-54.17flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products​
1759-54.18that may be sold.​
1760-54.19 (c) A local unit of government shall renew the retail registration of a cannabis business​
1761-54.20or hemp business when the office renews the license of the cannabis business or hemp​
1762-54.21business.​
1763-54.22 (d) A retail registration issued under this section may not be transferred.​
1764-54.23 Subd. 4.Compliance checks.(a) A local unit of government shall conduct compliance​
1765-54.24checks of every cannabis business and hemp business with a retail registration issued by​
1766-54.25the local unit of government. The checks shall assess compliance with age verification​
1767-54.26requirements, the applicable operation requirements, and the applicable limits on the types​
1768-54.27of cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived​
1769-54.28consumer products being sold.​
1770-54.29 (b) The local unit of government must conduct unannounced age verification compliance​
1771-54.30checks at least once each calendar year. Age verification compliance checks must involve​
1772-54.31persons at least 17 years of age, but under the age of 21, who, with the prior written consent​
1773-54.32of a parent or guardian if the person is under the age of 18, attempt to purchase adult-use​
1774-54​Article 1 Sec. 22.​
1775-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 55.1cannabis flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived​
1776-55.2consumer products under the direct supervision of a law enforcement officer or an employee​
1777-55.3of the local unit of government.​
1778-55.4 (c) Checks to ensure compliance with the applicable operation requirements and the​
1779-55.5limits on the types of cannabis flower, cannabis products, lower-potency hemp edibles, and​
1780-55.6hemp-derived consumer products that may be sold must be performed at least once each​
1781-55.7calendar year and may be performed by a law enforcement officer or an employee of the​
1782-55.8local unit of government.​
1783-55.9 Subd. 5.Registration suspension and cancellation; notice to office; penalties.(a) If​
1784-55.10a local unit of government determines that a cannabis business or hemp business with a​
1785-55.11retail registration issued by the local unit of government is not operating in compliance with​
1786-55.12the requirements of this chapter or that the operation of the business poses an immediate​
1787-55.13threat to the health or safety of the public, the local unit of government may suspend the​
1788-55.14retail registration of the cannabis business or hemp business. The local unit of government​
1789-55.15must immediately notify the office of the suspension and shall include a description of the​
1790-55.16grounds for the suspension.​
1791-55.17 (b) The office shall review the retail registration suspension and may order reinstatement​
1792-55.18of the retail registration or take any action described in section 342.19 or 342.21.​
1793-55.19 (c) The retail registration suspension must be for up to 30 days unless the office suspends​
1794-55.20the license and operating privilege of the cannabis business or hemp business for a longer​
1795-55.21period or revokes the license.​
1796-55.22 (d) The local unit of government may reinstate the retail registration if the local unit of​
1797-55.23government determines that any violation has been cured. The local unit of government​
1798-55.24must reinstate the retail registration if the office orders reinstatement.​
1799-55.25 (e) No cannabis microbusiness with a retail operations endorsement, cannabis​
1800-55.26mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis​
1801-55.27retailer, medical cannabis combination business, or lower-potency hemp edible retailer may​
1802-55.28make any sale to a customer or patient without a valid retail registration. A local unit of​
1803-55.29government may impose a civil penalty of up to $2,000 for each violation of this paragraph.​
1804-55.30Sec. 23. [342.23] CANNABIS BUSINESSES AND HEMP BUSINESSES; GENERAL​
1805-55.31OPERATIONAL REQUIREMENTS.​
1806-55.32 Subdivision 1.Records.(a) Cannabis businesses and hemp businesses must retain​
1807-55.33financial records for the current and previous tax years at the primary business location and​
1741+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 54.1calendar year and may be performed by a law enforcement officer or an employee of the​
1742+54.2local unit of government.​
1743+54.3 Subd. 5.Registration suspension and cancellation; notice to office; penalties.(a) If​
1744+54.4a local unit of government determines that a cannabis business or hemp business with a​
1745+54.5retail registration issued by the local unit of government is not operating in compliance with​
1746+54.6the requirements of this chapter or that the operation of the business poses an immediate​
1747+54.7threat to the health or safety of the public, the local unit of government may suspend the​
1748+54.8retail registration of the cannabis business or hemp business. The local unit of government​
1749+54.9must immediately notify the office of the suspension and shall include a description of the​
1750+54.10grounds for the suspension.​
1751+54.11 (b) The office shall review the retail registration suspension and may order reinstatement​
1752+54.12of the retail registration or take any action described in section 342.19 or 342.21.​
1753+54.13 (c) The retail registration suspension must be for up to 30 days unless the office suspends​
1754+54.14the license and operating privilege of the cannabis business or hemp business for a longer​
1755+54.15period or revokes the license.​
1756+54.16 (d) The local unit of government may reinstate the retail registration if the local unit of​
1757+54.17government determines that any violation has been cured. The local unit of government​
1758+54.18must reinstate the retail registration if the office orders reinstatement.​
1759+54.19 (e) No cannabis microbusiness with a retail operations endorsement, cannabis​
1760+54.20mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis​
1761+54.21retailer, or lower-potency hemp edible retailer may make any sale to a customer or patient​
1762+54.22without a valid retail registration. A local unit of government may impose a civil penalty​
1763+54.23of up to $2,000 for each violation of this paragraph.​
1764+54.24Sec. 23. [342.23] CANNABIS BUSINESSES AND HEMP BUSINESSES; GENERAL​
1765+54.25OPERATIONAL REQUIREMENTS.​
1766+54.26 Subdivision 1.Records.(a) Cannabis businesses and hemp businesses must retain​
1767+54.27financial records for the current and previous tax years at the primary business location and​
1768+54.28must make those records available for inspection by the office at any time during regular​
1769+54.29business hours.​
1770+54.30 (b) When applicable, a cannabis business or hemp business must maintain financial​
1771+54.31records for the previous ten tax years and must make those records available for inspection​
1772+54.32within one business day of receiving a request for inspection by the office.​
1773+54​Article 1 Sec. 23.​
1774+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 55.1 (c) The office may require a cannabis business or hemp business to submit to an audit​
1775+55.2of its business records. The office may select or approve the auditor and the cannabis business​
1776+55.3or hemp business must provide the auditor with access to all business records. The cost of​
1777+55.4the audit must be paid by the cannabis business or hemp business.​
1778+55.5 Subd. 2.Disposal; loss documentation.(a) Cannabis businesses and hemp businesses​
1779+55.6must dispose of cannabis plants, cannabis flower, cannabis products, artificially derived​
1780+55.7cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products that are​
1781+55.8damaged, have a broken seal, have been contaminated, or have not been sold by the expiration​
1782+55.9date on the label.​
1783+55.10 (b) Disposal must be conducted in a manner approved by the office.​
1784+55.11 (c) Disposal of any cannabis plants, cannabis flower, cannabis products, artificially​
1785+55.12derived cannabinoids, and hemp-derived consumer products that are required to be entered​
1786+55.13into the statewide monitoring system must be documented in the statewide monitoring​
1787+55.14system.​
1788+55.15 (d) Loss or theft of any cannabis plants, cannabis flower, cannabis products, artificially​
1789+55.16derived cannabinoids, or hemp-derived consumer products that are required to be entered​
1790+55.17into the statewide monitoring system must be reported to local law enforcement and a​
1791+55.18business must log any such loss or theft in the statewide monitoring system as soon as the​
1792+55.19loss or theft is discovered.​
1793+55.20 Subd. 3.Sale of approved products.Cannabis businesses and hemp businesses may​
1794+55.21only sell cannabis plants, cannabis flower, cannabis products, artificially derived​
1795+55.22cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products that are​
1796+55.23a type approved by the office and that comply with this chapter and rules adopted pursuant​
1797+55.24to this chapter regarding the testing, packaging, and labeling of cannabis plants, cannabis​
1798+55.25flower, cannabis products, artificially derived cannabinoids, lower-potency hemp edibles,​
1799+55.26and hemp-derived consumer products.​
1800+55.27 Subd. 4.Financial relationship.(a) Except for the lawful sale of cannabis plants,​
1801+55.28cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp​
1802+55.29edibles, and hemp-derived consumer products in the ordinary course of business and as​
1803+55.30otherwise provided in this subdivision, no cannabis business or hemp business may offer,​
1804+55.31give, accept, receive, or borrow money or anything else of value or accept or receive credit​
1805+55.32from any other cannabis business. This prohibition applies to offering or receiving a benefit​
1806+55.33in exchange for preferential placement by a retailer, including preferential placement on​
1807+55.34the retailer's shelves, display cases, or website. This prohibition applies to every cooperative​
18081808 55​Article 1 Sec. 23.​
1809-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 56.1must make those records available for inspection by the office at any time during regular
1810-56.2business hours.​
1811-56.3 (b) When applicable, a cannabis business or hemp business must maintain financial
1812-56.4records for the previous ten tax years and must make those records available for inspection
1813-56.5within one business day of receiving a request for inspection by the office.
1814-56.6 (c) The office may require a cannabis business or hemp business to submit to an audit
1815-56.7of its business records. The office may select or approve the auditor and the cannabis business
1816-56.8or hemp business must provide the auditor with access to all business records. The cost of
1817-56.9the audit must be paid by the cannabis business or hemp business.
1818-56.10 Subd. 2.Diversity report.Cannabis businesses and hemp businesses shall provide an​
1819-56.11annual report on the status of diversity in the business ownership, management, and
1820-56.12employment and in services for which the business contracts.
1821-56.13 Subd. 3.Disposal; loss documentation.(a) Cannabis businesses and hemp businesses
1822-56.14must dispose of cannabis plants, cannabis flower, cannabis products, artificially derived
1823-56.15cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products that are
1824-56.16damaged, have a broken seal, have been contaminated, or have not been sold by the expiration
1825-56.17date on the label.​
1826-56.18 (b) Disposal must be conducted in a manner approved by the office.
1827-56.19 (c) Disposal of any cannabis plants, cannabis flower, cannabis products, artificially
1828-56.20derived cannabinoids, and hemp-derived consumer products that are required to be entered
1829-56.21into the statewide monitoring system must be documented in the statewide monitoring
1830-56.22system.​
1831-56.23 (d) Loss or theft of any cannabis plants, cannabis flower, cannabis products, artificially
1832-56.24derived cannabinoids, or hemp-derived consumer products that are required to be entered
1833-56.25into the statewide monitoring system must be reported to local law enforcement and a
1834-56.26business must log any such loss or theft in the statewide monitoring system as soon as the
1835-56.27loss or theft is discovered.​
1836-56.28 Subd. 4.Sale of approved products.Cannabis businesses and hemp businesses may
1837-56.29only sell cannabis plants, cannabis flower, cannabis products, artificially derived
1838-56.30cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products that are
1839-56.31a product category approved by the office and that comply with this chapter and rules
1840-56.32adopted pursuant to this chapter regarding the testing, packaging, and labeling of cannabis​
1841-56​Article 1 Sec. 23.​
1842-REVISOR BD H0100-12HF100 TWELFTH ENGROSSMENT​ 57.1plants, cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency​
1843-57.2hemp edibles, and hemp-derived consumer products.
1844-57.3 Subd. 5.Financial relationship.(a) Except for the lawful sale of cannabis plants,
1845-57.4cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp
1846-57.5edibles, and hemp-derived consumer products in the ordinary course of business and as
1847-57.6otherwise provided in this subdivision, no cannabis business or hemp business may offer,​
1848-57.7give, accept, receive, or borrow money or anything else of value or accept or receive credit
1849-57.8from any other cannabis business. This prohibition applies to offering or receiving a benefit
1850-57.9in exchange for preferential placement by a retailer, including preferential placement on
1851-57.10the retailer's shelves, display cases, or website. This prohibition applies to every cooperative
1852-57.11member or every director, manager, and general partner of a cannabis business or hemp​
1853-57.12business.
1854-57.13 (b) This prohibition does not apply to merchandising credit in the ordinary course of
1855-57.14business for a period not to exceed 30 days.
1856-57.15 (c) This prohibition does not apply to free samples of usable cannabis flower, cannabis​
1857-57.16products, lower-potency hemp edibles, or hemp-derived consumer products packaged in a
1858-57.17sample jar protected by a plastic or metal mesh screen to allow customers to smell the​
1859-57.18cannabis flower, cannabis product, lower-potency hemp edible, or hemp-derived consumer
1860-57.19product before purchase. A sample jar may not contain more than eight grams of usable
1861-57.20cannabis flower, more than eight grams of a cannabis concentrate, an edible cannabis product
1862-57.21infused with more than 100 milligrams of tetrahydrocannabinol, a lower-potency hemp​
1863-57.22edible infused with more than 50 milligrams of tetrahydrocannabinol, or a hemp-derived
1864-57.23consumer product with a total weight of more than eight grams.​
1865-57.24 (d) This prohibition does not apply to free samples of cannabis flower, cannabis products,
1866-57.25lower-potency hemp edibles, or hemp-derived consumer products provided to a retailer or
1867-57.26cannabis wholesaler for the purposes of quality control and to allow retailers to determine
1868-57.27whether to offer a product for sale. A sample provided for these purposes may not contain
1869-57.28more than eight grams of usable cannabis flower, more than eight grams of a cannabis
1870-57.29concentrate, an edible cannabis product infused with more than 100 milligrams of
1871-57.30tetrahydrocannabinol, a lower-potency hemp edible infused with more than 50 milligrams
1872-57.31of tetrahydrocannabinol, or a hemp-derived consumer product with a total weight of more
1873-57.32than eight grams.
1874-57.33 (e) This prohibition does not apply to any fee charged by a licensed cannabis event
1875-57.34organizer to a cannabis business or hemp business for participation in a cannabis event.
1876-57​Article 1 Sec. 23.​
1877-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 58.1 Subd. 6.Customer privacy.Cannabis businesses and hemp businesses must not share
1878-58.2data on retail or wholesale customers with any federal agency, federal department, or federal
1879-58.3entity unless specifically ordered by a state or federal court.
1880-58.4 Sec. 24. [342.24] CANNABIS BUSINESSES; GENERAL OPERATIONAL
1881-58.5REQUIREMENTS AND PROHIBITIONS.
1882-58.6 Subdivision 1.Individuals under 21 years of age.(a) A cannabis business may not
1883-58.7employ an individual under 21 years of age and may not contract with an individual under
1884-58.821 years of age if the individual's scope of work involves the handling of cannabis plants,
1885-58.9cannabis flower, artificially derived cannabinoids, or cannabinoid products.​
1886-58.10 (b) A cannabis business may not permit an individual under 21 years of age to enter the
1887-58.11business premises other than entry by a patient enrolled in the registry program.
1888-58.12 (c) A cannabis business may not sell or give cannabis flower, cannabis products,
1889-58.13lower-potency hemp edibles, or hemp-derived consumer products to an individual under
1890-58.1421 years of age unless the individual is a patient; registered designated caregiver; or a parent,
1891-58.15legal guardian, or spouse of a patient who is authorized to use, possess, or transport medical
1892-58.16cannabis flower or medical cannabinoid products.
1893-58.17 Subd. 2.Use of cannabis flower and products within a licensed cannabis business.(a)
1894-58.18A cannabis business may not permit an individual who is not an employee to consume
1895-58.19cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer
1896-58.20products within its licensed premises unless the business is licensed to permit on-site
1897-58.21consumption.
1898-58.22 (b) Except as otherwise provided in this subdivision, a cannabis business may not permit
1899-58.23an employee to consume cannabis flower, cannabis products, lower-potency hemp edibles,
1900-58.24or hemp-derived consumer products within its licensed premises or while the employee is
1901-58.25otherwise engaged in activities within the course and scope of employment.​
1902-58.26 (c) A cannabis business may permit an employee to use medical cannabis flower and
1903-58.27medical cannabinoid products if that individual is a patient.
1904-58.28 (d) For quality control, employees of a licensed cannabis business may sample cannabis
1905-58.29flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products.​
1906-58.30Employees may not interact directly with customers for at least three hours after sampling
1907-58.31a product. Employees may not consume more than three samples in a single 24-hour period.
1908-58.32All samples must be recorded in the statewide monitoring system.
1809+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 56.1member or every director, manager, and general partner of a cannabis business or hemp
1810+56.2business.​
1811+56.3 (b) This prohibition does not apply to merchandising credit in the ordinary course of
1812+56.4business for a period not to exceed 30 days.
1813+56.5 (c) This prohibition does not apply to free samples of usable cannabis flower, cannabis
1814+56.6products, lower-potency hemp edibles, or hemp-derived consumer products packaged in a
1815+56.7sample jar protected by a plastic or metal mesh screen to allow customers to smell the​
1816+56.8cannabis flower, cannabis product, lower-potency hemp edible, or hemp-derived consumer
1817+56.9product before purchase. A sample jar may not contain more than eight grams of usable
1818+56.10cannabis flower, more than eight grams of a cannabis concentrate, an edible cannabis product
1819+56.11infused with more than 100 milligrams of tetrahydrocannabinol, a lower-potency hemp
1820+56.12edible infused with more than 50 milligrams of tetrahydrocannabinol, or a hemp-derived
1821+56.13consumer product with a total weight of more than eight grams.​
1822+56.14 (d) This prohibition does not apply to free samples of cannabis flower, cannabis products,​
1823+56.15lower-potency hemp edibles, or hemp-derived consumer products provided to a retailer or
1824+56.16cannabis wholesaler for the purposes of quality control and to allow retailers to determine
1825+56.17whether to offer a product for sale. A sample provided for these purposes may not contain
1826+56.18more than eight grams of usable cannabis flower, more than eight grams of a cannabis
1827+56.19concentrate, an edible cannabis product infused with more than 100 milligrams of
1828+56.20tetrahydrocannabinol, a lower-potency hemp edible infused with more than 50 milligrams
1829+56.21of tetrahydrocannabinol, or a hemp-derived consumer product with a total weight of more
1830+56.22than eight grams.​
1831+56.23 (e) This prohibition does not apply to any fee charged by a licensed cannabis event
1832+56.24organizer to a cannabis business or hemp business for participation in a cannabis event.
1833+56.25 Subd. 5.Customer privacy.Cannabis businesses and hemp businesses must not share
1834+56.26data on retail or wholesale customers with any federal agency, federal department, or federal
1835+56.27entity unless specifically ordered by a state or federal court.​
1836+56.28Sec. 24. [342.24] CANNABIS BUSINESSES; GENERAL OPERATIONAL
1837+56.29REQUIREMENTS.
1838+56.30 Subdivision 1.Individuals under 21 years of age.(a) A cannabis business may not
1839+56.31employ an individual under 21 years of age and may not contract with an individual under
1840+56.3221 years of age if the individual's scope of work involves the handling of cannabis plants,
1841+56.33cannabis flower, artificially derived cannabinoids, or cannabinoid products.​
1842+56​Article 1 Sec. 24.
1843+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 57.1 (b) A cannabis business may not permit an individual under 21 years of age to enter the
1844+57.2business premises other than entry by a patient enrolled in the registry program.
1845+57.3 (c) A cannabis business may not sell or give cannabis flower, cannabis products,​
1846+57.4lower-potency hemp edibles, or hemp-derived consumer products to an individual under
1847+57.521 years of age unless the individual is a patient; registered designated caregiver; or a parent,​
1848+57.6legal guardian, or spouse of a patient who is authorized to use, possess, or transport medical
1849+57.7cannabis flower or medical cannabinoid products.
1850+57.8 Subd. 2.Use of cannabis flower and products within a licensed cannabis business.(a)
1851+57.9A cannabis business may not permit an individual who is not an employee to consume
1852+57.10cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer
1853+57.11products within its licensed premises unless the business is licensed to permit on-site
1854+57.12consumption.
1855+57.13 (b) Except as otherwise provided in this subdivision, a cannabis business may not permit
1856+57.14an employee to consume cannabis flower, cannabis products, lower-potency hemp edibles,
1857+57.15or hemp-derived consumer products within its licensed premises or while the employee is
1858+57.16otherwise engaged in activities within the course and scope of employment.
1859+57.17 (c) A cannabis business may permit an employee to use medical cannabis flower and
1860+57.18medical cannabinoid products if that individual is a patient.
1861+57.19 (d) For quality control, employees of a licensed cannabis business may sample cannabis
1862+57.20flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products.
1863+57.21Employees may not interact directly with customers for at least three hours after sampling
1864+57.22a product. Employees may not consume more than three samples in a single 24-hour period.​
1865+57.23All samples must be recorded in the statewide monitoring system.
1866+57.24 Subd. 3.Restricted access.(a) Except as otherwise provided in this subdivision, a​
1867+57.25cannabis business may not permit any individual to enter a restricted area unless the cannabis
1868+57.26business records the individual's name, time of entry, time of exit, and authorization to enter
1869+57.27the restricted area through use of an electronic or manual entry log and the individual:
1870+57.28 (1) is a cannabis worker employed by or contracted with the cannabis business;
1871+57.29 (2) is an employee of the office or another enforcement agency;
1872+57.30 (3) is a contractor of the cannabis business, including but not limited to an electrician,
1873+57.31a plumber, an engineer, or an alarm technician, whose scope of work will not involve the
1874+57.32handling of cannabis flower, cannabis products, or hemp-derived consumer products and,
1875+57.33if the individual is working in an area with immediate access to cannabis flower, cannabis​
1876+57​Article 1 Sec. 24.​
1877+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 58.1products, or hemp-derived consumer products, the individual is supervised at all times by
1878+58.2a cannabis worker employed by or contracted with the cannabis business; or​
1879+58.3 (4) has explicit authorization from the office to enter a restricted area and, if the individual
1880+58.4is in an area with immediate access to cannabis flower, cannabis products, or hemp-derived
1881+58.5consumer products, the individual is supervised at all times by a cannabis worker employed
1882+58.6by or contracted with the cannabis business.
1883+58.7 (b) A cannabis business shall ensure that all areas of entry to restricted areas within its
1884+58.8licensed premises are conspicuously marked and cannot be entered without recording the​
1885+58.9individual's name, time of entry, time of exit, and authorization to enter the restricted area.​
1886+58.10 Subd. 4.Ventilation and filtration.A cannabis business must maintain a ventilation
1887+58.11and filtration system sufficient to meet the requirements for odor control established by the​
1888+58.12office.
1889+58.13 Subd. 5.Use of statewide monitoring system.(a) A cannabis business must use the
1890+58.14statewide monitoring system for integrated cannabis tracking, inventory, and verification
1891+58.15to track all cannabis plants, cannabis flower, cannabis products, and hemp-derived consumer
1892+58.16products the cannabis business has in its possession to the point of disposal, transfer, or​
1893+58.17sale.​
1894+58.18 (b) For the purposes of this subdivision, a cannabis business possesses the cannabis
1895+58.19plants and cannabis flower that the business cultivates from seed or immature plant, if
1896+58.20applicable, or receives from another cannabis business, and possesses the cannabis products
1897+58.21and hemp-derived consumer products that the business manufactures or receives from
1898+58.22another cannabis business.
1899+58.23 (c) Sale and transfer of cannabis plants, cannabis flower, cannabis products, and
1900+58.24hemp-derived consumer products must be recorded in the statewide monitoring system
1901+58.25within the time established by rule.​
1902+58.26 Subd. 6.Security.A cannabis business must maintain and follow a security plan to deter
1903+58.27and prevent the theft or diversion of cannabis plants, cannabis flower, cannabis products,
1904+58.28and hemp-derived consumer products, unauthorized entry into the cannabis business, and
1905+58.29the theft of currency.​
1906+58.30 Subd. 7.Remuneration.A cannabis business is prohibited from:
1907+58.31 (1) accepting or soliciting any form of remuneration from a health care practitioner who
1908+58.32certifies qualifying medical conditions for patients; or
19091909 58​Article 1 Sec. 24.​
1910-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 59.1 Subd. 3.Restricted access.(a) Except as otherwise provided in this subdivision, a​
1911-59.2cannabis business may not permit any individual to enter a restricted area unless the cannabis​
1912-59.3business records the individual's name, time of entry, time of exit, and authorization to enter​
1913-59.4the restricted area through the use of an electronic or manual entry log and the individual:​
1914-59.5 (1) is a cannabis worker employed by or contracted with the cannabis business;​
1915-59.6 (2) is an employee of the office or another enforcement agency;​
1916-59.7 (3) is a contractor of the cannabis business, including but not limited to an electrician,​
1917-59.8a plumber, an engineer, or an alarm technician, whose scope of work will not involve the​
1918-59.9handling of cannabis flower, cannabis products, or hemp-derived consumer products and,​
1919-59.10if the individual is working in an area with immediate access to cannabis flower, cannabis​
1920-59.11products, or hemp-derived consumer products, the individual is supervised at all times by​
1921-59.12a cannabis worker employed by or contracted with the cannabis business; or​
1922-59.13 (4) has explicit authorization from the office to enter a restricted area and, if the individual​
1923-59.14is in an area with immediate access to cannabis flower, cannabis products, or hemp-derived​
1924-59.15consumer products, the individual is supervised at all times by a cannabis worker employed​
1925-59.16by or contracted with the cannabis business.​
1926-59.17 (b) A cannabis business shall ensure that all areas of entry to restricted areas within its​
1927-59.18licensed premises are conspicuously marked and cannot be entered without recording the​
1928-59.19individual's name, time of entry, time of exit, and authorization to enter the restricted area.​
1929-59.20 Subd. 4.Ventilation and filtration.A cannabis business must maintain a ventilation​
1930-59.21and filtration system sufficient to meet the requirements for odor control established by the​
1931-59.22office.​
1932-59.23 Subd. 5.Use of statewide monitoring system.(a) A cannabis business must use the​
1933-59.24statewide monitoring system for integrated cannabis tracking, inventory, and verification​
1934-59.25to track all cannabis plants, cannabis flower, cannabis products, and hemp-derived consumer​
1935-59.26products the cannabis business has in its possession to the point of disposal, transfer, or​
1936-59.27sale.​
1937-59.28 (b) For the purposes of this subdivision, a cannabis business possesses the cannabis​
1938-59.29plants and cannabis flower that the business cultivates from seed or immature plant, if​
1939-59.30applicable, or receives from another cannabis business, and possesses the cannabis products​
1940-59.31and hemp-derived consumer products that the business manufactures or receives from​
1941-59.32another cannabis business.​
1942-59​Article 1 Sec. 24.​
1943-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 60.1 (c) Sale and transfer of cannabis plants, cannabis flower, cannabis products, and​
1944-60.2hemp-derived consumer products must be recorded in the statewide monitoring system​
1945-60.3within the time established by rule.​
1946-60.4 Subd. 6.Security.A cannabis business must maintain and follow a security plan to deter​
1947-60.5and prevent the theft or diversion of cannabis plants, cannabis flower, cannabis products,​
1948-60.6or hemp-derived consumer products; unauthorized entry into the cannabis business; and the​
1949-60.7theft of currency.​
1950-60.8 Subd. 7.Remuneration.A cannabis business is prohibited from:​
1951-60.9 (1) accepting or soliciting any form of remuneration from a health care practitioner who​
1952-60.10certifies qualifying medical conditions for patients; or​
1953-60.11 (2) offering any form of remuneration to a health care practitioner who certifies qualifying​
1954-60.12medical conditions for patients.​
1955-60.13 Subd. 8.Exclusions.The requirements under this section do not apply to hemp​
1956-60.14businesses.​
1957-60.15 Subd. 9.Exclusive contracts.A cannabis business may not directly or indirectly make​
1958-60.16an agreement with a cannabis retailer that binds the cannabis retailer to purchase the products​
1959-60.17of one cannabis cultivator or cannabis manufacturer to the exclusion of the products of other​
1960-60.18cannabis cultivators or cannabis manufacturers. A cannabis retailer who is a party to a​
1961-60.19violation of this section or who receives the benefits of a violation is equally guilty of a​
1962-60.20violation.​
1963-60.21Sec. 25. [342.25] CULTIVATION OF CANNABIS; GENERAL REQUIREMENTS.​
1964-60.22 Subdivision 1.Applicability.Every cannabis business with a license or endorsement​
1965-60.23authorizing the cultivation of cannabis must comply with the requirements of this section.​
1966-60.24 Subd. 2.Cultivation records.A business licensed or authorized to cultivate cannabis​
1967-60.25must prepare a cultivation record for each batch of cannabis plants and cannabis flower in​
1968-60.26the form required by the office and must maintain each record for at least five years. The​
1969-60.27cultivation record must include the quantity and timing, where applicable, of each pesticide,​
1970-60.28fertilizer, soil amendment, or plant amendment used to cultivate the batch, as well as any​
1971-60.29other information required by the office in rule. The cannabis business must present​
1972-60.30cultivation records to the office, the commissioner of agriculture, or the commissioner of​
1973-60.31health upon request.​
1974-60​Article 1 Sec. 25.​
1975-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 61.1 Subd. 3.Agricultural chemicals and other inputs.A business licensed or authorized​
1976-61.2to cultivate cannabis is subject to rules promulgated by the office in consultation with the​
1977-61.3commissioner of agriculture, subject to subdivision 5, governing the use of pesticides,​
1978-61.4fertilizers, soil amendments, plant amendments, and other inputs to cultivate cannabis.​
1979-61.5 Subd. 4.Cultivation plan.A business licensed or authorized to cultivate cannabis must​
1980-61.6prepare, maintain, and execute an operating plan and a cultivation plan as directed by the​
1981-61.7office in rule, which must include but is not limited to:​
1982-61.8 (1) water usage;​
1983-61.9 (2) recycling;​
1984-61.10 (3) solid waste disposal; and​
1985-61.11 (4) a pest management protocol that incorporates integrated pest management principles​
1986-61.12to control or prevent the introduction of pests to the cultivation site.​
1987-61.13 Subd. 5.Agricultural chemicals and other inputs; pollinator protection.(a) A business​
1988-61.14licensed or authorized to cultivate cannabis must comply with chapters 18B, 18C, 18D, and​
1989-61.15any other pesticide, fertilizer, soil amendment, and plant amendment laws and rules enforced​
1990-61.16by the commissioner of agriculture.​
1991-61.17 (b) A business licensed or authorized to cultivate cannabis must not apply pesticides​
1992-61.18when pollinators are present or allow pesticides to drift to flowering plants that are attractive​
1993-61.19to pollinators.​
1994-61.20 Subd. 6.Adulteration prohibited.A business licensed or authorized to cultivate cannabis​
1995-61.21must not treat or otherwise adulterate cannabis plants or cannabis flower with any substance​
1996-61.22or compound that has the effect or intent of altering the color, appearance, weight, potency,​
1997-61.23or odor of the cannabis.​
1998-61.24 Subd. 7.Indoor or outdoor cultivation authorized; security.A business licensed or​
1999-61.25authorized to cultivate cannabis may cultivate cannabis plants indoors or outdoors, subject​
2000-61.26to the security, fencing, lighting, and any other requirements imposed by the office in rule.​
2001-61.27 Subd. 8.Exception.Nothing in this section applies to the cultivation of hemp plants.​
2002-61.28Sec. 26. [342.26] MANUFACTURE OF CANNABIS PRODUCTS; GENERAL​
2003-61.29REQUIREMENTS.​
2004-61.30 Subdivision 1.Applicability.Every cannabis business with a license or endorsement​
2005-61.31authorizing the creation of cannabis concentrate and manufacture of cannabis products and​
1910+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 59.1 (2) offering any form of remuneration to a health care practitioner who certifies qualifying​
1911+59.2medical conditions for patients.​
1912+59.3 Subd. 8.Exclusions.The requirements under this section do not apply to hemp​
1913+59.4businesses.​
1914+59.5 Sec. 25. [342.25] CULTIVATION OF CANNABIS; GENERAL REQUIREMENTS.​
1915+59.6 Subdivision 1.Applicability.Every cannabis business with a license or endorsement​
1916+59.7authorizing the cultivation of cannabis must comply with the requirements of this section.​
1917+59.8 Subd. 2.Cultivation records.A business licensed or authorized to cultivate cannabis​
1918+59.9must prepare a cultivation record for each batch of cannabis plants and cannabis flower in​
1919+59.10the form required by the office and must maintain each record for at least five years. The​
1920+59.11cultivation record must include the quantity and timing, where applicable, of each pesticide,​
1921+59.12fertilizer, soil amendment, or plant amendment used to cultivate the batch, as well as any​
1922+59.13other information required by the office in rule. The cannabis business must present​
1923+59.14cultivation records to the office, the commissioner of agriculture, or the commissioner of​
1924+59.15health upon request.​
1925+59.16 Subd. 3.Agricultural chemicals and other inputs.A business licensed or authorized​
1926+59.17to cultivate cannabis is subject to rules promulgated by the office governing the use of​
1927+59.18pesticides, fertilizers, soil amendments, plant amendments, and other inputs to cultivate​
1928+59.19cannabis.​
1929+59.20 Subd. 4.Cultivation plan.A business licensed or authorized to cultivate cannabis must​
1930+59.21prepare, maintain, and execute an operating plan and a cultivation plan as directed by the​
1931+59.22office in rule, which must include but is not limited to:​
1932+59.23 (1) water usage;​
1933+59.24 (2) recycling;​
1934+59.25 (3) solid waste disposal; and​
1935+59.26 (4) a pest management protocol that incorporates integrated pest management principles​
1936+59.27to control or prevent the introduction of pests to the cultivation site.​
1937+59.28 Subd. 5.Pesticides; pollinator protection.(a) A business licensed or authorized to​
1938+59.29cultivate cannabis must comply with chapters 18B, 18D, 18E, and any other pesticide laws​
1939+59.30and rules enforced by the commissioner of agriculture.​
1940+59​Article 1 Sec. 25.​
1941+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 60.1 (b) A business licensed or authorized to cultivate cannabis must not apply pesticides​
1942+60.2when pollinators are present or allow pesticides to drift to flowering plants that are attractive​
1943+60.3to pollinators.​
1944+60.4 Subd. 6.Adulteration prohibited.A business licensed or authorized to cultivate cannabis​
1945+60.5must not treat or otherwise adulterate cannabis plants or cannabis flower with any substance​
1946+60.6or compound that has the effect or intent of altering the color, appearance, weight, or smell​
1947+60.7of the cannabis.​
1948+60.8 Subd. 7.Indoor, outdoor cultivation authorized; security.A business licensed or​
1949+60.9authorized to cultivate cannabis may cultivate cannabis plants indoors or outdoors, subject​
1950+60.10to the security, fencing, lighting, and any other requirements imposed by the office in rule.​
1951+60.11 Subd. 8.Seed limitation.The commissioner of agriculture must not issue a genetically​
1952+60.12engineered agriculturally related organism permit under chapter 18F for cannabis seed or​
1953+60.13cannabis plants. A cannabis cultivator must not cultivate a cannabis plant that is a genetically​
1954+60.14engineered organism as defined in section 18F.02, subdivision 5.​
1955+60.15 Subd. 9.Exception.Nothing in this section applies to the cultivation of hemp plants.​
1956+60.16Sec. 26. [342.26] MANUFACTURE OF CANNABIS PRODUCTS; GENERAL​
1957+60.17REQUIREMENTS.​
1958+60.18 Subdivision 1.Applicability.Every cannabis business with a license or endorsement​
1959+60.19authorizing the creation of cannabis concentrate and manufacture of cannabis products and​
1960+60.20hemp-derived consumer products for public consumption must comply with the requirements​
1961+60.21of this section.​
1962+60.22 Subd. 2.All manufacturer operations.(a) Cannabis manufacturing must take place in​
1963+60.23an enclosed, locked facility that is used exclusively for the manufacture of cannabis products,​
1964+60.24creation of hemp concentrate, creation of artificially derived cannabinoids, creation of​
1965+60.25lower-potency hemp edibles, or creation of hemp-derived consumer products, except that​
1966+60.26a business that also holds a cannabis cultivator license may operate in a facility that shares​
1967+60.27general office space, bathrooms, entryways, and walkways.​
1968+60.28 (b) Cannabis manufacturing must take place on equipment that is used exclusively for​
1969+60.29the manufacture of cannabis products, creation of hemp concentrate, creation of artificially​
1970+60.30derived cannabinoids, creation of lower-potency hemp edibles, or creation of hemp-derived​
1971+60.31consumer products.​
1972+60.32 (c) A business licensed or authorized to manufacture cannabis products must comply​
1973+60.33with all applicable packaging, labeling, and health and safety requirements.​
1974+60​Article 1 Sec. 26.​
1975+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 61.1 Subd. 3.Extraction and concentration.(a) A business licensed or authorized to​
1976+61.2manufacture cannabis products that creates cannabis concentrate, hemp concentrate, or​
1977+61.3artificially derived cannabinoids must obtain an endorsement from the office.​
1978+61.4 (b) A business licensed or authorized to manufacture cannabis products must inform the​
1979+61.5office of all methods of extraction and concentration that the manufacturer intends to use​
1980+61.6and identify the volatile chemicals, if any, that will be involved in the creation of cannabis​
1981+61.7concentrate or hemp concentrate. A cannabis manufacturer may not use a method of​
1982+61.8extraction and concentration or a volatile chemical without approval by the office.​
1983+61.9 (c) A business licensed or authorized to manufacture cannabis products must inform the​
1984+61.10office of all methods of conversion that the manufacturer will use, including any specific​
1985+61.11catalysts that the manufacturer will employ, to create artificially derived cannabinoids and​
1986+61.12the molecular nomenclature of all cannabinoids or other chemical compounds that the​
1987+61.13manufacturer will create. A business licensed or authorized to manufacture cannabis products​
1988+61.14may not use a method of conversion or a catalyst without approval by the office.​
1989+61.15 (d) A business licensed or authorized to manufacture cannabis products must obtain a​
1990+61.16certification from an independent third-party industrial hygienist or professional engineer​
1991+61.17approving:​
1992+61.18 (1) all electrical, gas, fire suppression, and exhaust systems; and​
1993+61.19 (2) the plan for safe storage and disposal of hazardous substances, including but not​
1994+61.20limited to any volatile chemicals.​
1995+61.21 (e) A business licensed or authorized to manufacture cannabis products that manufactures​
1996+61.22cannabis concentrate from cannabis flower received from an unlicensed person who is at​
1997+61.23least 21 years of age must comply with all health and safety requirements established by​
1998+61.24the office. At a minimum, the office shall require the manufacturer to:​
1999+61.25 (1) store the cannabis flower in an area that is segregated from cannabis flower and hemp​
2000+61.26plant parts received from a licensed cannabis business;​
2001+61.27 (2) perform the extraction and concentration on equipment that is used exclusively for​
2002+61.28extraction or concentration of cannabis flower received from unlicensed individuals;​
2003+61.29 (3) store any cannabis concentrate in an area that is segregated from cannabis concentrate,​
2004+61.30hemp concentrate, or artificially derived cannabinoids derived or manufactured from cannabis​
2005+61.31flower or hemp plant parts received from a licensed cannabis business; and​
2006+61.32 (4) provide any cannabis concentrate only to the person who provided the cannabis​
2007+61.33flower.​
20062008 61​Article 1 Sec. 26.​
2007-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 62.1hemp-derived consumer products for public consumption must comply with the requirements
2008-62.2of this section.
2009-62.3 Subd. 2.All manufacturer operations.(a) Cannabis manufacturing must take place in
2010-62.4an enclosed, locked facility that is used exclusively for the manufacture of cannabis products,
2011-62.5creation of hemp concentrate, creation of artificially derived cannabinoids, creation of
2012-62.6lower-potency hemp edibles, or creation of hemp-derived consumer products, except that
2013-62.7a business that also holds a cannabis cultivator license may operate in a facility that shares
2014-62.8general office space, bathrooms, entryways, and walkways.
2015-62.9 (b) Cannabis manufacturing must take place on equipment that is used exclusively for
2016-62.10the manufacture of cannabis products, creation of hemp concentrate, creation of artificially
2017-62.11derived cannabinoids, creation of lower-potency hemp edibles, or creation of hemp-derived
2018-62.12consumer products.
2019-62.13 (c) A business licensed or authorized to manufacture cannabis products must comply
2020-62.14with all applicable packaging, labeling, and health and safety requirements.
2021-62.15 Subd. 3.Extraction and concentration.(a) A business licensed or authorized to
2022-62.16manufacture cannabis products that creates cannabis concentrate, hemp concentrate, or
2023-62.17artificially derived cannabinoids must obtain an endorsement from the office.​
2024-62.18 (b) A business licensed or authorized to manufacture cannabis products must inform the
2025-62.19office of all methods of extraction and concentration that the manufacturer intends to use
2026-62.20and identify the volatile chemicals, if any, that will be involved in the creation of cannabis
2027-62.21concentrate or hemp concentrate. A cannabis manufacturer may not use a method of
2028-62.22extraction and concentration or a volatile chemical without approval by the office.
2029-62.23 (c) A business licensed or authorized to manufacture cannabis products must inform the​
2030-62.24office of all methods of conversion that the manufacturer will use, including any specific
2031-62.25catalysts that the manufacturer will employ, to create artificially derived cannabinoids and
2032-62.26the molecular nomenclature of all cannabinoids or other chemical compounds that the
2033-62.27manufacturer will create. A business licensed or authorized to manufacture cannabis products
2034-62.28may not use a method of conversion or a catalyst without approval by the office.
2035-62.29 (d) A business licensed or authorized to manufacture cannabis products must obtain a
2036-62.30certification from an independent third-party industrial hygienist or professional engineer
2037-62.31approving:
2038-62.32 (1) all electrical, gas, fire suppression, and exhaust systems; and
2009+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 62.1 (f) Upon the sale of cannabis concentrate, hemp concentrate, or artificially derived
2010+62.2cannabinoids to any person, cooperative, or business, a business licensed or authorized to
2011+62.3manufacture cannabis products must provide a statement to the buyer that discloses the
2012+62.4method of extraction and concentration or conversion used and any solvents, gases, or
2013+62.5catalysts, including but not limited to any volatile chemicals, involved in that method.
2014+62.6 Subd. 4.Production of consumer products.(a) A business licensed or authorized to
2015+62.7manufacture cannabis products that produces edible cannabis products or lower-potency
2016+62.8hemp edibles must obtain an edible cannabinoid product handler endorsement from the
2017+62.9office.
2018+62.10 (b) A business licensed or authorized to manufacture cannabis products must obtain an
2019+62.11endorsement from the office to produce:
2020+62.12 (1) cannabis products other than edible cannabis products; or
2021+62.13 (2) hemp-derived consumer products other than lower-potency hemp edibles.
2022+62.14 (c) All areas within the licensed premises of a business licensed or authorized to
2023+62.15manufacture cannabis products producing cannabis products, lower-potency hemp edibles,
2024+62.16or hemp-derived consumer products must meet the sanitary standards specified in rules
2025+62.17adopted by the office.​
2026+62.18 (d) A business licensed or authorized to manufacture cannabis products may only add
2027+62.19chemicals or compounds approved by the office to cannabis concentrate, hemp concentrate,
2028+62.20or artificially derived cannabinoids.
2029+62.21 (e) Upon the sale of any cannabis product, lower-potency hemp edible, or hemp-derived
2030+62.22consumer product to a cannabis business or hemp business, a business licensed or authorized
2031+62.23to manufacture cannabis products must provide a statement to the buyer that discloses the​
2032+62.24product's ingredients, including but not limited to any chemicals or compounds and any
2033+62.25major food allergens declared by name.
2034+62.26 (f) A business licensed or authorized to manufacture cannabis products shall not add
2035+62.27any cannabis flower, cannabis concentrate, artificially derived cannabinoid, hemp plant
2036+62.28part, or hemp concentrate to a product where the manufacturer of the product holds a​
2037+62.29trademark to the product's name, except that a business licensed or authorized to manufacture​
2038+62.30cannabis products may use a trademarked food product if the manufacturer uses the product
2039+62.31as a component or as part of a recipe and where the business licensed or authorized to
2040+62.32manufacture cannabis products does not state or advertise to the customer that the final
20392041 62​Article 1 Sec. 26.​
2040-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 63.1 (2) the plan for safe storage and disposal of hazardous substances, including but not​
2041-63.2limited to any volatile chemicals.​
2042-63.3 (e) A business licensed or authorized to manufacture cannabis products that manufactures​
2043-63.4cannabis concentrate from cannabis flower received from an unlicensed person who is at​
2044-63.5least 21 years of age must comply with all health and safety requirements established by​
2045-63.6the office. At a minimum, the office shall require the manufacturer to:​
2046-63.7 (1) store the cannabis flower in an area that is segregated from cannabis flower and hemp​
2047-63.8plant parts received from a licensed cannabis business;​
2048-63.9 (2) perform the extraction and concentration on equipment that is used exclusively for​
2049-63.10extraction or concentration of cannabis flower received from unlicensed individuals;​
2050-63.11 (3) store any cannabis concentrate in an area that is segregated from cannabis concentrate,​
2051-63.12hemp concentrate, or artificially derived cannabinoids derived or manufactured from cannabis​
2052-63.13flower or hemp plant parts received from a licensed cannabis business; and​
2053-63.14 (4) provide any cannabis concentrate only to the person who provided the cannabis​
2054-63.15flower.​
2055-63.16 (f) Upon the sale of cannabis concentrate, hemp concentrate, or artificially derived​
2056-63.17cannabinoids to any person, cooperative, or business, a business licensed or authorized to​
2057-63.18manufacture cannabis products must provide a statement to the buyer that discloses the​
2058-63.19method of extraction and concentration or conversion used and any solvents, gases, or​
2059-63.20catalysts, including but not limited to any volatile chemicals, involved in that method.​
2060-63.21 Subd. 4.Production of consumer products.(a) A business licensed or authorized to​
2061-63.22manufacture cannabis products that produces edible cannabis products or lower-potency​
2062-63.23hemp edibles must obtain an edible cannabinoid product handler endorsement from the​
2063-63.24office.​
2064-63.25 (b) A business licensed or authorized to manufacture cannabis products must obtain an​
2065-63.26endorsement from the office to produce:​
2066-63.27 (1) cannabis products other than edible cannabis products; or​
2067-63.28 (2) hemp-derived consumer products other than lower-potency hemp edibles.​
2068-63.29 (c) All areas within the licensed premises of a business licensed or authorized to​
2069-63.30manufacture cannabis products producing cannabis products, lower-potency hemp edibles,​
2070-63.31or hemp-derived consumer products must meet the sanitary standards specified in rules​
2071-63.32adopted by the office.​
2072-63​Article 1 Sec. 26.​
2073-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 64.1 (d) A business licensed or authorized to manufacture cannabis products may only add​
2074-64.2chemicals or compounds approved by the office to cannabis concentrate, hemp concentrate,​
2075-64.3or artificially derived cannabinoids.​
2076-64.4 (e) Upon the sale of any cannabis product, lower-potency hemp edible, or hemp-derived​
2077-64.5consumer product to a cannabis business or hemp business, a business licensed or authorized​
2078-64.6to manufacture cannabis products must provide a statement to the buyer that discloses the​
2079-64.7product's ingredients, including but not limited to any chemicals or compounds and any​
2080-64.8major food allergens declared by name.​
2081-64.9 (f) A business licensed or authorized to manufacture cannabis products shall not add​
2082-64.10any cannabis flower, cannabis concentrate, artificially derived cannabinoid, hemp plant​
2083-64.11part, or hemp concentrate to a product where the manufacturer of the product holds a​
2084-64.12trademark to the product's name, except that a business licensed or authorized to manufacture​
2085-64.13cannabis products may use a trademarked food product if the manufacturer uses the product​
2086-64.14as a component or as part of a recipe and where the business licensed or authorized to​
2087-64.15manufacture cannabis products does not state or advertise to the customer that the final​
2088-64.16retail cannabis product, lower-potency hemp edible, or hemp-derived consumer product​
2089-64.17contains a trademarked food product.​
2090-64.18 Subd. 5.Exception.Nothing in this section applies to the operations of a lower-potency​
2091-64.19hemp edible manufacturer.​
2092-64.20Sec. 27. [342.27] RETAIL SALE OF CANNABIS FLOWER AND PRODUCTS;​
2093-64.21GENERAL REQUIREMENTS.​
2094-64.22 Subdivision 1.Applicability.Every cannabis business with a license or endorsement​
2095-64.23authorizing the retail sale of cannabis flower or cannabis products must comply with the​
2096-64.24requirements of this section.​
2097-64.25 Subd. 2.Sale of cannabis and cannabinoid products.(a) A cannabis business with a​
2098-64.26license or endorsement authorizing the retail sale of cannabis flower or cannabis products​
2099-64.27may only sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use​
2100-64.28cannabis products, lower-potency hemp edibles, and hemp-derived consumer products to​
2101-64.29individuals who are at least 21 years of age.​
2102-64.30 (b) A cannabis business with a license or endorsement authorizing the retail sale of​
2103-64.31adult-use cannabis flower or adult-use cannabis products may sell immature cannabis plants​
2104-64.32and seedlings, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp​
2105-64.33edibles, and hemp-derived consumer products that:​
2042+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 63.1retail cannabis product, lower-potency hemp edible, or hemp-derived consumer product​
2043+63.2contains a trademarked food product.​
2044+63.3 Subd. 5.Exception.Nothing in this section applies to the operations of a lower-potency​
2045+63.4hemp edible manufacturer.​
2046+63.5 Sec. 27. [342.27] RETAIL SALE OF CANNABIS FLOWER AND PRODUCTS;​
2047+63.6GENERAL REQUIREMENTS.​
2048+63.7 Subdivision 1.Applicability.Every cannabis business with a license or endorsement​
2049+63.8authorizing the retail sale of cannabis flower or cannabis products must comply with the​
2050+63.9requirements of this section.​
2051+63.10 Subd. 2.Sale of cannabis and cannabinoid products.(a) A cannabis business with a​
2052+63.11license or endorsement authorizing the retail sale of cannabis flower or cannabis products​
2053+63.12may only sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use​
2054+63.13cannabis products, lower-potency hemp edibles, and hemp-derived consumer products to​
2055+63.14individuals who are at least 21 years of age.​
2056+63.15 (b) A cannabis business with a license or endorsement authorizing the retail sale of​
2057+63.16cannabis flower or cannabis products may sell immature cannabis plants and seedlings,​
2058+63.17adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles, and​
2059+63.18hemp-derived consumer products that:​
2060+63.19 (1) are obtained from a business licensed under this chapter; and​
2061+63.20 (2) meet all applicable packaging and labeling requirements.​
2062+63.21 (c) A cannabis business with a license or endorsement authorizing the retail sale of​
2063+63.22cannabis flower or cannabis products may sell up to two ounces of adult-use cannabis flower​
2064+63.23or hemp-derived consumer products consisting primarily of hemp plant parts, up to eight​
2065+63.24grams of adult-use cannabis concentrate or hemp-derived consumer products consisting​
2066+63.25primarily of hemp concentrate or artificially derived cannabinoids, and edible cannabis​
2067+63.26products and lower-potency hemp edibles infused with up to 800 milligrams of​
2068+63.27tetrahydrocannabinol during a single transaction to a customer.​
2069+63.28 (d) Edible cannabis products and hemp-derived consumer products intended to be eaten​
2070+63.29or consumed as a beverage may not include more than ten milligrams of tetrahydrocannabinol​
2071+63.30per serving and a single package may not include more than a total of 100 milligrams of​
2072+63.31tetrahydrocannabinol. A package may contain multiple servings of ten milligrams of​
2073+63.32tetrahydrocannabinol provided that each serving is indicated by scoring, wrapping, or other​
2074+63.33indicators designating the individual serving size.​
2075+63​Article 1 Sec. 27.​
2076+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 64.1 Subd. 3.Sale of other products.(a) A cannabis business with a license or endorsement​
2077+64.2authorizing the retail sale of cannabis flower or cannabis products may sell cannabis​
2078+64.3paraphernalia, including but not limited to childproof packaging containers and other devices​
2079+64.4designed to ensure the safe storage and monitoring of cannabis flower, cannabis products,​
2080+64.5lower-potency hemp edibles, and hemp-derived consumer products in the home to prevent​
2081+64.6access by individuals under 21 years of age.​
2082+64.7 (b) A cannabis business with a license or endorsement authorizing the retail sale of​
2083+64.8cannabis flower or cannabis products may sell hemp-derived topical products.​
2084+64.9 (c) A cannabis business with a license or endorsement authorizing the retail sale of​
2085+64.10cannabis flower or cannabis products may sell the following products that do not contain​
2086+64.11cannabis flower, cannabis concentrate, hemp concentrate, artificially derived cannabinoids,​
2087+64.12or tetrahydrocannabinol:​
2088+64.13 (1) drinks that do not contain alcohol and are packaged in sealed containers labeled for​
2089+64.14retail sale;​
2090+64.15 (2) books and videos on the cultivation and use of cannabis flower and products that​
2091+64.16contain cannabinoids;​
2092+64.17 (3) magazines and other publications published primarily for information and education​
2093+64.18on cannabis plants, cannabis flower, and products that contain cannabinoids;​
2094+64.19 (4) multiple-use bags designed to carry purchased items;​
2095+64.20 (5) clothing marked with the specific name, brand, or identifying logo of the retailer;​
2096+64.21 (6) hemp fiber products and products that contain hemp grain; and​
2097+64.22 (7) products that detect the presence of fentanyl or a fentanyl analog.​
2098+64.23 Subd. 4.Age verification.(a) Prior to initiating a sale, an employee of a cannabis​
2099+64.24business with a license or endorsement authorizing the retail sale of cannabis flower or​
2100+64.25cannabis products must verify that the customer is at least 21 years of age.​
2101+64.26 (b) Proof of age may be established only by one of the following:​
2102+64.27 (1) a valid driver's license or identification card issued by Minnesota, another state, or​
2103+64.28a province of Canada, and including the photograph and date of birth of the licensed person;​
2104+64.29 (2) a valid Tribal identification card as defined in section 171.072, paragraph (b);​
2105+64.30 (3) a valid passport issued by the United States;​
21062106 64​Article 1 Sec. 27.​
2107-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 65.1 (1) are obtained from a business licensed under this chapter; and​
2108-65.2 (2) meet all applicable packaging and labeling requirements.​
2109-65.3 (c) A cannabis business with a license or endorsement authorizing the retail sale of​
2110-65.4cannabis flower or cannabis products may sell up to two ounces of adult-use cannabis flower​
2111-65.5or hemp-derived consumer products consisting primarily of hemp plant parts, up to eight​
2112-65.6grams of adult-use cannabis concentrate or hemp-derived consumer products consisting​
2113-65.7primarily of hemp concentrate or artificially derived cannabinoids, and edible cannabis​
2114-65.8products and lower-potency hemp edibles infused with up to 800 milligrams of​
2115-65.9tetrahydrocannabinol during a single transaction to a customer.​
2116-65.10 (d) Edible adult-use cannabis products and hemp-derived consumer products intended​
2117-65.11to be eaten may not include more than ten milligrams of tetrahydrocannabinol per serving​
2118-65.12and a single package may not include more than a total of 200 milligrams of​
2119-65.13tetrahydrocannabinol. A package may contain multiple servings of ten milligrams of​
2120-65.14tetrahydrocannabinol provided that each serving is indicated by scoring, wrapping, or other​
2121-65.15indicators designating the individual serving size.​
2122-65.16 (e) Edible adult-use cannabis products and hemp-derived consumer products intended​
2123-65.17to be consumed as beverages may not include more than ten milligrams of​
2124-65.18tetrahydrocannabinol per serving. A single beverage container may not contain more than​
2125-65.19two servings.​
2126-65.20 Subd. 3.Sale of other products.(a) A cannabis business with a license or endorsement​
2127-65.21authorizing the retail sale of cannabis flower or cannabis products may sell cannabis​
2128-65.22paraphernalia, including but not limited to childproof packaging containers and other devices​
2129-65.23designed to ensure the safe storage and monitoring of cannabis flower, cannabis products,​
2130-65.24lower-potency hemp edibles, and hemp-derived consumer products in the home to prevent​
2131-65.25access by individuals under 21 years of age.​
2132-65.26 (b) A cannabis business with a license or endorsement authorizing the retail sale of​
2133-65.27cannabis flower or cannabis products may sell hemp-derived topical products.​
2134-65.28 (c) A cannabis business with a license or endorsement authorizing the retail sale of​
2135-65.29cannabis flower or cannabis products may sell the following products that do not contain​
2136-65.30cannabis flower, cannabis concentrate, hemp concentrate, artificially derived cannabinoids,​
2137-65.31or tetrahydrocannabinol:​
2138-65.32 (1) drinks that do not contain alcohol and are packaged in sealed containers labeled for​
2139-65.33retail sale;​
2107+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 65.1 (4) a valid instructional permit issued under section 171.05 to a person of legal age to​
2108+65.2purchase adult-use cannabis or adult-use cannabinoid products, that includes a photograph​
2109+65.3and the date of birth of the person issued the permit; or​
2110+65.4 (5) in the case of a foreign national, by a valid passport.​
2111+65.5 (c) A retailer may seize a form of identification listed under paragraph (b) if the cannabis​
2112+65.6retailer has reasonable grounds to believe that the form of identification has been altered or​
2113+65.7falsified or is being used to violate any law. A retailer that seizes a form of identification​
2114+65.8as authorized under this paragraph must deliver it to a law enforcement agency within 24​
2115+65.9hours of seizing it.​
2116+65.10 Subd. 5.Display of cannabis flower and products.(a) A cannabis business with a​
2117+65.11license or endorsement authorizing the retail sale of cannabis flower or cannabis products​
2118+65.12must designate a retail area where customers are permitted. The retail area shall include the​
2119+65.13portion of the premises where samples of cannabis flower and cannabis products available​
2120+65.14for sale are displayed. All other cannabis flower and cannabis products must be stored in​
2121+65.15the secure storage area.​
2122+65.16 (b) A cannabis business with a license or endorsement authorizing the retail sale of​
2123+65.17cannabis flower or cannabis products may display one sample of each type of cannabis​
2124+65.18flower or cannabis product available for sale. Samples of cannabis flower and cannabis​
2125+65.19products must be stored in a sample jar or display case and be accompanied by a label or​
2126+65.20notice containing the information required to be affixed to the packaging or container​
2127+65.21containing cannabis flower and cannabis products sold to customers. A sample may not​
2128+65.22contain more than eight grams of adult-use cannabis flower or adult-use cannabis concentrate​
2129+65.23or an edible cannabis product infused with more than 100 milligrams of tetrahydrocannabinol.​
2130+65.24A cannabis retailer may allow customers to smell the cannabis flower or cannabis product​
2131+65.25before purchase.​
2132+65.26 (c) A cannabis business with a license or endorsement authorizing the retail sale of​
2133+65.27cannabis flower or cannabis products may not sell cannabis flower or cannabis products​
2134+65.28used as a sample for display. If the retailer uses display samples of lower-potency hemp​
2135+65.29edibles or hemp-derived consumer products, the retailer may not sell the product used as a​
2136+65.30sample for display.​
2137+65.31 Subd. 6.Posting of notices.A cannabis business with a license or endorsement​
2138+65.32authorizing the retail sale of cannabis flower or cannabis products must post all notices as​
2139+65.33required by the office, including but not limited to:​
2140+65.34 (1) information about any product recall;​
21402141 65​Article 1 Sec. 27.​
2141-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 66.1 (2) books and videos on the cultivation and use of cannabis flower and products that​
2142-66.2contain cannabinoids;​
2143-66.3 (3) magazines and other publications published primarily for information and education​
2144-66.4on cannabis plants, cannabis flower, and products that contain cannabinoids;​
2145-66.5 (4) multiple-use bags designed to carry purchased items;​
2146-66.6 (5) clothing marked with the specific name, brand, or identifying logo of the retailer;​
2147-66.7 (6) hemp fiber products and products that contain hemp grain; and​
2148-66.8 (7) products that detect the presence of fentanyl or a fentanyl analog.​
2149-66.9 Subd. 4.Age verification.(a) Prior to initiating a sale, an employee of a cannabis​
2150-66.10business with a license or endorsement authorizing the retail sale of cannabis flower or​
2151-66.11cannabis products must verify that the customer is at least 21 years of age.​
2152-66.12 (b) Proof of age may be established only by one of the following:​
2153-66.13 (1) a valid driver's license or identification card issued by Minnesota, another state, or​
2154-66.14a province of Canada, and including the photograph and date of birth of the licensed person;​
2155-66.15 (2) a valid Tribal identification card as defined in section 171.072, paragraph (b);​
2156-66.16 (3) a valid passport issued by the United States;​
2157-66.17 (4) a valid instructional permit issued under section 171.05 to a person of legal age to​
2158-66.18purchase adult-use cannabis flower or adult-use cannabis products, which includes a​
2159-66.19photograph and the date of birth of the person issued the permit; or​
2160-66.20 (5) in the case of a foreign national, by a valid passport.​
2161-66.21 (c) A retailer may seize a form of identification listed under paragraph (b) if the cannabis​
2162-66.22retailer has reasonable grounds to believe that the form of identification has been altered or​
2163-66.23falsified or is being used to violate any law. A retailer that seizes a form of identification​
2164-66.24as authorized under this paragraph must deliver it to a law enforcement agency within 24​
2165-66.25hours of seizing it.​
2166-66.26 Subd. 5.Display of cannabis flower and products.(a) A cannabis business with a​
2167-66.27license or endorsement authorizing the retail sale of cannabis flower or cannabis products​
2168-66.28must designate a retail area where customers are permitted. The retail area shall include the​
2169-66.29portion of the premises where samples of cannabis flower and cannabis products available​
2170-66.30for sale are displayed. All other cannabis flower and cannabis products must be stored in​
2171-66.31the secure storage area.​
2142+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 66.1 (2) a statement that operating a motor vehicle under the influence of intoxicating​
2143+66.2cannabinoids is illegal; and​
2144+66.3 (3) a statement that cannabis flower, cannabis products, lower-potency hemp edibles,​
2145+66.4and hemp-derived consumer products are only intended for consumption by individuals​
2146+66.5who are at least 21 years of age.​
2147+66.6 Subd. 7.Hours of operation.(a) Except as provided by paragraph (b), a cannabis​
2148+66.7business with a license or endorsement authorizing the retail sale of cannabis flower or​
2149+66.8cannabis products may not sell cannabis flower, cannabis products, lower-potency hemp​
2150+66.9edibles, or hemp-derived consumer products between 2:00 a.m. and 8:00 a.m. on the days​
2151+66.10of Monday through Saturday nor between 2:00 a.m. and 10:00 a.m. on Sunday.​
2152+66.11 (b) A city or county may adopt an ordinance to prohibit sales for any period between​
2153+66.129:00 p.m. and 2:00 a.m. the following day or between 8:00 a.m. and 10:00 a.m. on the days​
2154+66.13of Monday through Saturday.​
2155+66.14 (c) A cannabis business with a license or endorsement authorizing the retail sale of​
2156+66.15cannabis flower or cannabis products may not be open to the public or sell any other products​
2157+66.16at times when the cannabis business is prohibited from selling cannabis flower, cannabis​
2158+66.17products, lower-potency hemp edibles, and hemp-derived consumer products.​
2159+66.18 Subd. 8.Building conditions.(a) A cannabis business with a license or endorsement​
2160+66.19authorizing the retail sale of cannabis flower or cannabis products shall maintain compliance​
2161+66.20with state and local building, fire, and zoning requirements or regulations.​
2162+66.21 (b) A cannabis business with a license or endorsement authorizing the retail sale of​
2163+66.22cannabis flower or cannabis products shall ensure that the licensed premises is maintained​
2164+66.23in a clean and sanitary condition, free from infestation by insects, rodents, or other pests.​
2165+66.24 Subd. 9.Security.A cannabis business with a license or endorsement authorizing the​
2166+66.25retail sale of cannabis flower or cannabis products shall maintain compliance with security​
2167+66.26requirements established by the office, including but not limited to requirements for​
2168+66.27maintaining video surveillance records, using specific locking mechanisms, establishing​
2169+66.28secure entries, and the number of employees working at all times.​
2170+66.29 Subd. 10.Lighting.A cannabis business with a license or endorsement authorizing the​
2171+66.30retail sale of cannabis flower or cannabis products must keep all lighting outside and inside​
2172+66.31the dispensary in good working order and sufficient wattage for security cameras.​
2173+66.32 Subd. 11.Deliveries.A cannabis business with a license or endorsement authorizing​
2174+66.33the retail sale of cannabis flower or cannabis products may only accept deliveries of cannabis​
21722175 66​Article 1 Sec. 27.​
2173-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 67.1 (b) A cannabis business with a license or endorsement authorizing the retail sale of​
2174-67.2cannabis flower or cannabis products may display one sample of each type of cannabis​
2175-67.3flower or cannabis product available for sale. Samples of cannabis flower and cannabis​
2176-67.4products must be stored in a sample jar or display case and be accompanied by a label or​
2177-67.5notice containing the information required to be affixed to the packaging or container​
2178-67.6containing cannabis flower and cannabis products sold to customers. A sample may not​
2179-67.7contain more than eight grams of adult-use cannabis flower or adult-use cannabis concentrate​
2180-67.8or an edible cannabis product infused with more than 100 milligrams of tetrahydrocannabinol.​
2181-67.9A cannabis retailer may allow customers to smell the cannabis flower or cannabis product​
2182-67.10before purchase.​
2183-67.11 (c) A cannabis business with a license or endorsement authorizing the retail sale of​
2184-67.12cannabis flower or cannabis products may not sell cannabis flower or cannabis products​
2185-67.13used as a sample for display. If the retailer uses display samples of lower-potency hemp​
2186-67.14edibles or hemp-derived consumer products, the retailer may not sell the product used as a​
2187-67.15sample for display.​
2188-67.16 Subd. 6.Posting of notices.A cannabis business with a license or endorsement​
2189-67.17authorizing the retail sale of cannabis flower or cannabis products must post all notices as​
2190-67.18required by the office, including but not limited to:​
2191-67.19 (1) information about any product recall;​
2192-67.20 (2) a statement that operating a motor vehicle under the influence of intoxicating​
2193-67.21cannabinoids is illegal; and​
2194-67.22 (3) a statement that cannabis flower, cannabis products, lower-potency hemp edibles,​
2195-67.23and hemp-derived consumer products are only intended for consumption by individuals​
2196-67.24who are at least 21 years of age.​
2197-67.25 Subd. 7.Hours of operation.(a) Except as provided by paragraph (b), a cannabis​
2198-67.26business with a license or endorsement authorizing the retail sale of cannabis flower or​
2199-67.27cannabis products may not sell cannabis flower, cannabis products, lower-potency hemp​
2200-67.28edibles, or hemp-derived consumer products between 2:00 a.m. and 8:00 a.m. on the days​
2201-67.29of Monday through Saturday nor between 2:00 a.m. and 10:00 a.m. on Sunday.​
2202-67.30 (b) A city or county may adopt an ordinance to prohibit sales for any period between​
2203-67.319:00 p.m. and 2:00 a.m. the following day or between 8:00 a.m. and 10:00 a.m. on the days​
2204-67.32of Monday through Saturday.​
2205-67​Article 1 Sec. 27.​
2206-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 68.1 (c) A cannabis business with a license or endorsement authorizing the retail sale of​
2207-68.2cannabis flower or cannabis products may not be open to the public or sell any other products​
2208-68.3at times when the cannabis business is prohibited from selling cannabis flower, cannabis​
2209-68.4products, lower-potency hemp edibles, and hemp-derived consumer products.​
2210-68.5 Subd. 8.Building conditions.(a) A cannabis business with a license or endorsement​
2211-68.6authorizing the retail sale of cannabis flower or cannabis products shall maintain compliance​
2212-68.7with state and local building, fire, and zoning requirements or regulations.​
2213-68.8 (b) A cannabis business with a license or endorsement authorizing the retail sale of​
2214-68.9cannabis flower or cannabis products shall ensure that the licensed premises is maintained​
2215-68.10in a clean and sanitary condition, free from infestation by insects, rodents, or other pests.​
2216-68.11 Subd. 9.Security.A cannabis business with a license or endorsement authorizing the​
2217-68.12retail sale of cannabis flower or cannabis products shall maintain compliance with security​
2218-68.13requirements established by the office, including but not limited to requirements for​
2219-68.14maintaining video surveillance records, using specific locking mechanisms, establishing​
2220-68.15secure entries, and the number of employees working at all times.​
2221-68.16 Subd. 10.Lighting.A cannabis business with a license or endorsement authorizing the​
2222-68.17retail sale of cannabis flower or cannabis products must keep all lighting outside and inside​
2223-68.18the dispensary in good working order and sufficient wattage for security cameras.​
2224-68.19 Subd. 11.Deliveries.A cannabis business with a license or endorsement authorizing​
2225-68.20the retail sale of cannabis flower or cannabis products may only accept deliveries of cannabis​
2226-68.21flower, cannabis products, and hemp-derived consumer products in a limited access area.​
2227-68.22Deliveries may not be accepted through the public access areas unless otherwise approved​
2228-68.23by the office.​
2229-68.24 Subd. 12.Prohibitions.A cannabis business with a license or endorsement authorizing​
2230-68.25the retail sale of cannabis flower or cannabis products shall not:​
2231-68.26 (1) sell cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
2232-68.27consumer products to a person who is visibly intoxicated;​
2233-68.28 (2) knowingly sell more cannabis flower, cannabis products, lower-potency hemp edibles,​
2234-68.29or hemp-derived consumer products than a customer is legally permitted to possess;​
2235-68.30 (3) give away immature cannabis plants or seedlings, cannabis flower, cannabis products,​
2236-68.31lower-potency hemp edibles, or hemp-derived consumer products;​
2237-68.32 (4) operate a drive-through window;​
2238-68​Article 1 Sec. 27.​
2239-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 69.1 (5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,​
2240-69.2lower-potency hemp edibles, or hemp-derived consumer products in vending machines; or​
2241-69.3 (6) sell cannabis plants, cannabis flower, or cannabis products if the cannabis retailer​
2242-69.4knows that any required security or statewide monitoring systems are not operational.​
2243-69.5 Subd. 13.Adult-use and medical cannabis; colocation.(a) A cannabis business with​
2244-69.6a license or endorsement authorizing the retail sale of adult-use cannabis flower or adult-use​
2245-69.7cannabis products that is also a licensed medical cannabis retailer may sell medical cannabis​
2246-69.8flower and medical cannabinoid products on a portion of the business's premises.​
2247-69.9 (b) The premises must provide an appropriate space for a pharmacist employee of the​
2248-69.10medical cannabis retailer to consult with a patient to determine the proper type of medical​
2249-69.11cannabis flower and medical cannabinoid products and proper dosage for the patient.​
2250-69.12 Subd. 14.Exception.Nothing in this section applies to the operations of a lower-potency​
2251-69.13hemp edible retailer.​
2252-69.14Sec. 28. [342.28] CANNABIS MICROBUSINESS LICENSING AND OPERATIONS.​
2253-69.15 Subdivision 1.Authorized actions.A cannabis microbusiness license, consistent with​
2254-69.16the specific license endorsement or endorsements, entitles the license holder to perform any​
2255-69.17or all of the following within the limits established by this section:​
2256-69.18 (1) grow cannabis plants from seed or immature plant to mature plant and harvest​
2257-69.19cannabis flower from a mature plant;​
2258-69.20 (2) make cannabis concentrate;​
2259-69.21 (3) make hemp concentrate, including hemp concentrate with a delta-9​
2260-69.22tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;​
2261-69.23 (4) manufacture artificially derived cannabinoids;​
2262-69.24 (5) manufacture adult-use cannabis products, lower-potency hemp edibles, and​
2263-69.25hemp-derived consumer products for public consumption;​
2264-69.26 (6) purchase immature cannabis plants and seedlings and cannabis flower from another​
2265-69.27cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, or a cannabis​
2266-69.28wholesaler;​
2267-69.29 (7) purchase hemp plant parts and propagules from an industrial hemp grower licensed​
2268-69.30under chapter 18K;​
2176+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 67.1flower, cannabis products, and hemp-derived consumer products in a limited access area.​
2177+67.2Deliveries may not be accepted through the public access areas unless otherwise approved​
2178+67.3by the office.​
2179+67.4 Subd. 12.Prohibitions.A cannabis business with a license or endorsement authorizing​
2180+67.5the retail sale of cannabis flower or cannabis products shall not:​
2181+67.6 (1) sell cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
2182+67.7consumer products to a person who is visibly intoxicated;​
2183+67.8 (2) knowingly sell more cannabis flower, cannabis products, lower-potency hemp edibles,​
2184+67.9or hemp-derived consumer products than a customer is legally permitted to possess;​
2185+67.10 (3) give away immature cannabis plants or seedlings, cannabis flower, cannabis products,​
2186+67.11lower-potency hemp edibles, or hemp-derived consumer products;​
2187+67.12 (4) operate a drive-through window;​
2188+67.13 (5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,​
2189+67.14lower-potency hemp edibles, or hemp-derived consumer products in vending machines; or​
2190+67.15 (6) sell cannabis plants, cannabis flower, or cannabis products if the cannabis retailer​
2191+67.16knows that any required security or statewide monitoring systems are not operational.​
2192+67.17 Subd. 13.Adult-use and medical cannabis; colocation.(a) A cannabis business with​
2193+67.18a license or endorsement authorizing the retail sale of adult-use cannabis flower or adult-use​
2194+67.19cannabis products that is also a licensed medical cannabis retailer may sell medical cannabis​
2195+67.20flower and medical cannabinoid products on a portion of the business's premises.​
2196+67.21 (b) The portion of the premises of the cannabis business where medical cannabis flower​
2197+67.22and medical cannabinoid products are sold must be definite and distinct from all other areas​
2198+67.23of the cannabis retailer and must provide an appropriate space for a pharmacist employee​
2199+67.24of the medical cannabis retailer to consult with a patient to determine the proper type of​
2200+67.25medical cannabis flower and medical cannabinoid products and proper dosage for the patient.​
2201+67.26 Subd. 14.Exception.Nothing in this section applies to the operations of a lower-potency​
2202+67.27hemp edible retailer.​
2203+67.28Sec. 28. [342.28] CANNABIS MICROBUSINESS LICENSING AND OPERATIONS.​
2204+67.29 Subdivision 1.Authorized actions.A cannabis microbusiness license, consistent with​
2205+67.30the specific license endorsement or endorsements, entitles the license holder to perform any​
2206+67.31or all of the following within the limits established by this section:​
2207+67​Article 1 Sec. 28.​
2208+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 68.1 (1) grow cannabis plants from seed or immature plant to mature plant and harvest​
2209+68.2cannabis flower from a mature plant;​
2210+68.3 (2) make cannabis concentrate;​
2211+68.4 (3) make hemp concentrate, including hemp concentrate with a delta-9​
2212+68.5tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;​
2213+68.6 (4) manufacture artificially derived cannabinoids;​
2214+68.7 (5) manufacture adult-use cannabis products, lower-potency hemp edibles, and​
2215+68.8hemp-derived consumer products for public consumption;​
2216+68.9 (6) purchase immature cannabis plants and seedlings, cannabis flower, and hemp plant​
2217+68.10parts from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis​
2218+68.11manufacturer, a cannabis wholesaler, or an industrial hemp grower;​
2219+68.12 (7) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids​
2220+68.13from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer,​
2221+68.14a cannabis wholesaler, or a licensed hemp grower for use in manufacturing adult-use cannabis​
2222+68.15products, lower-potency hemp edibles, or hemp-derived consumer products;​
2223+68.16 (8) package and label adult-use cannabis flower, adult-use cannabis products,​
2224+68.17lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;​
2225+68.18 (9) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use​
2226+68.19cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and​
2227+68.20other products authorized by law to other cannabis businesses and to customers;​
2228+68.21 (10) operate an establishment that permits on-site consumption of edible cannabis​
2229+68.22products and lower-potency hemp edibles; and​
2230+68.23 (11) perform other actions approved by the office.​
2231+68.24 Subd. 2.Size limitations.(a) A cannabis microbusiness that cultivates cannabis at an​
2232+68.25indoor facility may cultivate up to 2,000 square feet of plant canopy unless the office, by​
2233+68.26rule, increases that limit. The office may, by rule, increase the limit on plant canopy to no​
2234+68.27more than 5,000 square feet if the office determines that expansion is consistent with the​
2235+68.28goals identified in section 342.02, subdivision 1. Limitations on plant canopy apply to the​
2236+68.29area in which mature, flowering plants are cultivated. A cannabis microbusiness may not​
2237+68.30operate multiple tiers of cultivation.​
2238+68.31 (b) A cannabis microbusiness that cultivates cannabis at an outdoor location may cultivate​
2239+68.32up to one-half acre of mature, flowering plants unless the office, by rule, increases that limit.​
2240+68​Article 1 Sec. 28.​
2241+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 69.1The office may, by rule, increase the limit to no more than one acre if the office determines​
2242+69.2that expansion is consistent with the goals identified in section 342.02, subdivision 1.​
2243+69.3 (c) The office shall, by rule, establish a limit on the manufacturing of cannabis products,​
2244+69.4lower-potency hemp edibles, or hemp-derived consumer products a cannabis microbusiness​
2245+69.5that manufactures such products may perform. The limit must be equivalent to the amount​
2246+69.6of cannabis flower that can be harvested from a facility with a plant canopy of 2,000 square​
2247+69.7feet in a year, but may be increased to the amount that can be harvested from a facility with​
2248+69.8up to 5,000 square feet of plant canopy if the office expands the allowable area of cultivation​
2249+69.9under paragraph (a).​
2250+69.10 (d) A cannabis microbusiness with the appropriate endorsement may operate one retail​
2251+69.11location.​
2252+69.12 Subd. 3.Additional information required.In addition to the information required to​
2253+69.13be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2254+69.14a person, cooperative, or business seeking a cannabis microbusiness license must submit​
2255+69.15the following information in a form approved by the office:​
2256+69.16 (1) an operating plan demonstrating the proposed layout of the facility, including a​
2257+69.17diagram of ventilation and filtration systems; plans for wastewater and waste disposal for​
2258+69.18any cultivation or manufacturing activities; plans for providing electricity, water, and other​
2259+69.19utilities necessary for the normal operation of any cultivation or manufacturing activities;​
2260+69.20plans for compliance with applicable building codes and federal and state environmental​
2261+69.21and workplace safety requirements and policies; and plans to avoid sales to unlicensed​
2262+69.22cannabis businesses and individuals under 21 years of age;​
2263+69.23 (2) if the applicant is seeking an endorsement to cultivate cannabis plants and harvest​
2264+69.24cannabis flower, a cultivation plan demonstrating the proposed size and layout of the​
2265+69.25cultivation facility that will be used exclusively for cultivation, including the total amount​
2266+69.26of plant canopy;​
2267+69.27 (3) if the applicant is seeking an endorsement to create cannabis concentrate, hemp​
2268+69.28concentrate, or artificial cannabinoids, information identifying all methods of extraction,​
2269+69.29concentration, or conversion that the applicant intends to use and the volatile chemicals and​
2270+69.30catalysts, if any, that will be involved in extraction, concentration, or creation; and​
2271+69.31 (4) evidence that the applicant will comply with the applicable operation requirements​
2272+69.32for the license being sought.​
22692273 69​Article 1 Sec. 28.​
2270-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 70.1 (8) purchase hemp concentrate from an industrial hemp processor licensed under chapter​
2271-70.218K;​
2272-70.3 (9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids​
2273-70.4from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer,​
2274-70.5or a cannabis wholesaler for use in manufacturing adult-use cannabis products, lower-potency​
2275-70.6hemp edibles, or hemp-derived consumer products;​
2276-70.7 (10) package and label adult-use cannabis flower, adult-use cannabis products,​
2277-70.8lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;​
2278-70.9 (11) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use​
2279-70.10cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and​
2280-70.11other products authorized by law to other cannabis businesses and to customers;​
2281-70.12 (12) operate an establishment that permits on-site consumption of edible cannabis​
2282-70.13products and lower-potency hemp edibles; and​
2283-70.14 (13) perform other actions approved by the office.​
2284-70.15 Subd. 2.Size limitations.(a) A cannabis microbusiness that cultivates cannabis at an​
2285-70.16indoor facility may cultivate up to 5,000 square feet of plant canopy. The office may adjust​
2286-70.17plant canopy limits upward to meet market demand consistent with the goals identified in​
2287-70.18section 342.02, subdivision 1.​
2288-70.19 (b) A cannabis microbusiness that cultivates cannabis at an outdoor location may cultivate​
2289-70.20up to one-half acre of mature, flowering plants unless the office increases that limit. The​
2290-70.21office may increase the limit to no more than one acre if the office determines that expansion​
2291-70.22is consistent with the goals identified in section 342.02, subdivision 1.​
2292-70.23 (c) The office shall establish a limit on the manufacturing of cannabis products,​
2293-70.24lower-potency hemp edibles, or hemp-derived consumer products a cannabis microbusiness​
2294-70.25that manufactures such products may perform. The limit must be equivalent to the amount​
2295-70.26of cannabis flower that can be harvested from a facility with a plant canopy of 5,000 square​
2296-70.27feet in a year, but may be increased if the office expands the allowable area of cultivation​
2297-70.28under paragraph (a).​
2298-70.29 (d) A cannabis microbusiness with the appropriate endorsement may operate one retail​
2299-70.30location.​
2300-70.31 Subd. 3.Additional information required.In addition to the information required to​
2301-70.32be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2274+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 70.1 Subd. 4.Exception.The requirement of an attestation signed by a bona fide labor​
2275+70.2organization stating that the applicant has entered into a labor peace agreement is not required​
2276+70.3as part of an application for a cannabis microbusiness license.​
2277+70.4 Subd. 5.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2278+70.5cannabis microbusiness license may also hold a cannabis event organizer license.​
2279+70.6 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2280+70.7cannabis microbusiness license may own or operate any other cannabis business or hemp​
2281+70.8business or hold more than one cannabis microbusiness license.​
2282+70.9 (c) For purposes of this subdivision, a restriction on the number or type of license that​
2283+70.10a business may hold applies to every cooperative member or every director, manager, and​
2284+70.11general partner of a cannabis business.​
2285+70.12 Subd. 6.Cultivation endorsement.A cannabis microbusiness that cultivates cannabis​
2286+70.13plants and harvests cannabis flower must comply with the requirements in section 342.25.​
2287+70.14 Subd. 7.Extraction and concentration endorsement.A cannabis microbusiness that​
2288+70.15creates cannabis concentrate must comply with the requirements in section 342.26,​
2289+70.16subdivisions 2 and 3.​
2290+70.17 Subd. 8.Production of customer products endorsement.A cannabis microbusiness​
2291+70.18that manufacturers edible cannabis products, lower-potency hemp products, or hemp-derived​
2292+70.19consumer products must comply with the requirements in section 342.26, subdivisions 2​
2293+70.20and 4.​
2294+70.21 Subd. 9.Retail operations endorsement.A cannabis microbusiness that operates a​
2295+70.22retail location must comply with the requirements in section 342.27.​
2296+70.23 Subd. 10.On-site consumption endorsement.(a) A cannabis microbusiness may permit​
2297+70.24on-site consumption of edible cannabis products and lower-potency hemp edibles on a​
2298+70.25portion of its premises.​
2299+70.26 (b) The portion of the premises of the cannabis microbusiness where on-site consumption​
2300+70.27is permitted must be definite and distinct from all other areas of the microbusiness and must​
2301+70.28be accessed through a distinct entrance.​
2302+70.29 (c) Edible cannabis products and lower-potency hemp edibles sold for on-site​
2303+70.30consumption must comply with this chapter and rules adopted pursuant to this chapter​
2304+70.31regarding the testing, packaging, and labeling of cannabinoid products.​
23022305 70​Article 1 Sec. 28.​
2303-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 71.1a person, cooperative, or business seeking a cannabis microbusiness license must submit
2304-71.2the following information in a form approved by the office:
2305-71.3 (1) an operating plan demonstrating the proposed layout of the facility, including a
2306-71.4diagram of ventilation and filtration systems; plans for wastewater and waste disposal for
2307-71.5any cultivation or manufacturing activities; plans for providing electricity, water, and other
2308-71.6utilities necessary for the normal operation of any cultivation or manufacturing activities;
2309-71.7plans for compliance with applicable building codes and federal and state environmental
2310-71.8and workplace safety requirements and policies; and plans to avoid sales to unlicensed
2311-71.9cannabis businesses and individuals under 21 years of age;
2312-71.10 (2) if the applicant is seeking an endorsement to cultivate cannabis plants and harvest
2313-71.11cannabis flower, a cultivation plan demonstrating the proposed size and layout of the
2314-71.12cultivation facility that will be used exclusively for cultivation, including the total amount
2315-71.13of plant canopy;
2316-71.14 (3) if the applicant is seeking an endorsement to create cannabis concentrate, hemp
2317-71.15concentrate, or artificial cannabinoids, information identifying all methods of extraction,
2318-71.16concentration, or conversion that the applicant intends to use and the volatile chemicals and
2319-71.17catalysts, if any, that will be involved in extraction, concentration, or creation; and
2320-71.18 (4) evidence that the applicant will comply with the applicable operation requirements
2321-71.19for the license being sought.
2322-71.20 Subd. 4.Exception.The requirement of an attestation signed by a bona fide labor
2323-71.21organization stating that the applicant has entered into a labor peace agreement is not required
2324-71.22as part of an application for a cannabis microbusiness license.
2325-71.23 Subd. 5.Multiple licenses; limits.(a) A person, cooperative, or business holding a
2326-71.24cannabis microbusiness license may also hold a cannabis event organizer license.
2327-71.25 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a
2328-71.26cannabis microbusiness license may own or operate any other cannabis business or hemp​
2329-71.27business or hold more than one cannabis microbusiness license.
2330-71.28 (c) For purposes of this subdivision, a restriction on the number or type of license that
2331-71.29a business may hold applies to every cooperative member or every director, manager, and
2332-71.30general partner of a cannabis business.
2333-71.31 Subd. 6.Cultivation endorsement.A cannabis microbusiness that cultivates cannabis​
2334-71.32plants and harvests cannabis flower must comply with the requirements in section 342.25.​
2306+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 71.1 (d) Edible cannabinoid products and lower-potency hemp edibles sold for on-site
2307+71.2consumption must be served in the required packaging but may be removed from the​
2308+71.3products' packaging by customers and consumed on site.
2309+71.4 (e) Food and beverages not otherwise prohibited by this subdivision may be prepared
2310+71.5and sold on site provided that the cannabis microbusiness complies with all relevant state
2311+71.6and local laws, ordinances, licensing requirements, and zoning requirements.
2312+71.7 (f) A cannabis microbusiness shall ensure that the display and consumption of any edible
2313+71.8cannabis product or lower-potency hemp edible is not visible from outside of the licensed
2314+71.9premises of the business.
2315+71.10 (g) A cannabis microbusiness may offer recorded or live entertainment, provided that
2316+71.11the cannabis microbusiness complies with all relevant state and local laws, ordinances,
2317+71.12licensing requirements, and zoning requirements.
2318+71.13 (h) A cannabis microbusiness may not:
2319+71.14 (1) sell an edible cannabis product or a lower-potency hemp edible to an individual who
2320+71.15is under 21 years of age;
2321+71.16 (2) permit an individual who is under 21 years of age to enter the premises;
2322+71.17 (3) sell more than one single serving of an edible cannabis product or a lower-potency
2323+71.18hemp edible to a customer;
2324+71.19 (4) sell an edible cannabis product or a lower-potency hemp edible to a person who is
2325+71.20visibly intoxicated;
2326+71.21 (5) sell or allow the sale or consumption of alcohol or tobacco on the premises;
2327+71.22 (6) sell products that are intended to be eaten or consumed as a drink, other than packaged
2328+71.23and labeled edible cannabis products and lower-potency hemp edibles, that contain cannabis
2329+71.24flower or hemp plant parts or are infused with cannabis concentrate, hemp concentrate, or
2330+71.25artificially derived cannabinoids;
2331+71.26 (7) permit edible cannabis products or lower-potency hemp edibles sold in the portion
2332+71.27of the area designated for on-site consumption to be removed from that area;
2333+71.28 (8) permit adult-use cannabis flower, adult-use cannabis products, hemp-derived consumer
2334+71.29products, or tobacco to be consumed through smoking or a vaporized delivery method on
2335+71.30the premises; or
2336+71.31 (9) distribute or allow free samples of cannabis flower, cannabis products, lower-potency
2337+71.32hemp edibles, or hemp-derived consumer products.​
23352338 71​Article 1 Sec. 28.​
2336-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 72.1 Subd. 7.Extraction and concentration endorsement.A cannabis microbusiness that​
2337-72.2creates cannabis concentrate must comply with the requirements in section 342.26,​
2338-72.3subdivisions 2 and 3.​
2339-72.4 Subd. 8.Production of customer products endorsement.A cannabis microbusiness​
2340-72.5that manufacturers edible cannabis products, lower-potency hemp products, or hemp-derived​
2341-72.6consumer products must comply with the requirements in section 342.26, subdivisions 2​
2342-72.7and 4.​
2343-72.8 Subd. 9.Retail operations endorsement.A cannabis microbusiness that operates a​
2344-72.9retail location must comply with the requirements in section 342.27.​
2345-72.10 Subd. 10.On-site consumption endorsement.(a) A cannabis microbusiness may permit​
2346-72.11on-site consumption of edible cannabis products and lower-potency hemp edibles on a​
2347-72.12portion of its premises.​
2348-72.13 (b) The portion of the premises in which on-site consumption is permitted must be​
2349-72.14definite and distinct from all other areas of the microbusiness and must be accessed through​
2350-72.15a distinct entrance.​
2351-72.16 (c) Edible cannabis products and lower-potency hemp edibles sold for on-site​
2352-72.17consumption must comply with this chapter and rules adopted pursuant to this chapter​
2353-72.18regarding the testing, packaging, and labeling of cannabinoid products.​
2354-72.19 (d) Edible cannabinoid products and lower-potency hemp edibles sold for on-site​
2355-72.20consumption must be served in the required packaging but may be removed from the​
2356-72.21products' packaging by customers and consumed on site.​
2357-72.22 (e) Food and beverages not otherwise prohibited by this subdivision may be prepared​
2358-72.23and sold on site provided that the cannabis microbusiness complies with all relevant state​
2359-72.24and local laws, ordinances, licensing requirements, and zoning requirements.​
2360-72.25 (f) A cannabis microbusiness shall ensure that the display and consumption of any edible​
2361-72.26cannabis product or lower-potency hemp edible is not visible from outside of the licensed​
2362-72.27premises of the business.​
2363-72.28 (g) A cannabis microbusiness may offer recorded or live entertainment, provided that​
2364-72.29the cannabis microbusiness complies with all relevant state and local laws, ordinances,​
2365-72.30licensing requirements, and zoning requirements.​
2366-72.31 (h) A cannabis microbusiness may not:​
2367-72​Article 1 Sec. 28.​
2368-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 73.1 (1) sell an edible cannabis product or a lower-potency hemp edible to an individual who​
2369-73.2is under 21 years of age;​
2370-73.3 (2) permit an individual who is under 21 years of age to enter the premises;​
2371-73.4 (3) sell an edible cannabis product or a lower-potency hemp edible to a person who is​
2372-73.5visibly intoxicated;​
2373-73.6 (4) sell or allow the sale or consumption of alcohol or tobacco on the premises;​
2374-73.7 (5) sell products that are intended to be eaten or consumed as a drink, other than packaged​
2375-73.8and labeled edible cannabis products and lower-potency hemp edibles, that contain cannabis​
2376-73.9flower or hemp plant parts or are infused with cannabis concentrate, hemp concentrate, or​
2377-73.10artificially derived cannabinoids;​
2378-73.11 (6) permit edible cannabis products or lower-potency hemp edibles sold in the portion​
2379-73.12of the area designated for on-site consumption to be removed from that area;​
2380-73.13 (7) permit adult-use cannabis flower, adult-use cannabis products, hemp-derived consumer​
2381-73.14products, or tobacco to be consumed through smoking or a vaporized delivery method on​
2382-73.15the premises; or​
2383-73.16 (8) distribute or allow free samples of cannabis flower, cannabis products, lower-potency​
2384-73.17hemp edibles, or hemp-derived consumer products.​
2385-73.18Sec. 29. [342.29] CANNABIS MEZZOBUSINESS LICENSING AND OPERATIONS.​
2386-73.19 Subdivision 1.Authorized actions.A cannabis mezzobusiness license, consistent with​
2387-73.20the specific license endorsement or endorsements, entitles the license holder to perform any​
2388-73.21or all of the following within the limits established by this section:​
2389-73.22 (1) grow cannabis plants from seed or immature plant to mature plant and harvest​
2390-73.23cannabis flower from a mature plant for use as adult-use cannabis flower or for use in​
2391-73.24adult-use cannabis products;​
2392-73.25 (2) grow cannabis plants from seed or immature plant to mature plant and harvest​
2393-73.26cannabis flower from a mature plant for use as medical cannabis flower or for use in medical​
2394-73.27cannabinoid products;​
2395-73.28 (3) make cannabis concentrate;​
2396-73.29 (4) make hemp concentrate, including hemp concentrate with a delta-9​
2397-73.30tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;​
2398-73.31 (5) manufacture artificially derived cannabinoids;​
2339+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 72.1 Sec. 29. [342.29] CANNABIS MEZZOBUSINESS LICENSING AND OPERATIONS.​
2340+72.2 Subdivision 1.Authorized actions.A cannabis mezzobusiness license, consistent with​
2341+72.3the specific license endorsement or endorsements, entitles the license holder to perform any​
2342+72.4or all of the following within the limits established by this section:​
2343+72.5 (1) grow cannabis plants from seed or immature plant to mature plant and harvest​
2344+72.6cannabis flower from a mature plant;​
2345+72.7 (2) make cannabis concentrate;​
2346+72.8 (3) make hemp concentrate, including hemp concentrate with a delta-9​
2347+72.9tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;​
2348+72.10 (4) manufacture artificially derived cannabinoids;​
2349+72.11 (5) manufacture adult-use cannabis products, lower-potency hemp edibles, and​
2350+72.12hemp-derived consumer products for public consumption;​
2351+72.13 (6) purchase immature cannabis plants and seedlings, cannabis flower, and hemp plant​
2352+72.14parts from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis​
2353+72.15manufacturer, a cannabis wholesaler, or an industrial hemp grower;​
2354+72.16 (7) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids​
2355+72.17from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis manufacturer,​
2356+72.18a cannabis wholesaler, or a licensed hemp grower for use in manufacturing adult-use cannabis​
2357+72.19products, lower-potency hemp edibles, or hemp-derived consumer products;​
2358+72.20 (8) package and label adult-use cannabis flower, adult-use cannabis products,​
2359+72.21lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;​
2360+72.22 (9) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use​
2361+72.23cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and​
2362+72.24other products authorized by law to other cannabis businesses and to customers; and​
2363+72.25 (10) perform other actions approved by the office.​
2364+72.26 Subd. 2.Size limitations.(a) A cannabis mezzobusiness that cultivates cannabis at an​
2365+72.27indoor facility may cultivate up to 5,000 square feet of plant canopy unless the office, by​
2366+72.28rule, increases that limit. The office may, by rule, increase the limit on plant canopy to no​
2367+72.29more than 15,000 cubic feet if the office determines that expansion is consistent with the​
2368+72.30goals identified in section 342.02, subdivision 1. Limitations on plant canopy apply to the​
2369+72.31area in which mature, flowering plants are cultivated. A cannabis mezzobusiness may not​
2370+72.32operate multiple tiers of cultivation unless authorized by the office.​
2371+72​Article 1 Sec. 29.​
2372+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 73.1 (b) A cannabis mezzobusiness that cultivates cannabis at an outdoor location may​
2373+73.2cultivate up to one acre of mature, flowering plants unless the office, by rule, increases that​
2374+73.3limit. The office may, by rule, increase the limit to no more than three acres if the office​
2375+73.4determines that expansion is consistent with the goals identified in section 342.02, subdivision​
2376+73.51.​
2377+73.6 (c) The office shall, by rule, establish a limit on the manufacturing of cannabis products,​
2378+73.7lower-potency hemp edibles, or hemp-derived consumer products a cannabis mezzobusiness​
2379+73.8that manufactures such products may perform. The limit must be equivalent to the amount​
2380+73.9of cannabis flower that can be harvested from a facility with a plant canopy of 5,000 square​
2381+73.10feet in a year but may be increased to the amount that can be harvested from a facility with​
2382+73.11up to 15,000 cubic feet of plant canopy if the office expands the allowable area of cultivation​
2383+73.12under paragraph (a).​
2384+73.13 (d) A cannabis mezzobusiness with the appropriate endorsement may operate up to three​
2385+73.14retail locations.​
2386+73.15 Subd. 3.Additional information required.In addition to the information required to​
2387+73.16be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2388+73.17a person, cooperative, or business seeking a cannabis mezzobusiness license must submit​
2389+73.18the following information in a form approved by the office:​
2390+73.19 (1) an operating plan demonstrating the proposed layout of the facility, including a​
2391+73.20diagram of ventilation and filtration systems; plans for wastewater and waste disposal for​
2392+73.21any cultivation or manufacturing activities; plans for providing electricity, water, and other​
2393+73.22utilities necessary for the normal operation of any cultivation or manufacturing activities;​
2394+73.23plans for compliance with applicable building code and federal and state environmental and​
2395+73.24workplace safety requirements and policies; and plans to avoid sales to unlicensed cannabis​
2396+73.25businesses and individuals under 21 years of age;​
2397+73.26 (2) if the applicant is seeking an endorsement to cultivate cannabis plants and harvest​
2398+73.27cannabis flower, a cultivation plan demonstrating the proposed size and layout of the​
2399+73.28cultivation facility that will be used exclusively for cultivation, including the total amount​
2400+73.29of plant canopy;​
2401+73.30 (3) if the applicant is seeking an endorsement to create cannabis concentrate, hemp​
2402+73.31concentrate, or artificial cannabinoids, information identifying all methods of extraction,​
2403+73.32concentration, or conversion that the applicant intends to use and the volatile chemicals and​
2404+73.33catalysts, if any, that will be involved in extraction, concentration, or creation; and​
23992405 73​Article 1 Sec. 29.​
2400-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 74.1 (6) manufacture adult-use cannabis products, lower-potency hemp edibles, and​
2401-74.2hemp-derived consumer products for public consumption;​
2402-74.3 (7) process medical cannabinoid products;​
2403-74.4 (8) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis​
2404-74.5microbusiness, another cannabis mezzobusiness, a cannabis manufacturer, or a cannabis​
2405-74.6wholesaler;​
2406-74.7 (9) purchase cannabis concentrate, hemp concentrate, and synthetically derived​
2407-74.8cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis​
2408-74.9manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products,​
2409-74.10lower-potency hemp edibles, or hemp-derived consumer products;​
2410-74.11 (10) purchase hemp plant parts and propagules from a licensed hemp grower licensed​
2411-74.12under chapter 18K;​
2412-74.13 (11) purchase hemp concentrate from an industrial hemp processor licensed under chapter​
2413-74.1418K;​
2414-74.15 (12) package and label adult-use cannabis flower, adult-use cannabis products,​
2415-74.16lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;​
2416-74.17 (13) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use​
2417-74.18cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and​
2418-74.19other products authorized by law to other cannabis businesses and to customers; and​
2419-74.20 (14) perform other actions approved by the office.​
2420-74.21 Subd. 2.Size limitations.(a) A cannabis mezzobusiness that cultivates cannabis at an​
2421-74.22indoor facility may cultivate up to 15,000 square feet of plant canopy. The office may adjust​
2422-74.23plant canopy limits upward to meet market demand consistent with the goals identified in​
2423-74.24section 342.02, subdivision 1.​
2424-74.25 (b) A cannabis mezzobusiness that cultivates cannabis at an outdoor location may​
2425-74.26cultivate up to one acre of mature, flowering plants unless the office increases that limit.​
2426-74.27The office may increase the limit to no more than three acres if the office determines that​
2427-74.28expansion is consistent with the goals identified in section 342.02, subdivision 1.​
2428-74.29 (c) The office shall establish a limit on the manufacturing of cannabis products,​
2429-74.30lower-potency hemp edibles, or hemp-derived consumer products a cannabis mezzobusiness​
2430-74.31that manufactures such products may perform. The limit must be equivalent to the amount​
2431-74.32of cannabis flower that can be harvested from a facility with a plant canopy of 15,000 square​
2432-74​Article 1 Sec. 29.​
2433-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 75.1feet in a year but may be increased if the office expands the allowable area of cultivation​
2434-75.2under paragraph (a).​
2435-75.3 (d) A cannabis mezzobusiness with the appropriate endorsement may operate up to three​
2436-75.4retail locations.​
2437-75.5 Subd. 3.Additional information required.In addition to the information required to​
2438-75.6be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2439-75.7a person, cooperative, or business seeking a cannabis mezzobusiness license must submit​
2440-75.8the following information in a form approved by the office:​
2441-75.9 (1) an operating plan demonstrating the proposed layout of the facility, including a​
2442-75.10diagram of ventilation and filtration systems; plans for wastewater and waste disposal for​
2443-75.11any cultivation or manufacturing activities; plans for providing electricity, water, and other​
2444-75.12utilities necessary for the normal operation of any cultivation or manufacturing activities;​
2445-75.13plans for compliance with applicable building code and federal and state environmental and​
2446-75.14workplace safety requirements and policies; and plans to avoid sales to unlicensed cannabis​
2447-75.15businesses and individuals under 21 years of age;​
2448-75.16 (2) if the applicant is seeking an endorsement to cultivate cannabis plants and harvest​
2449-75.17cannabis flower, a cultivation plan demonstrating the proposed size and layout of the​
2450-75.18cultivation facility that will be used exclusively for cultivation, including the total amount​
2451-75.19of plant canopy;​
2452-75.20 (3) if the applicant is seeking an endorsement to create cannabis concentrate, hemp​
2453-75.21concentrate, or artificial cannabinoids, information identifying all methods of extraction,​
2454-75.22concentration, or conversion that the applicant intends to use and the volatile chemicals and​
2455-75.23catalysts, if any, that will be involved in extraction, concentration, or creation; and​
2456-75.24 (4) evidence that the applicant will comply with the applicable operation requirements​
2457-75.25for the license being sought.​
2458-75.26 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2459-75.27cannabis mezzobusiness license may also hold a cannabis event organizer license and a​
2460-75.28medical cannabis retailer license.​
2461-75.29 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2462-75.30cannabis mezzobusiness license may own or operate any other cannabis business or hemp​
2463-75.31business or hold more than one cannabis mezzobusiness license.​
2464-75​Article 1 Sec. 29.​
2465-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 76.1 (d) For purposes of this subdivision, a restriction on the number or type of license that​
2466-76.2a business may hold applies to every cooperative member or every director, manager, and​
2406+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 74.1 (4) evidence that the applicant will comply with the applicable operation requirements​
2407+74.2for the license being sought.​
2408+74.3 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2409+74.4cannabis mezzobusiness license may also hold a cannabis event organizer license.​
2410+74.5 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2411+74.6cannabis mezzobusiness license may own or operate any other cannabis business or hemp​
2412+74.7business or hold more than one cannabis mezzobusiness license.​
2413+74.8 (d) For purposes of this subdivision, a restriction on the number or type of license that​
2414+74.9a business may hold applies to every cooperative member or every director, manager, and​
2415+74.10general partner of a cannabis business.​
2416+74.11 Subd. 5.Cultivation endorsement.A cannabis mezzobusiness that cultivates cannabis​
2417+74.12plants and harvests cannabis flower must comply with the requirements in section 342.25.​
2418+74.13 Subd. 6.Extraction and concentration endorsement.A cannabis mezzobusiness that​
2419+74.14creates cannabis concentrate must comply with the requirements in section 342.26,​
2420+74.15subdivisions 2 and 3.​
2421+74.16 Subd. 7.Production of customer products endorsement.A cannabis mezzobusiness​
2422+74.17that manufacturers edible cannabis products, lower-potency hemp products, or hemp-derived​
2423+74.18consumer products must comply with the requirements in section 342.26, subdivisions 2​
2424+74.19and 4.​
2425+74.20 Subd. 8.Retail operations endorsement.A cannabis mezzobusiness that operates a​
2426+74.21retail location must comply with the requirements in section 342.27.​
2427+74.22Sec. 30. [342.30] CANNABIS CULTIVATOR LICENSING AND OPERATIONS.​
2428+74.23 Subdivision 1.Authorized actions.A cannabis cultivator license entitles the license​
2429+74.24holder to grow cannabis plants within the approved amount of space from seed or immature​
2430+74.25plant to mature plant, harvest cannabis flower from a mature plant, package and label​
2431+74.26immature cannabis plants and seedlings and cannabis flower for sale to other cannabis​
2432+74.27businesses, transport cannabis flower to a cannabis manufacturer located on the same​
2433+74.28premises, and perform other actions approved by the office.​
2434+74.29 Subd. 2.Size limitations.(a) A cannabis cultivator that cultivates cannabis at an indoor​
2435+74.30facility may cultivate up to 15,000 square feet of plant canopy unless the office, by rule,​
2436+74.31increases that limit. The office may, by rule, increase the limit on plant canopy to no more​
2437+74.32than 30,000 cubic feet if the office determines that expansion is consistent with the goals​
2438+74​Article 1 Sec. 30.​
2439+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 75.1identified in section 342.02, subdivision 1. Limitations on plant canopy apply to the area​
2440+75.2in which mature, flowering plants are cultivated. A cannabis cultivator may not operate​
2441+75.3multiple tiers of cultivation unless authorized by the office.​
2442+75.4 (b) A cannabis cultivator that cultivates cannabis at an outdoor location may cultivate​
2443+75.5up to two acres of mature, flowering plants unless the office, by rule, increases that limit.​
2444+75.6The office may, by rule, increase the limit to no more than four acres if the office determines​
2445+75.7that expansion is consistent with the goals identified in section 342.02, subdivision 1.​
2446+75.8 Subd. 3.Additional information required.In addition to the information required to​
2447+75.9be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2448+75.10a person, cooperative, or business seeking a cannabis cultivator license must submit the​
2449+75.11following information in a form approved by the office:​
2450+75.12 (1) an operating plan demonstrating the proposed size and layout of the cultivation​
2451+75.13facility; plans for wastewater and waste disposal for the cultivation facility; plans for​
2452+75.14providing electricity, water, and other utilities necessary for the normal operation of the​
2453+75.15cultivation facility; and plans for compliance with the applicable building code and federal​
2454+75.16and state environmental and workplace safety requirements;​
2455+75.17 (2) a cultivation plan demonstrating the proposed size and layout of the cultivation​
2456+75.18facility that will be used exclusively for cultivation including the total amount of plant​
2457+75.19canopy; and​
2458+75.20 (3) evidence that the business will comply with the applicable operation requirements​
2459+75.21for the license being sought.​
2460+75.22 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2461+75.23cannabis cultivator license may also hold a cannabis manufacturing license, medical cannabis​
2462+75.24cultivator license, medical cannabis producer license, license to grow industrial hemp, and​
2463+75.25cannabis event organizer license.​
2464+75.26 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2465+75.27cannabis cultivator license may own or operate any other cannabis business or hemp business.​
2466+75.28This prohibition does not prevent the transportation of cannabis flower from a cannabis​
2467+75.29cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business​
2468+75.30and located on the same premises.​
2469+75.31 (c) The office by rule may limit the number of cannabis cultivator licenses a person,​
2470+75.32cooperative, or business may hold.​
2471+75​Article 1 Sec. 30.​
2472+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 76.1 (d) For purposes of this subdivision, a restriction on the number or type of license a​
2473+76.2business may hold applies to every cooperative member or every director, manager, and​
24672474 76.3general partner of a cannabis business.​
2468-76.4 Subd. 5.Cultivation endorsement.A cannabis mezzobusiness that cultivates cannabis​
2469-76.5plants and harvests cannabis flower must comply with the requirements in section 342.25.​
2470-76.6 Subd. 6.Extraction and concentration endorsement.A cannabis mezzobusiness that​
2471-76.7creates cannabis concentrate must comply with the requirements in section 342.26,​
2472-76.8subdivisions 2 and 3.​
2473-76.9 Subd. 7.Production of customer products endorsement.A cannabis mezzobusiness​
2474-76.10that manufacturers edible cannabis products, lower-potency hemp products, or hemp-derived​
2475-76.11consumer products must comply with the requirements in section 342.26, subdivisions 2​
2476-76.12and 4.​
2477-76.13 Subd. 8.Retail operations endorsement.A cannabis mezzobusiness that operates a​
2478-76.14retail location must comply with the requirements in section 342.27.​
2479-76.15 Subd. 9.Medical cannabis endorsement.A cannabis mezzobusiness that cultivates​
2480-76.16cannabis plants for use as medical cannabis flower or for use in medical cannabinoid​
2481-76.17products, processes medical cannabinoid products, or both, must comply with sections​
2482-76.18342.49, paragraph (d); 342.50, paragraph (c), and any additional requirements established​
2483-76.19by the office.​
2484-76.20Sec. 30. [342.30] CANNABIS CULTIVATOR LICENSING AND OPERATIONS.​
2485-76.21 Subdivision 1.Authorized actions.A cannabis cultivator license entitles the license​
2486-76.22holder to grow cannabis plants within the approved amount of space from seed or immature​
2487-76.23plant to mature plant, harvest cannabis flower from a mature plant, package and label​
2488-76.24immature cannabis plants and seedlings and cannabis flower for sale to other cannabis​
2489-76.25businesses, transport cannabis flower to a cannabis manufacturer located on the same​
2490-76.26premises, and perform other actions approved by the office.​
2491-76.27 Subd. 2.Size limitations.(a) A cannabis cultivator that cultivates cannabis at an indoor​
2492-76.28facility may cultivate up to 30,000 square feet of plant canopy. The office may adjust plant​
2493-76.29canopy limits upward to meet market demand consistent with the goals identified in section​
2494-76.30342.02, subdivision 1.​
2495-76.31 (b) A cannabis cultivator that cultivates cannabis at an outdoor location may cultivate​
2496-76.32up to two acres of mature, flowering plants unless the office increases that limit. The office​
2497-76​Article 1 Sec. 30.​
2498-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 77.1may increase the limit to no more than four acres if the office determines that expansion is​
2499-77.2consistent with the goals identified in section 342.02, subdivision 1.​
2500-77.3 Subd. 3.Additional information required.In addition to the information required to​
2501-77.4be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2502-77.5a person, cooperative, or business seeking a cannabis cultivator license must submit the​
2503-77.6following information in a form approved by the office:​
2504-77.7 (1) an operating plan demonstrating the proposed size and layout of the cultivation​
2505-77.8facility; plans for wastewater and waste disposal for the cultivation facility; plans for​
2506-77.9providing electricity, water, and other utilities necessary for the normal operation of the​
2507-77.10cultivation facility; and plans for compliance with the applicable building code and federal​
2508-77.11and state environmental and workplace safety requirements;​
2509-77.12 (2) a cultivation plan demonstrating the proposed size and layout of the cultivation​
2510-77.13facility that will be used exclusively for cultivation including the total amount of plant​
2511-77.14canopy; and​
2512-77.15 (3) evidence that the business will comply with the applicable operation requirements​
2513-77.16for the license being sought.​
2514-77.17 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2515-77.18cannabis cultivator license may also hold a cannabis manufacturing license, medical cannabis​
2516-77.19cultivator license, medical cannabis producer license, license to grow industrial hemp, and​
2517-77.20cannabis event organizer license.​
2518-77.21 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2519-77.22cannabis cultivator license may own or operate any other cannabis business or hemp business.​
2520-77.23This prohibition does not prevent the transportation of cannabis flower from a cannabis​
2521-77.24cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business​
2522-77.25and located on the same premises.​
2523-77.26 (c) The office by rule may limit the number of cannabis cultivator licenses a person,​
2524-77.27cooperative, or business may hold.​
2525-77.28 (d) For purposes of this subdivision, a restriction on the number or type of license a​
2526-77.29business may hold applies to every cooperative member or every director, manager, and​
2527-77.30general partner of a cannabis business.​
2528-77.31 Subd. 5.Cultivation operations.A cannabis cultivator must comply with the​
2529-77.32requirements in section 342.25.​
2530-77​Article 1 Sec. 30.​
2531-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 78.1 Sec. 31. [342.31] CANNABIS MANUFACTURER LICENSING AND OPERATIONS.​
2532-78.2 Subdivision 1.Authorized actions.A cannabis manufacturer license, consistent with​
2533-78.3the specific license endorsement or endorsements, entitles the license holder to:​
2534-78.4 (1) purchase cannabis flower, cannabis products, hemp plant parts, hemp concentrate,​
2535-78.5and artificially derived cannabinoids from a cannabis microbusiness, a cannabis​
2536-78.6mezzobusiness, a cannabis cultivator, another cannabis manufacturer, or a cannabis​
2537-78.7wholesaler;​
2538-78.8 (2) purchase hemp plant parts and propagules from an industrial hemp grower licensed​
2539-78.9under chapter 18K;​
2540-78.10 (3) purchase hemp concentrate from an industrial hemp processor licensed under chapter​
2541-78.1118K;​
2542-78.12 (4) accept cannabis flower from unlicensed persons who are at least 21 years of age​
2543-78.13provided that the cannabis manufacturer does not accept more than two ounces from an​
2544-78.14individual on a single occasion;​
2545-78.15 (5) make cannabis concentrate;​
2546-78.16 (6) make hemp concentrate, including hemp concentrate with a delta-9​
2547-78.17tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;​
2548-78.18 (7) manufacture artificially derived cannabinoids;​
2549-78.19 (8) manufacture adult-use cannabis products, lower-potency hemp edibles, and​
2550-78.20hemp-derived consumer products for public consumption;​
2551-78.21 (9) package and label adult-use cannabis products, lower-potency hemp edibles, and​
2552-78.22hemp-derived consumer products for sale to customers;​
2553-78.23 (10) sell cannabis concentrate, hemp concentrate, artificially derived cannabinoids,​
2554-78.24cannabis products, lower-potency hemp edibles, and hemp-derived consumer products to​
2555-78.25other cannabis businesses; and​
2556-78.26 (11) perform other actions approved by the office.​
2557-78.27 Subd. 2.Size limitations.The office shall establish a limit on the manufacturing of​
2558-78.28cannabis products, lower-potency hemp edibles, or hemp-derived consumer products a​
2559-78.29cannabis manufacturer may perform.​
2560-78.30 Subd. 3.Additional information required.In addition to the information required to​
2561-78.31be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2562-78​Article 1 Sec. 31.​
2563-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 79.1a person, cooperative, or business seeking a cannabis manufacturer license must submit the​
2564-79.2following information in a form approved by the office:​
2565-79.3 (1) an operating plan demonstrating the proposed layout of the facility, including a​
2566-79.4diagram of ventilation and filtration systems; plans for wastewater and waste disposal for​
2567-79.5the manufacturing facility; plans for providing electricity, water, and other utilities necessary​
2568-79.6for the normal operation of the manufacturing facility; and plans for compliance with​
2569-79.7applicable building code and federal and state environmental and workplace safety​
2570-79.8requirements; and​
2571-79.9 (2) evidence that the business will comply with the applicable operation requirements​
2572-79.10for the endorsement being sought.​
2573-79.11 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2574-79.12cannabis manufacturer license may also hold a cannabis cultivator license, a medical cannabis​
2575-79.13cultivator license, a medical cannabis processor license, and a cannabis event organizer​
2576-79.14license.​
2577-79.15 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2578-79.16cannabis manufacturer license may own or operate any other cannabis business or hemp​
2579-79.17business. This prohibition does not prevent transportation of cannabis flower from a cannabis​
2580-79.18cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business​
2581-79.19and located on the same premises.​
2582-79.20 (c) The office by rule may limit the number of cannabis manufacturer licenses that a​
2583-79.21person or business may hold.​
2584-79.22 (d) For purposes of this subdivision, a restriction on the number or type of license that​
2585-79.23a business may hold applies to every cooperative member or every director, manager, and​
2586-79.24general partner of a cannabis business.​
2587-79.25 Subd. 5.Manufacturing operations.A cannabis manufacturer must comply with the​
2588-79.26requirements in section 342.26.​
2589-79.27Sec. 32. [342.32] CANNABIS RETAILER LICENSING AND OPERATIONS.​
2590-79.28 Subdivision 1.Authorized actions.A cannabis retailer license entitles the license holder​
2591-79.29to:​
2592-79.30 (1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2593-79.31lower-potency hemp edibles, and hemp-derived consumer products from cannabis​
2594-79​Article 1 Sec. 32.​
2595-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 80.1microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,​
2596-80.2and cannabis wholesalers;​
2597-80.3 (2) purchase lower-potency hemp edibles from a licensed lower-potency hemp edible​
2598-80.4manufacturer;​
2599-80.5 (3) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use​
2600-80.6cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and​
2601-80.7other products authorized by law to customers; and​
2602-80.8 (4) perform other actions approved by the office.​
2603-80.9 Subd. 2.Size limitations.A cannabis retailer may operate up to five retail locations.​
2604-80.10 Subd. 3.Additional information required.In addition to the information required to​
2605-80.11be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2606-80.12a person, cooperative, or business seeking a cannabis retail license must submit the following​
2607-80.13information in a form approved by the office:​
2608-80.14 (1) a list of every retail license held by the applicant and, if the applicant is a business,​
2609-80.15every retail license held, either as an individual or as part of another business, by each​
2610-80.16officer, director, manager, and general partner of the cannabis business;​
2611-80.17 (2) an operating plan demonstrating the proposed layout of the facility, including a​
2612-80.18diagram of ventilation and filtration systems; policies to avoid sales to individuals who are​
2613-80.19under 21 years of age; identification of a restricted area for storage; and plans to prevent​
2614-80.20the visibility of cannabis flower, cannabis products, lower-potency hemp edibles, and​
2615-80.21hemp-derived consumer products to individuals outside the retail location; and​
2616-80.22 (3) evidence that the business will comply with the applicable operation requirements​
2617-80.23for the license being sought.​
2618-80.24 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2619-80.25cannabis retailer license may also hold a cannabis delivery service license, a medical cannabis​
2620-80.26retailer license, and a cannabis event organizer license.​
2621-80.27 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2622-80.28cannabis retailer license may own or operate any other cannabis business or hemp business.​
2623-80.29 (c) No person, cooperative, or business may hold a license to own or operate more than​
2624-80.30one cannabis retail business in one city and three retail businesses in one county.​
2625-80.31 (d) The office by rule may limit the number of cannabis retailer licenses a person,​
2626-80.32cooperative, or business may hold.​
2627-80​Article 1 Sec. 32.​
2628-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 81.1 (e) For purposes of this subdivision, a restriction on the number or type of license a​
2629-81.2business may hold applies to every cooperative member or every director, manager, and​
2630-81.3general partner of a cannabis business.​
2631-81.4 Subd. 5.Municipal or county cannabis store.A city or county may establish, own,​
2632-81.5and operate a municipal cannabis store subject to the restrictions in this chapter.​
2633-81.6 Sec. 33. [342.33] CANNABIS WHOLESALER LICENSING.​
2634-81.7 Subdivision 1.Authorized actions.A cannabis wholesaler license entitles the license​
2635-81.8holder to:​
2636-81.9 (1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2637-81.10lower-potency hemp edibles, and hemp-derived consumer products from cannabis​
2638-81.11microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,​
2639-81.12and cannabis microbusinesses;​
2640-81.13 (2) purchase hemp plant parts and propagules from industrial hemp growers licensed​
2641-81.14under chapter 18K;​
2642-81.15 (3) purchase hemp concentrate from an industrial hemp processor licensed under chapter​
2643-81.1618K;​
2644-81.17 (4) sell immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2645-81.18lower-potency hemp edibles, and hemp-derived consumer products to cannabis​
2646-81.19microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, and cannabis retailers;​
2647-81.20 (5) sell lower-potency hemp edibles to lower-potency hemp edible retailers;​
2648-81.21 (6) import hemp-derived consumer products and lower-potency hemp edibles that contain​
2649-81.22hemp concentrate or artificially derived cannabinoids that are derived from hemp plants or​
2650-81.23hemp plant parts; and​
2651-81.24 (7) perform other actions approved by the office.​
2652-81.25 Subd. 2.Additional information required.In addition to the information required to​
2653-81.26be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2654-81.27a person, cooperative, or business seeking a cannabis wholesaler license must submit the​
2655-81.28following information in a form approved by the office:​
2656-81.29 (1) an operating plan demonstrating the proposed layout of the facility including a​
2657-81.30diagram of ventilation and filtration systems and policies to avoid sales to unlicensed​
2658-81.31cannabis businesses; and​
2659-81​Article 1 Sec. 33.​
2660-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 82.1 (2) evidence that the business will comply with the applicable operation requirements​
2661-82.2for the license being sought.​
2662-82.3 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2663-82.4cannabis wholesaler license may also hold a cannabis transporter license, a cannabis delivery​
2664-82.5service license, and a cannabis event organizer license.​
2665-82.6 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2666-82.7cannabis wholesaler license may own or operate any other cannabis business or hemp​
2667-82.8business.​
2668-82.9 (c) The office by rule may limit the number of cannabis wholesaler licenses a person or​
2669-82.10business may hold.​
2670-82.11 (d) For purposes of this subdivision, a restriction on the number or type of license a​
2671-82.12business may hold applies to every cooperative member or every director, manager, and​
2672-82.13general partner of a cannabis business.​
2673-82.14Sec. 34. [342.34] CANNABIS WHOLESALER OPERATIONS.​
2674-82.15 Subdivision 1.Separation of products.A cannabis wholesaler must ensure that cannabis​
2675-82.16plants, cannabis flower, and cannabis products are physically separated from all other​
2676-82.17products, including but not limited to lower-potency hemp edibles and hemp-derived​
2677-82.18consumer products, in a manner that prevents any cross-contamination.​
2678-82.19 Subd. 2.Records and labels.A cannabis wholesaler must maintain accurate records​
2679-82.20and ensure that appropriate labels remain affixed to cannabis plants, cannabis flower,​
2680-82.21cannabis products, lower-potency hemp edibles, and hemp-derived consumer products.​
2681-82.22 Subd. 3.Building conditions.(a) A cannabis wholesaler shall maintain compliance​
2682-82.23with state and local building, fire, and zoning requirements or regulations.​
2683-82.24 (b) A cannabis wholesaler shall ensure that the licensed premises is maintained in a​
2684-82.25clean and sanitary condition, free from infestation by insects, rodents, or other pests.​
2685-82.26 Subd. 4.Sale of other products.A cannabis wholesaler may purchase and sell other​
2686-82.27products or items for which the cannabis wholesaler has a license or authorization or that​
2687-82.28do not require a license or authorization. Products for which no license or authorization is​
2688-82.29required include but are not limited to industrial hemp products, products that contain hemp​
2689-82.30grain, hemp-derived topical products, and cannabis paraphernalia, including but not limited​
2690-82.31to childproof packaging containers and other devices designed to ensure the safe storage​
2691-82​Article 1 Sec. 34.​
2692-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 83.1and monitoring of cannabis flower and cannabis products in the home to prevent access by​
2693-83.2individuals under 21 years of age.​
2694-83.3 Subd. 5.Importation of hemp-derived products.(a) A cannabis wholesaler that imports​
2695-83.4lower-potency hemp edibles or hemp-derived consumer products, other than hemp-derived​
2696-83.5topical products, that are manufactured outside the boundaries of the state of Minnesota​
2697-83.6with the intent to sell the products to a cannabis microbusiness, cannabis mezzobusiness,​
2698-83.7cannabis retailer, or lower-potency hemp edible retailer must obtain a hemp-derived product​
2699-83.8importer endorsement from the office.​
2700-83.9 (b) A cannabis wholesaler with a hemp-derived product importer endorsement may sell​
2701-83.10products manufactured outside the boundaries of the state of Minnesota if:​
2702-83.11 (1) the manufacturer is licensed in another jurisdiction and subject to regulations designed​
2703-83.12to protect the health and safety of consumers that the office determines are substantially​
2704-83.13similar to the regulations in this state; or​
2705-83.14 (2) the cannabis wholesaler establishes, to the satisfaction of the office, that the​
2706-83.15manufacturer engages in practices that are substantially similar to the practices required for​
2707-83.16licensure of manufacturers in this state.​
2708-83.17 (c) The cannabis wholesaler must enter all relevant information regarding an imported​
2709-83.18hemp-derived consumer product into the statewide monitoring system before the product​
2710-83.19may be distributed. Relevant information includes information regarding the cultivation,​
2711-83.20processing, and testing of the industrial hemp used in the manufacture of the product and​
2712-83.21information regarding the testing of the hemp-derived consumer product. If information​
2713-83.22regarding the industrial hemp or hemp-derived consumer product was submitted to a​
2714-83.23statewide monitoring system used in another state, the office may require submission of​
2715-83.24any information provided to that statewide monitoring system and shall assist in the transfer​
2716-83.25of data from another state as needed and in compliance with any data classification​
2717-83.26established by either state.​
2718-83.27 (d) The office may suspend, revoke, or cancel the endorsement of a distributor who is​
2719-83.28prohibited from distributing products containing cannabinoids in any other jurisdiction,​
2720-83.29convicted of an offense involving the distribution of products containing cannabinoids in​
2721-83.30any other jurisdiction, or found liable for distributing any product that injured customers in​
2722-83.31any other jurisdiction. A cannabis wholesaler shall disclose all relevant information related​
2723-83.32to actions in another jurisdiction. Failure to disclose relevant information may result in​
2724-83.33disciplinary action by the office, including the suspension, revocation, or cancellation of​
2725-83.34an endorsement or license.​
2726-83​Article 1 Sec. 34.​
2727-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 84.1 (e) Notwithstanding any law to the contrary, it shall not be a defense in any civil or​
2728-84.2criminal action that a licensed wholesaler relied on information on a product label or​
2729-84.3otherwise provided by a manufacturer who is not licensed in this state.​
2730-84.4 Sec. 35. [342.35] CANNABIS TRANSPORTER LICENSING.​
2731-84.5 Subdivision 1.Authorized actions.A cannabis transporter license entitles the license​
2732-84.6holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis​
2733-84.7products, artificially derived cannabinoids, hemp plant parts, hemp concentrate,​
2734-84.8lower-potency hemp edibles, and hemp-derived consumer products from cannabis​
2735-84.9microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,​
2736-84.10cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis retailers,​
2737-84.11medical cannabis processors, and industrial hemp growers to cannabis microbusinesses,​
2738-84.12cannabis mezzobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis​
2739-84.13wholesalers, cannabis retailers, lower-potency hemp edible retailers, medical cannabis​
2740-84.14processors, medical cannabis retailers, and medical cannabis combination businesses and​
2741-84.15perform other actions approved by the office.​
2742-84.16 Subd. 2.Additional information required.In addition to the information required to​
2743-84.17be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2744-84.18a person, cooperative, or business seeking a cannabis transporter license must submit the​
2745-84.19following information in a form approved by the office:​
2746-84.20 (1) an appropriate surety bond, certificate of insurance, qualifications as a self-insurer,​
2747-84.21or other securities or agreements, in the amount of not less than $300,000, for loss of or​
2748-84.22damage to cargo;​
2749-84.23 (2) an appropriate surety bond, certificate of insurance, qualifications as a self-insurer,​
2750-84.24or other securities or agreements, in the amount of not less than $1,000,000, for injury to​
2751-84.25one or more persons in any one accident and, if an accident has resulted in injury to or​
2752-84.26destruction of property, of not less than $100,000 because of such injury to or destruction​
2753-84.27of property of others in any one accident;​
2754-84.28 (3) the number and type of equipment the business will use to transport immature cannabis​
2755-84.29plants and seedlings, cannabis flower, cannabis products, artificially derived cannabinoids,​
2756-84.30hemp plant parts, hemp concentrate, lower-potency hemp edibles, and hemp-derived​
2757-84.31consumer products;​
2758-84.32 (4) a loading, transporting, and unloading plan;​
2759-84​Article 1 Sec. 35.​
2760-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 85.1 (5) a description of the applicant's experience in the distribution or security business;​
2761-85.2and​
2762-85.3 (6) evidence that the business will comply with the applicable operation requirements​
2763-85.4for the license being sought.​
2764-85.5 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2765-85.6cannabis transporter license may also hold a cannabis wholesaler license, a cannabis delivery​
2766-85.7service license, and a cannabis event organizer license.​
2767-85.8 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2768-85.9cannabis transporter license may own or operate any other cannabis business.​
2769-85.10 (c) The office by rule may limit the number of cannabis transporter licenses a person or​
2770-85.11business may hold.​
2771-85.12 (d) For purposes of this subdivision, restrictions on the number or type of license a​
2772-85.13business may hold apply to every cooperative member or every director, manager, and​
2773-85.14general partner of a cannabis business.​
2774-85.15Sec. 36. [342.36] CANNABIS TRANSPORTER OPERATIONS.​
2775-85.16 Subdivision 1.Manifest required.Before transporting immature cannabis plants and​
2776-85.17seedlings, cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant​
2777-85.18parts, hemp concentrate, lower-potency hemp edibles, or hemp-derived consumer products,​
2778-85.19a cannabis transporter shall obtain a shipping manifest on a form established by the office.​
2779-85.20The manifest must be kept with the products at all times and the cannabis transporter must​
2780-85.21maintain a copy of the manifest in its records.​
2781-85.22 Subd. 2.Records of transportation.Records of transportation must be kept for a​
2782-85.23minimum of three years at the cannabis transporter's place of business and are subject to​
2783-85.24inspection upon request by the office or law enforcement agency. Records of transportation​
2784-85.25include the following:​
2785-85.26 (1) copies of transportation manifests for all deliveries;​
2786-85.27 (2) a transportation log documenting the chain of custody for each delivery, including​
2787-85.28every employee and vehicle used during transportation; and​
2788-85.29 (3) financial records showing payment for transportation services.​
2789-85.30 Subd. 3.Storage compartment.Immature cannabis plants and seedlings, cannabis​
2790-85.31flower, cannabis products, artificially derived cannabinoids, hemp plant parts, hemp​
2791-85.32concentrate, lower-potency hemp edibles, and hemp-derived consumer products must be​
2792-85​Article 1 Sec. 36.​
2793-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 86.1transported in a locked, safe, and secure storage compartment that is part of the motor vehicle​
2794-86.2or in a locked storage container that has a separate key or combination pad. Items being​
2795-86.3transported may not be visible from outside the motor vehicle.​
2796-86.4 Subd. 4.Identifying logos or business names prohibited.No vehicle or trailer may​
2797-86.5contain an image depicting the types of items being transported, including but not limited​
2798-86.6to an image depicting a cannabis or hemp leaf, or a name suggesting that the vehicle is used​
2799-86.7in transporting immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2800-86.8artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp​
2801-86.9edibles, or hemp-derived consumer products.​
2802-86.10 Subd. 5.Randomized deliveries.A cannabis transporter shall ensure that all delivery​
2803-86.11times and routes are randomized.​
2804-86.12 Subd. 6.Multiple employees.All cannabis transporter vehicles transporting immature​
2805-86.13cannabis plants and seedlings, cannabis flower, cannabis products, artificially derived​
2806-86.14cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles, or​
2807-86.15hemp-derived consumer products must be staffed with a minimum of two employees. At​
2808-86.16least one delivery team member shall remain with the motor vehicle at all times that the​
2809-86.17motor vehicle contains immature cannabis plants and seedlings, cannabis flower, cannabis​
2810-86.18products, artificially derived cannabinoids, hemp plant parts, hemp concentrate,​
2811-86.19lower-potency hemp edibles, or hemp-derived consumer products.​
2812-86.20 Subd. 7.Nonemployee passengers prohibited.Only a cannabis worker employed by​
2813-86.21or contracted with the cannabis transporter and who is at least 21 years of age may transport​
2814-86.22immature cannabis plants and seedlings, cannabis flower, cannabis products, artificially​
2815-86.23derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles, or​
2816-86.24hemp-derived consumer products. All passengers in a vehicle must be cannabis workers​
2817-86.25employed by or contracted with the cannabis transporter.​
2818-86.26 Subd. 8.Drivers license required.All drivers must carry a valid driver's license with​
2819-86.27the proper endorsements when operating a vehicle transporting immature cannabis plants​
2820-86.28and seedlings, cannabis flower, cannabis products, artificially derived cannabinoids, hemp​
2821-86.29plant parts, hemp concentrate, lower-potency hemp edibles, or hemp-derived consumer​
2822-86.30products.​
2823-86.31 Subd. 9.Vehicles subject to inspection.Any vehicle assigned for the purposes of​
2824-86.32transporting immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2825-86.33artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp​
2826-86​Article 1 Sec. 36.​
2827-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 87.1edibles, or hemp-derived consumer products is subject to inspection and may be stopped​
2828-87.2or inspected at any licensed cannabis business or while en route during transportation.​
2829-87.3 Sec. 37. [342.37] CANNABIS TESTING FACILITY LICENSING.​
2830-87.4 Subdivision 1.Authorized actions.A cannabis testing facility license entitles the license​
2831-87.5holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis​
2832-87.6products, hemp plant parts, hemp concentrate, artificially derived cannabinoids,​
2833-87.7lower-potency hemp edibles, and hemp-derived consumer products from cannabis​
2834-87.8microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,​
2835-87.9cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis​
2836-87.10cultivators, medical cannabis processors, medical cannabis combination businesses, and​
2837-87.11industrial hemp growers.​
2838-87.12 Subd. 2.Additional information required.In addition to the information required to​
2839-87.13be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2840-87.14a person, cooperative, or business seeking a cannabis testing facility license must submit​
2841-87.15the following information in a form approved by the office:​
2842-87.16 (1) an operating plan demonstrating the proposed layout of the facility, including a​
2843-87.17diagram of ventilation and filtration systems and policies to avoid sales to unlicensed​
2844-87.18businesses;​
2845-87.19 (2) proof of accreditation by a laboratory accrediting organization approved by the office​
2846-87.20that, at a minimum, requires a laboratory to operate formal management systems under the​
2847-87.21International Organization for Standardization; and​
2848-87.22 (3) evidence that the business will comply with the applicable operation requirements​
2849-87.23for the license being sought.​
2850-87.24 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2851-87.25cannabis testing facility license may not own or operate, or be employed by, any other​
2852-87.26cannabis business or hemp business.​
2853-87.27 (b) The office by rule may limit the number of cannabis testing facility licenses a person​
2854-87.28or business may hold.​
2855-87.29 (c) For purposes of this subdivision, a restriction on the number of licenses a business​
2856-87.30may hold applies to every cooperative member or every director, manager, and general​
2857-87.31partner of a cannabis business.​
2858-87​Article 1 Sec. 37.​
2859-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 88.1 Sec. 38. [342.38] CANNABIS TESTING FACILITY OPERATIONS.​
2860-88.2 Subdivision 1.Testing services.A cannabis testing facility shall provide some or all​
2861-88.3testing services required under section 342.61 and rules adopted pursuant to that section.​
2862-88.4 Subd. 2.Testing protocols.A cannabis testing facility shall follow all testing protocols,​
2863-88.5standards, and criteria adopted by rule by the office for the testing of different forms of​
2864-88.6cannabis plants and seedlings, cannabis flower, cannabis products, lower-potency hemp​
2865-88.7edibles, hemp-derived consumer products, hemp plant parts, hemp concentrate, and artificially​
2866-88.8derived cannabinoids; determining batch size; sampling; testing validity; and approval and​
2867-88.9disapproval of tested items.​
2868-88.10 Subd. 3.Records.Records of all business transactions and testing results; records​
2869-88.11required to be maintained pursuant to any applicable standards for accreditation; and records​
2870-88.12relevant to testing protocols, standards, and criteria adopted by the office must be kept for​
2871-88.13a minimum of three years at the cannabis testing facility's place of business and are subject​
2872-88.14to inspection upon request by the office or law enforcement agency.​
2873-88.15 Subd. 4.Disposal of cannabis flower and products.A testing facility shall dispose of​
2874-88.16or destroy used, unused, and waste cannabis plants and seedlings, cannabis flower, cannabis​
2875-88.17products, lower-potency hemp edibles, hemp-derived consumer products, hemp plant parts,​
2876-88.18hemp concentrate, and artificially derived cannabinoids pursuant to rules adopted by the​
2877-88.19office.​
2878-88.20Sec. 39. [342.39] CANNABIS EVENT ORGANIZER LICENSING.​
2879-88.21 Subdivision 1.Authorized actions.A cannabis event organizer license entitles the​
2880-88.22license holder to organize a temporary cannabis event lasting no more than four days.​
2881-88.23 Subd. 2.Additional information required.(a) In addition to the information required​
2882-88.24to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that​
2883-88.25section, a person, cooperative, or business seeking a cannabis event organizer license must​
2884-88.26submit the following information in a form approved by the office:​
2885-88.27 (1) the type and number of any other cannabis business license held by the applicant;​
2886-88.28 (2) the address and location where the temporary cannabis event will take place;​
2887-88.29 (3) the name of the temporary cannabis event;​
2888-88.30 (4) a diagram of the physical layout of the temporary cannabis event showing where the​
2889-88.31event will take place on the grounds, all entrances and exits that will be used by participants​
2890-88.32during the event, all cannabis consumption areas, all cannabis retail areas where cannabis​
2891-88​Article 1 Sec. 39.​
2892-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 89.1flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products​
2893-89.2will be sold, the location where cannabis waste will be stored, and any location where​
2894-89.3cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
2895-89.4products will be stored;​
2896-89.5 (5) a list of the name, number, and type of cannabis businesses and hemp businesses​
2897-89.6that will sell cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
2898-89.7lower-potency hemp edibles, and hemp-derived consumer products at the event, which may​
2899-89.8be supplemented or amended within 72 hours of the time at which the cannabis event begins;​
2900-89.9 (6) the dates and hours during which the cannabis event will take place;​
2901-89.10 (7) proof of local approval for the cannabis event; and​
2902-89.11 (8) evidence that the business will comply with the applicable operation requirements​
2903-89.12for the license being sought.​
2904-89.13 (b) A person, cooperative, or business seeking a cannabis event organizer license may​
2905-89.14also disclose whether the person or any officer, director, manager, and general partner of a​
2906-89.15cannabis business is serving or has previously served in the military.​
2907-89.16 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2908-89.17cannabis event organizer license may not hold a cannabis testing facility license, a​
2909-89.18lower-potency hemp edible manufacturer license, or a lower-potency hemp edible retailer​
2910-89.19license.​
2911-89.20 (b) The office by rule may limit the number of cannabis event licenses that a person or​
2912-89.21business may hold.​
2913-89.22 (c) For purposes of this subdivision, restrictions on the number or type of license that a​
2914-89.23business may hold apply to every cooperative member or every director, manager, and​
2915-89.24general partner of a cannabis business.​
2916-89.25Sec. 40. [342.40] CANNABIS EVENT ORGANIZER OPERATIONS.​
2917-89.26 Subdivision 1.Local approval.A cannabis event organizer must receive local approval,​
2918-89.27including obtaining any necessary permits or licenses issued by a local unit of government,​
2919-89.28before holding a cannabis event.​
2920-89.29 Subd. 2.Charging fees.(a) A cannabis event organizer may charge an entrance fee to​
2921-89.30a cannabis event.​
2922-89.31 (b) A cannabis event organizer may charge a fee to a cannabis business or hemp business​
2923-89.32in exchange for space to display and sell cannabis plants, adult-use cannabis flower, adult-use​
2475+76.4 Subd. 5.Cultivation operations.A cannabis cultivator must comply with the​
2476+76.5requirements in section 342.25.​
2477+76.6 Sec. 31. [342.31] CANNABIS MANUFACTURER LICENSING AND OPERATIONS.​
2478+76.7 Subdivision 1.Authorized actions.A cannabis manufacturer license, consistent with​
2479+76.8the specific license endorsement or endorsements, entitles the license holder to:​
2480+76.9 (1) purchase cannabis flower, cannabis products, hemp plant parts, hemp concentrate,​
2481+76.10and artificially derived cannabinoids from a cannabis microbusiness, a cannabis​
2482+76.11mezzobusiness, a cannabis cultivator, another cannabis manufacturer, a cannabis wholesaler,​
2483+76.12or an industrial hemp grower;​
2484+76.13 (2) accept cannabis flower from unlicensed persons who are at least 21 years of age​
2485+76.14provided that the cannabis manufacturer does not accept more than two ounces from an​
2486+76.15individual on a single occasion;​
2487+76.16 (3) make cannabis concentrate;​
2488+76.17 (4) make hemp concentrate, including hemp concentrate with a delta-9​
2489+76.18tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;​
2490+76.19 (5) manufacture artificially derived cannabinoids;​
2491+76.20 (6) manufacture adult-use cannabis products, lower-potency hemp edibles, and​
2492+76.21hemp-derived consumer products for public consumption;​
2493+76.22 (7) package and label adult-use cannabis products, lower-potency hemp edibles, and​
2494+76.23hemp-derived consumer products for sale to customers;​
2495+76.24 (8) sell cannabis concentrate, hemp concentrate, artificially derived cannabinoids,​
2496+76.25cannabis products, lower-potency hemp edibles, and hemp-derived consumer products to​
2497+76.26other cannabis businesses; and​
2498+76.27 (9) perform other actions approved by the office.​
2499+76.28 Subd. 2.Size limitations.The office shall, by rule, establish a limit on the manufacturing​
2500+76.29of cannabis products, lower-potency hemp edibles, or hemp-derived consumer products a​
2501+76.30cannabis manufacturer may perform. The limit must be equivalent to the amount of cannabis​
2502+76.31flower that can be harvested from a facility with a plant canopy of 15,000 square feet in a​
2503+76​Article 1 Sec. 31.​
2504+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 77.1year, but may be increased to the amount that can be harvested from a facility with up to​
2505+77.230,000 cubic feet of plant canopy if the office expands the allowable area of cultivation​
2506+77.3under section 342.30, subdivision 2.​
2507+77.4 Subd. 3.Additional information required.In addition to the information required to​
2508+77.5be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2509+77.6a person, cooperative, or business seeking a cannabis manufacturer license must submit the​
2510+77.7following information in a form approved by the office:​
2511+77.8 (1) an operating plan demonstrating the proposed layout of the facility, including a​
2512+77.9diagram of ventilation and filtration systems; plans for wastewater and waste disposal for​
2513+77.10the manufacturing facility; plans for providing electricity, water, and other utilities necessary​
2514+77.11for the normal operation of the manufacturing facility; and plans for compliance with​
2515+77.12applicable building code and federal and state environmental and workplace safety​
2516+77.13requirements; and​
2517+77.14 (2) evidence that the business will comply with the applicable operation requirements​
2518+77.15for the endorsement being sought.​
2519+77.16 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2520+77.17cannabis manufacturer license may also hold a cannabis cultivator license, a medical cannabis​
2521+77.18cultivator license, a medical cannabis processor license, and a cannabis event organizer​
2522+77.19license.​
2523+77.20 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2524+77.21cannabis manufacturer license may own or operate any other cannabis business or hemp​
2525+77.22business. This prohibition does not prevent transportation of cannabis flower from a cannabis​
2526+77.23cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business​
2527+77.24and located on the same premises.​
2528+77.25 (c) The office by rule may limit the number of cannabis manufacturer licenses that a​
2529+77.26person or business may hold.​
2530+77.27 (d) For purposes of this subdivision, a restriction on the number or type of license that​
2531+77.28a business may hold applies to every cooperative member or every director, manager, and​
2532+77.29general partner of a cannabis business.​
2533+77.30 Subd. 5.Cultivation operations.A cannabis manufacturer must comply with the​
2534+77.31requirements in section 342.26.​
2535+77​Article 1 Sec. 31.​
2536+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 78.1 Sec. 32. [342.32] CANNABIS RETAILER LICENSING AND OPERATIONS.​
2537+78.2 Subdivision 1.Authorized actions.A cannabis retailer license entitles the license holder​
2538+78.3to:​
2539+78.4 (1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2540+78.5lower-potency hemp edibles, and hemp-derived consumer products from cannabis​
2541+78.6microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,​
2542+78.7cannabis wholesalers, and industrial hemp growers;​
2543+78.8 (2) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use​
2544+78.9cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and​
2545+78.10other products authorized by law to customers; and​
2546+78.11 (3) perform other actions approved by the office.​
2547+78.12 Subd. 2.Size limitations.A cannabis retailer may operate up to five retail locations.​
2548+78.13 Subd. 3.Additional information required.In addition to the information required to​
2549+78.14be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2550+78.15a person, cooperative, or business seeking a cannabis retail license must submit the following​
2551+78.16information in a form approved by the office:​
2552+78.17 (1) a list of every retail license held by the applicant and, if the applicant is a business,​
2553+78.18every retail license held, either as an individual or as part of another business, by each​
2554+78.19officer, director, manager, and general partner of the cannabis business;​
2555+78.20 (2) an operating plan demonstrating the proposed layout of the facility, including a​
2556+78.21diagram of ventilation and filtration systems; policies to avoid sales to individuals who are​
2557+78.22under 21 years of age; identification of a restricted area for storage; and plans to prevent​
2558+78.23the visibility of cannabis flower, cannabinoid products, and hemp-derived consumer products​
2559+78.24to individuals outside the retail location; and​
2560+78.25 (3) evidence that the business will comply with the applicable operation requirements​
2561+78.26for the license being sought.​
2562+78.27 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2563+78.28cannabis retailer license may also hold a cannabis delivery service license, a medical cannabis​
2564+78.29retailer license, and a cannabis event organizer license.​
2565+78.30 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2566+78.31cannabis retailer license may own or operate any other cannabis business or hemp business.​
2567+78​Article 1 Sec. 32.​
2568+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 79.1 (c) No person, cooperative, or business may hold a license to own or operate more than​
2569+79.2one cannabis retail business in one city or county.​
2570+79.3 (d) The office by rule may limit the number of cannabis retailer licenses a person,​
2571+79.4cooperative, or business may hold.​
2572+79.5 (e) For purposes of this subdivision, a restriction on the number or type of license a​
2573+79.6business may hold applies to every cooperative member or every director, manager, and​
2574+79.7general partner of a cannabis business.​
2575+79.8 Subd. 5.Municipal or county cannabis store.A city or county may establish, own,​
2576+79.9and operate a municipal cannabis store subject to the restrictions in this chapter.​
2577+79.10Sec. 33. [342.33] CANNABIS WHOLESALER LICENSING.​
2578+79.11 Subdivision 1.Authorized actions.A cannabis wholesaler license entitles the license​
2579+79.12holder to:​
2580+79.13 (1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2581+79.14lower-potency hemp edibles, and hemp-derived consumer products from cannabis​
2582+79.15microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,​
2583+79.16lower-potency hemp edible manufacturers, and industrial hemp growers;​
2584+79.17 (2) sell immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2585+79.18lower-potency hemp edibles, and hemp-derived consumer products to cannabis​
2586+79.19microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, and cannabis retailers;​
2587+79.20 (3) sell lower-potency hemp edibles to lower-potency hemp edible retailers;​
2588+79.21 (4) import lower-potency hemp edibles and hemp-derived consumer products that contain​
2589+79.22hemp concentrate or artificially derived cannabinoids that are derived from hemp plants or​
2590+79.23hemp plant parts; and​
2591+79.24 (5) perform other actions approved by the office.​
2592+79.25 Subd. 2.Additional information required.In addition to the information required to​
2593+79.26be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2594+79.27a person, cooperative, or business seeking a cannabis wholesaler license must submit the​
2595+79.28following information in a form approved by the office:​
2596+79.29 (1) an operating plan demonstrating the proposed layout of the facility including a​
2597+79.30diagram of ventilation and filtration systems and policies to avoid sales to unlicensed​
2598+79.31cannabis businesses; and​
2599+79​Article 1 Sec. 33.​
2600+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 80.1 (2) evidence that the business will comply with the applicable operation requirements​
2601+80.2for the license being sought.​
2602+80.3 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2603+80.4cannabis wholesaler license may also hold a cannabis transporter license, a cannabis delivery​
2604+80.5service license, and a cannabis event organizer license.​
2605+80.6 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2606+80.7cannabis wholesaler license may own or operate any other cannabis business or hemp​
2607+80.8business.​
2608+80.9 (c) The office by rule may limit the number of cannabis wholesaler licenses a person or​
2609+80.10business may hold.​
2610+80.11 (d) For purposes of this subdivision, a restriction on the number or type of license a​
2611+80.12business may hold applies to every cooperative member or every director, manager, and​
2612+80.13general partner of a cannabis business.​
2613+80.14Sec. 34. [342.34] CANNABIS WHOLESALER OPERATIONS.​
2614+80.15 Subdivision 1.Separation of products.A cannabis wholesaler must ensure that cannabis​
2615+80.16plants, cannabis flower, and cannabis products are physically separated from all other​
2616+80.17products, including but not limited to lower-potency hemp edibles and hemp-derived​
2617+80.18consumer products, in a manner that prevents any cross-contamination.​
2618+80.19 Subd. 2.Records and labels.A cannabis wholesaler must maintain accurate records​
2619+80.20and ensure that appropriate labels remain affixed to cannabis plants, cannabis flower,​
2620+80.21cannabis products, lower-potency hemp edibles, and hemp-derived consumer products.​
2621+80.22 Subd. 3.Building conditions.(a) A cannabis wholesaler shall maintain compliance​
2622+80.23with state and local building, fire, and zoning requirements or regulations.​
2623+80.24 (b) A cannabis wholesaler shall ensure that the licensed premises is maintained in a​
2624+80.25clean and sanitary condition, free from infestation by insects, rodents, or other pests.​
2625+80.26 Subd. 4.Sale of other products.A cannabis wholesaler may purchase and sell other​
2626+80.27products or items for which the cannabis wholesaler has a license or authorization or that​
2627+80.28do not require a license or authorization. Products for which no license or authorization is​
2628+80.29required include but are not limited to industrial hemp products, products that contain hemp​
2629+80.30grain, hemp-derived topical products, and cannabis paraphernalia, including but not limited​
2630+80.31to childproof packaging containers and other devices designed to ensure the safe storage​
2631+80​Article 1 Sec. 34.​
2632+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 81.1and monitoring of cannabis flower and cannabis products in the home to prevent access by​
2633+81.2individuals under 21 years of age.​
2634+81.3 Subd. 5.Importation of hemp-derived products.(a) A cannabis wholesaler that imports​
2635+81.4lower-potency hemp edibles or hemp-derived consumer products that are manufactured​
2636+81.5outside the boundaries of the state of Minnesota with the intent to sell the products to a​
2637+81.6cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or lower-potency hemp​
2638+81.7edible retailer must obtain a hemp-derived product importer endorsement from the office.​
2639+81.8 (b) A cannabis wholesaler with a hemp-derived product importer endorsement may sell​
2640+81.9products manufactured outside the boundaries of the state of Minnesota if:​
2641+81.10 (1) the manufacturer is licensed in another jurisdiction and subject to regulations designed​
2642+81.11to protect the health and safety of consumers that the office determines are substantially​
2643+81.12similar to the regulations in this state; or​
2644+81.13 (2) the cannabis wholesaler establishes, to the satisfaction of the office, that the​
2645+81.14manufacturer engages in practices that are substantially similar to the practices required for​
2646+81.15licensure of manufacturers in this state.​
2647+81.16 (c) The cannabis wholesaler must enter all relevant information regarding an imported​
2648+81.17hemp-derived consumer product into the statewide monitoring system before the product​
2649+81.18may be distributed. Relevant information includes information regarding the cultivation,​
2650+81.19processing, and testing of the industrial hemp used in the manufacture of the product and​
2651+81.20information regarding the testing of the hemp-derived consumer product. If information​
2652+81.21regarding the industrial hemp or hemp-derived consumer product was submitted to a​
2653+81.22statewide monitoring system used in another state, the office may require submission of​
2654+81.23any information provided to that statewide monitoring system and shall assist in the transfer​
2655+81.24of data from another state as needed and in compliance with any data classification​
2656+81.25established by either state.​
2657+81.26 (d) The office may suspend, revoke, or cancel the endorsement of a distributor who is​
2658+81.27prohibited from distributing products containing cannabinoids in any other jurisdiction,​
2659+81.28convicted of an offense involving the distribution of products containing cannabinoids in​
2660+81.29any other jurisdiction, or found liable for distributing any product that injured customers in​
2661+81.30any other jurisdiction. A cannabis wholesaler shall disclose all relevant information related​
2662+81.31to actions in another jurisdiction. Failure to disclose relevant information may result in​
2663+81.32disciplinary action by the office, including the suspension, revocation, or cancellation of​
2664+81.33an endorsement or license.​
2665+81​Article 1 Sec. 34.​
2666+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 82.1 (e) Notwithstanding any law to the contrary, it shall not be a defense in any civil or​
2667+82.2criminal action that a licensed wholesaler relied on information on a product label or​
2668+82.3otherwise provided by a manufacturer who is not licensed in this state.​
2669+82.4 Sec. 35. [342.35] CANNABIS TRANSPORTER LICENSING.​
2670+82.5 Subdivision 1.Authorized actions.A cannabis transporter license entitles the license​
2671+82.6holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis​
2672+82.7products, artificially derived cannabinoids, hemp plant parts, hemp concentrate,​
2673+82.8lower-potency hemp edibles, and hemp-derived consumer products from cannabis​
2674+82.9microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,​
2675+82.10cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis retailers,​
2676+82.11medical cannabis processors, and industrial hemp growers to cannabis microbusinesses,​
2677+82.12cannabis mezzobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis​
2678+82.13wholesalers, cannabis retailers, lower-potency hemp edible retailers, medical cannabis​
2679+82.14processors, and medical cannabis retailers and perform other actions approved by the office.​
2680+82.15 Subd. 2.Additional information required.In addition to the information required to​
2681+82.16be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2682+82.17a person, cooperative, or business seeking a cannabis transporter license must submit the​
2683+82.18following information in a form approved by the office:​
2684+82.19 (1) an appropriate surety bond, certificate of insurance, qualifications as a self-insurer,​
2685+82.20or other securities or agreements, in the amount of not less than $300,000, for loss of or​
2686+82.21damage to cargo;​
2687+82.22 (2) an appropriate surety bond, certificate of insurance, qualifications as a self-insurer,​
2688+82.23or other securities or agreements, in the amount of not less than $1,000,000, for injury to​
2689+82.24one or more persons in any one accident and, if an accident has resulted in injury to or​
2690+82.25destruction of property, of not less than $100,000 because of such injury to or destruction​
2691+82.26of property of others in any one accident;​
2692+82.27 (3) the number and type of equipment the business will use to transport immature cannabis​
2693+82.28plants and seedlings, cannabis flower, cannabis products, artificially derived cannabinoids,​
2694+82.29hemp plant parts, hemp concentrate, lower-potency hemp edibles, and hemp-derived​
2695+82.30consumer products;​
2696+82.31 (4) a loading, transporting, and unloading plan;​
2697+82.32 (5) a description of the applicant's experience in the distribution or security business;​
2698+82.33and​
2699+82​Article 1 Sec. 35.​
2700+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 83.1 (6) evidence that the business will comply with the applicable operation requirements​
2701+83.2for the license being sought.​
2702+83.3 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2703+83.4cannabis transporter license may also hold a cannabis wholesaler license, a cannabis delivery​
2704+83.5service license, and a cannabis event organizer license.​
2705+83.6 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2706+83.7cannabis transporter license may own or operate any other cannabis business.​
2707+83.8 (c) The office by rule may limit the number of cannabis transporter licenses a person or​
2708+83.9business may hold.​
2709+83.10 (d) For purposes of this subdivision, restrictions on the number or type of license a​
2710+83.11business may hold apply to every cooperative member or every director, manager, and​
2711+83.12general partner of a cannabis business.​
2712+83.13Sec. 36. [342.36] CANNABIS TRANSPORTER OPERATIONS.​
2713+83.14 Subdivision 1.Manifest required.Before transporting immature cannabis plants and​
2714+83.15seedlings, cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant​
2715+83.16parts, hemp concentrate, lower-potency hemp edibles, or hemp-derived consumer products,​
2716+83.17a cannabis transporter shall obtain a shipping manifest on a form established by the office.​
2717+83.18The manifest must be kept with the products at all times and the cannabis transporter must​
2718+83.19maintain a copy of the manifest in its records.​
2719+83.20 Subd. 2.Records of transportation.Records of transportation must be kept for a​
2720+83.21minimum of three years at the cannabis transporter's place of business and are subject to​
2721+83.22inspection upon request by the office or law enforcement agency. Records of transportation​
2722+83.23include the following:​
2723+83.24 (1) copies of transportation manifests for all deliveries;​
2724+83.25 (2) a transportation log documenting the chain of custody for each delivery, including​
2725+83.26every employee and vehicle used during transportation; and​
2726+83.27 (3) financial records showing payment for transportation services.​
2727+83.28 Subd. 3.Storage compartment.Immature cannabis plants and seedlings, cannabis​
2728+83.29flower, cannabis products, artificially derived cannabinoids, hemp plant parts, hemp​
2729+83.30concentrate, lower-potency hemp edibles, and hemp-derived consumer products must be​
2730+83.31transported in a locked, safe, and secure storage compartment that is part of the motor vehicle​
2731+83​Article 1 Sec. 36.​
2732+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 84.1or in a locked storage container that has a separate key or combination pad. Items being​
2733+84.2transported may not be visible from outside the motor vehicle.​
2734+84.3 Subd. 4.Identifying logos or business names prohibited.No vehicle or trailer may​
2735+84.4contain an image depicting the types of items being transported, including but not limited​
2736+84.5to an image depicting a cannabis or hemp leaf, or a name suggesting that the vehicle is used​
2737+84.6in transporting immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2738+84.7artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp​
2739+84.8edibles, or hemp-derived consumer products.​
2740+84.9 Subd. 5.Randomized deliveries.A cannabis transporter shall ensure that all delivery​
2741+84.10times and routes are randomized.​
2742+84.11 Subd. 6.Multiple employees.All cannabis transporter vehicles transporting immature​
2743+84.12cannabis plants and seedlings, cannabis flower, cannabis products, artificially derived​
2744+84.13cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles, or​
2745+84.14hemp-derived consumer products must be staffed with a minimum of two employees. At​
2746+84.15least one delivery team member shall remain with the motor vehicle at all times that the​
2747+84.16motor vehicle contains immature cannabis plants and seedlings, cannabis flower, cannabis​
2748+84.17products, artificially derived cannabinoids, hemp plant parts, hemp concentrate,​
2749+84.18lower-potency hemp edibles, or hemp-derived consumer products.​
2750+84.19 Subd. 7.Nonemployee passengers prohibited.Only a cannabis worker employed by​
2751+84.20or contracted with the cannabis transporter and who is at least 21 years of age may transport​
2752+84.21immature cannabis plants and seedlings, cannabis flower, cannabis products, artificially​
2753+84.22derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles, or​
2754+84.23hemp-derived consumer products. All passengers in a vehicle must be cannabis workers​
2755+84.24employed by or contracted with the cannabis transporter.​
2756+84.25 Subd. 8.Drivers license required.All drivers must carry a valid driver's license with​
2757+84.26the proper endorsements when operating a vehicle transporting immature cannabis plants​
2758+84.27and seedlings, cannabis flower, cannabis products, artificially derived cannabinoids, hemp​
2759+84.28plant parts, hemp concentrate, lower-potency hemp edibles, or hemp-derived consumer​
2760+84.29products.​
2761+84.30 Subd. 9.Vehicles subject to inspection.Any vehicle assigned for the purposes of​
2762+84.31transporting immature cannabis plants and seedlings, cannabis flower, cannabis products,​
2763+84.32artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp​
2764+84.33edibles, or hemp-derived consumer products is subject to inspection and may be stopped​
2765+84.34or inspected at any licensed cannabis business or while en route during transportation.​
2766+84​Article 1 Sec. 36.​
2767+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 85.1 Sec. 37. [342.37] CANNABIS TESTING FACILITY LICENSING.​
2768+85.2 Subdivision 1.Authorized actions.A cannabis testing facility license entitles the license​
2769+85.3holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis​
2770+85.4products, hemp plant parts, hemp concentrate, artificially derived cannabinoids,​
2771+85.5lower-potency hemp edibles, and hemp-derived consumer products from cannabis​
2772+85.6microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,​
2773+85.7cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis​
2774+85.8cultivators, medical cannabis processors, and industrial hemp growers.​
2775+85.9 Subd. 2.Additional information required.In addition to the information required to​
2776+85.10be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2777+85.11a person, cooperative, or business seeking a cannabis testing facility license must submit​
2778+85.12the following information in a form approved by the office:​
2779+85.13 (1) an operating plan demonstrating the proposed layout of the facility, including a​
2780+85.14diagram of ventilation and filtration systems and policies to avoid sales to unlicensed​
2781+85.15businesses;​
2782+85.16 (2) proof of accreditation by a laboratory accrediting organization approved by the office​
2783+85.17that, at a minimum, requires a laboratory to operate formal management systems under the​
2784+85.18International Organization for Standardization; and​
2785+85.19 (3) evidence that the business will comply with the applicable operation requirements​
2786+85.20for the license being sought.​
2787+85.21 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2788+85.22cannabis testing facility license may not own or operate, or be employed by, any other​
2789+85.23cannabis business or hemp business.​
2790+85.24 (b) The office by rule may limit the number of cannabis testing facility licenses a person​
2791+85.25or business may hold.​
2792+85.26 (c) For purposes of this subdivision, a restriction on the number of licenses a business​
2793+85.27may hold applies to every cooperative member or every director, manager, and general​
2794+85.28partner of a cannabis business.​
2795+85.29Sec. 38. [342.38] CANNABIS TESTING FACILITY OPERATIONS.​
2796+85.30 Subdivision 1.Testing services.A cannabis testing facility shall provide some or all​
2797+85.31testing services required under section 342.61 and rules adopted pursuant to that section.​
2798+85​Article 1 Sec. 38.​
2799+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 86.1 Subd. 2.Testing protocols.A cannabis testing facility shall follow all testing protocols,​
2800+86.2standards, and criteria adopted by rule by the office for the testing of different forms of​
2801+86.3cannabis plants and seedlings, cannabis flower, cannabis products, lower-potency hemp​
2802+86.4edibles, hemp-derived consumer products, hemp plant parts, hemp concentrate, and artificially​
2803+86.5derived cannabinoids; determining batch size; sampling; testing validity; and approval and​
2804+86.6disapproval of tested items.​
2805+86.7 Subd. 3.Records.Records of all business transactions and testing results; records​
2806+86.8required to be maintained pursuant to any applicable standards for accreditation; and records​
2807+86.9relevant to testing protocols, standards, and criteria adopted by the office must be kept for​
2808+86.10a minimum of three years at the cannabis testing facility's place of business and are subject​
2809+86.11to inspection upon request by the office or law enforcement agency.​
2810+86.12 Subd. 4.Disposal of cannabis flower and products.A testing facility shall dispose of​
2811+86.13or destroy used, unused, and waste cannabis plants and seedlings, cannabis flower, cannabis​
2812+86.14products, lower-potency hemp edibles, hemp-derived consumer products, hemp plant parts,​
2813+86.15hemp concentrate, and artificially derived cannabinoids pursuant to rules adopted by the​
2814+86.16office.​
2815+86.17Sec. 39. [342.39] CANNABIS EVENT ORGANIZER LICENSING.​
2816+86.18 Subdivision 1.Authorized actions.A cannabis event organizer license entitles the​
2817+86.19license holder to organize a temporary cannabis event lasting no more than four days.​
2818+86.20 Subd. 2.Additional information required.(a) In addition to the information required​
2819+86.21to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that​
2820+86.22section, a person, cooperative, or business seeking a cannabis event organizer license must​
2821+86.23submit the following information in a form approved by the office:​
2822+86.24 (1) the type and number of any other cannabis business license held by the applicant;​
2823+86.25 (2) the address and location where the temporary cannabis event will take place;​
2824+86.26 (3) the name of the temporary cannabis event;​
2825+86.27 (4) a diagram of the physical layout of the temporary cannabis event showing where the​
2826+86.28event will take place on the grounds, all entrances and exits that will be used by participants​
2827+86.29during the event, all cannabis consumption areas, all cannabis retail areas where cannabis​
2828+86.30flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products​
2829+86.31will be sold, the location where cannabis waste will be stored, and any location where​
2830+86.32cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
2831+86.33products will be stored;​
2832+86​Article 1 Sec. 39.​
2833+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 87.1 (5) a list of the name, number, and type of cannabis businesses and hemp businesses​
2834+87.2that will sell cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
2835+87.3lower-potency hemp edibles, and hemp-derived consumer products at the event, which may​
2836+87.4be supplemented or amended within 72 hours of the time at which the cannabis event begins;​
2837+87.5 (6) the dates and hours during which the cannabis event will take place;​
2838+87.6 (7) proof of local approval for the cannabis event; and​
2839+87.7 (8) evidence that the business will comply with the applicable operation requirements​
2840+87.8for the license being sought.​
2841+87.9 (b) A person, cooperative, or business seeking a cannabis event organizer license may​
2842+87.10also disclose whether the person or any officer, director, manager, and general partner of a​
2843+87.11cannabis business is serving or has previously served in the military.​
2844+87.12 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2845+87.13cannabis event organizer license may not hold a cannabis testing facility license, a​
2846+87.14lower-potency hemp edible manufacturer license, or a lower-potency hemp edible retailer​
2847+87.15license.​
2848+87.16 (b) The office by rule may limit the number of cannabis event licenses that a person or​
2849+87.17business may hold.​
2850+87.18 (c) For purposes of this subdivision, restrictions on the number or type of license that a​
2851+87.19business may hold apply to every cooperative member or every director, manager, and​
2852+87.20general partner of a cannabis business.​
2853+87.21Sec. 40. [342.40] CANNABIS EVENT ORGANIZER OPERATIONS.​
2854+87.22 Subdivision 1.Local approval.A cannabis event organizer must receive local approval,​
2855+87.23including obtaining any necessary permits or licenses issued by a local unit of government,​
2856+87.24before holding a cannabis event.​
2857+87.25 Subd. 2.Charging fees.(a) A cannabis event organizer may charge an entrance fee to​
2858+87.26a cannabis event.​
2859+87.27 (b) A cannabis event organizer may charge a fee to a cannabis business or hemp business​
2860+87.28in exchange for space to display and sell cannabis plants, adult-use cannabis flower, adult-use​
2861+87.29cannabis products, lower-potency hemp edibles, and hemp-derived consumer products. Any​
2862+87.30fee paid for participation in a cannabis event shall not be based on or tied to the sale of​
2863+87.31cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency​
2864+87.32hemp edibles, or hemp-derived consumer products.​
2865+87​Article 1 Sec. 40.​
2866+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 88.1 Subd. 3.Security.A cannabis event organizer must hire or contract for licensed security​
2867+88.2personnel to provide security services at the cannabis event. All security personnel hired or​
2868+88.3contracted for shall be at least 21 years of age and present on the licensed event premises​
2869+88.4at all times that cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
2870+88.5lower-potency hemp edibles, or hemp-derived consumer products are available for sale or​
2871+88.6consumption of adult-use cannabis flower, adult-use cannabis products, lower-potency hemp​
2872+88.7edibles, or hemp-derived consumer products is allowed. The security personnel shall not​
2873+88.8consume cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
2874+88.9consumer products for at least 24 hours before the event or during the event.​
2875+88.10 Subd. 4.Limited access to event.A cannabis event organizer shall ensure that access​
2876+88.11to an event is limited to individuals who are at least 21 years of age. At or near each public​
2877+88.12entrance to any area where the sale or consumption of adult-use cannabis flower, adult-use​
2878+88.13cannabis products, lower-potency hemp edibles, or hemp-derived consumer products is​
2879+88.14allowed, a cannabis event organizer shall maintain a clearly visible and legible sign consisting​
2880+88.15of the following statement: "No persons under 21 allowed." The lettering of the sign shall​
2881+88.16be not less than one inch in height.​
2882+88.17 Subd. 5.Cannabis waste.A cannabis event organizer shall ensure that all used, unused,​
2883+88.18and waste cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
2884+88.19lower-potency hemp edibles, and hemp-derived consumer products that are not removed​
2885+88.20by a customer, cannabis business, or hemp business are disposed of in a manner approved​
2886+88.21by the office.​
2887+88.22 Subd. 6.Transportation of cannabis plants, flower, and products.All transportation​
2888+88.23of cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency​
2889+88.24hemp edibles, and hemp-derived consumer products intended for display or sale and all​
2890+88.25such items used for display or not sold during the cannabis event must be transported to​
2891+88.26and from the cannabis event by a licensed cannabis transporter.​
2892+88.27 Subd. 7.Cannabis event sales.(a) Cannabis microbusinesses with a retail endorsement,​
2893+88.28cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and lower-potency​
2894+88.29hemp edible retailers, including the cannabis event organizer, may be authorized to sell​
2895+88.30cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency​
2896+88.31hemp edibles, and hemp-derived consumer products to customers at a cannabis event.​
2897+88.32 (b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
2898+88.33lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must​
2899+88.34take place in a retail area as designated in the premises diagram.​
2900+88​Article 1 Sec. 40.​
2901+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 89.1 (c) Authorized retailers may only conduct sales within their specifically assigned area.​
2902+89.2 (d) Authorized retailers must verify the age of all customers pursuant to section 342.27,​
2903+89.3subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis​
2904+89.4flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
2905+89.5products to an individual under 21 years of age.​
2906+89.6 (e) Authorized retailers may display one sample of each type of cannabis plant, adult-use​
2907+89.7cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived​
2908+89.8consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis​
2909+89.9products must be stored in a sample jar or display case and be accompanied by a label or​
2910+89.10notice containing the information required to be affixed to the packaging or container​
2911+89.11containing adult-use cannabis flower and adult-use cannabis products sold to customers. A​
2912+89.12sample may not consist of more than eight grams of adult-use cannabis flower or adult-use​
2913+89.13cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams​
2914+89.14of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use​
2915+89.15cannabis flower or adult-use cannabis product before purchase.​
2916+89.16 (f) The notice requirements under section 342.27, subdivision 6, apply to authorized​
2917+89.17retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products,​
2918+89.18and hemp-derived consumer products for sale at a cannabis event.​
2919+89.19 (g) Authorized retailers may not:​
2920+89.20 (1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp​
2921+89.21edibles, or hemp-derived consumer products to a person who is visibly intoxicated;​
2922+89.22 (2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis​
2923+89.23products, lower-potency hemp edibles, or hemp-derived consumer products than a customer​
2924+89.24is legally permitted to possess;​
2925+89.25 (3) sell medical cannabis flower or medical cannabinoid products;​
2926+89.26 (4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp​
2927+89.27edibles, or hemp-derived consumer products; or​
2928+89.28 (5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,​
2929+89.29lower-potency hemp edibles, or hemp-derived consumer products in vending machines.​
2930+89.30 (h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis​
2931+89.31product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis​
2932+89.32plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles,​
2933+89.33and hemp-derived consumer products for sale at a cannabis event must be stored in a secure,​
29242934 89​Article 1 Sec. 40.​
2925-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 90.1cannabis products, lower-potency hemp edibles, and hemp-derived consumer products. Any​
2926-90.2fee paid for participation in a cannabis event shall not be based on or tied to the sale of​
2927-90.3cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency​
2928-90.4hemp edibles, or hemp-derived consumer products.​
2929-90.5 Subd. 3.Security.A cannabis event organizer must hire or contract for licensed security​
2930-90.6personnel to provide security services at the cannabis event. All security personnel hired or​
2931-90.7contracted for shall be at least 21 years of age and present on the licensed event premises​
2932-90.8at all times that cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
2933-90.9lower-potency hemp edibles, or hemp-derived consumer products are available for sale or​
2934-90.10consumption of adult-use cannabis flower, adult-use cannabis products, lower-potency hemp​
2935-90.11edibles, or hemp-derived consumer products is allowed. The security personnel shall not​
2936-90.12consume cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
2937-90.13consumer products for at least 24 hours before the event or during the event.​
2938-90.14 Subd. 4.Limited access to event.A cannabis event organizer shall ensure that access​
2939-90.15to an event is limited to individuals who are at least 21 years of age. At or near each public​
2940-90.16entrance to any area where the sale or consumption of adult-use cannabis flower, adult-use​
2941-90.17cannabis products, lower-potency hemp edibles, or hemp-derived consumer products is​
2942-90.18allowed, a cannabis event organizer shall maintain a clearly visible and legible sign consisting​
2943-90.19of the following statement: "No persons under 21 allowed." The lettering of the sign shall​
2944-90.20be not less than one inch in height.​
2945-90.21 Subd. 5.Cannabis waste.A cannabis event organizer shall ensure that all used, unused,​
2946-90.22and waste cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
2947-90.23lower-potency hemp edibles, and hemp-derived consumer products that are not removed​
2948-90.24by a customer, cannabis business, or hemp business are disposed of in a manner approved​
2949-90.25by the office.​
2950-90.26 Subd. 6.Transportation of cannabis plants, flower, and products.All transportation​
2951-90.27of cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency​
2952-90.28hemp edibles, and hemp-derived consumer products intended for display or sale and all​
2953-90.29such items used for display or not sold during the cannabis event must be transported to​
2954-90.30and from the cannabis event by a licensed cannabis transporter.​
2955-90.31 Subd. 7.Cannabis event sales.(a) Cannabis microbusinesses with a retail endorsement,​
2956-90.32cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and lower-potency​
2957-90.33hemp edible retailers, including the cannabis event organizer, may be authorized to sell​
2958-90​Article 1 Sec. 40.​
2959-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 91.1cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency​
2960-91.2hemp edibles, and hemp-derived consumer products to customers at a cannabis event.​
2961-91.3 (b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
2962-91.4lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must​
2963-91.5take place in a retail area as designated in the premises diagram.​
2964-91.6 (c) Authorized retailers may only conduct sales within their specifically assigned area.​
2965-91.7 (d) Authorized retailers must verify the age of all customers pursuant to section 342.27,​
2966-91.8subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis​
2967-91.9flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
2968-91.10products to an individual under 21 years of age.​
2969-91.11 (e) Authorized retailers may display one sample of each type of cannabis plant, adult-use​
2970-91.12cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived​
2971-91.13consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis​
2972-91.14products must be stored in a sample jar or display case and be accompanied by a label or​
2973-91.15notice containing the information required to be affixed to the packaging or container​
2974-91.16containing adult-use cannabis flower and adult-use cannabis products sold to customers. A​
2975-91.17sample may not consist of more than eight grams of adult-use cannabis flower or adult-use​
2976-91.18cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams​
2977-91.19of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use​
2978-91.20cannabis flower or adult-use cannabis product before purchase.​
2979-91.21 (f) The notice requirements under section 342.27, subdivision 6, apply to authorized​
2980-91.22retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products,​
2981-91.23and hemp-derived consumer products for sale at a cannabis event.​
2982-91.24 (g) Authorized retailers may not:​
2983-91.25 (1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp​
2984-91.26edibles, or hemp-derived consumer products to a person who is visibly intoxicated;​
2985-91.27 (2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis​
2986-91.28products, lower-potency hemp edibles, or hemp-derived consumer products than a customer​
2987-91.29is legally permitted to possess;​
2988-91.30 (3) sell medical cannabis flower or medical cannabinoid products;​
2989-91.31 (4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp​
2990-91.32edibles, or hemp-derived consumer products; or​
2991-91​Article 1 Sec. 40.​
2992-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 92.1 (5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,​
2993-92.2lower-potency hemp edibles, or hemp-derived consumer products in vending machines.​
2994-92.3 (h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis​
2995-92.4product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis​
2996-92.5plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles,​
2997-92.6and hemp-derived consumer products for sale at a cannabis event must be stored in a secure,​
2998-92.7locked container that is not accessible to the public. Such items being stored at a cannabis​
2999-92.8event shall not be left unattended.​
3000-92.9 (i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
3001-92.10lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis​
3002-92.11event must comply with this chapter and rules adopted pursuant to this chapter regarding​
3003-92.12the testing, packaging, and labeling of those items.​
3004-92.13 (j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold,​
3005-92.14damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring​
3006-92.15system.​
3007-92.16 Subd. 8.Cannabis event on-site consumption.(a) If approved by the local unit of​
3008-92.17government, a cannabis event may designate an area for consumption of adult-use cannabis​
3009-92.18flower, adult-use cannabis products, lower-potency hemp edibles, hemp-derived consumer​
3010-92.19products, or any combination of those items.​
3011-92.20 (b) Access to areas where consumption of adult-use cannabis flower, adult-use cannabis​
3012-92.21products, lower-potency hemp edibles, or hemp-derived consumer products is allowed shall​
3013-92.22be restricted to individuals who are at least 21 years of age.​
3014-92.23 (c) The cannabis event organizer shall ensure that consumption of adult-use cannabis​
3015-92.24flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
3016-92.25products within a designated consumption area is not visible from any public place.​
3017-92.26 (d) The cannabis event organizer shall not permit consumption of alcohol or tobacco.​
3018-92.27 (e) The cannabis event organizer shall not permit smoking, according to section 144.413,​
3019-92.28of adult-use cannabis flower or cannabis products at any location where smoking is not​
3020-92.29permitted under sections 144.413 to 144.417. Nothing in this section prohibits a statutory​
3021-92.30or home rule charter city or county from enacting and enforcing more stringent measures​
3022-92.31to protect individuals from secondhand smoke or involuntary exposure to aerosol or vapor​
3023-92.32from electronic delivery devices.​
3024-92​Article 1 Sec. 40.​
3025-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 93.1 Sec. 41. [342.41] CANNABIS DELIVERY SERVICE LICENSING.​
3026-93.2 Subdivision 1.Authorized actions.A cannabis delivery service license entitles the​
3027-93.3license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles,​
3028-93.4and hemp-derived consumer products from licensed cannabis microbusinesses with a retail​
3029-93.5endorsement, cannabis mezzobusinesses with a retail endorsement, cannabis retailers,​
3030-93.6medical cannabis retailers, and medical cannabis combination businesses; transport and​
3031-93.7deliver cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived​
3032-93.8consumable products to customers; and perform other actions approved by the office.​
3033-93.9 Subd. 2.Additional information required.In addition to the information required to​
3034-93.10be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
3035-93.11a person, cooperative, or business seeking a cannabis delivery service license must submit​
3036-93.12the following information in a form approved by the office:​
3037-93.13 (1) a list of all vehicles to be used in the delivery of cannabis flower, cannabis products,​
3038-93.14lower-potency hemp edibles, and hemp-derived consumer products including:​
3039-93.15 (i) the vehicle make, model, and color;​
3040-93.16 (ii) the vehicle identification number; and​
3041-93.17 (iii) the license plate number;​
3042-93.18 (2) proof of insurance for each vehicle;​
3043-93.19 (3) a business plan demonstrating policies to avoid sales of cannabis flower, cannabis​
3044-93.20products, lower-potency hemp edibles, and hemp-derived consumer products to individuals​
3045-93.21who are under 21 years of age and plans to prevent the visibility of cannabis flower, cannabis​
3046-93.22products, lower-potency hemp edibles, and hemp-derived consumer products to individuals​
3047-93.23outside the delivery vehicle; and​
3048-93.24 (4) evidence that the business will comply with the applicable operation requirements​
3049-93.25for the license being sought.​
3050-93.26 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
3051-93.27cannabis delivery service license may also hold a cannabis retailer license, a cannabis​
3052-93.28wholesaler license, a cannabis transporter license, a cannabis event organizer license, and​
3053-93.29a medical cannabis retailer license subject to the ownership limitations that apply to those​
3054-93.30licenses.​
3055-93​Article 1 Sec. 41.​
3056-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 94.1 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
3057-94.2cannabis delivery service license may own or operate any other cannabis business or hemp​
3058-94.3business.​
3059-94.4 (c) The office by rule may limit the number of cannabis delivery service licenses that a​
3060-94.5person or business may hold.​
3061-94.6 (d) For purposes of this subdivision, a restriction on the number or type of license that​
3062-94.7a business may hold applies to every cooperative member or every director, manager, and​
3063-94.8general partner of a cannabis business.​
3064-94.9 Sec. 42. [342.42] CANNABIS DELIVERY SERVICE OPERATIONS.​
3065-94.10 Subdivision 1.Age or registry verification.Prior to completing a delivery, a cannabis​
3066-94.11delivery service shall verify that the customer is at least 21 years of age or is enrolled in the​
3067-94.12registry program. Section 342.27, subdivision 4, applies to the verification of a customer's​
3068-94.13age. Registry verification issued by the Division of Medical Cannabis may be considered​
3069-94.14evidence that the person is enrolled in the registry program.​
3070-94.15 Subd. 2.Records.The office by rule shall establish record-keeping requirements for a​
3071-94.16cannabis delivery service, including but not limited to proof of delivery to individuals who​
3072-94.17are at least 21 years of age or enrolled in the registry program.​
3073-94.18 Subd. 3.Amount to be transported.The office by rule shall establish limits on the​
3074-94.19amount of cannabis flower, cannabis products, lower-potency hemp edibles, and​
3075-94.20hemp-derived consumer products that a cannabis delivery service may transport.​
3076-94.21 Subd. 4.Statewide monitoring system.Receipt of cannabis flower and cannabis products​
3077-94.22by the cannabis delivery service and a delivery to a customer must be recorded in the​
3078-94.23statewide monitoring system within the time established by rule.​
3079-94.24 Subd. 5.Storage compartment.Cannabis flower, cannabis products, lower-potency​
3080-94.25hemp edibles, and hemp-derived consumer products must be transported in a locked, safe,​
3081-94.26and secure storage compartment that is part of the cannabis delivery service vehicle or in a​
3082-94.27locked storage container that has a separate key or combination pad. Cannabis flower,​
3083-94.28cannabis products, lower-potency hemp edibles, and hemp-derived consumer products may​
3084-94.29not be visible from outside the cannabis delivery service vehicle.​
3085-94.30 Subd. 6.Identifying logos or business names prohibited.No cannabis delivery service​
3086-94.31vehicle or trailer may contain an image depicting the types of items being transported,​
3087-94.32including but not limited to an image depicting a cannabis or hemp leaf, or a name suggesting​
3088-94​Article 1 Sec. 42.​
3089-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 95.1that the cannabis delivery service vehicle is used for transporting cannabis flower, cannabis​
3090-95.2products, lower-potency hemp edibles, and hemp-derived consumer products.​
3091-95.3 Subd. 7.Nonemployee passengers prohibited.Only a cannabis worker employed by​
3092-95.4or contracted with the cannabis delivery service and who is at least 21 years of age may​
3093-95.5transport cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived​
3094-95.6consumer products. All passengers in a cannabis delivery service vehicle must be cannabis​
3095-95.7workers employed by or contracted with the cannabis delivery service.​
3096-95.8 Subd. 8.Vehicles subject to inspection.Any cannabis delivery service vehicle is subject​
3097-95.9to inspection at any time.​
3098-95.10Sec. 43. [342.43] HEMP BUSINESS LICENSE TYPES; MULTIPLE LICENSES.​
3099-95.11 Subdivision 1.License types.The office shall issue the following types of hemp business​
3100-95.12licenses:​
3101-95.13 (1) lower-potency hemp edible manufacturer; and​
3102-95.14 (2) lower-potency hemp edible retailer.​
3103-95.15 Subd. 2.Multiple licenses; limits.(a) A person, cooperative, or business may hold both​
3104-95.16a lower-potency hemp edible manufacturer and lower-potency hemp edible retailer license.​
3105-95.17 (b) Nothing in this section prohibits a person, cooperative, or business from holding a​
3106-95.18lower-potency hemp edible manufacturer license, a lower-potency hemp edible retailer​
3107-95.19license, or both, and also holding a license to cultivate industrial hemp issued pursuant to​
3108-95.20chapter 18K.​
3109-95.21 (c) Nothing in this section prohibits a person, cooperative, or business from holding a​
3110-95.22lower-potency hemp edible manufacturer license, a lower-potency hemp edible retailer​
3111-95.23license, or both, and also holding any other license, including but not limited to a license​
3112-95.24to prepare or sell food; sell tobacco, tobacco-related devices, electronic delivery devices as​
3113-95.25defined in section 609.685, subdivision 1, and nicotine and lobelia delivery products as​
3114-95.26described in section 609.6855; or manufacture or sell alcoholic beverages as defined in​
3115-95.27section 340A.101, subdivision 2.​
3116-95.28 (d) A person, cooperative, or business holding a lower-potency hemp edible manufacturer​
3117-95.29license, a lower-potency hemp edible retailer license, or both, may not hold a cannabis​
3118-95.30business license.​
3119-95​Article 1 Sec. 43.​
3120-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 96.1 Sec. 44. [342.44] HEMP BUSINESS LICENSES; APPLICATIONS AND ISSUANCE.​
3121-96.2 Subdivision 1.Application; contents.(a) Except as otherwise provided in this​
3122-96.3subdivision, the provisions of this chapter relating to license applications, license selection​
3123-96.4criteria, general ownership disqualifications and requirements, and general operational​
3124-96.5requirements do not apply to hemp businesses.​
3125-96.6 (b) The office, by rule, shall establish forms and procedures for the processing of hemp​
3126-96.7licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp​
3127-96.8license shall include the following information, if applicable:​
3128-96.9 (1) the name, address, and date of birth of the applicant;​
3129-96.10 (2) the address and legal property description of the business;​
3130-96.11 (3) proof of trade name registration;​
3131-96.12 (4) certification that the applicant will comply with the requirements of this chapter​
3132-96.13relating to the ownership and operation of a hemp business;​
3133-96.14 (5) identification of one or more controlling persons or managerial employees as agents​
3134-96.15who shall be responsible for dealing with the office on all matters; and​
3135-96.16 (6) a statement that the applicant agrees to respond to the office's supplemental requests​
3136-96.17for information.​
3137-96.18 (c) An applicant for a lower-potency hemp edible manufacturer license must submit an​
3138-96.19attestation signed by a bona fide labor organization stating that the applicant has entered​
3139-96.20into a labor peace agreement.​
3140-96.21 (d) An application on behalf of a corporation or association shall be signed by at least​
3141-96.22two officers or managing agents of that entity.​
3142-96.23 Subd. 2.Issuance; eligibility; prohibition on transfer.(a) The office may issue a hemp​
3143-96.24license to an applicant who:​
3144-96.25 (1) is at least 21 years of age;​
3145-96.26 (2) has completed an application for licensure or application for renewal and has fully​
3146-96.27and truthfully complied with all information requests relating to license application and​
3147-96.28renewal;​
3148-96.29 (3) has paid the applicable application and license fees pursuant to section 342.11;​
3149-96.30 (4) is not employed by the office or any state agency with regulatory authority over this​
3150-96.31chapter; and​
3151-96​Article 1 Sec. 44.​
3152-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 97.1 (5) does not hold any cannabis business license.​
3153-97.2 (b) Licenses must be renewed annually.​
3154-97.3 (c) Licenses may not be transferred.​
3155-97.4 Sec. 45. [342.45] LOWER-POTENCY HEMP EDIBLE MANUFACTURER.​
3156-97.5 Subdivision 1.Authorized actions.A lower-potency hemp edible manufacturer license​
3157-97.6entitles the license holder to:​
3158-97.7 (1) purchase hemp plant parts, hemp concentrate, and artificially derived cannabinoids​
3159-97.8from cannabis microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, cannabis​
3160-97.9wholesalers, and lower-potency hemp edible manufacturers;​
3161-97.10 (2) purchase hemp plant parts and propagules from industrial hemp growers licensed​
3162-97.11under chapter 18K;​
3163-97.12 (3) purchase hemp concentrate from an industrial hemp processor licensed under chapter​
3164-97.1318K;​
3165-97.14 (4) make hemp concentrate;​
3166-97.15 (5) manufacture artificially derived cannabinoids;​
3167-97.16 (6) manufacture lower-potency hemp edibles for public consumption;​
3168-97.17 (7) package and label lower-potency hemp edibles for sale to customers;​
3169-97.18 (8) sell hemp concentrate, artificially derived cannabinoids, and lower-potency hemp​
3170-97.19edibles to other cannabis businesses and hemp businesses; and​
3171-97.20 (9) perform other actions approved by the office.​
3172-97.21 Subd. 2.All manufacturer operations.(a) All hemp manufacturing must take place in​
3173-97.22a facility and on equipment that meets the applicable health and safety requirements​
3174-97.23established by the office, including requirements for cleaning and testing machinery between​
3175-97.24production of different products.​
3176-97.25 (b) A lower-potency hemp edible manufacturer must comply with all applicable​
3177-97.26packaging, labeling, and testing requirements.​
3178-97.27 Subd. 3.Extraction and concentration.(a) A lower-potency hemp edible manufacturer​
3179-97.28that creates hemp concentrate or artificially derived cannabinoids must obtain an endorsement​
3180-97.29from the office.​
3181-97​Article 1 Sec. 45.​
3182-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 98.1 (b) A lower-potency hemp edible manufacturer seeking an endorsement to create hemp​
3183-98.2concentrate must inform the office of all methods of extraction and concentration that the​
3184-98.3manufacturer intends to use and identify the volatile chemicals, if any, that will be involved​
3185-98.4in the creation of hemp concentrate. A lower-potency hemp edible manufacturer may not​
3186-98.5use a method of extraction and concentration or a volatile chemical without approval by​
3187-98.6the office.​
3188-98.7 (c) A lower-potency hemp edible manufacturer seeking an endorsement to create​
3189-98.8artificially derived cannabinoids must inform the office of all methods of conversion that​
3190-98.9the manufacturer will use, including any specific catalysts that the manufacturer will employ,​
3191-98.10to create artificially derived cannabinoids and the molecular nomenclature of all cannabinoids​
3192-98.11or other chemical compounds that the manufacturer will create. A business licensed or​
3193-98.12authorized to manufacture lower-potency hemp edibles may not use a method of conversion​
3194-98.13or a catalyst without approval by the office.​
3195-98.14 (d) A lower-potency hemp edible manufacturer must obtain a certification from an​
3196-98.15independent third-party industrial hygienist or professional engineer approving:​
3197-98.16 (1) all electrical, gas, fire suppression, and exhaust systems; and​
3198-98.17 (2) the plan for safe storage and disposal of hazardous substances, including but not​
3199-98.18limited to any volatile chemicals.​
3200-98.19 (e) Upon the sale of hemp concentrate or artificially derived cannabinoids to any person,​
3201-98.20cooperative, or business, a lower-potency hemp edible manufacturer must provide a statement​
3202-98.21to the buyer that discloses the method of extraction and concentration or conversion used​
3203-98.22and any solvents, gases, or catalysts, including but not limited to any volatile chemicals​
3204-98.23involved in that method.​
3205-98.24 Subd. 4.Production of consumer products.(a) A lower-potency hemp edible​
3206-98.25manufacturer that produces lower-potency hemp edibles must obtain an edible cannabinoid​
3207-98.26product handler endorsement from the office.​
3208-98.27 (b) All areas within the premises of a lower-potency hemp edible manufacturer used for​
3209-98.28producing lower-potency hemp edibles must meet the sanitary standards specified in rules​
3210-98.29adopted by the office.​
3211-98.30 (c) A lower-potency hemp edible manufacturer may only add chemicals or compounds​
3212-98.31approved by the office to hemp concentrate or artificially derived cannabinoids.​
3213-98.32 (d) Upon the sale of any lower-potency hemp edible to a cannabis business or hemp​
3214-98.33business, a lower-potency hemp edible manufacturer must provide a statement to the buyer​
3215-98​Article 1 Sec. 45.​
3216-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 99.1that discloses the product's ingredients, including but not limited to any chemicals or​
3217-99.2compounds and any major food allergens declared by name.​
3218-99.3 (e) A lower-potency hemp edible manufacturer shall not add any artificially derived​
3219-99.4cannabinoid, hemp plant part, or hemp concentrate to a product if the manufacturer of the​
3220-99.5product holds a trademark to the product's name, except that a lower-potency hemp edible​
3221-99.6manufacturer may use a trademarked food product if the manufacturer uses the product as​
3222-99.7a component or as part of a recipe and if the lower-potency hemp edible manufacturer does​
3223-99.8not state or advertise to the customer that the final retail lower-potency hemp edible contains​
3224-99.9a trademarked food product.​
3225-99.10 (f) A lower-potency hemp edible manufacturer shall not add any cannabis flower,​
3226-99.11cannabis concentrate, or cannabinoid derived from cannabis flower or cannabis concentrate​
3227-99.12to a product.​
3228-99.13 Subd. 5.Transportation of hemp concentrate, artificially derived cannabinoids,​
3229-99.14and lower-potency hemp edibles.(a) A lower-potency hemp edible manufacturer may​
3230-99.15transport hemp concentrate, artificially derived cannabinoids, and lower-potency hemp​
3231-99.16edibles on public roadways provided:​
3232-99.17 (1) the artificially derived cannabinoids, hemp concentrate, or lower-potency hemp​
3233-99.18edibles are in a locked, safe, and secure storage compartment that is part of the motor vehicle​
3234-99.19or in a locked storage container that has a separate key or combination pad;​
3235-99.20 (2) the artificially derived cannabinoids, hemp concentrate, or lower-potency hemp​
3236-99.21edibles are packaged in tamper-evident containers that are not visible or recognizable from​
3237-99.22outside the transporting vehicle;​
3238-99.23 (3) the lower-potency hemp edible manufacturer has a shipping manifest in the​
3239-99.24lower-potency hemp edible manufacturer's possession that describes the contents of all​
3240-99.25tamper-evident containers;​
3241-99.26 (4) all departures, arrivals, and stops are appropriately documented;​
3242-99.27 (5) no person other than a designated employee enters a vehicle at any time that the​
3243-99.28vehicle is transporting artificially derived cannabinoids, hemp concentrate, or lower-potency​
3244-99.29hemp edibles; and​
3245-99.30 (6) the lower-potency hemp edible manufacturer complies with any other rules adopted​
3246-99.31by the office.​
3247-99.32 (b) Any vehicle assigned for the purposes of transporting artificially derived cannabinoids,​
3248-99.33hemp concentrate, or lower-potency hemp edibles is subject to inspection at any time.​
3249-99​Article 1 Sec. 45.​
3250-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 100.1Sec. 46. [342.46] LOWER-POTENCY HEMP EDIBLE RETAILER.​
3251-100.2 Subdivision 1.Sale of lower-potency hemp edibles.(a) A lower-potency hemp edible​
3252-100.3retailer may only sell lower-potency hemp edibles to individuals who are at least 21 years​
3253-100.4of age.​
3254-100.5 (b) A lower-potency hemp edible retailer may sell lower-potency hemp edibles that:​
3255-100.6 (1) are obtained from a licensed Minnesota cannabis microbusiness, cannabis​
3256-100.7mezzobusiness, cannabis manufacturer, cannabis wholesaler, or lower-potency hemp edible​
3257-100.8manufacturer; and​
3258-100.9 (2) meet all applicable packaging and labeling requirements.​
3259-100.10 Subd. 2.Sale of other products.A lower-potency hemp edible retailer may sell other​
3260-100.11products or items for which the lower-potency hemp edible retailer has a license or​
3261-100.12authorization or that do not require a license or authorization.​
3262-100.13 Subd. 3.Age verification.Prior to initiating a sale, an employee of the lower-potency​
3263-100.14hemp edible retailer must verify that the customer is at least 21 years of age. Section 342.27,​
3264-100.15subdivision 4, applies to the verification of a customer's age.​
3265-100.16 Subd. 4.Display and storage of lower-potency hemp edibles.A lower-potency hemp​
3266-100.17edible retailer shall ensure that all lower-potency hemp edibles, other than lower-potency​
3267-100.18hemp edibles that are intended to be consumed as a beverage, are displayed behind a checkout​
3268-100.19counter where the public is not permitted or in a locked case. All lower-potency hemp​
3269-100.20edibles that are not displayed must be stored in a secure area.​
3270-100.21 Subd. 5.Transportation of lower-potency hemp edibles.(a) A lower-potency hemp​
3271-100.22edible retailer may transport lower-potency hemp edibles on public roadways provided:​
3272-100.23 (1) the lower-potency hemp edibles are in final packaging;​
3273-100.24 (2) the lower-potency hemp edibles are packaged in tamper-evident containers that are​
3274-100.25not visible or recognizable from outside the transporting vehicle;​
3275-100.26 (3) the lower-potency hemp edible retailer has a shipping manifest in the lower-potency​
3276-100.27hemp edible retailer's possession that describes the contents of all tamper-evident containers;​
3277-100.28 (4) all departures, arrivals, and stops are appropriately documented;​
3278-100.29 (5) no person other than a designated employee enters a vehicle at any time that the​
3279-100.30vehicle is transporting lower-potency hemp edibles; and​
3280-100​Article 1 Sec. 46.​
3281-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 101.1 (6) the lower-potency hemp edible retailer complies with any other rules adopted by the​
3282-101.2office.​
3283-101.3 (b) Any vehicle assigned for the purposes of transporting lower-potency hemp edibles​
3284-101.4is subject to inspection at any time.​
3285-101.5 Subd. 6.Compliant products.(a) A lower-potency hemp edible retailer shall ensure​
3286-101.6that all lower-potency hemp edibles offered for sale comply with the limits on the amount​
3287-101.7and types of cannabinoids that a lower-potency hemp edible can contain, including but not​
3288-101.8limited to the requirement that lower-potency hemp edibles:​
3289-101.9 (1) consist of servings that contain no more than five milligrams of delta-9​
3290-101.10tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams​
3291-101.11of cannabigerol, or any combination of those cannabinoids that does not exceed the identified​
3292-101.12amounts;​
3293-101.13 (2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids​
3294-101.14per serving; and​
3295-101.15 (3) do not contain an artificially derived cannabinoid other than delta-9​
3296-101.16tetrahydrocannabinol.​
3297-101.17 (b) If a lower-potency hemp edible is packaged in a manner that includes more than a​
3298-101.18single serving, the lower-potency hemp edible must indicate each serving by scoring,​
3299-101.19wrapping, or other indicators that appear on the lower-potency hemp edible designating the​
3300-101.20individual serving size. If it is not possible to indicate a single serving by scoring or use of​
3301-101.21another indicator that appears on the product, the lower-potency hemp edible may not be​
3302-101.22packaged in a manner that includes more than a single serving in each container. If the​
3303-101.23lower-potency hemp edible is meant to be consumed as a beverage, the beverage container​
3304-101.24may not contain more than two servings per container.​
3305-101.25 (c) A single package containing multiple servings of a lower-potency hemp edible must​
3306-101.26contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams of​
3307-101.27cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids that​
3308-101.28does not exceed the identified amounts.​
3309-101.29 Subd. 7.Prohibitions.A lower-potency hemp edible retailer may not:​
3310-101.30 (1) sell lower-potency hemp edibles to an individual who is under 21 years of age;​
3311-101.31 (2) sell a lower-potency hemp edible to a person who is visibly intoxicated;​
3312-101.32 (3) sell cannabis flower, cannabis products, or hemp-derived consumer products;​
3313-101​Article 1 Sec. 46.​
3314-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 102.1 (4) allow for the dispensing of lower-potency hemp edibles in vending machines; or​
3315-102.2 (5) distribute or allow free samples of lower-potency hemp edibles except when the​
3316-102.3business is licensed to permit on-site consumption and samples are consumed within its​
3317-102.4licensed premises.​
3318-102.5 Subd. 8.On-site consumption.(a) A lower-potency hemp edible retailer may permit​
3319-102.6on-site consumption of lower-potency hemp edibles on a portion of its premises if it has an​
3320-102.7on-site consumption endorsement.​
3321-102.8 (b) The office shall issue an on-site consumption endorsement to any lower-potency​
3322-102.9hemp edible retailer that also holds an on-sale license issued under chapter 340A.​
3323-102.10 (c) A lower-potency hemp edible retailer must ensure that lower-potency hemp edibles​
3324-102.11sold for on-site consumption comply with this chapter and rules adopted pursuant to this​
3325-102.12chapter regarding testing.​
3326-102.13 (d) Lower-potency hemp edibles sold for on-site consumption, other than lower-potency​
3327-102.14hemp edibles that are intended to be consumed as a beverage, must be served in the required​
3328-102.15packaging, but may be removed from the products' packaging by customers and consumed​
3329-102.16on site.​
3330-102.17 (e) Lower-potency hemp edibles that are intended to be consumed as a beverage may​
3331-102.18be served outside of their packaging provided that the information that is required to be​
3332-102.19contained on the label of a lower-potency hemp edible is posted or otherwise displayed by​
3333-102.20the lower-potency hemp edible retailer. Hemp workers who serve beverages under this​
3334-102.21paragraph are not required to obtain an edible cannabinoid product handler endorsement​
3335-102.22under section 342.07, subdivision 3.​
3336-102.23 (f) Food and beverages not otherwise prohibited by this subdivision may be prepared​
3337-102.24and sold on site provided that the lower-potency hemp edible retailer complies with all​
3338-102.25relevant state and local laws, ordinances, licensing requirements, and zoning requirements.​
3339-102.26 (g) A lower-potency hemp edible retailer may offer recorded or live entertainment​
3340-102.27provided that the lower-potency hemp edible retailer complies with all relevant state and​
3341-102.28local laws, ordinances, licensing requirements, and zoning requirements.​
3342-102.29 (h) In addition to the prohibitions under subdivision 7, a lower-potency hemp edible​
3343-102.30retailer with an on-site consumption endorsement may not:​
3344-102.31 (1) sell lower-potency hemp edibles to a customer who the lower-potency hemp edible​
3345-102.32retailer knows or reasonably should know is intoxicated or has consumed alcohol within​
3346-102.33the previous five hours;​
3347-102​Article 1 Sec. 46.​
3348-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 103.1 (2) sell lower-potency hemp edibles that are designed or reasonably expected to be mixed​
3349-103.2with an alcoholic beverage; or​
3350-103.3 (3) permit lower-potency hemp edibles that have been removed from the products'​
3351-103.4packaging to be removed from the premises of the lower-potency hemp edible retailer.​
3352-103.5 Subd. 9.Posting of notices.A lower-potency hemp edible retailer must post all notices​
3353-103.6as provided in section 342.27, subdivision 6.​
3354-103.7 Subd. 10.Building conditions.(a) A lower-potency hemp edible retailer shall maintain​
3355-103.8compliance with state and local building, fire, and zoning codes, requirements, or regulations.​
3356-103.9 (b) A lower-potency hemp edible retailer shall ensure that the licensed premises is​
3357-103.10maintained in a clean and sanitary condition, free from infestation by insects, rodents, or​
3358-103.11other pests.​
3359-103.12 Subd. 11.Enforcement.The office shall inspect lower-potency hemp edible retailers​
3360-103.13and take enforcement action as provided in sections 342.19 and 342.21.​
3361-103.14Sec. 47. [342.47] MEDICAL CANNABIS BUSINESS LICENSES.​
3362-103.15 Subdivision 1.License types.(a) The office shall issue the following types of medical​
3363-103.16cannabis business licenses:​
3364-103.17 (1) medical cannabis cultivator;​
3365-103.18 (2) medical cannabis processor;​
3366-103.19 (3) medical cannabis retailer; and​
3367-103.20 (4) medical cannabis combination business license.​
3368-103.21 (b) The Division of Medical Cannabis may oversee the licensing and regulation of​
3369-103.22medical cannabis businesses.​
3370-103.23 Subd. 2.Multiple licenses; limits.(a) Except as provided in subdivision 3, a person,​
3371-103.24cooperative, or business holding:​
3372-103.25 (1) a medical cannabis cultivator license may also hold a medical cannabis processor​
3373-103.26license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event​
3374-103.27organizer license subject to the ownership limitations that apply to those licenses;​
3375-103.28 (2) a medical cannabis processor license may also hold a medical cannabis cultivator​
3376-103.29license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event​
3377-103.30organizer license subject to the ownership limitations that apply to those licenses; or​
3378-103​Article 1 Sec. 47.​
3379-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 104.1 (3) a medical cannabis retailer license may also hold a cannabis mezzobusiness license,​
3380-104.2a cannabis retailer license, a cannabis delivery service license, and a cannabis event organizer​
3381-104.3license subject to the ownership limitations that apply to those licenses.​
3382-104.4 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
3383-104.5medical cannabis license may own or operate any other cannabis business or hemp business.​
3384-104.6 (c) The office by rule may limit the number of medical cannabis business licenses that​
3385-104.7a person or business may hold.​
3386-104.8 (d) For purposes of this subdivision, a restriction on the number of licenses or type of​
3387-104.9license that a business may hold applies to every cooperative member or every director,​
3388-104.10manager, and general partner of a medical cannabis business.​
3389-104.11 Subd. 3.Medical cannabis combination business license.(a) A person, cooperative,​
3390-104.12or business holding a medical cannabis combination license is prohibited from owning or​
3391-104.13operating any other cannabis business or hemp business.​
3392-104.14 (b) A person or business may only hold one medical cannabis combination license.​
3393-104.15 EFFECTIVE DATE.This section is effective March 1, 2025.​
3394-104.16Sec. 48. [342.48] MEDICAL CANNABIS BUSINESS APPLICATIONS.​
3395-104.17 In addition to the information required to be submitted under section 342.14, subdivision​
3396-104.181, and rules adopted pursuant to that section, a person, cooperative, or business seeking a​
3397-104.19medical cannabis business license must submit the following information in a form approved​
3398-104.20by the office:​
3399-104.21 (1) for medical cannabis cultivator license applicants:​
3400-104.22 (i) an operating plan demonstrating the proposed size and layout of the cultivation facility;​
3401-104.23plans for wastewater and waste disposal for the cultivation facility; plans for providing​
3402-104.24electricity, water, and other utilities necessary for the normal operation of the cultivation​
3403-104.25facility; and plans for compliance with applicable building code and federal and state​
3404-104.26environmental and workplace safety requirements;​
3405-104.27 (ii) a cultivation plan demonstrating the proposed size and layout of the cultivation​
3406-104.28facility that will be used exclusively for cultivation for medical cannabis, including the total​
3407-104.29amount of plant canopy; and​
3408-104.30 (iii) evidence that the business will comply with the applicable operation requirements​
3409-104.31for the license being sought;​
3410-104​Article 1 Sec. 48.​
3411-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 105.1 (2) for medical cannabis processor license applicants:​
3412-105.2 (i) an operating plan demonstrating the proposed layout of the facility, including a​
3413-105.3diagram of ventilation and filtration systems; plans for wastewater and waste disposal for​
3414-105.4the manufacturing facility; plans for providing electricity, water, and other utilities necessary​
3415-105.5for the normal operation of the manufacturing facility; and plans for compliance with​
3416-105.6applicable building code and federal and state environmental and workplace safety​
3417-105.7requirements;​
3418-105.8 (ii) all methods of extraction and concentration that the applicant intends to use and the​
3419-105.9volatile chemicals, if any, that are involved in extraction or concentration;​
3420-105.10 (iii) if the applicant is seeking an endorsement to manufacture products infused with​
3421-105.11cannabinoids for consumption by patients enrolled in the registry program, proof of an​
3422-105.12edible cannabinoid product handler endorsement from the office; and​
3423-105.13 (iv) evidence that the applicant will comply with the applicable operation requirements​
3424-105.14for the license being sought;​
3425-105.15 (3) for medical cannabis retailer license applicants:​
3426-105.16 (i) a list of every retail license held by the applicant and, if the applicant is a business,​
3427-105.17every retail license held, either as an individual or as part of another business, by each​
3428-105.18officer, director, manager, and general partner of the cannabis business;​
3429-105.19 (ii) an operating plan demonstrating the proposed layout of the facility, including a​
3430-105.20diagram of ventilation and filtration systems, policies to avoid sales to individuals who are​
3431-105.21not authorized to receive the distribution of medical cannabis flower or medical cannabinoid​
3432-105.22products, identification of a restricted area for storage, and plans to prevent the visibility of​
3433-105.23cannabis flower and cannabinoid products; and​
3434-105.24 (iii) evidence that the applicant will comply with the applicable operation requirements​
3435-105.25for the license being sought; or​
3436-105.26 (4) for medical cannabis combination license applicants:​
3437-105.27 (i) the information required under clauses (1) to (3); and​
3438-105.28 (ii) any additional information required under sections 342.30, subdivision 3; 342.31,​
3439-105.29subdivision 3; and 342.32, subdivision 3.​
3440-105​Article 1 Sec. 48.​
3441-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 106.1Sec. 49. [342.49] MEDICAL CANNABIS CULTIVATORS.​
3442-106.2 (a) A medical cannabis cultivator license entitles the license holder to grow cannabis​
3443-106.3plants within the approved amount of space up to 60,000 square feet of plant canopy from​
3444-106.4seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package​
3445-106.5and label cannabis flower as medical cannabis flower, sell medical cannabis flower to​
3446-106.6medical cannabis processors and medical cannabis retailers, transport medical cannabis​
3447-106.7flower to a medical cannabis processor located on the same premises, and perform other​
3448-106.8actions approved by the office.​
3449-106.9 (b) A medical cannabis cultivator license holder must comply with all requirements of​
3450-106.10section 342.25.​
3451-106.11 (c) A medical cannabis cultivator license holder must verify that every batch of medical​
3452-106.12cannabis flower has passed safety, potency, and consistency testing at a cannabis testing​
3453-106.13facility approved by the office for the testing of medical cannabis flower before the medical​
3454-106.14cannabis cultivator may package, label, or sell the medical cannabis flower to any other​
3455-106.15entity.​
3456-106.16 (d) A medical cannabis cultivator may exceed the limit of 60,000 square feet of plant​
3457-106.17canopy if it was legally cultivating medical cannabis with a greater plant canopy as of April​
3458-106.181, 2023.​
3459-106.19 EFFECTIVE DATE.This section is effective March 1, 2025.​
3460-106.20Sec. 50. [342.50] MEDICAL CANNABIS PROCESSORS.​
3461-106.21 (a) A medical cannabis processor license, consistent with the specific license endorsement​
3462-106.22or endorsements, entitles the license holder to:​
3463-106.23 (1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts,​
3464-106.24and hemp concentrate from medical cannabis cultivators and other medical cannabis​
3465-106.25processors;​
3466-106.26 (2) purchase hemp plant parts from industrial hemp growers;​
3467-106.27 (3) make cannabis concentrate from medical cannabis flower;​
3468-106.28 (4) make hemp concentrate, including hemp concentrate with a delta-9​
3469-106.29tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;​
3470-106.30 (5) manufacture medical cannabinoid products;​
3471-106​Article 1 Sec. 50.​
3472-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 107.1 (6) package and label medical cannabinoid products for sale to other medical cannabis​
3473-107.2processors and to medical cannabis retailers; and​
3474-107.3 (7) perform other actions approved by the office.​
3475-107.4 (b) A medical cannabis processor license holder must comply with all requirements of​
3476-107.5section 342.26, including requirements to obtain specific license endorsements.​
3477-107.6 (c) A medical cannabis processor license holder must verify that every batch of medical​
3478-107.7cannabinoid product has passed safety, potency, and consistency testing at a cannabis testing​
3479-107.8facility approved by the office for the testing of medical cannabinoid products before the​
3480-107.9medical cannabis processor may package, label, or sell the medical cannabinoid product to​
3481-107.10any other entity.​
3482-107.11 EFFECTIVE DATE.This section is effective March 1, 2025.​
3483-107.12Sec. 51. [342.51] MEDICAL CANNABIS RETAILERS.​
3484-107.13 Subdivision 1.Authorized actions.(a) A medical cannabis retailer license entitles the​
3485-107.14license holder to purchase medical cannabis flower and medical cannabinoid products from​
3486-107.15medical cannabis cultivators and medical cannabis processors and sell or distribute medical​
3487-107.16cannabis flower and medical cannabinoid products to any person authorized to receive​
3488-107.17medical cannabis flower or medical cannabinoid products.​
3489-107.18 (b) A medical cannabis retailer license holder must verify that all medical cannabis​
3490-107.19flower and medical cannabinoid products have passed safety, potency, and consistency​
3491-107.20testing at a cannabis testing facility approved by the office for the testing of medical cannabis​
3492-107.21flower and medical cannabinoid products before the medical cannabis retailer may distribute​
3493-107.22the medical cannabis flower or medical cannabinoid product to any person authorized to​
3494-107.23receive medical cannabis flower or medical cannabinoid products.​
3495-107.24 Subd. 2.Distribution requirements.(a) Prior to distribution of medical cannabis flower​
3496-107.25or medical cannabinoid products, a medical cannabis retailer licensee must:​
3497-107.26 (1) review and confirm the patient's registry verification;​
3498-107.27 (2) verify that the person requesting the distribution of medical cannabis flower or​
3499-107.28medical cannabinoid products is the patient, the patient's registered designated caregiver,​
3500-107.29or the patient's parent, legal guardian, or spouse using the procedures specified in section​
3501-107.30152.11, subdivision 2d;​
3502-107.31 (3) ensure that a pharmacist employee of the medical cannabis retailer has consulted​
3503-107.32with the patient if required according to subdivision 3; and​
3504-107​Article 1 Sec. 51.​
3505-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 108.1 (4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid​
3506-108.2product that includes recommended dosage requirements and other information as required​
3507-108.3by rules adopted by the office.​
3508-108.4 (b) A medical cannabis retailer may not deliver medical cannabis flower or medical​
3509-108.5cannabinoid products unless the medical cannabis retailer also holds a cannabis delivery​
3510-108.6service license. Delivery of medical cannabis flower and medical cannabinoid products are​
3511-108.7subject to the provisions of section 342.42.​
3512-108.8 Subd. 3.Final approval for distribution of medical cannabis flower and medical​
3513-108.9cannabinoid products.(a) A cannabis worker who is employed by a medical cannabis​
3514-108.10retailer and who is licensed as a pharmacist pursuant to chapter 151 shall be the only person​
3515-108.11who may give final approval for the distribution of medical cannabis flower and medical​
3516-108.12cannabinoid products. Prior to the distribution of medical cannabis flower or medical​
3517-108.13cannabinoid products, a pharmacist employed by the medical cannabis retailer must consult​
3518-108.14with the patient to determine the proper type of medical cannabis flower, medical cannabinoid​
3519-108.15product, or medical cannabis paraphernalia and proper dosage for the patient after reviewing​
3520-108.16the range of chemical compositions of medical cannabis flower or medical cannabinoid​
3521-108.17product. For purposes of this subdivision, a consultation may be conducted remotely by​
3522-108.18secure videoconference, telephone, or other remote means, as long as:​
3523-108.19 (1) the pharmacist engaging in the consultation is able to confirm the identity of the​
3524-108.20patient; and​
3525-108.21 (2) the consultation adheres to patient privacy requirements that apply to health care​
3526-108.22services delivered through telemedicine.​
3527-108.23 (b) Notwithstanding paragraph (a), a pharmacist consultation is not required prior to the​
3528-108.24distribution of medical cannabis flower or medical cannabinoid products when a medical​
3529-108.25cannabis retailer is distributing medical cannabis flower or medical cannabinoid products​
3530-108.26to a patient according to a patient-specific dosage plan established with that medical cannabis​
3531-108.27retailer and is not modifying the dosage or product being distributed under that plan. Medical​
3532-108.28cannabis flower or medical cannabinoid products distributed under this paragraph must be​
3533-108.29distributed by a pharmacy technician employed by the medical cannabis retailer.​
3534-108.30 Subd. 4.90-day supply.A medical cannabis retailer shall not distribute more than a​
3535-108.3190-day supply of medical cannabis flower or medical cannabinoid products to a patient,​
3536-108.32registered designated caregiver, or parent, legal guardian, or spouse of a patient according​
3537-108.33to the dosages established for the individual patient.​
3538-108​Article 1 Sec. 51.​
3539-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 109.1 Subd. 5.Distribution to recipient in a motor vehicle.A medical cannabis retailer may​
3540-109.2distribute medical cannabis flower and medical cannabinoid products to a patient, registered​
3541-109.3designated caregiver, or parent, legal guardian, or spouse of a patient who is at a dispensary​
3542-109.4location but remains in a motor vehicle, provided that:​
3543-109.5 (1) staff receive payment and distribute medical cannabis flower and medical cannabinoid​
3544-109.6products in a designated zone that is as close as feasible to the front door of the facility;​
3545-109.7 (2) the medical cannabis retailer ensures that the receipt of payment and distribution of​
3546-109.8medical cannabis flower and medical cannabinoid products are visually recorded by a​
3547-109.9closed-circuit television surveillance camera and provides any other necessary security​
3548-109.10safeguards;​
3549-109.11 (3) the medical cannabis retailer does not store medical cannabis flower or medical​
3550-109.12cannabinoid products outside a restricted access area and staff transport medical cannabis​
3551-109.13flower and medical cannabinoid products from a restricted access area to the designated​
3552-109.14zone for distribution only after confirming that the patient, designated caregiver, or parent,​
3553-109.15guardian, or spouse has arrived in the designated zone;​
3554-109.16 (4) the payment and distribution of medical cannabis flower and medical cannabinoid​
3555-109.17products take place only after a pharmacist consultation takes place, if required under​
3556-109.18subdivision 3;​
3557-109.19 (5) immediately following distribution of medical cannabis flower or medical cannabinoid​
3558-109.20products, staff enter the transaction in the statewide monitoring system; and​
3559-109.21 (6) immediately following distribution of medical cannabis flower and medical​
3560-109.22cannabinoid products, staff take the payment received into the facility.​
3561-109.23 EFFECTIVE DATE.This section is effective March 1, 2025.​
3562-109.24Sec. 52. [342.515] MEDICAL CANNABIS COMBINATION BUSINESSES.​
3563-109.25 Subdivision 1.Authorized actions.A medical cannabis combination business license​
3564-109.26entitles the license holder to perform any or all of the following within the limits established​
3565-109.27by this section:​
3566-109.28 (1) grow cannabis plants from seed or immature plant to mature plant and harvest​
3567-109.29adult-use cannabis flower and medical cannabis flower from a mature plant;​
3568-109.30 (2) make cannabis concentrate;​
3569-109.31 (3) make hemp concentrate, including hemp concentrate with a delta-9​
3570-109.32tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;​
2935+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 90.1locked container that is not accessible to the public. Such items being stored at a cannabis​
2936+90.2event shall not be left unattended.​
2937+90.3 (i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products,​
2938+90.4lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis​
2939+90.5event must comply with this chapter and rules adopted pursuant to this chapter regarding​
2940+90.6the testing, packaging, and labeling of those items.​
2941+90.7 (j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold,​
2942+90.8damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring​
2943+90.9system.​
2944+90.10 Subd. 8.Cannabis event on-site consumption.(a) If approved by the local unit of​
2945+90.11government, a cannabis event may designate an area for consumption of adult-use cannabis​
2946+90.12flower, adult-use cannabis products, lower-potency hemp edibles, hemp-derived consumer​
2947+90.13products, or any combination of those items.​
2948+90.14 (b) Access to areas where consumption of adult-use cannabis flower, adult-use cannabis​
2949+90.15products, lower-potency hemp edibles, or hemp-derived consumer products is allowed shall​
2950+90.16be restricted to individuals who are at least 21 years of age.​
2951+90.17 (c) The cannabis event organizer shall ensure that consumption of adult-use cannabis​
2952+90.18flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
2953+90.19products within a designated consumption area is not visible from any public place.​
2954+90.20 (d) The cannabis event organizer shall not permit consumption of alcohol or tobacco.​
2955+90.21Sec. 41. [342.41] CANNABIS DELIVERY SERVICE LICENSING.​
2956+90.22 Subdivision 1.Authorized actions.A cannabis delivery service license entitles the​
2957+90.23license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles,​
2958+90.24and hemp-derived consumer products from licensed cannabis microbusinesses with a retail​
2959+90.25endorsement, cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and​
2960+90.26medical cannabis retailers; transport and deliver cannabis flower, cannabis products,​
2961+90.27lower-potency hemp edibles, and hemp-derived consumable products to customers; and​
2962+90.28perform other actions approved by the office.​
2963+90.29 Subd. 2.Additional information required.In addition to the information required to​
2964+90.30be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section,​
2965+90.31a person, cooperative, or business seeking a cannabis delivery service license must submit​
2966+90.32the following information in a form approved by the office:​
2967+90​Article 1 Sec. 41.​
2968+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 91.1 (1) a list of all vehicles to be used in the delivery of cannabis flower, cannabis products,​
2969+91.2lower-potency hemp edibles, and hemp-derived consumer products including:​
2970+91.3 (i) the vehicle make, model, and color;​
2971+91.4 (ii) the vehicle identification number; and​
2972+91.5 (iii) the license plate number;​
2973+91.6 (2) proof of insurance for each vehicle;​
2974+91.7 (3) a business plan demonstrating policies to avoid sales of cannabis flower, cannabis​
2975+91.8products, lower-potency hemp edibles, and hemp-derived consumer products to individuals​
2976+91.9who are under 21 years of age and plans to prevent the visibility of cannabis flower, cannabis​
2977+91.10products, lower-potency hemp edibles, and hemp-derived consumer products to individuals​
2978+91.11outside the delivery vehicle; and​
2979+91.12 (4) evidence that the business will comply with the applicable operation requirements​
2980+91.13for the license being sought.​
2981+91.14 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a​
2982+91.15cannabis delivery service license may also hold a cannabis retailer license, a cannabis​
2983+91.16wholesaler license, a cannabis transporter license, a cannabis event organizer license, and​
2984+91.17a medical cannabis retailer license subject to the ownership limitations that apply to those​
2985+91.18licenses.​
2986+91.19 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
2987+91.20cannabis delivery service license may own or operate any other cannabis business or hemp​
2988+91.21business.​
2989+91.22 (c) The office by rule may limit the number of cannabis delivery service licenses that a​
2990+91.23person or business may hold.​
2991+91.24 (d) For purposes of this subdivision, a restriction on the number or type of license that​
2992+91.25a business may hold applies to every cooperative member or every director, manager, and​
2993+91.26general partner of a cannabis business.​
2994+91.27Sec. 42. [342.42] CANNABIS DELIVERY SERVICE OPERATIONS.​
2995+91.28 Subdivision 1.Age or registry verification.Prior to completing a delivery, a cannabis​
2996+91.29delivery service shall verify that the customer is at least 21 years of age or is enrolled in the​
2997+91.30registry program. Section 342.27, subdivision 4, applies to the verification of a customer's​
2998+91.31age. Registry verification issued by the Division of Medical Cannabis may be considered​
2999+91.32evidence that the person is enrolled in the registry program.​
3000+91​Article 1 Sec. 42.​
3001+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 92.1 Subd. 2.Records.The office by rule shall establish record-keeping requirements for a​
3002+92.2cannabis delivery service, including but not limited to proof of delivery to individuals who​
3003+92.3are at least 21 years of age or enrolled in the registry program.​
3004+92.4 Subd. 3.Amount to be transported.The office by rule shall establish limits on the​
3005+92.5amount of cannabis flower, cannabis products, lower-potency hemp edibles, and​
3006+92.6hemp-derived consumer products that a cannabis delivery service may transport.​
3007+92.7 Subd. 4.Statewide monitoring system.Receipt of cannabis flower and cannabis products​
3008+92.8by the cannabis delivery service and a delivery to a customer must be recorded in the​
3009+92.9statewide monitoring system within the time established by rule.​
3010+92.10 Subd. 5.Storage compartment.Cannabis flower, cannabis products, lower-potency​
3011+92.11hemp edibles, and hemp-derived consumer products must be transported in a locked, safe,​
3012+92.12and secure storage compartment that is part of the cannabis delivery service vehicle or in a​
3013+92.13locked storage container that has a separate key or combination pad. Cannabis flower,​
3014+92.14cannabis products, lower-potency hemp edibles, and hemp-derived consumer products may​
3015+92.15not be visible from outside the cannabis delivery service vehicle.​
3016+92.16 Subd. 6.Identifying logos or business names prohibited.No cannabis delivery service​
3017+92.17vehicle or trailer may contain an image depicting the types of items being transported,​
3018+92.18including but not limited to an image depicting a cannabis or hemp leaf, or a name suggesting​
3019+92.19that the cannabis delivery service vehicle is used for transporting cannabis flower, cannabis​
3020+92.20products, lower-potency hemp edibles, and hemp-derived consumer products.​
3021+92.21 Subd. 7.Nonemployee passengers prohibited.Only a cannabis worker employed by​
3022+92.22or contracted with the cannabis delivery service and who is at least 21 years of age may​
3023+92.23transport cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived​
3024+92.24consumer products. All passengers in a cannabis delivery service vehicle must be cannabis​
3025+92.25workers employed by or contracted with the cannabis delivery service.​
3026+92.26 Subd. 8.Vehicles subject to inspection.Any cannabis delivery service vehicle is subject​
3027+92.27to inspection and may be stopped or inspected at any licensed cannabis business or while​
3028+92.28en route during transportation.​
3029+92.29Sec. 43. [342.43] HEMP BUSINESS LICENSE TYPES; MULTIPLE LICENSES.​
3030+92.30 Subdivision 1.License types.The office shall issue the following types of hemp business​
3031+92.31licenses:​
3032+92.32 (1) lower-potency hemp edible manufacturer; and​
3033+92​Article 1 Sec. 43.​
3034+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 93.1 (2) lower-potency hemp edible retailer.​
3035+93.2 Subd. 2.Multiple licenses; limits.(a) A person, cooperative, or business may hold both​
3036+93.3a lower-potency hemp edible manufacturer and lower-potency hemp edible retailer license.​
3037+93.4 (b) Nothing in this section prohibits a person, cooperative, or business from holding a​
3038+93.5lower-potency hemp edible manufacturer license, a lower-potency hemp edible retailer​
3039+93.6license, or both, and also holding a license to cultivate industrial hemp issued pursuant to​
3040+93.7chapter 18K.​
3041+93.8 (c) Nothing in this section prohibits a person, cooperative, or business from holding a​
3042+93.9lower-potency hemp edible manufacturer license, a lower-potency hemp edible retailer​
3043+93.10license, or both, and also holding any other license, including but not limited to a license​
3044+93.11to prepare or sell food; sell tobacco, tobacco-related devices, electronic delivery devices as​
3045+93.12defined in section 609.685, subdivision 1, and nicotine and lobelia delivery products as​
3046+93.13described in section 609.6855; or manufacture or sell alcoholic beverages as defined in​
3047+93.14section 340A.101, subdivision 2.​
3048+93.15 (d) A person, cooperative, or business holding a lower-potency hemp edible manufacturer​
3049+93.16license, a lower-potency hemp edible retailer license, or both, may not hold a cannabis​
3050+93.17business license.​
3051+93.18Sec. 44. [342.44] HEMP BUSINESS LICENSES; APPLICATIONS AND ISSUANCE.​
3052+93.19 Subdivision 1.Application; contents.(a) Except as otherwise provided in this​
3053+93.20subdivision, the provisions of this chapter relating to license applications, license selection​
3054+93.21criteria, general ownership disqualifications and requirements, and general operational​
3055+93.22requirements do not apply to hemp businesses.​
3056+93.23 (b) The office, by rule, shall establish forms and procedures for the processing of hemp​
3057+93.24licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp​
3058+93.25license shall include the following information, if applicable:​
3059+93.26 (1) the name, address, and date of birth of the applicant;​
3060+93.27 (2) the address and legal property description of the business;​
3061+93.28 (3) proof of trade name registration;​
3062+93.29 (4) certification that the applicant will comply with the requirements of this chapter​
3063+93.30relating to the ownership and operation of a hemp business;​
3064+93.31 (5) identification of one or more controlling persons or managerial employees as agents​
3065+93.32who shall be responsible for dealing with the office on all matters; and​
3066+93​Article 1 Sec. 44.​
3067+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 94.1 (6) a statement that the applicant agrees to respond to the office's supplemental requests​
3068+94.2for information.​
3069+94.3 (c) An application on behalf of a corporation or association shall be signed by at least​
3070+94.4two officers or managing agents of that entity.​
3071+94.5 Subd. 2.Issuance; eligibility; prohibition on transfer.(a) The office may issue a hemp​
3072+94.6license to an applicant who:​
3073+94.7 (1) is at least 21 years of age;​
3074+94.8 (2) has completed an application for licensure or application for renewal and has fully​
3075+94.9and truthfully complied with all information requests relating to license application and​
3076+94.10renewal;​
3077+94.11 (3) has paid the applicable application and license fees pursuant to section 342.11;​
3078+94.12 (4) is not employed by the office or any state agency with regulatory authority over this​
3079+94.13chapter; and​
3080+94.14 (5) does not hold any cannabis business license.​
3081+94.15 (b) Licenses must be renewed annually.​
3082+94.16 (c) Licenses may not be transferred.​
3083+94.17Sec. 45. [342.45] LOWER-POTENCY HEMP EDIBLE MANUFACTURER.​
3084+94.18 Subdivision 1.Authorized actions.A lower-potency hemp edible manufacturer license​
3085+94.19entitles the license holder to:​
3086+94.20 (1) purchase hemp plant parts, hemp concentrate, and artificially derived cannabinoids​
3087+94.21from cannabis microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, cannabis​
3088+94.22wholesalers, other lower-potency hemp edible manufacturers, and industrial hemp growers;​
3089+94.23 (2) make hemp concentrate;​
3090+94.24 (3) manufacture artificially derived cannabinoids;​
3091+94.25 (4) manufacture lower-potency hemp edibles for public consumption;​
3092+94.26 (5) package and label lower-potency hemp edibles for sale to customers;​
3093+94.27 (6) sell hemp concentrate, artificially derived cannabinoids, and lower-potency hemp​
3094+94.28edibles to other cannabis businesses and hemp businesses; and​
3095+94.29 (7) perform other actions approved by the office.​
3096+94​Article 1 Sec. 45.​
3097+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 95.1 Subd. 2.All manufacturer operations.(a) All hemp manufacturing must take place in​
3098+95.2a facility and on equipment that meets the applicable health and safety requirements​
3099+95.3established by the office, including requirements for cleaning and testing machinery between​
3100+95.4production of different products.​
3101+95.5 (b) A lower-potency hemp edible manufacturer must comply with all applicable​
3102+95.6packaging, labeling, and testing requirements.​
3103+95.7 Subd. 3.Extraction and concentration.(a) A lower-potency hemp edible manufacturer​
3104+95.8that creates hemp concentrate or artificially derived cannabinoids must obtain an endorsement​
3105+95.9from the office.​
3106+95.10 (b) A lower-potency hemp edible manufacturer seeking an endorsement to create hemp​
3107+95.11concentrate must inform the office of all methods of extraction and concentration that the​
3108+95.12manufacturer intends to use and identify the volatile chemicals, if any, that will be involved​
3109+95.13in the creation of hemp concentrate. A lower-potency hemp edible manufacturer may not​
3110+95.14use a method of extraction and concentration or a volatile chemical without approval by​
3111+95.15the office.​
3112+95.16 (c) A lower-potency hemp edible manufacturer seeking an endorsement to create​
3113+95.17artificially derived cannabinoids must inform the office of all methods of conversion that​
3114+95.18the manufacturer will use, including any specific catalysts that the manufacturer will employ,​
3115+95.19to create artificially derived cannabinoids and the molecular nomenclature of all cannabinoids​
3116+95.20or other chemical compounds that the manufacturer will create. A business licensed or​
3117+95.21authorized to manufacture lower-potency hemp edibles may not use a method of conversion​
3118+95.22or a catalyst without approval by the office.​
3119+95.23 (d) A lower-potency hemp edible manufacturer must obtain a certification from an​
3120+95.24independent third-party industrial hygienist or professional engineer approving:​
3121+95.25 (1) all electrical, gas, fire suppression, and exhaust systems; and​
3122+95.26 (2) the plan for safe storage and disposal of hazardous substances, including but not​
3123+95.27limited to any volatile chemicals.​
3124+95.28 (e) Upon the sale of hemp concentrate or artificially derived cannabinoids to any person,​
3125+95.29cooperative, or business, a lower-potency hemp edible manufacturer must provide a statement​
3126+95.30to the buyer that discloses the method of extraction and concentration or conversion used​
3127+95.31and any solvents, gases, or catalysts, including but not limited to any volatile chemicals​
3128+95.32involved in that method.​
3129+95​Article 1 Sec. 45.​
3130+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 96.1 Subd. 4.Production of consumer products.(a) A lower-potency hemp edible​
3131+96.2manufacturer that produces lower-potency hemp edibles must obtain an edible cannabinoid​
3132+96.3product handler endorsement from the office.​
3133+96.4 (b) All areas within the premises of a lower-potency hemp edible manufacturer used for​
3134+96.5producing lower-potency hemp edibles must meet the sanitary standards specified in rules​
3135+96.6adopted by the office.​
3136+96.7 (c) A lower-potency hemp edible manufacturer may only add chemicals or compounds​
3137+96.8approved by the office to hemp concentrate or artificially derived cannabinoids.​
3138+96.9 (d) Upon the sale of any lower-potency hemp edible to a cannabis business or hemp​
3139+96.10business, a lower-potency hemp edible manufacturer must provide a statement to the buyer​
3140+96.11that discloses the product's ingredients, including but not limited to any chemicals or​
3141+96.12compounds and any major food allergens declared by name.​
3142+96.13 (e) A lower-potency hemp edible manufacturer shall not add any artificially derived​
3143+96.14cannabinoid, hemp plant part, or hemp concentrate to a product if the manufacturer of the​
3144+96.15product holds a trademark to the product's name, except that a lower-potency hemp edible​
3145+96.16manufacturer may use a trademarked food product if the manufacturer uses the product as​
3146+96.17a component or as part of a recipe and if the lower-potency hemp edible manufacturer does​
3147+96.18not state or advertise to the customer that the final retail lower-potency hemp edible contains​
3148+96.19a trademarked food product.​
3149+96.20 (f) A lower-potency hemp edible manufacturer shall not add any cannabis flower,​
3150+96.21cannabis concentrate, or cannabinoid derived from cannabis flower or cannabis concentrate​
3151+96.22to a product.​
3152+96.23 Subd. 5.Transportation of hemp concentrate, artificially derived cannabinoids,​
3153+96.24and lower-potency hemp edibles.(a) A lower-potency hemp edible manufacturer may​
3154+96.25transport hemp concentrate, artificially derived cannabinoids, and lower-potency hemp​
3155+96.26edibles on public roadways provided:​
3156+96.27 (1) the artificially derived cannabinoids, hemp concentrate, or lower-potency hemp​
3157+96.28edibles are in a locked, safe, and secure storage compartment that is part of the motor vehicle​
3158+96.29or in a locked storage container that has a separate key or combination pad;​
3159+96.30 (2) the artificially derived cannabinoids, hemp concentrate, or lower-potency hemp​
3160+96.31edibles are packaged in tamper-evident containers that are not visible or recognizable from​
3161+96.32outside the transporting vehicle;​
3162+96​Article 1 Sec. 45.​
3163+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 97.1 (3) the lower-potency hemp edible manufacturer has a shipping manifest in the​
3164+97.2lower-potency hemp edible manufacturer's possession that describes the contents of all​
3165+97.3tamper-evident containers;​
3166+97.4 (4) the transporting vehicle does not bear any markings to indicate that the vehicle​
3167+97.5contains artificially derived cannabinoids, hemp concentrate, or lower-potency hemp edibles​
3168+97.6and does not bear the name or logo of the lower-potency hemp edible manufacturer;​
3169+97.7 (5) all departures, arrivals, and stops are appropriately documented;​
3170+97.8 (6) no person other than a designated employee enters a vehicle at any time that the​
3171+97.9vehicle is transporting artificially derived cannabinoids, hemp concentrate, or lower-potency​
3172+97.10hemp edibles; and​
3173+97.11 (7) the lower-potency hemp edible manufacturer complies with any other rules adopted​
3174+97.12by the office.​
3175+97.13 (b) Any vehicle assigned for the purposes of transporting artificially derived cannabinoids,​
3176+97.14hemp concentrate, or lower-potency hemp edibles is subject to inspection and may be​
3177+97.15stopped or inspected at any point of delivery or while en route during transportation.​
3178+97.16Sec. 46. [342.46] LOWER-POTENCY HEMP EDIBLE RETAILER.​
3179+97.17 Subdivision 1.Sale of lower-potency hemp edibles.(a) A lower-potency hemp edible​
3180+97.18retailer may sell lower-potency hemp edibles to individuals who are at least 21 years of age.​
3181+97.19 (b) A lower-potency hemp edible retailer may sell lower-potency hemp edibles that:​
3182+97.20 (1) are obtained from a licensed Minnesota cannabis microbusiness, cannabis​
3183+97.21mezzobusiness, cannabis manufacturer, cannabis wholesaler, or lower-potency hemp edible​
3184+97.22manufacturer; and​
3185+97.23 (2) meet all applicable packaging and labeling requirements.​
3186+97.24 Subd. 2.Sale of other products.A lower-potency hemp edible retailer may sell other​
3187+97.25products or items for which the lower-potency hemp edible retailer has a license or​
3188+97.26authorization or that do not require a license or authorization.​
3189+97.27 Subd. 3.Age verification.Prior to initiating a sale, an employee of the lower-potency​
3190+97.28hemp edible retailer must verify that the customer is at least 21 years of age. Section 342.27,​
3191+97.29subdivision 4, applies to the verification of a customer's age.​
3192+97.30 Subd. 4.Display and storage of lower-potency hemp edibles.A lower-potency hemp​
3193+97.31edible retailer shall ensure that all lower-potency hemp edibles are displayed behind a​
3194+97​Article 1 Sec. 46.​
3195+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 98.1checkout counter where the public is not permitted. All lower-potency hemp edibles that​
3196+98.2are not displayed must be stored in a secure area.​
3197+98.3 Subd. 5.Transportation of lower-potency hemp edibles.(a) A lower-potency hemp​
3198+98.4edible retailer may transport lower-potency hemp edibles on public roadways provided:​
3199+98.5 (1) the lower-potency hemp edibles are in final packaging;​
3200+98.6 (2) the lower-potency hemp edibles are packaged in tamper-evident containers that are​
3201+98.7not visible or recognizable from outside the transporting vehicle;​
3202+98.8 (3) the lower-potency hemp edible retailer has a shipping manifest in the lower-potency​
3203+98.9hemp edible retailer's possession that describes the contents of all tamper-evident containers;​
3204+98.10 (4) the transporting vehicle does not bear any markings to indicate that the vehicle​
3205+98.11contains lower-potency hemp edibles and does not bear the name or logo of the lower-potency​
3206+98.12hemp edible retailer;​
3207+98.13 (5) all departures, arrivals, and stops are appropriately documented;​
3208+98.14 (6) no person other than a designated employee enters a vehicle at any time that the​
3209+98.15vehicle is transporting lower-potency hemp edibles; and​
3210+98.16 (7) the lower-potency hemp edible retailer complies with any other rules adopted by the​
3211+98.17office.​
3212+98.18 (b) Any vehicle assigned for the purposes of transporting lower-potency hemp edibles​
3213+98.19is subject to inspection and may be stopped or inspected at any point of delivery or while​
3214+98.20en route during transportation.​
3215+98.21 Subd. 6.Compliant products.(a) A lower-potency hemp edible retailer shall ensure​
3216+98.22that all lower-potency hemp edibles offered for sale comply with the limits on the amount​
3217+98.23and types of cannabinoids that a lower-potency hemp edible can contain, including but not​
3218+98.24limited to the requirement that lower-potency hemp edibles:​
3219+98.25 (1) consist of servings that contain no more than five milligrams of delta-9​
3220+98.26tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams​
3221+98.27of cannabigerol, or any combination of those cannabinoids that does not exceed the identified​
3222+98.28amounts;​
3223+98.29 (2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids​
3224+98.30per serving; and​
3225+98.31 (3) do not contain an artificially derived cannabinoid other than delta-9​
3226+98.32tetrahydrocannabinol.​
3227+98​Article 1 Sec. 46.​
3228+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 99.1 (b) If a lower-potency hemp edible is packaged in a manner that includes more than a​
3229+99.2single serving, the lower-potency edible product must indicate each serving by scoring,​
3230+99.3wrapping, or other indicators that appear on the lower-potency hemp edible designating the​
3231+99.4individual serving size. If the lower-potency hemp edible is meant to be consumed as a​
3232+99.5beverage or it is not possible to indicate a single serving by scoring or use of another indicator​
3233+99.6that appears on the product, the lower-potency hemp edible may not be packaged in a manner​
3234+99.7that includes more than a single serving in each container.​
3235+99.8 (c) A single package containing multiple servings of a lower-potency edible product​
3236+99.9must contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams​
3237+99.10of cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids​
3238+99.11that does not exceed the identified amounts.​
3239+99.12 Subd. 7.Prohibitions.A lower-potency edible product retailer may not:​
3240+99.13 (1) sell lower-potency hemp edibles to an individual who is under 21 years of age;​
3241+99.14 (2) sell a lower-potency hemp edible to a person who is visibly intoxicated;​
3242+99.15 (3) sell cannabis flower, cannabis products, or hemp-derived consumer products;​
3243+99.16 (4) allow for the dispensing of lower-potency hemp edibles in vending machines; or​
3244+99.17 (5) distribute or allow free samples of lower-potency hemp edibles.​
3245+99.18 Subd. 8.On-site consumption.(a) A lower-potency hemp edible retailer may permit​
3246+99.19on-site consumption of lower-potency hemp edibles on a portion of its premises if it has an​
3247+99.20on-site consumption endorsement.​
3248+99.21 (b) The office shall issue an on-site consumption endorsement to any lower-potency​
3249+99.22hemp edible retailer that also holds an on-sale license issued under chapter 340A.​
3250+99.23 (c) A lower-potency hemp edible retailer must ensure that lower-potency hemp edibles​
3251+99.24sold for on-site consumption comply with this chapter and rules adopted pursuant to this​
3252+99.25chapter regarding testing.​
3253+99.26 (d) Lower-potency hemp edibles sold for on-site consumption, other than lower-potency​
3254+99.27hemp edibles that are intended to be consumed as a beverage, must be served in the required​
3255+99.28packaging, but may be removed from the products' packaging by customers and consumed​
3256+99.29on site.​
3257+99.30 (e) Lower-potency hemp edibles that are intended to be consumed as a beverage may​
3258+99.31be served outside of their packaging provided that the information that is required to be​
3259+99.32contained on the label of a lower-potency hemp edible is posted or otherwise displayed by​
3260+99​Article 1 Sec. 46.​
3261+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 100.1the lower-potency hemp edible retailer. Hemp workers who serve beverages under this​
3262+100.2paragraph are not required to obtain an edible cannabinoid product handler endorsement​
3263+100.3under section 342.07, subdivision 3.​
3264+100.4 (f) Food and beverages not otherwise prohibited by this subdivision may be prepared​
3265+100.5and sold on site provided that the lower-potency hemp edible retailer complies with all​
3266+100.6relevant state and local laws, ordinances, licensing requirements, and zoning requirements.​
3267+100.7 (g) A lower-potency hemp edible retailer may offer recorded or live entertainment​
3268+100.8provided that the lower-potency hemp edible retailer complies with all relevant state and​
3269+100.9local laws, ordinances, licensing requirements, and zoning requirements.​
3270+100.10 (h) In addition to the prohibitions under subdivision 6, a lower-potency hemp edible​
3271+100.11retailer with an on-site consumption endorsement may not:​
3272+100.12 (1) sell lower-potency hemp edibles to a customer who the lower-potency hemp edible​
3273+100.13retailer knows or reasonably should know has consumed alcohol sold or provided by the​
3274+100.14lower-potency hemp edible retailer within the previous five hours;​
3275+100.15 (2) sell lower-potency hemp edibles that are designed or reasonably expected to be mixed​
3276+100.16with an alcoholic beverage; or​
3277+100.17 (3) permit lower-potency hemp edibles that have been removed from the products'​
3278+100.18packaging to be removed from the premises of the lower-potency hemp edible retailer.​
3279+100.19 Subd. 9.Posting of notices.A lower-potency hemp edible retailer must post all notices​
3280+100.20as provided in section 342.27, subdivision 6.​
3281+100.21 Subd. 10.Building conditions.(a) A lower-potency hemp edible retailer shall maintain​
3282+100.22compliance with state and local building, fire, and zoning codes, requirements, or regulations.​
3283+100.23 (b) A lower-potency hemp edible retailer shall ensure that the licensed premises is​
3284+100.24maintained in a clean and sanitary condition, free from infestation by insects, rodents, or​
3285+100.25other pests.​
3286+100.26 Subd. 11.Enforcement.The office shall inspect lower-potency hemp edible retailers​
3287+100.27and take enforcement action as provided in sections 342.19 and 342.21.​
3288+100.28Sec. 47. [342.47] MEDICAL CANNABIS BUSINESS LICENSES.​
3289+100.29 Subdivision 1.License types.(a) The office shall issue the following types of medical​
3290+100.30cannabis business licenses:​
3291+100.31 (1) medical cannabis cultivator;​
3292+100​Article 1 Sec. 47.​
3293+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 101.1 (2) medical cannabis processor; and​
3294+101.2 (3) medical cannabis retailer.​
3295+101.3 (b) The Division of Medical Cannabis may oversee the licensing and regulation of​
3296+101.4medical cannabis businesses.​
3297+101.5 Subd. 2.Multiple licenses; limits.(a) A person, cooperative, or business holding:​
3298+101.6 (1) a medical cannabis cultivator license may also hold a medical cannabis processor​
3299+101.7license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event​
3300+101.8organizer license subject to the ownership limitations that apply to those licenses;​
3301+101.9 (2) a medical cannabis processor license may also hold a medical cannabis cultivator​
3302+101.10license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event​
3303+101.11organizer license subject to the ownership limitations that apply to those licenses; or​
3304+101.12 (3) a medical cannabis retailer license may also hold a cannabis retailer license, a cannabis​
3305+101.13delivery service license, and a cannabis event organizer license subject to the ownership​
3306+101.14limitations that apply to those licenses.​
3307+101.15 (b) Except as provided in paragraph (a), no person, cooperative, or business holding a​
3308+101.16medical cannabis license may own or operate any other cannabis business or hemp business.​
3309+101.17 (c) The office by rule may limit the number of medical cannabis business licenses that​
3310+101.18a person or business may hold.​
3311+101.19 (d) For purposes of this subdivision, a restriction on the number of licenses or type of​
3312+101.20license that a business may hold applies to every cooperative member or every director,​
3313+101.21manager, and general partner of a medical cannabis business.​
3314+101.22 Subd. 3.Registered medical cannabis manufacturers.(a) As used in this subdivision,​
3315+101.23"medical cannabis manufacturer" means either of the two in-state manufacturers of medical​
3316+101.24cannabis registered with the commissioner of health pursuant to section 152.25 as of July​
3317+101.251, 2023.​
3318+101.26 (b) Notwithstanding any law to the contrary, the registration or reregistration period of​
3319+101.27a medical cannabis manufacturer expires on July 1, 2024.​
3320+101.28 EFFECTIVE DATE.This section is effective January 1, 2024.​
3321+101.29Sec. 48. [342.48] MEDICAL CANNABIS BUSINESS APPLICATIONS.​
3322+101.30 In addition to the information required to be submitted under section 342.14, subdivision​
3323+101.311, and rules adopted pursuant to that section, a person, cooperative, or business seeking a​
3324+101​Article 1 Sec. 48.​
3325+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 102.1medical cannabis business license must submit the following information in a form approved​
3326+102.2by the office:​
3327+102.3 (1) for medical cannabis cultivator license applicants:​
3328+102.4 (i) an operating plan demonstrating the proposed size and layout of the cultivation facility;​
3329+102.5plans for wastewater and waste disposal for the cultivation facility; plans for providing​
3330+102.6electricity, water, and other utilities necessary for the normal operation of the cultivation​
3331+102.7facility; and plans for compliance with applicable building code and federal and state​
3332+102.8environmental and workplace safety requirements;​
3333+102.9 (ii) a cultivation plan demonstrating the proposed size and layout of the cultivation​
3334+102.10facility that will be used exclusively for cultivation for medical cannabis, including the total​
3335+102.11amount of plant canopy; and​
3336+102.12 (iii) evidence that the business will comply with the applicable operation requirements​
3337+102.13for the license being sought;​
3338+102.14 (2) for medical cannabis processor license applicants:​
3339+102.15 (i) an operating plan demonstrating the proposed layout of the facility, including a​
3340+102.16diagram of ventilation and filtration systems; plans for wastewater and waste disposal for​
3341+102.17the manufacturing facility; plans for providing electricity, water, and other utilities necessary​
3342+102.18for the normal operation of the manufacturing facility; and plans for compliance with​
3343+102.19applicable building code and federal and state environmental and workplace safety​
3344+102.20requirements;​
3345+102.21 (ii) all methods of extraction and concentration that the applicant intends to use and the​
3346+102.22volatile chemicals, if any, that are involved in extraction or concentration;​
3347+102.23 (iii) if the applicant is seeking an endorsement to manufacture products infused with​
3348+102.24cannabinoids for consumption by patients enrolled in the registry program, proof of an​
3349+102.25edible cannabinoid product handler endorsement from the office; and​
3350+102.26 (iv) evidence that the applicant will comply with the applicable operation requirements​
3351+102.27for the license being sought; or​
3352+102.28 (3) for medical cannabis retailer license applicants:​
3353+102.29 (i) a list of every retail license held by the applicant and, if the applicant is a business,​
3354+102.30every retail license held, either as an individual or as part of another business, by each​
3355+102.31officer, director, manager, and general partner of the cannabis business;​
3356+102​Article 1 Sec. 48.​
3357+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 103.1 (ii) an operating plan demonstrating the proposed layout of the facility, including a​
3358+103.2diagram of ventilation and filtration systems, policies to avoid sales to individuals who are​
3359+103.3not authorized to receive the distribution of medical cannabis flower or medical cannabinoid​
3360+103.4products, identification of a restricted area for storage, and plans to prevent the visibility of​
3361+103.5cannabis flower and cannabinoid products;​
3362+103.6 (iii) if the applicant holds or is applying for a cannabis retailer license, a diagram showing​
3363+103.7the portion of the premises in which medical cannabis flower and medical cannabinoid​
3364+103.8products will be sold and distributed and identifying an area that is definite and distinct​
3365+103.9from all other areas of the cannabis retailer, is accessed through a distinct entrance, and​
3366+103.10contains an appropriate space for a pharmacist employee of the medical cannabis retailer​
3367+103.11to consult with the patient to determine the proper type of medical cannabis flower and​
3368+103.12medical cannabinoid products and proper dosage for the patient; and​
3369+103.13 (iv) evidence that the applicant will comply with the applicable operation requirements​
3370+103.14for the license being sought.​
3371+103.15Sec. 49. [342.49] MEDICAL CANNABIS CULTIVATORS.​
3372+103.16 (a) A medical cannabis cultivator license entitles the license holder to grow cannabis​
3373+103.17plants within the approved amount of space from seed or immature plant to mature plant,​
3374+103.18harvest cannabis flower from a mature plant, package and label cannabis flower as medical​
3375+103.19cannabis flower, sell medical cannabis flower to medical cannabis processors and medical​
3376+103.20cannabis retailers, transport medical cannabis flower to a medical cannabis processor located​
3377+103.21on the same premises, and perform other actions approved by the office.​
3378+103.22 (b) The office may, by rule, establish limits on the plant canopy in which a medical​
3379+103.23cannabis cultivator can grow cannabis plants and on the use of tiers within the approved​
3380+103.24plant canopy.​
3381+103.25 (c) A medical cannabis cultivator license holder must comply with all requirements of​
3382+103.26section 342.25.​
3383+103.27 (d) A medical cannabis cultivator license holder must verify that every batch of medical​
3384+103.28cannabis flower has passed safety, potency, and consistency testing at a cannabis testing​
3385+103.29facility approved by the office for the testing of medical cannabis flower before the medical​
3386+103.30cannabis cultivator may package, label, or sell the medical cannabis flower to any other​
3387+103.31entity.​
3388+103.32 EFFECTIVE DATE.This section is effective January 1, 2024.​
3389+103​Article 1 Sec. 49.​
3390+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 104.1Sec. 50. [342.50] MEDICAL CANNABIS PROCESSORS.​
3391+104.2 (a) A medical cannabis processor license, consistent with the specific license endorsement​
3392+104.3or endorsements, entitles the license holder to:​
3393+104.4 (1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts,​
3394+104.5and hemp concentrate from medical cannabis cultivators, other medical cannabis processors,​
3395+104.6and industrial hemp growers;​
3396+104.7 (2) make cannabis concentrate from medical cannabis flower;​
3397+104.8 (3) make hemp concentrate, including hemp concentrate with a delta-9​
3398+104.9tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;​
3399+104.10 (4) manufacture medical cannabinoid products;​
3400+104.11 (5) package and label medical cannabinoid products for sale to other medical cannabis​
3401+104.12processors and to medical cannabis retailers; and​
3402+104.13 (6) perform other actions approved by the office.​
3403+104.14 (b) A medical cannabis processor license holder must comply with all requirements of​
3404+104.15section 342.26, including requirements to obtain specific license endorsements.​
3405+104.16 (c) A medical cannabis processor license holder must verify that every batch of medical​
3406+104.17cannabinoid product has passed safety, potency, and consistency testing at a cannabis testing​
3407+104.18facility approved by the office for the testing of medical cannabinoid products before the​
3408+104.19medical cannabis processor may package, label, or sell the medical cannabinoid product to​
3409+104.20any other entity.​
3410+104.21 EFFECTIVE DATE.This section is effective January 1, 2024.​
3411+104.22Sec. 51. [342.51] MEDICAL CANNABIS RETAILERS.​
3412+104.23 Subdivision 1.Authorized actions.(a) A medical cannabis retailer license entitles the​
3413+104.24license holder to purchase medical cannabis flower and medical cannabinoid products from​
3414+104.25medical cannabis cultivators and medical cannabis processors and sell or distribute medical​
3415+104.26cannabis flower and medical cannabinoid products to any person authorized to receive​
3416+104.27medical cannabis flower or medical cannabinoid products.​
3417+104.28 (b) A medical cannabis retailer license holder must verify that all medical cannabis​
3418+104.29flower and medical cannabinoid products have passed safety, potency, and consistency​
3419+104.30testing at a cannabis testing facility approved by the office for the testing of medical cannabis​
3420+104.31flower and medical cannabinoid products before the medical cannabis retailer may distribute​
3421+104​Article 1 Sec. 51.​
3422+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 105.1the medical cannabis flower or medical cannabinoid product to any person authorized to​
3423+105.2receive medical cannabis flower or medical cannabinoid products.​
3424+105.3 Subd. 2.Distribution requirements.(a) Prior to distribution of medical cannabis flower​
3425+105.4or medical cannabinoid products, a medical cannabis retailer licensee must:​
3426+105.5 (1) review and confirm the patient's registry verification;​
3427+105.6 (2) verify that the person requesting the distribution of medical cannabis flower or​
3428+105.7medical cannabinoid products is the patient, the patient's registered designated caregiver,​
3429+105.8or the patient's parent, legal guardian, or spouse using the procedures specified in section​
3430+105.9152.11, subdivision 2d;​
3431+105.10 (3) ensure that a pharmacist employee of the medical cannabis retailer has consulted​
3432+105.11with the patient if required according to subdivision 3; and​
3433+105.12 (4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid​
3434+105.13product that includes recommended dosage requirements and other information as required​
3435+105.14by rules adopted by the office.​
3436+105.15 (b) A medical cannabis retailer may not deliver medical cannabis flower or medical​
3437+105.16cannabinoid products unless the medical cannabis retailer also holds a cannabis delivery​
3438+105.17service license. Delivery of medical cannabis flower and medical cannabinoid products are​
3439+105.18subject to the provisions of section 342.42.​
3440+105.19 Subd. 3.Final approval for distribution of medical cannabis flower and medical​
3441+105.20cannabinoid products.(a) A cannabis worker who is employed by a medical cannabis​
3442+105.21retailer and who is licensed as a pharmacist pursuant to chapter 151 shall be the only person​
3443+105.22who may give final approval for the distribution of medical cannabis flower and medical​
3444+105.23cannabinoid products. Prior to the distribution of medical cannabis flower or medical​
3445+105.24cannabinoid products, a pharmacist employed by the medical cannabis retailer must consult​
3446+105.25with the patient to determine the proper type of medical cannabis flower, medical cannabinoid​
3447+105.26product, or medical cannabis paraphernalia and proper dosage for the patient after reviewing​
3448+105.27the range of chemical compositions of medical cannabis flower or medical cannabinoid​
3449+105.28product. For purposes of this subdivision, a consultation may be conducted remotely by​
3450+105.29secure videoconference, telephone, or other remote means, as long as:​
3451+105.30 (1) the pharmacist engaging in the consultation is able to confirm the identity of the​
3452+105.31patient; and​
3453+105.32 (2) the consultation adheres to patient privacy requirements that apply to health care​
3454+105.33services delivered through telemedicine.​
3455+105​Article 1 Sec. 51.​
3456+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 106.1 (b) Notwithstanding paragraph (a), a pharmacist consultation is not required prior to the​
3457+106.2distribution of medical cannabis flower or medical cannabinoid products when a medical​
3458+106.3cannabis retailer is distributing medical cannabis flower or medical cannabinoid products​
3459+106.4to a patient according to a patient-specific dosage plan established with that medical cannabis​
3460+106.5retailer and is not modifying the dosage or product being distributed under that plan. Medical​
3461+106.6cannabis flower or medical cannabinoid products distributed under this paragraph must be​
3462+106.7distributed by a pharmacy technician employed by the medical cannabis retailer.​
3463+106.8 Subd. 4.90-day supply.A medical cannabis retailer shall not distribute more than a​
3464+106.990-day supply of medical cannabis flower or medical cannabinoid products to a patient,​
3465+106.10registered designated caregiver, or parent, legal guardian, or spouse of a patient according​
3466+106.11to the dosages established for the individual patient.​
3467+106.12 Subd. 5.Distribution to recipient in a motor vehicle.A medical cannabis retailer may​
3468+106.13distribute medical cannabis flower and medical cannabinoid products to a patient, registered​
3469+106.14designated caregiver, or parent, legal guardian, or spouse of a patient who is at a dispensary​
3470+106.15location but remains in a motor vehicle, provided that:​
3471+106.16 (1) staff receive payment and distribute medical cannabis flower and medical cannabinoid​
3472+106.17products in a designated zone that is as close as feasible to the front door of the facility;​
3473+106.18 (2) the medical cannabis retailer ensures that the receipt of payment and distribution of​
3474+106.19medical cannabis flower and medical cannabinoid products are visually recorded by a​
3475+106.20closed-circuit television surveillance camera and provides any other necessary security​
3476+106.21safeguards;​
3477+106.22 (3) the medical cannabis retailer does not store medical cannabis flower or medical​
3478+106.23cannabinoid products outside a restricted access area and staff transport medical cannabis​
3479+106.24flower and medical cannabinoid products from a restricted access area to the designated​
3480+106.25zone for distribution only after confirming that the patient, designated caregiver, or parent,​
3481+106.26guardian, or spouse has arrived in the designated zone;​
3482+106.27 (4) the payment and distribution of medical cannabis flower and medical cannabinoid​
3483+106.28products take place only after a pharmacist consultation takes place, if required under​
3484+106.29subdivision 3;​
3485+106.30 (5) immediately following distribution of medical cannabis flower or medical cannabinoid​
3486+106.31products, staff enter the transaction in the statewide monitoring system; and​
3487+106.32 (6) immediately following distribution of medical cannabis flower and medical​
3488+106.33cannabinoid products, staff take the payment received into the facility.​
3489+106​Article 1 Sec. 51.​
3490+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 107.1 EFFECTIVE DATE.This section is effective January 1, 2024.​
3491+107.2Sec. 52. [342.52] PATIENT REGISTRY PROGRAM.​
3492+107.3 Subdivision 1.Administration.The Division of Medical Cannabis must administer the​
3493+107.4medical cannabis registry program.​
3494+107.5 Subd. 2.Application procedure for patients.(a) A patient seeking to enroll in the​
3495+107.6registry program must submit to the Division of Medical Cannabis an application established​
3496+107.7by the Division of Medical Cannabis and a copy of the certification specified in paragraph​
3497+107.8(b) or, if the patient is a veteran who receives care from the United States Department of​
3498+107.9Veterans Affairs, the information required pursuant to subdivision 3. The patient must​
3499+107.10provide at least the following information in the application:​
3500+107.11 (1) the patient's name, mailing address, and date of birth;​
3501+107.12 (2) the name, mailing address, and telephone number of the patient's health care​
3502+107.13practitioner;​
3503+107.14 (3) the name, mailing address, and date of birth of the patient's registered designated​
3504+107.15caregiver, if any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian,​
3505+107.16or spouse will be acting as the patient's caregiver;​
3506+107.17 (4) a disclosure signed by the patient that includes:​
3507+107.18 (i) a statement that, notwithstanding any law to the contrary, the Office of Cannabis​
3508+107.19Management, the Division of Medical Cannabis, or an employee of the Office of Cannabis​
3509+107.20Management or Division of Medical Cannabis may not be held civilly or criminally liable​
3510+107.21for any injury, loss of property, personal injury, or death caused by an act or omission while​
3511+107.22acting within the employee's scope of office or employment under this section; and​
3512+107.23 (ii) the patient's acknowledgment that enrollment in the registry program is conditional​
3513+107.24on the patient's agreement to meet all other requirements of this section; and​
3514+107.25 (5) all other information required by the Division of Medical Cannabis.​
3515+107.26 (b) As part of the application under this subdivision, a patient must submit a copy of a​
3516+107.27certification from the patient's health care practitioner that is dated within 90 days prior to​
3517+107.28the submission of the application and that certifies that the patient has been diagnosed with​
3518+107.29a qualifying medical condition.​
3519+107.30 (c) A patient's health care practitioner may submit a statement to the Division of Medical​
3520+107.31Cannabis declaring that the patient is no longer diagnosed with a qualifying medical​
3521+107.32condition. Within 30 days after receipt of a statement from a patient's health care practitioner,​
3522+107​Article 1 Sec. 52.​
3523+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 108.1the Division of Medical Cannabis must provide written notice to a patient stating that the​
3524+108.2patient's enrollment in the registry program will be revoked in 30 days unless the patient​
3525+108.3submits a certification from a health care practitioner that the patient is currently diagnosed​
3526+108.4with a qualifying medical condition or, if the patient is a veteran, the patient submits​
3527+108.5confirmation that the patient is currently diagnosed with a qualifying medical condition in​
3528+108.6a form and manner consistent with the information required for an application made pursuant​
3529+108.7to subdivision 3. If the Division of Medical Cannabis revokes a patient's enrollment in the​
3530+108.8registry program pursuant to this paragraph, the division must provide notice to the patient​
3531+108.9and to the patient's health care practitioner.​
3532+108.10 Subd. 3.Application procedure for veterans.(a) The Division of Medical Cannabis​
3533+108.11shall establish an alternative certification procedure for veterans who receive care from the​
3534+108.12United States Department of Veterans Affairs to confirm that the veteran has been diagnosed​
3535+108.13with a qualifying medical condition.​
3536+108.14 (b) A patient who is also a veteran and is seeking to enroll in the registry program must​
3537+108.15submit to the Division of Medical Cannabis an application established by the Division of​
3538+108.16Medical Cannabis that includes the information identified in subdivision 2, paragraph (a),​
3539+108.17and the additional information required by the Division of Medical Cannabis to certify that​
3540+108.18the patient has been diagnosed with a qualifying medical condition.​
3541+108.19 Subd. 4.Enrollment; denial of enrollment; revocation.(a) Within 30 days after the​
3542+108.20receipt of an application and certification or other documentation of a diagnosis with a​
3543+108.21qualifying medical condition, the Division of Medical Cannabis must approve or deny a​
3544+108.22patient's enrollment in the registry program. If the Division of Medical Cannabis approves​
3545+108.23a patient's enrollment in the registry program, the office must provide notice to the patient​
3546+108.24and to the patient's health care practitioner.​
3547+108.25 (b) A patient's enrollment in the registry program must only be denied if the patient:​
3548+108.26 (1) does not submit a certification from a health care practitioner or, if the patient is a​
3549+108.27veteran, the documentation required under subdivision 3 that the patient has been diagnosed​
3550+108.28with a qualifying medical condition;​
3551+108.29 (2) has not signed the disclosure required in subdivision 2;​
3552+108.30 (3) does not provide the information required by the Division of Medical Cannabis;​
3553+108.31 (4) provided false information on the application; or​
3554+108.32 (5) at the time of application, is also enrolled in a federally approved clinical trial for​
3555+108.33the treatment of a qualifying medical condition with medical cannabis.​
3556+108​Article 1 Sec. 52.​
3557+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 109.1 (c) If the Division of Medical Cannabis denies a patient's enrollment in the registry​
3558+109.2program, the Division of Medical Cannabis must provide written notice to a patient of all​
3559+109.3reasons for denying enrollment. Denial of enrollment in the registry program is considered​
3560+109.4a final decision of the office and is subject to judicial review under chapter 14.​
3561+109.5 (d) A patient's enrollment in the registry program may be revoked only:​
3562+109.6 (1) pursuant to subdivision 2, paragraph (c);​
3563+109.7 (2) upon the death of the patient;​
3564+109.8 (3) if the patient's certifying health care practitioner has filed a declaration under​
3565+109.9subdivision 2, paragraph (c), that the patient's qualifying diagnosis no longer exists and the​
3566+109.10patient does not submit another certification within 30 days;​
3567+109.11 (4) if the patient does not comply with subdivision 6; or​
3568+109.12 (5) if the patient intentionally sells or diverts medical cannabis flower or medical​
3569+109.13cannabinoid products in violation of this chapter.​
3570+109.14If a patient's enrollment in the registry program has been revoked due to a violation of​
3571+109.15subdivision 6, the patient may apply for enrollment 12 months after the date on which the​
3572+109.16patient's enrollment was revoked. The office must process such an application in accordance​
3573+109.17with this subdivision.​
3574+109.18 Subd. 5.Registry verification.When a patient is enrolled in the registry program, the​
3575+109.19Division of Medical Cannabis must assign the patient a patient registry number and must​
3576+109.20issue the patient and the patient's registered designated caregiver, parent, legal guardian, or​
3577+109.21spouse, if applicable, a registry verification. The Division of Medical Cannabis must also​
3578+109.22make the registry verification available to medical cannabis retailers. The registry verification​
3579+109.23must include:​
3580+109.24 (1) the patient's name and date of birth;​
3581+109.25 (2) the patient registry number assigned to the patient; and​
3582+109.26 (3) the name and date of birth of the patient's registered designated caregiver, if any, or​
3583+109.27the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or​
3584+109.28spouse will act as a caregiver.​
3585+109.29 Subd. 6.Conditions of continued enrollment.As conditions of continued enrollment,​
3586+109.30a patient must:​
3587+109.31 (1) continue to receive regularly scheduled treatment for the patient's qualifying medical​
3588+109.32condition from the patient's health care practitioner; and​
35713589 109​Article 1 Sec. 52.​
3572-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 110.1 (4) manufacture artificially derived cannabinoids;​
3573-110.2 (5) manufacture medical cannabinoid products;​
3574-110.3 (6) manufacture adult-use cannabis products, lower-potency hemp edibles, and​
3575-110.4hemp-derived consumer products for public consumption;​
3576-110.5 (7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis​
3577-110.6microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler,​
3578-110.7a medical cannabis cultivator, or another medical cannabis combination business;​
3579-110.8 (8) purchase hemp plant parts and propagules from an industrial hemp grower licensed​
3580-110.9under chapter 18K;​
3581-110.10 (9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids​
3582-110.11from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a​
3583-110.12cannabis wholesaler, a medical cannabis processor, or another medical cannabis combination​
3584-110.13business;​
3585-110.14 (10) purchase hemp concentrate from an industrial hemp processor licensed under chapter​
3586-110.1518K;​
3587-110.16 (11) package and label medical cannabis and medical cannabinoid products for sale to​
3588-110.17medical cannabis processors, medical cannabis retailers, other medical cannabis combination​
3589-110.18businesses, and patients enrolled in the registry program, registered designated caregivers,​
3590-110.19and parents, legal guardians, and spouses of an enrolled patient;​
3591-110.20 (12) package and label adult-use cannabis flower, adult-use cannabis products,​
3592-110.21lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;​
3593-110.22 (13) sell medical cannabis flower and medical cannabinoid products to patients enrolled​
3594-110.23in the registry program, registered designated caregivers, and parents, legal guardians, and​
3595-110.24spouses of an enrolled patient;​
3596-110.25 (14) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use​
3597-110.26cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and​
3598-110.27other products authorized by law to other cannabis businesses and to customers; and​
3599-110.28 (15) perform other actions approved by the office.​
3600-110.29 Subd. 2.Cultivation; size limitations.(a) A medical cannabis combination business​
3601-110.30may cultivate cannabis to be sold as medical cannabis flower or used in medical cannabinoid​
3602-110.31products in an area of up to 60,000 square feet of plant canopy.​
3590+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 110.1 (2) report changes in the patient's qualifying medical condition to the patient's health​
3591+110.2care practitioner.​
3592+110.3 Subd. 7.Enrollment period.Enrollment in the registry program is valid for one year.​
3593+110.4To re-enroll, a patient must submit the information required in subdivision 2 and a patient​
3594+110.5who is also a veteran must submit the information required in subdivision 3.​
3595+110.6 Subd. 8.Allowable delivery methods.A patient in the registry program may receive​
3596+110.7medical cannabis flower and medical cannabinoid products. The office may approve​
3597+110.8additional delivery methods to expand the types of products that qualify as medical​
3598+110.9cannabinoid products.​
3599+110.10 Subd. 9.Registered designated caregiver.(a) The Division of Medical Cannabis must​
3600+110.11register a designated caregiver for a patient if the patient requires assistance in administering​
3601+110.12medical cannabis flower or medical cannabinoid products or in obtaining medical cannabis​
3602+110.13flower, medical cannabinoid products, or medical cannabis paraphernalia from a medical​
3603+110.14cannabis retailer.​
3604+110.15 (b) In order to serve as a designated caregiver, a person must:​
3605+110.16 (1) be at least:​
3606+110.17 (i) 18 years of age to obtain or assist with medical cannabinoid products or medical​
3607+110.18cannabis paraphernalia; and​
3608+110.19 (ii) 21 years of age to obtain or assist with medical cannabis flower;​
3609+110.20 (2) agree to only possess the patient's medical cannabis flower and medical cannabinoid​
3610+110.21products for purposes of assisting the patient; and​
3611+110.22 (3) agree that if the application is approved, the person will not serve as a registered​
3612+110.23designated caregiver for more than six registered patients at one time. Patients who reside​
3613+110.24in the same residence count as one patient.​
3614+110.25 (c) The office shall conduct a criminal background check on the designated caregiver​
3615+110.26prior to registration to ensure that the person does not have a conviction for a disqualifying​
3616+110.27felony offense. Any cost of the background check shall be paid by the person seeking​
3617+110.28registration as a designated caregiver. A designated caregiver must have the criminal​
3618+110.29background check renewed every two years.​
3619+110.30 (d) Nothing in this section shall be construed to prevent a registered designated caregiver​
3620+110.31from being enrolled in the registry program as a patient and possessing and administering​
3621+110.32medical cannabis flower or medical cannabinoid products as a patient.​
36033622 110​Article 1 Sec. 52.​
3604-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 111.1 (b) A medical cannabis combination business may cultivate cannabis to be sold as​
3605-111.2adult-use cannabis flower or used in adult-use cannabis products in an area authorized by​
3606-111.3the office as described in paragraph (c).​
3607-111.4 (c) The office shall authorize a medical cannabis combination business to cultivate​
3608-111.5cannabis for sale in the adult-use market in an area of plant canopy that is equal to one-half​
3609-111.6of the area the business used to cultivate cannabis sold in the medical market in the preceding​
3610-111.7year. The office shall establish an annual verification and authorization procedure. The​
3611-111.8office may increase the area of plant canopy in which a medical cannabis combination​
3612-111.9business is authorized to cultivate cannabis for sale in the adult-use market between​
3613-111.10authorization periods if the business demonstrates a significant increase in the sale of medical​
3614-111.11cannabis and medical cannabis products.​
3615-111.12 Subd. 3.Manufacturing; size limitations.The office may establish limits on cannabis​
3616-111.13manufacturing that are consistent with the area of plant canopy a business is authorized to​
3617-111.14cultivate.​
3618-111.15 Subd. 4.Retail locations.A medical cannabis combination business may operate up to​
3619-111.16one retail location in each congressional district. A medical cannabis combination business​
3620-111.17must offer medical cannabis flower, medical cannabinoid products, or both at every retail​
3621-111.18location.​
3622-111.19 Subd. 5.Failure to participate; suspension or revocation of license.The office may​
3623-111.20suspend or revoke a medical cannabis combination business license if the office determines​
3624-111.21that the business is no longer actively participating in the medical cannabis market. The​
3625-111.22office may, by rule, establish minimum requirements related to cannabis cultivation,​
3626-111.23manufacturing of medical cannabinoid products, retail sales of medical cannabis flower and​
3627-111.24medical cannabinoid products, and other relevant criteria to demonstrate active participation​
3628-111.25in the medical cannabis market.​
3629-111.26 Subd. 6.Operations.A medical cannabis combination business must comply with the​
3630-111.27relevant requirements of sections 342.25, 342.26, 342.27, and 342.51, subdivisions 2 to 5.​
3631-111.28 EFFECTIVE DATE.This section is effective March 1, 2025.​
3632-111.29Sec. 53. [342.52] PATIENT REGISTRY PROGRAM.​
3633-111.30 Subdivision 1.Administration.The Division of Medical Cannabis must administer the​
3634-111.31medical cannabis registry program.​
3635-111.32 Subd. 2.Application procedure for patients.(a) A patient seeking to enroll in the​
3636-111.33registry program must submit to the Division of Medical Cannabis an application established​
3637-111​Article 1 Sec. 53.​
3638-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 112.1by the Division of Medical Cannabis and a copy of the certification specified in paragraph​
3639-112.2(b) or, if the patient is a veteran who receives care from the United States Department of​
3640-112.3Veterans Affairs, the information required pursuant to subdivision 3. The patient must​
3641-112.4provide at least the following information in the application:​
3642-112.5 (1) the patient's name, mailing address, and date of birth;​
3643-112.6 (2) the name, mailing address, and telephone number of the patient's health care​
3644-112.7practitioner;​
3645-112.8 (3) the name, mailing address, and date of birth of the patient's registered designated​
3646-112.9caregiver, if any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian,​
3647-112.10or spouse will be acting as the patient's caregiver;​
3648-112.11 (4) a disclosure signed by the patient that includes:​
3649-112.12 (i) a statement that, notwithstanding any law to the contrary, the Office of Cannabis​
3650-112.13Management, the Division of Medical Cannabis, or an employee of the Office of Cannabis​
3651-112.14Management or Division of Medical Cannabis may not be held civilly or criminally liable​
3652-112.15for any injury, loss of property, personal injury, or death caused by an act or omission while​
3653-112.16acting within the employee's scope of office or employment under this section; and​
3654-112.17 (ii) the patient's acknowledgment that enrollment in the registry program is conditional​
3655-112.18on the patient's agreement to meet all other requirements of this section; and​
3656-112.19 (5) all other information required by the Division of Medical Cannabis.​
3657-112.20 (b) As part of the application under this subdivision, a patient must submit a copy of a​
3658-112.21certification from the patient's health care practitioner that is dated within 90 days prior to​
3659-112.22the submission of the application and that certifies that the patient has been diagnosed with​
3660-112.23a qualifying medical condition.​
3661-112.24 (c) A patient's health care practitioner may submit a statement to the Division of Medical​
3662-112.25Cannabis declaring that the patient is no longer diagnosed with a qualifying medical​
3663-112.26condition. Within 30 days after receipt of a statement from a patient's health care practitioner,​
3664-112.27the Division of Medical Cannabis must provide written notice to a patient stating that the​
3665-112.28patient's enrollment in the registry program will be revoked in 30 days unless the patient​
3666-112.29submits a certification from a health care practitioner that the patient is currently diagnosed​
3667-112.30with a qualifying medical condition or, if the patient is a veteran, the patient submits​
3668-112.31confirmation that the patient is currently diagnosed with a qualifying medical condition in​
3669-112.32a form and manner consistent with the information required for an application made pursuant​
3670-112.33to subdivision 3. If the Division of Medical Cannabis revokes a patient's enrollment in the​
3671-112​Article 1 Sec. 53.​
3672-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 113.1registry program pursuant to this paragraph, the division must provide notice to the patient​
3673-113.2and to the patient's health care practitioner.​
3674-113.3 Subd. 3.Application procedure for veterans.(a) The Division of Medical Cannabis​
3675-113.4shall establish an alternative certification procedure for veterans who receive care from the​
3676-113.5United States Department of Veterans Affairs to confirm that the veteran has been diagnosed​
3677-113.6with a qualifying medical condition.​
3678-113.7 (b) A patient who is also a veteran and is seeking to enroll in the registry program must​
3679-113.8submit to the Division of Medical Cannabis an application established by the Division of​
3680-113.9Medical Cannabis that includes the information identified in subdivision 2, paragraph (a),​
3681-113.10and the additional information required by the Division of Medical Cannabis to certify that​
3682-113.11the patient has been diagnosed with a qualifying medical condition.​
3683-113.12 Subd. 4.Enrollment; denial of enrollment; revocation.(a) Within 30 days after the​
3684-113.13receipt of an application and certification or other documentation of a diagnosis with a​
3685-113.14qualifying medical condition, the Division of Medical Cannabis must approve or deny a​
3686-113.15patient's enrollment in the registry program. If the Division of Medical Cannabis approves​
3687-113.16a patient's enrollment in the registry program, the office must provide notice to the patient​
3688-113.17and to the patient's health care practitioner.​
3689-113.18 (b) A patient's enrollment in the registry program must only be denied if the patient:​
3690-113.19 (1) does not submit a certification from a health care practitioner or, if the patient is a​
3691-113.20veteran, the documentation required under subdivision 3 that the patient has been diagnosed​
3692-113.21with a qualifying medical condition;​
3693-113.22 (2) has not signed the disclosure required in subdivision 2;​
3694-113.23 (3) does not provide the information required by the Division of Medical Cannabis;​
3695-113.24 (4) provided false information on the application; or​
3696-113.25 (5) at the time of application, is also enrolled in a federally approved clinical trial for​
3697-113.26the treatment of a qualifying medical condition with medical cannabis.​
3698-113.27 (c) If the Division of Medical Cannabis denies a patient's enrollment in the registry​
3699-113.28program, the Division of Medical Cannabis must provide written notice to a patient of all​
3700-113.29reasons for denying enrollment. Denial of enrollment in the registry program is considered​
3701-113.30a final decision of the office and is subject to judicial review under chapter 14.​
3702-113.31 (d) A patient's enrollment in the registry program may be revoked only:​
3703-113.32 (1) pursuant to subdivision 2, paragraph (c);​
3704-113​Article 1 Sec. 53.​
3705-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 114.1 (2) upon the death of the patient;​
3706-114.2 (3) if the patient's certifying health care practitioner has filed a declaration under​
3707-114.3subdivision 2, paragraph (c), that the patient's qualifying diagnosis no longer exists and the​
3708-114.4patient does not submit another certification within 30 days;​
3709-114.5 (4) if the patient does not comply with subdivision 6; or​
3710-114.6 (5) if the patient intentionally sells or diverts medical cannabis flower or medical​
3711-114.7cannabinoid products in violation of this chapter.​
3712-114.8If a patient's enrollment in the registry program has been revoked due to a violation of​
3713-114.9subdivision 6, the patient may apply for enrollment 12 months after the date on which the​
3714-114.10patient's enrollment was revoked. The office must process such an application in accordance​
3715-114.11with this subdivision.​
3716-114.12 Subd. 5.Registry verification.When a patient is enrolled in the registry program, the​
3717-114.13Division of Medical Cannabis must assign the patient a patient registry number and must​
3718-114.14issue the patient and the patient's registered designated caregiver, parent, legal guardian, or​
3719-114.15spouse, if applicable, a registry verification. The Division of Medical Cannabis must also​
3720-114.16make the registry verification available to medical cannabis retailers. The registry verification​
3721-114.17must include:​
3722-114.18 (1) the patient's name and date of birth;​
3723-114.19 (2) the patient registry number assigned to the patient; and​
3724-114.20 (3) the name and date of birth of the patient's registered designated caregiver, if any, or​
3725-114.21the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or​
3726-114.22spouse will act as a caregiver.​
3727-114.23 Subd. 6.Conditions of continued enrollment.As conditions of continued enrollment,​
3728-114.24a patient must:​
3729-114.25 (1) continue to receive regularly scheduled treatment for the patient's qualifying medical​
3730-114.26condition from the patient's health care practitioner; and​
3731-114.27 (2) report changes in the patient's qualifying medical condition to the patient's health​
3732-114.28care practitioner.​
3733-114.29 Subd. 7.Enrollment period.Enrollment in the registry program is valid for three years.​
3734-114.30To re-enroll, a patient must submit the information required in subdivision 2 and a patient​
3735-114.31who is also a veteran must submit the information required in subdivision 3.​
3736-114​Article 1 Sec. 53.​
3737-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 115.1 Subd. 8.Allowable delivery methods.A patient in the registry program may receive​
3738-115.2medical cannabis flower and medical cannabinoid products. The office may approve​
3739-115.3additional delivery methods to expand the types of products that qualify as medical​
3740-115.4cannabinoid products.​
3741-115.5 Subd. 9.Registered designated caregiver.(a) The Division of Medical Cannabis must​
3742-115.6register a designated caregiver for a patient if the patient requires assistance in administering​
3743-115.7medical cannabis flower or medical cannabinoid products or in obtaining medical cannabis​
3744-115.8flower, medical cannabinoid products, or medical cannabis paraphernalia from a medical​
3745-115.9cannabis retailer.​
3746-115.10 (b) In order to serve as a designated caregiver, a person must:​
3747-115.11 (1) be at least 18 years of age;​
3748-115.12 (2) agree to only possess the patient's medical cannabis flower and medical cannabinoid​
3749-115.13products for purposes of assisting the patient; and​
3750-115.14 (3) agree that if the application is approved, the person will not serve as a registered​
3751-115.15designated caregiver for more than six registered patients at one time. Patients who reside​
3752-115.16in the same residence count as one patient.​
3753-115.17 (c) The office shall conduct a criminal background check on the designated caregiver​
3754-115.18prior to registration to ensure that the person does not have a conviction for a disqualifying​
3755-115.19felony offense. Any cost of the background check shall be paid by the person seeking​
3756-115.20registration as a designated caregiver. A designated caregiver must have the criminal​
3757-115.21background check renewed every two years.​
3758-115.22 (d) Nothing in this section shall be construed to prevent a registered designated caregiver​
3759-115.23from being enrolled in the registry program as a patient and possessing and administering​
3760-115.24medical cannabis flower or medical cannabinoid products as a patient.​
3761-115.25 Subd. 10.Parents, legal guardians, spouses.A parent, legal guardian, or spouse of a​
3762-115.26patient may act as the caregiver for a patient. The parent, legal guardian, or spouse who is​
3763-115.27acting as a caregiver must follow all requirements for parents, legal guardians, and spouses​
3764-115.28under this chapter. Nothing in this section limits any legal authority that a parent, legal​
3765-115.29guardian, or spouse may have for the patient under any other law.​
3766-115.30 Subd. 11.Notice of change of name or address.Patients and registered designated​
3767-115.31caregivers must notify the Division of Medical Cannabis of any address or name change​
3768-115.32within 30 days of the change having occurred. A patient or registered designated caregiver​
3769-115.33is subject to a $100 fine for failure to notify the office of the change.​
3770-115​Article 1 Sec. 53.​
3771-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 116.1 EFFECTIVE DATE.This section is effective March 1, 2025.​
3772-116.2Sec. 54. [342.53] DUTIES OF OFFICE OF CANNABIS MANAGEMENT;​
3773-116.3REGISTRY PROGRAM.​
3774-116.4 The office may add an allowable form of medical cannabinoid product, and may add or​
3775-116.5modify a qualifying medical condition upon its own initiative, upon a petition from a member​
3776-116.6of the public or from the Cannabis Advisory Council or as directed by law. The office must​
3777-116.7evaluate all petitions and must make the addition or modification if the office determines​
3778-116.8that the addition or modification is warranted by the best available evidence and research.​
3779-116.9If the office wishes to add an allowable form or add or modify a qualifying medical condition,​
3780-116.10the office must notify the chairs and ranking minority members of the legislative committees​
3781-116.11and divisions with jurisdiction over health finance and policy by January 15 of the year in​
3782-116.12which the change becomes effective. In this notification, the office must specify the proposed​
3783-116.13addition or modification, the reasons for the addition or modification, any written comments​
3784-116.14received by the office from the public about the addition or modification, and any guidance​
3785-116.15received from the Cannabis Advisory Council. An addition or modification by the office​
3786-116.16under this subdivision becomes effective on August 1 of that year unless the legislature by​
3787-116.17law provides otherwise.​
3788-116.18 EFFECTIVE DATE.This section is effective March 1, 2025.​
3789-116.19Sec. 55. [342.54] DUTIES OF DIVISION OF MEDICAL CANNABIS; REGISTRY​
3790-116.20PROGRAM.​
3791-116.21 Subdivision 1.Duties related to health care practitioners.The Division of Medical​
3792-116.22Cannabis must:​
3793-116.23 (1) provide notice of the registry program to health care practitioners in the state;​
3794-116.24 (2) allow health care practitioners to participate in the registry program if they request​
3795-116.25to participate and meet the program's requirements;​
3796-116.26 (3) provide explanatory information and assistance to health care practitioners to​
3797-116.27understand the nature of the therapeutic use of medical cannabis flower and medical​
3798-116.28cannabinoid products within program requirements;​
3799-116.29 (4) make available to participating health care practitioners a certification form in which​
3800-116.30a health care practitioner certifies that a patient has a qualifying medical condition; and​
3801-116.31 (5) supervise the participation of health care practitioners in the registry reporting system​
3802-116.32in which health care practitioners report patient treatment and health records information​
3803-116​Article 1 Sec. 55.​
3804-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 117.1to the office in a manner that ensures stringent security and record keeping requirements​
3805-117.2and that prevents the unauthorized release of private data on individuals as defined in section​
3806-117.313.02.​
3807-117.4 Subd. 2.Duties related to the registry program.The Division of Medical Cannabis​
3808-117.5must:​
3809-117.6 (1) administer the registry program according to section 342.52;​
3810-117.7 (2) provide information to patients enrolled in the registry program on the existence of​
3811-117.8federally approved clinical trials for the treatment of the patient's qualifying medical condition​
3812-117.9with medical cannabis flower or medical cannabinoid products as an alternative to enrollment​
3813-117.10in the registry program;​
3814-117.11 (3) maintain safety criteria with which patients must comply as a condition of participation​
3815-117.12in the registry program to prevent patients from undertaking any task under the influence​
3816-117.13of medical cannabis flower or medical cannabinoid products that would constitute negligence​
3817-117.14or professional malpractice;​
3818-117.15 (4) review and publicly report on existing medical and scientific literature regarding the​
3819-117.16range of recommended dosages for each qualifying medical condition, the range of chemical​
3820-117.17compositions of medical cannabis flower and medical cannabinoid products that will likely​
3821-117.18be medically beneficial for each qualifying medical condition, and any risks of noncannabis​
3822-117.19drug interactions. This information must be updated by December 1 of each year. The office​
3823-117.20may consult with an independent laboratory under contract with the office or other experts​
3824-117.21in reporting and updating this information; and​
3825-117.22 (5) annually consult with cannabis businesses about medical cannabis that the businesses​
3826-117.23cultivate, manufacture, and offer for sale and post on the Division of Medical Cannabis​
3827-117.24website a list of the medical cannabis flower and medical cannabinoid products offered for​
3828-117.25sale by each medical cannabis retailer.​
3829-117.26 Subd. 3.Research.(a) The Division of Medical Cannabis must conduct or contract with​
3830-117.27a third party to conduct research and studies using data from health records submitted to​
3831-117.28the registry program under section 342.55, subdivision 2, and data submitted to the registry​
3832-117.29program under section 342.52, subdivisions 2 and 3. If the division contracts with a third​
3833-117.30party for research and studies, the third party must provide the division with access to all​
3834-117.31research and study results. The division must submit reports on intermediate or final research​
3835-117.32results to the legislature and major scientific journals. All data used by the division or a​
3836-117.33third party under this subdivision must be used or reported in an aggregated nonidentifiable​
3837-117​Article 1 Sec. 55.​
3838-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 118.1form as part of a scientific peer-reviewed publication of research or in the creation of​
3839-118.2summary data, as defined in section 13.02, subdivision 19.​
3840-118.3 (b) The Division of Medical Cannabis may submit medical research based on the data​
3841-118.4collected under sections 342.55, subdivision 2, and data collected through the statewide​
3842-118.5monitoring system to any federal agency with regulatory or enforcement authority over​
3843-118.6medical cannabis flower and medical cannabinoid products to demonstrate the effectiveness​
3844-118.7of medical cannabis flower or medical cannabinoid products for treating or alleviating the​
3845-118.8symptoms of a qualifying medical condition.​
3846-118.9 EFFECTIVE DATE.This section is effective March 1, 2025.​
3847-118.10Sec. 56. [342.55] DUTIES OF HEALTH CARE PRACTITIONERS; REGISTRY​
3848-118.11PROGRAM.​
3849-118.12 Subdivision 1.Health care practitioner duties before patient enrollment.Before a​
3850-118.13patient's enrollment in the registry program, a health care practitioner must:​
3851-118.14 (1) determine, in the health care practitioner's medical judgment, whether a patient has​
3852-118.15a qualifying medical condition and, if so determined, provide the patient with a certification​
3853-118.16of that diagnosis;​
3854-118.17 (2) advise patients, registered designated caregivers, and parents, legal guardians, and​
3855-118.18spouses acting as caregivers of any nonprofit patient support groups or organizations;​
3856-118.19 (3) provide to patients explanatory information from the Division of Medical Cannabis,​
3857-118.20including information about the experimental nature of the therapeutic use of medical​
3858-118.21cannabis flower and medical cannabinoid products; the possible risks, benefits, and side​
3859-118.22effects of the proposed treatment; and the application and other materials from the office;​
3860-118.23 (4) provide to patients a Tennessen warning as required under section 13.04, subdivision​
3861-118.242; and​
3862-118.25 (5) agree to continue treatment of the patient's qualifying medical condition and to report​
3863-118.26findings to the Division of Medical Cannabis.​
3864-118.27 Subd. 2.Duties upon patient's enrollment in registry program.Upon receiving​
3865-118.28notification from the Division of Medical Cannabis of the patient's enrollment in the registry​
3866-118.29program, a health care practitioner must:​
3867-118.30 (1) participate in the patient registry reporting system under the guidance and supervision​
3868-118.31of the Division of Medical Cannabis;​
3869-118​Article 1 Sec. 56.​
3870-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 119.1 (2) report to the Division of Medical Cannabis patient health records throughout the​
3871-119.2patient's ongoing treatment in a manner determined by the office and in accordance with​
3872-119.3subdivision 4;​
3873-119.4 (3) determine on a yearly basis if the patient continues to have a qualifying medical​
3874-119.5condition and, if so, issue the patient a new certification of that diagnosis. The patient​
3875-119.6assessment conducted under this clause may be conducted via telehealth, as defined in​
3876-119.7section 62A.673, subdivision 2; and​
3877-119.8 (4) otherwise comply with requirements established by the Office of Cannabis​
3878-119.9Management and the Division of Medical Cannabis.​
3879-119.10 Subd. 3.Participation not required.Nothing in this section requires a health care​
3880-119.11practitioner to participate in the registry program.​
3881-119.12 Subd. 4.Data.Data on patients collected by a health care practitioner and reported to​
3882-119.13the registry program, including data on patients who are veterans who receive care from​
3883-119.14the United States Department of Veterans Affairs, are health records under section 144.291​
3884-119.15and are private data on individuals under section 13.02 but may be used or reported in an​
3885-119.16aggregated nonidentifiable form as part of a scientific peer-reviewed publication of research​
3886-119.17conducted under section 342.54 or in the creation of summary data, as defined in section​
3887-119.1813.02, subdivision 19.​
3888-119.19 Subd. 5.Exception.The requirements of this section do not apply to a patient who is a​
3889-119.20veteran who receives care from the United States Department of Veterans Affairs or a health​
3890-119.21care practitioner employed by the United States Department of Veterans Affairs. Such a​
3891-119.22patient must meet the certification requirements developed pursuant to section 342.52,​
3892-119.23subdivision 3, before the patient's enrollment in the registry program.​
3893-119.24 EFFECTIVE DATE.This section is effective March 1, 2025.​
3894-119.25Sec. 57. [342.56] LIMITATIONS.​
3895-119.26 Subdivision 1.Limitations on consumption; locations of consumption.(a) Nothing​
3896-119.27in sections 342.47 to 342.60 permits any person to engage in, and does not prevent the​
3897-119.28imposition of any civil, criminal, or other penalties for:​
3898-119.29 (1) undertaking a task under the influence of medical cannabis flower or medical​
3899-119.30cannabinoid products that would constitute negligence or professional malpractice;​
3900-119.31 (2) possessing or consuming medical cannabis flower or medical cannabinoid products:​
3901-119.32 (i) on a school bus or van;​
3902-119​Article 1 Sec. 57.​
3903-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 120.1 (ii) in a correctional facility;​
3904-120.2 (iii) in a state-operated treatment program, including the Minnesota sex offender program;​
3905-120.3or​
3906-120.4 (iv) on the grounds of a child care facility or family or group family day care program;​
3907-120.5 (3) vaporizing or smoking medical cannabis:​
3908-120.6 (i) on any form of public transportation;​
3909-120.7 (ii) where the vapor would be inhaled by a nonpatient minor or where the smoke would​
3910-120.8be inhaled by a minor; or​
3911-120.9 (iii) in any public place, including any indoor or outdoor area used by or open to the​
3912-120.10general public or a place of employment, as defined in section 144.413, subdivision 1b; and​
3913-120.11 (4) operating, navigating, or being in actual physical control of a motor vehicle, aircraft,​
3914-120.12train, or motorboat or working on transportation property, equipment, or facilities while​
3915-120.13under the influence of medical cannabis flower or a medical cannabinoid product.​
3916-120.14 (b) Except for the use of medical cannabis flower or medical cannabinoid products, the​
3917-120.15vaporizing or smoking of cannabis flower, cannabis products, artificially derived​
3918-120.16cannabinoids, or hemp-derived consumer products is prohibited in a multifamily housing​
3919-120.17building, including balconies and patios appurtenant thereto. A violation of this paragraph​
3920-120.18is punishable through a civil administrative fine in an amount of $250.​
3921-120.19 Subd. 2.Health care facilities.(a) Health care facilities licensed under chapter 144A;​
3922-120.20hospice providers licensed under chapter 144A; boarding care homes or supervised living​
3923-120.21facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities​
3924-120.22owned, controlled, managed, or under common control with hospitals licensed under chapter​
3925-120.23144; and other health care facilities licensed by the commissioner of health or the​
3926-120.24commissioner of human services may adopt reasonable restrictions on the use of medical​
3927-120.25cannabis flower or medical cannabinoid products by a patient enrolled in the registry program​
3928-120.26who resides at or is actively receiving treatment or care at the facility. The restrictions may​
3929-120.27include a provision that the facility must not store or maintain a patient's supply of medical​
3930-120.28cannabis flower or medical cannabinoid products on behalf of the patient; that a patient​
3931-120.29store the patient's supply of medical cannabis flower or medicinal cannabinoid products in​
3932-120.30a locked container accessible only to the patient, the patient's designated caregiver, or the​
3933-120.31patient's parent, legal guardian, or spouse; that the facility is not responsible for providing​
3934-120.32medical cannabis for patients; and that medical cannabis flower or medical cannabinoid​
3935-120.33products are used only in a location specified by the facility or provider. Nothing in this​
3936-120​Article 1 Sec. 57.​
3937-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 121.1subdivision requires facilities and providers listed in this subdivision to adopt such​
3938-121.2restrictions.​
3939-121.3 (b) No facility or provider listed in this subdivision may unreasonably limit a patient's​
3940-121.4access to or use of medical cannabis flower or medical cannabinoid products to the extent​
3941-121.5that such use is authorized under sections 342.47 to 342.59. No facility or provider listed​
3942-121.6in this subdivision may prohibit a patient access to or use of medical cannabis flower or​
3943-121.7medical cannabinoid products due solely to the fact that cannabis is a Schedule I drug​
3944-121.8pursuant to the federal Uniform Controlled Substances Act. If a federal regulatory agency,​
3945-121.9the United States Department of Justice, or the federal Centers for Medicare and Medicaid​
3946-121.10Services takes one of the following actions, a facility or provider may suspend compliance​
3947-121.11with this paragraph until the regulatory agency, the United States Department of Justice, or​
3948-121.12the federal Centers for Medicare and Medicaid Services notifies the facility or provider that​
3949-121.13it may resume permitting the use of medical cannabis flower or medical cannabinoid products​
3950-121.14within the facility or in the provider's service setting:​
3951-121.15 (1) a federal regulatory agency or the United States Department of Justice initiates​
3952-121.16enforcement action against a facility or provider related to the facility's compliance with​
3953-121.17the medical cannabis program; or​
3954-121.18 (2) a federal regulatory agency, the United States Department of Justice, or the federal​
3955-121.19Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification​
3956-121.20to the facility or provider that expressly prohibits the use of medical cannabis in health care​
3957-121.21facilities or otherwise prohibits compliance with the medical cannabis program.​
3958-121.22 (c) An employee or agent of a facility or provider listed in this subdivision or a person​
3959-121.23licensed under chapter 144E is not violating this chapter or chapter 152 for the possession​
3960-121.24of medical cannabis flower or medical cannabinoid products while carrying out employment​
3961-121.25duties, including providing or supervising care to a patient enrolled in the registry program,​
3962-121.26or distribution of medical cannabis flower or medical cannabinoid products to a patient​
3963-121.27enrolled in the registry program who resides at or is actively receiving treatment or care at​
3964-121.28the facility or from the provider with which the employee or agent is affiliated.​
3965-121.29 Subd. 3.Child care facilities.A proprietor of a family or group family day care program​
3966-121.30must disclose to parents or guardians of children cared for on the premises of the family or​
3967-121.31group family day care program, if the proprietor permits the smoking or use of medical​
3968-121.32cannabis on the premises, outside of its hours of operation. Disclosure must include posting​
3969-121.33on the premises a conspicuous written notice and orally informing parents or guardians.​
3970-121.34 EFFECTIVE DATE.This section is effective March 1, 2025.​
3971-121​Article 1 Sec. 57.​
3972-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 122.1Sec. 58. [342.57] PROTECTIONS FOR REGISTRY PROGRAM PARTICIPANTS.​
3973-122.2 Subdivision 1.Presumption.There is a presumption that a patient enrolled in the registry​
3974-122.3program is engaged in the authorized use of medical cannabis flower and medical cannabinoid​
3975-122.4products. This presumption may be rebutted by evidence that the patient's use of medical​
3976-122.5cannabis flower or medical cannabinoid products was not for the purpose of treating or​
3977-122.6alleviating the patient's qualifying medical condition or symptoms associated with the​
3978-122.7patient's qualifying medical condition.​
3979-122.8 Subd. 2.Criminal and civil protections.(a) Subject to section 342.56, the following​
3980-122.9are not violations of this chapter or chapter 152:​
3981-122.10 (1) use or possession of medical cannabis flower, medical cannabinoid products, or​
3982-122.11medical cannabis paraphernalia by a patient enrolled in the registry program or by a visiting​
3983-122.12patient to whom medical cannabis flower or medical cannabinoid products are distributed​
3984-122.13under section 342.51, subdivision 5;​
3985-122.14 (2) possession of medical cannabis flower, medical cannabinoid products, or medical​
3986-122.15cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or​
3987-122.16spouse of a patient enrolled in the registry program; or​
3988-122.17 (3) possession of medical cannabis flower, medical cannabinoid products, or medical​
3989-122.18cannabis paraphernalia by any person while carrying out duties required under sections​
3990-122.19342.47 to 342.60.​
3991-122.20 (b) The Office of Cannabis Management, members of the Cannabis Advisory Council,​
3992-122.21Office of Cannabis Management employees, agents or contractors of the Office of Cannabis​
3993-122.22Management, and health care practitioners participating in the registry program are not​
3994-122.23subject to any civil penalties or disciplinary action by the Board of Medical Practice, the​
3995-122.24Board of Nursing, or any business, occupational, or professional licensing board or entity​
3996-122.25solely for participating in the registry program either in a professional capacity or as a​
3997-122.26patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or​
3998-122.27disciplinary action by the Board of Pharmacy when acting in accordance with sections​
3999-122.28342.47 to 342.60 either in a professional capacity or as a patient. Nothing in this section​
4000-122.29prohibits a professional licensing board from taking action in response to a violation of law.​
4001-122.30 (c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the​
4002-122.31governor, or an employee of a state agency must not be held civilly or criminally liable for​
4003-122.32any injury, loss of property, personal injury, or death caused by any act or omission while​
4004-122.33acting within the scope of office or employment under sections 342.47 to 342.60.​
4005-122​Article 1 Sec. 58.​
4006-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 123.1 (d) Federal, state, and local law enforcement authorities are prohibited from accessing​
4007-123.2the registry except when acting pursuant to a valid search warrant. Notwithstanding section​
4008-123.313.09, a violation of this paragraph is a gross misdemeanor.​
4009-123.4 (e) Notwithstanding any law to the contrary, the office and employees of the office must​
4010-123.5not release data or information about an individual contained in any report or document or​
4011-123.6in the registry and must not release data or information obtained about a patient enrolled in​
4012-123.7the registry program, except as provided in sections 342.47 to 342.60. Notwithstanding​
4013-123.8section 13.09, a violation of this paragraph is a gross misdemeanor.​
4014-123.9 (f) No information contained in a report or document, contained in the registry, or​
4015-123.10obtained from a patient under sections 342.47 to 342.60 may be admitted as evidence in a​
4016-123.11criminal proceeding, unless:​
4017-123.12 (1) the information is independently obtained; or​
4018-123.13 (2) admission of the information is sought in a criminal proceeding involving a criminal​
4019-123.14violation of sections 342.47 to 342.60.​
4020-123.15 (g) Possession of a registry verification or an application for enrollment in the registry​
4021-123.16program:​
4022-123.17 (1) does not constitute probable cause or reasonable suspicion;​
4023-123.18 (2) must not be used to support a search of the person or property of the person with a​
4024-123.19registry verification or application to enroll in the registry program; and​
4025-123.20 (3) must not subject the person or the property of the person to inspection by any​
4026-123.21government agency.​
4027-123.22 Subd. 3.School enrollment; rental property.(a) No school may refuse to enroll a​
4028-123.23patient as a pupil or otherwise penalize a patient solely because the patient is enrolled in​
4029-123.24the registry program, unless failing to do so would violate federal law or regulations or​
4030-123.25cause the school to lose a monetary or licensing-related benefit under federal law or​
4031-123.26regulations.​
4032-123.27 (b) No landlord may refuse to lease to a patient or otherwise penalize a patient solely​
4033-123.28because the patient is enrolled in the registry program, unless failing to do so would violate​
4034-123.29federal law or regulations or cause the landlord to lose a monetary or licensing-related​
4035-123.30benefit under federal law or regulations.​
4036-123.31 Subd. 4.Medical care.For purposes of medical care, including organ transplants, a​
4037-123.32patient's use of medical cannabis flower or medical cannabinoid products according to​
4038-123​Article 1 Sec. 58.​
4039-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 124.1sections 342.47 to 342.60 is considered the equivalent of the authorized use of a medication​
4040-124.2used at the discretion of a health care practitioner and does not disqualify a patient from​
4041-124.3needed medical care.​
4042-124.4 Subd. 5.Employment.(a) Unless a failure to do so would violate federal or state law​
4043-124.5or regulations or cause an employer to lose a monetary or licensing-related benefit under​
4044-124.6federal law or regulations, an employer may not discriminate against a person in hiring,​
4045-124.7termination, or any term or condition of employment, or otherwise penalize a person, if the​
4046-124.8discrimination is based on:​
4047-124.9 (1) the person's status as a patient enrolled in the registry program; or​
4048-124.10 (2) a patient's positive drug test for cannabis components or metabolites, unless the​
4049-124.11patient used, possessed, sold, transported, or was impaired by medical cannabis flower or​
4050-124.12a medical cannabinoid product on work premises, during working hours, or while operating​
4051-124.13an employer's machinery, vehicle, or equipment.​
4052-124.14 (b) An employee who is a patient and whose employer requires the employee to undergo​
4053-124.15drug testing according to section 181.953 may present the employee's registry verification​
4054-124.16as part of the employee's explanation under section 181.953, subdivision 6.​
4055-124.17 Subd. 6.Custody; visitation; parenting time.A person must not be denied custody of​
4056-124.18a minor child or visitation rights or parenting time with a minor child based solely on the​
4057-124.19person's status as a patient enrolled in the registry program. There must be no presumption​
4058-124.20of neglect or child endangerment for conduct allowed under sections 342.47 to 342.60,​
4059-124.21unless the person's behavior creates an unreasonable danger to the safety of the minor as​
4060-124.22established by clear and convincing evidence.​
4061-124.23 Subd. 7.Action for damages.In addition to any other remedy provided by law, a patient​
4062-124.24may bring an action for damages against any person who violates subdivision 3, 4, or 5. A​
4063-124.25person who violates subdivision 3, 4, or 5 is liable to a patient injured by the violation for​
4064-124.26the greater of the person's actual damages or a civil penalty of $100 and reasonable attorney​
4065-124.27fees.​
4066-124.28 Subd. 8.Sanctions restricted for those on parole, supervised release, or conditional​
4067-124.29release.(a) This subdivision applies to an individual placed on parole, supervised release,​
4068-124.30or conditional release.​
4069-124.31 (b) The commissioner of corrections may not:​
4070-124.32 (1) prohibit an individual from participating in the registry program as a condition of​
4071-124.33release; or​
4072-124​Article 1 Sec. 58.​
4073-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 125.1 (2) revoke an individual's parole, supervised release, or conditional release or otherwise​
4074-125.2sanction an individual solely:​
4075-125.3 (i) for participating in the registry program; or​
4076-125.4 (ii) for a positive drug test for cannabis components or metabolites.​
4077-125.5 EFFECTIVE DATE.This section is effective March 1, 2025.​
4078-125.6Sec. 59. [342.58] VIOLATION BY HEALTH CARE PRACTITIONER; CRIMINAL​
4079-125.7PENALTY.​
4080-125.8 A health care practitioner who knowingly refers patients to a medical cannabis business​
4081-125.9or to a designated caregiver, who advertises as a retailer or producer of medical cannabis​
4082-125.10flower or medical cannabinoid products, or who issues certifications while holding a financial​
4083-125.11interest in a cannabis retailer or medical cannabis business is guilty of a misdemeanor and​
4084-125.12may be sentenced to imprisonment for not more than 90 days or to payment of not more​
4085-125.13than $1,000, or both.​
4086-125.14 EFFECTIVE DATE.This section is effective March 1, 2025.​
4087-125.15Sec. 60. [342.59] DATA PRACTICES.​
4088-125.16 Subdivision 1.Data classification.Patient health records maintained by the Office of​
4089-125.17Cannabis Management or the Division of Medical Cannabis and government data in patient​
4090-125.18health records maintained by a health care practitioner are classified as private data on​
4091-125.19individuals, as defined in section 13.02, subdivision 12, or nonpublic data, as defined in​
4092-125.20section 13.02, subdivision 9.​
4093-125.21 Subd. 2.Allowable use; prohibited use.Data specified in subdivision 1 may be used​
4094-125.22to comply with chapter 13, to comply with a request from the legislative auditor or the state​
4095-125.23auditor in the performance of official duties, and for purposes specified in sections 342.47​
4096-125.24to 342.60. Data specified in subdivision 1 and maintained by the Office of Cannabis​
4097-125.25Management or Division of Medical Cannabis must not be used for any purpose not specified​
4098-125.26in sections 342.47 to 342.60 and must not be combined or linked in any manner with any​
4099-125.27other list, dataset, or database. Data specified in subdivision 1 must not be shared with any​
4100-125.28federal agency, federal department, or federal entity unless specifically ordered to do so by​
4101-125.29a state or federal court.​
4102-125.30 EFFECTIVE DATE.This section is effective March 1, 2025.​
4103-125​Article 1 Sec. 60.​
4104-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 126.1Sec. 61. [342.60] APPLIED RESEARCH.​
4105-126.2 The Division of Medical Cannabis may conduct, or award grants to health care providers​
4106-126.3or research organizations to conduct, applied research on the safety and efficacy of using​
4107-126.4medical cannabis flower or medical cannabinoid products to treat a specific health condition.​
4108-126.5A health care provider or research organization receiving a grant under this section must​
4109-126.6provide the office with access to all data collected in applied research funded under this​
4110-126.7section. The office may use data from applied research conducted or funded under this​
4111-126.8section as evidence to approve additional qualifying medical conditions or additional​
4112-126.9allowable forms of medical cannabis.​
4113-126.10 EFFECTIVE DATE.This section is effective March 1, 2025.​
4114-126.11Sec. 62. [342.61] TESTING.​
4115-126.12 Subdivision 1.Testing required.Cannabis businesses and hemp businesses shall not​
4116-126.13sell or offer for sale cannabis flower, cannabis products, artificially derived cannabinoids,​
4117-126.14lower-potency hemp edibles, or hemp-derived consumer products to another cannabis​
4118-126.15business or hemp business, or to a customer or patient, or otherwise transfer cannabis flower,​
4119-126.16cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or​
4120-126.17hemp-derived consumer products to another cannabis business or hemp business, unless:​
4121-126.18 (1) a representative sample of the batch of cannabis flower, cannabis products, artificially​
4122-126.19derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products​
4123-126.20has been tested according to this section and rules adopted under this chapter;​
4124-126.21 (2) the testing was completed by a cannabis testing facility licensed under this chapter;​
4125-126.22and​
4126-126.23 (3) the tested sample of cannabis flower, cannabis products, artificially derived​
4127-126.24cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products was found​
4128-126.25to meet testing standards established by the office.​
4129-126.26 Subd. 2.Procedures and standards established by office.(a) The office shall by rule​
4130-126.27establish procedures governing the sampling, handling, testing, storage, and transportation​
4131-126.28of cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency​
4132-126.29hemp edibles, or hemp-derived consumer products tested under this section; the contaminants​
4133-126.30for which cannabis flower, cannabis products, artificially derived cannabinoids,​
4134-126.31lower-potency hemp edibles, or hemp-derived consumer products must be tested; standards​
4135-126.32for potency and homogeneity testing; and procedures applicable to cannabis businesses,​
4136-126.33hemp businesses, and cannabis testing facilities regarding cannabis flower, cannabis products,​
4137-126​Article 1 Sec. 62.​
4138-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 127.1artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer​
4139-127.2products that fail to meet the standards for allowable levels of contaminants established by​
4140-127.3the office, that fail to meet the potency limits in this chapter, or that do not conform with​
4141-127.4the content of the cannabinoid profile listed on the label.​
4142-127.5 (b) All testing required under this section must be performed in a manner that is consistent​
4143-127.6with general requirements for testing and calibration activities.​
4144-127.7 Subd. 3.Standards established by Office of Cannabis Management.The office shall​
4145-127.8by rule establish standards for allowable levels of contaminants in cannabis flower, cannabis​
4146-127.9products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived​
4147-127.10consumer products, and growing media. Contaminants for which the office must establish​
4148-127.11allowable levels must include but are not limited to residual solvents, foreign material,​
4149-127.12microbiological contaminants, heavy metals, pesticide residue, and mycotoxins.​
4150-127.13 Subd. 4.Testing of samples; disclosures.(a) On a schedule determined by the office,​
4151-127.14every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis​
4152-127.15manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency​
4153-127.16hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or​
4154-127.17medical cannabis combination business shall make each batch of cannabis flower, cannabis​
4155-127.18products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived​
4156-127.19consumer products grown, manufactured, or imported by the cannabis business or hemp​
4157-127.20business available to a cannabis testing facility.​
4158-127.21 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis​
4159-127.22manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency​
4160-127.23hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or​
4161-127.24medical cannabis combination business must disclose all known information regarding​
4162-127.25pesticides, fertilizers, solvents, or other foreign materials, including but not limited to​
4163-127.26catalysts used in creating artificially derived cannabinoids, applied or added to the batch of​
4164-127.27cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp​
4165-127.28edibles, or hemp-derived consumer products subject to testing. Disclosure must be made​
4166-127.29to the cannabis testing facility and must include information about all applications by any​
4167-127.30person, whether intentional or accidental.​
4168-127.31 (c) The cannabis testing facility shall select one or more representative samples from​
4169-127.32each batch, test the samples for the presence of contaminants, and test the samples for​
4170-127.33potency and homogeneity and to allow the cannabis flower, cannabis product, artificially​
4171-127.34derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be​
4172-127​Article 1 Sec. 62.​
4173-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 128.1accurately labeled with its cannabinoid profile. Testing for contaminants must include testing​
4174-128.2for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide​
4175-128.3residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include​
4176-128.4testing for other contaminants. A cannabis testing facility must destroy or return to the​
4177-128.5cannabis business or hemp business any part of the sample that remains after testing.​
4178-128.6 Subd. 5.Test results.(a) If a sample meets the applicable testing standards, a cannabis​
4179-128.7testing facility shall issue a certification to a cannabis microbusiness, cannabis​
4180-128.8mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an​
4181-128.9endorsement to import products, lower-potency hemp edible manufacturer, medical cannabis​
4182-128.10cultivator, medical cannabis processor, or medical cannabis combination business and the​
4183-128.11cannabis business or hemp business may then sell or transfer the batch of cannabis flower,​
4184-128.12cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or​
4185-128.13hemp-derived consumer products from which the sample was taken to another cannabis​
4186-128.14business or hemp business, or offer the cannabis flower, cannabis products, lower-potency​
4187-128.15hemp edibles, or hemp-derived consumer products for sale to customers or patients. If a​
4188-128.16sample does not meet the applicable testing standards or if the testing facility is unable to​
4189-128.17test for a substance identified pursuant to subdivision 4, paragraph (b), the batch from which​
4190-128.18the sample was taken shall be subject to procedures established by the office for such batches,​
4191-128.19including destruction, remediation, or retesting.​
4192-128.20 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis​
4193-128.21manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency​
4194-128.22hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or​
4195-128.23medical cannabis combination business must maintain the test results for cannabis flower,​
4196-128.24cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or​
4197-128.25hemp-derived consumer products grown, manufactured, or imported by that cannabis​
4198-128.26business or hemp business for at least five years after the date of testing.​
4199-128.27 (c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis​
4200-128.28manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency​
4201-128.29hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or​
4202-128.30medical cannabis combination business shall make test results maintained by that cannabis​
4203-128.31business or hemp business available for review by any member of the public, upon request.​
4204-128.32Test results made available to the public must be in plain language.​
4205-128​Article 1 Sec. 62.​
4206-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 129.1Sec. 63. [342.62] PACKAGING.​
4207-129.2 Subdivision 1.General.All cannabis flower, cannabis products, lower-potency hemp​
4208-129.3edibles, and hemp-derived consumer products sold to customers or patients must be packaged​
4209-129.4as required by this section and rules adopted under this chapter.​
4210-129.5 Subd. 2.Packaging requirements.(a) Except as provided in paragraph (b), all cannabis​
4211-129.6flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products​
4212-129.7sold to customers or patients must be:​
4213-129.8 (1) prepackaged in packaging or a container that is child-resistant, tamper-evident, and​
4214-129.9opaque; or​
4215-129.10 (2) placed in packaging or a container that is plain, child-resistant, tamper-evident, and​
4216-129.11opaque at the final point of sale to a customer.​
4217-129.12 (b) The requirement that packaging be child-resistant does not apply to a lower-potency​
4218-129.13hemp edible that is intended to be consumed as a beverage.​
4219-129.14 (c) If a cannabis product, lower-potency hemp edible, or a hemp-derived consumer​
4220-129.15product is packaged in a manner that includes more than a single serving, each serving must​
4221-129.16be indicated by scoring, wrapping, or other indicators designating the individual serving​
4222-129.17size. If the item is a lower-potency hemp edible, serving indicators must meet the​
4223-129.18requirements of section 342.46, subdivision 6, paragraph (b).​
4224-129.19 (d) Edible cannabis products and lower-potency hemp edibles containing more than a​
4225-129.20single serving must be prepackaged or placed at the final point of sale in packaging or a​
4226-129.21container that is resealable.​
4227-129.22 Subd. 3.Packaging prohibitions.(a) Cannabis flower, cannabis products, lower-potency​
4228-129.23hemp edibles, or hemp-derived consumer products sold to customers or patients must not​
4229-129.24be packaged in a manner that:​
4230-129.25 (1) bears a reasonable resemblance to any commercially available product that does not​
4231-129.26contain cannabinoids, whether the manufacturer of the product holds a registered trademark​
4232-129.27or has registered the trade dress; or​
4233-129.28 (2) is designed to appeal to persons under 21 years of age.​
4234-129.29 (b) Packaging for cannabis flower, cannabis products, lower-potency hemp edibles, and​
4235-129.30hemp-derived consumer products must not contain or be coated with any perfluoroalkyl​
4236-129.31substance.​
4237-129​Article 1 Sec. 63.​
4238-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 130.1 (c) Edible cannabis products and lower-potency hemp edibles must not be packaged in​
4239-130.2a material that is not approved by the United States Food and Drug Administration for use​
4240-130.3in packaging food.​
4241-130.4Sec. 64. [342.63] LABELING.​
4242-130.5 Subdivision 1.General.All cannabis flower, cannabis products, lower-potency hemp​
4243-130.6edibles, and hemp-derived consumer products sold to customers or patients must be labeled​
4244-130.7as required by this section and rules adopted under this chapter.​
4245-130.8 Subd. 2.Content of label; cannabis.All cannabis flower and hemp-derived consumer​
4246-130.9products that consist of hemp plant parts sold to customers or patients must have affixed​
4247-130.10on the packaging or container of the cannabis flower or hemp-derived consumer product a​
4248-130.11label that contains at least the following information:​
4249-130.12 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,​
4250-130.13cannabis cultivator, medical cannabis cultivator, or industrial hemp grower where the​
4251-130.14cannabis flower or hemp plant part was cultivated;​
4252-130.15 (2) the net weight or volume of cannabis flower or hemp plant parts in the package or​
4253-130.16container;​
4254-130.17 (3) the batch number;​
4255-130.18 (4) the cannabinoid profile;​
4256-130.19 (5) a universal symbol established by the office indicating that the package or container​
4257-130.20contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a​
4258-130.21hemp-derived consumer product;​
4259-130.22 (6) verification that the cannabis flower or hemp plant part was tested according to​
4260-130.23section 342.61 and that the cannabis flower or hemp plant part complies with the applicable​
4261-130.24standards;​
4262-130.25 (7) the maximum dose, quantity, or consumption that may be considered medically safe​
4263-130.26within a 24-hour period;​
4264-130.27 (8) the following statement: "Keep this product out of reach of children."; and​
4265-130.28 (9) any other statements or information required by the office.​
4266-130.29 Subd. 3.Content of label; cannabinoid products.(a) All cannabis products,​
4267-130.30lower-potency hemp edibles, hemp-derived consumer products other than products subject​
4268-130.31to the requirements under subdivision 2, medical cannabinoid products, and hemp-derived​
3623+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 111.1 Subd. 10.Parents, legal guardians, spouses.A parent, legal guardian, or spouse of a​
3624+111.2patient may act as the caregiver for a patient. The parent, legal guardian, or spouse who is​
3625+111.3acting as a caregiver must follow all requirements for parents, legal guardians, and spouses​
3626+111.4under this chapter. Nothing in this section limits any legal authority that a parent, legal​
3627+111.5guardian, or spouse may have for the patient under any other law.​
3628+111.6 Subd. 11.Notice of change of name or address.Patients and registered designated​
3629+111.7caregivers must notify the Division of Medical Cannabis of any address or name change​
3630+111.8within 30 days of the change having occurred. A patient or registered designated caregiver​
3631+111.9is subject to a $100 fine for failure to notify the office of the change.​
3632+111.10 EFFECTIVE DATE.This section is effective January 1, 2024.​
3633+111.11Sec. 53. [342.53] DUTIES OF OFFICE OF CANNABIS MANAGEMENT;​
3634+111.12REGISTRY PROGRAM.​
3635+111.13 The office may add an allowable form of medical cannabinoid product, and may add or​
3636+111.14modify a qualifying medical condition upon its own initiative, upon a petition from a member​
3637+111.15of the public or from the Cannabis Advisory Council or as directed by law. The office must​
3638+111.16evaluate all petitions and must make the addition or modification if the office determines​
3639+111.17that the addition or modification is warranted by the best available evidence and research.​
3640+111.18If the office wishes to add an allowable form or add or modify a qualifying medical condition,​
3641+111.19the office must notify the chairs and ranking minority members of the legislative committees​
3642+111.20and divisions with jurisdiction over health finance and policy by January 15 of the year in​
3643+111.21which the change becomes effective. In this notification, the office must specify the proposed​
3644+111.22addition or modification, the reasons for the addition or modification, any written comments​
3645+111.23received by the office from the public about the addition or modification, and any guidance​
3646+111.24received from the Cannabis Advisory Council. An addition or modification by the office​
3647+111.25under this subdivision becomes effective on August 1 of that year unless the legislature by​
3648+111.26law provides otherwise.​
3649+111.27 EFFECTIVE DATE.This section is effective January 1, 2024.​
3650+111.28Sec. 54. [342.54] DUTIES OF DIVISION OF MEDICAL CANNABIS; REGISTRY​
3651+111.29PROGRAM.​
3652+111.30 Subdivision 1.Duties related to health care practitioners.The Division of Medical​
3653+111.31Cannabis must:​
3654+111.32 (1) provide notice of the registry program to health care practitioners in the state;​
3655+111​Article 1 Sec. 54.​
3656+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 112.1 (2) allow health care practitioners to participate in the registry program if they request​
3657+112.2to participate and meet the program's requirements;​
3658+112.3 (3) provide explanatory information and assistance to health care practitioners to​
3659+112.4understand the nature of the therapeutic use of medical cannabis flower and medical​
3660+112.5cannabinoid products within program requirements;​
3661+112.6 (4) make available to participating health care practitioners a certification form in which​
3662+112.7a health care practitioner certifies that a patient has a qualifying medical condition; and​
3663+112.8 (5) supervise the participation of health care practitioners in the registry reporting system​
3664+112.9in which health care practitioners report patient treatment and health records information​
3665+112.10to the office in a manner that ensures stringent security and record keeping requirements​
3666+112.11and that prevents the unauthorized release of private data on individuals as defined in section​
3667+112.1213.02.​
3668+112.13 Subd. 2.Duties related to the registry program.The Division of Medical Cannabis​
3669+112.14must:​
3670+112.15 (1) administer the registry program according to section 342.52;​
3671+112.16 (2) provide information to patients enrolled in the registry program on the existence of​
3672+112.17federally approved clinical trials for the treatment of the patient's qualifying medical condition​
3673+112.18with medical cannabis flower or medical cannabinoid products as an alternative to enrollment​
3674+112.19in the registry program;​
3675+112.20 (3) maintain safety criteria with which patients must comply as a condition of participation​
3676+112.21in the registry program to prevent patients from undertaking any task under the influence​
3677+112.22of medical cannabis flower or medical cannabinoid products that would constitute negligence​
3678+112.23or professional malpractice;​
3679+112.24 (4) review and publicly report on existing medical and scientific literature regarding the​
3680+112.25range of recommended dosages for each qualifying medical condition, the range of chemical​
3681+112.26compositions of medical cannabis flower and medical cannabinoid products that will likely​
3682+112.27be medically beneficial for each qualifying medical condition, and any risks of noncannabis​
3683+112.28drug interactions. This information must be updated by December 1 of each year. The office​
3684+112.29may consult with an independent laboratory under contract with the office or other experts​
3685+112.30in reporting and updating this information; and​
3686+112.31 (5) annually consult with cannabis businesses about medical cannabis that the businesses​
3687+112.32cultivate, manufacture, and offer for sale and post on the Division of Medical Cannabis​
3688+112​Article 1 Sec. 54.​
3689+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 113.1website a list of the medical cannabis flower and medical cannabinoid products offered for​
3690+113.2sale by each medical cannabis retailer.​
3691+113.3 Subd. 3.Research.(a) The Division of Medical Cannabis must conduct or contract with​
3692+113.4a third party to conduct research and studies using data from health records submitted to​
3693+113.5the registry program under section 342.55, subdivision 2, and data submitted to the registry​
3694+113.6program under section 342.52, subdivisions 2 and 3. If the division contracts with a third​
3695+113.7party for research and studies, the third party must provide the division with access to all​
3696+113.8research and study results. The division must submit reports on intermediate or final research​
3697+113.9results to the legislature and major scientific journals. All data used by the division or a​
3698+113.10third party under this subdivision must be used or reported in an aggregated nonidentifiable​
3699+113.11form as part of a scientific peer-reviewed publication of research or in the creation of​
3700+113.12summary data, as defined in section 13.02, subdivision 19.​
3701+113.13 (b) The Division of Medical Cannabis may submit medical research based on the data​
3702+113.14collected under sections 342.55, subdivision 2, and data collected through the statewide​
3703+113.15monitoring system to any federal agency with regulatory or enforcement authority over​
3704+113.16medical cannabis flower and medical cannabinoid products to demonstrate the effectiveness​
3705+113.17of medical cannabis flower or medical cannabinoid products for treating or alleviating the​
3706+113.18symptoms of a qualifying medical condition.​
3707+113.19 EFFECTIVE DATE.This section is effective January 1, 2024.​
3708+113.20Sec. 55. [342.55] DUTIES OF HEALTH CARE PRACTITIONERS; REGISTRY​
3709+113.21PROGRAM.​
3710+113.22 Subdivision 1.Health care practitioner duties before patient enrollment.Before a​
3711+113.23patient's enrollment in the registry program, a health care practitioner must:​
3712+113.24 (1) determine, in the health care practitioner's medical judgment, whether a patient has​
3713+113.25a qualifying medical condition and, if so determined, provide the patient with a certification​
3714+113.26of that diagnosis;​
3715+113.27 (2) advise patients, registered designated caregivers, and parents, legal guardians, and​
3716+113.28spouses acting as caregivers of any nonprofit patient support groups or organizations;​
3717+113.29 (3) provide to patients explanatory information from the Division of Medical Cannabis,​
3718+113.30including information about the experimental nature of the therapeutic use of medical​
3719+113.31cannabis flower and medical cannabinoid products; the possible risks, benefits, and side​
3720+113.32effects of the proposed treatment; and the application and other materials from the office;​
3721+113​Article 1 Sec. 55.​
3722+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 114.1 (4) provide to patients a Tennessen warning as required under section 13.04, subdivision​
3723+114.22; and​
3724+114.3 (5) agree to continue treatment of the patient's qualifying medical condition and to report​
3725+114.4findings to the Division of Medical Cannabis.​
3726+114.5 Subd. 2.Duties upon patient's enrollment in registry program.Upon receiving​
3727+114.6notification from the Division of Medical Cannabis of the patient's enrollment in the registry​
3728+114.7program, a health care practitioner must:​
3729+114.8 (1) participate in the patient registry reporting system under the guidance and supervision​
3730+114.9of the Division of Medical Cannabis;​
3731+114.10 (2) report to the Division of Medical Cannabis patient health records throughout the​
3732+114.11patient's ongoing treatment in a manner determined by the office and in accordance with​
3733+114.12subdivision 4;​
3734+114.13 (3) determine on a yearly basis if the patient continues to have a qualifying medical​
3735+114.14condition and, if so, issue the patient a new certification of that diagnosis. The patient​
3736+114.15assessment conducted under this clause may be conducted via telehealth, as defined in​
3737+114.16section 62A.673, subdivision 2; and​
3738+114.17 (4) otherwise comply with requirements established by the Office of Cannabis​
3739+114.18Management and the Division of Medical Cannabis.​
3740+114.19 Subd. 3.Participation not required.Nothing in this section requires a health care​
3741+114.20practitioner to participate in the registry program.​
3742+114.21 Subd. 4.Data.Data on patients collected by a health care practitioner and reported to​
3743+114.22the registry program, including data on patients who are veterans who receive care from​
3744+114.23the United States Department of Veterans Affairs, are health records under section 144.291​
3745+114.24and are private data on individuals under section 13.02 but may be used or reported in an​
3746+114.25aggregated nonidentifiable form as part of a scientific peer-reviewed publication of research​
3747+114.26conducted under section 342.54 or in the creation of summary data, as defined in section​
3748+114.2713.02, subdivision 19.​
3749+114.28 Subd. 5.Exception.The requirements of this section do not apply to a patient who is a​
3750+114.29veteran who receives care from the United States Department of Veterans Affairs or a health​
3751+114.30care practitioner employed by the United States Department of Veterans Affairs. Such a​
3752+114.31patient must meet the certification requirements developed pursuant to section 342.52,​
3753+114.32subdivision 3, before the patient's enrollment in the registry program. The Division of​
3754+114.33Medical Cannabis may establish policies and procedures to obtain medical records and other​
3755+114​Article 1 Sec. 55.​
3756+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 115.1relevant data from a health care practitioner employed by the United States Department of​
3757+115.2Veterans Affairs, provided that those policies and procedures are consistent with this section.​
3758+115.3 EFFECTIVE DATE.This section is effective January 1, 2024.​
3759+115.4Sec. 56. [342.56] LIMITATIONS.​
3760+115.5 Subdivision 1.Limitations on consumption; locations of consumption.Nothing in​
3761+115.6sections 342.47 to 342.60 permits any person to engage in, and does not prevent the​
3762+115.7imposition of any civil, criminal, or other penalties for:​
3763+115.8 (1) undertaking a task under the influence of medical cannabis flower or medical​
3764+115.9cannabinoid products that would constitute negligence or professional malpractice;​
3765+115.10 (2) possessing or consuming medical cannabis flower or medical cannabinoid products:​
3766+115.11 (i) on a school bus or van;​
3767+115.12 (ii) in a correctional facility;​
3768+115.13 (iii) in a state-operated treatment program, including the Minnesota sex offender program;​
3769+115.14or​
3770+115.15 (iv) on the grounds of a child care facility or family or group family day care program;​
3771+115.16 (3) vaporizing or smoking medical cannabis:​
3772+115.17 (i) on any form of public transportation;​
3773+115.18 (ii) where the vapor would be inhaled by a nonpatient minor or where the smoke would​
3774+115.19be inhaled by a minor; or​
3775+115.20 (iii) in any public place, including any indoor or outdoor area used by or open to the​
3776+115.21general public or a place of employment, as defined in section 144.413, subdivision 1b; and​
3777+115.22 (4) operating, navigating, or being in actual physical control of a motor vehicle, aircraft,​
3778+115.23train, or motorboat or working on transportation property, equipment, or facilities while​
3779+115.24under the influence of medical cannabis flower or a medical cannabinoid product.​
3780+115.25 Subd. 2.Health care facilities.(a) Health care facilities licensed under chapter 144A;​
3781+115.26hospice providers licensed under chapter 144A; boarding care homes or supervised living​
3782+115.27facilities licensed under section 144.50; assisted living facilities licensed under chapter​
3783+115.28144G; facilities owned, controlled, managed, or under common control with hospitals​
3784+115.29licensed under chapter 144; and other health care facilities licensed by the commissioner​
3785+115.30of health may adopt reasonable restrictions on the use of medical cannabis flower or medical​
3786+115.31cannabinoid products by a patient enrolled in the registry program who resides at or is​
3787+115​Article 1 Sec. 56.​
3788+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 116.1actively receiving treatment or care at the facility. The restrictions may include a provision​
3789+116.2that the facility must not store or maintain a patient's supply of medical cannabis flower or​
3790+116.3medical cannabinoid products, that the facility is not responsible for providing medical​
3791+116.4cannabis flower or medical cannabinoid products for patients, and that medical cannabis​
3792+116.5flower or medical cannabinoid products are used only in a location specified by the facility​
3793+116.6or provider.​
3794+116.7 (b) An employee or agent of a facility or provider listed in this subdivision or a person​
3795+116.8licensed under chapter 144E is not violating this chapter or chapter 152 for the possession​
3796+116.9of medical cannabis flower or medical cannabinoid products while carrying out employment​
3797+116.10duties, including providing or supervising care to a patient enrolled in the registry program,​
3798+116.11or distribution of medical cannabis flower or medical cannabinoid products to a patient​
3799+116.12enrolled in the registry program who resides at or is actively receiving treatment or care at​
3800+116.13the facility or from the provider with which the employee or agent is affiliated. Nothing in​
3801+116.14this subdivision requires facilities and providers listed in this subdivision to adopt such​
3802+116.15restrictions. No facility or provider listed in this subdivision may unreasonably limit a​
3803+116.16patient's access to or use of medical cannabis flower or medical cannabinoid products to​
3804+116.17the extent that such use is authorized under sections 342.47 to 342.60.​
3805+116.18 EFFECTIVE DATE.This section is effective January 1, 2024.​
3806+116.19Sec. 57. [342.57] PROTECTIONS FOR REGISTRY PROGRAM PARTICIPANTS.​
3807+116.20 Subdivision 1.Presumption.There is a presumption that a patient enrolled in the registry​
3808+116.21program is engaged in the authorized use of medical cannabis flower and medical cannabinoid​
3809+116.22products. This presumption may be rebutted by evidence that the patient's use of medical​
3810+116.23cannabis flower or medical cannabinoid products was not for the purpose of treating or​
3811+116.24alleviating the patient's qualifying medical condition or symptoms associated with the​
3812+116.25patient's qualifying medical condition.​
3813+116.26 Subd. 2.Criminal and civil protections.(a) Subject to section 342.56, the following​
3814+116.27are not violations of this chapter or chapter 152:​
3815+116.28 (1) use or possession of medical cannabis flower, medical cannabinoid products, or​
3816+116.29medical cannabis paraphernalia by a patient enrolled in the registry program or by a visiting​
3817+116.30patient to whom medical cannabis flower or medical cannabinoid products are distributed​
3818+116.31under section 342.51, subdivision 5;​
3819+116​Article 1 Sec. 57.​
3820+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 117.1 (2) possession of medical cannabis flower, medical cannabinoid products, or medical​
3821+117.2cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or​
3822+117.3spouse of a patient enrolled in the registry program; or​
3823+117.4 (3) possession of medical cannabis flower, medical cannabinoid products, or medical​
3824+117.5cannabis paraphernalia by any person while carrying out duties required under sections​
3825+117.6342.47 to 342.60.​
3826+117.7 (b) The Office of Cannabis Management, members of the Cannabis Advisory Council,​
3827+117.8Office of Cannabis Management employees, agents or contractors of the Office of Cannabis​
3828+117.9Management, and health care practitioners participating in the registry program are not​
3829+117.10subject to any civil penalties or disciplinary action by the Board of Medical Practice, the​
3830+117.11Board of Nursing, or any business, occupational, or professional licensing board or entity​
3831+117.12solely for participating in the registry program either in a professional capacity or as a​
3832+117.13patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or​
3833+117.14disciplinary action by the Board of Pharmacy when acting in accordance with sections​
3834+117.15342.47 to 342.60 either in a professional capacity or as a patient. Nothing in this section​
3835+117.16prohibits a professional licensing board from taking action in response to a violation of law.​
3836+117.17 (c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the​
3837+117.18governor, or an employee of a state agency must not be held civilly or criminally liable for​
3838+117.19any injury, loss of property, personal injury, or death caused by any act or omission while​
3839+117.20acting within the scope of office or employment under sections 342.47 to 342.60.​
3840+117.21 (d) Federal, state, and local law enforcement authorities are prohibited from accessing​
3841+117.22the registry except when acting pursuant to a valid search warrant. Notwithstanding section​
3842+117.2313.09, a violation of this paragraph is a gross misdemeanor.​
3843+117.24 (e) Notwithstanding any law to the contrary, the office and employees of the office must​
3844+117.25not release data or information about an individual contained in any report or document or​
3845+117.26in the registry and must not release data or information obtained about a patient enrolled in​
3846+117.27the registry program, except as provided in sections 342.47 to 342.60. Notwithstanding​
3847+117.28section 13.09, a violation of this paragraph is a gross misdemeanor.​
3848+117.29 (f) No information contained in a report or document, contained in the registry, or​
3849+117.30obtained from a patient under sections 342.47 to 342.60 may be admitted as evidence in a​
3850+117.31criminal proceeding, unless:​
3851+117.32 (1) the information is independently obtained; or​
3852+117​Article 1 Sec. 57.​
3853+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 118.1 (2) admission of the information is sought in a criminal proceeding involving a criminal​
3854+118.2violation of sections 342.47 to 342.60.​
3855+118.3 (g) Possession of a registry verification or an application for enrollment in the registry​
3856+118.4program:​
3857+118.5 (1) does not constitute probable cause or reasonable suspicion;​
3858+118.6 (2) must not be used to support a search of the person or property of the person with a​
3859+118.7registry verification or application to enroll in the registry program; and​
3860+118.8 (3) must not subject the person or the property of the person to inspection by any​
3861+118.9government agency.​
3862+118.10 Subd. 3.School enrollment; rental property.(a) No school may refuse to enroll a​
3863+118.11patient as a pupil or otherwise penalize a patient solely because the patient is enrolled in​
3864+118.12the registry program, unless failing to do so would violate federal law or regulations or​
3865+118.13cause the school to lose a monetary or licensing-related benefit under federal law or​
3866+118.14regulations.​
3867+118.15 (b) No landlord may refuse to lease to a patient or otherwise penalize a patient solely​
3868+118.16because the patient is enrolled in the registry program, unless failing to do so would violate​
3869+118.17federal law or regulations or cause the landlord to lose a monetary or licensing-related​
3870+118.18benefit under federal law or regulations.​
3871+118.19 Subd. 4.Medical care.For purposes of medical care, including organ transplants, a​
3872+118.20patient's use of medical cannabis flower or medical cannabinoid products according to​
3873+118.21sections 342.47 to 342.60 is considered the equivalent of the authorized use of a medication​
3874+118.22used at the discretion of a health care practitioner and does not disqualify a patient from​
3875+118.23needed medical care.​
3876+118.24 Subd. 5.Employment.(a) Unless a failure to do so would violate federal or state law​
3877+118.25or regulations or cause an employer to lose a monetary or licensing-related benefit under​
3878+118.26federal law or regulations, an employer may not discriminate against a person in hiring,​
3879+118.27termination, or any term or condition of employment, or otherwise penalize a person, if the​
3880+118.28discrimination is based on:​
3881+118.29 (1) the person's status as a patient enrolled in the registry program; or​
3882+118.30 (2) a patient's positive drug test for cannabis components or metabolites, unless the​
3883+118.31patient used, possessed, sold, transported, or was impaired by medical cannabis flower or​
3884+118.32a medical cannabinoid product on work premises, during working hours, or while operating​
3885+118.33an employer's machinery, vehicle, or equipment.​
3886+118​Article 1 Sec. 57.​
3887+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 119.1 (b) An employee who is a patient and whose employer requires the employee to undergo​
3888+119.2drug testing according to section 181.953 may present the employee's registry verification​
3889+119.3as part of the employee's explanation under section 181.953, subdivision 6.​
3890+119.4 Subd. 6.Custody; visitation; parenting time.A person must not be denied custody of​
3891+119.5a minor child or visitation rights or parenting time with a minor child based solely on the​
3892+119.6person's status as a patient enrolled in the registry program. There must be no presumption​
3893+119.7of neglect or child endangerment for conduct allowed under sections 342.47 to 342.60,​
3894+119.8unless the person's behavior creates an unreasonable danger to the safety of the minor as​
3895+119.9established by clear and convincing evidence.​
3896+119.10 Subd. 7.Action for damages.In addition to any other remedy provided by law, a patient​
3897+119.11may bring an action for damages against any person who violates subdivision 3, 4, or 5. A​
3898+119.12person who violates subdivision 3, 4, or 5 is liable to a patient injured by the violation for​
3899+119.13the greater of the person's actual damages or a civil penalty of $100 and reasonable attorney​
3900+119.14fees.​
3901+119.15 EFFECTIVE DATE.This section is effective January 1, 2024.​
3902+119.16Sec. 58. [342.58] VIOLATION BY HEALTH CARE PRACTITIONER; CRIMINAL​
3903+119.17PENALTY.​
3904+119.18 A health care practitioner who knowingly refers patients to a medical cannabis business​
3905+119.19or to a designated caregiver, who advertises as a retailer or producer of medical cannabis​
3906+119.20flower or medical cannabinoid products, or who issues certifications while holding a financial​
3907+119.21interest in a cannabis retailer or medical cannabis business is guilty of a misdemeanor and​
3908+119.22may be sentenced to imprisonment for not more than 90 days or to payment of not more​
3909+119.23than $1,000, or both.​
3910+119.24 EFFECTIVE DATE.This section is effective January 1, 2024.​
3911+119.25Sec. 59. [342.59] DATA PRACTICES.​
3912+119.26 Subdivision 1.Data classification.Patient health records maintained by the Office of​
3913+119.27Cannabis Management or the Division of Medical Cannabis and government data in patient​
3914+119.28health records maintained by a health care practitioner are classified as private data on​
3915+119.29individuals, as defined in section 13.02, subdivision 12, or nonpublic data, as defined in​
3916+119.30section 13.02, subdivision 9.​
3917+119.31 Subd. 2.Allowable use; prohibited use.Data specified in subdivision 1 may be used​
3918+119.32to comply with chapter 13, to comply with a request from the legislative auditor or the state​
3919+119​Article 1 Sec. 59.​
3920+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 120.1auditor in the performance of official duties, and for purposes specified in sections 342.47​
3921+120.2to 342.60. Data specified in subdivision 1 and maintained by the Office of Cannabis​
3922+120.3Management or Division of Medical Cannabis must not be used for any purpose not specified​
3923+120.4in sections 342.47 to 342.60 and must not be combined or linked in any manner with any​
3924+120.5other list, dataset, or database. Data specified in subdivision 1 must not be shared with any​
3925+120.6federal agency, federal department, or federal entity unless specifically ordered to do so by​
3926+120.7a state or federal court.​
3927+120.8 EFFECTIVE DATE.This section is effective January 1, 2024.​
3928+120.9Sec. 60. [342.60] CLINICAL TRIALS.​
3929+120.10 The Division of Medical Cannabis may conduct, or award grants to health care providers​
3930+120.11or research organizations to conduct, clinical trials on the safety and efficacy of using​
3931+120.12medical cannabis flower or medical cannabinoid products to treat a specific health condition.​
3932+120.13A health care provider or research organization receiving a grant under this section must​
3933+120.14provide the office with access to all data collected in a clinical trial funded under this section.​
3934+120.15The office may use data from clinical trials conducted or funded under this section as​
3935+120.16evidence to approve additional qualifying medical conditions or additional allowable forms​
3936+120.17of medical cannabis.​
3937+120.18 EFFECTIVE DATE.This section is effective January 1, 2024.​
3938+120.19Sec. 61. [342.61] TESTING.​
3939+120.20 Subdivision 1.Testing required.Cannabis businesses and hemp businesses shall not​
3940+120.21sell or offer for sale cannabis flower, cannabis products, artificially derived cannabinoids,​
3941+120.22lower-potency hemp edibles, or hemp-derived consumer products to another cannabis​
3942+120.23business or hemp business, or to a customer or patient, or otherwise transfer cannabis flower,​
3943+120.24cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or​
3944+120.25hemp-derived consumer products to another cannabis business or hemp business, unless:​
3945+120.26 (1) a representative sample of the batch of cannabis flower, cannabis products, artificially​
3946+120.27derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products​
3947+120.28has been tested according to this section and rules adopted under this chapter;​
3948+120.29 (2) the testing was completed by a cannabis testing facility licensed under this chapter;​
3949+120.30and​
3950+120​Article 1 Sec. 61.​
3951+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 121.1 (3) the tested sample of cannabis flower, cannabis products, artificially derived​
3952+121.2cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products was found​
3953+121.3to meet testing standards established by the office.​
3954+121.4 Subd. 2.Procedures and standards established by office.(a) The office shall by rule​
3955+121.5establish procedures governing the sampling, handling, testing, storage, and transportation​
3956+121.6of cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency​
3957+121.7hemp edibles, or hemp-derived consumer products tested under this section; the contaminants​
3958+121.8for which cannabis flower, cannabis products, artificially derived cannabinoids,​
3959+121.9lower-potency hemp edibles, or hemp-derived consumer products must be tested; standards​
3960+121.10for potency and homogeneity testing; and procedures applicable to cannabis businesses,​
3961+121.11hemp businesses, and cannabis testing facilities regarding cannabis flower, cannabis products,​
3962+121.12artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer​
3963+121.13products that fail to meet the standards for allowable levels of contaminants established by​
3964+121.14the office, that fail to meet the potency limits in this chapter, or that do not conform with​
3965+121.15the content of the cannabinoid profile listed on the label.​
3966+121.16 (b) All testing required under this section must be performed in a manner that is consistent​
3967+121.17with general requirements for testing and calibration activities.​
3968+121.18 Subd. 3.Standards established by Office of Cannabis Management.The office shall​
3969+121.19by rule establish standards for allowable levels of contaminants in cannabis flower, cannabis​
3970+121.20products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived​
3971+121.21consumer products, and growing media. Contaminants for which the office must establish​
3972+121.22allowable levels must include but are not limited to residual solvents, foreign material,​
3973+121.23microbiological contaminants, heavy metals, pesticide residue, and mycotoxins.​
3974+121.24 Subd. 4.Testing of samples; disclosures.(a) On a schedule determined by the office,​
3975+121.25every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis​
3976+121.26manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency​
3977+121.27hemp edible manufacturer, medical cannabis cultivator, or medical cannabis processor shall​
3978+121.28make each batch of cannabis flower, cannabis products, artificially derived cannabinoids,​
3979+121.29lower-potency hemp edibles, or hemp-derived consumer products grown, manufactured, or​
3980+121.30imported by the cannabis business or hemp business available to a cannabis testing facility.​
3981+121.31 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis​
3982+121.32manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency​
3983+121.33hemp edible manufacturer, medical cannabis cultivator, or medical cannabis processor must​
3984+121.34disclose all known information regarding pesticides, fertilizers, solvents, or other foreign​
3985+121​Article 1 Sec. 61.​
3986+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 122.1materials, including but not limited to catalysts used in creating artificially derived​
3987+122.2cannabinoids, applied or added to the batch of cannabis flower, cannabis products, artificially​
3988+122.3derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products​
3989+122.4subject to testing. Disclosure must be made to the cannabis testing facility and must include​
3990+122.5information about all applications by any person, whether intentional or accidental.​
3991+122.6 (c) The cannabis testing facility shall select one or more representative samples from​
3992+122.7each batch, test the samples for the presence of contaminants, and test the samples for​
3993+122.8potency and homogeneity and to allow the cannabis flower, cannabis product, artificially​
3994+122.9derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be​
3995+122.10accurately labeled with its cannabinoid profile. Testing for contaminants must include testing​
3996+122.11for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide​
3997+122.12residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include​
3998+122.13testing for other contaminants. A cannabis testing facility must destroy or return to the​
3999+122.14cannabis business or hemp business any part of the sample that remains after testing.​
4000+122.15 Subd. 5.Test results.(a) If a sample meets the applicable testing standards, a cannabis​
4001+122.16testing facility shall issue a certification to a cannabis microbusiness, cannabis​
4002+122.17mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an​
4003+122.18endorsement to import products, lower-potency hemp edible manufacturer, medical cannabis​
4004+122.19cultivator, or medical cannabis processor, and the cannabis business or hemp business may​
4005+122.20then sell or transfer the batch of cannabis flower, cannabis products, artificially derived​
4006+122.21cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products from which​
4007+122.22the sample was taken to another cannabis business or hemp business, or offer the cannabis​
4008+122.23flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products​
4009+122.24for sale to customers or patients. If a sample does not meet the applicable testing standards​
4010+122.25or if the testing facility is unable to test for a substance identified pursuant to subdivision​
4011+122.264, paragraph (b), the batch from which the sample was taken shall be subject to procedures​
4012+122.27established by the office for such batches, including destruction, remediation, or retesting.​
4013+122.28A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis​
4014+122.29manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency​
4015+122.30hemp edible manufacturer, medical cannabis cultivator, or medical cannabis processor must​
4016+122.31maintain the test results for cannabis flower, cannabis products, artificially derived​
4017+122.32cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products grown,​
4018+122.33manufactured, or imported by that cannabis business or hemp business for at least five years​
4019+122.34after the date of testing.​
4020+122​Article 1 Sec. 61.​
4021+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 123.1 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis​
4022+123.2manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency​
4023+123.3hemp edible manufacturer, medical cannabis cultivator, or medical cannabis processor shall​
4024+123.4make test results maintained by that cannabis business or hemp business available for review​
4025+123.5by any member of the public, upon request. Test results made available to the public must​
4026+123.6be in plain language.​
4027+123.7Sec. 62. [342.62] PACKAGING.​
4028+123.8 Subdivision 1.General.All cannabis flower, cannabis products, lower-potency hemp​
4029+123.9edibles, and hemp-derived consumer products sold to customers or patients must be packaged​
4030+123.10as required by this section and rules adopted under this chapter.​
4031+123.11 Subd. 2.Packaging requirements.(a) Except as provided in paragraph (b), all cannabis​
4032+123.12flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products​
4033+123.13sold to customers or patients must be:​
4034+123.14 (1) prepackaged in packaging or a container that is plain, child-resistant, tamper-evident,​
4035+123.15and opaque; or​
4036+123.16 (2) placed in packaging or a container that is plain, child-resistant, tamper-evident, and​
4037+123.17opaque at the final point of sale to a customer.​
4038+123.18 (b) The requirement that packaging be child-resistant does not apply to a lower-potency​
4039+123.19hemp edible that is sold pursuant to section 342.46, subdivision 8, paragraph (e), or:​
4040+123.20 (1) is intended to be consumed as a beverage;​
4041+123.21 (2) contains nonintoxicating cannabinoids;​
4042+123.22 (3) does not contain more than a combined total of 0.25 milligrams of intoxicating​
4043+123.23cannabinoids; and​
4044+123.24 (4) does not contain an artificially derived cannabinoid.​
4045+123.25 (c) If a cannabis product, lower-potency hemp edible, or a hemp-derived consumer​
4046+123.26product is packaged in a manner that includes more than a single serving, each serving must​
4047+123.27be indicated by scoring, wrapping, or other indicators designating the individual serving​
4048+123.28size. If the item is a lower-potency hemp edible, serving indicators must meet the​
4049+123.29requirements of section 342.46, subdivision 6, paragraph (b).​
4050+123.30 (d) Edible cannabis products and lower-potency hemp edibles containing more than a​
4051+123.31single serving must be prepackaged or placed at the final point of sale in packaging or a​
4052+123.32container that is resealable.​
4053+123​Article 1 Sec. 62.​
4054+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 124.1 Subd. 3.Packaging prohibitions.(a) Cannabis flower, cannabis products, lower-potency​
4055+124.2hemp edibles, or hemp-derived consumer products sold to customers or patients must not​
4056+124.3be packaged in a manner that:​
4057+124.4 (1) bears a reasonable resemblance to any commercially available product that does not​
4058+124.5contain cannabinoids, whether the manufacturer of the product holds a registered trademark​
4059+124.6or has registered the trade dress; or​
4060+124.7 (2) is designed to appeal to persons under 21 years of age.​
4061+124.8 (b) Packaging for cannabis flower, cannabis products, lower-potency hemp edibles, and​
4062+124.9hemp-derived consumer products must not contain or be coated with any perfluoroalkyl​
4063+124.10substance.​
4064+124.11 (c) Edible cannabis products and lower-potency hemp edibles must not be packaged in​
4065+124.12a material that is not approved by the United States Food and Drug Administration for use​
4066+124.13in packaging food.​
4067+124.14Sec. 63. [342.63] LABELING.​
4068+124.15 Subdivision 1.General.All cannabis flower, cannabis products, lower-potency hemp​
4069+124.16edibles, and hemp-derived consumer products sold to customers or patients must be labeled​
4070+124.17as required by this section and rules adopted under this chapter.​
4071+124.18 Subd. 2.Content of label; cannabis.All cannabis flower and hemp-derived consumer​
4072+124.19products that consist of hemp plant parts sold to customers or patients must have affixed​
4073+124.20on the packaging or container of the cannabis flower or hemp-derived consumer product a​
4074+124.21label that contains at least the following information:​
4075+124.22 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,​
4076+124.23cannabis cultivator, medical cannabis cultivator, or industrial hemp grower where the​
4077+124.24cannabis flower or hemp plant part was cultivated;​
4078+124.25 (2) the net weight or volume of cannabis flower or hemp plant parts in the package or​
4079+124.26container;​
4080+124.27 (3) the batch number;​
4081+124.28 (4) the cannabinoid profile;​
4082+124.29 (5) a universal symbol established by the office indicating that the package or container​
4083+124.30contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a​
4084+124.31hemp-derived consumer product;​
4085+124​Article 1 Sec. 63.​
4086+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 125.1 (6) verification that the cannabis flower or hemp plant part was tested according to​
4087+125.2section 342.61 and that the cannabis flower or hemp plant part complies with the applicable​
4088+125.3standards;​
4089+125.4 (7) the maximum dose, quantity, or consumption that may be considered medically safe​
4090+125.5within a 24-hour period;​
4091+125.6 (8) the following statement: "Keep this product out of reach of children."; and​
4092+125.7 (9) any other statements or information required by the office.​
4093+125.8 Subd. 3.Content of label; cannabinoid products.(a) All cannabis products,​
4094+125.9lower-potency hemp edibles, hemp-derived consumer products other than products subject​
4095+125.10to the requirements under subdivision 2, medical cannabinoid products, and hemp-derived​
4096+125.11topical products sold to customers or patients must have affixed to the packaging or container​
4097+125.12of the cannabis product a label that contains at least the following information:​
4098+125.13 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,​
4099+125.14cannabis cultivator, medical cannabis cultivator, or industrial hemp grower that cultivated​
4100+125.15the cannabis flower or hemp plant parts used in the cannabis product, lower-potency hemp​
4101+125.16edible, hemp-derived consumer product, or medical cannabinoid product;​
4102+125.17 (2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,​
4103+125.18cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis​
4104+125.19processor, or industrial hemp grower that manufactured the cannabis concentrate, hemp​
4105+125.20concentrate, or artificially derived cannabinoid and, if different, the name and license number​
4106+125.21of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer,​
4107+125.22lower-potency hemp edible manufacturer, or medical cannabis processor that manufactured​
4108+125.23the product;​
4109+125.24 (3) the net weight or volume of the cannabis product, lower-potency hemp edible, or​
4110+125.25hemp-derived consumer product in the package or container;​
4111+125.26 (4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer​
4112+125.27product;​
4113+125.28 (5) the batch number;​
4114+125.29 (6) the serving size;​
4115+125.30 (7) the cannabinoid profile per serving and in total;​
4116+125.31 (8) a list of ingredients;​
4117+125​Article 1 Sec. 63.​
4118+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 126.1 (9) a universal symbol established by the office indicating that the package or container​
4119+126.2contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a​
4120+126.3hemp-derived consumer product;​
4121+126.4 (10) a warning symbol developed by the office in consultation with the commissioner​
4122+126.5of health and the Minnesota Poison Control System that:​
4123+126.6 (i) is at least three-quarters of an inch tall and six-tenths of an inch wide;​
4124+126.7 (ii) is in a highly visible color;​
4125+126.8 (iii) includes a visual element that is commonly understood to mean a person should​
4126+126.9stop;​
4127+126.10 (iv) indicates that the product is not for children; and​
4128+126.11 (v) includes the phone number of the Minnesota Poison Control System;​
4129+126.12 (11) verification that the cannabis product, lower-potency hemp edible, hemp-derived​
4130+126.13consumer product, or medical cannabinoid product was tested according to section 342.61​
4131+126.14and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,​
4132+126.15or medical cannabinoid product complies with the applicable standards;​
4133+126.16 (12) the maximum dose, quantity, or consumption that may be considered medically​
4134+126.17safe within a 24-hour period;​
4135+126.18 (13) the following statement: "Keep this product out of reach of children."; and​
4136+126.19 (14) any other statements or information required by the office.​
4137+126.20 (b) The office may by rule establish alternative labeling requirements for lower-potency​
4138+126.21edible products that are imported into the state provided that those requirements provide​
4139+126.22consumers with information that is substantially similar to the information described in​
4140+126.23paragraph (a).​
4141+126.24 Subd. 4.Additional content of label; medical cannabis flower and medical​
4142+126.25cannabinoid products.In addition to the applicable requirements for labeling under​
4143+126.26subdivision 2 or 3, all medical cannabis flower and medical cannabinoid products must​
4144+126.27include at least the following information on the label affixed to the packaging or container​
4145+126.28of the medical cannabis flower or medical cannabinoid product:​
4146+126.29 (1) the patient's name and date of birth;​
4147+126​Article 1 Sec. 63.​
4148+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 127.1 (2) the name and date of birth of the patient's registered designated caregiver or, if listed​
4149+127.2on the registry verification, the name of the patient's parent, legal guardian, or spouse, if​
4150+127.3applicable; and​
4151+127.4 (3) the patient's registry identification number.​
4152+127.5 Subd. 5.Content of label; hemp-derived topical products.(a) All hemp-derived topical​
4153+127.6products sold to customers must have affixed to the packaging or container of the product​
4154+127.7a label that contains at least the following information:​
4155+127.8 (1) the manufacturer name, location, phone number, and website;​
4156+127.9 (2) the name and address of the independent, accredited laboratory used by the​
4157+127.10manufacturer to test the product;​
4158+127.11 (3) the net weight or volume of the product in the package or container;​
4159+127.12 (4) the type of topical product;​
4160+127.13 (5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid,​
4161+127.14derivative, or extract of hemp, per serving and in total;​
4162+127.15 (6) a list of ingredients;​
4163+127.16 (7) a statement that the product does not claim to diagnose, treat, cure, or prevent any​
4164+127.17disease and that the product has not been evaluated or approved by the United States Food​
4165+127.18and Drug Administration, unless the product has been so approved; and​
4166+127.19 (8) any other statements or information required by the office.​
4167+127.20 (b) The information required in paragraph (a), clauses (1), (2), and (5), may be provided​
4168+127.21through the use of a scannable barcode or matrix barcode that links to a page on a website​
4169+127.22maintained by the manufacturer or distributor if that page contains all of the information​
4170+127.23required by this subdivision.​
4171+127.24 Subd. 6.Additional warnings.The office shall review medical and scientific literature​
4172+127.25to determine whether it is appropriate to require additional health and safety warnings​
4173+127.26regarding the impact of cannabis flower, cannabis products, lower-potency hemp edibles,​
4174+127.27and hemp-derived consumer products. The review must specifically include the identification​
4175+127.28of any risks associated with use by pregnant or breastfeeding women or by women planning​
4176+127.29to become pregnant, and the effects use has on brain development for those under the age​
4177+127.30of 25. Any additional labeling requirement must contain only information that is supported​
4178+127.31by credible science and is helpful to consumers in considering potential health risks.​
4179+127​Article 1 Sec. 63.​
4180+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 128.1 Subd. 7.Additional information.(a) A cannabis microbusiness, cannabis mezzobusiness,​
4181+128.2cannabis retailer, or medical cannabis retailer must provide customers and patients with the​
4182+128.3following information:​
4183+128.4 (1) factual information about impairment effects and the expected timing of impairment​
4184+128.5effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,​
4185+128.6lower-potency hemp edibles, and hemp-derived consumer products;​
4186+128.7 (2) a statement that customers and patients must not operate a motor vehicle or heavy​
4187+128.8machinery while under the influence of cannabis flower, cannabis products, lower-potency​
4188+128.9hemp edibles, and hemp-derived consumer products;​
4189+128.10 (3) resources customers and patients may consult to answer questions about cannabis​
4190+128.11flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
4191+128.12products, and any side effects and adverse effects;​
4192+128.13 (4) contact information for the poison control center and a safety hotline or website for​
4193+128.14customers to report and obtain advice about side effects and adverse effects of cannabis​
4194+128.15flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
4195+128.16products; and​
4196+128.17 (5) any other information specified by the office.​
4197+128.18 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical​
4198+128.19cannabis retailer may include the information described in paragraph (a) on the label affixed​
4199+128.20to the packaging or container of cannabis flower, cannabis products, lower-potency hemp​
4200+128.21edibles, and hemp-derived consumer products by:​
4201+128.22 (1) posting the information in the premises of the cannabis microbusiness, cannabis​
4202+128.23mezzobusiness, cannabis retailer, or medical cannabis retailer; or​
4203+128.24 (2) providing the information on a separate document or pamphlet provided to customers​
4204+128.25or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency​
4205+128.26hemp edible, or a hemp-derived consumer product.​
4206+128.27Sec. 64. [342.64] ADVERTISEMENT.​
4207+128.28 Subdivision 1.Limitations applicable to all advertisements.Cannabis businesses,​
4208+128.29hemp businesses, and other persons shall not publish or cause to be published an​
4209+128.30advertisement for a cannabis business, a hemp business, cannabis flower, a cannabis product,​
4210+128.31a lower-potency hemp edible, or a hemp-derived consumer product in a manner that:​
4211+128.32 (1) contains false or misleading statements;​
4212+128​Article 1 Sec. 64.​
4213+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 129.1 (2) contains unverified claims about the health or therapeutic benefits or effects of​
4214+129.2consuming cannabis flower, a cannabis product, a lower-potency hemp edible, or a​
4215+129.3hemp-derived consumer product;​
4216+129.4 (3) promotes the overconsumption of cannabis flower, a cannabis product, a​
4217+129.5lower-potency hemp edible, or a hemp-derived consumer product;​
4218+129.6 (4) depicts a person under 21 years of age consuming cannabis flower, a cannabis product,​
4219+129.7a lower-potency hemp edible, or a hemp-derived consumer product; or​
4220+129.8 (5) includes an image designed or likely to appeal to individuals under 21 years of age,​
4221+129.9including cartoons, toys, animals, or children, or any other likeness to images, characters,​
4222+129.10or phrases that is designed to be appealing to individuals under 21 years of age or encourage​
4223+129.11consumption by individuals under 21 years of age.​
4224+129.12 Subd. 2.Outdoor advertisements; cannabis business signs.(a) Except as provided in​
4225+129.13paragraph (c), an outdoor advertisement of a cannabis business, a hemp business, cannabis​
4226+129.14flower, a cannabis product, a lower-potency hemp edible, or a hemp-derived consumer​
4227+129.15product is prohibited.​
4228+129.16 (b) Cannabis businesses and hemp businesses may erect up to two fixed outdoor signs​
4229+129.17on the exterior of the building or property of the cannabis business or hemp business. A​
4230+129.18fixed outdoor sign:​
4231+129.19 (1) may contain the name of the cannabis business and the address and nature of the​
4232+129.20cannabis business; and​
4233+129.21 (2) shall not include a logo or an image of any kind.​
4234+129.22 (c) The prohibition under paragraph (a) does not apply to an outdoor advertisement for​
4235+129.23a hemp business, or the goods or services the business offers, that is not related to the​
4236+129.24manufacture or sale of lower-potency hemp edibles and does not include an image,​
4237+129.25description, or any reference to the manufacture or sale of lower-potency hemp edibles.​
4238+129.26 Subd. 3.Audience under 21 years of age.Cannabis businesses, hemp businesses, and​
4239+129.27other persons shall not publish or cause to be published an advertisement for a cannabis​
4240+129.28business, a hemp business, cannabis flower, a cannabis product, a lower-potency hemp​
4241+129.29edible, or a hemp-derived consumer product in any print publication or on radio, television,​
4242+129.30or any other medium if 30 percent or more of the audience of that medium is reasonably​
4243+129.31expected to be individuals who are under 21 years of age, as determined by reliable, current​
4244+129.32audience composition data.​
4245+129​Article 1 Sec. 64.​
4246+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 130.1 Subd. 4.Certain unsolicited advertising.Cannabis businesses, hemp businesses, and​
4247+130.2other persons shall not utilize unsolicited pop-up advertisements on the internet to advertise​
4248+130.3a cannabis business, a hemp business, cannabis flower, a cannabis product, a lower-potency​
4249+130.4hemp edible, or a hemp-derived consumer product.​
4250+130.5 Subd. 5.Advertising using direct, individualized communication or dialogue.Before​
4251+130.6a cannabis business, hemp business, or another person may advertise a cannabis business,​
4252+130.7a hemp business, cannabis flower, a cannabis product, a lower-potency hemp edible, or a​
4253+130.8hemp-derived consumer product through direct, individualized communication or dialogue​
4254+130.9controlled by the cannabis business, hemp business, or other person, the cannabis business,​
4255+130.10hemp business, or other person must use a method of age affirmation to verify that the​
4256+130.11recipient of the direct, individualized communication or dialogue is 21 years of age or older.​
4257+130.12For purposes of this subdivision, the method of age affirmation may include user​
4258+130.13confirmation, birth date disclosure, or another similar registration method.​
4259+130.14 Subd. 6.Advertising using location-based devices.Cannabis businesses, hemp​
4260+130.15businesses, and other persons shall not advertise a cannabis business, a hemp business,​
4261+130.16cannabis flower, a cannabis product, a lower-potency hemp edible, or a hemp-derived​
4262+130.17consumer product with advertising directed toward location-based devices, including but​
4263+130.18not limited to cellular telephones, unless:​
4264+130.19 (1) the advertising occurs via a mobile device application that is installed on the device​
4265+130.20by the device's owner and includes a permanent and easy to implement opt-out feature; and​
4266+130.21 (2) the owner of the device is 21 years of age or older.​
4267+130.22 Subd. 7.Advertising restrictions for health care practitioners under the medical​
4268+130.23cannabis program.(a) A health care practitioner shall not publish or cause to be published​
4269+130.24an advertisement that:​
4270+130.25 (1) contains false or misleading statements about the registry program;​
4271+130.26 (2) uses colloquial terms to refer to medical cannabis flower or medical cannabinoid​
4272+130.27products, such as pot, weed, or grass;​
4273+130.28 (3) states or implies that the health care practitioner is endorsed by the office, the Division​
4274+130.29of Medical Cannabis, or the registry program;​
4275+130.30 (4) includes images of cannabis flower, hemp plant parts, or images of paraphernalia​
4276+130.31commonly used to smoke cannabis flower; or​
4277+130.32 (5) contains medical symbols that could reasonably be confused with symbols of​
4278+130.33established medical associations or groups.​
42694279 130​Article 1 Sec. 64.​
4270-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 131.1topical products sold to customers or patients must have affixed to the packaging or container​
4271-131.2of the cannabis product a label that contains at least the following information:​
4272-131.3 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,​
4273-131.4cannabis cultivator, medical cannabis cultivator, or industrial hemp grower that cultivated​
4274-131.5the cannabis flower or hemp plant parts used in the cannabis product, lower-potency hemp​
4275-131.6edible, hemp-derived consumer product, or medical cannabinoid product;​
4276-131.7 (2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,​
4277-131.8cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis​
4278-131.9processor, or industrial hemp grower that manufactured the cannabis concentrate, hemp​
4279-131.10concentrate, or artificially derived cannabinoid and, if different, the name and license number​
4280-131.11of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer,​
4281-131.12lower-potency hemp edible manufacturer, or medical cannabis processor that manufactured​
4282-131.13the product;​
4283-131.14 (3) the net weight or volume of the cannabis product, lower-potency hemp edible, or​
4284-131.15hemp-derived consumer product in the package or container;​
4285-131.16 (4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer​
4286-131.17product;​
4287-131.18 (5) the batch number;​
4288-131.19 (6) the serving size;​
4289-131.20 (7) the cannabinoid profile per serving and in total;​
4290-131.21 (8) a list of ingredients;​
4291-131.22 (9) a universal symbol established by the office indicating that the package or container​
4292-131.23contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a​
4293-131.24hemp-derived consumer product;​
4294-131.25 (10) a warning symbol developed by the office in consultation with the commissioner​
4295-131.26of health and the Minnesota Poison Control System that:​
4296-131.27 (i) is at least three-quarters of an inch tall and six-tenths of an inch wide;​
4297-131.28 (ii) is in a highly visible color;​
4298-131.29 (iii) includes a visual element that is commonly understood to mean a person should​
4299-131.30stop;​
4300-131.31 (iv) indicates that the product is not for children; and​
4301-131​Article 1 Sec. 64.​
4302-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 132.1 (v) includes the phone number of the Minnesota Poison Control System;​
4303-132.2 (11) verification that the cannabis product, lower-potency hemp edible, hemp-derived​
4304-132.3consumer product, or medical cannabinoid product was tested according to section 342.61​
4305-132.4and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,​
4306-132.5or medical cannabinoid product complies with the applicable standards;​
4307-132.6 (12) the maximum dose, quantity, or consumption that may be considered medically​
4308-132.7safe within a 24-hour period;​
4309-132.8 (13) the following statement: "Keep this product out of reach of children."; and​
4310-132.9 (14) any other statements or information required by the office.​
4311-132.10 (b) The office may by rule establish alternative labeling requirements for lower-potency​
4312-132.11hemp edibles that are imported into the state provided that those requirements provide​
4313-132.12consumers with information that is substantially similar to the information described in​
4314-132.13paragraph (a).​
4315-132.14 Subd. 4.Additional content of label; medical cannabis flower and medical​
4316-132.15cannabinoid products.In addition to the applicable requirements for labeling under​
4317-132.16subdivision 2 or 3, all medical cannabis flower and medical cannabinoid products must​
4318-132.17include at least the following information on the label affixed to the packaging or container​
4319-132.18of the medical cannabis flower or medical cannabinoid product:​
4320-132.19 (1) the patient's name and date of birth;​
4321-132.20 (2) the name and date of birth of the patient's registered designated caregiver or, if listed​
4322-132.21on the registry verification, the name of the patient's parent, legal guardian, or spouse, if​
4323-132.22applicable; and​
4324-132.23 (3) the patient's registry identification number.​
4325-132.24 Subd. 5.Content of label; hemp-derived topical products.(a) All hemp-derived topical​
4326-132.25products sold to customers must have affixed to the packaging or container of the product​
4327-132.26a label that contains at least the following information:​
4328-132.27 (1) the manufacturer name, location, phone number, and website;​
4329-132.28 (2) the name and address of the independent, accredited laboratory used by the​
4330-132.29manufacturer to test the product;​
4331-132.30 (3) the net weight or volume of the product in the package or container;​
4332-132.31 (4) the type of topical product;​
4333-132​Article 1 Sec. 64.​
4334-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 133.1 (5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid,​
4335-133.2derivative, or extract of hemp, per serving and in total;​
4336-133.3 (6) a list of ingredients;​
4337-133.4 (7) a statement that the product does not claim to diagnose, treat, cure, or prevent any​
4338-133.5disease and that the product has not been evaluated or approved by the United States Food​
4339-133.6and Drug Administration, unless the product has been so approved; and​
4340-133.7 (8) any other statements or information required by the office.​
4341-133.8 (b) The information required in paragraph (a), clauses (1), (2), and (5), may be provided​
4342-133.9through the use of a scannable barcode or matrix barcode that links to a page on a website​
4343-133.10maintained by the manufacturer or distributor if that page contains all of the information​
4344-133.11required by this subdivision.​
4345-133.12 Subd. 6.Additional information.(a) A cannabis microbusiness, cannabis mezzobusiness,​
4346-133.13cannabis retailer, medical cannabis retailer, or medical cannabis combination business must​
4347-133.14provide customers and patients with the following information:​
4348-133.15 (1) factual information about impairment effects and the expected timing of impairment​
4349-133.16effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,​
4350-133.17lower-potency hemp edibles, and hemp-derived consumer products;​
4351-133.18 (2) a statement that customers and patients must not operate a motor vehicle or heavy​
4352-133.19machinery while under the influence of cannabis flower, cannabis products, lower-potency​
4353-133.20hemp edibles, and hemp-derived consumer products;​
4354-133.21 (3) resources customers and patients may consult to answer questions about cannabis​
4355-133.22flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
4356-133.23products, and any side effects and adverse effects;​
4357-133.24 (4) contact information for the poison control center and a safety hotline or website for​
4358-133.25customers to report and obtain advice about side effects and adverse effects of cannabis​
4359-133.26flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
4360-133.27products;​
4361-133.28 (5) substance use disorder treatment options; and​
4362-133.29 (6) any other information specified by the office.​
4363-133.30 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical​
4364-133.31cannabis retailer may include the information described in paragraph (a) on the label affixed​
4365-133​Article 1 Sec. 64.​
4366-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 134.1to the packaging or container of cannabis flower, cannabis products, lower-potency hemp​
4367-134.2edibles, and hemp-derived consumer products by:​
4368-134.3 (1) posting the information in the premises of the cannabis microbusiness, cannabis​
4369-134.4mezzobusiness, cannabis retailer, medical cannabis retailer, or medical cannabis combination​
4370-134.5business; or​
4371-134.6 (2) providing the information on a separate document or pamphlet provided to customers​
4372-134.7or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency​
4373-134.8hemp edible, or a hemp-derived consumer product.​
4374-134.9Sec. 65. [342.64] ADVERTISEMENT.​
4375-134.10 Subdivision 1.Limitations applicable to all advertisements.Cannabis businesses,​
4376-134.11hemp businesses, and other persons shall not publish or cause to be published an​
4377-134.12advertisement for a cannabis business, a hemp business, cannabis flower, a cannabis product,​
4378-134.13a lower-potency hemp edible, or a hemp-derived consumer product in a manner that:​
4379-134.14 (1) contains false or misleading statements;​
4380-134.15 (2) contains unverified claims about the health or therapeutic benefits or effects of​
4381-134.16consuming cannabis flower, a cannabis product, a lower-potency hemp edible, or a​
4382-134.17hemp-derived consumer product;​
4383-134.18 (3) promotes the overconsumption of cannabis flower, a cannabis product, a​
4384-134.19lower-potency hemp edible, or a hemp-derived consumer product;​
4385-134.20 (4) depicts a person under 21 years of age consuming cannabis flower, a cannabis product,​
4386-134.21a lower-potency hemp edible, or a hemp-derived consumer product; or​
4387-134.22 (5) includes an image designed or likely to appeal to individuals under 21 years of age,​
4388-134.23including cartoons, toys, animals, or children, or any other likeness to images, characters,​
4389-134.24or phrases that is designed to be appealing to individuals under 21 years of age or encourage​
4390-134.25consumption by individuals under 21 years of age; and​
4391-134.26 (6) does not contain a warning as specified by the office regarding impairment and health​
4392-134.27risks.​
4393-134.28 Subd. 2.Outdoor advertisements; cannabis business signs.(a) Except as provided in​
4394-134.29paragraph (c), an outdoor advertisement of a cannabis business, a hemp business, cannabis​
4395-134.30flower, a cannabis product, a lower-potency hemp edible, or a hemp-derived consumer​
4396-134.31product is prohibited.​
4397-134​Article 1 Sec. 65.​
4398-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 135.1 (b) Cannabis businesses and hemp businesses may erect up to two fixed outdoor signs​
4399-135.2on the exterior of the building or property of the cannabis business or hemp business.​
4400-135.3 (c) The prohibition under paragraph (a) does not apply to an outdoor advertisement for​
4401-135.4a hemp business, or the goods or services the business offers, that is not related to the​
4402-135.5manufacture or sale of lower-potency hemp edibles and does not include an image,​
4403-135.6description, or any reference to the manufacture or sale of lower-potency hemp edibles.​
4404-135.7 Subd. 3.Audience under 21 years of age.Except as provided in subdivision 2, a​
4405-135.8cannabis business, hemp business, or other person shall not publish or cause to be published​
4406-135.9an advertisement for a cannabis business, a hemp business, cannabis flower, a cannabis​
4407-135.10product, a lower-potency hemp edible, or a hemp-derived consumer product in any print​
4408-135.11publication or on radio, television, or any other medium if 30 percent or more of the audience​
4409-135.12of that medium is reasonably expected to be individuals who are under 21 years of age, as​
4410-135.13determined by reliable, current audience composition data.​
4411-135.14 Subd. 4.Certain unsolicited advertising.A cannabis business, hemp business, or​
4412-135.15another person shall not utilize unsolicited pop-up advertisements on the internet to advertise​
4413-135.16a cannabis business, a hemp business, cannabis flower, a cannabis product, a lower-potency​
4414-135.17hemp edible, or a hemp-derived consumer product.​
4415-135.18 Subd. 5.Advertising using direct, individualized communication or dialogue.Before​
4416-135.19a cannabis business, hemp business, or another person may advertise a cannabis business,​
4417-135.20a hemp business, cannabis flower, a cannabis product, a lower-potency hemp edible, or a​
4418-135.21hemp-derived consumer product through direct, individualized communication or dialogue​
4419-135.22controlled by the cannabis business, hemp business, or other person, the cannabis business,​
4420-135.23hemp business, or other person must use a method of age affirmation to verify that the​
4421-135.24recipient of the direct, individualized communication or dialogue is 21 years of age or older.​
4422-135.25For purposes of this subdivision, the method of age affirmation may include user​
4423-135.26confirmation, birth date disclosure, or another similar registration method.​
4424-135.27 Subd. 6.Advertising using location-based devices.A cannabis business, hemp business,​
4425-135.28or another person shall not advertise a cannabis business, a hemp business, cannabis flower,​
4426-135.29a cannabis product, a lower-potency hemp edible, or a hemp-derived consumer product​
4427-135.30with advertising directed toward location-based devices, including but not limited to cellular​
4428-135.31telephones, unless the owner of the device is 21 years of age or older.​
4429-135.32 Subd. 7.Advertising restrictions for health care practitioners under the medical​
4430-135.33cannabis program.(a) A health care practitioner shall not publish or cause to be published​
4431-135.34an advertisement that:​
4432-135​Article 1 Sec. 65.​
4433-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 136.1 (1) contains false or misleading statements about the registry program;​
4434-136.2 (2) uses colloquial terms to refer to medical cannabis flower or medical cannabinoid​
4435-136.3products, such as pot, weed, or grass;​
4436-136.4 (3) states or implies that the health care practitioner is endorsed by the office, the Division​
4437-136.5of Medical Cannabis, or the registry program;​
4438-136.6 (4) includes images of cannabis flower, hemp plant parts, or images of paraphernalia​
4439-136.7commonly used to smoke cannabis flower;​
4440-136.8 (5) contains medical symbols that could reasonably be confused with symbols of​
4441-136.9established medical associations or groups; or​
4442-136.10 (6) does not contain a warning as specified by the office regarding impairment and health​
4443-136.11risks.​
4444-136.12 (b) A health care practitioner found by the office to have violated this subdivision is​
4445-136.13prohibited from certifying that patients have a qualifying medical condition for purposes​
4446-136.14of patient participation in the registry program. A decision by the office that a health care​
4447-136.15practitioner has violated this subdivision is a final decision and is not subject to the contested​
4448-136.16case procedures in chapter 14.​
4449-136.17Sec. 66. [342.65] INDUSTRIAL HEMP.​
4450-136.18 Nothing in this chapter shall limit the ability of a person licensed under chapter 18K to​
4451-136.19grow industrial hemp for commercial or research purposes, process industrial hemp for​
4452-136.20commercial purposes, sell hemp fiber products and hemp grain, manufacture hemp-derived​
4453-136.21topical products, or perform any other actions authorized by the commissioner of agriculture.​
4454-136.22For purposes of this section, "processing" has the meaning given in section 18K.02,​
4455-136.23subdivision 5, and does not include the process of creating artificially derived cannabinoids.​
4456-136.24Sec. 67. [342.66] HEMP-DERIVED TOPICAL PRODUCTS.​
4457-136.25 Subdivision 1.Scope.This section applies to the manufacture, marketing, distribution,​
4458-136.26and sale of hemp-derived topical products.​
4459-136.27 Subd. 2.License; not required.No license is required to manufacture, market, distribute,​
4460-136.28or sell hemp-derived topical products.​
4461-136.29 Subd. 3.Approved cannabinoids.(a) Products manufactured, marketed, distributed,​
4462-136.30and sold under this section may contain cannabidiol or cannabigerol. Except as provided​
4463-136​Article 1 Sec. 67.​
4464-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 137.1in paragraph (c), products may not contain any other cannabinoid unless approved by the​
4465-137.2office.​
4466-137.3 (b) The office may approve any cannabinoid, other than any tetrahydrocannabinol, and​
4467-137.4authorize its use in manufacturing, marketing, distribution, and sales under this section if​
4468-137.5the office determines that the cannabinoid is a nonintoxicating cannabinoid.​
4469-137.6 (c) A product manufactured, marketed, distributed, and sold under this section may​
4470-137.7contain cannabinoids other than cannabidiol, cannabigerol, or any other cannabinoid approved​
4471-137.8by the office provided that the cannabinoids are naturally occurring in hemp plants or hemp​
4472-137.9plant parts and the total of all other cannabinoids present in a product does not exceed one​
4473-137.10milligram per package.​
4474-137.11 Subd. 4.Approved products.Products sold to consumers under this section may only​
4475-137.12be manufactured, marketed, distributed, intended, or generally expected to be used by​
4476-137.13applying the product externally to a part of the body of a human or animal.​
4477-137.14 Subd. 5.Labeling.Hemp-derived topical products must meet the labeling requirements​
4478-137.15in section 342.63, subdivision 5.​
4479-137.16 Subd. 6.Prohibitions.(a) A product sold to consumers under this section must not be​
4480-137.17manufactured, marketed, distributed, or intended:​
4481-137.18 (1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention​
4482-137.19of disease in humans or other animals;​
4483-137.20 (2) to affect the structure or any function of the bodies of humans or other animals;​
4484-137.21 (3) to be consumed by combustion or vaporization of the product and inhalation of​
4485-137.22smoke, aerosol, or vapor from the product;​
4486-137.23 (4) to be consumed through chewing; or​
4487-137.24 (5) to be consumed through injection or application to a mucous membrane or nonintact​
4488-137.25skin.​
4489-137.26 (b) A product manufactured, marketed, distributed, or sold to consumers under this​
4490-137.27section must not:​
4491-137.28 (1) consist, in whole or in part, of any filthy, putrid, or decomposed substance;​
4492-137.29 (2) have been produced, prepared, packed, or held under unsanitary conditions where​
4493-137.30the product may have been rendered injurious to health, or where the product may have​
4494-137.31been contaminated with filth;​
4495-137​Article 1 Sec. 67.​
4496-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 138.1 (3) be packaged in a container that is composed, in whole or in part, of any poisonous​
4497-138.2or deleterious substance that may render the contents injurious to health;​
4498-138.3 (4) contain any additives or excipients that have been found by the United States Food​
4499-138.4and Drug Administration to be unsafe for human or animal consumption;​
4500-138.5 (5) contain a cannabinoid or an amount or percentage of cannabinoids that is different​
4501-138.6than the information stated on the label;​
4502-138.7 (6) contain a cannabinoid, other than cannabidiol, cannabigerol, or a cannabinoid​
4503-138.8approved by the office, in an amount that exceeds the standard established in subdivision​
4504-138.92, paragraph (c); or​
4505-138.10 (7) contain any contaminants for which testing is required by the office in amounts that​
4506-138.11exceed the acceptable minimum standards established by the office.​
4507-138.12 (c) No product containing any cannabinoid may be sold to any individual who is under​
4508-138.1321 years of age.​
4509-138.14 Subd. 7.Enforcement.The office may enforce this section under the relevant provisions​
4510-138.15of section 342.19, including but not limited to issuing administrative orders, embargoing​
4511-138.16products, and imposing civil penalties.​
4512-138.17Sec. 68. [342.67] LEGAL ASSISTANCE TO CANNABIS BUSINESSES AND HEMP​
4513-138.18BUSINESSES.​
4514-138.19 An attorney must not be subject to disciplinary action by the Minnesota Supreme Court​
4515-138.20or professional responsibility board for providing legal assistance to prospective or licensed​
4516-138.21cannabis businesses or hemp businesses, or others for activities that do not violate this​
4517-138.22chapter or chapter 152.​
4518-138.23Sec. 69. [342.70] CANNABIS INDUSTRY COMMUNITY RENEWAL GRANTS.​
4519-138.24 Subdivision 1.Establishment.The Office of Cannabis Management shall establish​
4520-138.25CanRenew, a program to award grants to eligible organizations for investments in​
4521-138.26communities where long-term residents are eligible to be social equity applicants.​
4522-138.27 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the​
4523-138.28meanings given.​
4524-138.29 (b) "Community investment" means a project or program designed to improve​
4525-138.30community-wide outcomes or experiences and may include efforts targeting economic​
4526-138​Article 1 Sec. 69.​
4527-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 139.1development, improving social determinants of health, violence prevention, youth​
4528-139.2development, or civil legal aid, among others.​
4529-139.3 (c) "Eligible community" means a community where long-term residents are eligible to​
4530-139.4be social equity applicants.​
4531-139.5 (d) "Eligible organization" means any organization able to make an investment in a​
4532-139.6community where long-term residents are eligible to be social equity applicants and may​
4533-139.7include educational institutions, nonprofit organizations, private businesses, community​
4534-139.8groups, units of local government, or partnerships between different types of organizations.​
4535-139.9 (e) "Program" means the CanRenew grant program.​
4536-139.10 (f) "Social equity applicant" means a person who meets the qualification requirements​
4537-139.11in section 342.17.​
4538-139.12 Subd. 3.Grants to organizations.(a) The Division of Social Equity must award grants​
4539-139.13to eligible organizations through a competitive grant process.​
4540-139.14 (b) To receive grant money, an eligible organization must submit a written application​
4541-139.15to the office, using a form developed by the office, explaining the community investment​
4542-139.16the organization wants to make in an eligible community.​
4543-139.17 (c) An eligible organization's grant application must also include:​
4544-139.18 (1) an analysis of the community's need for the proposed investment;​
4545-139.19 (2) a description of the positive impact that the proposed investment is expected to​
4546-139.20generate for that community;​
4547-139.21 (3) any evidence of the organization's ability to successfully achieve that positive impact;​
4548-139.22 (4) any evidence of the organization's past success in making similar community​
4549-139.23investments;​
4550-139.24 (5) an estimate of the cost of the proposed investment;​
4551-139.25 (6) the sources and amounts of any nonstate funds or in-kind contributions that will​
4552-139.26supplement grant money; and​
4553-139.27 (7) any additional information requested by the office.​
4554-139.28 (d) In awarding grants under this subdivision, the office shall give weight to applications​
4555-139.29from organizations that demonstrate a history of successful community investments,​
4556-139.30particularly in geographic areas that are now eligible communities. The office shall also​
4557-139​Article 1 Sec. 69.​
4558-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 140.1give weight to applications where there is demonstrated community support for the proposed​
4559-140.2investment. The office shall fund investments in eligible communities throughout the state.​
4560-140.3 Subd. 4.Program outreach.The office shall make extensive efforts to publicize these​
4561-140.4grants, including through partnerships with community organizations, particularly those​
4562-140.5located in eligible communities.​
4563-140.6 Subd. 5.Reports to the legislature.By January 15, 2024, and each January 15 thereafter,​
4564-140.7the office must submit a report to the chairs and ranking minority members of the committees​
4565-140.8of the house of representatives and the senate having jurisdiction over community​
4566-140.9development that details awards given through the CanRenew program and the use of grant​
4567-140.10money, including any measures of successful community impact from the grants.​
4568-140.11Sec. 70. [342.72] SUBSTANCE USE TREATMENT, RECOVERY, AND​
4569-140.12PREVENTION GRANTS.​
4570-140.13 Subdivision 1.Account established; appropriation.A substance use treatment, recovery,​
4571-140.14and prevention grant account is created in the special revenue fund. Money in the account,​
4572-140.15including interest earned, is appropriated to the office for the purposes specified in this​
4573-140.16section. Of the amount transferred from the general fund to the account, the office may use​
4574-140.17up to five percent for administrative expenses.​
4575-140.18 Subd. 2.Acceptance of gifts and grants.Notwithstanding sections 16A.013 to 16A.016,​
4576-140.19the office may accept money contributed by individuals and may apply for grants from​
4577-140.20charitable foundations to be used for the purposes identified in this section. The money​
4578-140.21accepted under this section must be deposited in the substance use treatment, recovery, and​
4579-140.22prevention grant account created under subdivision 1.​
4580-140.23 Subd. 3.Disposition of money; grants.(a) Money in the substance use treatment,​
4581-140.24recovery, and prevention grant account must be distributed as follows:​
4582-140.25 (1) at least 75 percent of the money is for grants for substance use disorder and mental​
4583-140.26health recovery and prevention programs. Funds must be used for recovery and prevention​
4584-140.27activities and supplies that assist individuals and families to initiate, stabilize, and maintain​
4585-140.28long-term recovery from substance use disorders and co-occurring mental health conditions.​
4586-140.29Recovery and prevention activities may include prevention education, school-linked​
4587-140.30behavioral health, school-based peer programs, peer supports, self-care and wellness,​
4588-140.31culturally specific healing, community public awareness, mutual aid networks, telephone​
4589-140.32recovery checkups, mental health warmlines, harm reduction, recovery community​
4590-140.33organization development, first episode psychosis programs, and recovery housing; and​
4591-140​Article 1 Sec. 70.​
4592-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 141.1 (2) up to 25 percent of the money is for substance use disorder treatment programs as​
4593-141.2defined in chapter 245G and may be used to implement, strengthen, or expand supportive​
4594-141.3services and activities that are not covered by medical assistance under chapter 256B,​
4595-141.4MinnesotaCare under chapter 256L, or the behavioral health fund under chapter 254B.​
4596-141.5Services and activities may include adoption or expansion of evidence-based practices;​
4597-141.6competency-based training; continuing education; culturally specific and culturally responsive​
4598-141.7services; sober recreational activities; developing referral relationships; family preservation​
4599-141.8and healing; and start-up or capacity funding for programs that specialize in adolescent,​
4600-141.9culturally specific, culturally responsive, disability-specific, co-occurring disorder, or family​
4601-141.10treatment services.​
4602-141.11 (b) The office shall consult with the Governor's Advisory Council on Opioids, Substance​
4603-141.12Use, and Addiction; the commissioner of human services; and the commissioner of health​
4604-141.13to develop an appropriate application process, establish grant requirements, determine what​
4605-141.14organizations are eligible to receive grants, and establish reporting requirements for grant​
4606-141.15recipients.​
4607-141.16 Subd. 4.Reports to the legislature.By January 15, 2024, and each January 15 thereafter,​
4608-141.17the office must submit a report to the chairs and ranking minority members of the committees​
4609-141.18of the house of representatives and the senate having jurisdiction over health and human​
4610-141.19services policy and finance that details grants awarded from the substance use treatment,​
4611-141.20recovery, and prevention grant account, including the total amount awarded, total number​
4612-141.21of recipients, and geographic distribution of those recipients.​
4613-141.22Sec. 71. [342.73] CANNABIS GROWER GRANTS.​
4614-141.23 Subdivision 1.Establishment.The office, in consultation with the commissioner of​
4615-141.24agriculture, shall establish CanGrow, a program to award grants to (1) eligible organizations​
4616-141.25to help farmers navigate the regulatory structure of the legal cannabis industry, and (2)​
4617-141.26nonprofit corporations to fund loans to farmers for expansion into the legal cannabis industry.​
4618-141.27 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the​
4619-141.28meanings given.​
4620-141.29 (b) "Eligible organization" means any organization capable of helping farmers navigate​
4621-141.30the regulatory structure of the legal cannabis industry, particularly individuals facing barriers​
4622-141.31to education or employment, and may include educational institutions, nonprofit​
4623-141.32organizations, private businesses, community groups, units of local government, or​
4624-141.33partnerships between different types of organizations.​
4280+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 131.1 (b) A health care practitioner found by the office to have violated this subdivision is​
4281+131.2prohibited from certifying that patients have a qualifying medical condition for purposes​
4282+131.3of patient participation in the registry program. A decision by the office that a health care​
4283+131.4practitioner has violated this subdivision is a final decision and is not subject to the contested​
4284+131.5case procedures in chapter 14.​
4285+131.6Sec. 65. [342.65] INDUSTRIAL HEMP.​
4286+131.7 Nothing in this chapter shall limit the ability of a person licensed under chapter 18K to​
4287+131.8grow industrial hemp for commercial or research purposes, process industrial hemp for​
4288+131.9commercial purposes, sell hemp fiber products and hemp grain, manufacture hemp-derived​
4289+131.10topical products, or perform any other actions authorized by the commissioner of agriculture.​
4290+131.11For purposes of this section, "processing" has the meaning given in section 18K.02,​
4291+131.12subdivision 5, and does not include the process of creating artificially derived cannabinoids.​
4292+131.13Sec. 66. [342.66] HEMP-DERIVED TOPICAL PRODUCTS.​
4293+131.14 Subdivision 1.Scope.This section applies to the manufacture, marketing, distribution,​
4294+131.15and sale of hemp-derived topical products.​
4295+131.16 Subd. 2.License; not required.No license is required to manufacture, market, distribute,​
4296+131.17or sell hemp-derived topical products.​
4297+131.18 Subd. 3.Approved cannabinoids.(a) Products manufactured, marketed, distributed,​
4298+131.19and sold under this section may contain cannabidiol or cannabigerol. Except as provided​
4299+131.20in paragraph (c), products may not contain any other cannabinoid unless approved by the​
4300+131.21office.​
4301+131.22 (b) The office may approve any cannabinoid, other than any tetrahydrocannabinol, and​
4302+131.23authorize its use in manufacturing, marketing, distribution, and sales under this section if​
4303+131.24the office determines that the cannabinoid is a nonintoxicating cannabinoid.​
4304+131.25 (c) A product manufactured, marketed, distributed, and sold under this section may​
4305+131.26contain cannabinoids other than cannabidiol, cannabigerol, or any other cannabinoid approved​
4306+131.27by the office provided that the cannabinoids are naturally occurring in hemp plants or hemp​
4307+131.28plant parts and the total of all other cannabinoids present in a product does not exceed one​
4308+131.29milligram per package.​
4309+131.30 Subd. 4.Approved products.Products sold to consumers under this section may only​
4310+131.31be manufactured, marketed, distributed, intended, or generally expected to be used by​
4311+131.32applying the product externally to a part of the body of a human or animal.​
4312+131​Article 1 Sec. 66.​
4313+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 132.1 Subd. 5.Labeling.Hemp-derived topical products must meet the labeling requirements​
4314+132.2in section 342.63, subdivision 5.​
4315+132.3 Subd. 6.Prohibitions.(a) A product sold to consumers under this section must not be​
4316+132.4manufactured, marketed, distributed, or intended:​
4317+132.5 (1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention​
4318+132.6of disease in humans or other animals;​
4319+132.7 (2) to affect the structure or any function of the bodies of humans or other animals;​
4320+132.8 (3) to be consumed by combustion or vaporization of the product and inhalation of​
4321+132.9smoke, aerosol, or vapor from the product;​
4322+132.10 (4) to be consumed through chewing; or​
4323+132.11 (5) to be consumed through injection or application to a mucous membrane or nonintact​
4324+132.12skin.​
4325+132.13 (b) A product manufactured, marketed, distributed, or sold to consumers under this​
4326+132.14section must not:​
4327+132.15 (1) consist, in whole or in part, of any filthy, putrid, or decomposed substance;​
4328+132.16 (2) have been produced, prepared, packed, or held under unsanitary conditions where​
4329+132.17the product may have been rendered injurious to health, or where the product may have​
4330+132.18been contaminated with filth;​
4331+132.19 (3) be packaged in a container that is composed, in whole or in part, of any poisonous​
4332+132.20or deleterious substance that may render the contents injurious to health;​
4333+132.21 (4) contain any additives or excipients that have been found by the United States Food​
4334+132.22and Drug Administration to be unsafe for human or animal consumption;​
4335+132.23 (5) contain a cannabinoid or an amount or percentage of cannabinoids that is different​
4336+132.24than the information stated on the label;​
4337+132.25 (6) contain a cannabinoid, other than cannabidiol, cannabigerol, or a cannabinoid​
4338+132.26approved by the office, in an amount that exceeds the standard established in subdivision​
4339+132.272, paragraph (c); or​
4340+132.28 (7) contain any contaminants for which testing is required by the office in amounts that​
4341+132.29exceed the acceptable minimum standards established by the office.​
4342+132.30 (c) No product containing any cannabinoid may be sold to any individual who is under​
4343+132.3121 years of age.​
4344+132​Article 1 Sec. 66.​
4345+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 133.1 Subd. 7.Enforcement.The office may enforce this section under the relevant provisions​
4346+133.2of section 342.19, including but not limited to issuing administrative orders, embargoing​
4347+133.3products, and imposing civil penalties.​
4348+133.4Sec. 67. [342.67] LEGAL ASSISTANCE TO CANNABIS BUSINESSES AND HEMP​
4349+133.5BUSINESSES.​
4350+133.6 An attorney must not be subject to disciplinary action by the Minnesota Supreme Court​
4351+133.7or professional responsibility board for providing legal assistance to prospective or licensed​
4352+133.8cannabis businesses or hemp businesses, or others for activities that do not violate this​
4353+133.9chapter or chapter 152.​
4354+133.10Sec. 68. [342.70] CANNABIS INDUSTRY COMMUNITY RENEWAL GRANTS.​
4355+133.11 Subdivision 1.Establishment.The Office of Cannabis Management shall establish​
4356+133.12CanRenew, a program to award grants to eligible organizations for investments in​
4357+133.13communities where long-term residents are eligible to be social equity applicants.​
4358+133.14 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the​
4359+133.15meanings given.​
4360+133.16 (b) "Community investment" means a project or program designed to improve​
4361+133.17community-wide outcomes or experiences and may include efforts targeting economic​
4362+133.18development, violence prevention, youth development, or civil legal aid, among others.​
4363+133.19 (c) "Eligible community" means a community where long-term residents are eligible to​
4364+133.20be social equity applicants.​
4365+133.21 (d) "Eligible organization" means any organization able to make an investment in a​
4366+133.22community where long-term residents are eligible to be social equity applicants and may​
4367+133.23include educational institutions, nonprofit organizations, private businesses, community​
4368+133.24groups, units of local government, or partnerships between different types of organizations.​
4369+133.25 (e) "Program" means the CanRenew grant program.​
4370+133.26 (f) "Social equity applicant" means a person who meets the qualification requirements​
4371+133.27in section 342.16.​
4372+133.28 Subd. 3.Grants to organizations.(a) The office must award grants to eligible​
4373+133.29organizations through a competitive grant process.​
4374+133​Article 1 Sec. 68.​
4375+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 134.1 (b) To receive grant money, an eligible organization must submit a written application​
4376+134.2to the office, using a form developed by the office, explaining the community investment​
4377+134.3the organization wants to make in an eligible community.​
4378+134.4 (c) An eligible organization's grant application must also include:​
4379+134.5 (1) an analysis of the community's need for the proposed investment;​
4380+134.6 (2) a description of the positive impact that the proposed investment is expected to​
4381+134.7generate for that community;​
4382+134.8 (3) any evidence of the organization's ability to successfully achieve that positive impact;​
4383+134.9 (4) any evidence of the organization's past success in making similar community​
4384+134.10investments;​
4385+134.11 (5) an estimate of the cost of the proposed investment;​
4386+134.12 (6) the sources and amounts of any nonstate funds or in-kind contributions that will​
4387+134.13supplement grant money; and​
4388+134.14 (7) any additional information requested by the office.​
4389+134.15 (d) In awarding grants under this subdivision, the office shall give weight to applications​
4390+134.16from organizations that demonstrate a history of successful community investments,​
4391+134.17particularly in geographic areas that are now eligible communities. The office shall also​
4392+134.18give weight to applications where there is demonstrated community support for the proposed​
4393+134.19investment. The office shall fund investments in eligible communities throughout the state.​
4394+134.20 Subd. 4.Program outreach.The office shall make extensive efforts to publicize these​
4395+134.21grants, including through partnerships with community organizations, particularly those​
4396+134.22located in eligible communities.​
4397+134.23 Subd. 5.Reports to the legislature.By January 15, 2024, and each January 15 thereafter,​
4398+134.24the office must submit a report to the chairs and ranking minority members of the committees​
4399+134.25of the house of representatives and the senate having jurisdiction over community​
4400+134.26development that details awards given through the CanRenew program and the use of grant​
4401+134.27money, including any measures of successful community impact from the grants.​
4402+134.28Sec. 69. [342.72] SUBSTANCE USE TREATMENT, RECOVERY, AND​
4403+134.29PREVENTION GRANTS.​
4404+134.30 Subdivision 1.Account established; appropriation.A substance use treatment, recovery,​
4405+134.31and prevention grant account is created in the special revenue fund. Money in the account,​
4406+134​Article 1 Sec. 69.​
4407+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 135.1including interest earned, is appropriated to the office for the purposes specified in this​
4408+135.2section. Of the amount transferred from the general fund to the account, the office may use​
4409+135.3up to three percent for administrative expenses.​
4410+135.4 Subd. 2.Acceptance of gifts and grants.Notwithstanding sections 16A.013 to 16A.016,​
4411+135.5the office may accept money contributed by individuals and may apply for grants from​
4412+135.6charitable foundations to be used for the purposes identified in this section. The money​
4413+135.7accepted under this section must be deposited in the substance use treatment, recovery, and​
4414+135.8prevention grant account created under subdivision 1.​
4415+135.9 Subd. 3.Disposition of money; grants.(a) Money in the substance use treatment,​
4416+135.10recovery, and prevention grant account must be distributed as follows:​
4417+135.11 (1) at least 75 percent of the money is for grants for substance use disorder and mental​
4418+135.12health recovery and prevention programs. Funds must be used for recovery and prevention​
4419+135.13activities and supplies that assist individuals and families to initiate, stabilize, and maintain​
4420+135.14long-term recovery from substance use disorders and co-occurring mental health conditions.​
4421+135.15Recovery and prevention activities may include prevention education, school-linked​
4422+135.16behavioral health, school-based peer programs, peer supports, self-care and wellness,​
4423+135.17culturally-specific healing, community public awareness, mutual aid networks, telephone​
4424+135.18recovery checkups, mental health warm lines, harm reduction, recovery community​
4425+135.19organization development, first episode psychosis programs, and recovery housing; and​
4426+135.20 (2) up to 25 percent of the money is for substance use disorder treatment programs, as​
4427+135.21defined in chapter 245G and may be used to implement, strengthen, or expand supportive​
4428+135.22services and activities that are not covered by Medical Assistance under chapter 256B,​
4429+135.23MinnesotaCare under chapter 256L, or the behavioral health fund under chapter 254B.​
4430+135.24Services and activities may include the adoption or expansion of evidence-based practices,​
4431+135.25competency-based training, continuing education, culturally-specific and​
4432+135.26culturally-responsive services, sober recreational activities, developing referral relationships,​
4433+135.27family preservation and healing, and start-up or capacity funding for programs that specialize​
4434+135.28in adolescent, culturally-specific, culturally-responsive, disability-specific, co-occurring​
4435+135.29disorder, or family treatment services.​
4436+135.30 (b) The office shall consult with the commissioner of human services, the commissioner​
4437+135.31of health, the Governor's Advisory Council on Opioids, Substance Use, and Addiction, and​
4438+135.32the Substance Use Disorder Advisory Council to develop an appropriate application process,​
4439+135.33establish grant requirements, determine what organizations are eligible to receive grants,​
4440+135.34and establish reporting requirements for grant recipients.​
4441+135​Article 1 Sec. 69.​
4442+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 136.1 Subd. 4.Reports to the legislature.By January 15, 2024, and each January 15 thereafter,​
4443+136.2the office must submit a report to the chairs and ranking minority members of the committees​
4444+136.3of the house of representatives and the senate having jurisdiction over health and human​
4445+136.4services policy and finance that details grants awarded from the substance use treatment,​
4446+136.5recovery, and prevention grant account, including the total amount awarded, total number​
4447+136.6of recipients, and geographic distribution of those recipients.​
4448+136.7Sec. 70. [342.73] CANNABIS GROWER GRANTS.​
4449+136.8 Subdivision 1.Establishment.The office, in consultation with the commissioner of​
4450+136.9agriculture, shall establish CanGrow, a program to award grants to (1) eligible organizations​
4451+136.10to help farmers navigate the regulatory structure of the legal cannabis industry, and (2)​
4452+136.11nonprofit corporations to fund loans to farmers for expansion into the legal cannabis industry.​
4453+136.12 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the​
4454+136.13meanings given.​
4455+136.14 (b) "Eligible organization" means any organization capable of helping farmers navigate​
4456+136.15the regulatory structure of the legal cannabis industry, particularly individuals facing barriers​
4457+136.16to education or employment, and may include educational institutions, nonprofit​
4458+136.17organizations, private businesses, community groups, units of local government, or​
4459+136.18partnerships between different types of organizations.​
4460+136.19 (c) "Industry" means the legal cannabis industry in the state of Minnesota.​
4461+136.20 (d) "Program" means the CanGrow grant program.​
4462+136.21 (e) "Social equity applicant" means a person who meets the qualification requirements​
4463+136.22in section 342.16.​
4464+136.23 Subd. 3.Technical assistance grants.(a) Grant money awarded to eligible organizations​
4465+136.24may be used for both developing technical assistance resources relevant to the regulatory​
4466+136.25structure of the legal cannabis industry and for providing such technical assistance or​
4467+136.26navigation services to farmers.​
4468+136.27 (b) The office must award grants to eligible organizations through a competitive grant​
4469+136.28process.​
4470+136.29 (c) To receive grant money, an eligible organization must submit a written application​
4471+136.30to the office, using a form developed by the office, explaining the organization's ability to​
4472+136.31assist farmers in navigating the regulatory structure of the legal cannabis industry, particularly​
4473+136.32farmers facing barriers to education or employment.​
4474+136​Article 1 Sec. 70.​
4475+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 137.1 (d) An eligible organization's grant application must also include:​
4476+137.2 (1) a description of the proposed technical assistance or navigation services, including​
4477+137.3the types of farmers targeted for assistance;​
4478+137.4 (2) any evidence of the organization's past success in providing technical assistance or​
4479+137.5navigation services to farmers, particularly farmers who live in areas where long-term​
4480+137.6residents are eligible to be social equity applicants;​
4481+137.7 (3) an estimate of the cost of providing the technical assistance;​
4482+137.8 (4) the sources and amounts of any nonstate funds or in-kind contributions that will​
4483+137.9supplement grant money, including any amounts that farmers will be charged to receive​
4484+137.10assistance; and​
4485+137.11 (5) any additional information requested by the office.​
4486+137.12 (e) In awarding grants under this subdivision, the office shall give weight to applications​
4487+137.13from organizations that demonstrate a history of successful technical assistance or navigation​
4488+137.14services, particularly for farmers facing barriers to education or employment. The office​
4489+137.15shall also give weight to applications where the proposed technical assistance will serve​
4490+137.16areas where long-term residents are eligible to be social equity applicants. The office shall​
4491+137.17fund technical assistance to farmers throughout the state.​
4492+137.18 Subd. 4.Loan financing grants.(a) The office shall establish a revolving loan account​
4493+137.19to make loan financing grants under the CanGrow program.​
4494+137.20 (b) The office must award grants to nonprofit corporations through a competitive grant​
4495+137.21process. When selecting grant recipients under this subdivision, the office must utilize the​
4496+137.22expertise of an employee of the office who is experienced in agricultural business​
4497+137.23development.​
4498+137.24 (c) To receive grant money, a nonprofit corporation must submit a written application​
4499+137.25to the office using a form developed by the office.​
4500+137.26 (d) In awarding grants under this subdivision, the office shall give weight to whether​
4501+137.27the nonprofit corporation:​
4502+137.28 (1) has a board of directors that includes individuals experienced in agricultural business​
4503+137.29development;​
4504+137.30 (2) has the technical skills to analyze projects;​
4505+137.31 (3) is familiar with other available public and private funding sources and economic​
4506+137.32development programs;​
4507+137​Article 1 Sec. 70.​
4508+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 138.1 (4) can initiate and implement economic development projects;​
4509+138.2 (5) can establish and administer a revolving loan account; and​
4510+138.3 (6) has established relationships with communities where long-term residents are eligible​
4511+138.4to be social equity applicants.​
4512+138.5The office shall make grants that will help farmers enter the legal cannabis industry​
4513+138.6throughout the state.​
4514+138.7 (e) A nonprofit corporation that receives grants under the program must:​
4515+138.8 (1) establish an office-certified revolving loan account for the purpose of making eligible​
4516+138.9loans; and​
4517+138.10 (2) enter into an agreement with the office that the office shall fund loans that the​
4518+138.11nonprofit corporation makes to farmers entering the legal cannabis industry. The office shall​
4519+138.12review existing agreements with nonprofit corporations every five years and may renew or​
4520+138.13terminate an agreement based on that review. In making this review, the office shall consider,​
4521+138.14among other criteria, the criteria in paragraph (d).​
4522+138.15 Subd. 5.Loans to farmers.(a) The criteria in this subdivision apply to loans made by​
4523+138.16nonprofit corporations under the program.​
4524+138.17 (b) A loan must be used to support a farmer in entering the legal cannabis industry.​
4525+138.18Priority must be given to loans to businesses owned by farmers who are eligible to be social​
4526+138.19equity applicants and businesses located in communities where long-term residents are​
4527+138.20eligible to be social equity applicants.​
4528+138.21 (c) Loans must be made to businesses that are not likely to undertake the project for​
4529+138.22which loans are sought without assistance from the program.​
4530+138.23 (d) The minimum state contribution to a loan is $2,500 and the maximum is either:​
4531+138.24 (1) $50,000; or​
4532+138.25 (2) $150,000, if state contributions are matched by an equal or greater amount of new​
4533+138.26private investment.​
4534+138.27 (e) Loan applications given preliminary approval by the nonprofit corporation must be​
4535+138.28forwarded to the office for approval. The office must give final approval for each loan made​
4536+138.29by the nonprofit corporation under the program.​
4537+138​Article 1 Sec. 70.​
4538+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 139.1 (f) If the borrower has met lender criteria, including being current with all payments for​
4539+139.2a minimum of three years, the office may approve either full or partial forgiveness of interest​
4540+139.3or principal amounts.​
4541+139.4 Subd. 6.Revolving loan account administration.(a) The office shall establish a​
4542+139.5minimum interest rate for loans or guarantees to ensure that necessary loan administration​
4543+139.6costs are covered. The interest rate charged by a nonprofit corporation for a loan under this​
4544+139.7section must not exceed the Wall Street Journal prime rate. For a loan under this section,​
4545+139.8the nonprofit corporation may charge a loan origination fee equal to or less than one percent​
4546+139.9of the loan value. The nonprofit corporation may retain the amount of the origination fee.​
4547+139.10 (b) Loan repayment of principal must be paid to the office for deposit in the revolving​
4548+139.11loan account. Loan interest payments must be deposited in a revolving loan account created​
4549+139.12by the nonprofit corporation originating the loan being repaid for further distribution or use,​
4550+139.13consistent with the criteria of this section.​
4551+139.14 (c) Administrative expenses of the nonprofit corporations with whom the office enters​
4552+139.15into agreements, including expenses incurred by a nonprofit corporation in providing​
4553+139.16financial, technical, managerial, and marketing assistance to a business receiving a loan​
4554+139.17under this section, are eligible program expenses that the office may agree to pay under the​
4555+139.18grant agreement.​
4556+139.19 Subd. 7.Program outreach.The office shall make extensive efforts to publicize these​
4557+139.20grants, including through partnerships with community organizations, particularly those​
4558+139.21located in areas where long-term residents are eligible to be social equity applicants.​
4559+139.22 Subd. 8.Reporting requirements.(a) A nonprofit corporation that receives a grant​
4560+139.23under subdivision 4 shall:​
4561+139.24 (1) submit an annual report to the office by January 15 of each year that the nonprofit​
4562+139.25corporation participates in the program that includes a description of agricultural businesses​
4563+139.26supported by the grant program, an account of loans made during the calendar year, the​
4564+139.27program's impact on farmers' ability to expand into the legal cannabis industry, the source​
4565+139.28and amount of money collected and distributed by the program, the program's assets and​
4566+139.29liabilities, and an explanation of administrative expenses; and​
4567+139.30 (2) provide for an independent annual audit to be performed in accordance with generally​
4568+139.31accepted accounting practices and auditing standards and submit a copy of each annual​
4569+139.32audit report to the office.​
4570+139​Article 1 Sec. 70.​
4571+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 140.1 (b) By February 15, 2024, and each February 15 thereafter, the office must submit a​
4572+140.2report to the chairs and ranking minority members of the committees of the house of​
4573+140.3representatives and the senate having jurisdiction over agriculture that details awards given​
4574+140.4through the CanGrow program and the use of grant money, including any measures of​
4575+140.5success toward helping farmers enter the legal cannabis industry.​
4576+140.6Sec. 71. [342.79] SUBSTANCE USE DISORDER ADVISORY COUNCIL.​
4577+140.7 Subdivision 1.Establishment.The Substance Use Disorder Advisory Council is​
4578+140.8established to develop and implement a comprehensive and effective statewide approach​
4579+140.9to substance use disorder prevention and treatment. The council shall:​
4580+140.10 (1) establish priorities to address public education and substance use disorder prevention​
4581+140.11and treatment needs;​
4582+140.12 (2) make recommendations to the legislature on the amount of money to be allocated​
4583+140.13for substance use disorder prevention and treatment initiatives;​
4584+140.14 (3) make recommendations to the commissioner of human services on grant and funding​
4585+140.15options for money appropriated from the general fund to the commissioner of human services​
4586+140.16for substance use disorder prevention and treatment;​
4587+140.17 (4) recommend to the commissioner of human services specific programs, projects, and​
4588+140.18initiatives to be funded; and​
4589+140.19 (5) consult with the commissioners of human services, health, and management and​
4590+140.20budget to develop measurable outcomes to determine the effectiveness of programs, projects,​
4591+140.21and initiatives funded.​
4592+140.22 Subd. 2.Membership.(a) The council shall consist of the following members, appointed​
4593+140.23by the commissioner of human services, except as otherwise specified:​
4594+140.24 (1) two members of the house of representatives, one from the majority party appointed​
4595+140.25by the speaker and one from the minority party appointed by the minority leader of the​
4596+140.26house of representatives;​
4597+140.27 (2) two members of the senate, one from the majority party appointed by the senate​
4598+140.28majority leader and one from the minority party appointed by the senate minority leader;​
4599+140.29 (3) the commissioner of human services or a designee;​
4600+140.30 (4) the director of the Office of Cannabis Management or a designee;​
4601+140​Article 1 Sec. 71.​
4602+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 141.1 (5) two members representing substance use disorder treatment programs licensed under​
4603+141.2chapter 245G;​
4604+141.3 (6) one public member who is a Minnesota resident and in recovery from a substance​
4605+141.4use disorder;​
4606+141.5 (7) one public member who is a family member of a person with a substance use disorder;​
4607+141.6 (8) one member who is a physician with experience in substance use disorders;​
4608+141.7 (9) one member who is a licensed psychologist, licensed professional clinical counselor,​
4609+141.8licensed marriage and family therapist, or licensed social worker;​
4610+141.9 (10) one member of each federally recognized Tribal Nation within the geographical​
4611+141.10boundaries of the state of Minnesota;​
4612+141.11 (11) one mental health advocate representing persons with mental illness;​
4613+141.12 (12) one member representing county social services agencies;​
4614+141.13 (13) one patient advocate;​
4615+141.14 (14) a representative from a community that experienced a disproportionate, negative​
4616+141.15impact from cannabis prohibition;​
4617+141.16 (15) one veteran; and​
4618+141.17 (16) one parent of a medical cannabis patient who is under age 21.​
4619+141.18 (b) The commissioner of human services shall coordinate appointments to ensure the​
4620+141.19geographic diversity of council members and shall ensure that at least one-third of council​
4621+141.20members reside outside of the seven-county metropolitan area.​
4622+141.21 (c) The council is governed by section 15.059, except that members of the council shall​
4623+141.22receive no compensation other than reimbursement for expenses. Notwithstanding section​
4624+141.2315.059, subdivision 6, the council shall not expire.​
4625+141.24 (d) The chair shall convene the council on a quarterly basis and may convene other​
4626+141.25meetings as necessary. The chair shall convene meetings at different locations in the state​
4627+141.26to provide geographic access to members of the public.​
4628+141.27 (e) The commissioner of human services shall provide staff and administrative services​
4629+141.28for the advisory council.​
4630+141.29 (f) The council is subject to chapter 13D.​
46254631 141​Article 1 Sec. 71.​
4626-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 142.1 (c) "Industry" means the legal cannabis industry in the state of Minnesota.​
4627-142.2 (d) "Program" means the CanGrow grant program.​
4628-142.3 (e) "Social equity applicant" means a person who meets the qualification requirements​
4629-142.4in section 342.17.​
4630-142.5 Subd. 3.Technical assistance grants.(a) Grant money awarded to eligible organizations​
4631-142.6may be used for both developing technical assistance resources relevant to the regulatory​
4632-142.7structure of the legal cannabis industry and for providing such technical assistance or​
4633-142.8navigation services to farmers.​
4634-142.9 (b) The office must award grants to eligible organizations through a competitive grant​
4635-142.10process.​
4636-142.11 (c) To receive grant money, an eligible organization must submit a written application​
4637-142.12to the office, using a form developed by the office, explaining the organization's ability to​
4638-142.13assist farmers in navigating the regulatory structure of the legal cannabis industry, particularly​
4639-142.14farmers facing barriers to education or employment.​
4640-142.15 (d) An eligible organization's grant application must also include:​
4641-142.16 (1) a description of the proposed technical assistance or navigation services, including​
4642-142.17the types of farmers targeted for assistance;​
4643-142.18 (2) any evidence of the organization's past success in providing technical assistance or​
4644-142.19navigation services to farmers, particularly farmers who live in areas where long-term​
4645-142.20residents are eligible to be social equity applicants;​
4646-142.21 (3) an estimate of the cost of providing the technical assistance;​
4647-142.22 (4) the sources and amounts of any nonstate funds or in-kind contributions that will​
4648-142.23supplement grant money, including any amounts that farmers will be charged to receive​
4649-142.24assistance; and​
4650-142.25 (5) any additional information requested by the office.​
4651-142.26 (e) In awarding grants under this subdivision, the office shall give weight to applications​
4652-142.27from organizations that demonstrate a history of successful technical assistance or navigation​
4653-142.28services, particularly for farmers facing barriers to education or employment. The office​
4654-142.29shall also give weight to applications where the proposed technical assistance will serve​
4655-142.30areas where long-term residents are eligible to be social equity applicants. The office shall​
4656-142.31fund technical assistance to farmers throughout the state.​
4657-142​Article 1 Sec. 71.​
4658-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 143.1 Subd. 4.Loan financing grants.(a) The CanGrow revolving loan account is established​
4659-143.2in the special revenue fund. Money in the account, including interest, is appropriated to the​
4660-143.3commissioner to make loan financing grants under the CanGrow program.​
4661-143.4 (b) The office must award grants to nonprofit corporations through a competitive grant​
4662-143.5process.​
4663-143.6 (c) To receive grant money, a nonprofit corporation must submit a written application​
4664-143.7to the office using a form developed by the office.​
4665-143.8 (d) In awarding grants under this subdivision, the office shall give weight to whether​
4666-143.9the nonprofit corporation:​
4667-143.10 (1) has a board of directors that includes individuals experienced in agricultural business​
4668-143.11development;​
4669-143.12 (2) has the technical skills to analyze projects;​
4670-143.13 (3) is familiar with other available public and private funding sources and economic​
4671-143.14development programs;​
4672-143.15 (4) can initiate and implement economic development projects;​
4673-143.16 (5) can establish and administer a revolving loan account; and​
4674-143.17 (6) has established relationships with communities where long-term residents are eligible​
4675-143.18to be social equity applicants.​
4676-143.19The office shall make grants that will help farmers enter the legal cannabis industry​
4677-143.20throughout the state.​
4678-143.21 (e) A nonprofit corporation that receives grants under the program must:​
4679-143.22 (1) establish an office-certified revolving loan account for the purpose of making eligible​
4680-143.23loans; and​
4681-143.24 (2) enter into an agreement with the office that the office shall fund loans that the​
4682-143.25nonprofit corporation makes to farmers entering the legal cannabis industry. The office shall​
4683-143.26review existing agreements with nonprofit corporations every five years and may renew or​
4684-143.27terminate an agreement based on that review. In making this review, the office shall consider,​
4685-143.28among other criteria, the criteria in paragraph (d).​
4686-143.29 Subd. 5.Loans to farmers.(a) The criteria in this subdivision apply to loans made by​
4687-143.30nonprofit corporations under the program.​
4688-143​Article 1 Sec. 71.​
4689-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 144.1 (b) A loan must be used to support a farmer in entering the legal cannabis industry.​
4690-144.2Priority must be given to loans to businesses owned by farmers who are eligible to be social​
4691-144.3equity applicants and businesses located in communities where long-term residents are​
4692-144.4eligible to be social equity applicants.​
4693-144.5 (c) Loans must be made to businesses that are not likely to undertake the project for​
4694-144.6which loans are sought without assistance from the program.​
4695-144.7 (d) The minimum state contribution to a loan is $2,500 and the maximum is either:​
4696-144.8 (1) $50,000; or​
4697-144.9 (2) $150,000, if state contributions are matched by an equal or greater amount of new​
4698-144.10private investment.​
4699-144.11 (e) Loan applications given preliminary approval by the nonprofit corporation must be​
4700-144.12forwarded to the office for approval. The office must give final approval for each loan made​
4701-144.13by the nonprofit corporation under the program.​
4702-144.14 (f) If the borrower has met lender criteria, including being current with all payments for​
4703-144.15a minimum of three years, the office may approve either full or partial forgiveness of interest​
4704-144.16or principal amounts.​
4705-144.17 Subd. 6.Revolving loan account administration.(a) The office shall establish a​
4706-144.18minimum interest rate for loans or guarantees to ensure that necessary loan administration​
4707-144.19costs are covered. The interest rate charged by a nonprofit corporation for a loan under this​
4708-144.20section must not exceed the Wall Street Journal prime rate. For a loan under this section,​
4709-144.21the nonprofit corporation may charge a loan origination fee equal to or less than one percent​
4710-144.22of the loan value. The nonprofit corporation may retain the amount of the origination fee.​
4711-144.23 (b) Loan repayment of principal must be paid to the office for deposit in the CanGrow​
4712-144.24revolving loan account. Loan interest payments must be deposited in a revolving loan​
4713-144.25account created by the nonprofit corporation originating the loan being repaid for further​
4714-144.26distribution or use, consistent with the criteria of this section.​
4715-144.27 (c) Administrative expenses of the nonprofit corporations with whom the office enters​
4716-144.28into agreements, including expenses incurred by a nonprofit corporation in providing​
4717-144.29financial, technical, managerial, and marketing assistance to a business receiving a loan​
4718-144.30under this section, are eligible program expenses that the office may agree to pay under the​
4719-144.31grant agreement.​
4720-144​Article 1 Sec. 71.​
4721-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 145.1 Subd. 7.Program outreach.The office shall make extensive efforts to publicize these​
4722-145.2grants, including through partnerships with community organizations, particularly those​
4723-145.3located in areas where long-term residents are eligible to be social equity applicants.​
4724-145.4 Subd. 8.Reporting requirements.(a) A nonprofit corporation that receives a grant​
4725-145.5under subdivision 4 shall:​
4726-145.6 (1) submit an annual report to the office by January 15 of each year that the nonprofit​
4727-145.7corporation participates in the program that includes a description of agricultural businesses​
4728-145.8supported by the grant program, an account of loans made during the calendar year, the​
4729-145.9program's impact on farmers' ability to expand into the legal cannabis industry, the source​
4730-145.10and amount of money collected and distributed by the program, the program's assets and​
4731-145.11liabilities, and an explanation of administrative expenses; and​
4732-145.12 (2) provide for an independent annual audit to be performed in accordance with generally​
4733-145.13accepted accounting practices and auditing standards and submit a copy of each annual​
4734-145.14audit report to the office.​
4735-145.15 (b) By February 15, 2024, and each February 15 thereafter, the office must submit a​
4736-145.16report to the chairs and ranking minority members of the committees of the house of​
4737-145.17representatives and the senate having jurisdiction over agriculture that details awards given​
4738-145.18through the CanGrow program and the use of grant money, including any measures of​
4739-145.19success toward helping farmers enter the legal cannabis industry. The report must include​
4740-145.20geographic information regarding the issuance of grants and loans under this section, the​
4741-145.21repayment rate of loans issued under subdivision 5, and a summary of the amount of loans​
4742-145.22forgiven.​
4743-145.23Sec. 72. [342.80] LAWFUL ACTIVITIES.​
4744-145.24 (a) Notwithstanding any law to the contrary, the cultivation, manufacturing, possessing,​
4745-145.25and selling of cannabis flower, cannabis products, artificially derived cannabinoids,​
4746-145.26lower-potency hemp edibles, and hemp-derived consumer products by a licensed cannabis​
4747-145.27business or hemp business in conformity with the rights granted by a cannabis business​
4748-145.28license or hemp business license is lawful and may not be the grounds for the seizure or​
4749-145.29forfeiture of property, arrest or prosecution, or search or inspections except as provided by​
4750-145.30this chapter.​
4751-145.31 (b) A person acting as an agent of a cannabis microbusiness, cannabis mezzobusiness,​
4752-145.32cannabis retailer, or lower-potency hemp edible retailer who sells or otherwise transfers​
4753-145.33cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
4754-145​Article 1 Sec. 72.​
4755-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 146.1products to a person under 21 years of age is not subject to arrest, prosecution, or forfeiture​
4756-146.2of property if the person complied with section 342.27, subdivision 4, and any rules​
4757-146.3promulgated pursuant to this chapter.​
4758-146.4Sec. 73. [342.81] CIVIL ACTIONS.​
4759-146.5 Subdivision 1.Right of action.A spouse, child, parent, guardian, employer, or other​
4760-146.6person injured in person, property, or means of support or who incurs other pecuniary loss​
4761-146.7by an intoxicated person or by the intoxication of another person, has a right of action in​
4762-146.8the person's own name for all damages sustained against a person who caused the intoxication​
4763-146.9of that person by illegally selling cannabis flower, cannabis products, lower-potency hemp​
4764-146.10edibles, or hemp-derived consumer products, or selling edible cannabinoid products as​
4765-146.11defined in section 151.72, subdivision 1, paragraph (f), for on-site consumption. All damages​
4766-146.12recovered by a minor under this section must be paid either to the minor or to the minor's​
4767-146.13parent, guardian, or next friend as the court directs.​
4768-146.14 Subd. 2.Actions.All suits for damages under this section must be by civil action in a​
4769-146.15court of this state having jurisdiction.​
4770-146.16 Subd. 3.Comparative negligence.Actions under this section are governed by section​
4771-146.17604.01.​
4772-146.18 Subd. 4.Defense.It is a defense for the defendant to prove by a preponderance of the​
4773-146.19evidence that the defendant reasonably and in good faith relied upon representations of​
4774-146.20proof of age in selling, bartering, furnishing, or giving the cannabis flower, cannabis products,​
4775-146.21lower-potency hemp edibles, hemp-derived consumer products, or edible cannabinoid​
4776-146.22products.​
4777-146.23 Subd. 5.Common law claims.Nothing in this chapter precludes common law tort claims​
4778-146.24against any person 21 years old or older who knowingly provides or furnishes cannabis​
4779-146.25flower, cannabis products, lower-potency hemp edibles, hemp-derived consumer products,​
4780-146.26or edible cannabinoid products to a person under the age of 21 years.​
4781-146.27Sec. 74. [342.82] NUISANCE; ACTION.​
4782-146.28 Subdivision 1.Nuisance.Any use of adult-use cannabis flower which is injurious to​
4783-146.29health, indecent or offensive to the senses, or an obstruction to the free use of property so​
4784-146.30as to interfere with the comfortable enjoyment of life or property is a nuisance.​
4785-146.31 Subd. 2.Actions; landlord; association.(a) A person who is injuriously affected or​
4786-146.32whose personal enjoyment is lessened by a nuisance under subdivision 1 may bring an​
4787-146​Article 1 Sec. 74.​
4788-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 147.1action for injunctive relief and the greater of the person's actual damages or a civil penalty​
4789-147.2of $250.​
4790-147.3 (b) If a landlord, as defined in section 504B.001, subdivision 7, or an association, as​
4791-147.4defined in section 515B.1-103, clause (4), fails to enforce the terms of a lease, governing​
4792-147.5document, or policy related to the use of adult-use cannabis flower on the premises or​
4793-147.6property, a person who is injuriously affected or whose personal enjoyment is lessened by​
4794-147.7a nuisance under subdivision 1 as a result of the failure to enforce the terms may bring an​
4795-147.8action against the landlord or association seeking injunctive relief and the greater of the​
4796-147.9person's actual damages or a civil penalty of $500.​
4797-147.10 EFFECTIVE DATE.This section is effective July 1, 2023, and applies to causes of​
4798-147.11actions accruing on or after that date.​
4799-147.12Sec. 75. EFFECTIVE DATE.​
4800-147.13 Except as otherwise provided, each section of this article is effective July 1, 2023.​
4801-147.14 ARTICLE 2​
4802-147.15 TAXES​
4803-147.16Section 1. Minnesota Statutes 2022, section 270B.12, is amended by adding a subdivision​
4804-147.17to read:​
4805-147.18 Subd. 4a.Office of Cannabis Management.The commissioner may disclose return​
4806-147.19information to the Office of Cannabis Management for the purpose of and to the extent​
4807-147.20necessary to administer section 270C.726.​
4808-147.21 EFFECTIVE DATE.This section is effective June 30, 2023.​
4809-147.22Sec. 2. Minnesota Statutes 2022, section 270C.19, is amended by adding a subdivision to​
4810-147.23read:​
4811-147.24 Subd. 6.Cannabis sales.(a) The commissioner is authorized to enter into a tax agreement​
4812-147.25with the governing body of any federally recognized Indian Tribe in Minnesota that provides​
4813-147.26for the state and the Tribal government to share state and local sales tax and gross receipts​
4814-147.27tax imposed on the sale of cannabis at retail by a Tribally owned business at a location off​
4815-147.28the reservation.​
4816-147.29 (b) Any payment to the Tribe under this subdivision must be limited to an approximation​
4817-147.30of the expenses borne by the Tribe in regulating the production and supplying of cannabis​
4818-147​Article 2 Sec. 2.​
4819-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 148.1products to the off-reservation retail business and to taxes paid by members of the Tribe at​
4820-148.2that business location.​
4821-148.3 (c) Authority under this subdivision applies only to Tribal governments that have a​
4822-148.4compact under section 3.9228.​
4823-148.5 (d) There is annually appropriated from the general fund to the commissioner the amount​
4824-148.6necessary to make the payments provided in this subdivision.​
4825-148.7Sec. 3. [270C.726] POSTING OF TAX DELINQUENCY; SALE OF CANNABIS.​
4826-148.8 Subdivision 1.Posting; notice.(a) Pursuant to the authority to disclose under section​
4827-148.9270B.12, subdivision 4a, the commissioner shall, by the 15th of each month, submit to the​
4828-148.10Office of Cannabis Management a list of all taxpayers subject to the tax imposed by section​
4829-148.11295.81 that are required to pay, withhold, or collect the tax imposed by section 290.02,​
4830-148.12290.0922, 290.92, 290.9727, 290.9728, 290.9729, 295.81, or 297A.62; or a local sales and​
4831-148.13use tax payable to, or administered and collected by, the commissioner, and who are ten​
4832-148.14days or more delinquent in either filing a tax return or paying the tax.​
4833-148.15 (b) The commissioner is under no obligation to list a taxpayer whose business is inactive.​
4834-148.16At least ten days before notifying the Office of Cannabis Management, the commissioner​
4835-148.17shall notify the taxpayer of the intended action.​
4836-148.18 (c) The Office of Cannabis Management shall post the list required by this section on​
4837-148.19the Office of Cannabis Management website. The list must prominently show the date of​
4838-148.20posting. If a previously listed taxpayer files all returns and pays all taxes specified in this​
4839-148.21subdivision then due, the commissioner shall notify the Office of Cannabis Management​
4840-148.22within two business days.​
4841-148.23 Subd. 2.Sales prohibited.Beginning the third business day after the list is posted, no​
4842-148.24cannabis cultivator, cannabis manufacturer, cannabis microbusiness, cannabis mezzobusiness,​
4843-148.25medical cannabis combination business, cannabis wholesaler, or industrial hemp grower as​
4844-148.26defined in chapter 342 may sell or deliver any product to a taxpayer included on the posted​
4845-148.27list.​
4846-148.28 Subd. 3.Penalty.A cannabis cultivator, cannabis manufacturer, cannabis microbusiness,​
4847-148.29cannabis mezzobusiness, medical cannabis combination business, cannabis wholesaler, or​
4848-148.30industrial hemp grower as defined in chapter 342 who violates subdivision 2 of this section​
4849-148.31is subject to the penalties provided in sections 342.19 and 342.21.​
4850-148.32 EFFECTIVE DATE.This section is effective June 30, 2023.​
4851-148​Article 2 Sec. 3.​
4852-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 149.1Sec. 4. Minnesota Statutes 2022, section 273.13, subdivision 24, is amended to read:​
4853-149.2 Subd. 24.Class 3.Commercial and industrial property and utility real and personal​
4854-149.3property is class 3a.​
4855-149.4 (1) Except as otherwise provided, each parcel of commercial, industrial, or utility real​
4856-149.5property has a classification rate of 1.5 percent of the first tier of market value, and 2.0​
4857-149.6percent of the remaining market value. In the case of contiguous parcels of property owned​
4858-149.7by the same person or entity, only the value equal to the first-tier value of the contiguous​
4859-149.8parcels qualifies for the reduced classification rate, except that contiguous parcels owned​
4860-149.9by the same person or entity shall be eligible for the first-tier value classification rate on​
4861-149.10each separate business operated by the owner of the property, provided the business is​
4862-149.11housed in a separate structure. For the purposes of this subdivision, the first tier means the​
4863-149.12first $150,000 of market value. Real property owned in fee by a utility for transmission line​
4864-149.13right-of-way shall be classified at the classification rate for the higher tier.​
4865-149.14 For purposes of this subdivision, parcels are considered to be contiguous even if they​
4866-149.15are separated from each other by a road, street, waterway, or other similar intervening type​
4867-149.16of property. Connections between parcels that consist of power lines or pipelines do not​
4868-149.17cause the parcels to be contiguous. Property owners who have contiguous parcels of property​
4869-149.18that constitute separate businesses that may qualify for the first-tier classification rate shall​
4870-149.19notify the assessor by July 1, for treatment beginning in the following taxes payable year.​
4871-149.20 (2) All personal property that is: (i) part of an electric generation, transmission, or​
4872-149.21distribution system; or (ii) part of a pipeline system transporting or distributing water, gas,​
4873-149.22crude oil, or petroleum products; and (iii) not described in clause (3), and all railroad​
4874-149.23operating property has a classification rate as provided under clause (1) for the first tier of​
4875-149.24market value and the remaining market value. In the case of multiple parcels in one county​
4876-149.25that are owned by one person or entity, only one first tier amount is eligible for the reduced​
4877-149.26rate.​
4878-149.27 (3) The entire market value of personal property that is: (i) tools, implements, and​
4879-149.28machinery of an electric generation, transmission, or distribution system; (ii) tools,​
4880-149.29implements, and machinery of a pipeline system transporting or distributing water, gas,​
4881-149.30crude oil, or petroleum products; or (iii) the mains and pipes used in the distribution of​
4882-149.31steam or hot or chilled water for heating or cooling buildings, has a classification rate as​
4883-149.32provided under clause (1) for the remaining market value in excess of the first tier.​
4884-149.33 (4) Real property used for raising, cultivating, processing, or storing cannabis plants,​
4885-149.34cannabis flower, or cannabis products for sale has a classification rate as provided under​
4886-149​Article 2 Sec. 4.​
4887-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 150.1clause (1) for the first tier of market value and the remaining market value. As used in this​
4888-150.2paragraph, "cannabis plant" has the meaning given in section 342.01, subdivision 19,​
4889-150.3"cannabis flower" has the meaning given in section 342.01, subdivision 16, and "cannabis​
4890-150.4product" has the meaning given in section 342.01, subdivision 20.​
4891-150.5 EFFECTIVE DATE.This section is effective beginning with assessment year 2024​
4892-150.6and thereafter.​
4893-150.7Sec. 5. Minnesota Statutes 2022, section 275.025, subdivision 2, is amended to read:​
4894-150.8 Subd. 2.Commercial-industrial tax capacity.For the purposes of this section,​
4895-150.9"commercial-industrial tax capacity" means the tax capacity of all taxable property classified​
4896-150.10as class 3 or class 5(1) under section 273.13, excluding:​
4897-150.11 (1) the tax capacity attributable to the first $150,000 of market value of each parcel of​
4898-150.12commercial-industrial property as defined under section 273.13, subdivision 24, clauses (1)​
4899-150.13and, (2), and (4);​
4900-150.14 (2) electric generation attached machinery under class 3; and​
4901-150.15 (3) property described in section 473.625.​
4902-150.16 County commercial-industrial tax capacity amounts are not adjusted for the captured​
4903-150.17net tax capacity of a tax increment financing district under section 469.177, subdivision 2,​
4904-150.18the net tax capacity of transmission lines deducted from a local government's total net tax​
4905-150.19capacity under section 273.425, or fiscal disparities contribution and distribution net tax​
4906-150.20capacities under chapter 276A or 473F. For purposes of this subdivision, the procedures​
4907-150.21for determining eligibility for tier 1 under section 273.13, subdivision 24, clauses (1) and​
4908-150.22(2), shall apply in determining the portion of a property eligible to be considered within the​
4909-150.23first $150,000 of market value.​
4910-150.24 EFFECTIVE DATE.This section is effective beginning with assessment year 2024​
4911-150.25and thereafter.​
4912-150.26Sec. 6. [289A.33] FILING REQUIREMENTS AND DUE DATES; SPECIAL RULES.​
4913-150.27 (a) Upon the request of any cannabis business as defined by section 342.01, subdivision​
4914-150.2814, required to collect and remit taxes imposed under section 295.81, chapter 290, or chapter​
4915-150.29297A, the commissioner shall waive the requirement that payment of tax must be made​
4916-150.30electronically if the failure to pay electronically is because the cannabis business is unable​
4917-150.31to secure banking services and the inability to secure the services is due to its engagement​
4918-150.32in cannabis-related business allowed under Minnesota law.​
4919-150​Article 2 Sec. 6.​
4920-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 151.1 (b) If, in consultation with the commissioner of commerce, the commissioner determines​
4921-151.2that the inability to find banking services is widespread and enforcement of the electronic​
4922-151.3payment requirement will significantly impede the ability of cannabis businesses to timely​
4923-151.4pay taxes imposed under section 295.81, chapter 290, or chapter 297A, the commissioner​
4924-151.5may publish notice on the department website that waives the requirement to pay the tax​
4925-151.6electronically. If such notice is published, a cannabis business must file returns and pay​
4926-151.7taxes lawfully due in the form and manner prescribed by the commissioner.​
4927-151.8 (c) Nothing in this section relieves a cannabis business from timely filing and paying​
4928-151.9taxes.​
4929-151.10 EFFECTIVE DATE.This section is effective the day following final enactment.​
4930-151.11Sec. 7. Minnesota Statutes 2022, section 290.0132, subdivision 29, is amended to read:​
4931-151.12 Subd. 29.Disallowed section 280E expenses; medical cannabis manufacturers​
4932-151.13licensees.The amount of expenses of a medical cannabis manufacturer business, as defined​
4933-151.14under section 152.22, subdivision 7 342.01, subdivision 53, related to the business of medical​
4934-151.15cannabis under sections 152.21 to 152.37 342.47 to 342.59, or a license holder under chapter​
4935-151.16342, related to the business of nonmedical cannabis under that chapter, and not allowed for​
4936-151.17federal income tax purposes under section 280E of the Internal Revenue Code is a subtraction.​
4937-151.18 EFFECTIVE DATE.This section is effective for taxable years beginning after December​
4938-151.1931, 2022.​
4939-151.20Sec. 8. Minnesota Statutes 2022, section 290.0134, subdivision 19, is amended to read:​
4940-151.21 Subd. 19.Disallowed section 280E expenses; medical cannabis manufacturers​
4941-151.22licensees.The amount of expenses of a medical cannabis manufacturer business, as defined​
4942-151.23under section 152.22, subdivision 7 342.01, subdivision 53, related to the business of medical​
4943-151.24cannabis under sections 152.21 to 152.37 342.47 to 342.59, or a license holder under chapter​
4944-151.25342, related to the business of nonmedical cannabis under that chapter, and not allowed for​
4945-151.26federal income tax purposes under section 280E of the Internal Revenue Code is a subtraction.​
4946-151.27 EFFECTIVE DATE.This section is effective for taxable years beginning after December​
4947-151.2831, 2022.​
4948-151.29Sec. 9. [295.81] CANNABIS GROSS RECEIPTS TAX.​
4949-151.30 Subdivision 1.Definitions.(a) For purposes of this section, the following terms have​
4950-151.31the meanings given.​
4951-151​Article 2 Sec. 9.​
4952-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 152.1 (b) "Bundled transaction" means the retail sale of two or more products when the products​
4953-152.2are otherwise distinct and identifiable and the products are sold for one nonitemized price.​
4954-152.3 (c) "Cannabis flower" has the meaning given in section 342.01, subdivision 16.​
4955-152.4 (d) "Cannabis product" has the meaning given in section 342.01, subdivision 20.​
4956-152.5 (e) "Cannabis solution product" means any cartridge, bottle, or other package that contains​
4957-152.6a taxable cannabis product in a solution that is consumed or meant to be consumed through​
4958-152.7the use of a heating element, power source, electronic circuit, or other electronic, chemical,​
4959-152.8or mechanical means that produces vapor or aerosol. A cannabis solution product includes​
4960-152.9any electronic delivery system, electronic vaping device, electronic vape pen, electronic​
4961-152.10oral device, electronic delivery device, or similar product or device, and any batteries,​
4962-152.11heating elements, or other components, parts, or accessories sold with and meant to be used​
4963-152.12in the consumption of a solution containing a taxable cannabis product.​
4964-152.13 (f) "Cannabis mezzobusiness" means a cannabis business licensed under section 342.29.​
4965-152.14 (g) "Cannabis microbusiness" means a cannabis business licensed under section 342.28.​
4966-152.15 (h) "Cannabis retailer" means a cannabis business licensed under section 342.32.​
4967-152.16 (i) "Commissioner" means the commissioner of revenue.​
4968-152.17 (j) "Gross receipts" means the total amount received in money or by barter or exchange​
4969-152.18for all taxable cannabis product sales at retail as measured by the sales price. Gross receipts​
4970-152.19include but are not limited to delivery charges and packaging costs. Gross receipts do not​
4971-152.20include:​
4972-152.21 (1) any taxes imposed directly on the customer that are separately stated on the invoice,​
4973-152.22bill of sale, or similar document given to the purchaser; and​
4974-152.23 (2) discounts, including cash, terms, or coupons, that are not reimbursed by a third party​
4975-152.24and that are allowed by the seller and taken by a purchaser on a sale.​
4976-152.25 (k) "Hemp-derived consumer product" has the meaning given in section 342.01,​
4977-152.26subdivision 37.​
4978-152.27 (l) "Lower-potency hemp edible" has the meaning given in section 342.01, subdivision​
4979-152.2850.​
4980-152.29 (m) "Lower-potency hemp edible retailer" means a cannabis business licensed under​
4981-152.30section 342.43, subdivision 1, clause (2).​
4982-152.31 (n) "Medical cannabis flower" has the meaning given in section 342.01, subdivision 54.​
4632+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 142.1 Subd. 3.Report and grants.(a) The commissioner of human services shall submit a​
4633+142.2report of the grants and funding recommended by the advisory council to be awarded for​
4634+142.3the upcoming fiscal year to the chairs and ranking minority members of the legislative​
4635+142.4committees with jurisdiction over health and human services policy and finance by March​
4636+142.51 of each year, beginning March 1, 2024.​
4637+142.6 (b) When awarding grants, the commissioner of human services shall consider the​
4638+142.7programs, projects, and initiatives recommended by the council that address the priorities​
4639+142.8established by the council, unless otherwise appropriated by the legislature.​
4640+142.9Sec. 72. [342.80] LAWFUL ACTIVITIES.​
4641+142.10 (a) Notwithstanding any law to the contrary, the cultivation, manufacturing, possessing,​
4642+142.11and selling of cannabis flower, cannabis products, artificially derived cannabinoids,​
4643+142.12lower-potency hemp edibles, and hemp-derived consumer products by a licensed cannabis​
4644+142.13business or hemp business in conformity with the rights granted by a cannabis business​
4645+142.14license or hemp business license is lawful and may not be the grounds for the seizure or​
4646+142.15forfeiture of property, arrest or prosecution, or search or inspections except as provided by​
4647+142.16this chapter.​
4648+142.17 (b) A person acting as an agent of a cannabis microbusiness, cannabis mezzobusiness,​
4649+142.18cannabis retailer, or lower-potency hemp edible retailer who sells or otherwise transfers​
4650+142.19cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
4651+142.20products to a person under 21 years of age is not subject to arrest, prosecution, or forfeiture​
4652+142.21of property if the person complied with section 342.27, subdivision 4, and any rules​
4653+142.22promulgated pursuant to this chapter.​
4654+142.23Sec. 73. [342.81] CIVIL ACTIONS.​
4655+142.24 Subdivision 1.Right of action.A spouse, child, parent, guardian, employer, or other​
4656+142.25person injured in person, property, or means of support or who incurs other pecuniary loss​
4657+142.26by an intoxicated person or by the intoxication of another person, has a right of action in​
4658+142.27the person's own name for all damages sustained against a person who caused the intoxication​
4659+142.28of that person by illegally selling cannabis flower, cannabis products, lower-potency hemp​
4660+142.29edibles, or hemp-derived consumer products. All damages recovered by a minor under this​
4661+142.30section must be paid either to the minor or to the minor's parent, guardian, or next friend as​
4662+142.31the court directs.​
4663+142.32 Subd. 2.Actions.All suits for damages under this section must be by civil action in a​
4664+142.33court of this state having jurisdiction.​
4665+142​Article 1 Sec. 73.​
4666+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 143.1 Subd. 3.Comparative negligence.Actions under this section are governed by section​
4667+143.2604.01.​
4668+143.3 Subd. 4.Defense.It is a defense for the defendant to prove by a preponderance of the​
4669+143.4evidence that the defendant reasonably and in good faith relied upon representations of​
4670+143.5proof of age in selling, bartering, furnishing, or giving the cannabis flower, cannabis products,​
4671+143.6lower-potency hemp edibles, or hemp-derived consumer products.​
4672+143.7 Subd. 5.Subrogation claims denied.There shall be no recovery by any insurance​
4673+143.8company against any cannabis microbusiness, cannabis mezzobusiness, cannabis retailer,​
4674+143.9or lower-potency hemp edible retailer under subrogation clauses of the uninsured,​
4675+143.10underinsured, collision, or other first-party coverages of a motor vehicle insurance policy​
4676+143.11as a result of payments made by the company to persons who have claims that arise in whole​
4677+143.12or in part under this section. Section 65B.53, subdivision 3, does not apply to actions under​
4678+143.13this section.​
4679+143.14 Subd. 6.Common law claims.Nothing in this chapter precludes common law tort claims​
4680+143.15against any person 21 years old or older who knowingly provides or furnishes cannabis​
4681+143.16flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products​
4682+143.17to a person under the age of 21 years.​
4683+143.18Sec. 74. SUBSTANCE USE DISORDER ADVISORY COUNCIL FIRST MEETING.​
4684+143.19 The commissioner of human services shall convene the first meeting of the Substance​
4685+143.20Use Disorder Advisory Council established under Minnesota Statutes, section 342.79, no​
4686+143.21later than October 1, 2023. The members shall elect a chair at the first meeting.​
4687+143.22Sec. 75. EFFECTIVE DATE.​
4688+143.23 Except as otherwise provided, each section of this article is effective July 1, 2023.​
4689+143.24 ARTICLE 2​
4690+143.25 TAXES​
4691+143.26Section 1. Minnesota Statutes 2022, section 270B.12, is amended by adding a subdivision​
4692+143.27to read:​
4693+143.28 Subd. 4a.Office of Cannabis Management.The commissioner may disclose return​
4694+143.29information to the Office of Cannabis Management for the purpose of and to the extent​
4695+143.30necessary to administer section 270C.726.​
4696+143.31 EFFECTIVE DATE.This section is effective June 30, 2023.​
4697+143​Article 2 Section 1.​
4698+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 144.1Sec. 2. [270C.726] POSTING OF TAX DELINQUENCY; SALE OF CANNABIS.​
4699+144.2 Subdivision 1.Posting; notice.(a) Pursuant to the authority to disclose under section​
4700+144.3270B.12, subdivision 4a, the commissioner shall, by the 15th of each month, submit to the​
4701+144.4Office of Cannabis Management a list of all taxpayers subject to the tax imposed by section​
4702+144.5295.81 that are required to pay, withhold, or collect the tax imposed by section 290.02,​
4703+144.6290.0922, 290.92, 290.9727, 290.9728, 290.9729, 295.81, or 297A.62; a local sales and​
4704+144.7use tax payable to the commissioner; or a local sales and use tax administered and collected​
4705+144.8by the commissioner, and that are ten days or more delinquent in either filing a tax return​
4706+144.9or paying the tax.​
4707+144.10 (b) The commissioner is under no obligation to list a taxpayer whose business is inactive.​
4708+144.11At least ten days before notifying the Office of Cannabis Management, the commissioner​
4709+144.12shall notify the taxpayer of the intended action.​
4710+144.13 (c) The Office of Cannabis Management shall post the list required by this section on​
4711+144.14the Office of Cannabis Management website. The list must prominently show the date of​
4712+144.15posting. If a previously listed taxpayer files all returns and pays all taxes specified in this​
4713+144.16subdivision then due, the commissioner shall notify the Office of Cannabis Management​
4714+144.17within two business days.​
4715+144.18 Subd. 2.Sales prohibited.Beginning the third business day after the list is posted, no​
4716+144.19cannabis cultivator, cannabis manufacturer, cannabis microbusiness, cannabis mezzobusiness,​
4717+144.20cannabis wholesaler, or industrial hemp grower as defined in chapter 342 may sell or deliver​
4718+144.21any product to a taxpayer included on the posted list.​
4719+144.22 Subd. 3.Penalty.A cannabis cultivator, cannabis manufacturer, cannabis microbusiness,​
4720+144.23cannabis mezzobusiness, cannabis wholesaler, or industrial hemp grower as defined in​
4721+144.24chapter 342 who violates subdivision 2 of this section is subject to the penalties provided​
4722+144.25in sections 342.19 and 342.21.​
4723+144.26 EFFECTIVE DATE.This section is effective June 30, 2023.​
4724+144.27Sec. 3. Minnesota Statutes 2022, section 273.13, subdivision 24, is amended to read:​
4725+144.28 Subd. 24.Class 3.Commercial and industrial property and utility real and personal​
4726+144.29property is class 3a.​
4727+144.30 (1) Except as otherwise provided, each parcel of commercial, industrial, or utility real​
4728+144.31property has a classification rate of 1.5 percent of the first tier of market value, and 2.0​
4729+144.32percent of the remaining market value. In the case of contiguous parcels of property owned​
4730+144.33by the same person or entity, only the value equal to the first-tier value of the contiguous​
4731+144​Article 2 Sec. 3.​
4732+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 145.1parcels qualifies for the reduced classification rate, except that contiguous parcels owned​
4733+145.2by the same person or entity shall be eligible for the first-tier value classification rate on​
4734+145.3each separate business operated by the owner of the property, provided the business is​
4735+145.4housed in a separate structure. For the purposes of this subdivision, the first tier means the​
4736+145.5first $150,000 of market value. Real property owned in fee by a utility for transmission line​
4737+145.6right-of-way shall be classified at the classification rate for the higher tier.​
4738+145.7 For purposes of this subdivision, parcels are considered to be contiguous even if they​
4739+145.8are separated from each other by a road, street, waterway, or other similar intervening type​
4740+145.9of property. Connections between parcels that consist of power lines or pipelines do not​
4741+145.10cause the parcels to be contiguous. Property owners who have contiguous parcels of property​
4742+145.11that constitute separate businesses that may qualify for the first-tier classification rate shall​
4743+145.12notify the assessor by July 1, for treatment beginning in the following taxes payable year.​
4744+145.13 (2) All personal property that is: (i) part of an electric generation, transmission, or​
4745+145.14distribution system; or (ii) part of a pipeline system transporting or distributing water, gas,​
4746+145.15crude oil, or petroleum products; and (iii) not described in clause (3), and all railroad​
4747+145.16operating property has a classification rate as provided under clause (1) for the first tier of​
4748+145.17market value and the remaining market value. In the case of multiple parcels in one county​
4749+145.18that are owned by one person or entity, only one first tier amount is eligible for the reduced​
4750+145.19rate.​
4751+145.20 (3) The entire market value of personal property that is: (i) tools, implements, and​
4752+145.21machinery of an electric generation, transmission, or distribution system; (ii) tools,​
4753+145.22implements, and machinery of a pipeline system transporting or distributing water, gas,​
4754+145.23crude oil, or petroleum products; or (iii) the mains and pipes used in the distribution of​
4755+145.24steam or hot or chilled water for heating or cooling buildings, has a classification rate as​
4756+145.25provided under clause (1) for the remaining market value in excess of the first tier.​
4757+145.26 (4) Real property used for raising, cultivating, processing, or storing cannabis plants,​
4758+145.27cannabis flower, or cannabis products for sale has a classification rate as provided under​
4759+145.28clause (1) for the first tier of market value and the remaining market value. As used in this​
4760+145.29paragraph, "cannabis plant" has the meaning given in section 342.01, subdivision 18,​
4761+145.30"cannabis flower" has the meaning given in section 342.01, subdivision 15, and "cannabis​
4762+145.31product" has the meaning given in section 342.01, subdivision 19.​
4763+145.32 EFFECTIVE DATE.This section is effective beginning with assessment year 2024​
4764+145.33and thereafter.​
4765+145​Article 2 Sec. 3.​
4766+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 146.1Sec. 4. Minnesota Statutes 2022, section 275.025, subdivision 2, is amended to read:​
4767+146.2 Subd. 2.Commercial-industrial tax capacity.For the purposes of this section,​
4768+146.3"commercial-industrial tax capacity" means the tax capacity of all taxable property classified​
4769+146.4as class 3 or class 5(1) under section 273.13, excluding:​
4770+146.5 (1) the tax capacity attributable to the first $150,000 of market value of each parcel of​
4771+146.6commercial-industrial property as defined under section 273.13, subdivision 24, clauses (1)​
4772+146.7and, (2), and (4);​
4773+146.8 (2) electric generation attached machinery under class 3; and​
4774+146.9 (3) property described in section 473.625.​
4775+146.10 County commercial-industrial tax capacity amounts are not adjusted for the captured​
4776+146.11net tax capacity of a tax increment financing district under section 469.177, subdivision 2,​
4777+146.12the net tax capacity of transmission lines deducted from a local government's total net tax​
4778+146.13capacity under section 273.425, or fiscal disparities contribution and distribution net tax​
4779+146.14capacities under chapter 276A or 473F. For purposes of this subdivision, the procedures​
4780+146.15for determining eligibility for tier 1 under section 273.13, subdivision 24, clauses (1) and​
4781+146.16(2), shall apply in determining the portion of a property eligible to be considered within the​
4782+146.17first $150,000 of market value.​
4783+146.18 EFFECTIVE DATE.This section is effective beginning with assessment year 2024​
4784+146.19and thereafter.​
4785+146.20Sec. 5. [289A.33] FILING REQUIREMENTS AND DUE DATES; SPECIAL RULES.​
4786+146.21 (a) Upon the request of any cannabis business as defined by section 342.01, subdivision​
4787+146.2213, required to collect and remit taxes imposed under section 295.81, chapter 290, or chapter​
4788+146.23297A, the commissioner shall waive the requirement that payment of tax must be made​
4789+146.24electronically if the failure to pay electronically is because the cannabis business is unable​
4790+146.25to secure banking services and the inability to secure the services is due to its engagement​
4791+146.26in cannabis-related business allowed under Minnesota law.​
4792+146.27 (b) If, in consultation with the commissioner of commerce, the commissioner determines​
4793+146.28the inability to find banking services is widespread and enforcement of the electronic payment​
4794+146.29requirement will significantly impede the ability of cannabis businesses to timely pay taxes​
4795+146.30imposed under section 295.81, chapter 290, or chapter 297A, the commissioner may publish​
4796+146.31notice on the department website that waives the requirement to pay the tax electronically.​
4797+146.32If such notice is published, a cannabis business must file returns and pay taxes lawfully due​
4798+146.33in the form and manner prescribed by the commissioner.​
4799+146​Article 2 Sec. 5.​
4800+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 147.1 (c) Nothing in this subdivision relieves a cannabis business from timely filing and paying​
4801+147.2taxes.​
4802+147.3 EFFECTIVE DATE.This section is effective the day following final enactment.​
4803+147.4Sec. 6. Minnesota Statutes 2022, section 290.0132, subdivision 29, is amended to read:​
4804+147.5 Subd. 29.Disallowed section 280E expenses; medical cannabis manufacturers​
4805+147.6licensees.The amount of expenses of a medical cannabis manufacturer business, as defined​
4806+147.7under section 152.22, subdivision 7 342.01, subdivision 51, related to the business of medical​
4807+147.8cannabis under sections 152.21 to 152.37 342.47 to 342.60, or a license holder under chapter​
4808+147.9342 related to the business of nonmedical cannabis under that chapter, and not allowed for​
4809+147.10federal income tax purposes under section 280E of the Internal Revenue Code is a subtraction.​
4810+147.11 EFFECTIVE DATE.This section is effective for taxable years beginning after December​
4811+147.1231, 2022.​
4812+147.13Sec. 7. Minnesota Statutes 2022, section 290.0134, subdivision 19, is amended to read:​
4813+147.14 Subd. 19.Disallowed section 280E expenses; medical cannabis manufacturers​
4814+147.15licensees.The amount of expenses of a medical cannabis manufacturer business, as defined​
4815+147.16under section 152.22, subdivision 7 342.01, subdivision 51, related to the business of medical​
4816+147.17cannabis under sections 152.21 to 152.37 342.47 to 342.60, or a license holder under chapter​
4817+147.18342 related to the business of nonmedical cannabis under that chapter, and not allowed for​
4818+147.19federal income tax purposes under section 280E of the Internal Revenue Code is a subtraction.​
4819+147.20 EFFECTIVE DATE.This section is effective for taxable years beginning after December​
4820+147.2131, 2022.​
4821+147.22Sec. 8. [295.81] CANNABIS GROSS RECEIPTS TAX.​
4822+147.23 Subdivision 1.Definitions.(a) For purposes of this section, the following terms have​
4823+147.24the meanings given.​
4824+147.25 (b) "Bundled transaction" means the retail sale of two or more products when the products​
4825+147.26are otherwise distinct and identifiable and the products are sold for one nonitemized price.​
4826+147.27 (c) "Cannabis flower" has the meaning given in section 342.01, subdivision 15.​
4827+147.28 (d) "Cannabis product" has the meaning given in section 342.01, subdivision 19.​
4828+147.29 (e) "Cannabis solution product" means any cartridge, bottle, or other package that contains​
4829+147.30a taxable cannabis product in a solution that is consumed or meant to be consumed through​
4830+147​Article 2 Sec. 8.​
4831+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 148.1the use of a heating element, power source, electronic circuit, or other electronic, chemical,​
4832+148.2or mechanical means that produces vapor or aerosol. A cannabis solution product includes​
4833+148.3any electronic delivery system, electronic vaping device, electronic vape pen, electronic​
4834+148.4oral device, electronic delivery device, or similar product or device, and any batteries,​
4835+148.5heating elements, or other components, parts, or accessories sold with and meant to be used​
4836+148.6in the consumption of a solution containing a taxable cannabis product.​
4837+148.7 (f) "Cannabis mezzobusiness" means a cannabis business licensed under section 342.29.​
4838+148.8 (g) "Cannabis microbusiness" means a cannabis business licensed under section 342.28.​
4839+148.9 (h) "Cannabis retailer" means a cannabis business licensed under section 342.32.​
4840+148.10 (i) "Commissioner" means the commissioner of revenue.​
4841+148.11 (j) "Gross receipts" means the total amount received in money or by barter or exchange​
4842+148.12for all taxable cannabis product sales at retail as measured by the sales price. Gross receipts​
4843+148.13include but are not limited to delivery charges and packaging costs. Gross receipts do not​
4844+148.14include:​
4845+148.15 (1) any taxes imposed directly on the customer that are separately stated on the invoice,​
4846+148.16bill of sale, or similar document given to the purchaser; and​
4847+148.17 (2) discounts, including cash, terms, or coupons, that are not reimbursed by a third party​
4848+148.18and that are allowed by the seller and taken by a purchaser on a sale.​
4849+148.19 (k) "Hemp-derived consumer product" has the meaning given in section 342.01,​
4850+148.20subdivision 35.​
4851+148.21 (l) "Lower-potency hemp edible" has the meaning given in section 342.01, subdivision​
4852+148.2248.​
4853+148.23 (m) "Lower-potency hemp edible retailer" means a cannabis business licensed under​
4854+148.24section 342.43, subdivision 1, clause (1).​
4855+148.25 (n) "Medical cannabis flower" has the meaning given in section 342.01, subdivision 52.​
4856+148.26 (o) "Medical cannabinoid product" has the meaning given in section 342.10, subdivision​
4857+148.2750.​
4858+148.28 (p) "Medical cannabis paraphernalia" has the meaning given in section 342.01,​
4859+148.29subdivision 53.​
4860+148.30 (q) "Retail sale" has the meaning given in section 297A.61, subdivision 4.​
4861+148​Article 2 Sec. 8.​
4862+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 149.1 (r) "Taxable cannabis product" means cannabis flower, cannabis product, cannabis​
4863+149.2solution product, hemp-derived consumer product, lower-potency hemp edible, and any​
4864+149.3substantially similar item.​
4865+149.4 (s) "Taxable cannabis product retailer" means a retailer that sells any taxable cannabis​
4866+149.5product, and includes a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness,​
4867+149.6and lower-potency hemp edible retailer. Taxable cannabis product retailer includes but is​
4868+149.7not limited to a:​
4869+149.8 (1) retailer maintaining a place of business in this state;​
4870+149.9 (2) marketplace provider maintaining a place of business in this state, as defined in​
4871+149.10section 297A.66, subdivision 1, paragraph (a);​
4872+149.11 (3) retailer not maintaining a place of business in this state; and​
4873+149.12 (4) marketplace provider not maintaining a place of business in this state, as defined in​
4874+149.13section 297A.66, subdivision 1, paragraph (b).​
4875+149.14 Subd. 2.Gross receipts tax imposed.(a) A tax equal to a rate established by subdivisions​
4876+149.152 and 3 of gross receipts from retail sales in Minnesota of taxable cannabis products is​
4877+149.16imposed on any taxable cannabis product retailer that sells these products to customers:​
4878+149.17 (1) for sales and purchases made on July 1, 2023, through June 30, 2027, the rate is​
4879+149.18equal to eight percent; and​
4880+149.19 (2) for sales and purchases made after June 30, 2027, the rate is equal to the amount​
4881+149.20established under subdivision 3.​
4882+149.21 (b) A taxable cannabis product retailer may but is not required to collect the tax imposed​
4883+149.22by this section from the purchaser as long as the tax is separately stated on the receipt,​
4884+149.23invoice, bill of sale, or similar document given to the purchaser.​
4885+149.24 (c) If a product subject to the tax imposed under this section is included in a bundled​
4886+149.25transaction, the entire sales price of the bundled transaction is subject to the tax imposed​
4887+149.26under this section.​
4888+149.27 (d) The tax imposed under this section is in addition to any other tax imposed on the​
4889+149.28sale or use of taxable cannabis products.​
4890+149.29 Subd. 3.Tax rate adjustment.(a) Beginning in March 2027, in each odd-numbered​
4891+149.30year, the commissioner of management and budget shall use the February forecast of general​
4892+149.31fund revenues and expenditures reflecting the most recently completed fiscal year to​
4893+149.32determine that the conditions in paragraph (b) are met.​
4894+149​Article 2 Sec. 8.​
4895+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 150.1 (b) Revenues raised by the tax imposed under this section combined with the tax imposed​
4896+150.2under chapter 297A on taxable cannabis products exceed the projected expenditures related​
4897+150.3to the ongoing regulation of cannabis for the upcoming biennium, including:​
4898+150.4 (1) the appropriations to the Office of Cannabis Management;​
4899+150.5 (2) the appropriations to the Department of Agriculture;​
4900+150.6 (3) the appropriations to the Cannabis Expungement Board;​
4901+150.7 (4) the appropriations to the Department of Commerce;​
4902+150.8 (5) the appropriations to the Department of Education;​
4903+150.9 (6) the appropriations to the Department of Employment and Economic Development;​
4904+150.10 (7) the appropriations to the Department of Health;​
4905+150.11 (8) the appropriations to the Department of Human Services;​
4906+150.12 (9) the appropriations to the Department of Labor and Industry;​
4907+150.13 (10) the appropriations to the Pollution Control Agency;​
4908+150.14 (11) the appropriations to the Department of Public Safety;​
4909+150.15 (12) the appropriations to the Department of Revenue;​
4910+150.16 (13) the transfers to the dual training account in the special revenue fund; and​
4911+150.17 (14) the transfers to the substance use treatment, recovery, and prevention grant account.​
4912+150.18 (c) The commissioner of management and budget shall report its determination to the​
4913+150.19commissioner no later than March 15 in the same odd-numbered year.​
4914+150.20 (d) The commissioner shall adjust the tax rate so that the revenues described in paragraph​
4915+150.21(a) equal or most closely exceed the expenditures in paragraph (b). The new rate must be​
4916+150.22rounded to the nearest one-quarter of one percent. The commissioner must post the new​
4917+150.23rate on the department website by April 1 of the same odd-numbered year. The new rate​
4918+150.24applies to sales and purchases made after June 30 of the same odd-numbered year.​
4919+150.25 Subd. 4.Use tax imposed; credit for taxes paid.(a) A person that receives taxable​
4920+150.26cannabis products for use or storage in Minnesota, other than from a taxable cannabis product​
4921+150.27retailer that paid the tax under subdivision 2, is subject to tax at the rate imposed under​
4922+150.28subdivision 2. Liability for the tax is incurred when the person has possession of the taxable​
4923+150.29cannabis product in Minnesota. The tax must be remitted to the commissioner in the same​
4924+150.30manner prescribed for taxes imposed under chapter 297A.​
4925+150​Article 2 Sec. 8.​
4926+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 151.1 (b) A person that has paid taxes to another state or any subdivision thereof on the same​
4927+151.2transaction and is subject to tax under this section is entitled to a credit for the tax legally​
4928+151.3due and paid to another state or subdivision thereof to the extent of the lesser of (1) the tax​
4929+151.4actually paid to the other state or subdivision thereof, or (2) the amount of tax imposed by​
4930+151.5Minnesota on the transaction subject to tax in the other state or subdivision thereof.​
4931+151.6 Subd. 5.Exemptions.(a) The use tax imposed under subdivision 4, paragraph (a), does​
4932+151.7not apply to the possession, use, or storage of taxable cannabis products if (1) the taxable​
4933+151.8cannabis products have an aggregate cost in any calendar month to the customer of $100​
4934+151.9or less, and (2) the taxable cannabis products were carried into this state by the customer.​
4935+151.10 (b) The tax imposed under this section does not apply to sales of medical items purchased​
4936+151.11by or for a patient enrolled in the registry program, including medical cannabis flower,​
4937+151.12medical cannabinoid products, or medical cannabis paraphernalia.​
4938+151.13 (c) Unless otherwise specified in this section, the exemptions applicable to taxes imposed​
4939+151.14under chapter 297A are not applicable to the taxes imposed under this section.​
4940+151.15 Subd. 6.Local taxes prohibited.A political subdivision of this state is prohibited from​
4941+151.16imposing a local sales tax solely on the sale of taxable cannabis products.​
4942+151.17 Subd. 7.Tax collection required.A taxable cannabis product retailer with nexus in​
4943+151.18Minnesota that is not subject to tax under subdivision 2 is required to collect the tax imposed​
4944+151.19under subdivision 4 from the purchaser of the taxable cannabis product and give the purchaser​
4945+151.20a receipt for the tax paid. The tax collected must be remitted to the commissioner in the​
4946+151.21same manner prescribed for the taxes imposed under chapter 297A.​
4947+151.22 Subd. 8.Taxes paid to another state or any subdivision thereof; credit.A taxable​
4948+151.23cannabis product retailer that has paid taxes to another state or any subdivision thereof​
4949+151.24measured by gross receipts and is subject to tax under this section on the same gross receipts​
4950+151.25is entitled to a credit for the tax legally due and paid to another state or any subdivision​
4951+151.26thereof to the extent of the lesser of (1) the tax actually paid to the other state or any​
4952+151.27subdivision thereof, or (2) the amount of tax imposed by Minnesota on the gross receipts​
4953+151.28subject to tax in the other taxing state or any subdivision thereof.​
4954+151.29 Subd. 9.Sourcing of sales.Section 297A.668 applies to the taxes imposed by this​
4955+151.30section.​
4956+151.31 Subd. 10.Administration.Unless specifically provided otherwise, the audit, assessment,​
4957+151.32refund, penalty, interest, enforcement, collection remedies, appeal, and administrative​
4958+151.33provisions of chapters 270C and 289A that are applicable to taxes imposed under chapter​
4959+151​Article 2 Sec. 8.​
4960+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 152.1297A, except the requirement to file returns and remit taxes due electronically if authorized​
4961+152.2under section 289A.33, apply to the tax imposed under this section.​
4962+152.3 Subd. 11.Returns; payment of tax.(a) A taxable cannabis product retailer must report​
4963+152.4the tax on a return prescribed by the commissioner and must remit the tax in a form and​
4964+152.5manner prescribed by the commissioner. The return and the tax must be filed and paid using​
4965+152.6the filing cycle and due dates provided for taxes imposed under section 289A.20, subdivision​
4966+152.74, and chapter 297A.​
4967+152.8 (b) Interest must be paid on an overpayment refunded or credited to the taxpayer from​
4968+152.9the date of payment of the tax until the date the refund is paid or credited. For purposes of​
4969+152.10this subdivision, the date of payment is the due date of the return or the date of actual​
4970+152.11payment of the tax, whichever is later.​
4971+152.12 Subd. 12.Deposit of revenues.The commissioner must deposit all revenues, including​
4972+152.13penalties and interest, derived from the tax imposed by this section in the general fund.​
4973+152.14 Subd. 13.Personal debt.The tax imposed by this section, and interest and penalties​
4974+152.15imposed with respect to it, are a personal debt of the person required to file a return from​
4975+152.16the time that the liability for it arises, irrespective of when the time for payment of the​
4976+152.17liability occurs. The debt must, in the case of the executor or administrator of the estate of​
4977+152.18a decedent and in the case of a fiduciary, only be that of the person in the person's official​
4978+152.19or fiduciary capacity, unless the person has voluntarily distributed the assets held in that​
4979+152.20capacity without reserving sufficient assets to pay the tax, interest, and penalties, in which​
4980+152.21event the person is personally liable for any deficiency.​
4981+152.22 EFFECTIVE DATE.This section is effective for gross receipts received after June 30,​
4982+152.232023.​
4983+152.24Sec. 9. Minnesota Statutes 2022, section 297A.61, subdivision 3, is amended to read:​
4984+152.25 Subd. 3.Sale and purchase.(a) "Sale" and "purchase" include, but are not limited to,​
4985+152.26each of the transactions listed in this subdivision. In applying the provisions of this chapter,​
4986+152.27the terms "tangible personal property" and "retail sale" include the taxable services listed​
4987+152.28in paragraph (g), clause (6), items (i) to (vi) and (viii), and the provision of these taxable​
4988+152.29services, unless specifically provided otherwise. Services performed by an employee for​
4989+152.30an employer are not taxable. Services performed by a partnership or association for another​
4990+152.31partnership or association are not taxable if one of the entities owns or controls more than​
4991+152.3280 percent of the voting power of the equity interest in the other entity. Services performed​
4992+152.33between members of an affiliated group of corporations are not taxable. For purposes of​
49834993 152​Article 2 Sec. 9.​
4984-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 153.1 (o) "Medical cannabinoid product" has the meaning given in section 342.01, subdivision​
4985-153.252.​
4986-153.3 (p) "Medical cannabis paraphernalia" has the meaning given in section 342.01,​
4987-153.4subdivision 55.​
4988-153.5 (q) "Retail sale" has the meaning given in section 297A.61, subdivision 4.​
4989-153.6 (r) "Taxable cannabis product" means cannabis flower, cannabis product, cannabis​
4990-153.7solution product, hemp-derived consumer product, lower-potency hemp edible, and any​
4991-153.8substantially similar item.​
4992-153.9 (s) "Taxable cannabis product retailer" means a retailer that sells any taxable cannabis​
4993-153.10product, and includes a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness,​
4994-153.11medical cannabis combination business, and lower-potency hemp edible retailer. Taxable​
4995-153.12cannabis product retailer includes but is not limited to a:​
4996-153.13 (1) retailer maintaining a place of business in this state;​
4997-153.14 (2) marketplace provider maintaining a place of business in this state, as defined in​
4998-153.15section 297A.66, subdivision 1, paragraph (a);​
4999-153.16 (3) retailer not maintaining a place of business in this state; and​
5000-153.17 (4) marketplace provider not maintaining a place of business in this state, as defined in​
5001-153.18section 297A.66, subdivision 1, paragraph (b).​
5002-153.19 Subd. 2.Gross receipts tax imposed.(a) A tax equal to ten percent of gross receipts​
5003-153.20from retail sales in Minnesota of taxable cannabis products is imposed on any taxable​
5004-153.21cannabis product retailer that sells these products to customers. A taxable cannabis product​
5005-153.22retailer may but is not required to collect the tax imposed by this section from the purchaser​
5006-153.23as long as the tax is separately stated on the receipt, invoice, bill of sale, or similar document​
5007-153.24given to the purchaser.​
5008-153.25 (b) If a product subject to the tax imposed under this section is included in a bundled​
5009-153.26transaction, the entire sales price of the bundled transaction is subject to the tax imposed​
5010-153.27under this section.​
5011-153.28 (c) The tax imposed under this section is in addition to any other tax imposed on the​
5012-153.29sale or use of taxable cannabis products.​
5013-153.30 Subd. 3.Use tax imposed; credit for taxes paid.(a) A person that receives taxable​
5014-153.31cannabis products for use or storage in Minnesota, other than from a taxable cannabis product​
5015-153.32retailer that paid the tax under subdivision 2, is subject to tax at the rate imposed under​
4994+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 153.1the preceding sentence, "affiliated group of corporations" means those entities that would​
4995+153.2be classified as members of an affiliated group as defined under United States Code, title​
4996+153.326, section 1504, disregarding the exclusions in section 1504(b).​
4997+153.4 (b) Sale and purchase include:​
4998+153.5 (1) any transfer of title or possession, or both, of tangible personal property, whether​
4999+153.6absolutely or conditionally, for a consideration in money or by exchange or barter; and​
5000+153.7 (2) the leasing of or the granting of a license to use or consume, for a consideration in​
5001+153.8money or by exchange or barter, tangible personal property, other than a manufactured​
5002+153.9home used for residential purposes for a continuous period of 30 days or more.​
5003+153.10 (c) Sale and purchase include the production, fabrication, printing, or processing of​
5004+153.11tangible personal property for a consideration for consumers who furnish either directly or​
5005+153.12indirectly the materials used in the production, fabrication, printing, or processing.​
5006+153.13 (d) Sale and purchase include the preparing for a consideration of food. Notwithstanding​
5007+153.14section 297A.67, subdivision 2, taxable food includes, but is not limited to, the following:​
5008+153.15 (1) prepared food sold by the retailer;​
5009+153.16 (2) soft drinks;​
5010+153.17 (3) candy; and​
5011+153.18 (4) dietary supplements.​
5012+153.19 (e) A sale and a purchase includes the furnishing for a consideration of electricity, gas,​
5013+153.20water, or steam for use or consumption within this state.​
5014+153.21 (f) A sale and a purchase includes the transfer for a consideration of prewritten computer​
5015+153.22software whether delivered electronically, by load and leave, or otherwise.​
5016+153.23 (g) A sale and a purchase includes the furnishing for a consideration of the following​
5017+153.24services:​
5018+153.25 (1) the privilege of admission to places of amusement, recreational areas, or athletic​
5019+153.26events, and the making available of amusement devices, tanning facilities, reducing salons,​
5020+153.27steam baths, health clubs, and spas or athletic facilities;​
5021+153.28 (2) lodging and related services by a hotel, rooming house, resort, campground, motel,​
5022+153.29or trailer camp, including furnishing the guest of the facility with access to telecommunication​
5023+153.30services, and the granting of any similar license to use real property in a specific facility,​
5024+153.31other than the renting or leasing of it for a continuous period of 30 days or more under an​
50165025 153​Article 2 Sec. 9.​
5017-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 154.1subdivision 2. Liability for the tax is incurred when the person has possession of the taxable​
5018-154.2cannabis product in Minnesota. The tax must be remitted to the commissioner in the same​
5019-154.3manner prescribed for taxes imposed under chapter 297A.​
5020-154.4 (b) A person that has paid taxes to another state or any subdivision thereof on the same​
5021-154.5transaction and is subject to tax under this section is entitled to a credit for the tax legally​
5022-154.6due and paid to another state or subdivision thereof to the extent of the lesser of (1) the tax​
5023-154.7actually paid to the other state or subdivision thereof, or (2) the amount of tax imposed by​
5024-154.8Minnesota on the transaction subject to tax in the other state or subdivision thereof.​
5025-154.9 Subd. 4.Exemptions.(a) The use tax imposed under subdivision 3, paragraph (a), does​
5026-154.10not apply to the possession, use, or storage of taxable cannabis products if (1) the taxable​
5027-154.11cannabis products have an aggregate cost in any calendar month to the customer of $100​
5028-154.12or less, and (2) the taxable cannabis products were carried into this state by the customer.​
5029-154.13 (b) The tax imposed under this section does not apply to sales of medical items purchased​
5030-154.14by or for a patient enrolled in the registry program, including medical cannabis flower,​
5031-154.15medical cannabinoid products, or medical cannabis paraphernalia.​
5032-154.16 (c) Unless otherwise specified in this section, the exemptions applicable to taxes imposed​
5033-154.17under chapter 297A are not applicable to the taxes imposed under this section.​
5034-154.18 (d) The tax imposed under this section does not apply to:​
5035-154.19 (1) sales made in Indian country as defined in United States Code, title 18, section 1151,​
5036-154.20by a cannabis business licensed by a Minnesota Tribal government, as defined in section​
5037-154.213.9228, subdivision 1, paragraph (f); or​
5038-154.22 (2) use tax owed on taxable cannabis products purchased on Tribally regulated land as​
5039-154.23defined in section 3.9228, subdivision 1, from a cannabis business licensed by a Minnesota​
5040-154.24Tribal government as defined in section 3.9228, subdivision 1, paragraph (f).​
5041-154.25 Subd. 5.Tax collection required.A taxable cannabis product retailer with nexus in​
5042-154.26Minnesota that is not subject to tax under subdivision 2 is required to collect the tax imposed​
5043-154.27under subdivision 4 from the purchaser of the taxable cannabis product and give the purchaser​
5044-154.28a receipt for the tax paid. The tax collected must be remitted to the commissioner in the​
5045-154.29same manner prescribed for the taxes imposed under chapter 297A.​
5046-154.30 Subd. 6.Taxes paid to another state or any subdivision thereof; credit.A taxable​
5047-154.31cannabis product retailer that has paid taxes to another state or any subdivision thereof​
5048-154.32measured by gross receipts and is subject to tax under this section on the same gross receipts​
5049-154.33is entitled to a credit for the tax legally due and paid to another state or any subdivision​
5026+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 154.1enforceable written agreement that may not be terminated without prior notice and including​
5027+154.2accommodations intermediary services provided in connection with other services provided​
5028+154.3under this clause;​
5029+154.4 (3) nonresidential parking services, whether on a contractual, hourly, or other periodic​
5030+154.5basis, except for parking at a meter;​
5031+154.6 (4) the granting of membership in a club, association, or other organization if:​
5032+154.7 (i) the club, association, or other organization makes available for the use of its members​
5033+154.8sports and athletic facilities, without regard to whether a separate charge is assessed for use​
5034+154.9of the facilities; and​
5035+154.10 (ii) use of the sports and athletic facility is not made available to the general public on​
5036+154.11the same basis as it is made available to members.​
5037+154.12Granting of membership means both onetime initiation fees and periodic membership dues.​
5038+154.13Sports and athletic facilities include golf courses; tennis, racquetball, handball, and squash​
5039+154.14courts; basketball and volleyball facilities; running tracks; exercise equipment; swimming​
5040+154.15pools; and other similar athletic or sports facilities;​
5041+154.16 (5) delivery of aggregate materials by a third party, excluding delivery of aggregate​
5042+154.17material used in road construction; and delivery of concrete block by a third party if the​
5043+154.18delivery would be subject to the sales tax if provided by the seller of the concrete block.​
5044+154.19For purposes of this clause, "road construction" means construction of:​
5045+154.20 (i) public roads;​
5046+154.21 (ii) cartways; and​
5047+154.22 (iii) private roads in townships located outside of the seven-county metropolitan area​
5048+154.23up to the point of the emergency response location sign; and​
5049+154.24 (6) services as provided in this clause:​
5050+154.25 (i) laundry and dry cleaning services including cleaning, pressing, repairing, altering,​
5051+154.26and storing clothes, linen services and supply, cleaning and blocking hats, and carpet,​
5052+154.27drapery, upholstery, and industrial cleaning. Laundry and dry cleaning services do not​
5053+154.28include services provided by coin operated facilities operated by the customer;​
5054+154.29 (ii) motor vehicle washing, waxing, and cleaning services, including services provided​
5055+154.30by coin operated facilities operated by the customer, and rustproofing, undercoating, and​
5056+154.31towing of motor vehicles;​
50505057 154​Article 2 Sec. 9.​
5051-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 155.1thereof to the extent of the lesser of (1) the tax actually paid to the other state or any
5052-155.2subdivision thereof, or (2) the amount of tax imposed by Minnesota on the gross receipts
5053-155.3subject to tax in the other taxing state or any subdivision thereof.
5054-155.4 Subd. 7.Sourcing of sales.Section 297A.668 applies to the taxes imposed by this
5055-155.5section.​
5056-155.6 Subd. 8.Administration.Unless specifically provided otherwise, the audit, assessment,
5057-155.7refund, penalty, interest, enforcement, collection remedies, appeal, and administrative
5058-155.8provisions of chapters 270C and 289A that are applicable to taxes imposed under chapter
5059-155.9297A, except the requirement to file returns and remit taxes due electronically if authorized
5060-155.10under section 289A.33, apply to the tax imposed under this section.
5061-155.11 Subd. 9.Returns; payment of tax.(a) A taxable cannabis product retailer must report
5062-155.12the tax on a return prescribed by the commissioner and must remit the tax in a form and
5063-155.13manner prescribed by the commissioner. The return and the tax must be filed and paid using
5064-155.14the filing cycle and due dates provided for taxes imposed under section 289A.20, subdivision
5065-155.154, and chapter 297A.
5066-155.16 (b) Interest must be paid on an overpayment refunded or credited to the taxpayer from
5067-155.17the date of payment of the tax until the date the refund is paid or credited. For purposes of​
5068-155.18this subdivision, the date of payment is the due date of the return or the date of actual
5069-155.19payment of the tax, whichever is later.
5070-155.20 Subd. 10.Deposit of revenues; account established.(a) The commissioner must deposit
5071-155.21the revenues, including penalties and interest, derived from the tax imposed by this section
5072-155.22as follows:
5073-155.23 (1) 80 percent to the general fund; and
5074-155.24 (2) 20 percent to the local government cannabis aid account in the special revenue fund.
5075-155.25 (b) The local government cannabis aid account is established in the special revenue fund.
5076-155.26 Subd. 11.Personal debt.The tax imposed by this section, and interest and penalties
5077-155.27imposed with respect to it, are a personal debt of the person required to file a return from
5078-155.28the time that the liability for it arises, irrespective of when the time for payment of the
5079-155.29liability occurs. The debt must, in the case of the executor or administrator of the estate of
5080-155.30a decedent and in the case of a fiduciary, be that of the person in the person's official or
5081-155.31fiduciary capacity only, unless the person has voluntarily distributed the assets held in that
5082-155.32capacity without reserving sufficient assets to pay the tax, interest, and penalties, in which
5083-155.33event the person is personally liable for any deficiency.​
5058+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 155.1 (iii) building and residential cleaning, maintenance, and disinfecting services and pest
5059+155.2control and exterminating services;
5060+155.3 (iv) detective, security, burglar, fire alarm, and armored car services; but not including
5061+155.4services performed within the jurisdiction they serve by off-duty licensed peace officers as
5062+155.5defined in section 626.84, subdivision 1, or services provided by a nonprofit organization
5063+155.6or any organization at the direction of a county for monitoring and electronic surveillance
5064+155.7of persons placed on in-home detention pursuant to court order or under the direction of the
5065+155.8Minnesota Department of Corrections;
5066+155.9 (v) pet grooming services;
5067+155.10 (vi) lawn care, fertilizing, mowing, spraying and sprigging services; garden planting
5068+155.11and maintenance; tree, bush, and shrub pruning, bracing, spraying, and surgery; indoor plant
5069+155.12care; tree, bush, shrub, and stump removal, except when performed as part of a land clearing
5070+155.13contract as defined in section 297A.68, subdivision 40; and tree trimming for public utility
5071+155.14lines. Services performed under a construction contract for the installation of shrubbery,​
5072+155.15plants, sod, trees, bushes, and similar items are not taxable;
5073+155.16 (vii) massages, except when provided by a licensed health care facility or professional
5074+155.17or upon written referral from a licensed health care facility or professional for treatment of​
5075+155.18illness, injury, or disease; and
5076+155.19 (viii) the furnishing of lodging, board, and care services for animals in kennels and other
5077+155.20similar arrangements, but excluding veterinary and horse boarding services.​
5078+155.21 (h) A sale and a purchase includes the furnishing for a consideration of tangible personal
5079+155.22property or taxable services by the United States or any of its agencies or instrumentalities,
5080+155.23or the state of Minnesota, its agencies, instrumentalities, or political subdivisions.
5081+155.24 (i) A sale and a purchase includes the furnishing for a consideration of
5082+155.25telecommunications services, ancillary services associated with telecommunication services,
5083+155.26and pay television services. Telecommunication services include, but are not limited to, the
5084+155.27following services, as defined in section 297A.669: air-to-ground radiotelephone service,
5085+155.28mobile telecommunication service, postpaid calling service, prepaid calling service, prepaid
5086+155.29wireless calling service, and private communication services. The services in this paragraph
5087+155.30are taxed to the extent allowed under federal law.
5088+155.31 (j) A sale and a purchase includes the furnishing for a consideration of installation if the​
5089+155.32installation charges would be subject to the sales tax if the installation were provided by
5090+155.33the seller of the item being installed.​
50845091 155​Article 2 Sec. 9.​
5085-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 156.1 EFFECTIVE DATE.This section is effective for gross receipts received after June 30,​
5086-156.22023.​
5087-156.3Sec. 10. [295.82] CANNABIS LOCAL TAX PROHIBITED.​
5088-156.4 A political subdivision of this state is prohibited from imposing a tax solely on the sale​
5089-156.5of taxable cannabis products as defined under section 295.81, subdivision 1, paragraph (r).​
5090-156.6 EFFECTIVE DATE.This section is effective the day following final enactment.​
5091-156.7Sec. 11. Minnesota Statutes 2022, section 297A.61, subdivision 3, is amended to read:​
5092-156.8 Subd. 3.Sale and purchase.(a) "Sale" and "purchase" include, but are not limited to,​
5093-156.9each of the transactions listed in this subdivision. In applying the provisions of this chapter,​
5094-156.10the terms "tangible personal property" and "retail sale" include the taxable services listed​
5095-156.11in paragraph (g), clause (6), items (i) to (vi) and (viii), and the provision of these taxable​
5096-156.12services, unless specifically provided otherwise. Services performed by an employee for​
5097-156.13an employer are not taxable. Services performed by a partnership or association for another​
5098-156.14partnership or association are not taxable if one of the entities owns or controls more than​
5099-156.1580 percent of the voting power of the equity interest in the other entity. Services performed​
5100-156.16between members of an affiliated group of corporations are not taxable. For purposes of​
5101-156.17the preceding sentence, "affiliated group of corporations" means those entities that would​
5102-156.18be classified as members of an affiliated group as defined under United States Code, title​
5103-156.1926, section 1504, disregarding the exclusions in section 1504(b).​
5104-156.20 (b) Sale and purchase include:​
5105-156.21 (1) any transfer of title or possession, or both, of tangible personal property, whether​
5106-156.22absolutely or conditionally, for a consideration in money or by exchange or barter; and​
5107-156.23 (2) the leasing of or the granting of a license to use or consume, for a consideration in​
5108-156.24money or by exchange or barter, tangible personal property, other than a manufactured​
5109-156.25home used for residential purposes for a continuous period of 30 days or more.​
5110-156.26 (c) Sale and purchase include the production, fabrication, printing, or processing of​
5111-156.27tangible personal property for a consideration for consumers who furnish either directly or​
5112-156.28indirectly the materials used in the production, fabrication, printing, or processing.​
5113-156.29 (d) Sale and purchase include the preparing for a consideration of food. Notwithstanding​
5114-156.30section 297A.67, subdivision 2, taxable food includes, but is not limited to, the following:​
5115-156.31 (1) prepared food sold by the retailer;​
5116-156​Article 2 Sec. 11.​
5117-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 157.1 (2) soft drinks;​
5118-157.2 (3) candy; and​
5119-157.3 (4) dietary supplements.​
5120-157.4 (e) A sale and a purchase includes the furnishing for a consideration of electricity, gas,​
5121-157.5water, or steam for use or consumption within this state.​
5122-157.6 (f) A sale and a purchase includes the transfer for a consideration of prewritten computer​
5123-157.7software whether delivered electronically, by load and leave, or otherwise.​
5124-157.8 (g) A sale and a purchase includes the furnishing for a consideration of the following​
5125-157.9services:​
5126-157.10 (1) the privilege of admission to places of amusement, recreational areas, or athletic​
5127-157.11events, and the making available of amusement devices, tanning facilities, reducing salons,​
5128-157.12steam baths, health clubs, and spas or athletic facilities;​
5129-157.13 (2) lodging and related services by a hotel, rooming house, resort, campground, motel,​
5130-157.14or trailer camp, including furnishing the guest of the facility with access to telecommunication​
5131-157.15services, and the granting of any similar license to use real property in a specific facility,​
5132-157.16other than the renting or leasing of it for a continuous period of 30 days or more under an​
5133-157.17enforceable written agreement that may not be terminated without prior notice and including​
5134-157.18accommodations intermediary services provided in connection with other services provided​
5135-157.19under this clause;​
5136-157.20 (3) nonresidential parking services, whether on a contractual, hourly, or other periodic​
5137-157.21basis, except for parking at a meter;​
5138-157.22 (4) the granting of membership in a club, association, or other organization if:​
5139-157.23 (i) the club, association, or other organization makes available for the use of its members​
5140-157.24sports and athletic facilities, without regard to whether a separate charge is assessed for use​
5141-157.25of the facilities; and​
5142-157.26 (ii) use of the sports and athletic facility is not made available to the general public on​
5143-157.27the same basis as it is made available to members.​
5144-157.28Granting of membership means both onetime initiation fees and periodic membership dues.​
5145-157.29Sports and athletic facilities include golf courses; tennis, racquetball, handball, and squash​
5146-157.30courts; basketball and volleyball facilities; running tracks; exercise equipment; swimming​
5147-157.31pools; and other similar athletic or sports facilities;​
5092+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 156.1 (k) A sale and a purchase includes the rental of a vehicle by a motor vehicle dealer to a​
5093+156.2customer when (1) the vehicle is rented by the customer for a consideration, or (2) the motor​
5094+156.3vehicle dealer is reimbursed pursuant to a service contract as defined in section 59B.02,​
5095+156.4subdivision 11.​
5096+156.5 (l) A sale and a purchase includes furnishing for a consideration of specified digital​
5097+156.6products or other digital products or granting the right for a consideration to use specified​
5098+156.7digital products or other digital products on a temporary or permanent basis and regardless​
5099+156.8of whether the purchaser is required to make continued payments for such right. Wherever​
5100+156.9the term "tangible personal property" is used in this chapter, other than in subdivisions 10​
5101+156.10and 38, the provisions also apply to specified digital products, or other digital products,​
5102+156.11unless specifically provided otherwise or the context indicates otherwise.​
5103+156.12 (m) The sale of the privilege of admission under section 297A.61, subdivision 3,​
5104+156.13paragraph (g), clause (1), to a place of amusement, recreational area, or athletic event​
5105+156.14includes all charges included in the privilege of admission's sales price, without deduction​
5106+156.15for amenities that may be provided, unless the amenities are separately stated and the​
5107+156.16purchaser of the privilege of admission is entitled to add or decline the amenities, and the​
5108+156.17amenities are not otherwise taxable.​
5109+156.18 (n) A sale and purchase includes the transfer for consideration of a taxable cannabis​
5110+156.19product as defined in section 295.81, subdivision 1, paragraph (r).​
5111+156.20 EFFECTIVE DATE.This section is effective for sales and purchases made after June​
5112+156.2130, 2023.​
5113+156.22Sec. 10. Minnesota Statutes 2022, section 297A.67, subdivision 2, is amended to read:​
5114+156.23 Subd. 2.Food and food ingredients.Except as otherwise provided in this subdivision,​
5115+156.24food and food ingredients are exempt. For purposes of this subdivision, "food" and "food​
5116+156.25ingredients" mean substances, whether in liquid, concentrated, solid, frozen, dried, or​
5117+156.26dehydrated form, that are sold for ingestion or chewing by humans and are consumed for​
5118+156.27their taste or nutritional value. Food and food ingredients exempt under this subdivision do​
5119+156.28not include candy, soft drinks, dietary supplements, and prepared foods. Food and food​
5120+156.29ingredients do not include alcoholic beverages and, tobacco, taxable cannabis products,​
5121+156.30medical cannabis flower, and medical cannabinoid products. For purposes of this subdivision,​
5122+156.31"alcoholic beverages" means beverages that are suitable for human consumption and contain​
5123+156.32one-half of one percent or more of alcohol by volume. For purposes of this subdivision,​
5124+156.33"tobacco" means cigarettes, cigars, chewing or pipe tobacco, or any other item that contains​
5125+156.34tobacco. For purposes of this subdivision, "taxable cannabis product" has the meaning given​
5126+156​Article 2 Sec. 10.​
5127+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 157.1in section 295.81, subdivision 1, paragraph (r), "medical cannabis flower" has the meaning​
5128+157.2given in section 342.01, subdivision 52, and "medical cannabinoid product" has the meaning​
5129+157.3given in section 342.01, subdivision 50. For purposes of this subdivision, "dietary​
5130+157.4supplements" means any product, other than tobacco, intended to supplement the diet that:​
5131+157.5 (1) contains one or more of the following dietary ingredients:​
5132+157.6 (i) a vitamin;​
5133+157.7 (ii) a mineral;​
5134+157.8 (iii) an herb or other botanical;​
5135+157.9 (iv) an amino acid;​
5136+157.10 (v) a dietary substance for use by humans to supplement the diet by increasing the total​
5137+157.11dietary intake; and​
5138+157.12 (vi) a concentrate, metabolite, constituent, extract, or combination of any ingredient​
5139+157.13described in items (i) to (v);​
5140+157.14 (2) is intended for ingestion in tablet, capsule, powder, softgel, gelcap, or liquid form,​
5141+157.15or if not intended for ingestion in such form, is not represented as conventional food and is​
5142+157.16not represented for use as a sole item of a meal or of the diet; and​
5143+157.17 (3) is required to be labeled as a dietary supplement, identifiable by the supplement facts​
5144+157.18box found on the label and as required pursuant to Code of Federal Regulations, title 21,​
5145+157.19section 101.36.​
5146+157.20 EFFECTIVE DATE.This section is effective for sales and purchases made after June​
5147+157.2130, 2023.​
5148+157.22Sec. 11. Minnesota Statutes 2022, section 297A.67, subdivision 7, is amended to read:​
5149+157.23 Subd. 7.Drugs; medical devices.(a) Sales of the following drugs and medical devices​
5150+157.24for human use are exempt:​
5151+157.25 (1) drugs, including over-the-counter drugs;​
5152+157.26 (2) single-use finger-pricking devices for the extraction of blood and other single-use​
5153+157.27devices and single-use diagnostic agents used in diagnosing, monitoring, or treating diabetes;​
5154+157.28 (3) insulin and medical oxygen for human use, regardless of whether prescribed or sold​
5155+157.29over the counter;​
5156+157.30 (4) prosthetic devices;​
51485157 157​Article 2 Sec. 11.​
5149-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 158.1 (5) delivery of aggregate materials by a third party, excluding delivery of aggregate​
5150-158.2material used in road construction; and delivery of concrete block by a third party if the​
5151-158.3delivery would be subject to the sales tax if provided by the seller of the concrete block.​
5152-158.4For purposes of this clause, "road construction" means construction of:​
5153-158.5 (i) public roads;​
5154-158.6 (ii) cartways; and​
5155-158.7 (iii) private roads in townships located outside of the seven-county metropolitan area​
5156-158.8up to the point of the emergency response location sign; and​
5157-158.9 (6) services as provided in this clause:​
5158-158.10 (i) laundry and dry cleaning services including cleaning, pressing, repairing, altering,​
5159-158.11and storing clothes, linen services and supply, cleaning and blocking hats, and carpet,​
5160-158.12drapery, upholstery, and industrial cleaning. Laundry and dry cleaning services do not​
5161-158.13include services provided by coin operated facilities operated by the customer;​
5162-158.14 (ii) motor vehicle washing, waxing, and cleaning services, including services provided​
5163-158.15by coin operated facilities operated by the customer, and rustproofing, undercoating, and​
5164-158.16towing of motor vehicles;​
5165-158.17 (iii) building and residential cleaning, maintenance, and disinfecting services and pest​
5166-158.18control and exterminating services;​
5167-158.19 (iv) detective, security, burglar, fire alarm, and armored car services; but not including​
5168-158.20services performed within the jurisdiction they serve by off-duty licensed peace officers as​
5169-158.21defined in section 626.84, subdivision 1, or services provided by a nonprofit organization​
5170-158.22or any organization at the direction of a county for monitoring and electronic surveillance​
5171-158.23of persons placed on in-home detention pursuant to court order or under the direction of the​
5172-158.24Minnesota Department of Corrections;​
5173-158.25 (v) pet grooming services;​
5174-158.26 (vi) lawn care, fertilizing, mowing, spraying and sprigging services; garden planting​
5175-158.27and maintenance; tree, bush, and shrub pruning, bracing, spraying, and surgery; indoor plant​
5176-158.28care; tree, bush, shrub, and stump removal, except when performed as part of a land clearing​
5177-158.29contract as defined in section 297A.68, subdivision 40; and tree trimming for public utility​
5178-158.30lines. Services performed under a construction contract for the installation of shrubbery,​
5179-158.31plants, sod, trees, bushes, and similar items are not taxable;​
5158+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 158.1 (5) durable medical equipment for home use only;​
5159+158.2 (6) mobility enhancing equipment;​
5160+158.3 (7) prescription corrective eyeglasses; and​
5161+158.4 (8) kidney dialysis equipment, including repair and replacement parts.​
5162+158.5 (b) Items purchased in transactions covered by:​
5163+158.6 (1) Medicare as defined under title XVIII of the Social Security Act, United States Code,​
5164+158.7title 42, section 1395, et seq.; or​
5165+158.8 (2) Medicaid as defined under title XIX of the Social Security Act, United States Code,​
5166+158.9title 42, section 1396, et seq.​
5167+158.10 (c) For purposes of this subdivision:​
5168+158.11 (1) "Drug" means a compound, substance, or preparation, and any component of a​
5169+158.12compound, substance, or preparation, other than food and food ingredients, dietary​
5170+158.13supplements, taxable cannabis products as defined under section 295.81, subdivision 1,​
5171+158.14paragraph (r), or alcoholic beverages that is:​
5172+158.15 (i) recognized in the official United States Pharmacopoeia, official Homeopathic​
5173+158.16Pharmacopoeia of the United States, or official National Formulary, and supplement to any​
5174+158.17of them;​
5175+158.18 (ii) intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease;​
5176+158.19or​
5177+158.20 (iii) intended to affect the structure or any function of the body.​
5178+158.21 (2) "Durable medical equipment" means equipment, including repair and replacement​
5179+158.22parts, including single-patient use items, but not including mobility enhancing equipment,​
5180+158.23that:​
5181+158.24 (i) can withstand repeated use;​
5182+158.25 (ii) is primarily and customarily used to serve a medical purpose;​
5183+158.26 (iii) generally is not useful to a person in the absence of illness or injury; and​
5184+158.27 (iv) is not worn in or on the body.​
5185+158.28 For purposes of this clause, "repair and replacement parts" includes all components or​
5186+158.29attachments used in conjunction with the durable medical equipment, including repair and​
5187+158.30replacement parts which are for single patient use only.​
51805188 158​Article 2 Sec. 11.​
5181-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 159.1 (vii) massages, except when provided by a licensed health care facility or professional​
5182-159.2or upon written referral from a licensed health care facility or professional for treatment of​
5183-159.3illness, injury, or disease; and​
5184-159.4 (viii) the furnishing of lodging, board, and care services for animals in kennels and other​
5185-159.5similar arrangements, but excluding veterinary and horse boarding services.​
5186-159.6 (h) A sale and a purchase includes the furnishing for a consideration of tangible personal​
5187-159.7property or taxable services by the United States or any of its agencies or instrumentalities,​
5188-159.8or the state of Minnesota, its agencies, instrumentalities, or political subdivisions.​
5189-159.9 (i) A sale and a purchase includes the furnishing for a consideration of​
5190-159.10telecommunications services, ancillary services associated with telecommunication services,​
5191-159.11and pay television services. Telecommunication services include, but are not limited to, the​
5192-159.12following services, as defined in section 297A.669: air-to-ground radiotelephone service,​
5193-159.13mobile telecommunication service, postpaid calling service, prepaid calling service, prepaid​
5194-159.14wireless calling service, and private communication services. The services in this paragraph​
5195-159.15are taxed to the extent allowed under federal law.​
5196-159.16 (j) A sale and a purchase includes the furnishing for a consideration of installation if the​
5197-159.17installation charges would be subject to the sales tax if the installation were provided by​
5198-159.18the seller of the item being installed.​
5199-159.19 (k) A sale and a purchase includes the rental of a vehicle by a motor vehicle dealer to a​
5200-159.20customer when (1) the vehicle is rented by the customer for a consideration, or (2) the motor​
5201-159.21vehicle dealer is reimbursed pursuant to a service contract as defined in section 59B.02,​
5202-159.22subdivision 11.​
5203-159.23 (l) A sale and a purchase includes furnishing for a consideration of specified digital​
5204-159.24products or other digital products or granting the right for a consideration to use specified​
5205-159.25digital products or other digital products on a temporary or permanent basis and regardless​
5206-159.26of whether the purchaser is required to make continued payments for such right. Wherever​
5207-159.27the term "tangible personal property" is used in this chapter, other than in subdivisions 10​
5208-159.28and 38, the provisions also apply to specified digital products, or other digital products,​
5209-159.29unless specifically provided otherwise or the context indicates otherwise.​
5210-159.30 (m) The sale of the privilege of admission under section 297A.61, subdivision 3,​
5211-159.31paragraph (g), clause (1), to a place of amusement, recreational area, or athletic event​
5212-159.32includes all charges included in the privilege of admission's sales price, without deduction​
5213-159.33for amenities that may be provided, unless the amenities are separately stated and the​
5189+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 159.1 (3) "Mobility enhancing equipment" means equipment, including repair and replacement​
5190+159.2parts, but not including durable medical equipment, that:​
5191+159.3 (i) is primarily and customarily used to provide or increase the ability to move from one​
5192+159.4place to another and that is appropriate for use either in a home or a motor vehicle;​
5193+159.5 (ii) is not generally used by persons with normal mobility; and​
5194+159.6 (iii) does not include any motor vehicle or equipment on a motor vehicle normally​
5195+159.7provided by a motor vehicle manufacturer.​
5196+159.8 (4) "Over-the-counter drug" means a drug that contains a label that identifies the product​
5197+159.9as a drug as required by Code of Federal Regulations, title 21, section 201.66. The label​
5198+159.10must include a "drug facts" panel or a statement of the active ingredients with a list of those​
5199+159.11ingredients contained in the compound, substance, or preparation. Over-the-counter drugs​
5200+159.12do not include grooming and hygiene products, regardless of whether they otherwise meet​
5201+159.13the definition. "Grooming and hygiene products" are soaps, cleaning solutions, shampoo,​
5202+159.14toothpaste, mouthwash, antiperspirants, and suntan lotions and sunscreens.​
5203+159.15 (5) "Prescribed" and "prescription" means a direction in the form of an order, formula,​
5204+159.16or recipe issued in any form of oral, written, electronic, or other means of transmission by​
5205+159.17a duly licensed health care professional.​
5206+159.18 (6) "Prosthetic device" means a replacement, corrective, or supportive device, including​
5207+159.19repair and replacement parts, worn on or in the body to:​
5208+159.20 (i) artificially replace a missing portion of the body;​
5209+159.21 (ii) prevent or correct physical deformity or malfunction; or​
5210+159.22 (iii) support a weak or deformed portion of the body.​
5211+159.23Prosthetic device does not include corrective eyeglasses.​
5212+159.24 (7) "Kidney dialysis equipment" means equipment that:​
5213+159.25 (i) is used to remove waste products that build up in the blood when the kidneys are not​
5214+159.26able to do so on their own; and​
5215+159.27 (ii) can withstand repeated use, including multiple use by a single patient, notwithstanding​
5216+159.28the provisions of clause (2).​
5217+159.29 (8) A transaction is covered by Medicare or Medicaid if any portion of the cost of the​
5218+159.30item purchased in the transaction is paid for or reimbursed by the federal government or​
5219+159.31the state of Minnesota pursuant to the Medicare or Medicaid program, by a private insurance​
52145220 159​Article 2 Sec. 11.​
5215-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 160.1purchaser of the privilege of admission is entitled to add or decline the amenities, and the
5216-160.2amenities are not otherwise taxable.
5217-160.3 (n) A sale and purchase includes the transfer for consideration of a taxable cannabis
5218-160.4product as defined in section 295.81, subdivision 1, paragraph (r).
5219-160.5 EFFECTIVE DATE.This section is effective for sales and purchases made after June
5220-160.630, 2023.​
5221-160.7Sec. 12. Minnesota Statutes 2022, section 297A.67, subdivision 2, is amended to read:
5222-160.8 Subd. 2.Food and food ingredients.Except as otherwise provided in this subdivision,​
5223-160.9food and food ingredients are exempt. For purposes of this subdivision, "food" and "food
5224-160.10ingredients" mean substances, whether in liquid, concentrated, solid, frozen, dried, or​
5225-160.11dehydrated form, that are sold for ingestion or chewing by humans and are consumed for
5226-160.12their taste or nutritional value. Food and food ingredients exempt under this subdivision do
5227-160.13not include candy, soft drinks, dietary supplements, and prepared foods. Food and food
5228-160.14ingredients do not include alcoholic beverages and, tobacco, taxable cannabis products,
5229-160.15medical cannabis flower, and medical cannabinoid products. For purposes of this subdivision,
5230-160.16"alcoholic beverages" means beverages that are suitable for human consumption and contain
5231-160.17one-half of one percent or more of alcohol by volume. For purposes of this subdivision,
5232-160.18"tobacco" means cigarettes, cigars, chewing or pipe tobacco, or any other item that contains
5233-160.19tobacco. For purposes of this subdivision, "taxable cannabis product" has the meaning given
5234-160.20in section 295.81, subdivision 1, paragraph (r), "medical cannabis flower" has the meaning
5235-160.21given in section 342.01, subdivision 54, and "medical cannabinoid product" has the meaning
5236-160.22given in section 342.01, subdivision 52. For purposes of this subdivision, "dietary
5237-160.23supplements" means any product, other than tobacco, intended to supplement the diet that:
5238-160.24 (1) contains one or more of the following dietary ingredients:
5239-160.25 (i) a vitamin;
5240-160.26 (ii) a mineral;
5241-160.27 (iii) an herb or other botanical;
5242-160.28 (iv) an amino acid;
5243-160.29 (v) a dietary substance for use by humans to supplement the diet by increasing the total
5244-160.30dietary intake; and
5245-160.31 (vi) a concentrate, metabolite, constituent, extract, or combination of any ingredient
5246-160.32described in items (i) to (v);​
5221+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 160.1company administering the Medicare or Medicaid program on behalf of the federal
5222+160.2government or the state of Minnesota, or by a managed care organization for the benefit of
5223+160.3a patient enrolled in a prepaid program that furnishes medical services in lieu of conventional
5224+160.4Medicare or Medicaid coverage pursuant to agreement with the federal government or the
5225+160.5state of Minnesota.​
5226+160.6 EFFECTIVE DATE.This section is effective for sales and purchases made after June
5227+160.730, 2023.​
5228+160.8Sec. 12. Minnesota Statutes 2022, section 297A.70, subdivision 2, is amended to read:
5229+160.9 Subd. 2.Sales to government.(a) All sales, except those listed in paragraph (b), to the
5230+160.10following governments and political subdivisions, or to the listed agencies or instrumentalities
5231+160.11of governments and political subdivisions, are exempt:
5232+160.12 (1) the United States and its agencies and instrumentalities;
5233+160.13 (2) school districts, local governments, the University of Minnesota, state universities,
5234+160.14community colleges, technical colleges, state academies, the Perpich Minnesota Center for
5235+160.15Arts Education, and an instrumentality of a political subdivision that is accredited as an
5236+160.16optional/special function school by the North Central Association of Colleges and Schools;
5237+160.17 (3) hospitals and nursing homes owned and operated by political subdivisions of the
5238+160.18state of tangible personal property and taxable services used at or by hospitals and nursing
5239+160.19homes;
5240+160.20 (4) notwithstanding paragraph (d), the sales and purchases by the Metropolitan Council
5241+160.21of vehicles and repair parts to equip operations provided for in section 473.4051 are exempt
5242+160.22through December 31, 2016;
5243+160.23 (5) other states or political subdivisions of other states, if the sale would be exempt from
5244+160.24taxation if it occurred in that state; and
5245+160.25 (6) public libraries, public library systems, multicounty, multitype library systems as
5246+160.26defined in section 134.001, county law libraries under chapter 134A, state agency libraries,
5247+160.27the state library under section 480.09, and the Legislative Reference Library.
5248+160.28 (b) This exemption does not apply to the sales of the following products and services:
5249+160.29 (1) building, construction, or reconstruction materials purchased by a contractor or a
5250+160.30subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed
5251+160.31maximum price covering both labor and materials for use in the construction, alteration, or​
5252+160.32repair of a building or facility;​
52475253 160​Article 2 Sec. 12.​
5248-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 161.1 (2) is intended for ingestion in tablet, capsule, powder, softgel, gelcap, or liquid form,​
5249-161.2or if not intended for ingestion in such form, is not represented as conventional food and is​
5250-161.3not represented for use as a sole item of a meal or of the diet; and​
5251-161.4 (3) is required to be labeled as a dietary supplement, identifiable by the supplement facts​
5252-161.5box found on the label and as required pursuant to Code of Federal Regulations, title 21,​
5253-161.6section 101.36.​
5254-161.7 EFFECTIVE DATE.This section is effective for sales and purchases made after June​
5255-161.830, 2023.​
5256-161.9Sec. 13. Minnesota Statutes 2022, section 297A.67, subdivision 7, is amended to read:​
5257-161.10 Subd. 7.Drugs; medical devices.(a) Sales of the following drugs and medical devices​
5258-161.11for human use are exempt:​
5259-161.12 (1) drugs, including over-the-counter drugs;​
5260-161.13 (2) single-use finger-pricking devices for the extraction of blood and other single-use​
5261-161.14devices and single-use diagnostic agents used in diagnosing, monitoring, or treating diabetes;​
5262-161.15 (3) insulin and medical oxygen for human use, regardless of whether prescribed or sold​
5263-161.16over the counter;​
5264-161.17 (4) prosthetic devices;​
5265-161.18 (5) durable medical equipment for home use only;​
5266-161.19 (6) mobility enhancing equipment;​
5267-161.20 (7) prescription corrective eyeglasses; and​
5268-161.21 (8) kidney dialysis equipment, including repair and replacement parts.​
5269-161.22 (b) Items purchased in transactions covered by:​
5270-161.23 (1) Medicare as defined under title XVIII of the Social Security Act, United States Code,​
5271-161.24title 42, section 1395, et seq.; or​
5272-161.25 (2) Medicaid as defined under title XIX of the Social Security Act, United States Code,​
5273-161.26title 42, section 1396, et seq.​
5274-161.27 (c) For purposes of this subdivision:​
5275-161.28 (1) "Drug" means a compound, substance, or preparation, and any component of a​
5276-161.29compound, substance, or preparation, other than food and food ingredients, dietary​
5254+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 161.1 (2) construction materials purchased by tax exempt entities or their contractors to be​
5255+161.2used in constructing buildings or facilities which will not be used principally by the tax​
5256+161.3exempt entities;​
5257+161.4 (3) the leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except​
5258+161.5for leases entered into by the United States or its agencies or instrumentalities;​
5259+161.6 (4) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2),​
5260+161.7and prepared food, candy, soft drinks, and alcoholic beverages as defined in section 297A.67,​
5261+161.8subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision​
5262+161.91, paragraph (r), except for lodging, prepared food, candy, soft drinks, and alcoholic​
5263+161.10beverages, and taxable cannabis products purchased directly by the United States or its​
5264+161.11agencies or instrumentalities; or​
5265+161.12 (5) goods or services purchased by a local government as inputs to a liquor store, gas​
5266+161.13or electric utility, solid waste hauling service, solid waste recycling service, landfill, golf​
5267+161.14course, marina, campground, cafe, or laundromat.​
5268+161.15 (c) As used in this subdivision, "school districts" means public school entities and districts​
5269+161.16of every kind and nature organized under the laws of the state of Minnesota, and any​
5270+161.17instrumentality of a school district, as defined in section 471.59.​
5271+161.18 (d) For purposes of the exemption granted under this subdivision, "local governments"​
5272+161.19has the following meaning:​
5273+161.20 (1) for the period prior to January 1, 2017, local governments means statutory or home​
5274+161.21rule charter cities, counties, and townships; and​
5275+161.22 (2) beginning January 1, 2017, local governments means statutory or home rule charter​
5276+161.23cities, counties, and townships; special districts as defined under section 6.465; any​
5277+161.24instrumentality of a statutory or home rule charter city, county, or township as defined in​
5278+161.25section 471.59; and any joint powers board or organization created under section 471.59.​
5279+161.26 EFFECTIVE DATE.This section is effective for sales and purchases made after June​
5280+161.2730, 2023.​
5281+161.28Sec. 13. Minnesota Statutes 2022, section 297A.70, subdivision 4, is amended to read:​
5282+161.29 Subd. 4.Sales to nonprofit groups.(a) All sales, except those listed in paragraph (b),​
5283+161.30to the following "nonprofit organizations" are exempt:​
52775284 161​Article 2 Sec. 13.​
5278-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 162.1supplements, taxable cannabis products as defined under section 295.81, subdivision 1,​
5279-162.2paragraph (r), or alcoholic beverages that is:​
5280-162.3 (i) recognized in the official United States Pharmacopoeia, official Homeopathic​
5281-162.4Pharmacopoeia of the United States, or official National Formulary, and supplement to any​
5282-162.5of them;​
5283-162.6 (ii) intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease;​
5284-162.7or​
5285-162.8 (iii) intended to affect the structure or any function of the body.​
5286-162.9 (2) "Durable medical equipment" means equipment, including repair and replacement​
5287-162.10parts, including single-patient use items, but not including mobility enhancing equipment,​
5288-162.11that:​
5289-162.12 (i) can withstand repeated use;​
5290-162.13 (ii) is primarily and customarily used to serve a medical purpose;​
5291-162.14 (iii) generally is not useful to a person in the absence of illness or injury; and​
5292-162.15 (iv) is not worn in or on the body.​
5293-162.16 For purposes of this clause, "repair and replacement parts" includes all components or​
5294-162.17attachments used in conjunction with the durable medical equipment, including repair and​
5295-162.18replacement parts which are for single patient use only.​
5296-162.19 (3) "Mobility enhancing equipment" means equipment, including repair and replacement​
5297-162.20parts, but not including durable medical equipment, that:​
5298-162.21 (i) is primarily and customarily used to provide or increase the ability to move from one​
5299-162.22place to another and that is appropriate for use either in a home or a motor vehicle;​
5300-162.23 (ii) is not generally used by persons with normal mobility; and​
5301-162.24 (iii) does not include any motor vehicle or equipment on a motor vehicle normally​
5302-162.25provided by a motor vehicle manufacturer.​
5303-162.26 (4) "Over-the-counter drug" means a drug that contains a label that identifies the product​
5304-162.27as a drug as required by Code of Federal Regulations, title 21, section 201.66. The label​
5305-162.28must include a "drug facts" panel or a statement of the active ingredients with a list of those​
5306-162.29ingredients contained in the compound, substance, or preparation. Over-the-counter drugs​
5307-162.30do not include grooming and hygiene products, regardless of whether they otherwise meet​
5285+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 162.1 (1) a corporation, society, association, foundation, or institution organized and operated​
5286+162.2exclusively for charitable, religious, or educational purposes if the item purchased is used​
5287+162.3in the performance of charitable, religious, or educational functions;​
5288+162.4 (2) any senior citizen group or association of groups that:​
5289+162.5 (i) in general limits membership to persons who are either age 55 or older, or persons​
5290+162.6with a physical disability;​
5291+162.7 (ii) is organized and operated exclusively for pleasure, recreation, and other nonprofit​
5292+162.8purposes, not including housing, no part of the net earnings of which inures to the benefit​
5293+162.9of any private shareholders; and​
5294+162.10 (iii) is an exempt organization under section 501(c) of the Internal Revenue Code; and​
5295+162.11 (3) an organization that qualifies for an exemption for memberships under subdivision​
5296+162.1212 if the item is purchased and used in the performance of the organization's mission.​
5297+162.13For purposes of this subdivision, charitable purpose includes the maintenance of a cemetery​
5298+162.14owned by a religious organization.​
5299+162.15 (b) This exemption does not apply to the following sales:​
5300+162.16 (1) building, construction, or reconstruction materials purchased by a contractor or a​
5301+162.17subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed​
5302+162.18maximum price covering both labor and materials for use in the construction, alteration, or​
5303+162.19repair of a building or facility;​
5304+162.20 (2) construction materials purchased by tax-exempt entities or their contractors to be​
5305+162.21used in constructing buildings or facilities that will not be used principally by the tax-exempt​
5306+162.22entities;​
5307+162.23 (3) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2),​
5308+162.24and prepared food, candy, soft drinks, taxable cannabis products as defined under section​
5309+162.25295.81, subdivision 1, paragraph (r), and alcoholic beverages as defined in section 297A.67,​
5310+162.26subdivision 2, except wine purchased by an established religious organization for sacramental​
5311+162.27purposes or as allowed under subdivision 9a; and​
5312+162.28 (4) leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except as​
5313+162.29provided in paragraph (c).​
5314+162.30 (c) This exemption applies to the leasing of a motor vehicle as defined in section 297B.01,​
5315+162.31subdivision 11, only if the vehicle is:​
53085316 162​Article 2 Sec. 13.​
5309-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 163.1the definition. "Grooming and hygiene products" are soaps, cleaning solutions, shampoo,​
5310-163.2toothpaste, mouthwash, antiperspirants, and suntan lotions and sunscreens.
5311-163.3 (5) "Prescribed" and "prescription" means a direction in the form of an order, formula,
5312-163.4or recipe issued in any form of oral, written, electronic, or other means of transmission by
5313-163.5a duly licensed health care professional.
5314-163.6 (6) "Prosthetic device" means a replacement, corrective, or supportive device, including
5315-163.7repair and replacement parts, worn on or in the body to:
5316-163.8 (i) artificially replace a missing portion of the body;
5317-163.9 (ii) prevent or correct physical deformity or malfunction; or
5318-163.10 (iii) support a weak or deformed portion of the body.
5319-163.11Prosthetic device does not include corrective eyeglasses.​
5320-163.12 (7) "Kidney dialysis equipment" means equipment that:​
5321-163.13 (i) is used to remove waste products that build up in the blood when the kidneys are not
5322-163.14able to do so on their own; and
5323-163.15 (ii) can withstand repeated use, including multiple use by a single patient, notwithstanding
5324-163.16the provisions of clause (2).
5325-163.17 (8) A transaction is covered by Medicare or Medicaid if any portion of the cost of the
5326-163.18item purchased in the transaction is paid for or reimbursed by the federal government or
5327-163.19the state of Minnesota pursuant to the Medicare or Medicaid program, by a private insurance
5328-163.20company administering the Medicare or Medicaid program on behalf of the federal
5329-163.21government or the state of Minnesota, or by a managed care organization for the benefit of
5330-163.22a patient enrolled in a prepaid program that furnishes medical services in lieu of conventional
5331-163.23Medicare or Medicaid coverage pursuant to agreement with the federal government or the
5332-163.24state of Minnesota.
5333-163.25 EFFECTIVE DATE.This section is effective for sales and purchases made after June
5334-163.2630, 2023.
5335-163.27Sec. 14. Minnesota Statutes 2022, section 297A.67, is amended by adding a subdivision
5336-163.28to read:
5337-163.29 Subd. 39.Reservation sales of taxable cannabis products.The sale of a taxable
5338-163.30cannabis product, as defined in section 295.81, subdivision 1, paragraph (r), that is made
5339-163.31in Indian country, as defined in United States Code, title 18, section 1151, by a cannabis
5317+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 163.1 (1) a truck, as defined in section 168.002, a bus, as defined in section 168.002, or a
5318+163.2passenger automobile, as defined in section 168.002, if the automobile is designed and used
5319+163.3for carrying more than nine persons including the driver; and
5320+163.4 (2) intended to be used primarily to transport tangible personal property or individuals,
5321+163.5other than employees, to whom the organization provides service in performing its charitable,
5322+163.6religious, or educational purpose.
5323+163.7 (d) A limited liability company also qualifies for exemption under this subdivision if
5324+163.8(1) it consists of a sole member that would qualify for the exemption, and (2) the items
5325+163.9purchased qualify for the exemption.
5326+163.10 EFFECTIVE DATE.This section is effective for sales and purchases made after June
5327+163.1130, 2023.​
5328+163.12Sec. 14. Minnesota Statutes 2022, section 297A.70, subdivision 18, is amended to read:​
5329+163.13 Subd. 18.Nursing homes and boarding care homes.(a) All sales, except those listed
5330+163.14in paragraph (b), to a nursing home licensed under section 144A.02 or a boarding care home
5331+163.15certified as a nursing facility under title 19 of the Social Security Act are exempt if the
5332+163.16facility:
5333+163.17 (1) is exempt from federal income taxation pursuant to section 501(c)(3) of the Internal
5334+163.18Revenue Code; and
5335+163.19 (2) is certified to participate in the medical assistance program under title 19 of the Social
5336+163.20Security Act, or certifies to the commissioner that it does not discharge residents due to the​
5337+163.21inability to pay.
5338+163.22 (b) This exemption does not apply to the following sales:
5339+163.23 (1) building, construction, or reconstruction materials purchased by a contractor or a
5340+163.24subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed
5341+163.25maximum price covering both labor and materials for use in the construction, alteration, or
5342+163.26repair of a building or facility;
5343+163.27 (2) construction materials purchased by tax-exempt entities or their contractors to be
5344+163.28used in constructing buildings or facilities that will not be used principally by the tax-exempt
5345+163.29entities;
5346+163.30 (3) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2),
5347+163.31and prepared food, candy, soft drinks, and alcoholic beverages as defined in section 297A.67,​
53405348 163​Article 2 Sec. 14.​
5341-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 164.1business licensed by a Minnesota Tribal government, as defined in section 3.9228,​
5342-164.2subdivision 1, paragraph (f), is exempt.​
5343-164.3 EFFECTIVE DATE.This section is effective for sales and purchases made after June​
5344-164.430, 2023.​
5345-164.5Sec. 15. Minnesota Statutes 2022, section 297A.70, subdivision 2, is amended to read:​
5346-164.6 Subd. 2.Sales to government.(a) All sales, except those listed in paragraph (b), to the​
5347-164.7following governments and political subdivisions, or to the listed agencies or instrumentalities​
5348-164.8of governments and political subdivisions, are exempt:​
5349-164.9 (1) the United States and its agencies and instrumentalities;​
5350-164.10 (2) school districts, local governments, the University of Minnesota, state universities,​
5351-164.11community colleges, technical colleges, state academies, the Perpich Minnesota Center for​
5352-164.12Arts Education, and an instrumentality of a political subdivision that is accredited as an​
5353-164.13optional/special function school by the North Central Association of Colleges and Schools;​
5354-164.14 (3) hospitals and nursing homes owned and operated by political subdivisions of the​
5355-164.15state of tangible personal property and taxable services used at or by hospitals and nursing​
5356-164.16homes;​
5357-164.17 (4) notwithstanding paragraph (d), the sales and purchases by the Metropolitan Council​
5358-164.18of vehicles and repair parts to equip operations provided for in section 473.4051 are exempt​
5359-164.19through December 31, 2016;​
5360-164.20 (5) other states or political subdivisions of other states, if the sale would be exempt from​
5361-164.21taxation if it occurred in that state; and​
5362-164.22 (6) public libraries, public library systems, multicounty, multitype library systems as​
5363-164.23defined in section 134.001, county law libraries under chapter 134A, state agency libraries,​
5364-164.24the state library under section 480.09, and the Legislative Reference Library.​
5365-164.25 (b) This exemption does not apply to the sales of the following products and services:​
5366-164.26 (1) building, construction, or reconstruction materials purchased by a contractor or a​
5367-164.27subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed​
5368-164.28maximum price covering both labor and materials for use in the construction, alteration, or​
5369-164.29repair of a building or facility;​
5370-164.30 (2) construction materials purchased by tax exempt entities or their contractors to be​
5371-164.31used in constructing buildings or facilities which will not be used principally by the tax​
5372-164.32exempt entities;​
5349+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 164.1subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision​
5350+164.21, paragraph (r); and​
5351+164.3 (4) leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except as​
5352+164.4provided in paragraph (c).​
5353+164.5 (c) This exemption applies to the leasing of a motor vehicle as defined in section 297B.01,​
5354+164.6subdivision 11, only if the vehicle is:​
5355+164.7 (1) a truck, as defined in section 168.002; a bus, as defined in section 168.002; or a​
5356+164.8passenger automobile, as defined in section 168.002, if the automobile is designed and used​
5357+164.9for carrying more than nine persons including the driver; and​
5358+164.10 (2) intended to be used primarily to transport tangible personal property or residents of​
5359+164.11the nursing home or boarding care home.​
5360+164.12 EFFECTIVE DATE.This section is effective for sales and purchases made after June​
5361+164.1330, 2023.​
5362+164.14Sec. 15. Minnesota Statutes 2022, section 297A.85, is amended to read:​
5363+164.15 297A.85 CANCELLATION OF PERMITS.​
5364+164.16 The commissioner may cancel a permit if one of the following conditions occurs:​
5365+164.17 (1) the permit holder has not filed a sales or use tax return for at least one year;​
5366+164.18 (2) the permit holder has not reported any sales or use tax liability on the permit holder's​
5367+164.19returns for at least two years;​
5368+164.20 (3) the permit holder requests cancellation of the permit;​
5369+164.21 (4) the permit is subject to cancellation under section 270C.722, subdivision 2, paragraph​
5370+164.22(a); or​
5371+164.23 (5) the permit is subject to cancellation under section 297A.84.; or​
5372+164.24 (6) the permit holder is a taxable cannabis product retailer as defined in section 295.81,​
5373+164.25subdivision 1, paragraph (s), other than a lower-potency hemp edible retailer as licensed​
5374+164.26under section 342.43, subdivision 1, and its license to sell a taxable cannabis product as​
5375+164.27defined in section 295.81, subdivision 1, paragraph (r), has been revoked by the Office of​
5376+164.28Cannabis Management.​
5377+164.29 EFFECTIVE DATE.This section is effective June 30, 2023.​
53735378 164​Article 2 Sec. 15.​
5374-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 165.1 (3) the leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except
5375-165.2for leases entered into by the United States or its agencies or instrumentalities;
5376-165.3 (4) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2),
5377-165.4and prepared food, candy, soft drinks, and alcoholic beverages as defined in section 297A.67,​
5378-165.5subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision​
5379-165.61, paragraph (r), except for lodging, prepared food, candy, soft drinks, and alcoholic
5380-165.7beverages, and taxable cannabis products purchased directly by the United States or its
5381-165.8agencies or instrumentalities; or
5382-165.9 (5) goods or services purchased by a local government as inputs to a liquor store, gas
5383-165.10or electric utility, solid waste hauling service, solid waste recycling service, landfill, golf
5384-165.11course, marina, campground, cafe, or laundromat.​
5385-165.12 (c) As used in this subdivision, "school districts" means public school entities and districts
5386-165.13of every kind and nature organized under the laws of the state of Minnesota, and any
5387-165.14instrumentality of a school district, as defined in section 471.59.
5388-165.15 (d) For purposes of the exemption granted under this subdivision, "local governments"
5389-165.16has the following meaning:
5390-165.17 (1) for the period prior to January 1, 2017, local governments means statutory or home
5391-165.18rule charter cities, counties, and townships; and
5392-165.19 (2) beginning January 1, 2017, local governments means statutory or home rule charter
5393-165.20cities, counties, and townships; special districts as defined under section 6.465; any
5394-165.21instrumentality of a statutory or home rule charter city, county, or township as defined in
5395-165.22section 471.59; and any joint powers board or organization created under section 471.59.​
5396-165.23 EFFECTIVE DATE.This section is effective for sales and purchases made after June
5397-165.2430, 2023.​
5398-165.25Sec. 16. Minnesota Statutes 2022, section 297A.70, subdivision 4, is amended to read:
5399-165.26 Subd. 4.Sales to nonprofit groups.(a) All sales, except those listed in paragraph (b),
5400-165.27to the following "nonprofit organizations" are exempt:
5401-165.28 (1) a corporation, society, association, foundation, or institution organized and operated
5402-165.29exclusively for charitable, religious, or educational purposes if the item purchased is used
5403-165.30in the performance of charitable, religious, or educational functions;
5404-165.31 (2) any senior citizen group or association of groups that:​
5405-165​Article 2 Sec. 16.​
5406-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 166.1 (i) in general limits membership to persons who are either age 55 or older, or persons
5407-166.2with a physical disability;
5408-166.3 (ii) is organized and operated exclusively for pleasure, recreation, and other nonprofit
5409-166.4purposes, not including housing, no part of the net earnings of which inures to the benefit
5410-166.5of any private shareholders; and
5411-166.6 (iii) is an exempt organization under section 501(c) of the Internal Revenue Code; and
5412-166.7 (3) an organization that qualifies for an exemption for memberships under subdivision
5413-166.812 if the item is purchased and used in the performance of the organization's mission.
5414-166.9For purposes of this subdivision, charitable purpose includes the maintenance of a cemetery
5415-166.10owned by a religious organization.
5416-166.11 (b) This exemption does not apply to the following sales:
5417-166.12 (1) building, construction, or reconstruction materials purchased by a contractor or a
5418-166.13subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed
5419-166.14maximum price covering both labor and materials for use in the construction, alteration, or
5420-166.15repair of a building or facility;
5421-166.16 (2) construction materials purchased by tax-exempt entities or their contractors to be
5422-166.17used in constructing buildings or facilities that will not be used principally by the tax-exempt
5423-166.18entities;​
5424-166.19 (3) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2),
5425-166.20and prepared food, candy, soft drinks, taxable cannabis products as defined under section
5426-166.21295.81, subdivision 1, paragraph (r), and alcoholic beverages as defined in section 297A.67,
5427-166.22subdivision 2, except wine purchased by an established religious organization for sacramental
5428-166.23purposes or as allowed under subdivision 9a; and
5429-166.24 (4) leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except as
5430-166.25provided in paragraph (c).
5431-166.26 (c) This exemption applies to the leasing of a motor vehicle as defined in section 297B.01,
5432-166.27subdivision 11, only if the vehicle is:
5433-166.28 (1) a truck, as defined in section 168.002, a bus, as defined in section 168.002, or a
5434-166.29passenger automobile, as defined in section 168.002, if the automobile is designed and used
5435-166.30for carrying more than nine persons including the driver; and
5436-166​Article 2 Sec. 16.​
5437-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 167.1 (2) intended to be used primarily to transport tangible personal property or individuals,
5438-167.2other than employees, to whom the organization provides service in performing its charitable,
5439-167.3religious, or educational purpose.​
5440-167.4 (d) A limited liability company also qualifies for exemption under this subdivision if
5441-167.5(1) it consists of a sole member that would qualify for the exemption, and (2) the items
5442-167.6purchased qualify for the exemption.
5443-167.7 EFFECTIVE DATE.This section is effective for sales and purchases made after June
5444-167.830, 2023.​
5445-167.9Sec. 17. Minnesota Statutes 2022, section 297A.70, subdivision 18, is amended to read:​
5446-167.10 Subd. 18.Nursing homes and boarding care homes.(a) All sales, except those listed
5447-167.11in paragraph (b), to a nursing home licensed under section 144A.02 or a boarding care home
5448-167.12certified as a nursing facility under title 19 of the Social Security Act are exempt if the​
5449-167.13facility:
5450-167.14 (1) is exempt from federal income taxation pursuant to section 501(c)(3) of the Internal
5451-167.15Revenue Code; and
5452-167.16 (2) is certified to participate in the medical assistance program under title 19 of the Social
5453-167.17Security Act, or certifies to the commissioner that it does not discharge residents due to the
5454-167.18inability to pay.
5455-167.19 (b) This exemption does not apply to the following sales:
5456-167.20 (1) building, construction, or reconstruction materials purchased by a contractor or a
5457-167.21subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed
5458-167.22maximum price covering both labor and materials for use in the construction, alteration, or​
5459-167.23repair of a building or facility;
5460-167.24 (2) construction materials purchased by tax-exempt entities or their contractors to be
5461-167.25used in constructing buildings or facilities that will not be used principally by the tax-exempt
5462-167.26entities;
5463-167.27 (3) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2),
5464-167.28and prepared food, candy, soft drinks, and alcoholic beverages as defined in section 297A.67,
5465-167.29subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision
5466-167.301, paragraph (r); and
5467-167.31 (4) leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except as
5468-167.32provided in paragraph (c).
5469-167Article 2 Sec. 17.​
5470-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 168.1 (c) This exemption applies to the leasing of a motor vehicle as defined in section 297B.01,
5471-168.2subdivision 11, only if the vehicle is:
5472-168.3 (1) a truck, as defined in section 168.002; a bus, as defined in section 168.002; or a
5473-168.4passenger automobile, as defined in section 168.002, if the automobile is designed and used
5474-168.5for carrying more than nine persons including the driver; and
5475-168.6 (2) intended to be used primarily to transport tangible personal property or residents of​
5476-168.7the nursing home or boarding care home.​
5477-168.8 EFFECTIVE DATE.This section is effective for sales and purchases made after June
5478-168.930, 2023.​
5479-168.10Sec. 18. Minnesota Statutes 2022, section 297A.85, is amended to read:
5480-168.11 297A.85 CANCELLATION OF PERMITS.
5481-168.12 The commissioner may cancel a permit if one of the following conditions occurs:
5482-168.13 (1) the permit holder has not filed a sales or use tax return for at least one year;
5483-168.14 (2) the permit holder has not reported any sales or use tax liability on the permit holder's
5484-168.15returns for at least two years;
5485-168.16 (3) the permit holder requests cancellation of the permit;
5486-168.17 (4) the permit is subject to cancellation under section 270C.722, subdivision 2, paragraph
5487-168.18(a); or
5488-168.19 (5) the permit is subject to cancellation under section 297A.84.; or
5489-168.20 (6) the permit holder is a taxable cannabis product retailer as defined in section 295.81,
5490-168.21subdivision 1, paragraph (s), other than a lower-potency hemp edible retailer as licensed
5491-168.22under section 342.43, subdivision 1, and its license to sell a taxable cannabis product as
5492-168.23defined in section 295.81, subdivision 1, paragraph (r), has been revoked by the Office of
5493-168.24Cannabis Management.
5494-168.25 EFFECTIVE DATE.This section is effective June 30, 2023.​
5495-168.26Sec. 19. Minnesota Statutes 2022, section 297D.01, is amended to read:
5496-168.27 297D.01 DEFINITIONS.
5497-168.28 Subdivision 1.Marijuana Illegal cannabis."Marijuana" "Illegal cannabis" means any
5498-168.29marijuana taxable cannabis product as defined in section 295.81, subdivision 1, paragraph
5499-168.30(r), whether real or counterfeit, as defined in section 152.01, subdivision 9, that is held,
5500-168Article 2 Sec. 19.​
5501-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 169.1possessed, transported, transferred, sold, or offered to be sold in violation of chapter 342
5502-169.2or Minnesota criminal laws.​
5503-169.3 Subd. 2.Controlled substance."Controlled substance" means any drug or substance,
5504-169.4whether real or counterfeit, as defined in section 152.01, subdivision 4, that is held, possessed,
5505-169.5transported, transferred, sold, or offered to be sold in violation of Minnesota laws. "Controlled
5506-169.6substance" does not include marijuana illegal cannabis.
5507-169.7 Subd. 3.Tax obligor or obligor."Tax obligor" or "obligor" means a person who in
5508-169.8violation of Minnesota law manufactures, produces, ships, transports, or imports into
5509-169.9Minnesota or in any manner acquires or possesses more than 42-1/2 grams of marijuana
5510-169.10illegal cannabis, or seven or more grams of any controlled substance, or ten or more dosage
5511-169.11units of any controlled substance which is not sold by weight. A quantity of marijuana illegal
5512-169.12cannabis or other controlled substance is measured by the weight of the substance whether
5513-169.13pure or impure or dilute, or by dosage units when the substance is not sold by weight, in
5514-169.14the tax obligor's possession. A quantity of a controlled substance is dilute if it consists of a
5515-169.15detectable quantity of pure controlled substance and any excipients or fillers.
5516-169.16 Subd. 4.Commissioner."Commissioner" means the commissioner of revenue.
5517-169.17 EFFECTIVE DATE.This section is effective June 30, 2023.​
5518-169.18Sec. 20. Minnesota Statutes 2022, section 297D.04, is amended to read:
5519-169.19 297D.04 TAX PAYMENT REQUIRED FOR POSSESSION.​
5520-169.20 No tax obligor may possess any marijuana illegal cannabis or controlled substance upon
5521-169.21which a tax is imposed by section 297D.08 unless the tax has been paid on the marijuana
5522-169.22illegal cannabis or other a controlled substance as evidenced by a stamp or other official
5523-169.23indicia.​
5524-169.24 EFFECTIVE DATE.This section is effective June 30, 2023.​
5525-169.25Sec. 21. Minnesota Statutes 2022, section 297D.06, is amended to read:
5526-169.26 297D.06 PHARMACEUTICALS.
5527-169.27 Nothing in this chapter requires persons registered under chapter 151 or otherwise
5528-169.28lawfully in possession of marijuana illegal cannabis or a controlled substance to pay the tax
5529-169.29required under this chapter.
5530-169.30 EFFECTIVE DATE.This section is effective June 30, 2023.
5531-169Article 2 Sec. 21.​
5532-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 170.1Sec. 22. Minnesota Statutes 2022, section 297D.07, is amended to read:
5533-170.2 297D.07 MEASUREMENT .
5534-170.3 For the purpose of calculating the tax under section 297D.08, a quantity of marijuana
5535-170.4illegal cannabis or other a controlled substance is measured by the weight of the substance
5536-170.5whether pure or impure or dilute, or by dosage units when the substance is not sold by
5537-170.6weight, in the tax obligor's possession. A quantity of a controlled substance is dilute if it
5538-170.7consists of a detectable quantity of pure controlled substance and any excipients or fillers.
5539-170.8 EFFECTIVE DATE.This section is effective June 30, 2023.​
5540-170.9Sec. 23. Minnesota Statutes 2022, section 297D.08, is amended to read:
5541-170.10 297D.08 TAX RATE.
5542-170.11 A tax is imposed on marijuana illegal cannabis and controlled substances as defined in
5543-170.12section 297D.01 at the following rates:
5544-170.13 (1) on each gram of marijuana illegal cannabis, or each portion of a gram, $3.50; and
5545-170.14 (2) on each gram of controlled substance, or portion of a gram, $200; or
5546-170.15 (3) on each ten dosage units of a controlled substance that is not sold by weight, or
5547-170.16portion thereof, $400.​
5548-170.17 EFFECTIVE DATE.This section is effective June 30, 2023.
5549-170.18Sec. 24. Minnesota Statutes 2022, section 297D.085, is amended to read:
5550-170.19 297D.085 CREDIT FOR PREVIOUSLY PAID TAXES.
5551-170.20 If another state or local unit of government has previously assessed an excise tax on the
5552-170.21marijuana illegal cannabis or controlled substances, the taxpayer must pay the difference
5553-170.22between the tax due under section 297D.08 and the tax previously paid. If the tax previously
5554-170.23paid to the other state or local unit of government was equal to or greater than the tax due
5555-170.24under section 297D.08, no tax is due. The burden is on the taxpayer to show that an excise
5556-170.25tax on the marijuana illegal cannabis or controlled substances has been paid to another state
5557-170.26or local unit of government.
5558-170.27 EFFECTIVE DATE.This section is effective June 30, 2023.​
5559-170​Article 2 Sec. 24.​
5560-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 171.1Sec. 25. Minnesota Statutes 2022, section 297D.09, subdivision 1a, is amended to read:
5561-171.2 Subd. 1a.Criminal penalty; sale without affixed stamps.In addition to the tax penalty
5562-171.3imposed, a tax obligor distributing or possessing marijuana illegal cannabis or controlled
5563-171.4substances without affixing the appropriate stamps, labels, or other indicia is guilty of a
5564-171.5crime and, upon conviction, may be sentenced to imprisonment for not more than seven
5565-171.6years or to payment of a fine of not more than $14,000, or both.
5566-171.7 EFFECTIVE DATE.This section is effective June 30, 2023.
5567-171.8Sec. 26. Minnesota Statutes 2022, section 297D.10, is amended to read:
5568-171.9 297D.10 STAMP PRICE.
5569-171.10 Official stamps, labels, or other indicia to be affixed to all marijuana illegal cannabis or
5570-171.11controlled substances shall be purchased from the commissioner. The purchaser shall pay
5571-171.12100 percent of face value for each stamp, label, or other indicia at the time of the purchase.​
5572-171.13 EFFECTIVE DATE.This section is effective June 30, 2023.
5573-171.14Sec. 27. Minnesota Statutes 2022, section 297D.11, is amended to read:
5574-171.15 297D.11 PAYMENT DUE.
5575-171.16 Subdivision 1.Stamps affixed.When a tax obligor purchases, acquires, transports, or
5576-171.17imports into this state marijuana illegal cannabis or controlled substances on which a tax is
5577-171.18imposed by section 297D.08, and if the indicia evidencing the payment of the tax have not
5578-171.19already been affixed, the tax obligor shall have them permanently affixed on the marijuana
5579-171.20illegal cannabis or controlled substance immediately after receiving the substance. Each
5580-171.21stamp or other official indicia may be used only once.
5581-171.22 Subd. 2.Payable on possession.Taxes imposed upon marijuana illegal cannabis or
5582-171.23controlled substances by this chapter are due and payable immediately upon acquisition or
5583-171.24possession in this state by a tax obligor.​
5584-171.25 EFFECTIVE DATE.This section is effective June 30, 2023.​
5585-171.26Sec. 28. [477A.31] LOCAL GOVERNMENT CANNABIS AID.
5586-171.27 Subdivision 1.Definitions.For purposes of this section, the following terms have the
5587-171.28meanings given:
5588-171.29 (1) "city" means a statutory or home rule charter city; and
5589-171​Article 2 Sec. 28.​
5590-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 172.1 (2) "director" means the director of the Office of Cannabis Management under section
5591-172.2342.02.​
5592-172.3 Subd. 2.Certification to commissioner of revenue.(a) By July 15, 2024, and annually
5593-172.4thereafter, the commissioner of management and budget must certify to the commissioner
5594-172.5of revenue the balance of the local government cannabis aid account in the special revenue
5595-172.6fund as of the immediately preceding June 30.
5596-172.7 (b) By June 1, 2024, and annually thereafter, the director must certify to the commissioner
5597-172.8of revenue the number of cannabis businesses, as defined under section 342.01, subdivision
5598-172.914, licensed under chapter 342 as of the previous January 1, disaggregated by county and
5599-172.10city.
5600-172.11 Subd. 3.Aid to counties.(a) Beginning for aid payable in 2024, the amount available
5601-172.12for aid to counties under this subdivision equals 50 percent of the amount certified in that
5602-172.13year to the commissioner under subdivision 2, paragraph (a).
5603-172.14 (b) Twenty percent of the amount under paragraph (a) must be distributed equally among
5604-172.15all counties.​
5605-172.16 (c) Eighty percent of the amount under paragraph (a) must be distributed proportionally
5606-172.17to each county according to the number of cannabis businesses located in the county as
5607-172.18compared to the number of cannabis businesses in all counties as of the most recent
5608-172.19certification under subdivision 2, paragraph (b).
5609-172.20 Subd. 4.Aid to cities.(a) Beginning for aid payable in 2024, the amount available for
5610-172.21aid to cities under this subdivision equals 50 percent of the amount certified in that year to
5611-172.22the commissioner under subdivision 2, paragraph (a).
5612-172.23 (b) The amount under paragraph (a) must be distributed proportionally to each city
5613-172.24according to the number of cannabis businesses located in the city as compared to the number
5614-172.25of cannabis businesses in all cities as of the most recent certification under subdivision 2,
5615-172.26paragraph (b).​
5616-172.27 Subd. 5.Payment.The commissioner of revenue must compute the amount of aid
5617-172.28payable to each county and city under this section. On or before September 1 of each year,
5618-172.29the commissioner must certify the amount to be paid to each county and city in that year.​
5619-172.30The commissioner must pay the full amount of the aid on December 26 annually.
5620-172.31 Subd. 6.Appropriation.Beginning in fiscal year 2025 and annually thereafter, the
5621-172.32amount in the local government cannabis aid account in the special revenue fund is annually
5622-172​Article 2 Sec. 28.​
5623-REVISOR BD H0100-12HF100 TWELFTH ENGROSSMENT​ 173.1appropriated to the commissioner of revenue to make the aid payments required under this​
5624-173.2section.​
5625-173.3 EFFECTIVE DATE.This section is effective July 1, 2023.
5626-173.4 ARTICLE 3
5627-173.5 BUSINESS DEVELOPMENT
5628-173.6Section 1. [116J.659] CANNABIS INDUSTRY STARTUP FINANCING GRANTS.​
5629-173.7 Subdivision 1.Establishment.The commissioner of employment and economic
5630-173.8development shall establish CanStartup, a program to award grants to nonprofit corporations
5631-173.9to fund loans to new cannabis microbusinesses and to support job creation in communities
5632-173.10where long-term residents are eligible to be social equity applicants.
5633-173.11 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the​
5634-173.12meanings given.​
5635-173.13 (b) "Cannabis microbusiness" means a cannabis business that meets the requirements
5636-173.14of section 342.28.​
5637-173.15 (c) "Commissioner" means the commissioner of employment and economic development.
5638-173.16 (d) "Industry" means the legal cannabis industry in the state of Minnesota.
5639-173.17 (e) "New business" means a legal cannabis business that has been in existence for three
5640-173.18years or less.​
5641-173.19 (f) "Program" means the CanStartup grant program.​
5642-173.20 (g) "Social equity applicant" means a person who meets the qualification requirements
5643-173.21in section 342.17.
5644-173.22 Subd. 3.Grants.(a) The CanStartup revolving loan account is established in the special
5645-173.23revenue fund. Money in the account, including interest, is appropriated to the commissioner
5646-173.24to make grants under the CanStartup program.
5647-173.25 (b) The commissioner must award grants to nonprofit corporations through a competitive
5648-173.26grant process.​
5649-173.27 (c) To receive grant money, a nonprofit corporation must submit a written application
5650-173.28to the commissioner using a form developed by the commissioner.​
5651-173.29 (d) In awarding grants under this subdivision, the commissioner shall give weight to
5652-173.30whether the nonprofit corporation:
5653-173​Article 3 Section 1.​
5654-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 174.1 (1) has a board of directors that includes citizens experienced in business and community
5655-174.2development, new business enterprises, and creating jobs for people facing barriers to​
5656-174.3education or employment;
5657-174.4 (2) has the technical skills to analyze projects;
5658-174.5 (3) is familiar with other available public and private funding sources and economic
5659-174.6development programs;
5660-174.7 (4) can initiate and implement economic development projects;
5661-174.8 (5) can establish and administer a revolving loan account;
5662-174.9 (6) can work with job referral networks that assist people facing barriers to education​
5663-174.10or employment; and
5664-174.11 (7) has established relationships with communities where long-term residents are eligible
5665-174.12to be social equity applicants.
5666-174.13The commissioner shall make grants that will assist new cannabis microbusinesses.
5667-174.14 (e) A nonprofit corporation that receives a grant under the program must:
5668-174.15 (1) establish a commissioner-certified revolving loan account for the purpose of making
5669-174.16eligible loans; and
5670-174.17 (2) enter into an agreement with the commissioner that the commissioner shall fund
5671-174.18loans that the nonprofit corporation makes to new cannabis microbusinesses. The
5672-174.19commissioner shall review existing agreements with nonprofit corporations every five years
5673-174.20and may renew or terminate an agreement based on that review. In making this review, the​
5674-174.21commissioner shall consider, among other criteria, the criteria in paragraph (d).
5675-174.22 Subd. 4.Loans to businesses.(a) The criteria in this subdivision apply to loans made
5676-174.23by nonprofit corporations under the program.
5677-174.24 (b) Loans must be used to support a new cannabis microbusiness in the legal cannabis
5678-174.25industry. Priority must be given to loans to businesses owned by individuals who are eligible
5679-174.26to be social equity applicants and businesses located in communities where long-term
5680-174.27residents are eligible to be social equity applicants.
5681-174.28 (c) Loans must be made to cannabis microbusinesses that are not likely to undertake the​
5682-174.29project for which loans are sought without assistance from the program.​
5683-174.30 (d) The minimum state contribution to a loan is $2,500 and the maximum is either:
5684-174.31 (1) $50,000; or
5685-174​Article 3 Section 1.​
5686-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 175.1 (2) $150,000, if state contributions are matched by an equal or greater amount of new
5687-175.2private investment.
5688-175.3 (e) Loan applications given preliminary approval by the nonprofit corporation must be
5689-175.4forwarded to the commissioner for approval. The commissioner must give final approval
5690-175.5for each loan made by the nonprofit corporation under the program.
5691-175.6 (f) A cannabis microbusiness that receives a loan may apply to renew the loan. Renewal
5692-175.7applications must be made on an annual basis and a cannabis microbusiness may receive
5693-175.8loans for up to six consecutive years. A nonprofit corporation may renew a loan to a cannabis
5694-175.9microbusiness that is no longer a new business provided the business would otherwise
5695-175.10qualify for an initial loan and is in good standing with the nonprofit corporation and the
5696-175.11commissioner. A nonprofit corporation may adjust the amount of a renewed loan, or not
5697-175.12renew a loan, if the nonprofit corporation determines that the cannabis microbusiness is
5698-175.13financially stable and is substantially likely to continue the project for which the loan renewal
5699-175.14is sought.​
5700-175.15 (g) If a borrower has met lender criteria, including being current with all payments for
5701-175.16a minimum of three years, the commissioner may approve either full or partial forgiveness
5702-175.17of interest or principal amounts.
5703-175.18 Subd. 5.Revolving loan account administration.(a) The commissioner shall establish
5704-175.19a minimum interest rate for loans or guarantees to ensure that necessary loan administration
5705-175.20costs are covered. The interest rate charged by a nonprofit corporation for a loan under this
5706-175.21section must not exceed the Wall Street Journal prime rate. For a loan under this section,
5707-175.22the nonprofit corporation may charge a loan origination fee equal to or less than one percent
5708-175.23of the loan value. The nonprofit corporation may retain the amount of the origination fee.
5709-175.24 (b) Loan repayment of principal must be paid to the commissioner for deposit in the
5710-175.25CanStartup revolving loan account. Loan interest payments must be deposited in a revolving
5711-175.26loan account created by the nonprofit corporation originating the loan being repaid for
5712-175.27further distribution or use, consistent with the criteria of this section.​
5713-175.28 (c) Administrative expenses of the nonprofit corporations with whom the commissioner​
5714-175.29enters into agreements, including expenses incurred by a nonprofit corporation in providing
5715-175.30financial, technical, managerial, and marketing assistance to a business receiving a loan
5716-175.31under this section, are eligible program expenses the commissioner may agree to pay under
5717-175.32the grant agreement.​
5718-175.33 Subd. 6.Program outreach.The commissioner shall make extensive efforts to publicize
5719-175.34this program, including through partnerships with community organizations, particularly
5720-175​Article 3 Section 1.​
5721-REVISOR BD H0100-12HF100 TWELFTH ENGROSSMENT​ 176.1those organizations located in areas where long-term residents are eligible to be social equity​
5722-176.2applicants.
5723-176.3 Subd. 7.Reporting requirements.(a) A nonprofit corporation that receives a grant
5724-176.4shall:
5725-176.5 (1) submit an annual report to the commissioner by February 1 of each year that the
5726-176.6nonprofit corporation participates in the program that includes a description of businesses
5727-176.7supported by the grant program, an account of loans made during the calendar year, the
5728-176.8program's impact on business creation and job creation, particularly in communities where
5729-176.9long-term residents are eligible to be social equity applicants, the source and amount of
5730-176.10money collected and distributed by the program, the program's assets and liabilities, and an
5731-176.11explanation of administrative expenses; and
5732-176.12 (2) provide for an independent annual audit to be performed in accordance with generally
5733-176.13accepted accounting practices and auditing standards and submit a copy of each annual
5734-176.14audit report to the commissioner.
5735-176.15 (b) By March 1, 2024, and each March 1 thereafter, the commissioner must submit a
5736-176.16report to the chairs and ranking minority members of the committees of the house of
5737-176.17representatives and the senate having jurisdiction over economic development that details
5738-176.18awards given through the CanStartup program and the use of grant money, including any
5739-176.19measures of success toward financing new cannabis microbusinesses and creating jobs in
5740-176.20communities where long-term residents are eligible to be social equity applicants.​
5741-176.21Sec. 2. [116J.6595] CANNABIS INDUSTRY NAVIGATION GRANTS.​
5742-176.22 Subdivision 1.Establishment.The commissioner of employment and economic
5743-176.23development shall establish CanNavigate, a program to award grants to eligible organizations
5744-176.24to help individuals navigate the regulatory structure of the legal cannabis industry.
5745-176.25 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the
5746-176.26meanings given.​
5747-176.27 (b) "Commissioner" means the commissioner of employment and economic development.
5748-176.28 (c) "Eligible organization" means any organization capable of helping individuals navigate
5749-176.29the regulatory structure of the legal cannabis industry, particularly individuals facing barriers
5750-176.30to education or employment, and may include educational institutions, nonprofit
5751-176.31organizations, private businesses, community groups, units of local government, or
5752-176.32partnerships between different types of organizations.
5753-176​Article 3 Sec. 2.​
5754-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 177.1 (d) "Industry" means the legal cannabis industry in the state of Minnesota.​
5755-177.2 (e) "Program" means the CanNavigate grant program.
5756-177.3 (f) "Social equity applicant" means a person who meets the qualification requirements
5757-177.4in section 342.17.​
5758-177.5 Subd. 3.Grants to organizations.(a) Grant money awarded to eligible organizations
5759-177.6may be used for both developing technical assistance resources relevant to the regulatory
5760-177.7structure of the legal cannabis industry and for providing technical assistance or navigation
5761-177.8services to individuals.
5762-177.9 (b) The commissioner must award grants to eligible organizations through a competitive
5763-177.10grant process.
5764-177.11 (c) To receive grant money, an eligible organization must submit a written application
5765-177.12to the commissioner, using a form developed by the commissioner, explaining the
5766-177.13organization's ability to assist individuals in navigating the regulatory structure of the legal
5767-177.14cannabis industry, particularly individuals facing barriers to education or employment.
5768-177.15 (d) An eligible organization's grant application must also include:
5769-177.16 (1) a description of the proposed technical assistance or navigation services, including
5770-177.17the types of individuals targeted for assistance;​
5771-177.18 (2) any evidence of the organization's past success in providing technical assistance or​
5772-177.19navigation services to individuals, particularly individuals who live in areas where long-term
5773-177.20residents are eligible to be social equity applicants;
5774-177.21 (3) an estimate of the cost of providing the technical assistance;
5775-177.22 (4) the sources and amounts of any nonstate money or in-kind contributions that will
5776-177.23supplement grant money, including any amounts that individuals will be charged to receive
5777-177.24assistance; and
5778-177.25 (5) any additional information requested by the commissioner.
5779-177.26 (e) In awarding grants under this subdivision, the commissioner shall give weight to
5780-177.27applications from organizations that demonstrate a history of successful technical assistance
5781-177.28or navigation services, particularly for individuals facing barriers to education or employment.
5782-177.29The commissioner shall also give weight to applications where the proposed technical
5783-177.30assistance will serve areas where long-term residents are eligible to be social equity
5784-177.31applicants. To the extent practicable, the commissioner shall fund technical assistance for
5785-177​Article 3 Sec. 2.​
5786-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 178.1a variety of sectors in the legal cannabis industry, including both processing and retail
5787-178.2sectors.​
5788-178.3 Subd. 4.Program outreach.The commissioner shall make extensive efforts to publicize
5789-178.4these grants, including through partnerships with community organizations, particularly
5790-178.5those organizations located in areas where long-term residents are eligible to be social equity
5791-178.6applicants.
5792-178.7 Subd. 5.Reports to the legislature.By January 15, 2024, and each January 15 thereafter,
5793-178.8the commissioner must submit a report to the chairs and ranking minority members of the
5794-178.9committees of the house of representatives and the senate having jurisdiction over economic
5795-178.10development that details awards given through the CanNavigate program and the use of
5796-178.11grant money, including any measures of success toward helping individuals navigate the​
5797-178.12regulatory structure of the legal cannabis industry.
5798-178.13Sec. 3. [116L.90] CANNABIS INDUSTRY TRAINING GRANTS.
5799-178.14 Subdivision 1.Establishment.The commissioner of employment and economic
5800-178.15development shall establish CanTrain, a program to award grants to (1) eligible organizations
5801-178.16to train people for work in the legal cannabis industry, and (2) eligible individuals to acquire
5802-178.17such training.
5803-178.18 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the
5804-178.19meanings given.
5805-178.20 (b) "Commissioner" means the commissioner of employment and economic development.
5806-178.21 (c) "Eligible organization" means any organization capable of providing training relevant
5807-178.22to the legal cannabis industry, particularly for individuals facing barriers to education or
5808-178.23employment, and may include educational institutions, nonprofit organizations, private
5809-178.24businesses, community groups, units of local government, labor organizations that represent
5810-178.25cannabis workers in the state, or partnerships between different types of organizations.
5811-178.26 (d) "Eligible individual" means a Minnesota resident who is 21 years old or older.​
5812-178.27 (e) "Industry" means the legal cannabis industry in Minnesota.​
5813-178.28 (f) "Program" means the CanTrain grant program.
5814-178.29 (g) "Social equity applicant" means a person who meets the qualification requirements
5815-178.30in section 342.17.​
5816-178Article 3 Sec. 3.​
5817-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 179.1 Subd. 3.Grants to organizations.(a) Grant money awarded to eligible organizations
5818-179.2may be used for both developing a training program relevant to the legal cannabis industry
5819-179.3and for providing such training to individuals.
5820-179.4 (b) The commissioner must award grants to eligible organizations through a competitive
5821-179.5grant process.
5822-179.6 (c) To receive grant money, an eligible organization must submit a written application
5823-179.7to the commissioner, using a form developed by the commissioner, explaining the
5824-179.8organization's ability to train individuals for successful careers in the legal cannabis industry,
5825-179.9particularly individuals facing barriers to education or employment.
5826-179.10 (d) An eligible organization's grant application must also include:​
5827-179.11 (1) a description of the proposed training;
5828-179.12 (2) an analysis of the degree of demand in the legal cannabis industry for the skills gained
5829-179.13through the proposed training;
5830-179.14 (3) any evidence of the organization's past success in training individuals for successful
5831-179.15careers, particularly in new or emerging industries;
5832-179.16 (4) an estimate of the cost of providing the proposed training;​
5833-179.17 (5) the sources and amounts of any nonstate funds or in-kind contributions that will
5834-179.18supplement grant money, including any amounts that individuals will be charged to
5835-179.19participate in the training; and
5836-179.20 (6) any additional information requested by the commissioner.
5837-179.21 (e) In awarding grants under this subdivision, the commissioner shall give weight to
5838-179.22applications from organizations that demonstrate a history of successful career training,
5839-179.23particularly for individuals facing barriers to education or employment. The commissioner
5840-179.24shall also give weight to applications where the proposed training will:
5841-179.25 (1) result in an industry-relevant credential; or​
5842-179.26 (2) include opportunities for hands-on or on-site experience in the industry.
5843-179.27The commissioner shall fund training for a broad range of careers in the legal cannabis
5844-179.28industry, including both potential business owners and employees and for work in the
5845-179.29growing, processing, and retail sectors of the legal cannabis industry.​
5846-179Article 3 Sec. 3.
5847-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 180.1 Subd. 4.Grants to individuals.(a) The commissioner shall award grants of up to
5848-180.2$20,000 to eligible individuals to pursue a training program relevant to a career in the legal
5849-180.3cannabis industry.
5850-180.4 (b) To receive grant money, an eligible individual must submit a written application to
5851-180.5the commissioner, using a form developed by the commissioner, identifying a training
5852-180.6program relevant to the legal cannabis industry and the estimated cost of completing that​
5853-180.7training. The application must also indicate whether:​
5854-180.8 (1) the applicant is eligible to be a social equity applicant;
5855-180.9 (2) the proposed training program results in an industry-relevant credential; and
5856-180.10 (3) the proposed training program includes opportunities for hands-on or on-site
5857-180.11experience in the industry.
5858-180.12The commissioner shall attempt to make the application process simple for individuals to
5859-180.13complete, such as by publishing lists of industry-relevant training programs along with the
5860-180.14training program's estimated cost of completing the training programs and whether the
5861-180.15training programs will result in an industry-relevant credential or include opportunities for
5862-180.16hands-on or on-site experience in the legal cannabis industry.
5863-180.17 (c) The commissioner must award grants to eligible individuals through a lottery process.
5864-180.18Applicants who have filed complete applications by the deadline set by the commissioner
5865-180.19shall receive one entry in the lottery, plus one additional entry for each of the following:
5866-180.20 (1) being eligible to be a social equity applicant;
5867-180.21 (2) seeking to enroll in a training program that results in an industry-relevant credential;​
5868-180.22and
5869-180.23 (3) seeking to enroll in a training program that includes opportunities for hands-on or​
5870-180.24on-site experience in the industry.
5871-180.25 (d) Grant money awarded to eligible individuals shall be used to pay the costs of enrolling
5872-180.26in a training program relevant to the legal cannabis industry, including tuition, fees, and
5873-180.27materials costs. Grant money may also be used to remove external barriers to attending such
5874-180.28a training program, such as the cost of child care, transportation, or other expenses approved
5875-180.29by the commissioner.
5876-180.30 Subd. 5.Program outreach.The commissioner shall make extensive efforts to publicize
5877-180.31these grants, including through partnerships with community organizations, particularly
5878-180Article 3 Sec. 3.​
5879-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 181.1those organizations located in areas where long-term residents are eligible to be social equity
5880-181.2applicants.
5881-181.3 Subd. 6.Reports to the legislature.By January 15, 2024, and each January 15 thereafter,
5882-181.4the commissioner must submit a report to the chairs and ranking minority members of the
5883-181.5committees of the house of representatives and the senate having jurisdiction over workforce
5884-181.6development that describes awards given through the CanTrain program and the use of
5885-181.7grant money, including any measures of success toward training people for successful
5886-181.8careers in the legal cannabis industry.
5887-181.9 ARTICLE 4
5888-181.10 CRIMINAL PENALTIES
5889-181.11Section 1. Minnesota Statutes 2022, section 97B.065, subdivision 1, is amended to read:
5890-181.12 Subdivision 1.Acts prohibited.(a) A person may not take wild animals with a firearm
5891-181.13or by archery:
5892-181.14 (1) when the person is under the influence of alcohol;
5893-181.15 (2) when the person is under the influence of a controlled substance, as defined in section
5894-181.16152.01, subdivision 4;​
5895-181.17 (3) when the person is under the influence of a combination of any two or more of the
5896-181.18elements in clauses (1) and, (2), and (7);
5897-181.19 (4) when the person's alcohol concentration is 0.08 or more;​
5898-181.20 (5) when the person's alcohol concentration as measured within two hours of the time
5899-181.21of taking is 0.08 or more; or​
5900-181.22 (6) when the person is under the influence of an intoxicating substance as defined in
5901-181.23section 169A.03, subdivision 11a, and the person knows or has reason to know that the
5902-181.24substance has the capacity to cause impairment; or​
5903-181.25 (7) when the person is under the influence of cannabis flower, a cannabis product, a
5904-181.26lower-potency hemp edible, a hemp-derived consumer product, an artificially derived
5905-181.27cannabinoid, or tetrahydrocannabinols, as those terms are defined in section 342.01.
5906-181.28 (b) An owner or other person having charge or control of a firearm or bow may not
5907-181.29authorize or permit an individual the person knows or has reason to believe is under the
5908-181.30influence of alcohol or a controlled substance, as provided under paragraph (a), to possess
5909-181.31the firearm or bow in this state or on a boundary water of this state.
5910-181​Article 4 Section 1.
5911-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 182.1 (c) A person may not possess a loaded or uncased firearm or an uncased bow afield
5912-182.2under any of the conditions in paragraph (a).
5913-182.3 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
5914-182.4committed on or after that date.
5915-182.5Sec. 2. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5916-182.6read:
5917-182.7 Subd. 25.Artificially derived cannabinoid."Artificially derived cannabinoid" has the
5918-182.8meaning given in section 342.01, subdivision 6.
5919-182.9Sec. 3. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5920-182.10read:
5921-182.11 Subd. 26.Cannabis concentrate."Cannabis concentrate" has the meaning given in
5922-182.12section 342.01, subdivision 15.
5923-182.13Sec. 4. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5924-182.14read:
5925-182.15 Subd. 27.Cannabis flower."Cannabis flower" has the meaning given in section 342.01,
5926-182.16subdivision 16.
5927-182.17Sec. 5. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5928-182.18read:
5929-182.19 Subd. 28.Cannabis plant."Cannabis plant" has the meaning given in section 342.01,​
5930-182.20subdivision 19.​
5931-182.21Sec. 6. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5932-182.22read:
5933-182.23 Subd. 29.Cannabis product."Cannabis product" has the meaning given in section
5934-182.24342.01, subdivision 20.
5935-182.25Sec. 7. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5936-182.26read:​
5937-182.27 Subd. 30.Edible cannabis product."Edible cannabis product" has the meaning given
5938-182.28in section 342.01, subdivision 31.
5939-182​Article 4 Sec. 7.​
5940-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 183.1Sec. 8. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5941-183.2read:
5942-183.3 Subd. 31.Hemp-derived consumer product."Hemp-derived consumer product" has
5943-183.4the meaning given in section 342.01, subdivision 37.
5944-183.5Sec. 9. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to​
5945-183.6read:
5946-183.7 Subd. 32.Lower-potency hemp edible."Lower-potency hemp edible" has the meaning
5947-183.8given in section 342.01, subdivision 50.
5948-183.9Sec. 10. Minnesota Statutes 2022, section 152.021, subdivision 1, is amended to read:
5949-183.10 Subdivision 1.Sale crimes.A person is guilty of controlled substance crime in the first
5950-183.11degree if:
5951-183.12 (1) on one or more occasions within a 90-day period the person unlawfully sells one or
5952-183.13more mixtures of a total weight of 17 grams or more containing cocaine or methamphetamine;
5953-183.14 (2) on one or more occasions within a 90-day period the person unlawfully sells one or
5954-183.15more mixtures of a total weight of ten grams or more containing cocaine or methamphetamine
5955-183.16and:
5956-183.17 (i) the person or an accomplice possesses on their person or within immediate reach, or
5957-183.18uses, whether by brandishing, displaying, threatening with, or otherwise employing, a
5958-183.19firearm; or
5959-183.20 (ii) the offense involves two aggravating factors;
5960-183.21 (3) on one or more occasions within a 90-day period the person unlawfully sells one or
5961-183.22more mixtures of a total weight of ten grams or more containing heroin;
5962-183.23 (4) on one or more occasions within a 90-day period the person unlawfully sells one or
5963-183.24more mixtures of a total weight of 50 grams or more containing a narcotic drug other than
5964-183.25cocaine, heroin, or methamphetamine; or
5965-183.26 (5) on one or more occasions within a 90-day period the person unlawfully sells one or
5966-183.27more mixtures of a total weight of 50 grams or more containing amphetamine, phencyclidine,
5967-183.28or hallucinogen or, if the controlled substance is packaged in dosage units, equaling 200 or​
5968-183.29more dosage units; or.
5969-183​Article 4 Sec. 10.​
5970-REVISOR BD H0100-12HF100 TWELFTH ENGROSSMENT​ 184.1 (6) on one or more occasions within a 90-day period the person unlawfully sells one or​
5971-184.2more mixtures of a total weight of 25 kilograms or more containing marijuana or​
5972-184.3Tetrahydrocannabinols.
5973-184.4 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
5974-184.5committed on or after that date.
5975-184.6Sec. 11. Minnesota Statutes 2022, section 152.021, subdivision 2, is amended to read:
5976-184.7 Subd. 2.Possession crimes.(a) A person is guilty of a controlled substance crime in
5977-184.8the first degree if:
5978-184.9 (1) the person unlawfully possesses one or more mixtures of a total weight of 50 grams
5979-184.10or more containing cocaine or methamphetamine;
5980-184.11 (2) the person unlawfully possesses one or more mixtures of a total weight of 25 grams
5981-184.12or more containing cocaine or methamphetamine and:
5982-184.13 (i) the person or an accomplice possesses on their person or within immediate reach, or
5983-184.14uses, whether by brandishing, displaying, threatening with, or otherwise employing, a
5984-184.15firearm; or​
5985-184.16 (ii) the offense involves two aggravating factors;
5986-184.17 (3) the person unlawfully possesses one or more mixtures of a total weight of 25 grams
5987-184.18or more containing heroin;
5988-184.19 (4) the person unlawfully possesses one or more mixtures of a total weight of 500 grams
5989-184.20or more containing a narcotic drug other than cocaine, heroin, or methamphetamine;
5990-184.21 (5) the person unlawfully possesses one or more mixtures of a total weight of 500 grams
5991-184.22or more containing amphetamine, phencyclidine, or hallucinogen or, if the controlled
5992-184.23substance is packaged in dosage units, equaling 500 or more dosage units; or
5993-184.24 (6) the person unlawfully possesses one or more mixtures of a total weight of 50
5994-184.25kilograms or more containing marijuana or Tetrahydrocannabinols, or possesses 500 or​
5995-184.26more marijuana plants.:
5996-184.27 (i) 50 kilograms or more of cannabis flower;
5997-184.28 (ii) ten kilograms or more of cannabis concentrate; or
5998-184.29 (iii) edible cannabis products, lower-potency hemp edibles, hemp-derived consumer
5999-184.30products, or any combination of those infused with more than one kilogram of
6000-184.31tetrahydrocannabinols.
6001-184​Article 4 Sec. 11.​
6002-REVISOR BD H0100-12HF100 TWELFTH ENGROSSMENT​ 185.1 (b) For the purposes of this subdivision, the weight of fluid used in a water pipe may​
6003-185.2not be considered in measuring the weight of a mixture except in cases where the mixture
6004-185.3contains four or more fluid ounces of fluid.
6005-185.4 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
6006-185.5committed on or after that date.
6007-185.6Sec. 12. Minnesota Statutes 2022, section 152.022, subdivision 1, is amended to read:
6008-185.7 Subdivision 1.Sale crimes.A person is guilty of controlled substance crime in the
6009-185.8second degree if:
6010-185.9 (1) on one or more occasions within a 90-day period the person unlawfully sells one or
6011-185.10more mixtures of a total weight of ten grams or more containing a narcotic drug other than
6012-185.11heroin;​
6013-185.12 (2) on one or more occasions within a 90-day period the person unlawfully sells one or​
6014-185.13more mixtures of a total weight of three grams or more containing cocaine or
6015-185.14methamphetamine and:
6016-185.15 (i) the person or an accomplice possesses on their person or within immediate reach, or
6017-185.16uses, whether by brandishing, displaying, threatening with, or otherwise employing, a​
6018-185.17firearm; or​
6019-185.18 (ii) the offense involves three aggravating factors;
6020-185.19 (3) on one or more occasions within a 90-day period the person unlawfully sells one or​
6021-185.20more mixtures of a total weight of three grams or more containing heroin;
6022-185.21 (4) on one or more occasions within a 90-day period the person unlawfully sells one or
6023-185.22more mixtures of a total weight of ten grams or more containing amphetamine, phencyclidine,
6024-185.23or hallucinogen or, if the controlled substance is packaged in dosage units, equaling 50 or​
6025-185.24more dosage units;
6026-185.25 (5) on one or more occasions within a 90-day period the person unlawfully sells one or
6027-185.26more mixtures of a total weight of ten kilograms or more containing marijuana or
6028-185.27Tetrahydrocannabinols;
6029-185.28 (6) (5) the person unlawfully sells any amount of a Schedule I or II narcotic drug to a
6030-185.29person under the age of 18, or conspires with or employs a person under the age of 18 to
6031-185.30unlawfully sell the substance; or
6032-185.31 (7) (6) the person unlawfully sells any of the following in a school zone, a park zone, a
6033-185.32public housing zone, or a drug treatment facility:​
6034-185​Article 4 Sec. 12.​
6035-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 186.1 (i) any amount of a Schedule I or II narcotic drug, lysergic acid diethylamide (LSD),
6036-186.23,4-methylenedioxy amphetamine, or 3,4-methylenedioxymethamphetamine; or
6037-186.3 (ii) one or more mixtures containing methamphetamine or amphetamine; or.
6038-186.4 (iii) one or more mixtures of a total weight of five kilograms or more containing marijuana
6039-186.5or Tetrahydrocannabinols.​
6040-186.6 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
6041-186.7committed on or after that date.
6042-186.8Sec. 13. Minnesota Statutes 2022, section 152.022, subdivision 2, is amended to read:
6043-186.9 Subd. 2.Possession crimes.(a) A person is guilty of controlled substance crime in the
6044-186.10second degree if:​
6045-186.11 (1) the person unlawfully possesses one or more mixtures of a total weight of 25 grams
6046-186.12or more containing cocaine or methamphetamine;​
6047-186.13 (2) the person unlawfully possesses one or more mixtures of a total weight of ten grams
6048-186.14or more containing cocaine or methamphetamine and:
6049-186.15 (i) the person or an accomplice possesses on their person or within immediate reach, or
6050-186.16uses, whether by brandishing, displaying, threatening with, or otherwise employing, a
6051-186.17firearm; or
6052-186.18 (ii) the offense involves three aggravating factors;
6053-186.19 (3) the person unlawfully possesses one or more mixtures of a total weight of six grams
6054-186.20or more containing heroin;
6055-186.21 (4) the person unlawfully possesses one or more mixtures of a total weight of 50 grams
6056-186.22or more containing a narcotic drug other than cocaine, heroin, or methamphetamine;
6057-186.23 (5) the person unlawfully possesses one or more mixtures of a total weight of 50 grams
6058-186.24or more containing amphetamine, phencyclidine, or hallucinogen or, if the controlled
6059-186.25substance is packaged in dosage units, equaling 100 or more dosage units; or
6060-186.26 (6) the person unlawfully possesses one or more mixtures of a total weight of 25
6061-186.27kilograms or more containing marijuana or Tetrahydrocannabinols, or possesses 100 or
6062-186.28more marijuana plants.:
6063-186.29 (i) 25 kilograms or more of cannabis flower;
6064-186.30 (ii) five kilograms or more of cannabis concentrate; or
6065-186​Article 4 Sec. 13.​
6066-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 187.1 (iii) edible cannabis products, lower-potency hemp edibles, hemp-derived consumer
6067-187.2products, or any combination of those infused with more than 500 grams of
6068-187.3tetrahydrocannabinols.​
6069-187.4 (b) For the purposes of this subdivision, the weight of fluid used in a water pipe may
6070-187.5not be considered in measuring the weight of a mixture except in cases where the mixture
6071-187.6contains four or more fluid ounces of fluid.
6072-187.7 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
6073-187.8committed on or after that date.
6074-187.9Sec. 14. Minnesota Statutes 2022, section 152.023, subdivision 1, is amended to read:
6075-187.10 Subdivision 1.Sale crimes.A person is guilty of controlled substance crime in the third
6076-187.11degree if:
6077-187.12 (1) the person unlawfully sells one or more mixtures containing a narcotic drug;
6078-187.13 (2) on one or more occasions within a 90-day period the person unlawfully sells one or
6079-187.14more mixtures containing phencyclidine or hallucinogen, it is packaged in dosage units,​
6080-187.15and equals ten or more dosage units;
6081-187.16 (3) the person unlawfully sells one or more mixtures containing a controlled substance
6082-187.17classified in Schedule I, II, or III, except a Schedule I or II narcotic drug, cannabis flower,
6083-187.18or cannabinoid products to a person under the age of 18; or
6084-187.19 (4) the person conspires with or employs a person under the age of 18 to unlawfully sell
6085-187.20one or more mixtures containing a controlled substance listed in Schedule I, II, or III, except
6086-187.21a Schedule I or II narcotic drug; or, cannabis flower, or cannabinoid products.​
6087-187.22 (5) on one or more occasions within a 90-day period the person unlawfully sells one or
6088-187.23more mixtures of a total weight of five kilograms or more containing marijuana or
6089-187.24Tetrahydrocannabinols.​
5379+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 165.1Sec. 16. Minnesota Statutes 2022, section 297D.01, is amended to read:
5380+165.2 297D.01 DEFINITIONS.
5381+165.3 Subdivision 1.Marijuana Illegal cannabis."Marijuana" "Illegal cannabis" means any
5382+165.4marijuana taxable cannabis product as defined in section 295.81, subdivision 1, paragraph
5383+165.5(r), whether real or counterfeit, as defined in section 152.01, subdivision 9, that is held,
5384+165.6possessed, transported, transferred, sold, or offered to be sold in violation of chapter 342
5385+165.7or Minnesota criminal laws.
5386+165.8 Subd. 2.Controlled substance."Controlled substance" means any drug or substance,
5387+165.9whether real or counterfeit, as defined in section 152.01, subdivision 4, that is held, possessed,
5388+165.10transported, transferred, sold, or offered to be sold in violation of Minnesota laws. "Controlled
5389+165.11substance" does not include marijuana illegal cannabis.​
5390+165.12 Subd. 3.Tax obligor or obligor."Tax obligor" or "obligor" means a person who in
5391+165.13violation of Minnesota law manufactures, produces, ships, transports, or imports into
5392+165.14Minnesota or in any manner acquires or possesses more than 42-1/2 grams of marijuana
5393+165.15illegal cannabis, or seven or more grams of any controlled substance, or ten or more dosage
5394+165.16units of any controlled substance which is not sold by weight. A quantity of marijuana illegal
5395+165.17cannabis or other controlled substance is measured by the weight of the substance whether
5396+165.18pure or impure or dilute, or by dosage units when the substance is not sold by weight, in
5397+165.19the tax obligor's possession. A quantity of a controlled substance is dilute if it consists of a
5398+165.20detectable quantity of pure controlled substance and any excipients or fillers.​
5399+165.21 Subd. 4.Commissioner."Commissioner" means the commissioner of revenue.
5400+165.22 EFFECTIVE DATE.This section is effective June 30, 2023.​
5401+165.23Sec. 17. Minnesota Statutes 2022, section 297D.04, is amended to read:
5402+165.24 297D.04 TAX PAYMENT REQUIRED FOR POSSESSION.​
5403+165.25 No tax obligor may possess any marijuana illegal cannabis or controlled substance upon
5404+165.26which a tax is imposed by section 297D.08 unless the tax has been paid on the marijuana
5405+165.27illegal cannabis or other a controlled substance as evidenced by a stamp or other official
5406+165.28indicia.
5407+165.29 EFFECTIVE DATE.This section is effective June 30, 2023.
5408+165​Article 2 Sec. 17.
5409+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 166.1Sec. 18. Minnesota Statutes 2022, section 297D.06, is amended to read:​
5410+166.2 297D.06 PHARMACEUTICALS.​
5411+166.3 Nothing in this chapter requires persons registered under chapter 151 or otherwise
5412+166.4lawfully in possession of marijuana illegal cannabis or a controlled substance to pay the tax
5413+166.5required under this chapter.
5414+166.6 EFFECTIVE DATE.This section is effective June 30, 2023.
5415+166.7Sec. 19. Minnesota Statutes 2022, section 297D.07, is amended to read:
5416+166.8 297D.07 MEASUREMENT .
5417+166.9 For the purpose of calculating the tax under section 297D.08, a quantity of marijuana
5418+166.10illegal cannabis or other a controlled substance is measured by the weight of the substance
5419+166.11whether pure or impure or dilute, or by dosage units when the substance is not sold by
5420+166.12weight, in the tax obligor's possession. A quantity of a controlled substance is dilute if it
5421+166.13consists of a detectable quantity of pure controlled substance and any excipients or fillers.
5422+166.14 EFFECTIVE DATE.This section is effective June 30, 2023.
5423+166.15Sec. 20. Minnesota Statutes 2022, section 297D.08, is amended to read:
5424+166.16 297D.08 TAX RATE.
5425+166.17 A tax is imposed on marijuana illegal cannabis and controlled substances as defined in
5426+166.18section 297D.01 at the following rates:
5427+166.19 (1) on each gram of marijuana illegal cannabis, or each portion of a gram, $3.50; and
5428+166.20 (2) on each gram of controlled substance, or portion of a gram, $200; or
5429+166.21 (3) on each ten dosage units of a controlled substance that is not sold by weight, or
5430+166.22portion thereof, $400.
5431+166.23 EFFECTIVE DATE.This section is effective June 30, 2023.​
5432+166.24Sec. 21. Minnesota Statutes 2022, section 297D.085, is amended to read:
5433+166.25 297D.085 CREDIT FOR PREVIOUSLY PAID TAXES.
5434+166.26 If another state or local unit of government has previously assessed an excise tax on the
5435+166.27marijuana illegal cannabis or controlled substances, the taxpayer must pay the difference
5436+166.28between the tax due under section 297D.08 and the tax previously paid. If the tax previously
5437+166.29paid to the other state or local unit of government was equal to or greater than the tax due
5438+166​Article 2 Sec. 21.​
5439+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 167.1under section 297D.08, no tax is due. The burden is on the taxpayer to show that an excise
5440+167.2tax on the marijuana illegal cannabis or controlled substances has been paid to another state
5441+167.3or local unit of government.​
5442+167.4 EFFECTIVE DATE.This section is effective June 30, 2023.
5443+167.5Sec. 22. Minnesota Statutes 2022, section 297D.09, subdivision 1a, is amended to read:
5444+167.6 Subd. 1a.Criminal penalty; sale without affixed stamps.In addition to the tax penalty
5445+167.7imposed, a tax obligor distributing or possessing marijuana illegal cannabis or controlled
5446+167.8substances without affixing the appropriate stamps, labels, or other indicia is guilty of a​
5447+167.9crime and, upon conviction, may be sentenced to imprisonment for not more than seven
5448+167.10years or to payment of a fine of not more than $14,000, or both.​
5449+167.11 EFFECTIVE DATE.This section is effective June 30, 2023.​
5450+167.12Sec. 23. Minnesota Statutes 2022, section 297D.10, is amended to read:​
5451+167.13 297D.10 STAMP PRICE.​
5452+167.14 Official stamps, labels, or other indicia to be affixed to all marijuana illegal cannabis or​
5453+167.15controlled substances shall be purchased from the commissioner. The purchaser shall pay
5454+167.16100 percent of face value for each stamp, label, or other indicia at the time of the purchase.
5455+167.17 EFFECTIVE DATE.This section is effective June 30, 2023.
5456+167.18Sec. 24. Minnesota Statutes 2022, section 297D.11, is amended to read:
5457+167.19 297D.11 PAYMENT DUE.
5458+167.20 Subdivision 1.Stamps affixed.When a tax obligor purchases, acquires, transports, or​
5459+167.21imports into this state marijuana illegal cannabis or controlled substances on which a tax is
5460+167.22imposed by section 297D.08, and if the indicia evidencing the payment of the tax have not
5461+167.23already been affixed, the tax obligor shall have them permanently affixed on the marijuana
5462+167.24illegal cannabis or controlled substance immediately after receiving the substance. Each
5463+167.25stamp or other official indicia may be used only once.
5464+167.26 Subd. 2.Payable on possession.Taxes imposed upon marijuana illegal cannabis or​
5465+167.27controlled substances by this chapter are due and payable immediately upon acquisition or​
5466+167.28possession in this state by a tax obligor.
5467+167.29 EFFECTIVE DATE.This section is effective June 30, 2023.
5468+167​Article 2 Sec. 24.​
5469+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 168.1 ARTICLE 3
5470+168.2 BUSINESS DEVELOPMENT
5471+168.3Section 1. [116J.659] CANNABIS INDUSTRY STARTUP FINANCING GRANTS.
5472+168.4 Subdivision 1.Establishment.The commissioner of employment and economic
5473+168.5development shall establish CanStartup, a program to award grants to nonprofit corporations
5474+168.6to fund loans to new cannabis microbusinesses and to support job creation in communities
5475+168.7where long-term residents are eligible to be social equity applicants.​
5476+168.8 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the
5477+168.9meanings given.​
5478+168.10 (b) "Cannabis microbusiness" means a cannabis business that meets the requirements
5479+168.11of section 342.28.
5480+168.12 (c) "Commissioner" means the commissioner of employment and economic development.
5481+168.13 (d) "Industry" means the legal cannabis industry in the state of Minnesota.​
5482+168.14 (e) "New business" means a legal cannabis business that has been in existence for three
5483+168.15years or less.​
5484+168.16 (f) "Program" means the CanStartup grant program.​
5485+168.17 (g) "Social equity applicant" means a person who meets the qualification requirements
5486+168.18in section 342.16.
5487+168.19 Subd. 3.Grants.(a) The commissioner shall establish a revolving loan account to make
5488+168.20grants under the CanStartup program.
5489+168.21 (b) The commissioner must award grants to nonprofit corporations through a competitive
5490+168.22grant process.
5491+168.23 (c) To receive grant money, a nonprofit corporation must submit a written application
5492+168.24to the commissioner using a form developed by the commissioner.
5493+168.25 (d) In awarding grants under this subdivision, the commissioner shall give weight to​
5494+168.26whether the nonprofit corporation:
5495+168.27 (1) has a board of directors that includes citizens experienced in business and community
5496+168.28development, new business enterprises, and creating jobs for people facing barriers to​
5497+168.29education or employment;
5498+168.30 (2) has the technical skills to analyze projects;
5499+168​Article 3 Section 1.​
5500+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 169.1 (3) is familiar with other available public and private funding sources and economic
5501+169.2development programs;
5502+169.3 (4) can initiate and implement economic development projects;
5503+169.4 (5) can establish and administer a revolving loan account;
5504+169.5 (6) can work with job referral networks that assist people facing barriers to education
5505+169.6or employment; and
5506+169.7 (7) has established relationships with communities where long-term residents are eligible
5507+169.8to be social equity applicants.​
5508+169.9The commissioner shall make grants that will assist new cannabis microbusinesses.​
5509+169.10 (e) A nonprofit corporation that receives a grant under the program must:
5510+169.11 (1) establish a commissioner-certified revolving loan account for the purpose of making
5511+169.12eligible loans; and
5512+169.13 (2) enter into an agreement with the commissioner that the commissioner shall fund
5513+169.14loans that the nonprofit corporation makes to new cannabis microbusinesses. The
5514+169.15commissioner shall review existing agreements with nonprofit corporations every five years
5515+169.16and may renew or terminate an agreement based on that review. In making this review, the
5516+169.17commissioner shall consider, among other criteria, the criteria in paragraph (d).​
5517+169.18 Subd. 4.Loans to businesses.(a) The criteria in this subdivision apply to loans made
5518+169.19by nonprofit corporations under the program.
5519+169.20 (b) Loans must be used to support a new cannabis microbusiness in the legal cannabis
5520+169.21industry. Priority must be given to loans to businesses owned by individuals who are eligible
5521+169.22to be social equity applicants and businesses located in communities where long-term
5522+169.23residents are eligible to be social equity applicants.​
5523+169.24 (c) Loans must be made to cannabis microbusinesses that are not likely to undertake the
5524+169.25project for which loans are sought without assistance from the program.​
5525+169.26 (d) The minimum state contribution to a loan is $2,500 and the maximum is either:
5526+169.27 (1) $50,000; or
5527+169.28 (2) $150,000, if state contributions are matched by an equal or greater amount of new
5528+169.29private investment.​
5529+169​Article 3 Section 1.​
5530+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 170.1 (e) Loan applications given preliminary approval by the nonprofit corporation must be
5531+170.2forwarded to the commissioner for approval. The commissioner must give final approval
5532+170.3for each loan made by the nonprofit corporation under the program.
5533+170.4 (f) A cannabis microbusiness that receives a loan may apply to renew the loan. Renewal
5534+170.5applications must be made on an annual basis and a cannabis microbusiness may receive
5535+170.6loans for up to six consecutive years. A nonprofit corporation may renew a loan to a cannabis
5536+170.7microbusiness that is no longer a new business provided the business would otherwise
5537+170.8qualify for an initial loan and is in good standing with the nonprofit corporation and the
5538+170.9commissioner. A nonprofit corporation may adjust the amount of a renewed loan, or not
5539+170.10renew a loan, if the nonprofit corporation determines that the cannabis microbusiness is
5540+170.11financially stable and is substantially likely to continue the project for which the loan renewal
5541+170.12is sought.
5542+170.13 (g) If a borrower has met lender criteria, including being current with all payments for
5543+170.14a minimum of three years, the commissioner may approve either full or partial forgiveness
5544+170.15of interest or principal amounts.​
5545+170.16 Subd. 5.Revolving loan account administration.(a) The commissioner shall establish
5546+170.17a minimum interest rate for loans or guarantees to ensure that necessary loan administration
5547+170.18costs are covered. The interest rate charged by a nonprofit corporation for a loan under this
5548+170.19section must not exceed the Wall Street Journal prime rate. For a loan under this section,
5549+170.20the nonprofit corporation may charge a loan origination fee equal to or less than one percent
5550+170.21of the loan value. The nonprofit corporation may retain the amount of the origination fee.
5551+170.22 (b) Loan repayment of principal must be paid to the commissioner for deposit in the
5552+170.23revolving loan account. Loan interest payments must be deposited in a revolving loan
5553+170.24account created by the nonprofit corporation originating the loan being repaid for further
5554+170.25distribution or use, consistent with the criteria of this section.​
5555+170.26 (c) Administrative expenses of the nonprofit corporations with whom the commissioner
5556+170.27enters into agreements, including expenses incurred by a nonprofit corporation in providing
5557+170.28financial, technical, managerial, and marketing assistance to a business receiving a loan
5558+170.29under this section, are eligible program expenses the commissioner may agree to pay under​
5559+170.30the grant agreement.
5560+170.31 Subd. 6.Program outreach.The commissioner shall make extensive efforts to publicize
5561+170.32this program, including through partnerships with community organizations, particularly
5562+170.33those organizations located in areas where long-term residents are eligible to be social equity
5563+170.34applicants.​
5564+170​Article 3 Section 1.​
5565+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 171.1 Subd. 7.Reporting requirements.(a) A nonprofit corporation that receives a grant
5566+171.2shall:
5567+171.3 (1) submit an annual report to the commissioner by February 1 of each year that the
5568+171.4nonprofit corporation participates in the program that includes a description of businesses
5569+171.5supported by the grant program, an account of loans made during the calendar year, the
5570+171.6program's impact on business creation and job creation, particularly in communities where
5571+171.7long-term residents are eligible to be social equity applicants, the source and amount of
5572+171.8money collected and distributed by the program, the program's assets and liabilities, and an
5573+171.9explanation of administrative expenses; and
5574+171.10 (2) provide for an independent annual audit to be performed in accordance with generally
5575+171.11accepted accounting practices and auditing standards and submit a copy of each annual
5576+171.12audit report to the commissioner.​
5577+171.13 (b) By March 1, 2024, and each March 1 thereafter, the commissioner must submit a
5578+171.14report to the chairs and ranking minority members of the committees of the house of
5579+171.15representatives and the senate having jurisdiction over economic development that details
5580+171.16awards given through the CanStartup program and the use of grant money, including any
5581+171.17measures of success toward financing new cannabis microbusinesses and creating jobs in
5582+171.18communities where long-term residents are eligible to be social equity applicants.​
5583+171.19Sec. 2. [116J.6595] CANNABIS INDUSTRY NAVIGATION GRANTS.
5584+171.20 Subdivision 1.Establishment.The commissioner of employment and economic
5585+171.21development shall establish CanNavigate, a program to award grants to eligible organizations
5586+171.22to help individuals navigate the regulatory structure of the legal cannabis industry.
5587+171.23 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the
5588+171.24meanings given.​
5589+171.25 (b) "Commissioner" means the commissioner of employment and economic development.​
5590+171.26 (c) "Eligible organization" means any organization capable of helping individuals navigate
5591+171.27the regulatory structure of the legal cannabis industry, particularly individuals facing barriers
5592+171.28to education or employment, and may include educational institutions, nonprofit
5593+171.29organizations, private businesses, community groups, units of local government, or​
5594+171.30partnerships between different types of organizations.​
5595+171.31 (d) "Industry" means the legal cannabis industry in the state of Minnesota.
5596+171.32 (e) "Program" means the CanNavigate grant program.​
5597+171​Article 3 Sec. 2.​
5598+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 172.1 (f) "Social equity applicant" means a person who meets the qualification requirements
5599+172.2in section 342.16.
5600+172.3 Subd. 3.Grants to organizations.(a) Grant money awarded to eligible organizations
5601+172.4may be used for both developing technical assistance resources relevant to the regulatory
5602+172.5structure of the legal cannabis industry and for providing technical assistance or navigation
5603+172.6services to individuals.
5604+172.7 (b) The commissioner must award grants to eligible organizations through a competitive
5605+172.8grant process.​
5606+172.9 (c) To receive grant money, an eligible organization must submit a written application
5607+172.10to the commissioner, using a form developed by the commissioner, explaining the
5608+172.11organization's ability to assist individuals in navigating the regulatory structure of the legal
5609+172.12cannabis industry, particularly individuals facing barriers to education or employment.​
5610+172.13 (d) An eligible organization's grant application must also include:
5611+172.14 (1) a description of the proposed technical assistance or navigation services, including
5612+172.15the types of individuals targeted for assistance;
5613+172.16 (2) any evidence of the organization's past success in providing technical assistance or
5614+172.17navigation services to individuals, particularly individuals who live in areas where long-term
5615+172.18residents are eligible to be social equity applicants;
5616+172.19 (3) an estimate of the cost of providing the technical assistance;
5617+172.20 (4) the sources and amounts of any nonstate money or in-kind contributions that will
5618+172.21supplement grant money, including any amounts that individuals will be charged to receive
5619+172.22assistance; and
5620+172.23 (5) any additional information requested by the commissioner.​
5621+172.24 (e) In awarding grants under this subdivision, the commissioner shall give weight to
5622+172.25applications from organizations that demonstrate a history of successful technical assistance
5623+172.26or navigation services, particularly for individuals facing barriers to education or employment.​
5624+172.27The commissioner shall also give weight to applications where the proposed technical
5625+172.28assistance will serve areas where long-term residents are eligible to be social equity
5626+172.29applicants. To the extent practicable, the commissioner shall fund technical assistance for
5627+172.30a variety of sectors in the legal cannabis industry, including both processing and retail
5628+172.31sectors.
5629+172​Article 3 Sec. 2.​
5630+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 173.1 Subd. 4.Program outreach.The commissioner shall make extensive efforts to publicize
5631+173.2these grants, including through partnerships with community organizations, particularly
5632+173.3those organizations located in areas where long-term residents are eligible to be social equity
5633+173.4applicants.​
5634+173.5 Subd. 5.Reports to the legislature.By January 15, 2024, and each January 15 thereafter,
5635+173.6the commissioner must submit a report to the chairs and ranking minority members of the
5636+173.7committees of the house of representatives and the senate having jurisdiction over economic
5637+173.8development that details awards given through the CanNavigate program and the use of
5638+173.9grant money, including any measures of success toward helping individuals navigate the​
5639+173.10regulatory structure of the legal cannabis industry.​
5640+173.11Sec. 3. [116L.90] CANNABIS INDUSTRY TRAINING GRANTS.
5641+173.12 Subdivision 1.Establishment.The commissioner of employment and economic
5642+173.13development shall establish CanTrain, a program to award grants to (1) eligible organizations
5643+173.14to train people for work in the legal cannabis industry, and (2) eligible individuals to acquire
5644+173.15such training.
5645+173.16 Subd. 2.Definitions.(a) For the purposes of this section, the following terms have the
5646+173.17meanings given.​
5647+173.18 (b) "Commissioner" means the commissioner of employment and economic development.
5648+173.19 (c) "Eligible organization" means any organization capable of providing training relevant
5649+173.20to the legal cannabis industry, particularly for individuals facing barriers to education or
5650+173.21employment, and may include educational institutions, nonprofit organizations, private
5651+173.22businesses, community groups, units of local government, or partnerships between different
5652+173.23types of organizations.
5653+173.24 (d) "Eligible individual" means a Minnesota resident who is 21 years old or older.​
5654+173.25 (e) "Industry" means the legal cannabis industry in Minnesota.
5655+173.26 (f) "Program" means the CanTrain grant program.​
5656+173.27 (g) "Social equity applicant" means a person who meets the qualification requirements
5657+173.28in section 342.16.
5658+173.29 Subd. 3.Grants to organizations.(a) Grant money awarded to eligible organizations
5659+173.30may be used for both developing a training program relevant to the legal cannabis industry
5660+173.31and for providing such training to individuals.
5661+173​Article 3 Sec. 3.
5662+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 174.1 (b) The commissioner must award grants to eligible organizations through a competitive
5663+174.2grant process.
5664+174.3 (c) To receive grant money, an eligible organization must submit a written application
5665+174.4to the commissioner, using a form developed by the commissioner, explaining the
5666+174.5organization's ability to train individuals for successful careers in the legal cannabis industry,
5667+174.6particularly individuals facing barriers to education or employment.
5668+174.7 (d) An eligible organization's grant application must also include:
5669+174.8 (1) a description of the proposed training;
5670+174.9 (2) an analysis of the degree of demand in the legal cannabis industry for the skills gained
5671+174.10through the proposed training;
5672+174.11 (3) any evidence of the organization's past success in training individuals for successful
5673+174.12careers, particularly in new or emerging industries;
5674+174.13 (4) an estimate of the cost of providing the proposed training;​
5675+174.14 (5) the sources and amounts of any nonstate funds or in-kind contributions that will
5676+174.15supplement grant money, including any amounts that individuals will be charged to​
5677+174.16participate in the training; and
5678+174.17 (6) any additional information requested by the commissioner.
5679+174.18 (e) In awarding grants under this subdivision, the commissioner shall give weight to
5680+174.19applications from organizations that demonstrate a history of successful career training,
5681+174.20particularly for individuals facing barriers to education or employment. The commissioner
5682+174.21shall also give weight to applications where the proposed training will:
5683+174.22 (1) result in an industry-relevant credential; or
5684+174.23 (2) include opportunities for hands-on or on-site experience in the industry.
5685+174.24The commissioner shall fund training for a broad range of careers in the legal cannabis
5686+174.25industry, including both potential business owners and employees and for work in the​
5687+174.26growing, processing, and retail sectors of the legal cannabis industry.​
5688+174.27 Subd. 4.Grants to individuals.(a) The commissioner shall award grants of $....... to​
5689+174.28eligible individuals to pursue a training program relevant to a career in the legal cannabis
5690+174.29industry.​
5691+174.30 (b) To receive grant money, an eligible individual must submit a written application to
5692+174.31the commissioner, using a form developed by the commissioner, identifying a training
5693+174​Article 3 Sec. 3.
5694+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 175.1program relevant to the legal cannabis industry and the estimated cost of completing that
5695+175.2training. The application must also indicate whether:
5696+175.3 (1) the applicant is eligible to be a social equity applicant;
5697+175.4 (2) the proposed training program results in an industry-relevant credential; and​
5698+175.5 (3) the proposed training program includes opportunities for hands-on or on-site
5699+175.6experience in the industry.
5700+175.7The commissioner shall attempt to make the application process simple for individuals to
5701+175.8complete, such as by publishing lists of industry-relevant training programs along with the
5702+175.9training program's estimated cost of completing the training programs and whether the​
5703+175.10training programs will result in an industry-relevant credential or include opportunities for​
5704+175.11hands-on or on-site experience in the legal cannabis industry.​
5705+175.12 (c) The commissioner must award grants to eligible individuals through a lottery process.
5706+175.13Applicants who have filed complete applications by the deadline set by the commissioner​
5707+175.14shall receive one entry in the lottery, plus one additional entry for each of the following:
5708+175.15 (1) being eligible to be a social equity applicant;
5709+175.16 (2) seeking to enroll in a training program that results in an industry-relevant credential;
5710+175.17and
5711+175.18 (3) seeking to enroll in a training program that includes opportunities for hands-on or
5712+175.19on-site experience in the industry.
5713+175.20 (d) Grant money awarded to eligible individuals shall be used to pay the costs of enrolling
5714+175.21in a training program relevant to the legal cannabis industry, including tuition, fees, and
5715+175.22materials costs. Grant money may also be used to remove external barriers to attending such
5716+175.23a training program, such as the cost of child care, transportation, or other expenses approved
5717+175.24by the commissioner.​
5718+175.25 Subd. 5.Program outreach.The commissioner shall make extensive efforts to publicize
5719+175.26these grants, including through partnerships with community organizations, particularly
5720+175.27those organizations located in areas where long-term residents are eligible to be social equity
5721+175.28applicants.
5722+175.29 Subd. 6.Reports to the legislature.By January 15, 2024, and each January 15 thereafter,
5723+175.30the commissioner must submit a report to the chairs and ranking minority members of the
5724+175.31committees of the house of representatives and the senate having jurisdiction over workforce
5725+175.32development that describes awards given through the CanTrain program and the use of
5726+175​Article 3 Sec. 3.
5727+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 176.1grant money, including any measures of success toward training people for successful
5728+176.2careers in the legal cannabis industry.​
5729+176.3 ARTICLE 4
5730+176.4 CRIMINAL PENALTIES
5731+176.5Section 1. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision
5732+176.6to read:
5733+176.7 Subd. 25.Artificially derived cannabinoid."Artificially derived cannabinoid" has the
5734+176.8meaning given in section 342.01, subdivision 6.
5735+176.9Sec. 2. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5736+176.10read:
5737+176.11 Subd. 26.Cannabis concentrate."Cannabis concentrate" has the meaning given in​
5738+176.12section 342.01, subdivision 14.
5739+176.13Sec. 3. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to​
5740+176.14read:
5741+176.15 Subd. 27.Cannabis flower."Cannabis flower" has the meaning given in section 342.01,
5742+176.16subdivision 15.
5743+176.17Sec. 4. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5744+176.18read:
5745+176.19 Subd. 28.Cannabis plant."Cannabis plant" has the meaning given in section 342.01,
5746+176.20subdivision 18.​
5747+176.21Sec. 5. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5748+176.22read:
5749+176.23 Subd. 29.Cannabis product."Cannabis product" has the meaning given in section
5750+176.24342.01, subdivision 19.
5751+176.25Sec. 6. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5752+176.26read:
5753+176.27 Subd. 30.Edible cannabis product."Edible cannabis product" has the meaning given
5754+176.28in section 342.01, subdivision 29.
5755+176​Article 4 Sec. 6.
5756+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 177.1Sec. 7. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5757+177.2read:
5758+177.3 Subd. 31.Hemp-derived consumer product."Hemp-derived consumer product" has
5759+177.4the meaning given in section 342.01, subdivision 35.​
5760+177.5Sec. 8. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to
5761+177.6read:
5762+177.7 Subd. 32.Lower-potency hemp edible."Lower-potency hemp edible" has the meaning
5763+177.8given in section 342.01, subdivision 48.​
5764+177.9Sec. 9. Minnesota Statutes 2022, section 152.021, subdivision 1, is amended to read:
5765+177.10 Subdivision 1.Sale crimes.A person is guilty of controlled substance crime in the first
5766+177.11degree if:
5767+177.12 (1) on one or more occasions within a 90-day period the person unlawfully sells one or
5768+177.13more mixtures of a total weight of 17 grams or more containing cocaine or methamphetamine;
5769+177.14 (2) on one or more occasions within a 90-day period the person unlawfully sells one or
5770+177.15more mixtures of a total weight of ten grams or more containing cocaine or methamphetamine
5771+177.16and:
5772+177.17 (i) the person or an accomplice possesses on their person or within immediate reach, or
5773+177.18uses, whether by brandishing, displaying, threatening with, or otherwise employing, a
5774+177.19firearm; or​
5775+177.20 (ii) the offense involves two aggravating factors;​
5776+177.21 (3) on one or more occasions within a 90-day period the person unlawfully sells one or​
5777+177.22more mixtures of a total weight of ten grams or more containing heroin;
5778+177.23 (4) on one or more occasions within a 90-day period the person unlawfully sells one or
5779+177.24more mixtures of a total weight of 50 grams or more containing a narcotic drug other than
5780+177.25cocaine, heroin, or methamphetamine; or
5781+177.26 (5) on one or more occasions within a 90-day period the person unlawfully sells one or
5782+177.27more mixtures of a total weight of 50 grams or more containing amphetamine, phencyclidine,
5783+177.28or hallucinogen or, if the controlled substance is packaged in dosage units, equaling 200 or
5784+177.29more dosage units; or.
5785+177​Article 4 Sec. 9.
5786+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 178.1 (6) on one or more occasions within a 90-day period the person unlawfully sells one or
5787+178.2more mixtures of a total weight of 25 kilograms or more containing marijuana or
5788+178.3Tetrahydrocannabinols.
5789+178.4 EFFECTIVE DATE.This section is effective January 1, 2024, and applies to crimes
5790+178.5committed on or after that date.​
5791+178.6Sec. 10. Minnesota Statutes 2022, section 152.021, subdivision 2, is amended to read:
5792+178.7 Subd. 2.Possession crimes.(a) A person is guilty of a controlled substance crime in
5793+178.8the first degree if:
5794+178.9 (1) the person unlawfully possesses one or more mixtures of a total weight of 50 grams
5795+178.10or more containing cocaine or methamphetamine;
5796+178.11 (2) the person unlawfully possesses one or more mixtures of a total weight of 25 grams
5797+178.12or more containing cocaine or methamphetamine and:
5798+178.13 (i) the person or an accomplice possesses on their person or within immediate reach, or
5799+178.14uses, whether by brandishing, displaying, threatening with, or otherwise employing, a
5800+178.15firearm; or
5801+178.16 (ii) the offense involves two aggravating factors;
5802+178.17 (3) the person unlawfully possesses one or more mixtures of a total weight of 25 grams
5803+178.18or more containing heroin;
5804+178.19 (4) the person unlawfully possesses one or more mixtures of a total weight of 500 grams
5805+178.20or more containing a narcotic drug other than cocaine, heroin, or methamphetamine;
5806+178.21 (5) the person unlawfully possesses one or more mixtures of a total weight of 500 grams
5807+178.22or more containing amphetamine, phencyclidine, or hallucinogen or, if the controlled
5808+178.23substance is packaged in dosage units, equaling 500 or more dosage units; or
5809+178.24 (6) the person unlawfully possesses one or more mixtures of a total weight of 50
5810+178.25kilograms or more containing marijuana or Tetrahydrocannabinols, or possesses 500 or
5811+178.26more marijuana plants.:
5812+178.27 (i) 50 kilograms or more of cannabis flower;
5813+178.28 (ii) ten kilograms or more of cannabis concentrate; or
5814+178.29 (iii) edible cannabis products, lower-potency hemp edibles, hemp-derived consumer
5815+178.30products, or any combination of those infused with more than one kilogram of
5816+178.31tetrahydrocannabinols.​
5817+178​Article 4 Sec. 10.​
5818+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 179.1 (b) For the purposes of this subdivision, the weight of fluid used in a water pipe may
5819+179.2not be considered in measuring the weight of a mixture except in cases where the mixture
5820+179.3contains four or more fluid ounces of fluid.​
5821+179.4 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
5822+179.5committed on or after that date.​
5823+179.6Sec. 11. Minnesota Statutes 2022, section 152.022, subdivision 1, is amended to read:
5824+179.7 Subdivision 1.Sale crimes.A person is guilty of controlled substance crime in the
5825+179.8second degree if:
5826+179.9 (1) on one or more occasions within a 90-day period the person unlawfully sells one or
5827+179.10more mixtures of a total weight of ten grams or more containing a narcotic drug other than
5828+179.11heroin;
5829+179.12 (2) on one or more occasions within a 90-day period the person unlawfully sells one or
5830+179.13more mixtures of a total weight of three grams or more containing cocaine or
5831+179.14methamphetamine and:​
5832+179.15 (i) the person or an accomplice possesses on their person or within immediate reach, or
5833+179.16uses, whether by brandishing, displaying, threatening with, or otherwise employing, a
5834+179.17firearm; or
5835+179.18 (ii) the offense involves three aggravating factors;
5836+179.19 (3) on one or more occasions within a 90-day period the person unlawfully sells one or
5837+179.20more mixtures of a total weight of three grams or more containing heroin;​
5838+179.21 (4) on one or more occasions within a 90-day period the person unlawfully sells one or​
5839+179.22more mixtures of a total weight of ten grams or more containing amphetamine, phencyclidine,
5840+179.23or hallucinogen or, if the controlled substance is packaged in dosage units, equaling 50 or
5841+179.24more dosage units;
5842+179.25 (5) on one or more occasions within a 90-day period the person unlawfully sells one or
5843+179.26more mixtures of a total weight of ten kilograms or more containing marijuana or
5844+179.27Tetrahydrocannabinols;
5845+179.28 (6) (5) the person unlawfully sells any amount of a Schedule I or II narcotic drug to a
5846+179.29person under the age of 18, or conspires with or employs a person under the age of 18 to
5847+179.30unlawfully sell the substance; or
5848+179.31 (7) (6) the person unlawfully sells any of the following in a school zone, a park zone, a
5849+179.32public housing zone, or a drug treatment facility:
5850+179​Article 4 Sec. 11.​
5851+REVISOR BD H0100-11HF100 ELEVENTH ENGROSSMENT​ 180.1 (i) any amount of a Schedule I or II narcotic drug, lysergic acid diethylamide (LSD),
5852+180.23,4-methylenedioxy amphetamine, or 3,4-methylenedioxymethamphetamine; or
5853+180.3 (ii) one or more mixtures containing methamphetamine or amphetamine; or.
5854+180.4 (iii) one or more mixtures of a total weight of five kilograms or more containing marijuana
5855+180.5or Tetrahydrocannabinols.
5856+180.6 EFFECTIVE DATE.This section is effective January 1, 2024, and applies to crimes
5857+180.7committed on or after that date.
5858+180.8Sec. 12. Minnesota Statutes 2022, section 152.022, subdivision 2, is amended to read:​
5859+180.9 Subd. 2.Possession crimes.(a) A person is guilty of controlled substance crime in the
5860+180.10second degree if:
5861+180.11 (1) the person unlawfully possesses one or more mixtures of a total weight of 25 grams
5862+180.12or more containing cocaine or methamphetamine;
5863+180.13 (2) the person unlawfully possesses one or more mixtures of a total weight of ten grams
5864+180.14or more containing cocaine or methamphetamine and:
5865+180.15 (i) the person or an accomplice possesses on their person or within immediate reach, or
5866+180.16uses, whether by brandishing, displaying, threatening with, or otherwise employing, a
5867+180.17firearm; or​
5868+180.18 (ii) the offense involves three aggravating factors;
5869+180.19 (3) the person unlawfully possesses one or more mixtures of a total weight of six grams
5870+180.20or more containing heroin;
5871+180.21 (4) the person unlawfully possesses one or more mixtures of a total weight of 50 grams
5872+180.22or more containing a narcotic drug other than cocaine, heroin, or methamphetamine;​
5873+180.23 (5) the person unlawfully possesses one or more mixtures of a total weight of 50 grams
5874+180.24or more containing amphetamine, phencyclidine, or hallucinogen or, if the controlled
5875+180.25substance is packaged in dosage units, equaling 100 or more dosage units; or
5876+180.26 (6) the person unlawfully possesses one or more mixtures of a total weight of 25
5877+180.27kilograms or more containing marijuana or Tetrahydrocannabinols, or possesses 100 or
5878+180.28more marijuana plants.:
5879+180.29 (i) 25 kilograms or more of cannabis flower;
5880+180.30 (ii) five kilograms or more of cannabis concentrate; or
5881+180​Article 4 Sec. 12.​
5882+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 181.1 (iii) edible cannabis products, lower-potency hemp edibles, hemp-derived consumer
5883+181.2products, or any combination of those infused with more than 500 grams of
5884+181.3tetrahydrocannabinols.
5885+181.4 (b) For the purposes of this subdivision, the weight of fluid used in a water pipe may
5886+181.5not be considered in measuring the weight of a mixture except in cases where the mixture
5887+181.6contains four or more fluid ounces of fluid.
5888+181.7 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
5889+181.8committed on or after that date.
5890+181.9Sec. 13. Minnesota Statutes 2022, section 152.023, subdivision 1, is amended to read:
5891+181.10 Subdivision 1.Sale crimes.A person is guilty of controlled substance crime in the third
5892+181.11degree if:
5893+181.12 (1) the person unlawfully sells one or more mixtures containing a narcotic drug;
5894+181.13 (2) on one or more occasions within a 90-day period the person unlawfully sells one or
5895+181.14more mixtures containing phencyclidine or hallucinogen, it is packaged in dosage units,
5896+181.15and equals ten or more dosage units;
5897+181.16 (3) the person unlawfully sells one or more mixtures containing a controlled substance
5898+181.17classified in Schedule I, II, or III, except a Schedule I or II narcotic drug, cannabis flower,
5899+181.18or cannabinoid products to a person under the age of 18; or
5900+181.19 (4) the person conspires with or employs a person under the age of 18 to unlawfully sell
5901+181.20one or more mixtures containing a controlled substance listed in Schedule I, II, or III, except
5902+181.21a Schedule I or II narcotic drug; or.
5903+181.22 (5) on one or more occasions within a 90-day period the person unlawfully sells one or
5904+181.23more mixtures of a total weight of five kilograms or more containing marijuana or​
5905+181.24Tetrahydrocannabinols.
5906+181.25 EFFECTIVE DATE.This section is effective January 1, 2024, and applies to crimes
5907+181.26committed on or after that date.
5908+181.27Sec. 14. Minnesota Statutes 2022, section 152.023, subdivision 2, is amended to read:
5909+181.28 Subd. 2.Possession crimes.(a) A person is guilty of controlled substance crime in the
5910+181.29third degree if:
5911+181​Article 4 Sec. 14.
5912+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 182.1 (1) on one or more occasions within a 90-day period the person unlawfully possesses
5913+182.2one or more mixtures of a total weight of ten grams or more containing a narcotic drug other
5914+182.3than heroin;
5915+182.4 (2) on one or more occasions within a 90-day period the person unlawfully possesses
5916+182.5one or more mixtures of a total weight of three grams or more containing heroin;
5917+182.6 (3) on one or more occasions within a 90-day period the person unlawfully possesses
5918+182.7one or more mixtures containing a narcotic drug, it is packaged in dosage units, and equals
5919+182.850 or more dosage units;
5920+182.9 (4) on one or more occasions within a 90-day period the person unlawfully possesses
5921+182.10any amount of a schedule I or II narcotic drug or five or more dosage units of lysergic acid
5922+182.11diethylamide (LSD), 3,4-methylenedioxy amphetamine, or
5923+182.123,4-methylenedioxymethamphetamine in a school zone, a park zone, a public housing zone,
5924+182.13or a drug treatment facility;
5925+182.14 (5) on one or more occasions within a 90-day period the person unlawfully possesses
5926+182.15one or more mixtures of a total weight of ten kilograms or more containing marijuana or
5927+182.16Tetrahydrocannabinols:
5928+182.17 (i) more than ten kilograms of cannabis flower;
5929+182.18 (ii) more than two kilograms of cannabis concentrate; or
5930+182.19 (iii) edible cannabis products, lower-potency hemp edibles, hemp-derived consumer
5931+182.20products, or any combination of those infused with more than 200 grams of
5932+182.21tetrahydrocannabinol; or
5933+182.22 (6) the person unlawfully possesses one or more mixtures containing methamphetamine
5934+182.23or amphetamine in a school zone, a park zone, a public housing zone, or a drug treatment
5935+182.24facility.​
5936+182.25 (b) For the purposes of this subdivision, the weight of fluid used in a water pipe may
5937+182.26not be considered in measuring the weight of a mixture except in cases where the mixture
5938+182.27contains four or more fluid ounces of fluid.​
5939+182.28 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
5940+182.29committed on or after that date.​
5941+182.30Sec. 15. Minnesota Statutes 2022, section 152.024, subdivision 1, is amended to read:​
5942+182.31 Subdivision 1.Sale crimes.A person is guilty of controlled substance crime in the fourth
5943+182.32degree if:
5944+182​Article 4 Sec. 15.​
5945+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 183.1 (1) the person unlawfully sells one or more mixtures containing a controlled substance
5946+183.2classified in Schedule I, II, or III, except marijuana or Tetrahydrocannabinols;
5947+183.3 (2) the person unlawfully sells one or more mixtures containing a controlled substance
5948+183.4classified in Schedule IV or V to a person under the age of 18; or
5949+183.5 (3) the person conspires with or employs a person under the age of 18 to unlawfully sell
5950+183.6a controlled substance classified in Schedule IV or V; or.
5951+183.7 (4) the person unlawfully sells any amount of marijuana or Tetrahydrocannabinols in a
5952+183.8school zone, a park zone, a public housing zone, or a drug treatment facility, except a small
5953+183.9amount for no remuneration.​
5954+183.10 EFFECTIVE DATE.This section is effective January 1, 2024, and applies to crimes
5955+183.11committed on or after that date.
5956+183.12Sec. 16. Minnesota Statutes 2022, section 152.025, subdivision 1, is amended to read:
5957+183.13 Subdivision 1.Sale crimes.A person is guilty of a controlled substance crime in the
5958+183.14fifth degree and upon conviction may be sentenced as provided in subdivision 4 if:
5959+183.15 (1) the person unlawfully sells one or more mixtures containing marijuana or​
5960+183.16tetrahydrocannabinols, except a small amount of marijuana for no remuneration; or
5961+183.17 (2) the person unlawfully sells one or more mixtures containing a controlled substance
5962+183.18classified in Schedule IV.
5963+183.19 EFFECTIVE DATE.This section is effective January 1, 2024, and applies to crimes
5964+183.20committed on or after that date.
5965+183.21Sec. 17. Minnesota Statutes 2022, section 152.025, subdivision 2, is amended to read:
5966+183.22 Subd. 2.Possession and other crimes.A person is guilty of controlled substance crime
5967+183.23in the fifth degree and upon conviction may be sentenced as provided in subdivision 4 if:
5968+183.24 (1) the person unlawfully possesses one or more mixtures containing a controlled
5969+183.25substance classified in Schedule I, II, III, or IV, except a small amount of marijuana cannabis
5970+183.26flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products;
5971+183.27or
5972+183.28 (2) the person procures, attempts to procure, possesses, or has control over a controlled
5973+183.29substance by any of the following means:
5974+183.30 (i) fraud, deceit, misrepresentation, or subterfuge;
5975+183​Article 4 Sec. 17.
5976+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 184.1 (ii) using a false name or giving false credit; or​
5977+184.2 (iii) falsely assuming the title of, or falsely representing any person to be, a manufacturer,
5978+184.3wholesaler, pharmacist, physician, doctor of osteopathic medicine licensed to practice
5979+184.4medicine, dentist, podiatrist, veterinarian, or other authorized person for the purpose of
5980+184.5obtaining a controlled substance.​
5981+184.6 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
5982+184.7committed on or after that date.
5983+184.8Sec. 18. [152.0263] CANNABIS POSSESSION CRIMES.
5984+184.9 Subdivision 1.Possession of cannabis in the first degree.A person is guilty of cannabis
5985+184.10possession in the first degree and may be sentenced to imprisonment of not more than five
5986+184.11years or to payment of a fine of not more than $10,000, or both, if the person unlawfully
5987+184.12possesses any of the following:
5988+184.13 (1) more than 1.5 pounds but not more than ten kilograms of cannabis flower;
5989+184.14 (2) more than 160 grams but not more than two kilograms of cannabis concentrate; or​
5990+184.15 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer
5991+184.16products infused with more than 16 grams but not more than 200 grams of​
5992+184.17tetrahydrocannabinol.
5993+184.18 Subd. 2.Possession of cannabis in the second degree.A person is guilty of cannabis
5994+184.19possession in the second degree and may be sentenced to imprisonment of not more than​
5995+184.20one year or to payment of a fine of not more than $3,000, or both, if the person unlawfully​
5996+184.21possesses any of the following:
5997+184.22 (1) more than one pound but not more than 1.5 pounds of cannabis flower in any place
5998+184.23other than the person's residence;
5999+184.24 (2) more than 80 grams but not more than 160 grams of cannabis concentrate; or​
6000+184.25 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer
6001+184.26products infused with more than eight grams but not more than 16 grams of​
6002+184.27tetrahydrocannabinol.
6003+184.28 Subd. 3.Possession of cannabis in the third degree.A person is guilty of cannabis
6004+184.29possession in the third degree and may be sentenced to imprisonment of not more than 90
6005+184.30days or to payment of a fine of not more than $1,000, or both, if the person unlawfully
6006+184.31possesses any of the following:
6007+184​Article 4 Sec. 18.
6008+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 185.1 (1) more than four ounces but not more than one pound of cannabis flower in any place
6009+185.2other than the person's residence;
6010+185.3 (2) more than 16 grams but not more than 80 grams of cannabis concentrate; or
6011+185.4 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer
6012+185.5products infused with more than 1,600 milligrams but not more than eight grams of
6013+185.6tetrahydrocannabinol.​
6014+185.7 Subd. 4.Possession of cannabis in the fourth degree.A person is guilty of a petty
6015+185.8misdemeanor if the person unlawfully possesses any of the following:
6016+185.9 (1) more than two ounces but not more than four ounces of cannabis flower in any place
6017+185.10other than the person's residence;​
6018+185.11 (2) more than eight grams but not more than 16 grams of cannabis concentrate; or​
6019+185.12 (3) edible cannabinoid products infused with more than 800 milligrams but not more
6020+185.13than 1,600 milligrams of tetrahydrocannabinol.
6021+185.14 Subd. 5.Use of cannabis in public.A local unit of government may adopt an ordinance
6022+185.15establishing a petty misdemeanor offense for a person who unlawfully uses cannabis flower,
6023+185.16cannabis products, lower-potency hemp edibles, or hemp-derived consumer products in a
6024+185.17public place provided that the definition of public place does not include the following:
6025+185.18 (1) a private residence, including the person's curtilage or yard;
6026+185.19 (2) private property not generally accessible by the public, unless the person is explicitly
6027+185.20prohibited from consuming cannabis flower, cannabis products, lower-potency hemp edibles,
6028+185.21or hemp-derived consumer products on the property by the owner of the property; or​
6029+185.22 (3) the premises of an establishment or event licensed to permit on-site consumption.
6030+185.23 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes
6031+185.24committed on or after that date.
6032+185.25Sec. 19. [152.0264] CANNABIS SALE CRIMES.
6033+185.26 Subdivision 1.Sale of cannabis in the first degree.A person is guilty of the sale of
6034+185.27cannabis in the first degree and may be sentenced to imprisonment of not more than five
6035+185.28years or to payment of a fine of not more than $10,000, or both, if the person unlawfully
6036+185.29sells more than two ounces of cannabis flower; more than eight grams of cannabis
6037+185.30concentrate; or edible cannabis products, lower-potency hemp edibles, or hemp-derived
6038+185.31consumer products infused with more than 800 milligrams of tetrahydrocannabinol:​
6039+185​Article 4 Sec. 19.​
6040+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 186.1 (1) to a minor and the defendant is an adult who is more than 36 months older than the
6041+186.2minor;​
6042+186.3 (2) within ten years of two or more convictions under subdivision 2 or 3; or​
6043+186.4 (3) within ten years of a conviction under this subdivision.
6044+186.5 Subd. 2.Sale of cannabis in the second degree.A person is guilty of sale of cannabis
6045+186.6in the second degree and may be sentenced to imprisonment of not more than one year or
6046+186.7to payment of a fine of not more than $3,000, or both, if the person unlawfully sells:
6047+186.8 (1) more than two ounces of cannabis flower; more than eight grams of cannabis
6048+186.9concentrate; or edible cannabis products, lower-potency hemp edibles, or hemp-derived
6049+186.10consumer products infused with more than 800 milligrams of tetrahydrocannabinol:​
6050+186.11 (i) to a minor and the defendant is an adult who is not more than 36 months older than
6051+186.12the minor;​
6052+186.13 (ii) in a school zone, a park zone, a public housing zone, or a drug treatment facility; or
6053+186.14 (iii) within ten years of a conviction under subdivision 1, 2, or 3; or
6054+186.15 (2) up to two ounces of cannabis flower; up to eight grams of cannabis concentrate;
6055+186.16edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer products
6056+186.17infused with up to 800 milligrams of tetrahydrocannabinol to a minor.
6057+186.18 Subd. 3.Sale of cannabis in the third degree.A person is guilty of sale of cannabis in
6058+186.19the third degree and may be sentenced to imprisonment of not more than 90 days or to
6059+186.20payment of a fine of not more than $1,000, or both, if the person unlawfully sells:
6060+186.21 (1) more than two ounces of cannabis flower;
6061+186.22 (2) more than eight grams of cannabis concentrate; or​
6062+186.23 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer
6063+186.24products infused with more than 800 milligrams of tetrahydrocannabinol.
6064+186.25 Subd. 4.Sale of cannabis in the fourth degree.(a) A person is guilty of a petty
6065+186.26misdemeanor if the person unlawfully sells:
6066+186.27 (1) not more than two ounces of cannabis flower;
6067+186.28 (2) not more than eight grams of cannabis concentrate; or
6068+186.29 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer
6069+186.30products infused with not more than 800 milligrams of tetrahydrocannabinol.
6070+186​Article 4 Sec. 19.​
6071+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 187.1 (b) A sale for no remuneration by an individual over the age of 21 to another individual
6072+187.2over the age of 21 is not an unlawful sale under this subdivision.
6073+187.3 Subd. 5.Sale of cannabis by a minor.(a) A minor is guilty of a petty misdemeanor if:
6074+187.4 (1) the minor unlawfully sells cannabis flower, cannabis concentrate, cannabis products,
6075+187.5lower-potency hemp edibles, or hemp-derived consumer products; and
6076+187.6 (2) the minor has not previously received a petty misdemeanor disposition or been
6077+187.7adjudicated delinquent for committing an act in violation of this section.
6078+187.8 (b) A minor sentenced under this subdivision is required to participate in a drug education
6079+187.9program unless the court enters a written finding that a drug education program is​
6080+187.10inappropriate. The program must be approved by an area mental health board with a
6081+187.11curriculum approved by the state alcohol and drug abuse authority.
6082+187.12 (c) A minor who receives a disposition pursuant to this subdivision is required to perform
6083+187.13community service.
6084+187.14 EFFECTIVE DATE.This section is effective January 1, 2024, and applies to crimes
6085+187.15committed on or after that date.
6086+187.16Sec. 20. [152.0265] CANNABIS CULTIVATION CRIMES.
6087+187.17 Subdivision 1.Cultivation of cannabis in the first degree.A person is guilty of
6088+187.18cultivation of cannabis in the first degree and may be sentenced to imprisonment of not
6089+187.19more than five years or to payment of a fine of not more than $10,000, or both, if the person​
6090+187.20unlawfully cultivates more than 23 cannabis plants.
6091+187.21 Subd. 2.Cultivation of cannabis in the second degree.A person is guilty of cultivation
6092+187.22of cannabis in the second degree and may be sentenced to imprisonment of not more than
6093+187.23one year or to payment of a fine of not more than $3,000, or both, if the person unlawfully
6094+187.24cultivates more than 16 cannabis plants but not more than 23 cannabis plants.​
60906095 187.25 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
60916096 187.26committed on or after that date.​
6092-187.27Sec. 15. Minnesota Statutes 2022, section 152.023, subdivision 2, is amended to read:​
6093-187.28 Subd. 2.Possession crimes.(a) A person is guilty of controlled substance crime in the​
6094-187.29third degree if:​
6095-187​Article 4 Sec. 15.​
6096-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 188.1 (1) on one or more occasions within a 90-day period the person unlawfully possesses​
6097-188.2one or more mixtures of a total weight of ten grams or more containing a narcotic drug other​
6098-188.3than heroin;​
6099-188.4 (2) on one or more occasions within a 90-day period the person unlawfully possesses​
6100-188.5one or more mixtures of a total weight of three grams or more containing heroin;​
6101-188.6 (3) on one or more occasions within a 90-day period the person unlawfully possesses​
6102-188.7one or more mixtures containing a narcotic drug, it is packaged in dosage units, and equals​
6103-188.850 or more dosage units;​
6104-188.9 (4) on one or more occasions within a 90-day period the person unlawfully possesses​
6105-188.10any amount of a schedule I or II narcotic drug or five or more dosage units of lysergic acid​
6106-188.11diethylamide (LSD), 3,4-methylenedioxy amphetamine, or​
6107-188.123,4-methylenedioxymethamphetamine in a school zone, a park zone, a public housing zone,​
6108-188.13or a drug treatment facility;​
6109-188.14 (5) on one or more occasions within a 90-day period the person unlawfully possesses​
6110-188.15one or more mixtures of a total weight of ten kilograms or more containing marijuana or​
6111-188.16Tetrahydrocannabinols:​
6112-188.17 (i) more than ten kilograms of cannabis flower;​
6113-188.18 (ii) more than two kilograms of cannabis concentrate; or​
6114-188.19 (iii) edible cannabis products, lower-potency hemp edibles, hemp-derived consumer​
6115-188.20products, or any combination of those infused with more than 200 grams of​
6116-188.21tetrahydrocannabinol; or​
6117-188.22 (6) the person unlawfully possesses one or more mixtures containing methamphetamine​
6118-188.23or amphetamine in a school zone, a park zone, a public housing zone, or a drug treatment​
6119-188.24facility.​
6120-188.25 (b) For the purposes of this subdivision, the weight of fluid used in a water pipe may​
6121-188.26not be considered in measuring the weight of a mixture except in cases where the mixture​
6122-188.27contains four or more fluid ounces of fluid.​
6123-188.28 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6124-188.29committed on or after that date.​
6125-188.30Sec. 16. Minnesota Statutes 2022, section 152.024, subdivision 1, is amended to read:​
6126-188.31 Subdivision 1.Sale crimes.A person is guilty of controlled substance crime in the fourth​
6127-188.32degree if:​
6128-188​Article 4 Sec. 16.​
6129-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 189.1 (1) the person unlawfully sells one or more mixtures containing a controlled substance​
6130-189.2classified in Schedule I, II, or III, except marijuana or Tetrahydrocannabinols;​
6131-189.3 (2) the person unlawfully sells one or more mixtures containing a controlled substance​
6132-189.4classified in Schedule IV or V to a person under the age of 18; or​
6133-189.5 (3) the person conspires with or employs a person under the age of 18 to unlawfully sell​
6134-189.6a controlled substance classified in Schedule IV or V; or.​
6135-189.7 (4) the person unlawfully sells any amount of marijuana or Tetrahydrocannabinols in a​
6136-189.8school zone, a park zone, a public housing zone, or a drug treatment facility, except a small​
6137-189.9amount for no remuneration.​
6138-189.10 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6139-189.11committed on or after that date.​
6140-189.12Sec. 17. Minnesota Statutes 2022, section 152.025, subdivision 1, is amended to read:​
6141-189.13 Subdivision 1.Sale crimes.A person is guilty of a controlled substance crime in the​
6142-189.14fifth degree and upon conviction may be sentenced as provided in subdivision 4 if:​
6143-189.15 (1) the person unlawfully sells one or more mixtures containing marijuana or​
6144-189.16tetrahydrocannabinols, except a small amount of marijuana for no remuneration; or​
6145-189.17 (2) the person unlawfully sells one or more mixtures containing a controlled substance​
6146-189.18classified in Schedule IV.​
6147-189.19 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6148-189.20committed on or after that date.​
6149-189.21Sec. 18. Minnesota Statutes 2022, section 152.025, subdivision 2, is amended to read:​
6150-189.22 Subd. 2.Possession and other crimes.A person is guilty of controlled substance crime​
6151-189.23in the fifth degree and upon conviction may be sentenced as provided in subdivision 4 if:​
6152-189.24 (1) the person unlawfully possesses one or more mixtures containing a controlled​
6153-189.25substance classified in Schedule I, II, III, or IV, except a small amount of marijuana cannabis​
6154-189.26flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products;​
6155-189.27or​
6156-189.28 (2) the person procures, attempts to procure, possesses, or has control over a controlled​
6157-189.29substance by any of the following means:​
6158-189.30 (i) fraud, deceit, misrepresentation, or subterfuge;​
6159-189​Article 4 Sec. 18.​
6160-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 190.1 (ii) using a false name or giving false credit; or​
6161-190.2 (iii) falsely assuming the title of, or falsely representing any person to be, a manufacturer,​
6162-190.3wholesaler, pharmacist, physician, doctor of osteopathic medicine licensed to practice​
6163-190.4medicine, dentist, podiatrist, veterinarian, or other authorized person for the purpose of​
6164-190.5obtaining a controlled substance.​
6165-190.6 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6166-190.7committed on or after that date.​
6167-190.8Sec. 19. [152.0263] CANNABIS POSSESSION CRIMES.​
6168-190.9 Subdivision 1.Possession of cannabis in the first degree.A person is guilty of cannabis​
6169-190.10possession in the first degree and may be sentenced to imprisonment for not more than five​
6170-190.11years or to payment of a fine of not more than $10,000, or both, if the person unlawfully​
6171-190.12possesses any of the following:​
6172-190.13 (1) more than two pounds but not more than ten kilograms of cannabis flower;​
6173-190.14 (2) more than 160 grams but not more than two kilograms of cannabis concentrate; or​
6174-190.15 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
6175-190.16products infused with more than 16 grams but not more than 200 grams of​
6176-190.17tetrahydrocannabinol.​
6177-190.18 Subd. 2.Possession of cannabis in the second degree.A person is guilty of cannabis​
6178-190.19possession in the second degree and may be sentenced to imprisonment for not more than​
6179-190.20one year or to payment of a fine of not more than $3,000, or both, if the person unlawfully​
6180-190.21possesses any of the following:​
6181-190.22 (1) more than one pound but not more than two pounds of cannabis flower in any place​
6182-190.23other than the person's residence;​
6183-190.24 (2) more than 80 grams but not more than 160 grams of cannabis concentrate; or​
6184-190.25 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
6185-190.26products infused with more than eight grams but not more than 16 grams of​
6186-190.27tetrahydrocannabinol.​
6187-190.28 Subd. 3.Possession of cannabis in the third degree.A person is guilty of cannabis​
6188-190.29possession in the third degree and may be sentenced to imprisonment for not more than 90​
6189-190.30days or to payment of a fine of not more than $1,000, or both, if the person unlawfully​
6190-190.31possesses any of the following:​
6191-190​Article 4 Sec. 19.​
6192-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 191.1 (1) more than four ounces but not more than one pound of cannabis flower in any place​
6193-191.2other than the person's residence;​
6194-191.3 (2) more than 16 grams but not more than 80 grams of cannabis concentrate; or​
6195-191.4 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
6196-191.5products infused with more than 1,600 milligrams but not more than eight grams of​
6197-191.6tetrahydrocannabinol.​
6198-191.7 Subd. 4.Possession of cannabis in the fourth degree.A person is guilty of a petty​
6199-191.8misdemeanor if the person unlawfully possesses any of the following:​
6200-191.9 (1) more than two ounces but not more than four ounces of cannabis flower in any place​
6201-191.10other than the person's residence;​
6202-191.11 (2) more than eight grams but not more than 16 grams of cannabis concentrate; or​
6203-191.12 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
6204-191.13products infused with more than 800 milligrams but not more than 1,600 milligrams of​
6205-191.14tetrahydrocannabinol.​
6206-191.15 Subd. 5.Use of cannabis in public.A local unit of government may adopt an ordinance​
6207-191.16establishing a petty misdemeanor offense for a person who unlawfully uses cannabis flower,​
6208-191.17cannabis products, lower-potency hemp edibles, or hemp-derived consumer products in a​
6209-191.18public place provided that the definition of public place does not include the following:​
6210-191.19 (1) a private residence, including the person's curtilage or yard;​
6211-191.20 (2) private property not generally accessible by the public, unless the person is explicitly​
6212-191.21prohibited from consuming cannabis flower, cannabis products, lower-potency hemp edibles,​
6213-191.22or hemp-derived consumer products on the property by the owner of the property; or​
6214-191.23 (3) the premises of an establishment or event licensed to permit on-site consumption.​
6215-191.24 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6216-191.25committed on or after that date.​
6217-191.26Sec. 20. [152.0264] CANNABIS SALE CRIMES.​
6218-191.27 Subdivision 1.Sale of cannabis in the first degree.An adult is guilty of the sale of​
6219-191.28cannabis in the first degree and may be sentenced to imprisonment for not more than five​
6220-191.29years or to payment of a fine of not more than $10,000, or both, if the adult unlawfully sells​
6221-191.30more than two ounces of cannabis flower; more than eight grams of cannabis concentrate;​
6222-191​Article 4 Sec. 20.​
6223-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 192.1or edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
6224-192.2products infused with more than 800 milligrams of tetrahydrocannabinol:​
6225-192.3 (1) to a minor and the defendant is more than 36 months older than the minor;​
6226-192.4 (2) within ten years of two or more convictions under subdivision 2 or 3; or​
6227-192.5 (3) within ten years of a conviction under this subdivision.​
6228-192.6 Subd. 2.Sale of cannabis in the second degree.An adult is guilty of sale of cannabis​
6229-192.7in the second degree and may be sentenced to imprisonment for not more than one year or​
6230-192.8to payment of a fine of not more than $3,000, or both, if the adult:​
6231-192.9 (1) unlawfully sells more than two ounces of cannabis flower; more than eight grams​
6232-192.10of cannabis concentrate; or edible cannabis products, lower-potency hemp edibles, or​
6233-192.11hemp-derived consumer products infused with more than 800 milligrams of​
6234-192.12tetrahydrocannabinol:​
6235-192.13 (i) in a school zone, a park zone, or a drug treatment facility; or​
6236-192.14 (ii) within ten years of a conviction under subdivision 1, 2, or 3; or​
6237-192.15 (2) unlawfully sells cannabis flower, cannabis concentrate, edible cannabis products,​
6238-192.16lower-potency hemp edibles, or hemp-derived consumer products to a minor.​
6239-192.17 Subd. 3.Sale of cannabis in the third degree.An adult is guilty of sale of cannabis in​
6240-192.18the third degree and may be sentenced to imprisonment for not more than 90 days or to​
6241-192.19payment of a fine of not more than $1,000, or both, if the adult unlawfully sells:​
6242-192.20 (1) more than two ounces of cannabis flower;​
6243-192.21 (2) more than eight grams of cannabis concentrate; or​
6244-192.22 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
6245-192.23products infused with more than 800 milligrams of tetrahydrocannabinol.​
6246-192.24 Subd. 4.Sale of cannabis in the fourth degree.(a) An adult is guilty of a petty​
6247-192.25misdemeanor if the adult unlawfully sells:​
6248-192.26 (1) not more than two ounces of cannabis flower;​
6249-192.27 (2) not more than eight grams of cannabis concentrate; or​
6250-192.28 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
6251-192.29products infused with not more than 800 milligrams of tetrahydrocannabinol.​
6252-192​Article 4 Sec. 20.​
6253-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 193.1 (b) A sale for no remuneration by an individual over the age of 21 to another individual​
6254-193.2over the age of 21 is not an unlawful sale under this subdivision.​
6255-193.3 Subd. 5.Sale of cannabis by a minor.(a) A minor is guilty of a petty misdemeanor if​
6256-193.4the minor unlawfully sells:​
6257-193.5 (1) not more than two ounces of cannabis flower;​
6258-193.6 (2) not more than eight grams of cannabis concentrate; or​
6259-193.7 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
6260-193.8products infused with not more than 800 milligrams of tetrahydrocannabinol.​
6261-193.9 (b) A minor is guilty of a misdemeanor if the minor unlawfully sells:​
6262-193.10 (1) more than two ounces of cannabis flower;​
6263-193.11 (2) more than eight grams of cannabis concentrate; or​
6264-193.12 (3) edible cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
6265-193.13products infused with more than 800 milligrams of tetrahydrocannabinol.​
6266-193.14 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6267-193.15committed on or after that date.​
6268-193.16Sec. 21. [152.0265] CANNABIS CULTIVATION CRIMES.​
6269-193.17 Subdivision 1.Cultivation of cannabis in the first degree.A person is guilty of​
6270-193.18cultivation of cannabis in the first degree and may be sentenced to imprisonment for not​
6271-193.19more than five years or to payment of a fine of not more than $10,000, or both, if the person​
6272-193.20unlawfully cultivates more than 23 cannabis plants.​
6273-193.21 Subd. 2.Cultivation of cannabis in the second degree.A person is guilty of cultivation​
6274-193.22of cannabis in the second degree and may be sentenced to imprisonment for not more than​
6275-193.23one year or to payment of a fine of not more than $3,000, or both, if the person unlawfully​
6276-193.24cultivates more than 16 cannabis plants but not more than 23 cannabis plants.​
6277-193.25 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6278-193.26committed on or after that date.​
6279-193.27Sec. 22. Minnesota Statutes 2022, section 152.11, subdivision 2, is amended to read:​
6280-193.28 Subd. 2. Prescription requirements for Schedule III or IV controlled substances.(a)​
6281-193.29Except as provided in paragraph (b), no person may dispense a controlled substance included​
6282-193.30in Schedule III or IV of section 152.02 without a prescription issued, as permitted under​
6283-193​Article 4 Sec. 22.​
6284-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 194.1subdivision 1, by a doctor of medicine, a doctor of osteopathic medicine licensed to practice​
6285-194.2medicine, a doctor of dental surgery, a doctor of dental medicine, a doctor of podiatry, a​
6286-194.3doctor of optometry limited to Schedule IV, or a doctor of veterinary medicine, lawfully​
6287-194.4licensed to prescribe in this state or from a practitioner licensed to prescribe controlled​
6288-194.5substances by the state in which the prescription is issued, and having a current federal drug​
6289-194.6enforcement administration registration number. Such prescription may not be dispensed​
6290-194.7or refilled except with the documented consent of the prescriber, and in no event more than​
6291-194.8six months after the date on which such prescription was issued and no such prescription​
6292-194.9may be refilled more than five times.​
6293-194.10 (b) This subdivision does not apply to cannabis plants, cannabis flower, cannabis products,​
6294-194.11or hemp-derived consumer products sold or transferred in compliance with chapter 342.​
6295-194.12Sec. 23. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6296-194.13to read:​
6297-194.14 Subd. 3a.Artificially derived cannabinoid."Artificially derived cannabinoid" has the​
6298-194.15meaning given in section 342.01, subdivision 6.​
6299-194.16Sec. 24. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6300-194.17to read:​
6301-194.18 Subd. 3b.Cannabis flower."Cannabis flower" has the meaning given in section 342.01,​
6302-194.19subdivision 16.​
6303-194.20Sec. 25. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6304-194.21to read:​
6305-194.22 Subd. 3c.Cannabis product."Cannabis product" has the meaning given in section​
6306-194.23342.01, subdivision 20.​
6307-194.24Sec. 26. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6308-194.25to read:​
6309-194.26 Subd. 10a.Hemp-derived consumer product."Hemp-derived consumer product" has​
6310-194.27the meaning given in section 342.01, subdivision 37.​
6311-194​Article 4 Sec. 26.​
6312-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 195.1Sec. 27. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6313-195.2to read:​
6314-195.3 Subd. 11b.Lower-potency hemp edible."Lower-potency hemp edible" has the meaning​
6315-195.4given in section 342.01, subdivision 50.​
6316-195.5Sec. 28. Minnesota Statutes 2022, section 169A.20, subdivision 1, is amended to read:​
6317-195.6 Subdivision 1.Driving while impaired crime; motor vehicle.It is a crime for any​
6318-195.7person to drive, operate, or be in physical control of any motor vehicle, as defined in section​
6319-195.8169A.03, subdivision 15, within this state or on any boundary water of this state when:​
6320-195.9 (1) the person is under the influence of alcohol;​
6321-195.10 (2) the person is under the influence of a controlled substance;​
6322-195.11 (3) the person is under the influence of an intoxicating substance and the person knows​
6323-195.12or has reason to know that the substance has the capacity to cause impairment;​
6324-195.13 (4) the person is under the influence of a combination of any two or more of the elements​
6325-195.14named in clauses (1) to (3) or (8);​
6326-195.15 (5) the person's alcohol concentration at the time, or as measured within two hours of​
6327-195.16the time, of driving, operating, or being in physical control of the motor vehicle is 0.08 or​
6328-195.17more;​
6329-195.18 (6) the vehicle is a commercial motor vehicle and the person's alcohol concentration at​
6330-195.19the time, or as measured within two hours of the time, of driving, operating, or being in​
6331-195.20physical control of the commercial motor vehicle is 0.04 or more; or​
6332-195.21 (7) the person's body contains any amount of a controlled substance listed in Schedule​
6333-195.22I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6334-195.23lower-potency hemp edible, a hemp-derived consumer product, an artificially derived​
6335-195.24cannabinoid, or tetrahydrocannabinols; or​
6336-195.25 (8) the person is under the influence of cannabis flower, a cannabis product, a​
6337-195.26lower-potency hemp edible, a hemp-derived consumer product, an artificially derived​
6338-195.27cannabinoid, or tetrahydrocannabinols.​
6339-195.28 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6340-195.29committed on or after that date.​
6341-195​Article 4 Sec. 28.​
6342-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 196.1Sec. 29. Minnesota Statutes 2022, section 169A.31, subdivision 1, is amended to read:​
6343-196.2 Subdivision 1.Crime described.It is a crime for any person to drive, operate, or be in​
6344-196.3physical control of any class of school bus or Head Start bus within this state when there is​
6345-196.4physical evidence present in the person's body of the consumption of any alcohol, cannabis​
6346-196.5flower, a cannabis product, an artificially derived cannabinoid, or tetrahydrocannabinols.​
6347-196.6 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6348-196.7committed on or after that date.​
6349-196.8Sec. 30. [169A.36] OPEN PACKAGE LAW.​
6350-196.9 Subdivision 1.Definitions.As used in this section:​
6351-196.10 (1) "motor vehicle" does not include motorboats in operation or off-road recreational​
6352-196.11vehicles except while operated on a roadway or shoulder of a roadway that is not part of a​
6353-196.12grant-in-aid trail or trail designated for that vehicle by the commissioner of natural resources;​
6354-196.13and​
6355-196.14 (2) "possession" means either that the person had actual possession of the package or​
6356-196.15that the person consciously exercised dominion and control over the package.​
6357-196.16 Subd. 2.Use; crime described.It is a crime for a person to use cannabis flower, a​
6358-196.17cannabis product, a lower-potency hemp edible, a hemp-derived consumer product, or any​
6359-196.18other product containing an artificially derived cannabinoid in a motor vehicle when the​
6360-196.19vehicle is on a street or highway.​
6361-196.20 Subd. 3.Possession; crime described.It is a crime for a person to have in possession,​
6362-196.21while in a private motor vehicle on a street or highway, any cannabis flower, a cannabis​
6363-196.22product, a lower-potency hemp edible, a hemp-derived consumer product, or any other​
6364-196.23product containing an artificially derived cannabinoid that:​
6365-196.24 (1) is in packaging or another container that does not comply with the relevant packaging​
6366-196.25requirements in chapter 152 or 342;​
6367-196.26 (2) has been removed from the packaging in which it was sold;​
6368-196.27 (3) is in packaging that has been opened or the seal has been broken; or​
6369-196.28 (4) is in packaging of which the contents have been partially removed.​
6370-196.29 Subd. 4.Liability of nonpresent owner; crime described.It is a crime for the owner​
6371-196.30of any private motor vehicle or the driver, if the owner is not present in the motor vehicle,​
6372-196.31to keep or allow to be kept in a motor vehicle when the vehicle is on a street or highway​
6373-196​Article 4 Sec. 30.​
6374-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 197.1any cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6375-197.2consumer product, or any other product containing an artificially derived cannabinoid that:​
6376-197.3 (1) is in packaging or another container that does not comply with the relevant packaging​
6377-197.4requirements in chapter 152 or 342;​
6378-197.5 (2) has been removed from the packaging in which it was sold;​
6379-197.6 (3) is in packaging that has been opened or the seal has been broken; or​
6380-197.7 (4) is in packaging of which the contents have been partially removed.​
6381-197.8 Subd. 5.Criminal penalty.A person who violates subdivision 2, 3, or 4 is guilty of a​
6382-197.9misdemeanor.​
6383-197.10 Subd. 6.Exceptions.(a) This section does not prohibit the possession or consumption​
6384-197.11of cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6385-197.12consumer product, or any other product containing an artificially derived cannabinoid by​
6386-197.13passengers in:​
6387-197.14 (1) a bus that is operated by a motor carrier of passengers as defined in section 221.012,​
6388-197.15subdivision 26;​
6389-197.16 (2) a vehicle that is operated for commercial purposes in a manner similar to a bicycle​
6390-197.17as defined in section 169.011, subdivision 4, with five or more passengers who provide​
6391-197.18pedal power to the drive train of the vehicle; or​
6392-197.19 (3) a vehicle providing limousine service as defined in section 221.84, subdivision 1.​
6393-197.20 (b) Subdivisions 3 and 4 do not apply to: (1) a package that is in the trunk of the vehicle​
6394-197.21if the vehicle is equipped with a trunk; or (2) a package that is in another area of the vehicle​
6395-197.22not normally occupied by the driver and passengers if the vehicle is not equipped with a​
6396-197.23trunk. A utility compartment or glove compartment is deemed to be within the area occupied​
6397-197.24by the driver and passengers.​
6398-197.25 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6399-197.26committed on or after that date.​
6400-197.27Sec. 31. Minnesota Statutes 2022, section 169A.51, subdivision 1, is amended to read:​
6401-197.28 Subdivision 1.Implied consent; conditions; election of test.(a) Any person who drives,​
6402-197.29operates, or is in physical control of a motor vehicle within this state or on any boundary​
6403-197.30water of this state consents, subject to the provisions of sections 169A.50 to 169A.53 (implied​
6404-197.31consent law), and section 169A.20 (driving while impaired), to a chemical test of that​
6405-197​Article 4 Sec. 31.​
6406-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 198.1person's blood, breath, or urine for the purpose of determining the presence of alcohol,; a​
6407-198.2controlled substance or its metabolite,; cannabis flower, a cannabis product, a lower-potency​
6408-198.3hemp edible, a hemp-derived consumer product, artificially derived cannabinoids, or​
6409-198.4tetrahydrocannabinols; or an intoxicating substance. The test must be administered at the​
6410-198.5direction of a peace officer.​
6411-198.6 (b) The test may be required of a person when an officer has probable cause to believe​
6412-198.7the person was driving, operating, or in physical control of a motor vehicle in violation of​
6413-198.8section 169A.20 (driving while impaired), and one of the following conditions exist:​
6414-198.9 (1) the person has been lawfully placed under arrest for violation of section 169A.20 or​
6415-198.10an ordinance in conformity with it;​
6416-198.11 (2) the person has been involved in a motor vehicle accident or collision resulting in​
6417-198.12property damage, personal injury, or death;​
6418-198.13 (3) the person has refused to take the screening test provided for by section 169A.41​
6419-198.14(preliminary screening test); or​
6420-198.15 (4) the screening test was administered and indicated an alcohol concentration of 0.08​
6421-198.16or more.​
6422-198.17 (c) The test may also be required of a person when an officer has probable cause to​
6423-198.18believe the person was driving, operating, or in physical control of a commercial motor​
6424-198.19vehicle with the presence of any alcohol.​
6425-198.20Sec. 32. Minnesota Statutes 2022, section 169A.51, subdivision 4, is amended to read:​
6426-198.21 Subd. 4.Requirement of urine or blood test.A blood or urine test may be required​
6427-198.22pursuant to a search warrant under sections 626.04 to 626.18 even after a breath test has​
6428-198.23been administered if there is probable cause to believe that:​
6429-198.24 (1) there is impairment by a controlled substance or; an intoxicating substance; or​
6430-198.25cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived consumer​
6431-198.26product, artificially derived cannabinoids, or tetrahydrocannabinols that is not subject to​
6432-198.27testing by a breath test;​
6433-198.28 (2) a controlled substance listed in Schedule I or II or its metabolite, other than marijuana​
6434-198.29cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived consumer​
6435-198.30product, artificially derived cannabinoids, or tetrahydrocannabinols, is present in the person's​
6436-198.31body; or​
6437-198​Article 4 Sec. 32.​
6438-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 199.1 (3) the person is unconscious or incapacitated to the point that the peace officer providing​
6439-199.2a breath test advisory, administering a breath test, or serving the search warrant has a​
6440-199.3good-faith belief that the person is mentally or physically unable to comprehend the breath​
6441-199.4test advisory or otherwise voluntarily submit to chemical tests.​
6442-199.5 Action may be taken against a person who refuses to take a blood test under this​
6443-199.6subdivision only if a urine test was offered and action may be taken against a person who​
6444-199.7refuses to take a urine test only if a blood test was offered. This limitation does not apply​
6445-199.8to an unconscious person under the circumstances described in clause (3).​
6446-199.9Sec. 33. Minnesota Statutes 2022, section 169A.72, is amended to read:​
6447-199.10 169A.72 DRIVER EDUCATION PROGRAMS.​
6448-199.11 Driver training courses offered through the public schools and driver training courses​
6449-199.12offered by private or commercial schools or institutes shall include instruction which must​
6450-199.13encompass at least:​
6451-199.14 (1) information on the effects of consumption of beverage alcohol products and the use​
6452-199.15of illegal drugs, cannabis flower, cannabis products, lower-potency hemp edibles,​
6453-199.16hemp-derived consumer products, artificially derived cannabinoids, tetrahydrocannabinol​
6454-199.17derived from any source, prescription drugs, and nonprescription drugs on the ability of a​
6455-199.18person to operate a motor vehicle;​
6456-199.19 (2) the hazards of driving while under the influence of alcohol, a controlled substance,​
6457-199.20or drugs an intoxicating substance; and​
6458-199.21 (3) the legal penalties and financial consequences resulting from violations of laws​
6459-199.22prohibiting the operation of a motor vehicle while under the influence of alcohol, a controlled​
6460-199.23substance, or drugs an intoxicating substance.​
6461-199.24Sec. 34. Minnesota Statutes 2022, section 244.05, subdivision 2, is amended to read:​
6462-199.25 Subd. 2.Rules.(a) The commissioner of corrections shall adopt by rule standards and​
6463-199.26procedures for the establishment of conditions of release and the revocation of supervised​
6464-199.27or conditional release, and shall specify the period of revocation for each violation of release.​
6465-199.28Procedures for the revocation of release shall provide due process of law for the inmate.​
6466-199.29 (b) The commissioner may prohibit an inmate placed on parole, supervised release, or​
6467-199.30conditional release from using adult-use cannabis flower as defined in section 342.01,​
6468-199.31subdivision 3, or adult-use cannabis products as defined in section 342.01, subdivision 3,​
6469-199.32hemp-derived consumer products as defined in section 342.01, subdivision 35, or​
6470-199​Article 4 Sec. 34.​
6471-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 200.1lower-potency hemp edibles as defined in section 342.01, subdivision 48, if the inmate​
6472-200.2undergoes a chemical use assessment and abstinence is consistent with a recommended​
6473-200.3level of care for the defendant in accordance with the criteria under section 254B.04,​
6474-200.4subdivision 4.​
6475-200.5 (c) The commissioner of corrections shall not prohibit an inmate placed on parole,​
6476-200.6supervised release, or conditional release from participating in the registry program as​
6477-200.7defined in section 342.01, subdivision 61, as a condition of release or revoke a patient's​
6478-200.8parole, supervised release, or conditional release or otherwise sanction a patient on parole,​
6479-200.9supervised release, or conditional release solely for participating in the registry program or​
6480-200.10for a positive drug test for cannabis components or metabolites.​
6481-200.11 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to supervised​
6482-200.12release granted on or after that date.​
6483-200.13Sec. 35. Minnesota Statutes 2022, section 192A.555, is amended to read:​
6484-200.14 192A.555 DRIVING WHILE UNDER THE INFLUENCE OR RECKLESS​
6485-200.15DRIVING.​
6486-200.16 Any person subject to this code who drives, operates or is in physical control of any​
6487-200.17motor vehicle or aircraft while under the influence of an alcoholic beverage or; controlled​
6488-200.18substance; cannabis flower, cannabis product, lower-potency hemp edible, hemp-derived​
6489-200.19consumer product, artificially derived cannabinoid, or tetrahydrocannabinols, as those terms​
6490-200.20are defined in section 342.01, or a combination thereof or whose blood contains 0.08 percent​
6491-200.21or more by weight of alcohol or who operates said motor vehicle or aircraft in a reckless or​
6492-200.22wanton manner, shall be punished as a court-martial may direct.​
6493-200.23 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6494-200.24committed on or after that date.​
6495-200.25Sec. 36. Minnesota Statutes 2022, section 360.0752, subdivision 2, is amended to read:​
6496-200.26 Subd. 2.Crime; acts prohibited.(a) It is a crime for any person to operate or attempt​
6497-200.27to operate an aircraft on or over land or water within this state or over any boundary water​
6498-200.28of this state under any of the following conditions:​
6499-200.29 (1) when the person is under the influence of alcohol;​
6500-200.30 (2) when the person is under the influence of a controlled substance;​
6501-200​Article 4 Sec. 36.​
6502-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 201.1 (3) when the person is under the influence of a combination of any two or more of the​
6503-201.2elements named in clauses (1), (2), and (6), and (9);​
6504-201.3 (4) when the person's alcohol concentration is 0.04 or more;​
6505-201.4 (5) when the person's alcohol concentration as measured within two hours of the time​
6506-201.5of operation or attempted operation is 0.04 or more;​
6507-201.6 (6) when the person is under the influence of an intoxicating substance and the person​
6508-201.7knows or has reason to know that the substance has the capacity to cause impairment;​
6509-201.8 (7) when the person's body contains any amount of a controlled substance listed in​
6510-201.9Schedule I or II, other than marijuana or tetrahydrocannabinols; or​
6511-201.10 (8) within eight hours of having consumed any alcoholic beverage or used any controlled​
6512-201.11substance; or​
6513-201.12 (9) when the person is under the influence of cannabis flower, a cannabis product, a​
6514-201.13lower-potency hemp edible, a hemp-derived consumer product, an artificially derived​
6515-201.14cannabinoid, or tetrahydrocannabinols, as those terms are defined in section 342.01.​
6516-201.15 (b) If proven by a preponderance of the evidence, it shall be an affirmative defense to a​
6517-201.16violation of paragraph (a), clause (7), that the defendant used the controlled substance​
6518-201.17according to the terms of a prescription issued for the defendant in accordance with sections​
6519-201.18152.11 and 152.12.​
6520-201.19 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6521-201.20committed on or after that date.​
6522-201.21Sec. 37. Minnesota Statutes 2022, section 609.135, subdivision 1, is amended to read:​
6523-201.22 Subdivision 1.Terms and conditions.(a) Except when a sentence of life imprisonment​
6524-201.23is required by law, or when a mandatory minimum sentence is required by section 609.11,​
6525-201.24any court may stay imposition or execution of sentence and:​
6526-201.25 (1) may order intermediate sanctions without placing the defendant on probation; or​
6527-201.26 (2) may place the defendant on probation with or without supervision and on the terms​
6528-201.27the court prescribes, including intermediate sanctions when practicable. The court may order​
6529-201.28the supervision to be under the probation officer of the court, or, if there is none and the​
6530-201.29conviction is for a felony or gross misdemeanor, by the commissioner of corrections, or in​
6531-201.30any case by some other suitable and consenting person. Unless the court directs otherwise,​
6532-201.31state parole and probation agents and probation officers may impose community work​
6533-201​Article 4 Sec. 37.​
6534-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 202.1service or probation violation sanctions, consistent with section 243.05, subdivision 1;​
6535-202.2sections 244.196 to 244.199; or 401.02, subdivision 5.​
6536-202.3 No intermediate sanction may be ordered performed at a location that fails to observe​
6537-202.4applicable requirements or standards of chapter 181A or 182, or any rule promulgated under​
6538-202.5them.​
6539-202.6 (b) For purposes of this subdivision, subdivision 6, and section 609.14, the term​
6540-202.7"intermediate sanctions" includes but is not limited to incarceration in a local jail or​
6541-202.8workhouse, home detention, electronic monitoring, intensive probation, sentencing to service,​
6542-202.9reporting to a day reporting center, chemical dependency or mental health treatment or​
6543-202.10counseling, restitution, fines, day-fines, community work service, work service in a restorative​
6544-202.11justice program, work in lieu of or to work off fines and, with the victim's consent, work in​
6545-202.12lieu of or to work off restitution.​
6546-202.13 (c) A court may not stay the revocation of the driver's license of a person convicted of​
6547-202.14violating the provisions of section 169A.20.​
6548-202.15 (d) If the court orders a fine, day-fine, or restitution as an intermediate sanction, payment​
6549-202.16is due on the date imposed unless the court otherwise establishes a due date or a payment​
6550-202.17plan.​
6551-202.18 (e) The court may prohibit a defendant from using adult-use cannabis flower as defined​
6552-202.19in section 342.01, subdivision 4, or adult-use cannabis products as defined in section 342.01,​
6553-202.20subdivision 2, if the defendant undergoes a chemical use assessment and abstinence is​
6554-202.21consistent with a recommended level of care for the defendant in accordance with the criteria​
6555-202.22under section 254B.04, subdivision 4. The assessment must be conducted by an assessor​
6556-202.23qualified under section 245G.11, subdivisions 1 and 5.​
6557-202.24 (f) A court shall not impose an intermediate sanction that has the effect of prohibiting​
6558-202.25a person from participating in the registry program as defined in section 342.01, subdivision​
6559-202.2663.​
6560-202.27 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to sentences​
6561-202.28ordered on or after that date.​
6562-202.29Sec. 38. Minnesota Statutes 2022, section 609.2111, is amended to read:​
6563-202.30 609.2111 DEFINITIONS.​
6564-202.31 (a) For purposes of sections 609.2111 to 609.2114, the terms defined in this subdivision​
6565-202.32have the meanings given them.​
6566-202​Article 4 Sec. 38.​
6567-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 203.1 (b) "Motor vehicle" has the meaning given in section 609.52, subdivision 1, and includes​
6568-203.2attached trailers.​
6569-203.3 (c) "Controlled substance" has the meaning given in section 152.01, subdivision 4.​
6570-203.4 (d) "Intoxicating substance" has the meaning given in section 169A.03, subdivision 11a.​
6571-203.5 (e) "Qualified prior driving offense" includes a prior conviction:​
6572-203.6 (1) for a violation of section 169A.20 under the circumstances described in section​
6573-203.7169A.24 or 169A.25;​
6574-203.8 (2) under section 609.2112, subdivision 1, paragraph (a), clauses (2) to (6); 609.2113,​
6575-203.9subdivision 1, clauses (2) to (6); 2, clauses (2) to (6); or 3, clauses (2) to (6); or 609.2114,​
6576-203.10subdivision 1, paragraph (a), clauses (2) to (6); or 2, clauses (2) to (6);​
6577-203.11 (3) under Minnesota Statutes 2012, section 609.21, subdivision 1, clauses (2) to (6); or​
6578-203.12 (4) under Minnesota Statutes 2006, section 609.21, subdivision 1, clauses (2) to (6); 2,​
6579-203.13clauses (2) to (6); 2a, clauses (2) to (6); 2b, clauses (2) to (6); 3, clauses (2) to (6); or 4,​
6580-203.14clauses (2) to (6).​
6581-203.15 (f) "Artificially derived cannabinoid" has the meaning given in section 342.01, subdivision​
6582-203.166.​
6583-203.17 (g) "Cannabis flower" has the meaning given in section 342.01, subdivision 16.​
6584-203.18 (h) "Cannabis product" has the meaning given in section 342.01, subdivision 20.​
6585-203.19 (i) "Hemp-derived consumer product" has the meaning given in section 342.01,​
6586-203.20subdivision 37.​
6587-203.21 (j) "Lower-potency hemp edible" has the meaning given in section 342.01, subdivision​
6588-203.2250.​
6589-203.23 EFFECTIVE DATE.This section is effective August 1, 2023.​
6590-203.24Sec. 39. Minnesota Statutes 2022, section 609.2112, subdivision 1, is amended to read:​
6591-203.25 Subdivision 1.Criminal vehicular homicide.(a) Except as provided in paragraph (b),​
6592-203.26a person is guilty of criminal vehicular homicide and may be sentenced to imprisonment​
6593-203.27for not more than ten years or to payment of a fine of not more than $20,000, or both, if the​
6594-203.28person causes the death of a human being not constituting murder or manslaughter as a​
6595-203.29result of operating a motor vehicle:​
6596-203.30 (1) in a grossly negligent manner;​
6597-203​Article 4 Sec. 39.​
6598-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 204.1 (2) in a negligent manner while under the influence of:​
6599-204.2 (i) alcohol;​
6600-204.3 (ii) a controlled substance; or​
6601-204.4 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6602-204.5consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6603-204.6 (iii) (iv) any combination of those elements;​
6604-204.7 (3) while having an alcohol concentration of 0.08 or more;​
6605-204.8 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6606-204.9of the time of driving;​
6607-204.10 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6608-204.11person knows or has reason to know that the substance has the capacity to cause impairment;​
6609-204.12 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6610-204.13I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6611-204.14lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6612-204.15cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6613-204.16 (7) where the driver who causes the collision leaves the scene of the collision in violation​
6614-204.17of section 169.09, subdivision 1 or 6; or​
6615-204.18 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6616-204.19citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6617-204.20knowledge that remedial action was not taken, the driver had reason to know that the defect​
6618-204.21created a present danger to others, and the death was caused by the defective maintenance.​
6619-204.22 (b) If a person is sentenced under paragraph (a) for a violation under paragraph (a),​
6620-204.23clauses (2) to (6), occurring within ten years of a qualified prior driving offense, the statutory​
6621-204.24maximum sentence of imprisonment is 15 years.​
6622-204.25 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6623-204.26committed on or after that date.​
6624-204.27Sec. 40. Minnesota Statutes 2022, section 609.2113, subdivision 1, is amended to read:​
6625-204.28 Subdivision 1.Great bodily harm.A person is guilty of criminal vehicular operation​
6626-204.29resulting in great bodily harm and may be sentenced to imprisonment for not more than five​
6627-204.30years or to payment of a fine of not more than $10,000, or both, if the person causes great​
6628-204​Article 4 Sec. 40.​
6629-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 205.1bodily harm to another not constituting attempted murder or assault as a result of operating​
6630-205.2a motor vehicle:​
6631-205.3 (1) in a grossly negligent manner;​
6632-205.4 (2) in a negligent manner while under the influence of:​
6633-205.5 (i) alcohol;​
6634-205.6 (ii) a controlled substance; or​
6635-205.7 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6636-205.8consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6637-205.9 (iii) (iv) any combination of those elements;​
6638-205.10 (3) while having an alcohol concentration of 0.08 or more;​
6639-205.11 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6640-205.12of the time of driving;​
6641-205.13 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6642-205.14person knows or has reason to know that the substance has the capacity to cause impairment;​
6643-205.15 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6644-205.16I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6645-205.17lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6646-205.18cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6647-205.19 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6648-205.20of section 169.09, subdivision 1 or 6; or​
6649-205.21 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6650-205.22citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6651-205.23knowledge that remedial action was not taken, the driver had reason to know that the defect​
6652-205.24created a present danger to others, and the injury was caused by the defective maintenance.​
6653-205.25 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6654-205.26committed on or after that date.​
6655-205.27Sec. 41. Minnesota Statutes 2022, section 609.2113, subdivision 2, is amended to read:​
6656-205.28 Subd. 2.Substantial bodily harm.A person is guilty of criminal vehicular operation​
6657-205.29resulting in substantial bodily harm and may be sentenced to imprisonment for not more​
6658-205.30than three years or to payment of a fine of not more than $10,000, or both, if the person​
6659-205.31causes substantial bodily harm to another as a result of operating a motor vehicle:​
6660-205​Article 4 Sec. 41.​
6661-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 206.1 (1) in a grossly negligent manner;​
6662-206.2 (2) in a negligent manner while under the influence of:​
6663-206.3 (i) alcohol;​
6664-206.4 (ii) a controlled substance; or​
6665-206.5 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6666-206.6consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6667-206.7 (iii) (iv) any combination of those elements;​
6668-206.8 (3) while having an alcohol concentration of 0.08 or more;​
6669-206.9 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6670-206.10of the time of driving;​
6671-206.11 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6672-206.12person knows or has reason to know that the substance has the capacity to cause impairment;​
6673-206.13 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6674-206.14I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6675-206.15lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6676-206.16cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6677-206.17 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6678-206.18of section 169.09, subdivision 1 or 6; or​
6679-206.19 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6680-206.20citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6681-206.21knowledge that remedial action was not taken, the driver had reason to know that the defect​
6682-206.22created a present danger to others, and the injury was caused by the defective maintenance.​
6683-206.23 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6684-206.24committed on or after that date.​
6685-206.25Sec. 42. Minnesota Statutes 2022, section 609.2113, subdivision 3, is amended to read:​
6686-206.26 Subd. 3.Bodily harm.A person is guilty of criminal vehicular operation resulting in​
6687-206.27bodily harm and may be sentenced to imprisonment for not more than one year or to payment​
6688-206.28of a fine of not more than $3,000, or both, if the person causes bodily harm to another as a​
6689-206.29result of operating a motor vehicle:​
6690-206.30 (1) in a grossly negligent manner;​
6691-206​Article 4 Sec. 42.​
6692-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 207.1 (2) in a negligent manner while under the influence of:​
6693-207.2 (i) alcohol;​
6694-207.3 (ii) a controlled substance; or​
6695-207.4 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6696-207.5consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6697-207.6 (iii) (iv) any combination of those elements;​
6698-207.7 (3) while having an alcohol concentration of 0.08 or more;​
6699-207.8 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6700-207.9of the time of driving;​
6701-207.10 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6702-207.11person knows or has reason to know that the substance has the capacity to cause impairment;​
6703-207.12 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6704-207.13I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6705-207.14lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6706-207.15cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6707-207.16 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6708-207.17of section 169.09, subdivision 1 or 6; or​
6709-207.18 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6710-207.19citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6711-207.20knowledge that remedial action was not taken, the driver had reason to know that the defect​
6712-207.21created a present danger to others, and the injury was caused by the defective maintenance.​
6713-207.22 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6714-207.23committed on or after that date.​
6715-207.24Sec. 43. Minnesota Statutes 2022, section 609.2114, subdivision 1, is amended to read:​
6716-207.25 Subdivision 1.Death to an unborn child.(a) Except as provided in paragraph (b), a​
6717-207.26person is guilty of criminal vehicular operation resulting in death to an unborn child and​
6718-207.27may be sentenced to imprisonment for not more than ten years or to payment of a fine of​
6719-207.28not more than $20,000, or both, if the person causes the death of an unborn child as a result​
6720-207.29of operating a motor vehicle:​
6721-207.30 (1) in a grossly negligent manner;​
6722-207.31 (2) in a negligent manner while under the influence of:​
6723-207​Article 4 Sec. 43.​
6724-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 208.1 (i) alcohol;​
6725-208.2 (ii) a controlled substance; or​
6726-208.3 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6727-208.4consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6728-208.5 (iii) (iv) any combination of those elements;​
6729-208.6 (3) while having an alcohol concentration of 0.08 or more;​
6730-208.7 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6731-208.8of the time of driving;​
6732-208.9 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6733-208.10person knows or has reason to know that the substance has the capacity to cause impairment;​
6734-208.11 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6735-208.12I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6736-208.13lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6737-208.14cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6738-208.15 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6739-208.16of section 169.09, subdivision 1 or 6; or​
6740-208.17 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6741-208.18citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6742-208.19knowledge that remedial action was not taken, the driver had reason to know that the defect​
6743-208.20created a present danger to others, and the injury was caused by the defective maintenance.​
6744-208.21 (b) If a person is sentenced under paragraph (a) for a violation under paragraph (a),​
6745-208.22clauses (2) to (6), occurring within ten years of a qualified prior driving offense, the statutory​
6746-208.23maximum sentence of imprisonment is 15 years.​
6747-208.24 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6748-208.25committed on or after that date.​
6749-208.26Sec. 44. Minnesota Statutes 2022, section 609.2114, subdivision 2, is amended to read:​
6750-208.27 Subd. 2.Injury to an unborn child.A person is guilty of criminal vehicular operation​
6751-208.28resulting in injury to an unborn child and may be sentenced to imprisonment for not more​
6752-208.29than five years or to payment of a fine of not more than $10,000, or both, if the person​
6753-208.30causes the great bodily harm to an unborn child subsequently born alive as a result of​
6754-208.31operating a motor vehicle:​
6755-208​Article 4 Sec. 44.​
6756-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 209.1 (1) in a grossly negligent manner;​
6757-209.2 (2) in a negligent manner while under the influence of:​
6758-209.3 (i) alcohol;​
6759-209.4 (ii) a controlled substance; or​
6760-209.5 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6761-209.6consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6762-209.7 (iii) (iv) any combination of those elements;​
6763-209.8 (3) while having an alcohol concentration of 0.08 or more;​
6764-209.9 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6765-209.10of the time of driving;​
6766-209.11 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6767-209.12person knows or has reason to know that the substance has the capacity to cause impairment;​
6768-209.13 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6769-209.14I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6770-209.15lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6771-209.16cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6772-209.17 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6773-209.18of section 169.09, subdivision 1 or 6; or​
6774-209.19 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6775-209.20citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6776-209.21knowledge that remedial action was not taken, the driver had reason to know that the defect​
6777-209.22created a present danger to others, and the injury was caused by the defective maintenance.​
6778-209.23 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6779-209.24committed on or after that date.​
6780-209.25Sec. 45. Minnesota Statutes 2022, section 609.5311, subdivision 1, is amended to read:​
6781-209.26 Subdivision 1.Controlled substances.All controlled substances that were manufactured,​
6782-209.27distributed, dispensed, or acquired in violation of chapter 152 or 342 are subject to forfeiture​
6783-209.28under this section, except as provided in subdivision 3 and section 609.5316.​
6784-209.29 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to violations​
6785-209.30committed on or after that date.​
6786-209​Article 4 Sec. 45.​
6787-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 210.1Sec. 46. Minnesota Statutes 2022, section 609.5314, subdivision 1, is amended to read:​
6788-210.2 Subdivision 1.Property subject to administrative forfeiture.(a) The following are​
6789-210.3subject to administrative forfeiture under this section:​
6790-210.4 (1) all money totaling $1,500 or more, precious metals, and precious stones that there​
6791-210.5is probable cause to believe represent the proceeds of a controlled substance offense;​
6792-210.6 (2) all money found in proximity to controlled substances when there is probable cause​
6793-210.7to believe that the money was exchanged for the purchase of a controlled substance;​
6794-210.8 (3) all conveyance devices containing controlled substances with a retail value of $100​
6795-210.9or more if there is probable cause to believe that the conveyance device was used in the​
6796-210.10transportation or exchange of a controlled substance intended for distribution or sale; and​
6797-210.11 (4) all firearms, ammunition, and firearm accessories found:​
6798-210.12 (i) in a conveyance device used or intended for use to commit or facilitate the commission​
6799-210.13of a felony offense involving a controlled substance;​
6800-210.14 (ii) on or in proximity to a person from whom a felony amount of controlled substance​
6801-210.15is seized; or​
6802-210.16 (iii) on the premises where a controlled substance is seized and in proximity to the​
6803-210.17controlled substance, if possession or sale of the controlled substance would be a felony​
6804-210.18under chapter 152.​
6805-210.19 (b) The Department of Corrections Fugitive Apprehension Unit shall not seize items​
6806-210.20listed in paragraph (a), clauses (3) and (4), for the purposes of forfeiture.​
6807-210.21 (c) Money is the property of an appropriate agency and may be seized and recovered by​
6808-210.22the appropriate agency if:​
6809-210.23 (1) the money is used by an appropriate agency, or furnished to a person operating on​
6810-210.24behalf of an appropriate agency, to purchase or attempt to purchase a controlled substance;​
6811-210.25and​
6812-210.26 (2) the appropriate agency records the serial number or otherwise marks the money for​
6813-210.27identification.​
6814-210.28 (d) As used in this section, "money" means United States currency and coin; the currency​
6815-210.29and coin of a foreign country; a bank check, cashier's check, or traveler's check; a prepaid​
6816-210.30credit card; cryptocurrency; or a money order.​
6817-210​Article 4 Sec. 46.​
6818-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 211.1 (e) As used in this section, "controlled substance" does not include cannabis flower as​
6819-211.2defined in section 342.01, subdivision 15, cannabis products as defined in section 342.01,​
6820-211.3subdivision 19, hemp-derived consumer products as defined in section 342.01, subdivision​
6821-211.435, or lower-potency hemp edibles as defined in section 342.01, subdivision 48.​
6822-211.5 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6823-211.6committed on or after that date.​
6824-211.7Sec. 47. Minnesota Statutes 2022, section 609.5316, subdivision 2, is amended to read:​
6825-211.8 Subd. 2.Controlled substances.(a) Controlled substances listed in Schedule I that are​
6826-211.9possessed, transferred, sold, or offered for sale in violation of chapter 152 or 342, are​
6827-211.10contraband and must be seized and summarily forfeited. Controlled substances listed in​
6828-211.11Schedule I that are seized or come into the possession of peace officers, the owners of which​
6829-211.12are unknown, are contraband and must be summarily forfeited.​
6830-211.13 (b) Species of plants from which controlled substances in Schedules I and II may be​
6831-211.14derived that have been planted or cultivated in violation of chapter 152 or of which the​
6832-211.15owners or cultivators are unknown, or that are wild growths, may be seized and summarily​
6833-211.16forfeited to the state. The appropriate agency or its authorized agent may seize the plants if​
6834-211.17the person in occupancy or in control of land or premises where the plants are growing or​
6835-211.18being stored fails to produce an appropriate registration or proof that the person is the holder​
6836-211.19of appropriate registration.​
6837-211.20 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6838-211.21committed on or after that date.​
6839-211.22Sec. 48. Minnesota Statutes 2022, section 624.7142, subdivision 1, is amended to read:​
6840-211.23 Subdivision 1.Acts prohibited.A person may not carry a pistol on or about the person's​
6841-211.24clothes or person in a public place:​
6842-211.25 (1) when the person is under the influence of a controlled substance, as defined in section​
6843-211.26152.01, subdivision 4;​
6844-211.27 (2) when the person is under the influence of a combination of any two or more of the​
6845-211.28elements named in clauses (1) and, (4), and (7);​
6846-211.29 (3) when the person is under the influence of an intoxicating substance as defined in​
6847-211.30section 169A.03, subdivision 11a, and the person knows or has reason to know that the​
6848-211.31substance has the capacity to cause impairment;​
6849-211​Article 4 Sec. 48.​
6850-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 212.1 (4) when the person is under the influence of alcohol;​
6851-212.2 (5) when the person's alcohol concentration is 0.10 or more; or​
6852-212.3 (6) when the person's alcohol concentration is less than 0.10, but more than 0.04; or​
6853-212.4 (7) when the person is under the influence of cannabis flower, a cannabis product, a​
6854-212.5lower-potency hemp edible, a hemp-derived consumer product, an artificially derived​
6855-212.6cannabinoid, or tetrahydrocannabinols, as those terms are defined in section 342.01.​
6856-212.7 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6857-212.8committed on or after that date.​
6858-212.9Sec. 49. DWI CONTROLLED SUBSTANCE ROADSIDE TESTING INSTRUMENT​
6859-212.10PILOT PROJECT; REPORT REQUIRED.​
6860-212.11 (a) The commissioner of public safety must design, plan, and implement a pilot project​
6861-212.12to study oral fluid roadside testing instruments to determine the presence of a controlled​
6862-212.13substance or intoxicating substance in individuals stopped or arrested for driving while​
6863-212.14impaired offenses. The pilot project must determine the practicality, accuracy, and efficacy​
6864-212.15of these testing instruments and determine and make recommendations on the best instrument​
6865-212.16or instruments to pursue in the future.​
6866-212.17 (b) The pilot project must begin on September 1, 2023, and continue until August 31,​
6867-212.182024.​
6868-212.19 (c) The commissioner must consult with law enforcement officials, prosecutors, criminal​
6869-212.20defense attorneys, and other interested and knowledgeable parties when designing,​
6870-212.21implementing, and evaluating the pilot project.​
6871-212.22 (d) All oral fluid samples obtained for the purpose of this pilot project must be obtained​
6872-212.23by a certified drug recognition evaluator and may only be collected with the express voluntary​
6873-212.24consent of the person stopped or arrested for suspicion of driving while impaired. Results​
6874-212.25of tests conducted under the pilot project are to be used for the purpose of analyzing the​
6875-212.26practicality, accuracy, and efficacy of the instrument. Results may not be used to decide​
6876-212.27whether an arrest should be made and are not admissible in any legal proceeding.​
6877-212.28 (e) By February 1, 2025, the commissioner must report to the chairs and ranking minority​
6878-212.29members of the legislative committees with jurisdiction over public safety on the results of​
6879-212.30the pilot project. At a minimum, the report must include information on how accurate the​
6880-212.31instruments were when tested against laboratory results, how often participants were found​
6881-212.32to have controlled substances or intoxicating substances in their systems, how often there​
6882-212​Article 4 Sec. 49.​
6883-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 213.1was commingling of controlled substances or intoxicating substances with alcohol, the types​
6884-213.2of controlled substances or intoxicating substances found in participants' systems and which​
6885-213.3types were most common, and the number of participants in the project. In addition, the​
6886-213.4report must assess the practicality and reliability of using the instruments in the field and​
6887-213.5make recommendations on continuing the project permanently.​
6888-213.6 EFFECTIVE DATE.This section is effective the day following final enactment.​
6889-213.7 ARTICLE 5​
6890-213.8 EXPUNGEMENT​
6891-213.9Section 1. Minnesota Statutes 2022, section 609A.01, is amended to read:​
6892-213.10 609A.01 EXPUNGEMENT OF CRIMINAL RECORDS.​
6893-213.11 This chapter provides the grounds and procedures for expungement of criminal records​
6894-213.12under section 13.82; 152.18, subdivision 1; 299C.11, where a petition is authorized under​
6895-213.13section 609A.02, subdivision 3; expungement is automatic under section 609A.055;​
6896-213.14expungement is considered by a panel under section 609A.06; or other applicable law. The​
6897-213.15remedy available is limited to a court order sealing the records and prohibiting the disclosure​
6898-213.16of their existence or their opening except under court order or statutory authority. Nothing​
6899-213.17in this chapter authorizes the destruction of records or their return to the subject of the​
6900-213.18records.​
6901-213.19 EFFECTIVE DATE.This section is effective August 1, 2023.​
6902-213.20Sec. 2. [609A.055] AUTOMATIC EXPUNGEMENT OF CERTAIN CANNABIS​
6903-213.21OFFENSES.​
6904-213.22 Subdivision 1.Eligibility; dismissal, exoneration, or conviction of nonfelony cannabis​
6905-213.23offenses.(a) A person is eligible for expungement:​
6906-213.24 (1) upon the dismissal and discharge of proceedings against a person under section​
6907-213.25152.18, subdivision 1, for violation of section 152.024, 152.025, or 152.027;​
6908-213.26 (2) if the person was convicted of or received a stayed sentence for a violation of section​
6909-213.27152.027, subdivision 3 or 4;​
6910-213.28 (3) if the person was arrested and all charges were dismissed prior to a determination​
6911-213.29of probable cause for charges under section 152.021, subdivision 2, paragraph (a), clause​
6912-213.30(6); 152.022, subdivision 2, paragraph (a), clause (6); 152.023, subdivision 2, paragraph​
6913-213​Article 5 Sec. 2.​
6914-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 214.1(a), clause (5); 152.024, subdivision 2, clause (2); 152.025, subdivision 2, clause (1); or​
6915-214.2152.027, subdivision 3 or 4; or​
6916-214.3 (4) if all pending actions or proceedings were resolved in favor of the person for charges​
6917-214.4under section 152.021, subdivision 2, paragraph (a), clause (6); 152.022, subdivision 2,​
6918-214.5paragraph (a), clause (6); 152.023, subdivision 2, paragraph (a), clause (5); 152.024,​
6919-214.6subdivision 2, clause (2); 152.025, subdivision 2, clause (1); or 152.027, subdivision 3 or​
6920-214.74.​
6921-214.8 (b) For purposes of this section:​
6922-214.9 (1) a verdict of not guilty by reason of mental illness is not a resolution in favor of the​
6923-214.10person; and​
6924-214.11 (2) an action or proceeding is resolved in favor of the person if the person received an​
6925-214.12order under section 590.11 determining that the person is eligible for compensation based​
6926-214.13on exoneration.​
6927-214.14 Subd. 2.Bureau of Criminal Apprehension to identify eligible individuals.(a) The​
6928-214.15Bureau of Criminal Apprehension shall identify bureau records that qualify for expungement​
6929-214.16pursuant to subdivision 1.​
6930-214.17 (b) The Bureau of Criminal Apprehension shall notify the judicial branch of:​
6931-214.18 (1) the name and date of birth of each person whose case is eligible for an order of​
6932-214.19expungement; and​
6933-214.20 (2) the court file number of the eligible case.​
6934-214.21 Subd. 3.Expungement relief; notification requirements.(a) The Bureau of Criminal​
6935-214.22Apprehension shall grant expungement relief to each qualifying person whose records the​
6936-214.23bureau possesses and seal the bureau's records without requiring an application, petition,​
6937-214.24or motion. The bureau shall seal records related to an expungement within 60 days after the​
6938-214.25bureau sent notice of the expungement to the judicial branch pursuant to subdivision 2,​
6939-214.26paragraph (b), unless an order of the judicial branch prohibits sealing the records or additional​
6940-214.27information establishes that the records are not eligible for expungement.​
6941-214.28 (b) Nonpublic criminal records maintained by the bureau and subject to a grant of​
6942-214.29expungement relief must display a notation stating "expungement relief granted pursuant​
6943-214.30to section 609A.055."​
6944-214.31 (c) The bureau shall inform the judicial branch of all cases that are granted expungement​
6945-214.32relief pursuant to this section. The bureau may notify the judicial branch using electronic​
6946-214​Article 5 Sec. 2.​
6947-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 215.1means and may notify the judicial branch immediately or in a monthly report. Upon receiving​
6948-215.2notice of an expungement, the judicial branch shall seal all related records, including records​
6949-215.3of the person's arrest, indictment, trial, verdict, and dismissal or discharge of the case. Upon​
6950-215.4receiving notice of an expungement, the judicial branch shall issue any order necessary to​
6951-215.5seal related records. The judicial branch shall not order the Department of Health or the​
6952-215.6Department of Human Services to seal records under this section.​
6953-215.7 (d) The bureau shall inform each arresting or citing law enforcement agency or​
6954-215.8prosecutorial office with records affected by the grant of expungement relief issued pursuant​
6955-215.9to paragraph (a) that expungement has been granted. The bureau shall notify each agency​
6956-215.10or office of an expungement within 60 days after the bureau sent notice of the expungement​
6957-215.11to the judicial branch. The bureau may notify each agency or office using electronic means.​
6958-215.12Upon receiving notification of an expungement, an agency or office shall seal all records​
6959-215.13related to the expungement, including the records of the person's arrest, indictment, trial,​
6960-215.14verdict, and dismissal or discharge of the case.​
6961-215.15 (e) The bureau shall provide information on its publicly facing website clearly stating​
6962-215.16that persons who are noncitizens may need copies of records affected by a grant of​
6963-215.17expungement relief for immigration purposes, explaining how they can obtain these copies​
6964-215.18after expungement or other granted relief, and stating that a noncitizen should consult with​
6965-215.19an immigration attorney.​
6966-215.20 (f) Data on a person whose offense has been expunged under this subdivision, including​
6967-215.21any notice sent pursuant to paragraph (d), are private data on individuals as defined in section​
6968-215.2213.02, subdivision 12.​
6969-215.23 (g) Section 609A.03, subdivision 6, applies to an order issued under this section sealing​
6970-215.24the record of proceedings under section 152.18.​
6971-215.25 (h) The limitations under section 609A.03, subdivision 7a, paragraph (b), do not apply​
6972-215.26to an order issued under this section.​
6973-215.27 (i) The subject whose record qualifies for expungement shall be given access to copies​
6974-215.28of the records of arrest, conviction, or incarceration for any purposes, including immigration​
6975-215.29purposes.​
6976-215.30 (j) Relief granted under this subdivision shall not impact the ability of a petitioner to​
6977-215.31file for relief under section 590.01.​
6978-215.32 Subd. 4.Immunity from civil liability.The Department of Public Safety, commissioner​
6979-215.33of public safety, Bureau of Criminal Apprehension, superintendent of the Bureau of Criminal​
6980-215​Article 5 Sec. 2.​
6981-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 216.1Apprehension, and all employees of the Bureau of Criminal Apprehension shall not be held​
6982-216.2civilly liable when acting in good faith to exercise the powers granted by this section or for​
6983-216.3acts or omissions occurring within the scope of the performance of their duties under this​
6984-216.4section.​
6985-216.5 Subd. 5.Report.The Bureau of Criminal Apprehension shall issue a report to the​
6986-216.6legislative committees and divisions with jurisdiction over public safety policy and finance​
6987-216.7upon completion of the work required under subdivision 2. The report shall contain summary​
6988-216.8data and must include the total number of expungements granted by the Bureau of Criminal​
6989-216.9Apprehension.​
6990-216.10 EFFECTIVE DATE.This section is effective August 1, 2023.​
6991-216.11Sec. 3. [609A.06] EXPUNGEMENT AND RESENTENCING OF FELONY​
6992-216.12CANNABIS OFFENSES.​
6993-216.13 Subdivision 1.Cannabis Expungement Board.(a) The Cannabis Expungement Board​
6994-216.14is created with the powers and duties established by law.​
6995-216.15 (b) The Cannabis Expungement Board is composed of the following members:​
6996-216.16 (1) the chief justice of the supreme court or a designee;​
6997-216.17 (2) the attorney general or a designee;​
6998-216.18 (3) one public defender, appointed by the governor upon recommendation of the state​
6999-216.19public defender;​
7000-216.20 (4) the commissioner of corrections or a designee; and​
7001-216.21 (5) one public member with relevant experience, appointed by the governor.​
7002-216.22 (c) In appointing the public member described in paragraph (b), clause (5), the governor​
7003-216.23shall prioritize appointment of an individual with experience as an advocate for victim's​
7004-216.24rights.​
7005-216.25 (d) Subject to the notice requirements in section 15.0575, subdivision 4, a member may​
7006-216.26be removed by the appointing authority at any time (1) for cause, after notice and hearing,​
7007-216.27or (2) after missing three consecutive meetings. Vacancies shall be filled by the appointing​
7008-216.28authority.​
7009-216.29 (e) Members are eligible for compensation pursuant to section 15.0575, subdivision 3.​
7010-216.30 (f) The Cannabis Expungement Board shall have the following powers and duties:​
7011-216​Article 5 Sec. 3.​
7012-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 217.1 (1) to obtain and review the records, including but not limited to all matters, files,​
7013-217.2documents, and papers incident to the arrest, indictment, information, trial, appeal, or​
7014-217.3dismissal and discharge, which relate to a charge for sale or possession of a controlled​
7015-217.4substance;​
7016-217.5 (2) to determine whether a person committed an act involving the sale or possession of​
7017-217.6cannabis flower or cannabinoid products that would either be a lesser offense or no longer​
7018-217.7be a crime after August 1, 2023;​
7019-217.8 (3) to determine whether a person's conviction should be vacated, charges should be​
7020-217.9dismissed, and records should be expunged, or whether the person should be resentenced​
7021-217.10to a lesser offense;​
7022-217.11 (4) to identify violations of section 152.027, subdivisions 3 and 4, that were not​
7023-217.12automatically expunged pursuant to section 609A.055; and​
7024-217.13 (5) to notify the judicial branch of individuals eligible for an expungement or resentencing​
7025-217.14to a lesser offense.​
7026-217.15 (g) The Cannabis Expungement Board shall determine when it has completed its work.​
7027-217.16 Subd. 2.Executive director.(a) The governor must appoint the initial executive director​
7028-217.17of the Cannabis Expungement Board. The executive director must be knowledgeable about​
7029-217.18expungement law and criminal justice. The executive director serves at the pleasure of the​
7030-217.19board in the unclassified service as an executive branch employee. Any vacancy shall be​
7031-217.20filled by the board.​
7032-217.21 (b) The executive director's salary is set in accordance with section 15A.0815, subdivision​
7033-217.223.​
7034-217.23 (c) The executive director may obtain office space and supplies and hire administrative​
7035-217.24staff necessary to carry out the board's official functions, including providing administrative​
7036-217.25support to the board and attending board meetings. Any additional staff serve in the classified​
7037-217.26service.​
7038-217.27 (d) At the direction of the board, the executive director may enter into interagency​
7039-217.28agreements with the Department of Corrections or any other agency to obtain material and​
7040-217.29personnel support necessary to carry out the board's mandates, policies, activities, and​
7041-217.30objectives.​
7042-217.31 Subd. 3.Eligibility; cannabis offense.(a) A person is eligible for an expungement or​
7043-217.32resentencing to a lesser offense if:​
7044-217​Article 5 Sec. 3.​
7045-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 218.1 (1) the person was convicted of, or adjudication was stayed for, a violation of any of the​
7046-218.2following involving the sale or possession of marijuana or tetrahydrocannabinols:​
7047-218.3 (i) section 152.021, subdivision 1, clause (6);​
7048-218.4 (ii) section 152.021, subdivision 2, clause (6);​
7049-218.5 (iii) section 152.022, subdivision 1, clause (5), or clause (7), item (iii);​
7050-218.6 (iv) section 152.022, subdivision 2, clause (6);​
7051-218.7 (v) section 152.023, subdivision 1, clause (5);​
7052-218.8 (vi) section 152.023, subdivision 2, clause (5);​
7053-218.9 (vii) section 152.024, subdivision (4); or​
7054-218.10 (viii) section 152.025, subdivision 2, clause (1);​
7055-218.11 (2) the offense did not involve a dangerous weapon, the intentional infliction of bodily​
7056-218.12harm on another, an attempt to inflict bodily harm on another, or an act committed with the​
7057-218.13intent to cause fear in another of immediate bodily harm or death;​
7058-218.14 (3) the act on which the charge was based would either be a lesser offense or no longer​
7059-218.15be a crime after August 1, 2023; and​
7060-218.16 (4) the person did not appeal the conviction, any appeal was denied, or the deadline to​
7061-218.17file an appeal has expired.​
7062-218.18 (b) For purposes of this subdivision, a "lesser offense" means a nonfelony offense if the​
7063-218.19person was charged with a felony.​
7064-218.20 Subd. 4.Bureau of Criminal Apprehension to identify eligible records.(a) The​
7065-218.21Bureau of Criminal Apprehension shall identify convictions and sentences where adjudication​
7066-218.22was stayed that qualify for review under subdivision 3, paragraph (a), clause (1).​
7067-218.23 (b) The Bureau of Criminal Apprehension shall notify the Cannabis Expungement Board​
7068-218.24of:​
7069-218.25 (1) the name and date of birth of a person whose record is eligible for review; and​
7070-218.26 (2) the court file number of the eligible conviction or stay of adjudication.​
7071-218.27 (c) For the purposes of identifying background studies records that may be expunged​
7072-218.28or resentenced, the Bureau of Criminal Apprehension shall share the information provided​
7073-218.29to the Cannabis Expungement Board under paragraph (b) with the Department of Human​
7074-218​Article 5 Sec. 3.​
7075-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 219.1Services. The Bureau of Criminal Apprehension and the Department of Human Services​
7076-219.2shall consult about the form and manner of information sharing.​
7077-219.3 Subd. 5.Access to records.Notwithstanding chapter 13 or any law to the contrary, the​
7078-219.4Cannabis Expungement Board shall have free access to records, including but not limited​
7079-219.5to all matters, files, documents, and papers incident to the arrest, indictment, information,​
7080-219.6trial, appeal, or dismissal and discharge that relate to a charge and conviction or stay of​
7081-219.7adjudication for sale or possession of a controlled substance held by law enforcement​
7082-219.8agencies, prosecuting authorities, and court administrators. The Cannabis Expungement​
7083-219.9Board may issue subpoenas for and compel the production of books, records, accounts,​
7084-219.10documents, and papers. If any person fails or refuses to produce any books, records, accounts,​
7085-219.11documents, or papers material in the matter under consideration after having been lawfully​
7086-219.12required by order or subpoena, any judge of the district court in any county of the state​
7087-219.13where the order or subpoena was made returnable, on application of the commissioner of​
7088-219.14management and budget or commissioner of administration, as the case may be, shall compel​
7089-219.15obedience or punish disobedience as for contempt, as in the case of disobedience of a similar​
7090-219.16order or subpoena issued by such court.​
7091-219.17 Subd. 6.Meetings; anonymous identifier.(a) The Cannabis Expungement Board shall​
7092-219.18hold meetings at least monthly and shall hold a meeting whenever the board takes formal​
7093-219.19action on a review of a conviction or stay of adjudication for an offense involving the sale​
7094-219.20or possession of marijuana or tetrahydrocannabinols. All board meetings shall be open to​
7095-219.21the public and subject to chapter 13D.​
7096-219.22 (b) Any victim of a crime being reviewed and any law enforcement agency may submit​
7097-219.23an oral or written statement at the meeting, giving a recommendation on whether a person's​
7098-219.24record should be expunged or the person should be resentenced to a lesser offense. The​
7099-219.25board must consider the victim's and the law enforcement agency's statement when making​
7100-219.26the board's decision.​
7101-219.27 (c) Section 13D.05 governs the board's treatment of not public data, as defined by section​
7102-219.2813.02, subdivision 8a, discussed at open meetings of the board. Notwithstanding section​
7103-219.2913.03, subdivision 11, the board shall assign an anonymous, unique identifier to each victim​
7104-219.30of a crime and person whose conviction or stay of adjudication the board reviews. The​
7105-219.31identifier shall be used in any discussion in a meeting open to the public and on any records​
7106-219.32available to the public to protect the identity of the person whose records are being​
7107-219.33considered.​
7108-219​Article 5 Sec. 3.​
7109-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 220.1 Subd. 7.Review and determination.(a) The Cannabis Expungement Board shall review​
7110-220.2all available records to determine whether the conviction or stay of adjudication is eligible​
7111-220.3for an expungement or resentencing to a lesser offense. An expungement under this section​
7112-220.4is presumed to be in the public interest unless there is clear and convincing evidence that​
7113-220.5an expungement or resentencing to a lesser offense would create a risk to public safety.​
7114-220.6 (b) If the Cannabis Expungement Board determines that an expungement is in the public​
7115-220.7interest, the board shall determine whether a person's conviction should be vacated and​
7116-220.8charges should be dismissed.​
7117-220.9 (c) If the Cannabis Expungement Board determines that an expungement is in the public​
7118-220.10interest, the board shall determine whether the limitations under section 609A.03, subdivision​
7119-220.115a, apply.​
7120-220.12 (d) If the Cannabis Expungement Board determines that an expungement is in the public​
7121-220.13interest, the board shall determine whether the limitations under section 609A.03, subdivision​
7122-220.147a, paragraph (b), clause (5), apply.​
7123-220.15 (e) If the Cannabis Expungement Board determines that an expungement is not in the​
7124-220.16public interest, the board shall determine whether the person is eligible for resentencing to​
7125-220.17a lesser offense.​
7126-220.18 (f) In making a determination under this subdivision, the Cannabis Expungement Board​
7127-220.19shall consider:​
7128-220.20 (1) the nature and severity of the underlying crime, including but not limited to the total​
7129-220.21amount of marijuana or tetrahydrocannabinols possessed by the person and whether the​
7130-220.22offense involved a dangerous weapon, the intentional infliction of bodily harm on another,​
7131-220.23an attempt to inflict bodily harm on another, or an act committed with the intent to cause​
7132-220.24fear in another of immediate bodily harm or death;​
7133-220.25 (2) whether an expungement or resentencing the person a lesser offense would increase​
7134-220.26the risk, if any, the person poses to other individuals or society;​
7135-220.27 (3) if the person is under sentence, whether an expungement or resentencing to a lesser​
7136-220.28offense would result in the release of the person and whether release earlier than the date​
7137-220.29that the person would be released under the sentence currently being served would present​
7138-220.30a danger to the public or would be compatible with the welfare of society;​
7139-220.31 (4) aggravating or mitigating factors relating to the underlying crime, including the​
7140-220.32person's level of participation and the context and circumstances of the underlying crime;​
7141-220.33 (5) statements from victims and law enforcement, if any;​
7142-220​Article 5 Sec. 3.​
7143-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 221.1 (6) if an expungement or resentencing the person to a lesser offense is considered,​
7144-221.2whether there is good cause to restore the person's right to possess firearms and ammunition;​
7145-221.3 (7) if an expungement is considered, whether an expunged record of a conviction or stay​
7146-221.4of adjudication may be opened for purposes of a background check required under section​
7147-221.5122A.18, subdivision 8; and​
7148-221.6 (8) other factors deemed relevant by the Cannabis Expungement Board.​
7149-221.7 (g) In making a determination under this subdivision, the Cannabis Expungement Board​
7150-221.8shall not consider the impact the expungement would have on the offender based on any​
7151-221.9records held by the Department of Health or Human Services.​
7152-221.10 (h) The affirmative vote of three members is required for action taken at any meeting.​
7153-221.11 Subd. 8.Identification of eligible misdemeanor and petty misdemeanor records.The​
7154-221.12board shall identify violations of section 152.027, subdivisions 3 and 4, that were not​
7155-221.13automatically expunged pursuant to section 609A.055. Pursuant to subdivision 10, the board​
7156-221.14shall notify the judicial branch that any identified records are eligible for expungement.​
7157-221.15 Subd. 9.Annual report.Until the board completes its work, the board shall issue a​
7158-221.16report by January 15 of each year to the legislative committees and divisions with jurisdiction​
7159-221.17over public safety policy and finance on the board's work. The report shall contain summary​
7160-221.18data and must include:​
7161-221.19 (1) the total number of cases reviewed in the previous year;​
7162-221.20 (2) the total number of cases in which the board determined that an expungement is in​
7163-221.21the public interest;​
7164-221.22 (3) the total number of cases in which the board determined that resentencing to a lesser​
7165-221.23offense is appropriate, the original sentence in those cases, and the lesser offense​
7166-221.24recommended by the board;​
7167-221.25 (4) the total number of cases in which the board determined that no change to the original​
7168-221.26sentence was appropriate; and​
7169-221.27 (5) the total number of cases remaining to be reviewed.​
7170-221.28 Subd. 10.Notice to judicial branch and offenders.(a) The Cannabis Expungement​
7171-221.29Board shall identify any conviction or stay of adjudication that qualifies for an order of​
7172-221.30expungement or resentencing to a lesser offense and notify the judicial branch of:​
7173-221.31 (1) the name and date of birth of a person whose conviction or stay of adjudication is​
7174-221.32eligible for an order of expungement or resentencing to a lesser offense;​
7175-221​Article 5 Sec. 3.​
7176-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 222.1 (2) the court file number of the eligible conviction or stay of adjudication;​
7177-222.2 (3) whether the person is eligible for an expungement;​
7178-222.3 (4) if the person is eligible for an expungement, whether the person's conviction should​
7179-222.4be vacated and charges should be dismissed;​
7180-222.5 (5) if the person is eligible for an expungement, whether there is good cause to restore​
7181-222.6the offender's right to possess firearms and ammunition;​
7182-222.7 (6) if the person is eligible for an expungement, whether the limitations under section​
7183-222.8609A.03, subdivision 7a, paragraph (b), clause (5), apply; and​
7184-222.9 (7) if the person is eligible for resentencing to a lesser offense, the lesser sentence to be​
7185-222.10imposed.​
7186-222.11 (b) The Cannabis Expungement Board shall make a reasonable and good faith effort to​
7187-222.12notify any person whose conviction or stay of adjudication qualifies for an order of​
7188-222.13expungement that the offense qualifies and notice is being sent to the judicial branch. Notice​
7189-222.14sent pursuant to this paragraph shall inform the person that, following the order of​
7190-222.15expungement, any records of an arrest, conviction, or incarceration should not appear on​
7191-222.16any background check or study.​
7192-222.17 Subd. 11.Data classification.All data collected, created, received, maintained, or​
7193-222.18disseminated by the Cannabis Expungement Board in which each victim of a crime and​
7194-222.19person whose conviction or stay of adjudication that the Cannabis Expungement Board​
7195-222.20reviews is or can be identified as the subject of the data is classified as private data on​
7196-222.21individuals, as defined in section 13.02, subdivision 12.​
7197-222.22 Subd. 12.Order of expungement.(a) Upon receiving notice that an offense qualifies​
7198-222.23for expungement, the court shall issue an order sealing all records relating to an arrest,​
7199-222.24indictment or information, trial, verdict, or dismissal and discharge for an offense described​
7200-222.25in subdivision 3. The courts shall not order the Department of Health or Human Services​
7201-222.26to seal records under this section. If the Cannabis Expungement Board determined that the​
7202-222.27person's conviction should be vacated and charges should be dismissed, the order shall​
7203-222.28vacate and dismiss the charges.​
7204-222.29 (b) If the Cannabis Expungement Board determined that there is good cause to restore​
7205-222.30the person's right to possess firearms and ammunition, the court shall issue an order pursuant​
7206-222.31to section 609.165, subdivision 1d.​
7207-222.32 (c) If the Cannabis Expungement Board determined that an expunged record of a​
7208-222.33conviction or stay of adjudication may not be opened for purposes of a background check​
7209-222​Article 5 Sec. 3.​
7210-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 223.1required under section 122A.18, subdivision 8, the court shall direct the order specifically​
7211-223.2to the Professional Educator Licensing and Standards Board.​
7212-223.3 (d) The court administrator shall send a copy of an expungement order issued under this​
7213-223.4section to each agency and jurisdiction whose records are affected by the terms of the order​
7214-223.5and send a letter to the last known address of the person whose offense has been expunged​
7215-223.6identifying each agency to which the order was sent.​
7216-223.7 (e) In consultation with the commissioner of human services, the court shall establish a​
7217-223.8schedule on which it shall provide the commissioner of human services a list identifying​
7218-223.9the name and court file number or, if no court file number is available, the citation number​
7219-223.10of each record for a person who received an expungement under this section.​
7220-223.11 (f) Data on the person whose offense has been expunged in a letter sent under this​
7221-223.12subdivision are private data on individuals as defined in section 13.02, subdivision 12.​
7222-223.13 Subd. 13.Resentencing.(a) If the Cannabis Expungement Board determined that a​
7223-223.14person is eligible for resentencing to a lesser offense and the person is currently under​
7224-223.15sentence, the court shall proceed as if the appellate court directed a reduction of the conviction​
7225-223.16to an offense of lesser degree pursuant to rule 28.02, subdivision 12, of the Rules of Criminal​
7226-223.17Procedure.​
7227-223.18 (b) If the Cannabis Expungement Board determined that a person is eligible for​
7228-223.19resentencing to a lesser offense and the person completed or has been discharged from the​
7229-223.20sentence, the court may issue an order amending the conviction to an offense of lesser degree​
7230-223.21without holding a hearing.​
7231-223.22 (c) If the Cannabis Expungement Board determined that there is good cause to restore​
7232-223.23the person's right to possess firearms and ammunition, the court shall, as necessary, issue​
7233-223.24an order pursuant to section 609.165, subdivision 1d.​
7234-223.25 (d) In consultation with the commissioner of human services, the court shall establish​
7235-223.26a schedule on which it shall provide the commissioner of human services a list identifying​
7236-223.27the name and court file number or, if no court file number is available, the citation number​
7237-223.28of each record for a person who was resentenced under this section.​
7238-223.29 EFFECTIVE DATE.This section is effective August 1, 2023.​
7239-223.30Sec. 4. PROCUREMENT .​
7240-223.31 To the extent practicable, the commissioner of public safety must comply with the​
7241-223.32requirements of Minnesota Statutes, chapter 16C. The commissioner of administration may​
7242-223​Article 5 Sec. 4.​
7243-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 224.1waive the application of any provision of Minnesota Statutes, chapter 16C, on a case by​
7244-224.2case basis if the commissioner of public safety demonstrates that full compliance with that​
7245-224.3chapter would be impractical given the effective date or other deadlines established by this​
7246-224.4act related to the responsibilities established under Minnesota Statutes, section 609A.055.​
7247-224.5 EFFECTIVE DATE.This section is effective the day following final enactment.​
7248-224.6Sec. 5. TRANSITION PERIOD.​
7249-224.7 Beginning August 1, 2023, through March 1, 2024, the Department of Corrections must​
7250-224.8provide the Cannabis Expungement Board with administrative assistance, technical​
7251-224.9assistance, office space, and other assistance necessary for the board to carry out its duties​
7252-224.10under Minnesota Statutes, section 609A.06. The Cannabis Expungement Board shall​
7253-224.11reimburse the Department of Corrections for the services and space provided.​
7254-224.12 EFFECTIVE DATE.This section is effective the day following final enactment.​
7255-224.13 ARTICLE 6​
7256-224.14 MISCELLANEOUS PROVISIONS​
7257-224.15Section 1. [3.9224] MEDICAL CANNABIS; COMPACTS TO BE NEGOTIATED.​
7258-224.16 Subdivision 1.Definitions.(a) As used in this section, the following terms have the​
7259-224.17meanings given.​
7260-224.18 (b) "Medical cannabis law" or "medical cannabis program" means the regulatory​
7261-224.19framework for cultivation, production, distribution, and sale of cannabis to qualifying​
7262-224.20patients for therapeutic use in the treatment of a qualifying condition.​
7263-224.21 (c) "Medical cannabis flower" means cannabis flower approved for sale under the medical​
7264-224.22cannabis law of a Minnesota Tribal government or under a compact entered into under this​
7265-224.23section.​
7266-224.24 (d) "Medical cannabis product" means a cannabis product approved for sale under the​
7267-224.25medical cannabis law of a Minnesota Tribal government or under a compact entered into​
7268-224.26under this section.​
7269-224.27 (e) "Medical cannabis business" means a medical cannabis cultivator, processor, or​
7270-224.28retailer.​
7271-224.29 (f) "Medical cannabis industry" means every item, product, person, process, action,​
7272-224.30business, or other thing or activity related to medical cannabis flower or medical cannabis​
7273-224​Article 6 Section 1.​
7274-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 225.1products and subject to regulation under the law of a Minnesota Tribal government or under​
7275-225.2a compact entered into under this section.​
7276-225.3 (g) "Cannabis product" means any of the following:​
7277-225.4 (1) cannabis concentrate;​
7278-225.5 (2) a product infused with cannabinoids (whether artificially derived, or extracted or​
7279-225.6derived from cannabis plants or cannabis flower) including but not limited to​
7280-225.7tetrahydrocannabinol; or​
7281-225.8 (3) any other product that contains cannabis concentrate.​
7282-225.9 (h) "Minnesota Tribal governments" means the following federally recognized Indian​
7283-225.10Tribes located in Minnesota:​
7284-225.11 (1) Bois Forte Band;​
7285-225.12 (2) Fond Du Lac Band;​
7286-225.13 (3) Grand Portage Band;​
7287-225.14 (4) Leech Lake Band;​
7288-225.15 (5) Mille Lacs Band;​
7289-225.16 (6) White Earth Band;​
7290-225.17 (7) Red Lake Nation;​
7291-225.18 (8) Lower Sioux Indian Community;​
7292-225.19 (9) Prairie Island Indian Community;​
7293-225.20 (10) Shakopee Mdewakanton Sioux Community; and​
7294-225.21 (11) Upper Sioux Indian Community.​
7295-225.22 (i) "Tribal medical cannabis business" means a medical cannabis business licensed by​
7296-225.23a Minnesota Tribal government, including the business categories identified in paragraph​
7297-225.24(d), as well as any others that may be provided under the law of a Minnesota Tribal​
7298-225.25government.​
7299-225.26 (j) "Tribally regulated land" means:​
7300-225.27 (1) all land held in trust by the United States for the benefit of a Minnesota Tribal​
7301-225.28government ("trust land");​
7302-225.29 (2) all land held by a Minnesota Tribal government in restricted fee status; and​
7303-225​Article 6 Section 1.​
7304-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 226.1 (3) all land within the exterior boundaries of the reservation of a Minnesota Tribal​
7305-226.2government that is subject to the civil regulatory jurisdiction of the Tribal government. For​
7306-226.3the purposes of this section, land that is subject to the civil regulatory jurisdiction of the​
7307-226.4Tribal government includes:​
7308-226.5 (i) trust land, or fee land held (including leased land) by the Tribe, entities organized​
7309-226.6under Tribal law, or individual Indians; and​
7310-226.7 (ii) land held (including leased land) by non-Indian entities or individuals who consent​
7311-226.8to the civil regulation of the Tribal government or are otherwise subject to such regulation​
7312-226.9under federal law.​
7313-226.10 Subd. 2.Acknowledgment and purpose; negotiations authorized.(a) The state of​
7314-226.11Minnesota acknowledges the sovereign right of Minnesota Tribal governments to regulate​
7315-226.12the medical cannabis industry and address other matters of cannabis regulation related to​
7316-226.13the internal affairs of Minnesota Tribal governments or otherwise within their jurisdiction,​
7317-226.14without regard to whether such Tribal government has entered a compact authorized by this​
7318-226.15section. The purpose of this section is to provide for the negotiation of compacts to​
7319-226.16proactively address jurisdictional issues related to the regulation of the medical cannabis​
7320-226.17industry. The legislature finds that these agreements will facilitate and promote a cooperative​
7321-226.18and mutually beneficial relationship between the state and the Tribes regarding the​
7322-226.19legalization of cannabis. Such cooperative agreements will enhance public health and safety,​
7323-226.20ensure a lawful and well-regulated medical cannabis market, encourage economic​
7324-226.21development, and provide fiscal benefits to both Indian Tribes and the state.​
7325-226.22 (b) The governor or his designee shall negotiate in good faith, and has the authority to​
7326-226.23execute and bind the state to, a compact with any Minnesota Tribal government wishing to​
7327-226.24enter into such a compact regulating medical cannabis flower and medical cannabis products.​
7328-226.25 Subd. 3.Terms of compact; rights of parties.(a) A compact agreed to under this​
7329-226.26section may address any issues related to the medical cannabis industry, including medical​
7330-226.27cannabis flower, medical cannabis products, extracts, concentrates, and artificially derived​
7331-226.28cannabinoids that affect the interest of both the state and Minnesota Tribal government or​
7332-226.29otherwise have an impact on Tribal-state relations. Indian Tribes are not required to enter​
7333-226.30into compacts pursuant to this section in order to: regulate the medical cannabis industry,​
7334-226.31or engage in medical cannabis businesses or activities on Tribally regulated land or participate​
7335-226.32as a licensee in the state's legal medical cannabis market.​
7336-226.33 (b) The state shall not, as a condition for entering into a compact under this section:​
7337-226​Article 6 Section 1.​
7338-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 227.1 (1) require any Minnesota Tribal government to waive any right, privilege, or immunity​
7339-227.2based on their status as independent sovereigns;​
7340-227.3 (2) require that any revenue generated by a medical cannabis business licensed by a​
7341-227.4Minnesota Tribal government be subject to any state cannabis gross receipt taxes or state​
7342-227.5and local sales or use taxes on sales of cannabis;​
7343-227.6 (3) require any taxes collected by Minnesota Tribal governments to be shared in any​
7344-227.7manner with the state or any subdivisions thereof;​
7345-227.8 (4) require a Minnesota Tribal government to consent to state licensing of a medical​
7346-227.9cannabis business on the Tribally regulated land of the Minnesota Tribal government;​
7347-227.10 (5) require any Minnesota Tribal government or any medical cannabis business licensed​
7348-227.11by a Minnesota Tribal government pursuant to a compact agreed to under this section to​
7349-227.12comply with specific state law or regulations on Tribally regulated land; or​
7350-227.13 (6) impose, or attempt to impose, and shall not require or attempt to require any Indian​
7351-227.14Tribe to impose, any taxes, fees, assessments, and other charges related to the production,​
7352-227.15processing, sale, purchase, distribution, or possession of medical cannabis flower and medical​
7353-227.16cannabis products on Minnesota Tribal governments, or their members, on a reservation or​
7354-227.17Tribally regulated land.​
7355-227.18 (d) Compacts agreed to under this section may allow an exemption from any otherwise​
7356-227.19applicable tax for: (i) sales to a Minnesota Tribal government, a Tribal medical cannabis​
7357-227.20business, or Tribal members, of medical cannabis flower and cannabis products grown,​
7358-227.21produced, or processed as provided for in said compacts; or, (ii) for activities of Tribal​
7359-227.22medical cannabis businesses.​
7360-227.23 Subd. 4.Civil and criminal immunities.(a) Without limiting any immunity or exemption​
7361-227.24that may apply under federal law, the following acts, when performed by a Tribal medical​
7362-227.25cannabis business or an employee in the course of their employment for a Tribal medical​
7363-227.26cannabis business, pursuant to a compact entered into under this section, do not constitute​
7364-227.27a criminal or civil offense under state law:​
7365-227.28 (1) the cultivation of medical cannabis flower, and the extraction, processing, or​
7366-227.29manufacture of medical cannabis and artificially derived cannabinoid products, extracts, or​
7367-227.30concentrates;​
7368-227.31 (2) the possession, purchase, and receipt of medical cannabis seed, flower, and medical​
7369-227.32cannabis products that are properly packaged and labeled as authorized under a compact​
7370-227​Article 6 Section 1.​
7371-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 228.1entered into pursuant to this section, and the sale, delivery, transport, or distribution of such​
7372-228.2products to a licensed cannabis business; and​
7373-228.3 (3) the delivery, distribution, and sale of medical cannabis seed, flower, and medical​
7374-228.4cannabis products as authorized under a compact entered into pursuant to this section and​
7375-228.5that takes place on or, originates from, the premises of a Tribal medical cannabis business​
7376-228.6on Tribally regulated land, to any person eligible to participate in a medical cannabis program.​
7377-228.7 (b) The following acts, when performed by a patron of a Tribal medical cannabis business​
7378-228.8do not constitute a criminal or civil offense under state law: the purchase, possession, or​
7379-228.9receipt of medical cannabis seed, flower, and medical cannabis products as authorized under​
7380-228.10a compact entered into pursuant to this section.​
7381-228.11 (c) Without limiting any immunity or exemption that may apply under federal law,​
7382-228.12actions by a Tribal medical cannabis business, a Tribal member, employee, or agent of a​
7383-228.13Minnesota Tribal government or Tribal medical cannabis business on Tribally regulated​
7384-228.14land pursuant to Tribal laws governing cannabis, or a compact entered into under this section,​
7385-228.15do not constitute a criminal or civil offense under state law.​
7386-228.16 (d) The following acts, when performed by a state-licensed medical cannabis business,​
7387-228.17or an employee of such business, and which would be permitted under the terms of the​
7388-228.18applicable medical cannabis business license if undertaken with another state-licensed​
7389-228.19medical cannabis business, are permitted under the state license conditions when undertaken​
7390-228.20with a Tribal medical cannabis business and do not constitute a criminal or civil offense​
7391-228.21under state law: the possession, purchase, wholesale and retail sale, delivery, transport,​
7392-228.22distribution, and receipt of medical cannabis, seed, flower, and medical cannabis products​
7393-228.23that are properly packaged and labeled as authorized under a compact entered into pursuant​
7394-228.24to this section.​
7395-228.25 (e) Without limiting any immunity or exemption that may apply under federal law, the​
7396-228.26following acts, when performed by a Minnesota Tribal government, a Tribal medical cannabis​
7397-228.27business licensed by such Tribal government, or an employee of such Tribal government​
7398-228.28or Tribal medical cannabis business, regardless of whether the Minnesota Tribal government​
7399-228.29issuing such license has compacted with the state under this section, do not constitute a​
7400-228.30criminal or civil offense under state law: purchase, sale, receipt, or delivery (including​
7401-228.31delivery that involves transit through the state, outside a reservation), of medical cannabis​
7402-228.32flower, seed, and medical cannabis products from or to another Minnesota Tribal government​
7403-228.33or cannabis business licensed by such government.​
7404-228​Article 6 Section 1.​
7405-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 229.1 (f) Notwithstanding any other provision of law, a state-licensed cannabis testing facility​
7406-229.2may provide cannabis testing services to a Tribal medical cannabis business, and the​
7407-229.3possession or transport of cannabis flower or cannabis products for such purpose by a Tribal​
7408-229.4cannabis business shall not constitute a criminal or civil offense under state law.​
7409-229.5 Subd. 5.Publication.The governor shall post any compact entered into under this section​
7410-229.6on a publicly accessible website.​
7411-229.7 EFFECTIVE DATE.This section is effective the day following final enactment.​
7412-229.8Sec. 2. [3.9228] ADULT-USE CANNABIS; COMPACTS TO BE NEGOTIATED.​
7413-229.9 Subdivision 1.Definitions.(a) As used in this section, the following terms have the​
7414-229.10meanings given.​
7415-229.11 (b) "Adult-use cannabis flower" means cannabis flower approved for sale to adults under​
7416-229.12the law of a Minnesota Tribal government or under a compact entered under this section.​
7417-229.13 (c) "Adult-use cannabis product" means cannabis product approved for sale to adults​
7418-229.14under the law of a Minnesota Tribal government or under a compact entered under this​
7419-229.15section.​
7420-229.16 (d) "Cannabis business" means a cannabis cultivator, manufacturer, retailer, wholesaler,​
7421-229.17transporter, testing facility, microbusiness, mezzobusiness, event organizer, delivery service,​
7422-229.18or lower potency hemp edible manufacturer or retailer.​
7423-229.19 (e) "Cannabis industry" means every item, product, person, process, action, business,​
7424-229.20or other thing or activity related to cannabis flower or cannabis products and subject to​
7425-229.21regulation under the law of a Minnesota Tribal government or under a compact entered​
7426-229.22under this section.​
7427-229.23 (f) "Cannabis product" means any of the following:​
7428-229.24 (1) cannabis concentrate;​
7429-229.25 (2) a product infused with cannabinoids (whether artificially derived, or extracted or​
7430-229.26derived from cannabis plants or cannabis flower) including but not limited to​
7431-229.27tetrahydrocannabinol; or​
7432-229.28 (3) any other product that contains cannabis concentrate.​
7433-229.29 (g) "Minnesota Tribal governments" means the following federally recognized Indian​
7434-229.30Tribes located in Minnesota:​
7435-229.31 (1) Bois Forte Band;​
7436-229​Article 6 Sec. 2.​
7437-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 230.1 (2) Fond Du Lac Band;​
7438-230.2 (3) Grand Portage Band;​
7439-230.3 (4) Leech Lake Band;​
7440-230.4 (5) Mille Lacs Band;​
7441-230.5 (6) White Earth Band;​
7442-230.6 (7) Red Lake Nation;​
7443-230.7 (8) Lower Sioux Indian Community;​
7444-230.8 (9) Prairie Island Indian Community;​
7445-230.9 (10) Shakopee Mdewakanton Sioux Community; and​
7446-230.10 (11) Upper Sioux Indian Community.​
7447-230.11 (h) "Tribal cannabis business" means a cannabis business licensed by a Minnesota Tribal​
7448-230.12government, including the business categories identified in paragraph (d), as well as any​
7449-230.13others that may be provided under the law of a Minnesota Tribal government.​
7450-230.14 (i) "Tribally regulated land" means:​
7451-230.15 (1) all land held in trust by the United States for the benefit of a Minnesota Tribal​
7452-230.16government ("trust land");​
7453-230.17 (2) all land held by a Minnesota Tribal government in restricted fee status; and​
7454-230.18 (3) all land within the exterior boundaries of the reservation of a Minnesota Tribal​
7455-230.19government that is subject to the civil regulatory jurisdiction of the Tribal government. For​
7456-230.20the purposes of this section, land that is subject to the civil regulatory jurisdiction of the​
7457-230.21Tribal government includes:​
7458-230.22 (i) trust land, or fee land held (including leased land) by the Tribe, entities organized​
7459-230.23under Tribal law, or individual Indians; and​
7460-230.24 (ii) land held (including leased land) by non-Indian entities or individuals who consent​
7461-230.25to the civil regulation of the Tribal government or are otherwise subject to such regulation​
7462-230.26under federal law.​
7463-230.27 Subd. 2.Acknowledgment and purpose; negotiations authorized.(a) The state of​
7464-230.28Minnesota acknowledges the sovereign right of Minnesota Tribal governments to regulate​
7465-230.29the cannabis industry and address other matters of cannabis regulation related to the internal​
7466-230.30affairs of Minnesota Tribal governments or otherwise within their jurisdiction, without​
7467-230​Article 6 Sec. 2.​
7468-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 231.1regard to whether such Tribal government has entered a compact authorized by this section.​
7469-231.2The purpose of this section is to provide for the negotiation of compacts to proactively​
7470-231.3address jurisdictional issues related to the regulation of the cannabis industry. The legislature​
7471-231.4finds that these agreements will facilitate and promote a cooperative and mutually beneficial​
7472-231.5relationship between the state and the Tribes regarding the legalization of cannabis. Such​
7473-231.6cooperative agreements will enhance public health and safety, ensure a lawful and​
7474-231.7well-regulated cannabis market, encourage economic development, and provide fiscal​
7475-231.8benefits to both Indian Tribes and the state.​
7476-231.9 (b) The governor or his designee shall negotiate in good faith, and has the authority to​
7477-231.10execute and bind the state to, a compact with any Minnesota Tribal government wishing to​
7478-231.11enter into such compact regulating adult-use cannabis flower and adult-use cannabis products.​
7479-231.12 Subd. 3.Terms of compact; rights of parties.(a) A compact agreed to under this​
7480-231.13section may address any issues related to the cannabis industry including adult-use cannabis​
7481-231.14flower, adult-use cannabis products, extracts, concentrates, and artificially derived​
7482-231.15cannabinoids that affect the interest of both the state and Minnesota Tribal government or​
7483-231.16otherwise have an impact on Tribal-state relations. Indian Tribes are not required to enter​
7484-231.17into compacts pursuant to this section in order to: regulate the cannabis industry, or engage​
7485-231.18in cannabis businesses or activities on Tribally regulated lands; or participate as a licensee​
7486-231.19in the state's legal cannabis market.​
7487-231.20 (b) The state shall not, as a condition for entering into a compact under this section:​
7488-231.21 (1) require any Minnesota Tribal government to waive any right, privilege, or immunity​
7489-231.22based on their status as independent sovereigns;​
7490-231.23 (2) require that any revenue generated by cannabis businesses licensed by a Minnesota​
7491-231.24Tribal government be subject to any state cannabis gross receipt taxes imposed under section​
7492-231.25295.81 or state and local sales or use taxes on sales of cannabis;​
7493-231.26 (3) require any taxes collected by Minnesota Tribal governments to be shared in any​
7494-231.27manner with the state or any subdivisions thereof;​
7495-231.28 (4) require a Minnesota Tribal government to consent to state licensing of cannabis​
7496-231.29businesses on the Tribally regulated land of the Minnesota Tribal government;​
7497-231.30 (5) require any Minnesota Tribal government, or any cannabis business licensed by a​
7498-231.31Minnesota Tribal government pursuant to a compact agreed to under this section, to comply​
7499-231.32with specific state law or regulations on Tribally regulated land; or​
7500-231​Article 6 Sec. 2.​
7501-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 232.1 (6) impose, or attempt to impose, and shall not require or attempt to require any Indian​
7502-232.2Tribe to impose, any taxes, fees, assessments, and other charges related to the production,​
7503-232.3processing, sale, purchase, distribution, or possession of adult-use cannabis flower and​
7504-232.4adult-use cannabis products on Minnesota Tribal governments, or their members, on a​
7505-232.5reservation or Tribally regulated land.​
7506-232.6 (d) Compacts agreed to under this section may allow an exemption from any otherwise​
7507-232.7applicable tax for: (i) sales to a Minnesota Tribal government, a Tribal cannabis business,​
7508-232.8or Tribal members, of cannabis flower and adult use cannabis products grown, produced,​
7509-232.9or processed as provided for in said compacts; or, (ii) for activities of Tribal cannabis​
7510-232.10businesses.​
7511-232.11 Subd. 4.Civil and criminal immunities.(a) Without limiting any immunity or exemption​
7512-232.12that may apply under federal law, the following acts, when performed by a Tribal cannabis​
7513-232.13business or an employee in the course of their employment for a Tribal cannabis business,​
7514-232.14pursuant to a compact entered into under this section, do not constitute a criminal or civil​
7515-232.15offense under state law:​
7516-232.16 (1) the cultivation of cannabis flower, and the extraction, processing, or manufacture of​
7517-232.17adult-use cannabis and artificially derived cannabinoid products, extracts, or concentrates;​
7518-232.18 (2) the possession, purchase, and receipt of adult-use cannabis seed, flower, and adult-use​
7519-232.19cannabis products that are properly packaged and labeled as authorized under a compact​
7520-232.20entered into pursuant to this section, and the sale, delivery, transport, or distribution of such​
7521-232.21products to a licensed cannabis business; and​
7522-232.22 (3) the delivery, distribution, and sale of adult-use cannabis seed, flower, and adult-use​
7523-232.23cannabis products as authorized under a compact entered into pursuant to this section and​
7524-232.24that takes place on, or originates from, the premises of a Tribal cannabis business on Tribally​
7525-232.25regulated land, to any person 21 years of age or older.​
7526-232.26 (b) The following acts, when performed by a patron of a Tribal cannabis business do​
7527-232.27not constitute a criminal or civil offense under state law: the purchase, possession, or receipt​
7528-232.28of adult-use cannabis seed, flower, and adult-use cannabis products as authorized under a​
7529-232.29compact entered into pursuant to this section.​
7530-232.30 (c) Without limiting any immunity or exemption that may apply under federal law,​
7531-232.31actions by a Tribal cannabis business, a Tribal member, employee, or agent of a Minnesota​
7532-232.32Tribal government or Tribal cannabis business on Tribally regulated land pursuant to Tribal​
7533-232.33laws governing cannabis, or a compact entered into under this section, do not constitute a​
7534-232.34criminal or civil offense under state law.​
7535-232​Article 6 Sec. 2.​
7536-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 233.1 (d) The following acts, when performed by a state-licensed cannabis business, or an​
7537-233.2employee of such business, and which would be permitted under the terms of the applicable​
7538-233.3cannabis business license if undertaken with another state-licensed cannabis business, are​
7539-233.4permitted under the state license conditions when undertaken with a Tribal cannabis business​
7540-233.5and do not constitute a criminal or civil offense under state law: the possession, purchase,​
7541-233.6wholesale and retail sale, delivery, transport, distribution, and receipt of adult-use cannabis,​
7542-233.7seed, flower, and adult-use cannabis products that are properly packaged and labeled as​
7543-233.8authorized under a compact entered into pursuant to this section.​
7544-233.9 (e) Without limiting any immunity or exemption that may apply under federal law, the​
7545-233.10following acts, when performed by a Minnesota Tribal government, a Tribal cannabis​
7546-233.11business licensed by such Tribal government, or an employee of such Tribal government​
7547-233.12or Tribal cannabis business, regardless of whether the Minnesota Tribal government issuing​
7548-233.13such license has compacted with the state under this section, do not constitute a criminal or​
7549-233.14civil offense under state law: purchase, sale, receipt, or delivery (including delivery that​
7550-233.15involves transit through the state, outside a reservation), of adult-use cannabis flower, seed,​
7551-233.16or adult-use cannabis product from or to another Minnesota Tribal government or cannabis​
7552-233.17business licensed by such government.​
7553-233.18 (f) Notwithstanding any other provision of law, a state-licensed cannabis testing facility​
7554-233.19may provide cannabis testing services to a Tribal cannabis business, and the possession or​
7555-233.20transport of cannabis flower or cannabis products for such purpose by a Tribal cannabis​
7556-233.21business shall not constitute a criminal or civil offense under state law.​
7557-233.22 Subd. 5.Publication.The governor shall post any compact entered into under this section​
7558-233.23on a publicly accessible website.​
7559-233.24 EFFECTIVE DATE.This section is effective the day following final enactment.​
7560-233.25Sec. 3. Minnesota Statutes 2022, section 13.411, is amended by adding a subdivision to​
7561-233.26read:​
7562-233.27 Subd. 12.Cannabis businesses.Data submitted to the Office of Cannabis Management​
7563-233.28for a cannabis business license or a hemp business license and data relating to investigations​
7564-233.29and disciplinary proceedings involving cannabis businesses and hemp businesses licensed​
7565-233.30by the Office of Cannabis Management are classified under section 342.20.​
7566-233​Article 6 Sec. 3.​
7567-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 234.1Sec. 4. Minnesota Statutes 2022, section 13.871, is amended by adding a subdivision to​
7568-234.2read:​
7569-234.3 Subd. 15.Cannabis Expungement Board records.Data collected, created, received,​
7570-234.4maintained, or disseminated by the Cannabis Expungement Board are classified under​
7571-234.5section 609A.06, subdivision 11.​
7572-234.6Sec. 5. Minnesota Statutes 2022, section 18K.02, subdivision 5, is amended to read:​
7573-234.7 Subd. 5.Processing."Processing" means rendering by refinement hemp plants or hemp​
7574-234.8plant parts from their natural or original state after harvest. Processing includes but is not​
7575-234.9limited to decortication, devitalization, chopping, crushing, extraction, and packaging.​
7576-234.10Processing does not include typical farm operations such as sorting, grading, baling, and​
7577-234.11harvesting. Processing does not include the production of artificially derived cannabinoids​
7578-234.12as defined in section 342.01, subdivision 6.​
7579-234.13 EFFECTIVE DATE.This section is effective July 1, 2024.​
7580-234.14Sec. 6. Minnesota Statutes 2022, section 34A.01, subdivision 4, is amended to read:​
7581-234.15 Subd. 4.Food."Food" means every ingredient used for, entering into the consumption​
7582-234.16of, or used or intended for use in the preparation of food, drink, confectionery, or condiment​
7583-234.17for humans or other animals, whether simple, mixed, or compound; and articles used as​
7584-234.18components of these ingredients, except that edible cannabinoid cannabis products, as​
7585-234.19defined in section 151.72, subdivision 1, paragraph (c) 342.01, subdivision 20, lower-potency​
7586-234.20hemp edibles as defined in section 342.01, subdivision 50, and hemp-derived consumer​
7587-234.21products, as defined in section 342.01, subdivision 37, that are intended to be eaten or​
7588-234.22consumed as a beverage are not food.​
7589-234.23 EFFECTIVE DATE.This section is effective March 1, 2025.​
7590-234.24Sec. 7. [120B.215] EDUCATION ON CANNABIS USE AND SUBSTANCE USE.​
7591-234.25 Subdivision 1.Model program.The commissioner of education, in consultation with​
7592-234.26the commissioners of health and human services, local district and school health education​
7593-234.27specialists, and other qualified experts, shall identify one or more model programs that may​
7594-234.28be used to educate middle school and high school students on the health effects on children​
7595-234.29and adolescents of cannabis use and substance use, including but not limited to the use of​
7596-234.30fentanyl or mixtures containing fentanyl, consistent with local standards as required in​
7597-234.31section 120B.021, subdivision 1, paragraph (a), clause (6), for elementary and secondary​
7598-234.32school students. The commissioner must publish a list of model programs that include​
7599-234​Article 6 Sec. 7.​
7600-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 235.1written materials, resources, and training for instructors by June 1, 2025. A model program​
7601-235.2identified by the commissioner must be medically accurate, age and developmentally​
7602-235.3appropriate, culturally inclusive, and grounded in science, and must address:​
7603-235.4 (1) the physical and mental health effects of cannabis use and substance use by children,​
7604-235.5adolescents, and persons under 25 years of age, including effects on the developing brains​
7605-235.6of children, adolescents, and persons under 25 years of age;​
7606-235.7 (2) unsafe or unhealthy behaviors associated with cannabis use and substance use;​
7607-235.8 (3) signs of substance use disorders;​
7608-235.9 (4) treatment options; and​
7609-235.10 (5) healthy coping strategies for children and adolescents.​
7610-235.11 Subd. 2.School programs.(a) Starting in the 2026-2027 school year, a school district​
7611-235.12or charter school must implement a comprehensive education program on cannabis use and​
7612-235.13substance use, including but not limited to the use of fentanyl or mixtures containing fentanyl,​
7613-235.14for students in middle school and high school. The program must include instruction on the​
7614-235.15topics listed in subdivision 1 and must:​
7615-235.16 (1) respect community values and encourage students to communicate with parents,​
7616-235.17guardians, and other trusted adults about cannabis use and substance use, including but not​
7617-235.18limited to the use of fentanyl or mixtures containing fentanyl; and​
7618-235.19 (2) refer students to local resources where students may obtain medically accurate​
7619-235.20information about cannabis use and substance use, including but not limited to the use of​
7620-235.21fentanyl or mixtures containing fentanyl, and treatment for a substance use disorder.​
7621-235.22 (b) District efforts to develop, implement, or improve instruction or curriculum as a​
7622-235.23result of the provisions of this section must be consistent with sections 120B.10 and 120B.11.​
7623-235.24 Subd. 3.Parental review.Notwithstanding any law to the contrary, each school district​
7624-235.25shall have a procedure for a parent, a guardian, or an adult student 18 years of age or older​
7625-235.26to review the content of the instructional materials to be provided to a minor child or to an​
7626-235.27adult student pursuant to this section. The district or charter school must allow a parent or​
7627-235.28adult student to opt out of instruction under this section with no academic or other penalty​
7628-235.29for the student and must inform parents and adult students of this right to opt out.​
7629-235.30 Subd. 4.Youth council.A school district or charter school may establish one or more​
7630-235.31youth councils in which student members of the council receive education and training on​
7631-235​Article 6 Sec. 7.​
7632-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 236.1cannabis use and substance use, including but not limited to the use of fentanyl or mixtures​
7633-236.2containing fentanyl, and provide peer-to-peer education on these topics.​
7634-236.3Sec. 8. [144.196] CANNABIS DATA COLLECTION AND BIENNIAL REPORTS.​
7635-236.4 Subdivision 1.General.The commissioner of health shall engage in research and data​
7636-236.5collection activities to measure the prevalence of cannabis flower use and the use of cannabis​
7637-236.6products, lower-potency hemp edibles, and hemp-derived consumer products in the state​
7638-236.7by persons under 21 years of age and by persons 21 years of age or older, and the trends in​
7639-236.8hospital-treated cannabis poisoning and adverse events. In order to collect data, the​
7640-236.9commissioner may modify existing data collection tools used by the department or other​
7641-236.10state agencies or may establish one or more new data collection tools.​
7642-236.11 Subd. 2.Statewide assessment; baseline data; updates.(a) The commissioner shall​
7643-236.12conduct a statewide assessment to establish a baseline for the prevalence of cannabis flower​
7644-236.13use and the use of cannabis products, lower-potency hemp edibles, and hemp-derived​
7645-236.14consumer products in the state, and the trends in hospital-treated cannabis poisoning and​
7646-236.15adverse events broken out by:​
7647-236.16 (1) the current age of the customer;​
7648-236.17 (2) the age at which the customer began consuming cannabis flower, cannabis products,​
7649-236.18lower-potency hemp edibles, or hemp-derived consumer products;​
7650-236.19 (3) whether the customer consumes cannabis flower, cannabis products, lower-potency​
7651-236.20hemp edibles, or hemp-derived consumer products, and by type of product that the customer​
7652-236.21consumes, if applicable;​
7653-236.22 (4) the amount of cannabis flower, cannabis product, lower-potency hemp edible, or​
7654-236.23hemp-derived consumer product typically consumed at one time;​
7655-236.24 (5) the typical frequency of consumption; and​
7656-236.25 (6) other criteria specified by the commissioner.​
7657-236.26 (b) The initial assessment must be completed by July 1, 2024. The commissioner shall​
7658-236.27collect updated data under this subdivision at least every two years thereafter.​
7659-236.28 Subd. 3.Reports.Beginning January 1, 2025, and January 1 every two years thereafter,​
7660-236.29the commissioner shall issue a public report on the prevalence of cannabis flower use and​
7661-236.30the use of cannabis products, lower-potency hemp edibles, and hemp-derived consumer​
7662-236.31products in the state by persons under age 21 and by persons age 21 or older. The report​
7663-236.32may include recommendations from the commissioner for changes to this chapter that would​
7664-236​Article 6 Sec. 8.​
7665-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 237.1discourage or prevent personal use of cannabis flower, cannabis products, lower-potency​
7666-237.2hemp edibles, or hemp-derived consumer products by persons under age 21, that would​
7667-237.3discourage personal use of cannabis flower, cannabis products, lower-potency hemp edibles,​
7668-237.4or hemp-derived consumer products by pregnant or breastfeeding individuals, that would​
7669-237.5prevent access to cannabis flower, cannabis products, lower-potency hemp edibles, or​
7670-237.6hemp-derived consumer products by young children, or that would otherwise promote public​
7671-237.7health.​
7672-237.8Sec. 9. [144.197] CANNABIS EDUCATION PROGRAMS.​
7673-237.9 Subdivision 1.Youth education.The commissioner of health, in consultation with the​
7674-237.10commissioners of human services and education and in collaboration with local health​
7675-237.11departments, shall conduct a long-term, coordinated education program to raise public​
7676-237.12awareness about and address the top three adverse health effects, as determined by the​
7677-237.13commissioner, associated with the use of cannabis flower, cannabis products, lower-potency​
7678-237.14hemp edibles, or hemp-derived consumer products by persons under age 25. In conducting​
7679-237.15this education program, the commissioner shall engage and consult with youth around the​
7680-237.16state on program content and on methods to effectively disseminate program information​
7681-237.17to youth around the state.​
7682-237.18 Subd. 2.Education for pregnant and breastfeeding individuals; individuals who​
7683-237.19may become pregnant.The commissioner of health, in consultation with the commissioners​
7684-237.20of human services and education, shall conduct a long-term, coordinated program to educate​
7685-237.21pregnant individuals, breastfeeding individuals, and individuals who may become pregnant​
7686-237.22on the adverse health effects of prenatal exposure to cannabis flower, cannabis products,​
7687-237.23lower-potency hemp edibles, or hemp-derived consumer products and on the adverse health​
7688-237.24effects experienced by infants and children who are exposed to cannabis flower, cannabis​
7689-237.25products, lower-potency hemp edibles, or hemp-derived consumer products in breast milk,​
7690-237.26from secondhand smoke, or by ingesting cannabinoid products. This education program​
7691-237.27must also educate individuals on what constitutes a substance use disorder, signs of a​
7692-237.28substance use disorder, and treatment options for persons with a substance use disorder.​
7693-237.29 Subd. 3.Home visiting programs.The commissioner of health shall provide training,​
7694-237.30technical assistance, and education materials to local public health home visiting programs​
7695-237.31and Tribal home visiting programs and child welfare workers regarding the safe and unsafe​
7696-237.32use of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
7697-237.33consumer products in homes with infants and young children. Training, technical assistance,​
7698-237.34and education materials shall address substance use, the signs of a substance use disorder,​
7699-237​Article 6 Sec. 9.​
7700-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 238.1treatment options for persons with a substance use disorder, the dangers of driving under​
7701-238.2the influence of cannabis flower, cannabis products, lower-potency hemp edibles, or​
7702-238.3hemp-derived consumer products, how to safely consume cannabis flower, cannabis products,​
7703-238.4lower-potency hemp edibles, or hemp-derived consumer products in homes with infants​
7704-238.5and young children, and how to prevent infants and young children from being exposed to​
7705-238.6cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
7706-238.7products by ingesting cannabinoid products or through secondhand smoke.​
7707-238.8 Subd. 4.Local and Tribal health departments.The commissioner of health shall​
7708-238.9distribute grants to local health departments and Tribal health departments for these​
7709-238.10departments to create and disseminate educational materials on cannabis flower, cannabis​
7710-238.11products, lower-potency hemp edibles, and hemp-derived consumer products and to provide​
7711-238.12safe use and prevention training, education, technical assistance, and community engagement​
7712-238.13regarding cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived​
7713-238.14consumer products.​
7714-238.15Sec. 10. Minnesota Statutes 2022, section 144.99, subdivision 1, is amended to read:​
7715-238.16 Subdivision 1.Remedies available.The provisions of chapters 103I and 157 and sections​
7716-238.17115.71 to 115.77; 144.12, subdivision 1, paragraphs (1), (2), (5), (6), (10), (12), (13), (14),​
7717-238.18and (15); 144.1201 to 144.1204; 144.121; 144.1215; 144.1222; 144.35; 144.381 to 144.385;​
7718-238.19144.411 to 144.417; 144.495; 144.71 to 144.74; 144.9501 to 144.9512; 144.97 to 144.98;​
7719-238.20144.992; 152.22 to 152.37; 326.70 to 326.785; 327.10 to 327.131; and 327.14 to 327.28​
7720-238.21and all rules, orders, stipulation agreements, settlements, compliance agreements, licenses,​
7721-238.22registrations, certificates, and permits adopted or issued by the department or under any​
7722-238.23other law now in force or later enacted for the preservation of public health may, in addition​
7723-238.24to provisions in other statutes, be enforced under this section.​
7724-238.25 EFFECTIVE DATE.This section is effective March 1, 2025.​
7725-238.26Sec. 11. Minnesota Statutes 2022, section 144A.4791, subdivision 14, is amended to read:​
7726-238.27 Subd. 14.Application of other law.Home care providers may exercise the authority​
7727-238.28and are subject to the protections in section 152.34 342.57, subdivision 2.​
7728-238.29 EFFECTIVE DATE.This section is effective March 1, 2025.​
7729-238.30Sec. 12. Minnesota Statutes 2022, section 152.01, subdivision 9, is amended to read:​
7730-238.31 Subd. 9.Marijuana.(a) "Marijuana" means all parts of the plant of any species of the​
7731-238.32genus Cannabis, including all agronomical varieties, whether growing or not; the seeds​
7732-238​Article 6 Sec. 12.​
7733-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 239.1thereof; the resin extracted from any part of such plant; and every compound, manufacture,​
7734-239.2salt, derivative, mixture, or preparation of such plant, its seeds or resin, but shall:​
7735-239.3 (1) cannabis plants;​
7736-239.4 (2) cannabis flower;​
7737-239.5 (3) cannabis concentrate;​
7738-239.6 (4) cannabis products;​
7739-239.7 (5) cannabis seed; or​
7740-239.8 (6) a mixture containing any tetrahydrocannabinol or artificially derived cannabinoid​
7741-239.9in a concentration that exceeds 0.3 percent as measured by weight.​
7742-239.10 (b) Marijuana does not include:​
7743-239.11 (1) the mature stalks of such a cannabis plant,;​
7744-239.12 (2) fiber from such stalks,;​
7745-239.13 (3) any other compound, manufacture, salt, derivative, mixture, or preparation of such​
7746-239.14mature stalks, except the resin extracted therefrom, fiber, oil, or cake;​
7747-239.15 (4) oil or cake made from the seeds of such a cannabis plant, any other compound,​
7748-239.16manufacture, salt, derivative, mixture, or preparation of such mature stalks, except the resin​
7749-239.17extracted therefrom, fiber, oil, or cake, or;​
7750-239.18 (5) the sterilized seed of such a cannabis plant which is incapable of germination.​
7751-239.19Marijuana does not include; or​
7752-239.20 (6) industrial hemp as defined in section 152.22, subdivision 5a 18K.02, subdivision 3.​
7753-239.21Sec. 13. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7754-239.22read:​
7755-239.23 Subd. 5d.Indian lands."Indian lands" means all lands within the limits of any Indian​
7756-239.24reservation within the boundaries of Minnesota and any lands within the boundaries of​
7757-239.25Minnesota, title to which are either held in trust by the United States or over which an Indian​
7758-239.26Tribe exercises governmental power.​
7759-239.27 EFFECTIVE DATE.This section is effective the day following final enactment.​
7760-239​Article 6 Sec. 13.​
7761-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 240.1Sec. 14. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7762-240.2read:​
7763-240.3 Subd. 15.Tribal medical cannabis board."Tribal medical cannabis board" means an​
7764-240.4agency established by each federally recognized Tribal government and duly authorized by​
7765-240.5that Tribe's governing body to perform regulatory oversight and monitor compliance with​
7766-240.6a Tribal medical cannabis program and applicable regulations.​
7767-240.7 EFFECTIVE DATE.This section is effective the day following final enactment.​
7768-240.8Sec. 15. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7769-240.9read:​
7770-240.10 Subd. 16.Tribal medical cannabis program."Tribal medical cannabis program" means​
7771-240.11a program established by a federally recognized Tribal government within the boundaries​
7772-240.12of Minnesota regarding the commercial production, processing, sale or distribution, and​
7773-240.13possession of medical cannabis and medical cannabis products.​
7774-240.14 EFFECTIVE DATE.This section is effective the day following final enactment.​
7775-240.15Sec. 16. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7776-240.16read:​
7777-240.17 Subd. 17.Tribal medical cannabis program manufacturer."Tribal medical cannabis​
7778-240.18program manufacturer" means an entity designated by a Tribal medical cannabis board​
7779-240.19within the boundaries of Minnesota or a federally recognized Tribal government within the​
7780-240.20boundaries of Minnesota to engage in production, processing, and sale or distribution of​
7781-240.21medical cannabis and medical cannabis products under that Tribe's Tribal medical cannabis​
7782-240.22program.​
7783-240.23 EFFECTIVE DATE.This section is effective the day following final enactment.​
7784-240.24Sec. 17. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7785-240.25read:​
7786-240.26 Subd. 18.Tribal medical cannabis program patient."Tribal medical cannabis program​
7787-240.27patient" means a person who possesses a valid registration verification card or equivalent​
7788-240.28document that is issued under the laws or regulations of a Tribal Nation within the boundaries​
7789-240.29of Minnesota and that verifies that the person is enrolled in or authorized to participate in​
7790-240.30that Tribal Nation's Tribal medical cannabis program.​
7791-240.31 EFFECTIVE DATE.This section is effective the day following final enactment.​
7792-240​Article 6 Sec. 17.​
7793-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 241.1Sec. 18. Minnesota Statutes 2022, section 152.29, subdivision 4, is amended to read:​
7794-241.2 Subd. 4.Report.(a) Each manufacturer shall report to the commissioner on a monthly​
7795-241.3basis the following information on each individual patient for the month prior to the report:​
7796-241.4 (1) the amount and dosages of medical cannabis distributed;​
7797-241.5 (2) the chemical composition of the medical cannabis; and​
7798-241.6 (3) the tracking number assigned to any medical cannabis distributed.​
7799-241.7 (b) For transactions involving Tribal medical cannabis program patients, each​
7800-241.8manufacturer shall report to the commissioner on a weekly basis the following information​
7801-241.9on each individual Tribal medical cannabis program patient for the week prior to the report:​
7802-241.10 (1) the name of the Tribal medical cannabis program in which the Tribal medical cannabis​
7803-241.11program patient is enrolled;​
7804-241.12 (2) the amount and dosages of medical cannabis distributed;​
7805-241.13 (3) the chemical composition of the medical cannabis distributed; and​
7806-241.14 (4) the tracking number assigned to the medical cannabis distributed.​
7807-241.15 EFFECTIVE DATE.This section is effective the day following final enactment.​
7808-241.16Sec. 19. Minnesota Statutes 2022, section 152.29, is amended by adding a subdivision to​
7809-241.17read:​
7810-241.18 Subd. 5.Distribution to Tribal medical cannabis program patient.(a) A manufacturer​
7811-241.19may distribute medical cannabis in accordance with subdivisions 1 to 4 to a Tribal medical​
7812-241.20cannabis program patient.​
7813-241.21 (b) Prior to distribution, the Tribal medical cannabis program patient must provide to​
7814-241.22the manufacturer:​
7815-241.23 (1) a valid medical cannabis registration verification card or equivalent document issued​
7816-241.24by a Tribal medical cannabis program that indicates that the Tribal medical cannabis program​
7817-241.25patient is authorized to use medical cannabis on Indian lands over which the Tribe has​
7818-241.26jurisdiction; and​
7819-241.27 (2) a valid photographic identification card issued by the Tribal medical cannabis​
7820-241.28program, a valid driver's license, or a valid state identification card.​
7821-241.29 (c) A manufacturer shall distribute medical cannabis to a Tribal medical cannabis program​
7822-241.30patient only in a form allowed under section 152.22, subdivision 6.​
7823-241​Article 6 Sec. 19.​
7824-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 242.1 EFFECTIVE DATE.This section is effective the day following final enactment.​
7825-242.2Sec. 20. [152.291] TRIBAL MEDICAL CANNABIS PROGRAM MANUFACTURER​
7826-242.3TRANSPORTATION.​
7827-242.4 (a) A Tribal medical cannabis program manufacturer may transport medical cannabis​
7828-242.5to testing laboratories in the state and to other Indian lands.​
7829-242.6 (b) A Tribal medical cannabis program manufacturer must staff a motor vehicle used to​
7830-242.7transport medical cannabis with at least two employees of the manufacturer. Each employee​
7831-242.8in the transport vehicle must carry identification specifying that the employee is an employee​
7832-242.9of the manufacturer, and one employee in the transport vehicle must carry a detailed​
7833-242.10transportation manifest that includes the place and time of departure, the address of the​
7834-242.11destination, and a description and count of the medical cannabis being transported.​
7835-242.12 EFFECTIVE DATE.This section is effective the day following final enactment.​
7836-242.13Sec. 21. Minnesota Statutes 2022, section 152.30, is amended to read:​
7837-242.14 152.30 PATIENT DUTIES.​
7838-242.15 (a) A patient shall apply to the commissioner for enrollment in the registry program by​
7839-242.16submitting an application as required in section 152.27 and an annual registration fee as​
7840-242.17determined under section 152.35.​
7841-242.18 (b) As a condition of continued enrollment, patients shall agree to:​
7842-242.19 (1) continue to receive regularly scheduled treatment for their qualifying medical​
7843-242.20condition from their health care practitioner; and​
7844-242.21 (2) report changes in their qualifying medical condition to their health care practitioner.​
7845-242.22 (c) A patient shall only receive medical cannabis from a registered manufacturer or​
7846-242.23Tribal medical cannabis program but is not required to receive medical cannabis products​
7847-242.24from only a registered manufacturer or Tribal medical cannabis program.​
7848-242.25 EFFECTIVE DATE.This section is effective the day following final enactment.​
7849-242​Article 6 Sec. 21.​
7850-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 243.1Sec. 22. Minnesota Statutes 2022, section 152.32, is amended to read:​
7851-243.2 152.32 PROTECTIONS FOR REGISTRY PROGRAM OR TRIBAL MEDICAL​
7852-243.3CANNABIS PROGRAM PARTICIPATION.​
7853-243.4 Subdivision 1.Presumption.(a) There is a presumption that a patient enrolled in the​
7854-243.5registry program under sections 152.22 to 152.37 or a Tribal medical cannabis program​
7855-243.6patient is engaged in the authorized use of medical cannabis.​
7856-243.7 (b) The presumption may be rebutted by evidence that:​
7857-243.8 (1) a patient's conduct related to use of medical cannabis was not for the purpose of​
7858-243.9treating or alleviating the patient's qualifying medical condition or symptoms associated​
7859-243.10with the patient's qualifying medical condition.; or​
7860-243.11 (2) a Tribal medical cannabis program patient's use of medical cannabis was not for a​
7861-243.12purpose authorized by the Tribal medical cannabis program.​
7862-243.13 Subd. 2.Criminal and civil protections.(a) Subject to section 152.23, the following​
7863-243.14are not violations under this chapter:​
7864-243.15 (1) use or possession of medical cannabis or medical cannabis products by a patient​
7865-243.16enrolled in the registry program, or; possession by a registered designated caregiver or the​
7866-243.17parent, legal guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed​
7867-243.18on the registry verification; or use or possession of medical cannabis or medical cannabis​
7868-243.19products by a Tribal medical cannabis program patient;​
7869-243.20 (2) possession, dosage determination, or sale of medical cannabis or medical cannabis​
7870-243.21products by a medical cannabis manufacturer, employees of a manufacturer, a Tribal medical​
7871-243.22cannabis program manufacturer, employees of a Tribal medical cannabis program​
7872-243.23manufacturer, a laboratory conducting testing on medical cannabis, or employees of the​
7873-243.24laboratory; and​
7874-243.25 (3) possession of medical cannabis or medical cannabis products by any person while​
7875-243.26carrying out the duties required under sections 152.22 to 152.37.​
7876-243.27 (b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and​
7877-243.28associated property is not subject to forfeiture under sections 609.531 to 609.5316.​
7878-243.29 (c) The commissioner, members of a Tribal medical cannabis board, the commissioner's​
7879-243.30or Tribal medical cannabis board's staff, the commissioner's or Tribal medical cannabis​
7880-243.31board's agents or contractors, and any health care practitioner are not subject to any civil or​
7881-243.32disciplinary penalties by the Board of Medical Practice, the Board of Nursing, or by any​
7882-243​Article 6 Sec. 22.​
7883-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 244.1business, occupational, or professional licensing board or entity, solely for the participation​
7884-244.2in the registry program under sections 152.22 to 152.37 or in a Tribal medical cannabis​
7885-244.3program. A pharmacist licensed under chapter 151 is not subject to any civil or disciplinary​
7886-244.4penalties by the Board of Pharmacy when acting in accordance with the provisions of​
7887-244.5sections 152.22 to 152.37. Nothing in this section affects a professional licensing board​
7888-244.6from taking action in response to violations of any other section of law.​
7889-244.7 (d) Notwithstanding any law to the contrary, the commissioner, the governor of​
7890-244.8Minnesota, or an employee of any state agency may not be held civilly or criminally liable​
7891-244.9for any injury, loss of property, personal injury, or death caused by any act or omission​
7892-244.10while acting within the scope of office or employment under sections 152.22 to 152.37.​
7893-244.11 (e) Federal, state, and local law enforcement authorities are prohibited from accessing​
7894-244.12the patient registry under sections 152.22 to 152.37 except when acting pursuant to a valid​
7895-244.13search warrant.​
7896-244.14 (f) Notwithstanding any law to the contrary, neither the commissioner nor a public​
7897-244.15employee may release data or information about an individual contained in any report,​
7898-244.16document, or registry created under sections 152.22 to 152.37 or any information obtained​
7899-244.17about a patient participating in the program, except as provided in sections 152.22 to 152.37.​
7900-244.18 (g) No information contained in a report, document, or registry or obtained from a patient​
7901-244.19under sections 152.22 to 152.37 or from a Tribal medical cannabis program patient may be​
7902-244.20admitted as evidence in a criminal proceeding unless independently obtained or in connection​
7903-244.21with a proceeding involving a violation of sections 152.22 to 152.37.​
7904-244.22 (h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty​
7905-244.23of a gross misdemeanor.​
7906-244.24 (i) An attorney may not be subject to disciplinary action by the Minnesota Supreme​
7907-244.25Court, a Tribal court, or the professional responsibility board for providing legal assistance​
7908-244.26to prospective or registered manufacturers or others related to activity that is no longer​
7909-244.27subject to criminal penalties under state law pursuant to sections 152.22 to 152.37, or for​
7910-244.28providing legal assistance to a Tribal medical cannabis program or a Tribal medical cannabis​
7911-244.29program manufacturer.​
7912-244.30 (j) Possession of a registry verification or application for enrollment in the program by​
7913-244.31a person entitled to possess or apply for enrollment in the registry program does The​
7914-244.32following do not constitute probable cause or reasonable suspicion, nor and shall it not be​
7915-244.33used to support a search of the person or property of the person possessing or applying for​
7916-244​Article 6 Sec. 22.​
7917-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 245.1the registry verification or equivalent, or otherwise subject the person or property of the​
7918-245.2person to inspection by any governmental agency.:​
7919-245.3 (1) possession of a registry verification or application for enrollment in the registry​
7920-245.4program by a person entitled to possess a registry verification or apply for enrollment in​
7921-245.5the registry program; or​
7922-245.6 (2) possession of a verification or equivalent issued by a Tribal medical cannabis program​
7923-245.7or application for enrollment in a Tribal medical cannabis program by a person entitled to​
7924-245.8possess such a verification or application.​
7925-245.9 Subd. 3.Discrimination prohibited.(a) No school or landlord may refuse to enroll or​
7926-245.10lease to and may not otherwise penalize a person solely for the person's status as a patient​
7927-245.11enrolled in the registry program under sections 152.22 to 152.37 or for the person's status​
7928-245.12as a Tribal medical cannabis program patient, unless failing to do so would violate federal​
7929-245.13law or regulations or cause the school or landlord to lose a monetary or licensing-related​
7930-245.14benefit under federal law or regulations.​
7931-245.15 (b) For the purposes of medical care, including organ transplants, a registry program​
7932-245.16enrollee's use of medical cannabis under sections 152.22 to 152.37, or a Tribal medical​
7933-245.17cannabis program patient's use of medical cannabis as authorized by the Tribal medical​
7934-245.18cannabis program, is considered the equivalent of the authorized use of any other medication​
7935-245.19used at the discretion of a physician, advanced practice registered nurse, or physician assistant​
7936-245.20and does not constitute the use of an illicit substance or otherwise disqualify a patient from​
7937-245.21needed medical care.​
7938-245.22 (c) Unless a failure to do so would violate federal law or regulations or cause an employer​
7939-245.23to lose a monetary or licensing-related benefit under federal law or regulations, an employer​
7940-245.24may not discriminate against a person in hiring, termination, or any term or condition of​
7941-245.25employment, or otherwise penalize a person, if the discrimination is based upon either any​
7942-245.26of the following:​
7943-245.27 (1) the person's status as a patient enrolled in the registry program under sections 152.22​
7944-245.28to 152.37; or​
7945-245.29 (2) the person's status as a Tribal medical cannabis program patient; or​
7946-245.30 (2) (3) a patient's positive drug test for cannabis components or metabolites, unless the​
7947-245.31patient used, possessed, or was impaired by medical cannabis on the premises of the place​
7948-245.32of employment or during the hours of employment.​
7949-245​Article 6 Sec. 22.​
7950-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 246.1 (d) An employee who is required to undergo employer drug testing pursuant to section​
7951-246.2181.953 may present verification of enrollment in the patient registry or of enrollment in a​
7952-246.3Tribal medical cannabis program as part of the employee's explanation under section 181.953,​
7953-246.4subdivision 6.​
7954-246.5 (e) A person shall not be denied custody of a minor child or visitation rights or parenting​
7955-246.6time with a minor child solely based on the person's status as a patient enrolled in the registry​
7956-246.7program under sections 152.22 to 152.37, or on the person's status as a Tribal medical​
7957-246.8cannabis program patient. There shall be no presumption of neglect or child endangerment​
7958-246.9for conduct allowed under sections 152.22 to 152.37 or under a Tribal medical cannabis​
7959-246.10program, unless the person's behavior is such that it creates an unreasonable danger to the​
7960-246.11safety of the minor as established by clear and convincing evidence.​
7961-246.12 EFFECTIVE DATE.This section is effective the day following final enactment.​
7962-246.13Sec. 23. Minnesota Statutes 2022, section 152.33, subdivision 1, is amended to read:​
7963-246.14 Subdivision 1.Intentional diversion; criminal penalty.In addition to any other​
7964-246.15applicable penalty in law, a manufacturer or an agent of a manufacturer who intentionally​
7965-246.16transfers medical cannabis to a person other than another registered manufacturer, a patient,​
7966-246.17a Tribal medical cannabis program patient, a registered designated caregiver or, if listed on​
7967-246.18the registry verification, a parent, legal guardian, or spouse of a patient is guilty of a felony​
7968-246.19punishable by imprisonment for not more than two years or by payment of a fine of not​
7969-246.20more than $3,000, or both. A person convicted under this subdivision may not continue to​
7970-246.21be affiliated with the manufacturer and is disqualified from further participation under​
7971-246.22sections 152.22 to 152.37.​
7972-246.23 EFFECTIVE DATE.This section is effective the day following final enactment.​
7973-246.24Sec. 24. Minnesota Statutes 2022, section 152.35, is amended to read:​
7974-246.25 152.35 FEES; DEPOSIT OF REVENUE.​
7975-246.26 (a) The commissioner shall collect an enrollment fee of $200 from patients enrolled​
7976-246.27under this section. If the patient provides evidence of receiving Social Security disability​
7977-246.28insurance (SSDI), Supplemental Security Income (SSI), veterans disability, or railroad​
7978-246.29disability payments, or being enrolled in medical assistance or MinnesotaCare, then the fee​
7979-246.30shall be $50. For purposes of this section:​
7980-246​Article 6 Sec. 24.​
7981-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 247.1 (1) a patient is considered to receive SSDI if the patient was receiving SSDI at the time​
7982-247.2the patient was transitioned to retirement benefits by the United States Social Security​
7983-247.3Administration; and​
7984-247.4 (2) veterans disability payments include VA dependency and indemnity compensation.​
7985-247.5Unless a patient provides evidence of receiving payments from or participating in one of​
7986-247.6the programs specifically listed in this paragraph, the commissioner of health must collect​
7987-247.7the $200 enrollment fee from a patient to enroll the patient in the registry program. The fees​
7988-247.8shall be payable annually and are due on the anniversary date of the patient's enrollment.​
7989-247.9The fee amount shall be deposited in the state treasury and credited to the state government​
7990-247.10special revenue fund.​
7991-247.11 (b) (a) The commissioner shall collect an application fee of $20,000 from each entity​
7992-247.12submitting an application for registration as a medical cannabis manufacturer. Revenue​
7993-247.13from the fee shall be deposited in the state treasury and credited to the state government​
7994-247.14special revenue fund.​
7995-247.15 (c) (b) The commissioner shall establish and collect an annual fee from a medical cannabis​
7996-247.16manufacturer equal to the cost of regulating and inspecting the manufacturer in that year.​
7997-247.17Revenue from the fee amount shall be deposited in the state treasury and credited to the​
7998-247.18state government special revenue fund.​
7999-247.19 (d) (c) A medical cannabis manufacturer may charge patients enrolled in the registry​
8000-247.20program a reasonable fee for costs associated with the operations of the manufacturer. The​
8001-247.21manufacturer may establish a sliding scale of patient fees based upon a patient's household​
8002-247.22income and may accept private donations to reduce patient fees.​
8003-247.23 EFFECTIVE DATE.This section is effective the day following final enactment.​
8004-247.24Sec. 25. Minnesota Statutes 2022, section 175.45, subdivision 1, is amended to read:​
8005-247.25 Subdivision 1.Duties; goal.The commissioner of labor and industry shall convene​
8006-247.26industry representatives, identify occupational competency standards, and provide technical​
8007-247.27assistance to develop dual-training programs. The competency standards shall be identified​
8008-247.28for employment in occupations in advanced manufacturing, health care services, information​
8009-247.29technology, and agriculture, and the legal cannabis industry. Competency standards are not​
8010-247.30rules and are exempt from the rulemaking provisions of chapter 14, and the provisions in​
8011-247.31section 14.386 concerning exempt rules do not apply.​
8012-247​Article 6 Sec. 25.​
8013-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 248.1Sec. 26. Minnesota Statutes 2022, section 181.938, subdivision 2, is amended to read:​
8014-248.2 Subd. 2.Prohibited practice.(a) An employer may not refuse to hire a job applicant​
8015-248.3or discipline or discharge an employee because the applicant or employee engages in or has​
8016-248.4engaged in the use or enjoyment of lawful consumable products, if the use or enjoyment​
8017-248.5takes place off the premises of the employer during nonworking hours. For purposes of this​
8018-248.6section, "lawful consumable products" means products whose use or enjoyment is lawful​
8019-248.7and which are consumed during use or enjoyment, and includes food, alcoholic or​
8020-248.8nonalcoholic beverages, and tobacco, cannabis flower, as defined in section 342.01,​
8021-248.9subdivision 16, cannabis products, as defined in section 342.01, subdivision 20,​
8022-248.10lower-potency hemp edibles as defined in section 342.01, subdivision 50, and hemp-derived​
8023-248.11consumer products as defined in section 342.01, subdivision 37.​
8024-248.12 (b) Cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived​
8025-248.13consumer products are lawful consumable products for the purpose of Minnesota law,​
8026-248.14regardless of whether federal or other state law considers cannabis use, possession,​
8027-248.15impairment, sale, or transfer to be unlawful. Nothing in this section shall be construed to​
8028-248.16limit an employer's ability to discipline or discharge an employee for cannabis flower,​
8029-248.17cannabis product, lower-potency hemp edible, or hemp-derived consumer product use,​
8030-248.18possession, impairment, sale, or transfer during working hours, on work premises, or while​
8031-248.19operating an employer's vehicle, machinery, or equipment, or if a failure to do so would​
8032-248.20violate federal or state law or regulations or cause an employer to lose a monetary or​
8033-248.21licensing-related benefit under federal law or regulations.​
8034-248.22Sec. 27. Minnesota Statutes 2022, section 181.950, subdivision 2, is amended to read:​
8035-248.23 Subd. 2.Confirmatory test; confirmatory retest."Confirmatory test" and "confirmatory​
8036-248.24retest" mean a drug or alcohol test or cannabis test that uses a method of analysis allowed​
8037-248.25under one of the programs listed in section 181.953, subdivision 1.​
8038-248.26Sec. 28. Minnesota Statutes 2022, section 181.950, subdivision 4, is amended to read:​
8039-248.27 Subd. 4.Drug."Drug" means a controlled substance as defined in section 152.01,​
8040-248.28subdivision 4, but does not include marijuana, tetrahydrocannabinols, cannabis flower as​
8041-248.29defined in section 342.01, subdivision 16, cannabis products as defined in section 342.01,​
8042-248.30subdivision 20, lower-potency hemp edibles as defined in section 342.01, subdivision 50,​
8043-248.31and hemp-derived consumer products as defined in section 342.01, subdivision 37.​
8044-248​Article 6 Sec. 28.​
8045-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 249.1Sec. 29. Minnesota Statutes 2022, section 181.950, subdivision 5, is amended to read:​
8046-249.2 Subd. 5.Drug and alcohol testing."Drug and alcohol testing," "drug or alcohol testing,"​
8047-249.3and "drug or alcohol test" mean analysis of a body component sample according to the​
8048-249.4standards established under one of the programs listed in section 181.953, subdivision 1,​
8049-249.5for the purpose of measuring the presence or absence of drugs, alcohol, or their metabolites​
8050-249.6in the sample tested. "Drug and alcohol testing," "drug or alcohol testing," and "drug or​
8051-249.7alcohol test" do not include cannabis or cannabis testing, unless stated otherwise.​
8052-249.8Sec. 30. Minnesota Statutes 2022, section 181.950, is amended by adding a subdivision​
8053-249.9to read:​
8054-249.10 Subd. 5a.Cannabis testing."Cannabis testing" means the analysis of a body component​
8055-249.11sample according to the standards established under one of the programs listed in section​
8056-249.12181.953, subdivision 1, for the purpose of measuring the presence or absence of cannabis​
8057-249.13flower, as defined in section 342.01, subdivision 16, cannabis products, as defined in section​
8058-249.14342.01, subdivision 20, lower-potency hemp edibles as defined in section 342.01, subdivision​
8059-249.1550, hemp-derived consumer products as defined in section 342.01, subdivision 37, or cannabis​
8060-249.16metabolites in the sample tested. The definitions in this section apply to cannabis testing​
8061-249.17unless stated otherwise.​
8062-249.18Sec. 31. Minnesota Statutes 2022, section 181.950, subdivision 8, is amended to read:​
8063-249.19 Subd. 8.Initial screening test."Initial screening test" means a drug or alcohol test or​
8064-249.20cannabis test which uses a method of analysis under one of the programs listed in section​
8065-249.21181.953, subdivision 1.​
8066-249.22Sec. 32. Minnesota Statutes 2022, section 181.950, subdivision 13, is amended to read:​
8067-249.23 Subd. 13.Safety-sensitive position."Safety-sensitive position" means a job, including​
8068-249.24any supervisory or management position, in which an impairment caused by drug or, alcohol,​
8069-249.25or cannabis usage would threaten the health or safety of any person.​
8070-249.26Sec. 33. Minnesota Statutes 2022, section 181.951, subdivision 4, is amended to read:​
8071-249.27 Subd. 4.Random testing.An employer may request or require employees to undergo​
8072-249.28cannabis testing or drug and alcohol testing on a random selection basis only if (1) they are​
8073-249.29employed in safety-sensitive positions, or (2) they are employed as professional athletes if​
8074-249.30the professional athlete is subject to a collective bargaining agreement permitting random​
8075-249.31testing but only to the extent consistent with the collective bargaining agreement.​
8076-249​Article 6 Sec. 33.​
8077-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 250.1Sec. 34. Minnesota Statutes 2022, section 181.951, subdivision 5, is amended to read:​
8078-250.2 Subd. 5.Reasonable suspicion testing.An employer may request or require an employee​
8079-250.3to undergo cannabis testing and drug and alcohol testing if the employer has a reasonable​
8080-250.4suspicion that the employee:​
8081-250.5 (1) is under the influence of drugs or alcohol;​
8082-250.6 (2) has violated the employer's written work rules prohibiting the use, possession, sale,​
8083-250.7or transfer of drugs or alcohol, cannabis flower, cannabis products, lower-potency hemp​
8084-250.8edibles, or hemp-derived consumer products while the employee is working or while the​
8085-250.9employee is on the employer's premises or operating the employer's vehicle, machinery, or​
8086-250.10equipment, provided the work rules are in writing and contained in the employer's written​
8087-250.11cannabis testing or drug and alcohol testing policy;​
8088-250.12 (3) has sustained a personal injury, as that term is defined in section 176.011, subdivision​
8089-250.1316, or has caused another employee to sustain a personal injury; or​
8090-250.14 (4) has caused a work-related accident or was operating or helping to operate machinery,​
8091-250.15equipment, or vehicles involved in a work-related accident.​
8092-250.16Sec. 35. Minnesota Statutes 2022, section 181.951, subdivision 6, is amended to read:​
8093-250.17 Subd. 6.Treatment program testing.An employer may request or require an employee​
8094-250.18to undergo cannabis testing and drug and alcohol testing if the employee has been referred​
8095-250.19by the employer for substance use disorder treatment or evaluation or is participating in a​
8096-250.20substance use disorder treatment program under an employee benefit plan, in which case​
8097-250.21the employee may be requested or required to undergo cannabis testing and drug or alcohol​
8098-250.22testing without prior notice during the evaluation or treatment period and for a period of up​
8099-250.23to two years following completion of any prescribed substance use disorder treatment​
8100-250.24program.​
8101-250.25Sec. 36. Minnesota Statutes 2022, section 181.951, is amended by adding a subdivision​
8102-250.26to read:​
8103-250.27 Subd. 8.Limitations on cannabis testing.(a) An employer must not request or require​
8104-250.28a job applicant to undergo cannabis testing solely for the purpose of determining the presence​
8105-250.29or absence of cannabis as a condition of employment unless otherwise required by state or​
8106-250.30federal law.​
8107-250.31 (b) Unless otherwise required by state or federal law, an employer must not refuse to​
8108-250.32hire a job applicant solely because the job applicant submits to a cannabis test or a drug and​
8109-250​Article 6 Sec. 36.​
8110-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 251.1alcohol test authorized by this section and the results of the test indicate the presence of​
8111-251.2cannabis.​
8112-251.3 (c) An employer must not request or require an employee or job applicant to undergo​
8113-251.4cannabis testing on an arbitrary or capricious basis.​
8114-251.5 (d) Cannabis testing authorized under paragraph (d) must comply with the safeguards​
8115-251.6for testing employees provided in sections 181.953 and 181.954.​
8116-251.7Sec. 37. Minnesota Statutes 2022, section 181.951, is amended by adding a subdivision​
8117-251.8to read:​
8118-251.9 Subd. 9.Cannabis testing exceptions.For the following positions, cannabis and its​
8119-251.10metabolites are considered a drug and subject to the drug and alcohol testing provisions in​
8120-251.11sections 181.950 to 181.957:​
8121-251.12 (1) a safety-sensitive position, as defined in section 181.950, subdivision 13;​
8122-251.13 (2) a peace officer position, as defined in section 626.84, subdivision 1;​
8123-251.14 (3) a firefighter position, as defined in section 299N.01, subdivision 3;​
8124-251.15 (4) a position requiring face-to-face care, training, education, supervision, counseling,​
8125-251.16consultation, or medical assistance to:​
8126-251.17 (i) children;​
8127-251.18 (ii) vulnerable adults, as defined in section 626.5572, subdivision 21; or​
8128-251.19 (iii) patients who receive health care services from a provider for the treatment,​
8129-251.20examination, or emergency care of a medical, psychiatric, or mental condition;​
8130-251.21 (5) a position requiring a commercial driver's license or requiring an employee to operate​
8131-251.22a motor vehicle for which state or federal law requires drug or alcohol testing of a job​
8132-251.23applicant or an employee;​
8133-251.24 (6) a position of employment funded by a federal grant; or​
8134-251.25 (7) any other position for which state or federal law requires testing of a job applicant​
8135-251.26or an employee for cannabis.​
8136-251.27Sec. 38. Minnesota Statutes 2022, section 181.952, is amended by adding a subdivision​
8137-251.28to read:​
8138-251.29 Subd. 3.Cannabis policy.(a) Unless otherwise provided by state or federal law, an​
8139-251.30employer is not required to permit or accommodate cannabis flower, cannabis product,​
8140-251​Article 6 Sec. 38.​
8141-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 252.1lower-potency hemp edible, or hemp-derived consumer product use, possession, impairment,​
8142-252.2sale, or transfer while an employee is working or while an employee is on the employer's​
8143-252.3premises or operating the employer's vehicle, machinery, or equipment.​
8144-252.4 (b) An employer may only enact and enforce written work rules prohibiting cannabis​
8145-252.5flower, cannabis product, lower-potency hemp edible, and hemp-derived consumer product​
8146-252.6use, possession, impairment, sale, or transfer while an employee, is working or while an​
8147-252.7employee is on the employer's premises or operating the employer's vehicle, machinery, or​
8148-252.8equipment in a written policy that contains the minimum information required by this section.​
8149-252.9Sec. 39. Minnesota Statutes 2022, section 181.953, is amended to read:​
8150-252.10 181.953 RELIABILITY AND FAIRNESS SAFEGUARDS.​
8151-252.11 Subdivision 1.Use of licensed, accredited, or certified laboratory required.(a) An​
8152-252.12employer who requests or requires an employee or job applicant to undergo drug or alcohol​
8153-252.13testing or cannabis testing shall use the services of a testing laboratory that meets one of​
8154-252.14the following criteria for drug testing:​
8155-252.15 (1) is certified by the National Institute on Drug Abuse as meeting the mandatory​
8156-252.16guidelines published at 53 Federal Register 11970 to 11989, April 11, 1988;​
8157-252.17 (2) is accredited by the College of American Pathologists, 325 Waukegan Road,​
8158-252.18Northfield, Illinois, 60093-2750, under the forensic urine drug testing laboratory program;​
8159-252.19or​
8160-252.20 (3) is licensed to test for drugs by the state of New York, Department of Health, under​
8161-252.21Public Health Law, article 5, title V, and rules adopted under that law.​
8162-252.22 (b) For alcohol testing, the laboratory must either be:​
8163-252.23 (1) licensed to test for drugs and alcohol by the state of New York, Department of Health,​
8164-252.24under Public Health Law, article 5, title V, and the rules adopted under that law; or​
8165-252.25 (2) accredited by the College of American Pathologists, 325 Waukegan Road, Northfield,​
8166-252.26Illinois, 60093-2750, in the laboratory accreditation program.​
8167-252.27 Subd. 3.Laboratory testing, reporting, and sample retention requirements.A testing​
8168-252.28laboratory that is not certified by the National Institute on Drug Abuse according to​
8169-252.29subdivision 1 shall follow the chain-of-custody procedures prescribed for employers in​
8170-252.30subdivision 5. A testing laboratory shall conduct a confirmatory test on all samples that​
8171-252.31produced a positive test result on an initial screening test. A laboratory shall disclose to the​
8172-252.32employer a written test result report for each sample tested within three working days after​
8173-252​Article 6 Sec. 39.​
8174-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 253.1a negative test result on an initial screening test or, when the initial screening test produced​
8175-253.2a positive test result, within three working days after a confirmatory test. A test report must​
8176-253.3indicate the drugs, alcohol, or drug or alcohol metabolites, or cannabis or cannabis​
8177-253.4metabolites tested for and whether the test produced negative or positive test results. A​
8178-253.5laboratory shall retain and properly store for at least six months all samples that produced​
8179-253.6a positive test result.​
8180-253.7 Subd. 4.Prohibitions on employers.An employer may not conduct drug or alcohol​
8181-253.8testing or cannabis testing of its own employees and job applicants using a testing laboratory​
8182-253.9owned and operated by the employer; except that, one agency of the state may test the​
8183-253.10employees of another agency of the state. Except as provided in subdivision 9, an employer​
8184-253.11may not request or require an employee or job applicant to contribute to, or pay the cost of,​
8185-253.12drug or alcohol testing or cannabis testing under sections 181.950 to 181.954.​
8186-253.13 Subd. 5.Employer chain-of-custody procedures.An employer shall establish its own​
8187-253.14reliable chain-of-custody procedures to ensure proper record keeping, handling, labeling,​
8188-253.15and identification of the samples to be tested. The procedures must require the following:​
8189-253.16 (1) possession of a sample must be traceable to the employee from whom the sample is​
8190-253.17collected, from the time the sample is collected through the time the sample is delivered to​
8191-253.18the laboratory;​
8192-253.19 (2) the sample must always be in the possession of, must always be in view of, or must​
8193-253.20be placed in a secured area by a person authorized to handle the sample;​
8194-253.21 (3) a sample must be accompanied by a written chain-of-custody record; and​
8195-253.22 (4) individuals relinquishing or accepting possession of the sample must record the time​
8196-253.23the possession of the sample was transferred and must sign and date the chain-of-custody​
8197-253.24record at the time of transfer.​
8198-253.25 Subd. 6.Rights of employees and job applicants.(a) Before requesting an employee​
8199-253.26or job applicant to undergo drug or alcohol testing or requesting cannabis testing, an employer​
8200-253.27shall provide the employee or job applicant with a form, developed by the employer, on​
8201-253.28which to acknowledge that the employee or job applicant has seen the employer's drug and​
8202-253.29alcohol testing or cannabis testing policy.​
8203-253.30 (b) If an employee or job applicant tests positive for drug use, the employee must be​
8204-253.31given written notice of the right to explain the positive test and the employer may request​
8205-253.32that the employee or job applicant indicate any over-the-counter or prescription medication​
8206-253​Article 6 Sec. 39.​
8207-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 254.1that the individual is currently taking or has recently taken and any other information relevant​
8208-254.2to the reliability of, or explanation for, a positive test result.​
8209-254.3 (c) Within three working days after notice of a positive test result on a confirmatory test,​
8210-254.4the employee or job applicant may submit information to the employer, in addition to any​
8211-254.5information already submitted under paragraph (b), to explain that result, or may request a​
8212-254.6confirmatory retest of the original sample at the employee's or job applicant's own expense​
8213-254.7as provided under subdivision 9.​
8214-254.8 Subd. 7.Notice of test results.Within three working days after receipt of a test result​
8215-254.9report from the testing laboratory, an employer shall inform in writing an employee or job​
8216-254.10applicant who has undergone drug or alcohol testing or cannabis testing of (1) a negative​
8217-254.11test result on an initial screening test or of a negative or positive test result on a confirmatory​
8218-254.12test and (2) the right provided in subdivision 8. In the case of a positive test result on a​
8219-254.13confirmatory test, the employer shall also, at the time of this notice, inform the employee​
8220-254.14or job applicant in writing of the rights provided in subdivisions 6, paragraph (b), 9, and​
8221-254.15either subdivision 10 or 11, whichever applies.​
8222-254.16 Subd. 8.Right to test result report.An employee or job applicant has the right to​
8223-254.17request and receive from the employer a copy of the test result report on any drug or alcohol​
8224-254.18test or cannabis test.​
8225-254.19 Subd. 9.Confirmatory retests.An employee or job applicant may request a confirmatory​
8226-254.20retest of the original sample at the employee's or job applicant's own expense after notice​
8227-254.21of a positive test result on a confirmatory test. Within five working days after notice of the​
8228-254.22confirmatory test result, the employee or job applicant shall notify the employer in writing​
8229-254.23of the employee's or job applicant's intention to obtain a confirmatory retest. Within three​
8230-254.24working days after receipt of the notice, the employer shall notify the original testing​
8231-254.25laboratory that the employee or job applicant has requested the laboratory to conduct the​
8232-254.26confirmatory retest or transfer the sample to another laboratory licensed under subdivision​
8233-254.271 to conduct the confirmatory retest. The original testing laboratory shall ensure that the​
8234-254.28chain-of-custody procedures in subdivision 3 are followed during transfer of the sample to​
8235-254.29the other laboratory. The confirmatory retest must use the same drug or, alcohol, or cannabis​
8236-254.30threshold detection levels as used in the original confirmatory test. If the confirmatory retest​
8237-254.31does not confirm the original positive test result, no adverse personnel action based on the​
8238-254.32original confirmatory test may be taken against the employee or job applicant.​
8239-254.33 Subd. 10.Limitations on employee discharge, discipline, or discrimination.(a) An​
8240-254.34employer may not discharge, discipline, discriminate against, or request or require​
8241-254​Article 6 Sec. 39.​
8242-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 255.1rehabilitation of an employee on the basis of a positive test result from an initial screening​
8243-255.2test that has not been verified by a confirmatory test.​
8244-255.3 (b) In addition to the limitation under paragraph (a), an employer may not discharge an​
8245-255.4employee for whom a positive test result on a confirmatory test was the first such result for​
8246-255.5the employee on a drug or alcohol test or cannabis test requested by the employer unless​
8247-255.6the following conditions have been met:​
8248-255.7 (1) the employer has first given the employee an opportunity to participate in, at the​
8249-255.8employee's own expense or pursuant to coverage under an employee benefit plan, either a​
8250-255.9drug or, alcohol, or cannabis counseling or rehabilitation program, whichever is more​
8251-255.10appropriate, as determined by the employer after consultation with a certified chemical use​
8252-255.11counselor or a physician trained in the diagnosis and treatment of substance use disorder;​
8253-255.12and​
8254-255.13 (2) the employee has either refused to participate in the counseling or rehabilitation​
8255-255.14program or has failed to successfully complete the program, as evidenced by withdrawal​
8256-255.15from the program before its completion or by a positive test result on a confirmatory test​
8257-255.16after completion of the program.​
8258-255.17 (c) Notwithstanding paragraph (a), an employer may temporarily suspend the tested​
8259-255.18employee or transfer that employee to another position at the same rate of pay pending the​
8260-255.19outcome of the confirmatory test and, if requested, the confirmatory retest, provided the​
8261-255.20employer believes that it is reasonably necessary to protect the health or safety of the​
8262-255.21employee, coemployees, or the public. An employee who has been suspended without pay​
8263-255.22must be reinstated with back pay if the outcome of the confirmatory test or requested​
8264-255.23confirmatory retest is negative.​
8265-255.24 (d) An employer may not discharge, discipline, discriminate against, or request or require​
8266-255.25rehabilitation of an employee on the basis of medical history information revealed to the​
8267-255.26employer pursuant to subdivision 6 unless the employee was under an affirmative duty to​
8268-255.27provide the information before, upon, or after hire.​
8269-255.28 (e) An employee must be given access to information in the employee's personnel file​
8270-255.29relating to positive test result reports and other information acquired in the drug and alcohol​
8271-255.30testing process or cannabis testing process and conclusions drawn from and actions taken​
8272-255.31based on the reports or other acquired information.​
8273-255.32 Subd. 10a.Additional limitations for cannabis.An employer may discipline, discharge,​
8274-255.33or take other adverse personnel action against an employee for cannabis flower, cannabis​
8275-255.34product, lower-potency hemp edible, or hemp-derived consumer product use, possession,​
8276-255​Article 6 Sec. 39.​
8277-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 256.1impairment, sale, or transfer while an employee is working, on the employer's premises, or​
8278-256.2operating the employer's vehicle, machinery, or equipment as follows:​
8279-256.3 (1) if, as the result of consuming cannabis flower, a cannabis product, a lower-potency​
8280-256.4hemp edible, or a hemp-derived consumer product, the employee does not possess that​
8281-256.5clearness of intellect and control of self that the employee otherwise would have;​
8282-256.6 (2) if cannabis testing verifies the presence of cannabis flower, a cannabis product, a​
8283-256.7lower-potency hemp edible, or a hemp-derived consumer product following a confirmatory​
8284-256.8test;​
8285-256.9 (3) as provided in the employer's written work rules for cannabis flower, cannabis​
8286-256.10products, lower-potency hemp edibles, or hemp-derived consumer products and cannabis​
8287-256.11testing, provided that the rules are in writing and in a written policy that contains the​
8288-256.12minimum information required by section 181.952; or​
8289-256.13 (4) as otherwise authorized or required under state or federal law or regulations, or if a​
8290-256.14failure to do so would cause an employer to lose a monetary or licensing-related benefit​
8291-256.15under federal law or regulations.​
8292-256.16 Subd. 11.Limitation on withdrawal of job offer.If a job applicant has received a job​
8293-256.17offer made contingent on the applicant passing drug and alcohol testing, the employer may​
8294-256.18not withdraw the offer based on a positive test result from an initial screening test that has​
8295-256.19not been verified by a confirmatory test.​
8296-256.20Sec. 40. Minnesota Statutes 2022, section 181.954, is amended to read:​
8297-256.21 181.954 PRIVACY, CONFIDENTIALITY, AND PRIVILEGE SAFEGUARDS.​
8298-256.22 Subdivision 1.Privacy limitations.A laboratory may only disclose to the employer test​
8299-256.23result data regarding the presence or absence of drugs, alcohol, or their metabolites in a​
8300-256.24sample tested.​
8301-256.25 Subd. 2.Confidentiality limitations.Test result reports and other information acquired​
8302-256.26in the drug or alcohol testing or cannabis testing process are, with respect to private sector​
8303-256.27employees and job applicants, private and confidential information, and, with respect to​
8304-256.28public sector employees and job applicants, private data on individuals as that phrase is​
8305-256.29defined in chapter 13, and may not be disclosed by an employer or laboratory to another​
8306-256.30employer or to a third-party individual, governmental agency, or private organization without​
8307-256.31the written consent of the employee or job applicant tested.​
8308-256​Article 6 Sec. 40.​
8309-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 257.1 Subd. 3.Exceptions to privacy and confidentiality disclosure​
8310-257.2limitations.Notwithstanding subdivisions 1 and 2, evidence of a positive test result on a​
8311-257.3confirmatory test may be: (1) used in an arbitration proceeding pursuant to a collective​
8312-257.4bargaining agreement, an administrative hearing under chapter 43A or other applicable state​
8313-257.5or local law, or a judicial proceeding, provided that information is relevant to the hearing​
8314-257.6or proceeding; (2) disclosed to any federal agency or other unit of the United States​
8315-257.7government as required under federal law, regulation, or order, or in accordance with​
8316-257.8compliance requirements of a federal government contract; and (3) disclosed to a substance​
8317-257.9abuse treatment facility for the purpose of evaluation or treatment of the employee.​
8318-257.10 Subd. 4.Privilege.Positive test results from an employer drug or alcohol testing or​
8319-257.11cannabis testing program may not be used as evidence in a criminal action against the​
8320-257.12employee or job applicant tested.​
8321-257.13Sec. 41. Minnesota Statutes 2022, section 181.955, is amended to read:​
8322-257.14 181.955 CONSTRUCTION.​
8323-257.15 Subdivision 1.Freedom to collectively bargain.Sections 181.950 to 181.954 shall not​
8324-257.16be construed to limit the parties to a collective bargaining agreement from bargaining and​
8325-257.17agreeing with respect to a drug and alcohol testing or a cannabis testing policy that meets​
8326-257.18or exceeds, and does not otherwise conflict with, the minimum standards and requirements​
8327-257.19for employee protection provided in those sections.​
8328-257.20 Subd. 2.Employee protections under existing collective bargaining​
8329-257.21agreements.Sections 181.950 to 181.954 shall not be construed to interfere with or diminish​
8330-257.22any employee protections relating to drug and alcohol testing or cannabis testing already​
8331-257.23provided under collective bargaining agreements in effect on the effective date of those​
8332-257.24sections that exceed the minimum standards and requirements for employee protection​
8333-257.25provided in those sections.​
8334-257.26 Subd. 3.Professional athletes.Sections 181.950 to 181.954 shall not be construed to​
8335-257.27interfere with the operation of a drug and alcohol testing or cannabis testing program if:​
8336-257.28 (1) the drug and alcohol testing program is permitted under a contract between the​
8337-257.29employer and employees; and​
8338-257.30 (2) the covered employees are employed as professional athletes.​
8339-257.31 Upon request of the commissioner of labor and industry, the exclusive representative​
8340-257.32of the employees and the employer shall certify to the commissioner of labor and industry​
8341-257.33that the drug and alcohol testing or cannabis testing program permitted under the contract​
8342-257​Article 6 Sec. 41.​
8343-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 258.1should operate without interference from the sections specified in this subdivision. This​
8344-258.2subdivision must not be construed to create an exemption from controlled substance crimes​
8345-258.3in chapter 152.​
8346-258.4Sec. 42. Minnesota Statutes 2022, section 181.957, subdivision 1, is amended to read:​
8347-258.5 Subdivision 1.Excluded employees and job applicants.Except as provided under​
8348-258.6subdivision 2, the employee and job applicant protections provided under sections 181.950​
8349-258.7to 181.956 do not apply to employees and job applicants where the specific work performed​
8350-258.8requires those employees and job applicants to be subject to drug and alcohol testing or​
8351-258.9cannabis testing pursuant to:​
8352-258.10 (1) federal regulations that specifically preempt state regulation of drug and alcohol​
8353-258.11testing or cannabis testing with respect to those employees and job applicants;​
8354-258.12 (2) federal regulations or requirements necessary to operate federally regulated facilities;​
8355-258.13 (3) federal contracts where the drug and alcohol testing or cannabis testing is conducted​
8356-258.14for security, safety, or protection of sensitive or proprietary data; or​
8357-258.15 (4) state agency rules that adopt federal regulations applicable to the interstate component​
8358-258.16of a federally regulated industry, and the adoption of those rules is for the purpose of​
8359-258.17conforming the nonfederally regulated intrastate component of the industry to identical​
8360-258.18regulation.​
8361-258.19Sec. 43. Minnesota Statutes 2022, section 245C.08, subdivision 1, is amended to read:​
8362-258.20 Subdivision 1.Background studies conducted by Department of Human Services.(a)​
8363-258.21For a background study conducted by the Department of Human Services, the commissioner​
8364-258.22shall review:​
8365-258.23 (1) information related to names of substantiated perpetrators of maltreatment of​
8366-258.24vulnerable adults that has been received by the commissioner as required under section​
8367-258.25626.557, subdivision 9c, paragraph (j);​
8368-258.26 (2) the commissioner's records relating to the maltreatment of minors in licensed​
8369-258.27programs, and from findings of maltreatment of minors as indicated through the social​
8370-258.28service information system;​
8371-258.29 (3) information from juvenile courts as required in subdivision 4 for individuals listed​
8372-258.30in section 245C.03, subdivision 1, paragraph (a), when there is reasonable cause;​
8373-258​Article 6 Sec. 43.​
8374-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 259.1 (4) information from the Bureau of Criminal Apprehension, including information​
8375-259.2regarding a background study subject's registration in Minnesota as a predatory offender​
8376-259.3under section 243.166;​
8377-259.4 (5) except as provided in clause (6), information received as a result of submission of​
8378-259.5fingerprints for a national criminal history record check, as defined in section 245C.02,​
8379-259.6subdivision 13c, when the commissioner has reasonable cause for a national criminal history​
8380-259.7record check as defined under section 245C.02, subdivision 15a, or as required under section​
8381-259.8144.057, subdivision 1, clause (2);​
8382-259.9 (6) for a background study related to a child foster family setting application for licensure,​
8383-259.10foster residence settings, children's residential facilities, a transfer of permanent legal and​
8384-259.11physical custody of a child under sections 260C.503 to 260C.515, or adoptions, and for a​
8385-259.12background study required for family child care, certified license-exempt child care, child​
8386-259.13care centers, and legal nonlicensed child care authorized under chapter 119B, the​
8387-259.14commissioner shall also review:​
8388-259.15 (i) information from the child abuse and neglect registry for any state in which the​
8389-259.16background study subject has resided for the past five years;​
8390-259.17 (ii) when the background study subject is 18 years of age or older, or a minor under​
8391-259.18section 245C.05, subdivision 5a, paragraph (c), information received following submission​
8392-259.19of fingerprints for a national criminal history record check; and​
8393-259.20 (iii) when the background study subject is 18 years of age or older or a minor under​
8394-259.21section 245C.05, subdivision 5a, paragraph (d), for licensed family child care, certified​
8395-259.22license-exempt child care, licensed child care centers, and legal nonlicensed child care​
8396-259.23authorized under chapter 119B, information obtained using non-fingerprint-based data​
8397-259.24including information from the criminal and sex offender registries for any state in which​
8398-259.25the background study subject resided for the past five years and information from the national​
8399-259.26crime information database and the national sex offender registry; and​
8400-259.27 (7) for a background study required for family child care, certified license-exempt child​
8401-259.28care centers, licensed child care centers, and legal nonlicensed child care authorized under​
8402-259.29chapter 119B, the background study shall also include, to the extent practicable, a name​
8403-259.30and date-of-birth search of the National Sex Offender Public website.​
8404-259.31 (b) Except as otherwise provided in this paragraph, notwithstanding expungement by a​
8405-259.32court, the commissioner may consider information obtained under paragraph (a), clauses​
8406-259.33(3) and (4), unless the commissioner received notice of the petition for expungement and​
8407-259.34the court order for expungement is directed specifically to the commissioner. The​
8408-259​Article 6 Sec. 43.​
8409-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 260.1commissioner may not consider information obtained under paragraph (a), clauses (3) and​
8410-260.2(4), or from any other source that identifies a violation of chapter 152 without determining​
8411-260.3if the offense involved the possession of marijuana or tetrahydrocannabinol and, if so,​
8412-260.4whether the person received a grant of expungement or order of expungement, or the person​
8413-260.5was resentenced to a lesser offense. If the person received a grant of expungement or order​
8414-260.6of expungement, the commissioner may not consider information related to that violation​
8415-260.7but may consider any other relevant information arising out of the same incident.​
8416-260.8 (c) The commissioner shall also review criminal case information received according​
8417-260.9to section 245C.04, subdivision 4a, from the Minnesota court information system that relates​
8418-260.10to individuals who have already been studied under this chapter and who remain affiliated​
8419-260.11with the agency that initiated the background study.​
8420-260.12 (d) When the commissioner has reasonable cause to believe that the identity of a​
8421-260.13background study subject is uncertain, the commissioner may require the subject to provide​
8422-260.14a set of classifiable fingerprints for purposes of completing a fingerprint-based record check​
8423-260.15with the Bureau of Criminal Apprehension. Fingerprints collected under this paragraph​
8424-260.16shall not be saved by the commissioner after they have been used to verify the identity of​
8425-260.17the background study subject against the particular criminal record in question.​
8426-260.18 (e) The commissioner may inform the entity that initiated a background study under​
8427-260.19NETStudy 2.0 of the status of processing of the subject's fingerprints.​
8428-260.20Sec. 44. Minnesota Statutes 2022, section 256.01, subdivision 18c, is amended to read:​
8429-260.21 Subd. 18c.Drug convictions.(a) The state court administrator shall provide a report​
8430-260.22every six months by electronic means to the commissioner of human services, including​
8431-260.23the name, address, date of birth, and, if available, driver's license or state identification card​
8432-260.24number, date of the sentence, effective date of the sentence, and county in which the​
8433-260.25conviction occurred, of each person convicted of a felony under chapter 152, except for​
8434-260.26convictions under section 152.0263 or 152.0264, during the previous six months.​
8435-260.27 (b) The commissioner shall determine whether the individuals who are the subject of​
8436-260.28the data reported under paragraph (a) are receiving public assistance under chapter 256D​
8437-260.29or 256J, and if the an individual is receiving assistance under chapter 256D or 256J, the​
8438-260.30commissioner shall instruct the county to proceed under section 256D.024 or 256J.26,​
8439-260.31whichever is applicable, for this individual.​
8440-260​Article 6 Sec. 44.​
8441-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 261.1 (c) The commissioner shall not retain any data received under paragraph (a) or (d) that​
8442-261.2does not relate to an individual receiving publicly funded assistance under chapter 256D or​
8443-261.3256J.​
8444-261.4 (d) In addition to the routine data transfer under paragraph (a), the state court​
8445-261.5administrator shall provide a onetime report of the data fields under paragraph (a) for​
8446-261.6individuals with a felony drug conviction under chapter 152 dated from July 1, 1997, until​
8447-261.7the date of the data transfer. The commissioner shall perform the tasks identified under​
8448-261.8paragraph (b) related to this data and shall retain the data according to paragraph (c).​
8449-261.9Sec. 45. Minnesota Statutes 2022, section 256B.0625, subdivision 13d, is amended to​
8450-261.10read:​
8451-261.11 Subd. 13d.Drug formulary.(a) The commissioner shall establish a drug formulary. Its​
8452-261.12establishment and publication shall not be subject to the requirements of the Administrative​
8453-261.13Procedure Act, but the Formulary Committee shall review and comment on the formulary​
8454-261.14contents.​
8455-261.15 (b) The formulary shall not include:​
8456-261.16 (1) drugs, active pharmaceutical ingredients, or products for which there is no federal​
8457-261.17funding;​
8458-261.18 (2) over-the-counter drugs, except as provided in subdivision 13;​
8459-261.19 (3) drugs or active pharmaceutical ingredients when used for the treatment of impotence​
8460-261.20or erectile dysfunction;​
8461-261.21 (4) drugs or active pharmaceutical ingredients for which medical value has not been​
8462-261.22established;​
8463-261.23 (5) drugs from manufacturers who have not signed a rebate agreement with the​
8464-261.24Department of Health and Human Services pursuant to section 1927 of title XIX of the​
8465-261.25Social Security Act; and​
8466-261.26 (6) medical cannabis flower as defined in section 152.22, subdivision 6 342.01,​
8467-261.27subdivision 54, or medical cannabinoid products as defined in section 342.01, subdivision​
8468-261.2852.​
8469-261.29 (c) If a single-source drug used by at least two percent of the fee-for-service medical​
8470-261.30assistance recipients is removed from the formulary due to the failure of the manufacturer​
8471-261.31to sign a rebate agreement with the Department of Health and Human Services, the​
8472-261.32commissioner shall notify prescribing practitioners within 30 days of receiving notification​
8473-261​Article 6 Sec. 45.​
8474-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 262.1from the Centers for Medicare and Medicaid Services (CMS) that a rebate agreement was​
8475-262.2not signed.​
8476-262.3Sec. 46. Minnesota Statutes 2022, section 256D.024, subdivision 1, is amended to read:​
8477-262.4 Subdivision 1.Person convicted of drug offenses.(a) If an applicant or recipient has​
8478-262.5been convicted of a drug offense after July 1, 1997, the assistance unit is ineligible for​
8479-262.6benefits under this chapter until five years after the applicant has completed terms of the​
8480-262.7court-ordered sentence, unless the person is participating in a drug treatment program, has​
8481-262.8successfully completed a drug treatment program, or has been assessed by the county and​
8482-262.9determined not to be in need of a drug treatment program. Persons subject to the limitations​
8483-262.10of this subdivision who become eligible for assistance under this chapter shall be subject​
8484-262.11to random drug testing as a condition of continued eligibility and shall lose eligibility for​
8485-262.12benefits for five years beginning the month following:​
8486-262.13 (1) any positive test result for an illegal controlled substance; or​
8487-262.14 (2) discharge of sentence after conviction for another drug felony.​
8488-262.15 (b) For the purposes of this subdivision, "drug offense" means a conviction that occurred​
8489-262.16after July 1, 1997, of sections 152.021 to 152.025, 152.0261, 152.0262, or 152.096. Drug​
8490-262.17offense also means a conviction in another jurisdiction of the possession, use, or distribution​
8491-262.18of a controlled substance, or conspiracy to commit any of these offenses, if the offense​
8492-262.19occurred after July 1, 1997, and the conviction is a felony offense in that jurisdiction, or in​
8493-262.20the case of New Jersey, a high misdemeanor for a crime that would be a felony if committed​
8494-262.21in Minnesota.​
8495-262.22 (c) This subdivision does not apply for convictions or positive test results related to​
8496-262.23cannabis, marijuana, or tetrahydrocannabinols.​
8497-262.24Sec. 47. Minnesota Statutes 2022, section 256D.024, subdivision 3, is amended to read:​
8498-262.25 Subd. 3.Fleeing felons.An individual who is fleeing to avoid prosecution, or custody,​
8499-262.26or confinement after conviction for a crime that is a felony under the laws of the jurisdiction​
8500-262.27from which the individual flees, or in the case of New Jersey, is a high misdemeanor, would​
8501-262.28be a felony if committed in Minnesota, is ineligible to receive benefits under this chapter.​
8502-262​Article 6 Sec. 47.​
8503-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 263.1Sec. 48. Minnesota Statutes 2022, section 256J.26, subdivision 1, is amended to read:​
8504-263.2 Subdivision 1.Person convicted of drug offenses.(a) An individual who has been​
8505-263.3convicted of a felony level drug offense committed during the previous ten years from the​
8506-263.4date of application or recertification is subject to the following:​
8507-263.5 (1) Benefits for the entire assistance unit must be paid in vendor form for shelter and​
8508-263.6utilities during any time the applicant is part of the assistance unit.​
8509-263.7 (2) The convicted applicant or participant shall be subject to random drug testing as a​
8510-263.8condition of continued eligibility and following any positive test for an illegal controlled​
8511-263.9substance is subject to the following sanctions:​
8512-263.10 (i) for failing a drug test the first time, the residual amount of the participant's grant after​
8513-263.11making vendor payments for shelter and utility costs, if any, must be reduced by an amount​
8514-263.12equal to 30 percent of the MFIP standard of need for an assistance unit of the same size.​
8515-263.13When a sanction under this subdivision is in effect, the job counselor must attempt to meet​
8516-263.14with the person face-to-face. During the face-to-face meeting, the job counselor must explain​
8517-263.15the consequences of a subsequent drug test failure and inform the participant of the right to​
8518-263.16appeal the sanction under section 256J.40. If a face-to-face meeting is not possible, the​
8519-263.17county agency must send the participant a notice of adverse action as provided in section​
8520-263.18256J.31, subdivisions 4 and 5, and must include the information required in the face-to-face​
8521-263.19meeting; or​
8522-263.20 (ii) for failing a drug test two times, the participant is permanently disqualified from​
8523-263.21receiving MFIP assistance, both the cash and food portions. The assistance unit's MFIP​
8524-263.22grant must be reduced by the amount which would have otherwise been made available to​
8525-263.23the disqualified participant. Disqualification under this item does not make a participant​
8526-263.24ineligible for the Supplemental Nutrition Assistance Program (SNAP). Before a​
8527-263.25disqualification under this provision is imposed, the job counselor must attempt to meet​
8528-263.26with the participant face-to-face. During the face-to-face meeting, the job counselor must​
8529-263.27identify other resources that may be available to the participant to meet the needs of the​
8530-263.28family and inform the participant of the right to appeal the disqualification under section​
8531-263.29256J.40. If a face-to-face meeting is not possible, the county agency must send the participant​
8532-263.30a notice of adverse action as provided in section 256J.31, subdivisions 4 and 5, and must​
8533-263.31include the information required in the face-to-face meeting.​
8534-263.32 (3) A participant who fails a drug test the first time and is under a sanction due to other​
8535-263.33MFIP program requirements is considered to have more than one occurrence of​
8536-263​Article 6 Sec. 48.​
8537-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 264.1noncompliance and is subject to the applicable level of sanction as specified under section​
8538-264.2256J.46, subdivision 1, paragraph (d).​
8539-264.3 (b) Applicants requesting only SNAP benefits or participants receiving only SNAP​
8540-264.4benefits, who have been convicted of a drug offense that occurred after July 1, 1997, may,​
8541-264.5if otherwise eligible, receive SNAP benefits if the convicted applicant or participant is​
8542-264.6subject to random drug testing as a condition of continued eligibility. Following a positive​
8543-264.7test for an illegal controlled substance, the applicant is subject to the following sanctions:​
8544-264.8 (1) for failing a drug test the first time, SNAP benefits shall be reduced by an amount​
8545-264.9equal to 30 percent of the applicable SNAP benefit allotment. When a sanction under this​
8546-264.10clause is in effect, a job counselor must attempt to meet with the person face-to-face. During​
8547-264.11the face-to-face meeting, a job counselor must explain the consequences of a subsequent​
8548-264.12drug test failure and inform the participant of the right to appeal the sanction under section​
8549-264.13256J.40. If a face-to-face meeting is not possible, a county agency must send the participant​
8550-264.14a notice of adverse action as provided in section 256J.31, subdivisions 4 and 5, and must​
8551-264.15include the information required in the face-to-face meeting; and​
8552-264.16 (2) for failing a drug test two times, the participant is permanently disqualified from​
8553-264.17receiving SNAP benefits. Before a disqualification under this provision is imposed, a job​
8554-264.18counselor must attempt to meet with the participant face-to-face. During the face-to-face​
8555-264.19meeting, the job counselor must identify other resources that may be available to the​
8556-264.20participant to meet the needs of the family and inform the participant of the right to appeal​
8557-264.21the disqualification under section 256J.40. If a face-to-face meeting is not possible, a county​
8558-264.22agency must send the participant a notice of adverse action as provided in section 256J.31,​
8559-264.23subdivisions 4 and 5, and must include the information required in the face-to-face meeting.​
8560-264.24 (c) For the purposes of this subdivision, "drug offense" means an offense that occurred​
8561-264.25during the previous ten years from the date of application or recertification of sections​
8562-264.26152.021 to 152.025, 152.0261, 152.0262, 152.096, or 152.137. Drug offense also means a​
8563-264.27conviction in another jurisdiction of the possession, use, or distribution of a controlled​
8564-264.28substance, or conspiracy to commit any of these offenses, if the offense occurred during​
8565-264.29the previous ten years from the date of application or recertification and the conviction is​
8566-264.30a felony offense in that jurisdiction, or in the case of New Jersey, a high misdemeanor for​
8567-264.31a crime that would be a felony if committed in Minnesota.​
8568-264.32 (d) This subdivision does not apply for convictions or positive test results related to​
8569-264.33cannabis, marijuana, or tetrahydrocannabinols.​
8570-264​Article 6 Sec. 48.​
8571-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 265.1Sec. 49. Minnesota Statutes 2022, section 256J.26, subdivision 3, is amended to read:​
8572-265.2 Subd. 3.Fleeing felons.An individual who is fleeing to avoid prosecution, or custody,​
8573-265.3or confinement after conviction for a crime that is a felony under the laws of the jurisdiction​
8574-265.4from which the individual flees, or in the case of New Jersey, is a high misdemeanor, would​
8575-265.5be a felony if committed in Minnesota, is disqualified from receiving MFIP.​
8576-265.6Sec. 50. Minnesota Statutes 2022, section 340A.402, subdivision 1, is amended to read:​
8577-265.7 Subdivision 1.Disqualifiers.No retail license may be issued to:​
8578-265.8 (1) a person under 21 years of age;​
8579-265.9 (2) a person who has had an intoxicating liquor or 3.2 percent malt liquor license revoked​
8580-265.10within five years of the license application, or to any person who at the time of the violation​
8581-265.11owns any interest, whether as a holder of more than five percent of the capital stock of a​
8582-265.12corporation licensee, as a partner or otherwise, in the premises or in the business conducted​
8583-265.13thereon, or to a corporation, partnership, association, enterprise, business, or firm in which​
8584-265.14any such person is in any manner interested;​
8585-265.15 (3) a person not of good moral character and repute; or​
8586-265.16 (4) a person who:​
8587-265.17 (i) has had a license or registration issued pursuant to chapter 342 or section 151.72,​
8588-265.18subdivision 5b, revoked;​
8589-265.19 (ii) has been convicted of an offense under section 151.72, subdivision 7; or​
8590-265.20 (iii) has been convicted under any other statute for the illegal sale of marijuana, cannabis​
8591-265.21flower, cannabis products, lower-potency hemp edibles, hemp-derived consumer products,​
8592-265.22or edible cannabinoid products and the sale took place on the premises of a business that​
8593-265.23sells intoxicating liquor or 3.2 percent malt liquor to customers; or​
8594-265.24 (4) (5) a person who has a direct or indirect interest in a manufacturer, brewer, or​
8595-265.25wholesaler.​
8596-265.26 In addition, no new retail license may be issued to, and the governing body of a​
8597-265.27municipality may refuse to renew the license of, a person who, within five years of the​
8598-265.28license application, has been convicted of a felony or a willful violation of a federal or state​
8599-265.29law or local ordinance governing the manufacture, sale, distribution, or possession for sale​
8600-265.30or distribution of an alcoholic beverage. The Alcohol and Gambling Enforcement Division​
8601-265.31or licensing authority may require that fingerprints be taken and forwarded to the Federal​
8602-265.32Bureau of Investigation for purposes of a criminal history check.​
8603-265​Article 6 Sec. 50.​
8604-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 266.1Sec. 51. [340A.4022] RETAIL LICENSE NOT PROHIBITED; LOWER-POTENCY​
8605-266.2HEMP EDIBLES.​
8606-266.3 (a) Nothing in this chapter:​
8607-266.4 (1) prohibits the issuance of a retail license or permit to a person also holding a hemp​
8608-266.5business license authorizing the manufacture or retail sale of lower-potency hemp edibles;​
8609-266.6 (2) allows any agreement between a licensing authority and retail license or permit holder​
8610-266.7that prohibits the license or permit holder from also holding a lower-potency hemp edible​
8611-266.8manufacturer or retailer license; or​
8612-266.9 (3) allows the revocation or suspension of a retail license or permit, or the imposition​
8613-266.10of a penalty on a retail license or permit holder, due to the retail license or permit holder​
8614-266.11also holding a lower-potency hemp edible manufacturer or retailer license.​
8615-266.12 (b) For purposes of this section, "hemp business license authorizing manufacture or​
8616-266.13retail sale of lower-potency hemp edibles" means a license issued by the Office of Cannabis​
8617-266.14Management pursuant to sections 342.43 to 342.46.​
8618-266.15Sec. 52. Minnesota Statutes 2022, section 340A.412, subdivision 14, is amended to read:​
8619-266.16 Subd. 14.Exclusive liquor stores.(a) Except as otherwise provided in this subdivision,​
8620-266.17an exclusive liquor store may sell only the following items:​
8621-266.18 (1) alcoholic beverages;​
8622-266.19 (2) tobacco products;​
8623-266.20 (3) ice;​
8624-266.21 (4) beverages, either liquid or powder, specifically designated for mixing with intoxicating​
8625-266.22liquor;​
8626-266.23 (5) soft drinks;​
8627-266.24 (6) liqueur-filled candies;​
8628-266.25 (7) food products that contain more than one-half of one percent alcohol by volume;​
8629-266.26 (8) cork extraction devices;​
8630-266.27 (9) books and videos on the use of alcoholic beverages;​
8631-266.28 (10) magazines and other publications published primarily for information and education​
8632-266.29on alcoholic beverages;​
8633-266.30 (11) multiple-use bags designed to carry purchased items;​
8634-266​Article 6 Sec. 52.​
8635-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 267.1 (12) devices designed to ensure safe storage and monitoring of alcohol in the home, to​
8636-267.2prevent access by underage drinkers;​
8637-267.3 (13) home brewing equipment;​
8638-267.4 (14) clothing marked with the specific name, brand, or identifying logo of the exclusive​
8639-267.5liquor store, and bearing no other name, brand, or identifying logo;​
8640-267.6 (15) citrus fruit; and​
8641-267.7 (16) glassware.;​
8642-267.8 (17) lower-potency hemp edibles as defined in section 342.01, subdivision 50; and​
8643-267.9 (18) products that detect the presence of fentanyl or a fentanyl analog.​
8644-267.10 (b) An exclusive liquor store that has an on-sale, or combination on-sale and off-sale​
8645-267.11license may sell food for on-premise consumption when authorized by the municipality​
8646-267.12issuing the license.​
8647-267.13 (c) An exclusive liquor store may offer live or recorded entertainment.​
8648-267.14 EFFECTIVE DATE.This section is effective March 1, 2025.​
8649-267.15Sec. 53. Minnesota Statutes 2022, section 461.12, is amended by adding a subdivision to​
8650-267.16read:​
8651-267.17 Subd. 2a.Penalties for sales of certain products; licensees.(a) A licensee's authority​
8652-267.18to sell tobacco, tobacco-related devices, electronic delivery devices, or nicotine or lobelia​
8653-267.19delivery products at that location must be suspended for not less than seven days and may​
8654-267.20be revoked if the licensee:​
8655-267.21 (1) holds a license or registration issued pursuant to chapter 342 or section 151.72,​
8656-267.22subdivision 5b, and the license or registration is revoked;​
8657-267.23 (2) is convicted of an offense under section 151.72, subdivision 7; or​
8658-267.24 (3) has been convicted under any other statute for the illegal sale of marijuana, cannabis​
8659-267.25flower, cannabis products, lower-potency hemp edibles, hemp-derived consumer products,​
8660-267.26or edible cannabinoid products and the sale took place on the premises of a business that​
8661-267.27sells tobacco, tobacco-related devices, electronic delivery devices, or nicotine or lobelia​
8662-267.28delivery products.​
8663-267.29 (b) No suspension, revocation, or other penalty may take effect until the licensee has​
8664-267.30received notice, served personally or by mail, of the alleged violation and an opportunity​
8665-267​Article 6 Sec. 53.​
8666-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 268.1for a hearing before a person authorized by the licensing authority to conduct the hearing.​
8667-268.2A decision that a violation has occurred must be in writing.​
8668-268.3Sec. 54. Minnesota Statutes 2022, section 484.014, subdivision 3, is amended to read:​
8669-268.4 Subd. 3.Mandatory expungement.(a) The court shall order expungement of an eviction​
8670-268.5case commenced solely on the grounds provided in section 504B.285, subdivision 1, clause​
8671-268.6(1), if the court finds that the defendant occupied real property that was subject to contract​
8672-268.7for deed cancellation or mortgage foreclosure and:​
8673-268.8 (1) the time for contract cancellation or foreclosure redemption has expired and the​
8674-268.9defendant vacated the property prior to commencement of the eviction action; or​
8675-268.10 (2) the defendant was a tenant during the contract cancellation or foreclosure redemption​
8676-268.11period and did not receive a notice under section 504B.285, subdivision 1a, 1b, or 1c, to​
8677-268.12vacate on a date prior to commencement of the eviction case.​
8678-268.13 (b) If a tenant brings a motion for the expungement of an eviction, the court shall order​
8679-268.14the expungement of an eviction case that was commenced on the grounds of a violation of​
8680-268.15section 504B.171 or any other claim of breach regardless of when the original eviction was​
8681-268.16ordered, if the tenant could receive an automatic expungement under section 609A.055, or​
8682-268.17if the breach was based solely on the possession of marijuana or tetrahydrocannabinols.​
8683-268.18Sec. 55. Minnesota Statutes 2022, section 504B.171, subdivision 1, is amended to read:​
8684-268.19 Subdivision 1.Terms of covenant.(a) In every lease or license of residential premises,​
8685-268.20whether in writing or parol, the landlord or licensor and the tenant or licensee covenant that:​
8686-268.21 (1) neither will:​
8687-268.22 (i) unlawfully allow controlled substances in those premises or in the common area and​
8688-268.23curtilage of the premises in violation of any criminal provision of chapter 152;​
8689-268.24 (ii) allow prostitution or prostitution-related activity as defined in section 617.80,​
8690-268.25subdivision 4, to occur on the premises or in the common area and curtilage of the premises;​
8691-268.26 (iii) allow the unlawful use or possession of a firearm in violation of section 609.66,​
8692-268.27subdivision 1a, 609.67, or 624.713, on the premises or in the common area and curtilage of​
8693-268.28the premises; or​
8694-268.29 (iv) allow stolen property or property obtained by robbery in those premises or in the​
8695-268.30common area and curtilage of the premises; and​
8696-268​Article 6 Sec. 55.​
8697-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 269.1 (2) the common area and curtilage of the premises will not be used by either the landlord​
8698-269.2or licensor or the tenant or licensee or others acting under the control of either to manufacture,​
8699-269.3sell, give away, barter, deliver, exchange, distribute, purchase, or possess a controlled​
8700-269.4substance in violation of any criminal provision of chapter 152. The covenant is not violated​
8701-269.5when a person other than the landlord or licensor or the tenant or licensee possesses or​
8702-269.6allows controlled substances in the premises, common area, or curtilage, unless the landlord​
8703-269.7or licensor or the tenant or licensee knew or had reason to know of that activity.​
8704-269.8 (b) In every lease or license of residential premises, whether in writing or parol, the​
8705-269.9tenant or licensee covenant that the tenant or licensee will not commit an act enumerated​
8706-269.10under section 504B.206, subdivision 1, paragraph (a), against a tenant or licensee or any​
8707-269.11authorized occupant.​
8708-269.12 (c) A landlord cannot prohibit a tenant from legally possessing, and a tenant cannot​
8709-269.13waive the right to legally possess, any cannabis products, lower-potency hemp edibles, or​
8710-269.14hemp-derived consumer products, or using any cannabinoid product or hemp-derived​
8711-269.15consumer product, other than consumption by combustion or vaporization of the product​
8712-269.16and inhalation of smoke, aerosol, or vapor from the product.​
8713-269.17Sec. 56. [504B.1715] COVENANTS; SOBER HOMES.​
8714-269.18 A sober housing program for people with substance use disorders may prohibit people​
8715-269.19in the program from the possession and use of cannabis flower, cannabis products,​
8716-269.20lower-potency hemp edibles, or hemp-derived consumer products.​
8717-269.21Sec. 57. Minnesota Statutes 2022, section 609B.425, subdivision 2, is amended to read:​
8718-269.22 Subd. 2.Benefit eligibility.(a) A person convicted of a drug offense after July 1, 1997,​
8719-269.23is ineligible for general assistance benefits and Supplemental Security Income under chapter​
8720-269.24256D until:​
8721-269.25 (1) five years after completing the terms of a court-ordered sentence; or​
8722-269.26 (2) unless the person is participating in a drug treatment program, has successfully​
8723-269.27completed a program, or has been determined not to be in need of a drug treatment program.​
8724-269.28 (b) A person who becomes eligible for assistance under chapter 256D is subject to​
8725-269.29random drug testing and shall lose eligibility for benefits for five years beginning the month​
8726-269.30following:​
8727-269.31 (1) any positive test for an illegal controlled substance; or​
8728-269​Article 6 Sec. 57.​
8729-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 270.1 (2) discharge of sentence for conviction of another drug felony.​
8730-270.2 (c) Parole violators and fleeing felons are ineligible for benefits and persons fraudulently​
8731-270.3misrepresenting eligibility are also ineligible to receive benefits for ten years.​
8732-270.4 (d) This subdivision does not apply for convictions or positive test results related to​
8733-270.5cannabis, marijuana, or tetrahydrocannabinols.​
8734-270.6Sec. 58. Minnesota Statutes 2022, section 609B.435, subdivision 2, is amended to read:​
8735-270.7 Subd. 2.Drug offenders; random testing; sanctions.A person who is an applicant for​
8736-270.8benefits from the Minnesota family investment program or MFIP, the vehicle for temporary​
8737-270.9assistance for needy families or TANF, and who has been convicted of a drug offense shall​
8738-270.10be subject to certain conditions, including random drug testing, in order to receive MFIP​
8739-270.11benefits. Following any positive test for a controlled substance, the convicted applicant or​
8740-270.12participant is subject to the following sanctions:​
8741-270.13 (1) a first time drug test failure results in a reduction of benefits in an amount equal to​
8742-270.1430 percent of the MFIP standard of need; and​
8743-270.15 (2) a second time drug test failure results in permanent disqualification from receiving​
8744-270.16MFIP assistance.​
8745-270.17A similar disqualification sequence occurs if the applicant is receiving Supplemental Nutrition​
8746-270.18Assistance Program (SNAP) benefits.​
8747-270.19This subdivision does not apply for convictions or positive test results related to cannabis,​
8748-270.20marijuana, or tetrahydrocannabinols.​
8749-270.21Sec. 59. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8750-270.22to read:​
8751-270.23 Subd. 13.Adult-use cannabis flower."Adult-use cannabis flower" has the meaning​
8752-270.24given in section 342.01, subdivision 3.​
8753-270.25Sec. 60. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8754-270.26to read:​
8755-270.27 Subd. 14.Adult-use cannabis product."Adult-use cannabis product" has the meaning​
8756-270.28given in section 342.01, subdivision 4.​
8757-270​Article 6 Sec. 60.​
8758-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 271.1Sec. 61. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8759-271.2to read:​
8760-271.3 Subd. 15.Medical cannabis flower."Medical cannabis flower" has the meaning given​
8761-271.4in section 342.01, subdivision 54.​
8762-271.5Sec. 62. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8763-271.6to read:​
8764-271.7 Subd. 16.Medical cannabinoid product."Medical cannabinoid product" has the​
8765-271.8meaning given in section 342.01, subdivision 52.​
8766-271.9Sec. 63. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8767-271.10to read:​
8768-271.11 Subd. 17.Patient."Patient" has the meaning given in section 342.01, subdivision 59.​
8769-271.12Sec. 64. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8770-271.13to read:​
8771-271.14 Subd. 18.Qualifying medical condition."Qualifying medical condition" has the meaning​
8772-271.15given in section 342.01, subdivision 63.​
8773-271.16Sec. 65. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8774-271.17to read:​
8775-271.18 Subd. 19.Registry or registry program."Registry" or "registry program" has the​
8776-271.19meaning given in section 342.01, subdivision 65.​
8777-271.20Sec. 66. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8778-271.21to read:​
8779-271.22 Subd. 20.Hemp-derived consumer product."Hemp-derived consumer product" has​
8780-271.23the meaning given in section 342.01, subdivision 37.​
8781-271.24Sec. 67. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8782-271.25to read:​
8783-271.26 Subd. 21.Lower-potency hemp edible."Lower-potency hemp edible" has the meaning​
8784-271.27given in section 342.01, subdivision 50.​
8785-271​Article 6 Sec. 67.​
8786-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 272.1Sec. 68. Minnesota Statutes 2022, section 624.713, subdivision 1, is amended to read:​
8787-272.2 Subdivision 1.Ineligible persons.The following persons shall not be entitled to possess​
8788-272.3ammunition or a pistol or semiautomatic military-style assault weapon or, except for clause​
8789-272.4(1), any other firearm:​
8790-272.5 (1) a person under the age of 18 years except that a person under 18 may possess​
8791-272.6ammunition designed for use in a firearm that the person may lawfully possess and may​
8792-272.7carry or possess a pistol or semiautomatic military-style assault weapon (i) in the actual​
8793-272.8presence or under the direct supervision of the person's parent or guardian, (ii) for the​
8794-272.9purpose of military drill under the auspices of a legally recognized military organization​
8795-272.10and under competent supervision, (iii) for the purpose of instruction, competition, or target​
8796-272.11practice on a firing range approved by the chief of police or county sheriff in whose​
8797-272.12jurisdiction the range is located and under direct supervision; or (iv) if the person has​
8798-272.13successfully completed a course designed to teach marksmanship and safety with a pistol​
8799-272.14or semiautomatic military-style assault weapon and approved by the commissioner of natural​
8800-272.15resources;​
8801-272.16 (2) except as otherwise provided in clause (9), a person who has been convicted of, or​
8802-272.17adjudicated delinquent or convicted as an extended jurisdiction juvenile for committing, in​
8803-272.18this state or elsewhere, a crime of violence. For purposes of this section, crime of violence​
8804-272.19includes crimes in other states or jurisdictions which would have been crimes of violence​
8805-272.20as herein defined if they had been committed in this state;​
8806-272.21 (3) a person who is or has ever been committed in Minnesota or elsewhere by a judicial​
8807-272.22determination that the person is mentally ill, developmentally disabled, or mentally ill and​
8808-272.23dangerous to the public, as defined in section 253B.02, to a treatment facility, or who has​
8809-272.24ever been found incompetent to stand trial or not guilty by reason of mental illness, unless​
8810-272.25the person's ability to possess a firearm and ammunition has been restored under subdivision​
8811-272.264;​
8812-272.27 (4) a person who has been convicted in Minnesota or elsewhere of a misdemeanor or​
8813-272.28gross misdemeanor violation of chapter 152, unless three years have elapsed since the date​
8814-272.29of conviction and, during that time, the person has not been convicted of any other such​
8815-272.30violation of chapter 152 or a similar law of another state; or a person who is or has ever​
8816-272.31been committed by a judicial determination for treatment for the habitual use of a controlled​
8817-272.32substance or marijuana, as defined in sections 152.01 and 152.02, unless the person's ability​
8818-272.33to possess a firearm and ammunition has been restored under subdivision 4;​
8819-272​Article 6 Sec. 68.​
8820-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 273.1 (5) a person who has been committed to a treatment facility in Minnesota or elsewhere​
8821-273.2by a judicial determination that the person is chemically dependent as defined in section​
8822-273.3253B.02, unless the person has completed treatment or the person's ability to possess a​
8823-273.4firearm and ammunition has been restored under subdivision 4. Property rights may not be​
8824-273.5abated but access may be restricted by the courts;​
8825-273.6 (6) a peace officer who is informally admitted to a treatment facility pursuant to section​
8826-273.7253B.04 for chemical dependency, unless the officer possesses a certificate from the head​
8827-273.8of the treatment facility discharging or provisionally discharging the officer from the​
8828-273.9treatment facility. Property rights may not be abated but access may be restricted by the​
8829-273.10courts;​
8830-273.11 (7) a person, including a person under the jurisdiction of the juvenile court, who has​
8831-273.12been charged with committing a crime of violence and has been placed in a pretrial diversion​
8832-273.13program by the court before disposition, until the person has completed the diversion program​
8833-273.14and the charge of committing the crime of violence has been dismissed;​
8834-273.15 (8) except as otherwise provided in clause (9), a person who has been convicted in​
8835-273.16another state of committing an offense similar to the offense described in section 609.224,​
8836-273.17subdivision 3, against a family or household member or section 609.2242, subdivision 3,​
8837-273.18unless three years have elapsed since the date of conviction and, during that time, the person​
8838-273.19has not been convicted of any other violation of section 609.224, subdivision 3, or 609.2242,​
8839-273.20subdivision 3, or a similar law of another state;​
8840-273.21 (9) a person who has been convicted in this state or elsewhere of assaulting a family or​
8841-273.22household member and who was found by the court to have used a firearm in any way​
8842-273.23during commission of the assault is prohibited from possessing any type of firearm or​
8843-273.24ammunition for the period determined by the sentencing court;​
8844-273.25 (10) a person who:​
8845-273.26 (i) has been convicted in any court of a crime punishable by imprisonment for a term​
8846-273.27exceeding one year;​
8847-273.28 (ii) is a fugitive from justice as a result of having fled from any state to avoid prosecution​
8848-273.29for a crime or to avoid giving testimony in any criminal proceeding;​
8849-273.30 (iii) is an unlawful user of any controlled substance as defined in chapter 152. The use​
8850-273.31of medical cannabis flower or medical cannabinoid products by a patient enrolled in the​
8851-273.32registry program or the use of adult-use cannabis flower, adult-use cannabis products,​
8852-273​Article 6 Sec. 68.​
8853-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 274.1lower-potency hemp edibles, or hemp-derived consumer products by a person 21 years of​
8854-274.2age or older does not constitute the unlawful use of a controlled substance under this item;​
8855-274.3 (iv) has been judicially committed to a treatment facility in Minnesota or elsewhere as​
8856-274.4a person who is mentally ill, developmentally disabled, or mentally ill and dangerous to the​
8857-274.5public, as defined in section 253B.02;​
8858-274.6 (v) is an alien who is illegally or unlawfully in the United States;​
8859-274.7 (vi) has been discharged from the armed forces of the United States under dishonorable​
8860-274.8conditions;​
8861-274.9 (vii) has renounced the person's citizenship having been a citizen of the United States;​
8862-274.10or​
8863-274.11 (viii) is disqualified from possessing a firearm under United States Code, title 18, section​
8864-274.12922(g)(8) or (9), as amended through March 1, 2014;​
8865-274.13 (11) a person who has been convicted of the following offenses at the gross misdemeanor​
8866-274.14level, unless three years have elapsed since the date of conviction and, during that time, the​
8867-274.15person has not been convicted of any other violation of these sections: section 609.229​
8868-274.16(crimes committed for the benefit of a gang); 609.2231, subdivision 4 (assaults motivated​
8869-274.17by bias); 609.255 (false imprisonment); 609.378 (neglect or endangerment of a child);​
8870-274.18609.582, subdivision 4 (burglary in the fourth degree); 609.665 (setting a spring gun); 609.71​
8871-274.19(riot); or 609.749 (harassment or stalking). For purposes of this paragraph, the specified​
8872-274.20gross misdemeanor convictions include crimes committed in other states or jurisdictions​
8873-274.21which would have been gross misdemeanors if conviction occurred in this state;​
8874-274.22 (12) a person who has been convicted of a violation of section 609.224 if the court​
8875-274.23determined that the assault was against a family or household member in accordance with​
8876-274.24section 609.2242, subdivision 3 (domestic assault), unless three years have elapsed since​
8877-274.25the date of conviction and, during that time, the person has not been convicted of another​
8878-274.26violation of section 609.224 or a violation of a section listed in clause (11); or​
8879-274.27 (13) a person who is subject to an order for protection as described in section 260C.201,​
8880-274.28subdivision 3, paragraph (d), or 518B.01, subdivision 6, paragraph (g).​
8881-274.29 A person who issues a certificate pursuant to this section in good faith is not liable for​
8882-274.30damages resulting or arising from the actions or misconduct with a firearm or ammunition​
8883-274.31committed by the individual who is the subject of the certificate.​
8884-274.32 The prohibition in this subdivision relating to the possession of firearms other than​
8885-274.33pistols and semiautomatic military-style assault weapons does not apply retroactively to​
8886-274​Article 6 Sec. 68.​
8887-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 275.1persons who are prohibited from possessing a pistol or semiautomatic military-style assault​
8888-275.2weapon under this subdivision before August 1, 1994.​
8889-275.3 The lifetime prohibition on possessing, receiving, shipping, or transporting firearms and​
8890-275.4ammunition for persons convicted or adjudicated delinquent of a crime of violence in clause​
8891-275.5(2), applies only to offenders who are discharged from sentence or court supervision for a​
8892-275.6crime of violence on or after August 1, 1993.​
8893-275.7 Participation as a patient in the registry program or use of adult-use cannabis flower,​
8894-275.8adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
8895-275.9products by a person 21 years of age or older does not disqualify the person from possessing​
8896-275.10firearms and ammunition under this section.​
8897-275.11 For purposes of this section, "judicial determination" means a court proceeding pursuant​
8898-275.12to sections 253B.07 to 253B.09 or a comparable law from another state.​
8899-275.13Sec. 69. Minnesota Statutes 2022, section 624.714, subdivision 6, is amended to read:​
8900-275.14 Subd. 6.Granting and denial of permits.(a) The sheriff must, within 30 days after the​
8901-275.15date of receipt of the application packet described in subdivision 3:​
8902-275.16 (1) issue the permit to carry;​
8903-275.17 (2) deny the application for a permit to carry solely on the grounds that the applicant​
8904-275.18failed to qualify under the criteria described in subdivision 2, paragraph (b); or​
8905-275.19 (3) deny the application on the grounds that there exists a substantial likelihood that the​
8906-275.20applicant is a danger to self or the public if authorized to carry a pistol under a permit.​
8907-275.21 (b) Failure of the sheriff to notify the applicant of the denial of the application within​
8908-275.2230 days after the date of receipt of the application packet constitutes issuance of the permit​
8909-275.23to carry and the sheriff must promptly fulfill the requirements under paragraph (c). To deny​
8910-275.24the application, the sheriff must provide the applicant with written notification and the​
8911-275.25specific factual basis justifying the denial under paragraph (a), clause (2) or (3), including​
8912-275.26the source of the factual basis. The sheriff must inform the applicant of the applicant's right​
8913-275.27to submit, within 20 business days, any additional documentation relating to the propriety​
8914-275.28of the denial. Upon receiving any additional documentation, the sheriff must reconsider the​
8915-275.29denial and inform the applicant within 15 business days of the result of the reconsideration.​
8916-275.30Any denial after reconsideration must be in the same form and substance as the original​
8917-275.31denial and must specifically address any continued deficiencies in light of the additional​
8918-275.32documentation submitted by the applicant. The applicant must be informed of the right to​
8919-275.33seek de novo review of the denial as provided in subdivision 12.​
8920-275​Article 6 Sec. 69.​
8921-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 276.1 (c) Upon issuing a permit to carry, the sheriff must provide a laminated permit card to​
8922-276.2the applicant by first class mail unless personal delivery has been made. Within five business​
8923-276.3days, the sheriff must submit the information specified in subdivision 7, paragraph (a), to​
8924-276.4the commissioner for inclusion solely in the database required under subdivision 15,​
8925-276.5paragraph (a). The sheriff must transmit the information in a manner and format prescribed​
8926-276.6by the commissioner.​
8927-276.7 (d) Within five business days of learning that a permit to carry has been suspended or​
8928-276.8revoked, the sheriff must submit information to the commissioner regarding the suspension​
8929-276.9or revocation for inclusion solely in the databases required or permitted under subdivision​
8930-276.1015.​
8931-276.11 (e) Notwithstanding paragraphs (a) and (b), the sheriff may suspend the application​
8932-276.12process if a charge is pending against the applicant that, if resulting in conviction, will​
8933-276.13prohibit the applicant from possessing a firearm.​
8934-276.14 (f) A sheriff shall not deny an application for a permit to carry solely because the applicant​
8935-276.15is a patient enrolled in the registry program and uses medical cannabis flower or medical​
8936-276.16cannabinoid products for a qualifying medical condition or because the person is 21 years​
8937-276.17of age or older and uses adult-use cannabis flower, adult-use cannabis products,​
8938-276.18lower-potency hemp edibles, or hemp-derived consumer products.​
8939-276.19Sec. 70. Minnesota Statutes 2022, section 624.7151, is amended to read:​
8940-276.20 624.7151 STANDARDIZED FORMS.​
8941-276.21 By December 1, 1992, the commissioner shall adopt statewide standards governing the​
8942-276.22form and contents, as required by sections 624.7131 to 624.714, of every application for a​
8943-276.23pistol transferee permit, pistol transferee permit, report of transfer of a pistol, application​
8944-276.24for a permit to carry a pistol, and permit to carry a pistol that is granted or renewed on or​
8945-276.25after January 1, 1993.​
8946-276.26 Every application for a pistol transferee permit, pistol transferee permit, report of transfer​
8947-276.27of a pistol, application for a permit to carry a pistol, and permit to carry a pistol that is​
8948-276.28received, granted, or renewed by a police chief or county sheriff on or after January 1, 1993,​
8949-276.29must meet the statewide standards adopted by the commissioner. Notwithstanding the​
8950-276.30previous sentence, neither failure of the Department of Public Safety to adopt standards nor​
8951-276.31failure of the police chief or county sheriff to meet them shall delay the timely processing​
8952-276.32of applications nor invalidate permits issued on other forms meeting the requirements of​
8953-276.33sections 624.7131 to 624.714.​
8954-276​Article 6 Sec. 70.​
8955-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 277.1 Any form used for the purpose of approving or disapproving a person from purchasing,​
8956-277.2owning, possessing, or carrying a firearm that inquires about the applicant's use of controlled​
8957-277.3substances shall specifically authorize a patient in the registry program to refrain from​
8958-277.4reporting the use of medical cannabis flower and medical cannabinoid products and shall​
8959-277.5specifically authorize a person 21 years of age or older from refraining from reporting the​
8960-277.6use of adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles,​
8961-277.7or hemp-derived consumer products.​
8962-277.8Sec. 71. [624.7152] LAWFUL CANNABIS USERS.​
8963-277.9 (a) A person may not be denied the right to purchase, own, possess, or carry a firearm​
8964-277.10solely on the basis that the person is a patient in the registry program.​
8965-277.11 (b) A person may not be denied the right to purchase, own, possess, or carry a firearm​
8966-277.12solely on the basis that the person is 21 years of age or older and uses adult-use cannabis​
8967-277.13flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
8968-277.14products.​
8969-277.15 (c) A state or local agency may not access a database containing the identities of patients​
8970-277.16in the registry program to obtain information for the purpose of approving or disapproving​
8971-277.17a person from purchasing, owning, possessing, or carrying a firearm.​
8972-277.18 (d) A state or local agency may not use information gathered from a database containing​
8973-277.19the identities of patients in the registry program to obtain information for the purpose of​
8974-277.20approving or disapproving a person from purchasing, owning, possessing, or carrying a​
8975-277.21firearm.​
8976-277.22 (e) A state or local agency may not inquire about a person's status as a patient in the​
8977-277.23registry program for the purpose of approving or disapproving the person from purchasing,​
8978-277.24owning, possessing, or carrying a firearm.​
8979-277.25 (f) A state or local agency may not inquire about the use of adult-use cannabis flower,​
8980-277.26adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
8981-277.27products by a person 21 years of age or older for the purpose of approving or disapproving​
8982-277.28the person from purchasing, owning, possessing, or carrying a firearm.​
8983-277.29Sec. 72. HIGH INTENSITY DRUG TRAFFICKING AREA REPORT.​
8984-277.30 The commissioner of public safety shall contract with Hennepin County to produce a​
8985-277.31statewide baseline high intensity drug trafficking area report on marijuana. The report must​
8986-277.32include information on past and present marijuana use in Minnesota; potency of marijuana;​
8987-277​Article 6 Sec. 72.​
8988-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 278.1impacts of marijuana use on public health, emergency room admissions, traffic accidents,​
8989-278.2impaired driving citations, workforce, and schools; marijuana crimes and the juvenile justice​
8990-278.3system; marijuana's influence on the opioid epidemic; and the illicit market for marijuana.​
8991-278.4The report must be submitted to the chairs and ranking minority members of the house of​
8992-278.5representatives and senate committees with jurisdiction over public safety, health, education​
8993-278.6policy, labor, and transportation by February 1, 2024.​
8994-278.7Sec. 73. REPEALER.​
8995-278.8 (a) Minnesota Statutes 2022, sections 152.22, subdivisions 1, 2, 3, 4, 5, 5a, 5b, 6, 7, 8,​
8996-278.99, 10, 11, 12, 13, and 14; 152.23; 152.24; 152.25, subdivisions 1, 1a, 1b, 1c, 2, 3, and 4;​
8997-278.10152.26; 152.261; 152.27, subdivisions 1, 2, 3, 4, 5, 6, and 7; 152.28, subdivisions 1, 2, and​
8998-278.113; 152.29, subdivisions 1, 2, 3, 3a, and 4; 152.291; 152.30; 152.31; 152.32, subdivisions 1,​
8999-278.122, and 3; 152.33, subdivisions 1, 1a, 2, 3, 4, 5, and 6; 152.34; 152.35; 152.36, subdivisions​
9000-278.131, 1a, 2, 3, 4, and 5; and 152.37, are repealed.​
9001-278.14 (b) Minnesota Statutes 2022, section 152.027, subdivisions 3 and 4, are repealed.​
9002-278.15 (c) Minnesota Statutes 2022, section 152.21, is repealed.​
9003-278.16 EFFECTIVE DATE.Paragraph (a) is effective March 1, 2025. Paragraph (b) is effective​
9004-278.17August 1, 2023. Paragraph (c) is effective July 1, 2023.​
9005-278.18 ARTICLE 7​
9006-278.19 TEMPORARY REGULATION OF CERTAIN PRODUCTS​
9007-278.20Section 1. Minnesota Statutes 2022, section 34A.01, subdivision 4, is amended to read:​
9008-278.21 Subd. 4.Food."Food" means every ingredient used for, entering into the consumption​
9009-278.22of, or used or intended for use in the preparation of food, drink, confectionery, or condiment​
9010-278.23for humans or other animals, whether simple, mixed, or compound; and articles used as​
9011-278.24components of these ingredients, except that edible cannabinoid products, as defined in​
9012-278.25section 151.72, subdivision 1, paragraph (c) (f), are not food.​
9013-278.26 EFFECTIVE DATE.This section is effective the day following final enactment.​
9014-278.27Sec. 2. Minnesota Statutes 2022, section 151.72, is amended to read:​
9015-278.28 151.72 SALE OF CERTAIN CANNABINOID PRODUCTS.​
9016-278.29 Subdivision 1.Definitions.(a) For the purposes of this section, the following terms have​
9017-278.30the meanings given.​
9018-278​Article 7 Sec. 2.​
9019-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 279.1 (a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant​
9020-279.2or hemp plant parts with a chemical makeup that is changed after extraction to create a​
9021-279.3different cannabinoid or other chemical compound by applying a catalyst other than heat​
9022-279.4or light. Artificially derived cannabinoid includes but is not limited to any​
9023-279.5tetrahydrocannabinol created from cannabidiol.​
9024-279.6 (b) "Batch" means a specific quantity of a specific product containing cannabinoids​
9025-279.7derived from hemp, including an edible cannabinoid product, that is manufactured at the​
9026-279.8same time and using the same methods, equipment, and ingredients that is uniform and​
9027-279.9intended to meet specifications for identity, strength, purity, and composition, and that is​
9028-279.10manufactured, packaged, and labeled according to a single batch production record executed​
9029-279.11and documented.​
9030-279.12 (b) (c) "Certified hemp" means hemp plants that have been tested and found to meet the​
9031-279.13requirements of chapter 18K and the rules adopted thereunder.​
9032-279.14 (d) "Commissioner" means the commissioner of health.​
9033-279.15 (e) "Distributor" means a person who sells, arranges a sale, or delivers a product​
9034-279.16containing cannabinoids derived from hemp, including an edible cannabinoid product, that​
9035-279.17the person did not manufacture to a retail establishment for sale to consumers. Distributor​
9036-279.18does not include a common carrier used only to complete delivery to a retailer.​
9037-279.19 (c) (f) "Edible cannabinoid product" means any product that is intended to be eaten or​
9038-279.20consumed as a beverage by humans, contains a cannabinoid in combination with food​
9039-279.21ingredients, and is not a drug.​
9040-279.22 (d) (g) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision​
9041-279.233.​
9042-279.24 (e) (h) "Label" has the meaning given in section 151.01, subdivision 18.​
9043-279.25 (f) (i) "Labeling" means all labels and other written, printed, or graphic matter that are:​
9044-279.26 (1) affixed to the immediate container in which a product regulated under this section​
9045-279.27is sold;​
9046-279.28 (2) provided, in any manner, with the immediate container, including but not limited to​
9047-279.29outer containers, wrappers, package inserts, brochures, or pamphlets; or​
9048-279.30 (3) provided on that portion of a manufacturer's website that is linked by a scannable​
9049-279.31barcode or matrix barcode.​
9050-279​Article 7 Sec. 2.​
9051-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 280.1 (g) (j) "Matrix barcode" means a code that stores data in a two-dimensional array of​
9052-280.2geometrically shaped dark and light cells capable of being read by the camera on a​
9053-280.3smartphone or other mobile device.​
9054-280.4 (h) (k) "Nonintoxicating cannabinoid" means substances extracted from certified hemp​
9055-280.5plants that do not produce intoxicating effects when consumed by any route of administration.​
9056-280.6 (l) "Synthetic cannabinoid" means a substance with a similar chemical structure and​
9057-280.7pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp​
9058-280.8plants, or hemp plant parts and is instead created or produced by chemical or biochemical​
9059-280.9synthesis.​
9060-280.10 Subd. 2.Scope.(a) This section applies to the sale of any product that contains​
9061-280.11cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended​
9062-280.12for human or animal consumption by any route of administration.​
9063-280.13 (b) This section does not apply to any product dispensed by a registered medical cannabis​
9064-280.14manufacturer pursuant to sections 152.22 to 152.37.​
9065-280.15 (c) The board commissioner must have no authority over food products, as defined in​
9066-280.16section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from​
9067-280.17hemp.​
9068-280.18 Subd. 3.Sale of cannabinoids derived from hemp.(a) Notwithstanding any other​
9069-280.19section of this chapter, a product containing nonintoxicating cannabinoids, including an​
9070-280.20edible cannabinoid product, may be sold for human or animal consumption only if all of​
9071-280.21the requirements of this section are met, provided that a product sold for human or animal​
9072-280.22consumption does not contain more than 0.3 percent of any tetrahydrocannabinol and an​
9073-280.23edible cannabinoid product does not contain an amount of any tetrahydrocannabinol that​
9074-280.24exceeds the limits established in subdivision 5a, paragraph (f).​
9075-280.25 (b) A product containing nonintoxicating cannabinoids, other than an edible cannabinoid​
9076-280.26product, may be sold for human or animal consumption only if it is intended for application​
9077-280.27externally to a part of the body of a human or animal. Such a product must not be​
9078-280.28manufactured, marketed, distributed, or intended to be consumed:​
9079-280.29 (1) by combustion or vaporization of the product and inhalation of smoke, aerosol, or​
9080-280.30vapor from the product;​
9081-280.31 (2) through chewing, drinking, or swallowing; or​
9082-280.32 (3) through injection or application to a mucous membrane or nonintact skin.​
9083-280​Article 7 Sec. 2.​
9084-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 281.1 (b) (c) No other substance extracted or otherwise derived from hemp may be sold for​
9085-281.2human consumption if the substance is intended:​
9086-281.3 (1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention​
9087-281.4of disease in humans or other animals; or​
9088-281.5 (2) to affect the structure or any function of the bodies of humans or other animals.​
9089-281.6 (c) (d) No product containing any cannabinoid or tetrahydrocannabinol extracted or​
9090-281.7otherwise derived from hemp may be sold to any individual who is under the age of 21.​
9091-281.8 (d) (e) Products that meet the requirements of this section are not controlled substances​
9092-281.9under section 152.02.​
9093-281.10 (f) Products may be sold for on-site consumption provided that all of the following​
9094-281.11conditions are met:​
9095-281.12 (1) the retailer must also hold an on-sale license issued under chapter 340A;​
9096-281.13 (2) products must be served in original packaging, but may be removed from the products'​
9097-281.14packaging by customers and consumed on site;​
9098-281.15 (3) products must not be sold to a customer who the retailer knows or reasonably should​
9099-281.16know is intoxicated;​
9100-281.17 (4) products must not be permitted to be mixed with an alcoholic beverage; and​
9101-281.18 (5) products that have been removed from packaging must not be removed from the​
9102-281.19premises.​
9103-281.20 Subd. 4.Testing requirements.(a) A manufacturer of a product regulated under this​
9104-281.21section must submit representative samples of each batch of the product to an independent,​
9105-281.22accredited laboratory in order to certify that the product complies with the standards adopted​
9106-281.23by the board on or before July 1, 2023, or the standards adopted by the commissioner.​
9107-281.24Testing must be consistent with generally accepted industry standards for herbal and botanical​
9108-281.25substances, and, at a minimum, the testing must confirm that the product:​
9109-281.26 (1) contains the amount or percentage of cannabinoids that is stated on the label of the​
9110-281.27product;​
9111-281.28 (2) does not contain more than trace amounts of any mold, residual solvents or other​
9112-281.29catalysts, pesticides, fertilizers, or heavy metals; and​
9113-281.30 (3) does not contain more than 0.3 percent of any tetrahydrocannabinol.​
9114-281​Article 7 Sec. 2.​
9115-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 282.1 (b) A manufacturer of a product regulated under this section must disclose all known​
9116-282.2information regarding pesticides, fertilizers, solvents, or other foreign materials applied to​
9117-282.3industrial hemp or added to industrial hemp during any production or processing stages of​
9118-282.4any batch from which a representative sample has been sent for testing, including any​
9119-282.5catalysts used to create artificially derived cannabinoids. The disclosure must be made to​
9120-282.6the laboratory performing testing or sampling and, upon request, to the commissioner. The​
9121-282.7disclosure must include all information known to the licensee regardless of whether the​
9122-282.8application or addition was made intentionally or accidentally, or by the manufacturer or​
9123-282.9any other person.​
9124-282.10 (b) (c) Upon the request of the board commissioner, the manufacturer of the product​
9125-282.11must provide the board commissioner with the results of the testing required in this section.​
9126-282.12 (d) The commissioner may determine that any testing laboratory that does not operate​
9127-282.13formal management systems under the International Organization for Standardization is not​
9128-282.14an accredited laboratory and require that a representative sample of a batch of the product​
9129-282.15be retested by a testing laboratory that meets this requirement.​
9130-282.16 (c) (e) Testing of the hemp from which the nonintoxicating cannabinoid was derived,​
9131-282.17or possession of a certificate of analysis for such hemp, does not meet the testing requirements​
9132-282.18of this section.​
9133-282.19 Subd. 5.Labeling requirements.(a) A product regulated under this section must bear​
9134-282.20a label that contains, at a minimum:​
9135-282.21 (1) the name, location, contact phone number, and website of the manufacturer of the​
9136-282.22product;​
9137-282.23 (2) the name and address of the independent, accredited laboratory used by the​
9138-282.24manufacturer to test the product; and​
9139-282.25 (3) the batch number; and​
9140-282.26 (3) (4) an accurate statement of the amount or percentage of cannabinoids found in each​
9141-282.27unit of the product meant to be consumed.​
9142-282.28 (b) The information in paragraph (a) may be provided on an outer package if the​
9143-282.29immediate container that holds the product is too small to contain all of the information.​
9144-282.30 (c) The information required in paragraph (a) may be provided through the use of a​
9145-282.31scannable barcode or matrix barcode that links to a page on the manufacturer's website if​
9146-282.32that page contains all of the information required by this subdivision.​
9147-282​Article 7 Sec. 2.​
9148-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 283.1 (d) The label must also include a statement stating that the product does not claim to​
9149-283.2diagnose, treat, cure, or prevent any disease and has not been evaluated or approved by the​
9150-283.3United States Food and Drug Administration (FDA) unless the product has been so approved.​
9151-283.4 (e) The information required by this subdivision must be prominently and conspicuously​
9152-283.5placed on the label or displayed on the website in terms that can be easily read and understood​
9153-283.6by the consumer.​
9154-283.7 (f) The labeling must not contain any claim that the product may be used or is effective​
9155-283.8for the prevention, treatment, or cure of a disease or that it may be used to alter the structure​
9156-283.9or function of human or animal bodies, unless the claim has been approved by the FDA.​
9157-283.10 Subd. 5a.Additional requirements for edible cannabinoid products.(a) In addition​
9158-283.11to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid​
9159-283.12must meet the requirements of this subdivision.​
9160-283.13 (b) An edible cannabinoid product must not:​
9161-283.14 (1) bear the likeness or contain cartoon-like characteristics of a real or fictional person,​
9162-283.15animal, or fruit that appeals to children;​
9163-283.16 (2) be modeled after a brand of products primarily consumed by or marketed to children;​
9164-283.17 (3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a​
9165-283.18commercially available candy or snack food item;​
9166-283.19 (4) be substantively similar to a meat food product; poultry food product as defined in​
9167-283.20section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision​
9168-283.217;​
9169-283.22 (4) (5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved​
9170-283.23by the United States Food and Drug Administration for use in food;​
9171-283.24 (5) (6) be packaged in a way that resembles the trademarked, characteristic, or​
9172-283.25product-specialized packaging of any commercially available food product; or​
9173-283.26 (6) (7) be packaged in a container that includes a statement, artwork, or design that could​
9174-283.27reasonably mislead any person to believe that the package contains anything other than an​
9175-283.28edible cannabinoid product.​
9176-283.29 (c) An edible cannabinoid product must be prepackaged in packaging or a container that​
9177-283.30is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is​
9178-283.31child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The​
9179-283.32requirement that packaging be child-resistant does not apply to an edible cannabinoid product​
9180-283​Article 7 Sec. 2.​
9181-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 284.1that is intended to be consumed as a beverage and which contains no more than a trace​
9182-284.2amount of any tetrahydrocannabinol.​
9183-284.3 (d) If an edible cannabinoid product, other than a product that is intended to be consumed​
9184-284.4as a beverage, is intended for more than a single use or contains multiple servings, each​
9185-284.5serving must be indicated by scoring, wrapping, or other indicators designating the individual​
9186-284.6serving size that appear on the edible cannabinoid product.​
9187-284.7 (e) A label containing at least the following information must be affixed to the packaging​
9188-284.8or container of all edible cannabinoid products sold to consumers:​
9189-284.9 (1) the serving size;​
9190-284.10 (2) the cannabinoid profile per serving and in total;​
9191-284.11 (3) a list of ingredients, including identification of any major food allergens declared​
9192-284.12by name; and​
9193-284.13 (4) the following statement: "Keep this product out of reach of children."​
9194-284.14 (f) An edible cannabinoid product must not contain more than five milligrams of any​
9195-284.15tetrahydrocannabinol in a single serving, or. An edible cannabinoid product, other than a​
9196-284.16product that is intended to be consumed as a beverage, may not contain more than a total​
9197-284.17of 50 milligrams of any tetrahydrocannabinol per package. An edible cannabinoid product​
9198-284.18that is intended to be consumed as a beverage may not contain more than two servings per​
9199-284.19container.​
9200-284.20 (g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9​
9201-284.21tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an​
9202-284.22artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing​
9203-284.23any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and​
9204-284.24HHC, unless the commissioner authorizes use of the artificially derived cannabinoid in​
9205-284.25edible cannabinoid products. Edible cannabinoid products are prohibited from containing​
9206-284.26synthetic cannabinoids.​
9207-284.27 (h) Every person selling edible cannabinoid products to consumers, other than products​
9208-284.28that are intended to be consumed as a beverage, must ensure that all edible cannabinoid​
9209-284.29products are displayed behind a checkout counter where the public is not permitted or in a​
9210-284.30locked case.​
9211-284.31 Subd. 5b.Registration; prohibitions.(a) On or before October 1, 2023, every person​
9212-284.32selling edible cannabinoid products to consumers must register with the commissioner in​
9213-284​Article 7 Sec. 2.​
9214-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 285.1a form and manner established by the commissioner. After October 1, 2023, the sale of​
9215-285.2edible cannabinoid products by a person that is not registered is prohibited.​
9216-285.3 (b) The registration form must contain an attestation of compliance and each registrant​
9217-285.4must affirm that it is operating and will continue to operate in compliance with the​
9218-285.5requirements of this section and all other applicable state and local laws and ordinances.​
9219-285.6 (c) The commissioner shall not charge a fee for registration under this subdivision.​
9220-285.7 Subd. 5c.Age verification.(a) Prior to initiating a sale or otherwise providing an edible​
9221-285.8cannabinoid product to an individual, an employee of a retailer must verify that the individual​
9222-285.9is at least 21 years of age.​
9223-285.10 (b) Proof of age may be established only by one of the following:​
9224-285.11 (1) a valid driver's license or identification card issued by Minnesota, another state, or​
9225-285.12a province of Canada and including the photograph and date of birth of the licensed person;​
9226-285.13 (2) a valid Tribal identification card as defined in section 171.072, paragraph (b);​
9227-285.14 (3) a valid passport issued by the United States;​
9228-285.15 (4) a valid instructional permit issued under section 171.05 to a person of legal age to​
9229-285.16purchase edible cannabinoid products, which includes a photograph and the date of birth​
9230-285.17of the person issued the permit; or​
9231-285.18 (5) in the case of a foreign national, by a valid passport.​
9232-285.19 (c) A registered retailer may seize a form of identification listed under paragraph (b) if​
9233-285.20the registered retailer has reasonable grounds to believe that the form of identification has​
9234-285.21been altered or falsified or is being used to violate any law. A registered retailer that seizes​
9235-285.22a form of identification as authorized under this paragraph must deliver it to a law​
9236-285.23enforcement agency within 24 hours of seizing it.​
9237-285.24 Subd. 6.Noncompliant products; enforcement.(a) A product regulated under this​
9238-285.25section, including an edible cannabinoid product, shall be considered an adulterated drug​
9239-285.26a noncompliant product if the product is offered for sale in this state or if the product is​
9240-285.27manufactured, imported, distributed, or stored with the intent to be offered for sale in this​
9241-285.28state in violation of any provision of this section, including but not limited to if:​
9242-285.29 (1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;​
9243-285.30 (2) it has been produced, prepared, packed, or held under unsanitary conditions where​
9244-285.31it may have been rendered injurious to health, or where it may have been contaminated with​
9245-285.32filth;​
9246-285​Article 7 Sec. 2.​
9247-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 286.1 (3) its container is composed, in whole or in part, of any poisonous or deleterious​
9248-286.2substance that may render the contents injurious to health;​
9249-286.3 (4) it contains any food additives, color additives, or excipients that have been found by​
9250-286.4the FDA to be unsafe for human or animal consumption;​
9251-286.5 (5) it contains an amount or percentage of nonintoxicating cannabinoids that is different​
9252-286.6than the amount or percentage stated on the label;​
9253-286.7 (6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is​
9254-286.8an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits​
9255-286.9established in subdivision 5a, paragraph (f); or​
9256-286.10 (7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers,​
9257-286.11or heavy metals.​
9258-286.12 (b) A product regulated under this section shall be considered a misbranded drug​
9259-286.13noncompliant product if the product's labeling is false or misleading in any manner or in​
9260-286.14violation of the requirements of this section.​
9261-286.15 (c) The board's authority to issue cease and desist orders under section 151.06; to embargo​
9262-286.16adulterated and misbranded drugs under section 151.38; and to seek injunctive relief under​
9263-286.17section 214.11, extends to any commissioner may assume that any product regulated under​
9264-286.18this section that is present in the state, other than a product lawfully possessed for personal​
9265-286.19use, has been manufactured, imported, distributed, or stored with the intent to be offered​
9266-286.20for sale in this state if a product of the same type and brand was sold in the state on or after​
9267-286.21July 1, 2023, or if the product is in the possession of a person who has sold any product in​
9268-286.22violation of this section.​
9269-286.23 (d) The commissioner may enforce this section, including enforcement against a​
9270-286.24manufacturer or distributor of a product regulated under this section, under sections 144.989​
9271-286.25to 144.993.​
9272-286.26 (e) The commissioner may enter into an interagency agreement with the Office of​
9273-286.27Cannabis Management and the commissioner of agriculture to perform inspections and take​
9274-286.28other enforcement actions on behalf of the commissioner.​
9275-286.29 Subd. 7.Violations; criminal penalties.(a) Notwithstanding section 144.99, subdivision​
9276-286.3011, a person who does any of the following regarding a product regulated under this section​
9277-286.31is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than​
9278-286.32one year or to payment of a fine of not more than $3,000, or both:​
9279-286.33 (1) knowingly alters or otherwise falsifies testing results;​
9280-286​Article 7 Sec. 2.​
9281-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 287.1 (2) intentionally alters or falsifies any information required to be included on the label​
9282-287.2of an edible cannabinoid product; or​
9283-287.3 (3) intentionally makes a false material statement to the commissioner.​
9284-287.4 (b) Notwithstanding section 144.99, subdivision 11, a person who does any of the​
9285-287.5following on the premises of a registered retailer or another business that sells retail goods​
9286-287.6to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for​
9287-287.7not more than one year or to payment of a fine of not more than $3,000, or both:​
9288-287.8 (1) sells an edible cannabinoid product knowing that the product does not comply with​
9289-287.9the limits on the amount or types of cannabinoids that a product may contain;​
9290-287.10 (2) sells an edible cannabinoid product knowing that the product does not comply with​
9291-287.11the applicable testing, packaging, or labeling requirements; or​
9292-287.12 (3) sells an edible cannabinoid product to a person under the age of 21, except that it is​
9293-287.13an affirmative defense to a charge under this clause if the defendant proves by a​
9294-287.14preponderance of the evidence that the defendant reasonably and in good faith relied on​
9295-287.15proof of age as described in subdivision 5c.​
9296-287.16 EFFECTIVE DATE.This section is effective the day following final enactment.​
9297-287.17Sec. 3. Minnesota Statutes 2022, section 340A.412, subdivision 14, is amended to read:​
9298-287.18 Subd. 14.Exclusive liquor stores.(a) Except as otherwise provided in this subdivision,​
9299-287.19an exclusive liquor store may sell only the following items:​
9300-287.20 (1) alcoholic beverages;​
9301-287.21 (2) tobacco products;​
9302-287.22 (3) ice;​
9303-287.23 (4) beverages, either liquid or powder, specifically designated for mixing with intoxicating​
9304-287.24liquor;​
9305-287.25 (5) soft drinks;​
9306-287.26 (6) liqueur-filled candies;​
9307-287.27 (7) food products that contain more than one-half of one percent alcohol by volume;​
9308-287.28 (8) cork extraction devices;​
9309-287.29 (9) books and videos on the use of alcoholic beverages;​
9310-287​Article 7 Sec. 3.​
9311-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 288.1 (10) magazines and other publications published primarily for information and education​
9312-288.2on alcoholic beverages;​
9313-288.3 (11) multiple-use bags designed to carry purchased items;​
9314-288.4 (12) devices designed to ensure safe storage and monitoring of alcohol in the home, to​
9315-288.5prevent access by underage drinkers;​
9316-288.6 (13) home brewing equipment;​
9317-288.7 (14) clothing marked with the specific name, brand, or identifying logo of the exclusive​
9318-288.8liquor store, and bearing no other name, brand, or identifying logo;​
9319-288.9 (15) citrus fruit; and​
9320-288.10 (16) glassware.;​
9321-288.11 (17) edible cannabinoid products as defined in section 151.72, subdivision 1, paragraph​
9322-288.12(f); and​
9323-288.13 (18) products that detect the presence of fentanyl or a fentanyl analog.​
9324-288.14 (b) An exclusive liquor store that has an on-sale, or combination on-sale and off-sale​
9325-288.15license may sell food for on-premise consumption when authorized by the municipality​
9326-288.16issuing the license.​
9327-288.17 (c) An exclusive liquor store may offer live or recorded entertainment.​
9328-288.18 EFFECTIVE DATE.This section is effective the day following final enactment.​
9329-288.19Sec. 4. EDIBLE CANNABINOID PRODUCTS; ENFORCEMENT .​
9330-288.20 (a) The Department of Health shall enforce the provisions of Minnesota Statutes, section​
9331-288.21151.72, and all rules, orders, stipulation agreements, settlements, compliance agreements,​
9332-288.22and registrations related to that section adopted or issued by the Office of Medical Cannabis​
9333-288.23or the Department of Health pursuant to the Health Enforcement Consolidation Act of 1993​
9334-288.24contained in Minnesota Statutes, sections 144.989 to 144.993, and the authority to embargo​
9335-288.25products described in paragraph (b). The commissioner of health may assign enforcement​
9336-288.26responsibilities to the Office of Medical Cannabis.​
9337-288.27 (b) Whenever a duly authorized agent of the Department of Health finds or has probable​
9338-288.28cause to believe that any product is being sold in violation of the provisions of Minnesota​
9339-288.29Statutes, section 151.72, the agent shall affix thereto an appropriate marking, giving notice​
9340-288.30that the article is, or is suspected of being in violation of Minnesota Statutes, section 151.72,​
9341-288.31has been embargoed, and warning that it is unlawful for any person to remove or dispose​
9342-288​Article 7 Sec. 4.​
9343-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 289.1of the embargoed article by sale or otherwise without permission from the agent or the court.​
9344-289.2When an agent of the Department of Health has embargoed an article, the Department of​
9345-289.3Health shall, within 30 days, petition the district court in whose jurisdiction the article is​
9346-289.4embargoed for an order of condemnation. When an embargoed article is not so found by​
9347-289.5the agent, the agent shall remove the marking. If the court finds that an embargoed article​
9348-289.6is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the article​
9349-289.7shall be destroyed at the expense of the claimant thereof, who shall also pay all court costs​
9350-289.8and fees, storage, and other proper expenses. If the violation can be corrected by proper​
9351-289.9labeling or processing of the article, or by filing the proper documents with the court, the​
9352-289.10court, after the costs, fees, and expenses have been paid and a sufficient bond has been​
9353-289.11executed, may order that the article be delivered to the claimant for labeling, processing,​
9354-289.12or filing under supervision of an agent of the board. The expense of the supervision shall​
9355-289.13be paid by the claimant. The bond shall be returned to the claimant on the representation to​
9356-289.14the court by the board that the article is no longer in violation of this chapter and that the​
9357-289.15expenses of supervision have been paid.​
9358-289.16 (c) The enforcement authority under paragraphs (a) and (b) shall transfer to the Office​
9359-289.17of Cannabis Management at any such time that the powers and duties of the Department of​
9360-289.18Health with respect to the medical cannabis program under Minnesota Statutes, sections​
9361-289.19152.22 to 152.37, are transferred to the Office of Cannabis Management. The director of​
9362-289.20the Office of Cannabis Management may assign enforcement responsibilities to the Division​
9363-289.21of Medical Cannabis.​
9364-289.22 (d) This section shall expire on March 1, 2025.​
9365-289.23 EFFECTIVE DATE.This section is effective the day following final enactment.​
9366-289.24Sec. 5. TRANSFER OF ACTIVE AND INACTIVE COMPLAINTS.​
9367-289.25 (a) The Board of Pharmacy shall transfer all data, including not public data as defined​
9368-289.26in Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive​
9369-289.27complaints involving alleged violations of Minnesota Statutes, section 151.72, to the​
9370-289.28Department of Health. The Board of Pharmacy and Department of Health shall ensure that​
9371-289.29the transfer takes place in a manner and on a schedule that prioritizes public health.​
9372-289.30 (b) The Department of Health shall transfer all complaint data described in paragraph​
9373-289.31(a) to the Office of Cannabis Management at any such time that the powers and duties of​
9374-289.32the Department of Health with respect to the medical cannabis program under Minnesota​
9375-289.33Statutes, sections 152.22 to 152.37, are transferred to the Office of Cannabis Management.​
9376-289​Article 7 Sec. 5.​
9377-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 290.1The director of the Office of Cannabis Management may assign enforcement responsibilities​
9378-290.2to the Division of Medical Cannabis.​
9379-290.3 EFFECTIVE DATE.This section is effective the day following final enactment.​
9380-290.4Sec. 6. REPEALER.​
9381-290.5 Minnesota Statutes 2022, section 151.72, is repealed.​
9382-290.6 EFFECTIVE DATE.This section is effective March 1, 2025.​
9383-290.7 ARTICLE 8​
9384-290.8 SCHEDULING OF MARIJUANA​
9385-290.9Section 1. Minnesota Statutes 2022, section 152.02, subdivision 2, is amended to read:​
9386-290.10 Subd. 2.Schedule I.(a) Schedule I consists of the substances listed in this subdivision.​
9387-290.11 (b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the​
9388-290.12following substances, including their analogs, isomers, esters, ethers, salts, and salts of​
9389-290.13isomers, esters, and ethers, whenever the existence of the analogs, isomers, esters, ethers,​
9390-290.14and salts is possible:​
9391-290.15 (1) acetylmethadol;​
9392-290.16 (2) allylprodine;​
9393-290.17 (3) alphacetylmethadol (except levo-alphacetylmethadol, also known as levomethadyl​
9394-290.18acetate);​
9395-290.19 (4) alphameprodine;​
9396-290.20 (5) alphamethadol;​
9397-290.21 (6) alpha-methylfentanyl benzethidine;​
9398-290.22 (7) betacetylmethadol;​
9399-290.23 (8) betameprodine;​
9400-290.24 (9) betamethadol;​
9401-290.25 (10) betaprodine;​
9402-290.26 (11) clonitazene;​
9403-290.27 (12) dextromoramide;​
9404-290.28 (13) diampromide;​
9405-290​Article 8 Section 1.​
9406-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 291.1 (14) diethyliambutene;​
9407-291.2 (15) difenoxin;​
9408-291.3 (16) dimenoxadol;​
9409-291.4 (17) dimepheptanol;​
9410-291.5 (18) dimethyliambutene;​
9411-291.6 (19) dioxaphetyl butyrate;​
9412-291.7 (20) dipipanone;​
9413-291.8 (21) ethylmethylthiambutene;​
9414-291.9 (22) etonitazene;​
9415-291.10 (23) etoxeridine;​
9416-291.11 (24) furethidine;​
9417-291.12 (25) hydroxypethidine;​
9418-291.13 (26) ketobemidone;​
9419-291.14 (27) levomoramide;​
9420-291.15 (28) levophenacylmorphan;​
9421-291.16 (29) 3-methylfentanyl;​
9422-291.17 (30) acetyl-alpha-methylfentanyl;​
9423-291.18 (31) alpha-methylthiofentanyl;​
9424-291.19 (32) benzylfentanyl beta-hydroxyfentanyl;​
9425-291.20 (33) beta-hydroxy-3-methylfentanyl;​
9426-291.21 (34) 3-methylthiofentanyl;​
9427-291.22 (35) thenylfentanyl;​
9428-291.23 (36) thiofentanyl;​
9429-291.24 (37) para-fluorofentanyl;​
9430-291.25 (38) morpheridine;​
9431-291.26 (39) 1-methyl-4-phenyl-4-propionoxypiperidine;​
9432-291.27 (40) noracymethadol;​
9433-291​Article 8 Section 1.​
9434-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 292.1 (41) norlevorphanol;​
9435-292.2 (42) normethadone;​
9436-292.3 (43) norpipanone;​
9437-292.4 (44) 1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine (PEPAP);​
9438-292.5 (45) phenadoxone;​
9439-292.6 (46) phenampromide;​
9440-292.7 (47) phenomorphan;​
9441-292.8 (48) phenoperidine;​
9442-292.9 (49) piritramide;​
9443-292.10 (50) proheptazine;​
9444-292.11 (51) properidine;​
9445-292.12 (52) propiram;​
9446-292.13 (53) racemoramide;​
9447-292.14 (54) tilidine;​
9448-292.15 (55) trimeperidine;​
9449-292.16 (56) N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide (acetyl fentanyl);​
9450-292.17 (57) 3,4-dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-​
9451-292.18methylbenzamide(U47700);​
9452-292.19 (58) N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide(furanylfentanyl);​
9453-292.20 (59) 4-(4-bromophenyl)-4-dimethylamino-1-phenethylcyclohexanol (bromadol);​
9454-292.21 (60) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (Cyclopropryl​
9455-292.22fentanyl);​
9456-292.23 (61) N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) (butyryl fentanyl);​
9457-292.24 (62) 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) (MT-45);​
9458-292.25 (63) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl​
9459-292.26fentanyl);​
9460-292.27 (64) N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl);​
9461-292.28 (65) N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl);​
9462-292​Article 8 Section 1.​
9463-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 293.1 (66) N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide​
9464-293.2(para-chloroisobutyryl fentanyl);​
9465-293.3 (67) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl​
9466-293.4fentanyl);​
9467-293.5 (68) N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide​
9468-293.6(para-methoxybutyryl fentanyl);​
9469-293.7 (69) N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil);​
9470-293.8 (70) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl​
9471-293.9fentanyl or para-fluoroisobutyryl fentanyl);​
9472-293.10 (71) N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl or​
9473-293.11acryloylfentanyl);​
9474-293.12 (72) 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (methoxyacetyl​
9475-293.13fentanyl);​
9476-293.14 (73) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (ortho-fluorofentanyl​
9477-293.15or 2-fluorofentanyl);​
9478-293.16 (74) N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide​
9479-293.17(tetrahydrofuranyl fentanyl); and​
9480-293.18 (75) Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers,​
9481-293.19esters and ethers, meaning any substance not otherwise listed under another federal​
9482-293.20Administration Controlled Substance Code Number or not otherwise listed in this section,​
9483-293.21and for which no exemption or approval is in effect under section 505 of the Federal Food,​
9484-293.22Drug, and Cosmetic Act, United States Code , title 21, section 355, that is structurally related​
9485-293.23to fentanyl by one or more of the following modifications:​
9486-293.24 (i) replacement of the phenyl portion of the phenethyl group by any monocycle, whether​
9487-293.25or not further substituted in or on the monocycle;​
9488-293.26 (ii) substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo,​
9489-293.27haloalkyl, amino, or nitro groups;​
9490-293.28 (iii) substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether,​
9491-293.29hydroxyl, halo, haloalkyl, amino, or nitro groups;​
9492-293.30 (iv) replacement of the aniline ring with any aromatic monocycle whether or not further​
9493-293.31substituted in or on the aromatic monocycle; or​
9494-293​Article 8 Section 1.​
9495-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 294.1 (v) replacement of the N-propionyl group by another acyl group.​
9496-294.2 (c) Opium derivatives. Any of the following substances, their analogs, salts, isomers,​
9497-294.3and salts of isomers, unless specifically excepted or unless listed in another schedule,​
9498-294.4whenever the existence of the analogs, salts, isomers, and salts of isomers is possible:​
9499-294.5 (1) acetorphine;​
9500-294.6 (2) acetyldihydrocodeine;​
9501-294.7 (3) benzylmorphine;​
9502-294.8 (4) codeine methylbromide;​
9503-294.9 (5) codeine-n-oxide;​
9504-294.10 (6) cyprenorphine;​
9505-294.11 (7) desomorphine;​
9506-294.12 (8) dihydromorphine;​
9507-294.13 (9) drotebanol;​
9508-294.14 (10) etorphine;​
9509-294.15 (11) heroin;​
9510-294.16 (12) hydromorphinol;​
9511-294.17 (13) methyldesorphine;​
9512-294.18 (14) methyldihydromorphine;​
9513-294.19 (15) morphine methylbromide;​
9514-294.20 (16) morphine methylsulfonate;​
9515-294.21 (17) morphine-n-oxide;​
9516-294.22 (18) myrophine;​
9517-294.23 (19) nicocodeine;​
9518-294.24 (20) nicomorphine;​
9519-294.25 (21) normorphine;​
9520-294.26 (22) pholcodine; and​
9521-294.27 (23) thebacon.​
9522-294​Article 8 Section 1.​
9523-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 295.1 (d) Hallucinogens. Any material, compound, mixture or preparation which contains any​
9524-295.2quantity of the following substances, their analogs, salts, isomers (whether optical, positional,​
9525-295.3or geometric), and salts of isomers, unless specifically excepted or unless listed in another​
9526-295.4schedule, whenever the existence of the analogs, salts, isomers, and salts of isomers is​
9527-295.5possible:​
9528-295.6 (1) methylenedioxy amphetamine;​
9529-295.7 (2) methylenedioxymethamphetamine;​
9530-295.8 (3) methylenedioxy-N-ethylamphetamine (MDEA);​
9531-295.9 (4) n-hydroxy-methylenedioxyamphetamine;​
9532-295.10 (5) 4-bromo-2,5-dimethoxyamphetamine (DOB);​
9533-295.11 (6) 2,5-dimethoxyamphetamine (2,5-DMA);​
9534-295.12 (7) 4-methoxyamphetamine;​
9535-295.13 (8) 5-methoxy-3, 4-methylenedioxyamphetamine;​
9536-295.14 (9) alpha-ethyltryptamine;​
9537-295.15 (10) bufotenine;​
9538-295.16 (11) diethyltryptamine;​
9539-295.17 (12) dimethyltryptamine;​
9540-295.18 (13) 3,4,5-trimethoxyamphetamine;​
9541-295.19 (14) 4-methyl-2, 5-dimethoxyamphetamine (DOM);​
9542-295.20 (15) ibogaine;​
9543-295.21 (16) lysergic acid diethylamide (LSD);​
9544-295.22 (17) mescaline;​
9545-295.23 (18) parahexyl;​
9546-295.24 (19) N-ethyl-3-piperidyl benzilate;​
9547-295.25 (20) N-methyl-3-piperidyl benzilate;​
9548-295.26 (21) psilocybin;​
9549-295.27 (22) psilocyn;​
9550-295.28 (23) tenocyclidine (TPCP or TCP);​
9551-295​Article 8 Section 1.​
9552-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 296.1 (24) N-ethyl-1-phenyl-cyclohexylamine (PCE);​
9553-296.2 (25) 1-(1-phenylcyclohexyl) pyrrolidine (PCPy);​
9554-296.3 (26) 1-[1-(2-thienyl)cyclohexyl]-pyrrolidine (TCPy);​
9555-296.4 (27) 4-chloro-2,5-dimethoxyamphetamine (DOC);​
9556-296.5 (28) 4-ethyl-2,5-dimethoxyamphetamine (DOET);​
9557-296.6 (29) 4-iodo-2,5-dimethoxyamphetamine (DOI);​
9558-296.7 (30) 4-bromo-2,5-dimethoxyphenethylamine (2C-B);​
9559-296.8 (31) 4-chloro-2,5-dimethoxyphenethylamine (2C-C);​
9560-296.9 (32) 4-methyl-2,5-dimethoxyphenethylamine (2C-D);​
9561-296.10 (33) 4-ethyl-2,5-dimethoxyphenethylamine (2C-E);​
9562-296.11 (34) 4-iodo-2,5-dimethoxyphenethylamine (2C-I);​
9563-296.12 (35) 4-propyl-2,5-dimethoxyphenethylamine (2C-P);​
9564-296.13 (36) 4-isopropylthio-2,5-dimethoxyphenethylamine (2C-T-4);​
9565-296.14 (37) 4-propylthio-2,5-dimethoxyphenethylamine (2C-T-7);​
9566-296.15 (38) 2-(8-bromo-2,3,6,7-tetrahydrofuro [2,3-f][1]benzofuran-4-yl)ethanamine​
9567-296.16(2-CB-FLY);​
9568-296.17 (39) bromo-benzodifuranyl-isopropylamine (Bromo-DragonFLY);​
9569-296.18 (40) alpha-methyltryptamine (AMT);​
9570-296.19 (41) N,N-diisopropyltryptamine (DiPT);​
9571-296.20 (42) 4-acetoxy-N,N-dimethyltryptamine (4-AcO-DMT);​
9572-296.21 (43) 4-acetoxy-N,N-diethyltryptamine (4-AcO-DET);​
9573-296.22 (44) 4-hydroxy-N-methyl-N-propyltryptamine (4-HO-MPT);​
9574-296.23 (45) 4-hydroxy-N,N-dipropyltryptamine (4-HO-DPT);​
9575-296.24 (46) 4-hydroxy-N,N-diallyltryptamine (4-HO-DALT);​
9576-296.25 (47) 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT);​
9577-296.26 (48) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT);​
9578-296.27 (49) 5-methoxy-α-methyltryptamine (5-MeO-AMT);​
9579-296​Article 8 Section 1.​
9580-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 297.1 (50) 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT);​
9581-297.2 (51) 5-methylthio-N,N-dimethyltryptamine (5-MeS-DMT);​
9582-297.3 (52) 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT);​
9583-297.4 (53) 5-methoxy-α-ethyltryptamine (5-MeO-AET);​
9584-297.5 (54) 5-methoxy-N,N-dipropyltryptamine (5-MeO-DPT);​
9585-297.6 (55) 5-methoxy-N,N-diethyltryptamine (5-MeO-DET);​
9586-297.7 (56) 5-methoxy-N,N-diallyltryptamine (5-MeO-DALT);​
9587-297.8 (57) methoxetamine (MXE);​
9588-297.9 (58) 5-iodo-2-aminoindane (5-IAI);​
9589-297.10 (59) 5,6-methylenedioxy-2-aminoindane (MDAI);​
9590-297.11 (60) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe);​
9591-297.12 (61) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe);​
9592-297.13 (62) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe);​
9593-297.14 (63) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);​
9594-297.15 (64) 2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine (2C-T-2);​
9595-297.16 (65) N,N-Dipropyltryptamine (DPT);​
9596-297.17 (66) 3-[1-(Piperidin-1-yl)cyclohexyl]phenol (3-HO-PCP);​
9597-297.18 (67) N-ethyl-1-(3-methoxyphenyl)cyclohexanamine (3-MeO-PCE);​
9598-297.19 (68) 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo);​
9599-297.20 (69) 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine (methoxydine, 4-MeO-PCP);​
9600-297.21 (70) 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexan-1-one (N-Ethylnorketamine,​
9601-297.22ethketamine, NENK);​
9602-297.23 (71) methylenedioxy-N,N-dimethylamphetamine (MDDMA);​
9603-297.24 (72) 3-(2-Ethyl(methyl)aminoethyl)-1H-indol-4-yl (4-AcO-MET); and​
9604-297.25 (73) 2-Phenyl-2-(methylamino)cyclohexanone (deschloroketamine).​
9605-297.26 (e) Peyote. All parts of the plant presently classified botanically as Lophophora williamsii​
9606-297.27Lemaire, whether growing or not, the seeds thereof, any extract from any part of the plant,​
9607-297.28and every compound, manufacture, salts, derivative, mixture, or preparation of the plant,​
9608-297​Article 8 Section 1.​
9609-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 298.1its seeds or extracts. The listing of peyote as a controlled substance in Schedule I does not​
9610-298.2apply to the nondrug use of peyote in bona fide religious ceremonies of the American Indian​
9611-298.3Church, and members of the American Indian Church are exempt from registration. Any​
9612-298.4person who manufactures peyote for or distributes peyote to the American Indian Church,​
9613-298.5however, is required to obtain federal registration annually and to comply with all other​
9614-298.6requirements of law.​
9615-298.7 (f) Central nervous system depressants. Unless specifically excepted or unless listed in​
9616-298.8another schedule, any material compound, mixture, or preparation which contains any​
9617-298.9quantity of the following substances, their analogs, salts, isomers, and salts of isomers​
9618-298.10whenever the existence of the analogs, salts, isomers, and salts of isomers is possible:​
9619-298.11 (1) mecloqualone;​
9620-298.12 (2) methaqualone;​
9621-298.13 (3) gamma-hydroxybutyric acid (GHB), including its esters and ethers;​
9622-298.14 (4) flunitrazepam;​
9623-298.15 (5) 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexanone (2-MeO-2-deschloroketamine,​
9624-298.16methoxyketamine);​
9625-298.17 (6) tianeptine;​
9626-298.18 (7) clonazolam;​
9627-298.19 (8) etizolam;​
9628-298.20 (9) flubromazolam; and​
9629-298.21 (10) flubromazepam.​
9630-298.22 (g) Stimulants. Unless specifically excepted or unless listed in another schedule, any​
9631-298.23material compound, mixture, or preparation which contains any quantity of the following​
9632-298.24substances, their analogs, salts, isomers, and salts of isomers whenever the existence of the​
9633-298.25analogs, salts, isomers, and salts of isomers is possible:​
9634-298.26 (1) aminorex;​
9635-298.27 (2) cathinone;​
9636-298.28 (3) fenethylline;​
9637-298.29 (4) methcathinone;​
9638-298.30 (5) methylaminorex;​
9639-298​Article 8 Section 1.​
9640-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 299.1 (6) N,N-dimethylamphetamine;​
9641-299.2 (7) N-benzylpiperazine (BZP);​
9642-299.3 (8) methylmethcathinone (mephedrone);​
9643-299.4 (9) 3,4-methylenedioxy-N-methylcathinone (methylone);​
9644-299.5 (10) methoxymethcathinone (methedrone);​
9645-299.6 (11) methylenedioxypyrovalerone (MDPV);​
9646-299.7 (12) 3-fluoro-N-methylcathinone (3-FMC);​
9647-299.8 (13) methylethcathinone (MEC);​
9648-299.9 (14) 1-benzofuran-6-ylpropan-2-amine (6-APB);​
9649-299.10 (15) dimethylmethcathinone (DMMC);​
9650-299.11 (16) fluoroamphetamine;​
9651-299.12 (17) fluoromethamphetamine;​
9652-299.13 (18) α-methylaminobutyrophenone (MABP or buphedrone);​
9653-299.14 (19) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone);​
9654-299.15 (20) 2-(methylamino)-1-(4-methylphenyl)butan-1-one (4-MEMABP or BZ-6378);​
9655-299.16 (21) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl) pentan-1-one (naphthylpyrovalerone or​
9656-299.17naphyrone);​
9657-299.18 (22) (alpha-pyrrolidinopentiophenone (alpha-PVP);​
9658-299.19 (23) (RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-hexanone (4-Me-PHP or MPHP);​
9659-299.20 (24) 2-(1-pyrrolidinyl)-hexanophenone (Alpha-PHP);​
9660-299.21 (25) 4-methyl-N-ethylcathinone (4-MEC);​
9661-299.22 (26) 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP);​
9662-299.23 (27) 2-(methylamino)-1-phenylpentan-1-one (pentedrone);​
9663-299.24 (28) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone);​
9664-299.25 (29) 4-fluoro-N-methylcathinone (4-FMC);​
9665-299.26 (30) 3,4-methylenedioxy-N-ethylcathinone (ethylone);​
9666-299.27 (31) alpha-pyrrolidinobutiophenone (α-PBP);​
9667-299​Article 8 Section 1.​
9668-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 300.1 (32) 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB);​
9669-300.2 (33) 1-phenyl-2-(1-pyrrolidinyl)-1-heptanone (PV8);​
9670-300.3 (34) 6-(2-Aminopropyl)-2,3-dihydrobenzofuran (6-APDB);​
9671-300.4 (35) 4-methyl-alpha-ethylaminopentiophenone (4-MEAPP);​
9672-300.5 (36) 4'-chloro-alpha-pyrrolidinopropiophenone (4'-chloro-PPP);​
9673-300.6 (37) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one (dibutylone, bk-DMBDB);​
9674-300.7 (38) 1-(3-chlorophenyl) piperazine (meta-chlorophenylpiperazine or mCPP);​
9675-300.8 (39) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one (N-ethylpentylone, ephylone);​
9676-300.9and​
9677-300.10 (40) any other substance, except bupropion or compounds listed under a different​
9678-300.11schedule, that is structurally derived from 2-aminopropan-1-one by substitution at the​
9679-300.121-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the​
9680-300.13compound is further modified in any of the following ways:​
9681-300.14 (i) by substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy,​
9682-300.15haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring​
9683-300.16system by one or more other univalent substituents;​
9684-300.17 (ii) by substitution at the 3-position with an acyclic alkyl substituent;​
9685-300.18 (iii) by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or​
9686-300.19methoxybenzyl groups; or​
9687-300.20 (iv) by inclusion of the 2-amino nitrogen atom in a cyclic structure.​
9688-300.21 (h) Marijuana, tetrahydrocannabinols, and synthetic cannabinoids. Unless specifically​
9689-300.22excepted or unless listed in another schedule, any natural or synthetic material, compound,​
9690-300.23mixture, or preparation that contains any quantity of the following substances, their analogs,​
9691-300.24isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence​
9692-300.25of the isomers, esters, ethers, or salts is possible:​
9693-300.26 (1) marijuana;​
9694-300.27 (2) tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, except​
9695-300.28that tetrahydrocannabinols do not include any material, compound, mixture, or preparation​
9696-300.29that qualifies as industrial hemp as defined in section 18K.02, subdivision 3; synthetic​
9697-300.30equivalents of the substances contained in the cannabis plant or in the resinous extractives​
9698-300.31of the plant; or synthetic substances with similar chemical structure and pharmacological​
9699-300​Article 8 Section 1.​
9700-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 301.1activity to those substances contained in the plant or resinous extract, including, but not​
9701-301.2limited to, 1 cis or trans tetrahydrocannabinol, 6 cis or trans tetrahydrocannabinol, and 3,4​
9702-301.3cis or trans tetrahydrocannabinol;​
9703-301.4 (3) (h) Synthetic cannabinoids, including the following substances:​
9704-301.5 (i) (1) Naphthoylindoles, which are any compounds containing a 3-(1-napthoyl)indole​
9705-301.6structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl,​
9706-301.7alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or​
9707-301.82-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any​
9708-301.9extent and whether or not substituted in the naphthyl ring to any extent. Examples of​
9709-301.10naphthoylindoles include, but are not limited to:​
9710-301.11 (A) (i) 1-Pentyl-3-(1-naphthoyl)indole (JWH-018 and AM-678);​
9711-301.12 (B) (ii) 1-Butyl-3-(1-naphthoyl)indole (JWH-073);​
9712-301.13 (C) (iii) 1-Pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081);​
9713-301.14 (D) (iv) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);​
9714-301.15 (E) (v) 1-Propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015);​
9715-301.16 (F) (vi) 1-Hexyl-3-(1-naphthoyl)indole (JWH-019);​
9716-301.17 (G) (vii) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);​
9717-301.18 (H) (viii) 1-Pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210);​
9718-301.19 (I) (ix) 1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);​
9719-301.20 (J) (x) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201).​
9720-301.21 (ii) (2) Napthylmethylindoles, which are any compounds containing a​
9721-301.221H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the​
9722-301.23indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,​
9723-301.241-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further​
9724-301.25substituted in the indole ring to any extent and whether or not substituted in the naphthyl​
9725-301.26ring to any extent. Examples of naphthylmethylindoles include, but are not limited to:​
9726-301.27 (A) (i) 1-Pentyl-1H-indol-3-yl-(1-naphthyl)methane (JWH-175);​
9727-301.28 (B) (ii) 1-Pentyl-1H-indol-3-yl-(4-methyl-1-naphthyl)methane (JWH-184).​
9728-301.29 (iii) (3) Naphthoylpyrroles, which are any compounds containing a 3-(1-naphthoyl)pyrrole​
9729-301.30structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl,​
9730-301.31alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or​
9731-301​Article 8 Section 1.​
9732-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 302.12-(4-morpholinyl)ethyl group whether or not further substituted in the pyrrole ring to any​
9733-302.2extent, whether or not substituted in the naphthyl ring to any extent. Examples of​
9734-302.3naphthoylpyrroles include, but are not limited to,​
9735-302.4(5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone (JWH-307).​
9736-302.5 (iv) (4) Naphthylmethylindenes, which are any compounds containing a​
9737-302.6naphthylideneindene structure with substitution at the 3-position of the indene ring by an​
9738-302.7alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,​
9739-302.81-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not further​
9740-302.9substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring​
9741-302.10to any extent. Examples of naphthylemethylindenes include, but are not limited to,​
9742-302.11E-1-[1-(1-naphthalenylmethylene)-1H-inden-3-yl]pentane (JWH-176).​
9743-302.12 (v) (5) Phenylacetylindoles, which are any compounds containing a 3-phenylacetylindole​
9744-302.13structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl,​
9745-302.14alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or​
9746-302.152-(4-morpholinyl)ethyl group whether or not further substituted in the indole ring to any​
9747-302.16extent, whether or not substituted in the phenyl ring to any extent. Examples of​
9748-302.17phenylacetylindoles include, but are not limited to:​
9749-302.18 (A) (i) 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole (RCS-8);​
9750-302.19 (B) (ii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);​
9751-302.20 (C) (iii) 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251);​
9752-302.21 (D) (iv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).​
9753-302.22 (vi) (6) Cyclohexylphenols, which are compounds containing a​
9754-302.232-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic​
9755-302.24ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,​
9756-302.251-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not substituted​
9757-302.26in the cyclohexyl ring to any extent. Examples of cyclohexylphenols include, but are not​
9758-302.27limited to:​
9759-302.28 (A) (i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497);​
9760-302.29 (B) (ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol​
9761-302.30(Cannabicyclohexanol or CP 47,497 C8 homologue);​
9762-302.31 (C) (iii) 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]​
9763-302.32-phenol (CP 55,940).​
9764-302​Article 8 Section 1.​
9765-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 303.1 (vii) (7) Benzoylindoles, which are any compounds containing a 3-(benzoyl)indole​
9766-303.2structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl,​
9767-303.3alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or​
9768-303.42-(4-morpholinyl)ethyl group whether or not further substituted in the indole ring to any​
9769-303.5extent and whether or not substituted in the phenyl ring to any extent. Examples of​
9770-303.6benzoylindoles include, but are not limited to:​
9771-303.7 (A) (i) 1-Pentyl-3-(4-methoxybenzoyl)indole (RCS-4);​
9772-303.8 (B) (ii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694);​
9773-303.9 (C) (iii) (4-methoxyphenyl-[2-methyl-1-(2-(4-morpholinyl)ethyl)indol-3-yl]methanone​
9774-303.10(WIN 48,098 or Pravadoline).​
9775-303.11 (viii) (8) Others specifically named:​
9776-303.12 (A) (i) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)​
9777-303.13-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (HU-210);​
9778-303.14 (B) (ii) (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)​
9779-303.15-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Dexanabinol or HU-211);​
9780-303.16 (C) (iii) 2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]​
9781-303.17-1,4-benzoxazin-6-yl-1-naphthalenylmethanone (WIN 55,212-2);​
9782-303.18 (D) (iv) (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144);​
9783-303.19 (E) (v) (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone​
9784-303.20(XLR-11);​
9785-303.21 (F) (vi) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide​
9786-303.22(AKB-48(APINACA));​
9787-303.23 (G) (vii) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide​
9788-303.24(5-Fluoro-AKB-48);​
9789-303.25 (H) (viii) 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22);​
9790-303.26 (I) (ix) 8-quinolinyl ester-1-(5-fluoropentyl)-1H-indole-3-carboxylic acid (5-Fluoro​
9791-303.27PB-22);​
9792-303.28 (J) (x) N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole- 3-carboxamide​
9793-303.29(AB-PINACA);​
9794-303.30 (K) (xi) N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-​
9795-303.311H-indazole-3-carboxamide (AB-FUBINACA);​
9796-303​Article 8 Section 1.​
9797-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 304.1 (L) (xii) N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-​
9798-304.2indazole-3-carboxamide(AB-CHMINACA);​
9799-304.3 (M) (xiii) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-​
9800-304.4methylbutanoate (5-fluoro-AMB);​
9801-304.5 (N) (xiv) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl) methanone (THJ-2201);​
9802-304.6 (O) (xv) (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone)​
9803-304.7(FUBIMINA);​
9804-304.8 (P) (xvi) (7-methoxy-1-(2-morpholinoethyl)-N-((1S,2S,4R)-1,3,3-trimethylbicyclo​
9805-304.9[2.2.1]heptan-2-yl)-1H-indole-3-carboxamide (MN-25 or UR-12);​
9806-304.10 (Q) (xvii) (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)​
9807-304.11-1H-indole-3-carboxamide (5-fluoro-ABICA);​
9808-304.12 (R) (xviii) N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)​
9809-304.13-1H-indole-3-carboxamide;​
9810-304.14 (S) (xix) N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)​
9811-304.15-1H-indazole-3-carboxamide;​
9812-304.16 (T) (xx) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)​
9813-304.17-3,3-dimethylbutanoate;​
9814-304.18 (U) (xxi) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1​
9815-304.19H-indazole-3-carboxamide (MAB-CHMINACA);​
9816-304.20 (V) (xxii)​
9817-304.21N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-pentyl-1H-indazole-3-carboxamide​
9818-304.22(ADB-PINACA);​
9819-304.23 (W) (xxiii) methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate (FUB-AMB);​
9820-304.24 (X) (xxiv)​
9821-304.25N-[(1S)-2-amino-2-oxo-1-(phenylmethyl)ethyl]-1-(cyclohexylmethyl)-1H-Indazole-​
9822-304.263-carboxamide. (APP-CHMINACA);​
9823-304.27 (Y) (xxv) quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FUB-PB-22); and​
9824-304.28 (Z) (xxvi) methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]valinate​
9825-304.29(MMB-CHMICA).​
9826-304.30 (ix) (9) Additional substances specifically named:​
9827-304​Article 8 Section 1.​
9828-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 305.1 (A) (i) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1​
9829-305.2H-pyrrolo[2,3-B]pyridine-3-carboxamide (5F-CUMYL-P7AICA);​
9830-305.3 (B) (ii) 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1 H-indazole-3-carboxamide​
9831-305.4(4-CN-Cumyl-Butinaca);​
9832-305.5 (C) (iii) naphthalen-1-yl-1-(5-fluoropentyl)-1-H-indole-3-carboxylate (NM2201;​
9833-305.6CBL2201);​
9834-305.7 (D) (iv) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1​
9835-305.8H-indazole-3-carboxamide (5F-ABPINACA);​
9836-305.9 (E) (v) methyl-2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate​
9837-305.10(MDMB CHMICA);​
9838-305.11 (F) (vi) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate​
9839-305.12(5F-ADB; 5F-MDMB-PINACA); and​
9840-305.13 (G) (vii) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)​
9841-305.141H-indazole-3-carboxamide (ADB-FUBINACA).​
9842-305.15 (i) A controlled substance analog, to the extent that it is implicitly or explicitly intended​
9843-305.16for human consumption.​
9844-305.17 EFFECTIVE DATE.This section is effective the day following final enactment.​
9845-305.18Sec. 2. Minnesota Statutes 2022, section 152.02, subdivision 4, is amended to read:​
9846-305.19 Subd. 4.Schedule III.(a) Schedule III consists of the substances listed in this subdivision.​
9847-305.20 (b) Stimulants. Unless specifically excepted or unless listed in another schedule, any​
9848-305.21material, compound, mixture, or preparation which contains any quantity of the following​
9849-305.22substances having a potential for abuse associated with a stimulant effect on the central​
9850-305.23nervous system, including its salts, isomers, and salts of such isomers whenever the existence​
9851-305.24of such salts, isomers, and salts of isomers is possible within the specific chemical​
9852-305.25designation:​
9853-305.26 (1) benzphetamine;​
9854-305.27 (2) chlorphentermine;​
9855-305.28 (3) clortermine;​
9856-305.29 (4) phendimetrazine.​
9857-305​Article 8 Sec. 2.​
9858-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 306.1 (c) Depressants. Unless specifically excepted or unless listed in another schedule, any​
9859-306.2material, compound, mixture, or preparation which contains any quantity of the following​
9860-306.3substances having a potential for abuse associated with a depressant effect on the central​
9861-306.4nervous system:​
9862-306.5 (1) any compound, mixture, or preparation containing amobarbital, secobarbital,​
9863-306.6pentobarbital or any salt thereof and one or more other active medicinal ingredients which​
9864-306.7are not listed in any schedule;​
9865-306.8 (2) any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or​
9866-306.9any salt of any of these drugs and approved by the food and drug administration for marketing​
9867-306.10only as a suppository;​
9868-306.11 (3) any substance which contains any quantity of a derivative of barbituric acid, or any​
9869-306.12salt of a derivative of barbituric acid, except those substances which are specifically listed​
9870-306.13in other schedules;​
9871-306.14 (4) any drug product containing gamma hydroxybutyric acid, including its salts, isomers,​
9872-306.15and salts of isomers, for which an application is approved under section 505 of the federal​
9873-306.16Food, Drug, and Cosmetic Act;​
9874-306.17 (5) any of the following substances:​
9875-306.18 (i) chlorhexadol;​
9876-306.19 (ii) ketamine, its salts, isomers and salts of isomers;​
9877-306.20 (iii) lysergic acid;​
9878-306.21 (iv) lysergic acid amide;​
9879-306.22 (v) methyprylon;​
9880-306.23 (vi) sulfondiethylmethane;​
9881-306.24 (vii) sulfonenthylmethane;​
9882-306.25 (viii) sulfonmethane;​
9883-306.26 (ix) tiletamine and zolazepam and any salt thereof;​
9884-306.27 (x) embutramide;​
9885-306.28 (xi) Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-Dihydropyridin-3-yl)​
9886-306.29benzonitrile].​
9887-306.30 (d) Nalorphine.​
9888-306​Article 8 Sec. 2.​
9889-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 307.1 (e) Narcotic drugs. Unless specifically excepted or unless listed in another schedule,​
9890-307.2any material, compound, mixture, or preparation containing any of the following narcotic​
9891-307.3drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities​
9892-307.4as follows:​
9893-307.5 (1) not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams​
9894-307.6per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;​
9895-307.7 (2) not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams​
9896-307.8per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic​
9897-307.9amounts;​
9898-307.10 (3) not more than 1.80 grams of dihydrocodeine per 100 milliliters or not more than 90​
9899-307.11milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized​
9900-307.12therapeutic amounts;​
9901-307.13 (4) not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than​
9902-307.1415 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized​
9903-307.15therapeutic amounts;​
9904-307.16 (5) not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not​
9905-307.17more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients​
9906-307.18in recognized therapeutic amounts;​
9907-307.19 (6) not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with​
9908-307.20one or more active, nonnarcotic ingredients in recognized therapeutic amounts.​
9909-307.21 (f) Anabolic steroids, human growth hormone, and chorionic gonadotropin.​
9910-307.22 (1) Anabolic steroids, for purposes of this subdivision, means any drug or hormonal​
9911-307.23substance, chemically and pharmacologically related to testosterone, other than estrogens,​
9912-307.24progestins, corticosteroids, and dehydroepiandrosterone, and includes:​
9913-307.25 (i) 3[beta],17[beta]-dihydroxy-5[alpha]-androstane;​
9914-307.26 (ii) 3[alpha],17[beta]-dihydroxy-5[alpha]-androstane;​
9915-307.27 (iii) androstanedione (5[alpha]-androstan-3,17-dione);​
9916-307.28 (iv) 1-androstenediol (3[beta],17[beta]-dihydroxy-5[alpha]-androst-l-ene;​
9917-307.29 (v) 3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene);​
9918-307.30 (vi) 4-androstenediol (3[beta],17[beta]-dihydroxy-androst-4-ene);​
9919-307.31 (vii) 5-androstenediol (3[beta],17[beta]-dihydroxy-androst-5-ene);​
9920-307​Article 8 Sec. 2.​
9921-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 308.1 (viii) 1-androstenedione (5[alpha]-androst-1-en-3,17-dione);​
9922-308.2 (ix) 4-androstenedione (androst-4-en-3,17-dione);​
9923-308.3 (x) 5-androstenedione (androst-5-en-3,17-dione);​
9924-308.4 (xi) bolasterone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);​
9925-308.5 (xii) boldenone (17[beta]-hydroxyandrost-1,4-diene-3-one);​
9926-308.6 (xiii) boldione (androsta-1,4-diene-3,17-dione);​
9927-308.7 (xiv) calusterone (7[beta],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);​
9928-308.8 (xv) clostebol (4-chloro-17[beta]-hydroxyandrost-4-en-3-one);​
9929-308.9 (xvi) dehydrochloromethyltestosterone​
9930-308.10(4-chloro-17[beta]-hydroxy-17[alpha]-methylandrost-1,4-dien-3-one);​
9931-308.11 (xvii) desoxymethyltestosterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[beta]-ol);​
9932-308.12 (xviii) [delta]1-dihydrotestosterone- (17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);​
9933-308.13 (xix) 4-dihydrotestosterone (17[beta]-hydroxy-androstan-3-one);​
9934-308.14 (xx) drostanolone (17[beta]hydroxy-2[alpha]-methyl-5[alpha]-androstan-3-one);​
9935-308.15 (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]-hydroxyestr-4-ene);​
9936-308.16 (xxii) fluoxymesterone​
9937-308.17(9-fluoro-17[alpha]-methyl-11[beta],17[beta]-dihydroxyandrost-4-en-3-one);​
9938-308.18 (xxiii) formebolone​
9939-308.19(2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-1,4-dien-3-one);​
9940-308.20 (xxiv) furazabol​
9941-308.21(17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan)13[beta]-ethyl-17[beta]​
9942-308.22-hydroxygon-4-en-3-one;​
9943-308.23 (xxv) 4-hydroxytestosterone (4,17[beta]-dihydroxyandrost-4-en-3-one);​
9944-308.24 (xxvi) 4-hydroxy-19-nortestosterone (4,17[beta]-dihydroxyestr-4-en-3-one);​
9945-308.25 (xxvii) mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one);​
9946-308.26 (xxviii) mesterolone (1[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one);​
9947-308.27 (xxix) methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-dien-3-one);​
9948-308.28 (xxx) methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene);​
9949-308​Article 8 Sec. 2.​
9950-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 309.1 (xxxi) methasterone (2 alpha-17 alpha-dimethyl-5 alpha-androstan-17beta-ol-3-one);​
9951-309.2 (xxxii) methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);​
9952-309.3 (xxxiii) 17[alpha]-methyl-3[beta],17[beta]-dihydroxy-5[alpha]-androstane;​
9953-309.4 (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5[alpha]-androstane;​
9954-309.5 (xxxv) 17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene;​
9955-309.6 (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone​
9956-309.7(17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one);​
9957-309.8 (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one);​
9958-309.9 (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9-11-trien-3-one);​
9959-309.10 (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]-hydroxyandrost-4-en-3-one);​
9960-309.11 (xl) mibolerone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyestr-4-en-3-one);​
9961-309.12 (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone​
9962-309.13(17[beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one);​
9963-309.14 (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one);​
9964-309.15 (xliii) 19-nor-4-androstenediol (3[beta],17[beta]-dihydroxyestr-4-ene;​
9965-309.16 (xliv) 3[alpha],17[beta]-dihydroxyestr-4-ene); 19-nor-5-androstenediol​
9966-309.17(3[beta],17[beta]-dihydroxyestr-5-ene;​
9967-309.18 (xlv) 3[alpha],17[beta]-dihydroxyestr-5-ene);​
9968-309.19 (xlvi) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);​
9969-309.20 (xlvii) 19-nor-5-androstenedione (estr-5-en-3,17-dione);​
9970-309.21 (xlviii) norbolethone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4-en-3-one);​
9971-309.22 (xlix) norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3-one);​
9972-309.23 (l) norethandrolone (17[alpha]-ethyl-17[beta]-hydroxyestr-4-en-3-one);​
9973-309.24 (li) normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one);​
9974-309.25 (lii) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-5[alpha]-androstan-3-one);​
9975-309.26 (liii) oxymesterone (17[alpha]-methyl-4,17[beta]-dihydroxyandrost-4-en-3-one);​
9976-309.27 (liv) oxymetholone​
9977-309.28(17[alpha]-methyl-2-hydroxymethylene-17[beta]-hydroxy-5[alpha]-androstan-3-one);​
9978-309​Article 8 Sec. 2.​
9979-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 310.1 (lv) prostanozol (17 beta-hydroxy-5 alpha-androstano[3,2-C]pryazole;​
9980-310.2 (lvi) stanozolol​
9981-310.3(17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androst-2-eno[3,2-c]-pyrazole);​
9982-310.4 (lvii) stenbolone (17[beta]-hydroxy-2-methyl-5[alpha]-androst-1-en-3-one);​
9983-310.5 (lviii) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);​
9984-310.6 (lix) testosterone (17[beta]-hydroxyandrost-4-en-3-one);​
9985-310.7 (lx) tetrahydrogestrinone​
9986-310.8(13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4,9,11-trien-3-one);​
9987-310.9 (lxi) trenbolone (17[beta]-hydroxyestr-4,9,11-trien-3-one);​
9988-310.10 (lxii) any salt, ester, or ether of a drug or substance described in this paragraph.​
9989-310.11Anabolic steroids are not included if they are: (A) expressly intended for administration​
9990-310.12through implants to cattle or other nonhuman species; and (B) approved by the United States​
9991-310.13Food and Drug Administration for that use;​
9992-310.14 (2) Human growth hormones.​
9993-310.15 (3) Chorionic gonadotropin, except that a product containing chorionic gonadotropin is​
9994-310.16not included if it is:​
9995-310.17 (i) expressly intended for administration to cattle or other nonhuman species; and​
9996-310.18 (ii) approved by the United States Food and Drug Administration for that use.​
9997-310.19 (g) Hallucinogenic substances. Dronabinol (synthetic) in sesame oil and encapsulated​
9998-310.20in a soft gelatin capsule in a United States Food and Drug Administration approved product.​
9999-310.21 (h) Any material, compound, mixture, or preparation containing the following narcotic​
10000-310.22drug or its salt: buprenorphine.​
10001-310.23 (i) Marijuana, tetrahydrocannabinols, and synthetic cannabinoids. Unless specifically​
10002-310.24excepted or unless listed in another schedule, any natural or synthetic material, compound,​
10003-310.25mixture, or preparation that contains any quantity of the following substances, their analogs,​
10004-310.26isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence​
10005-310.27of the isomers, esters, ethers, or salts is possible:​
10006-310.28 (1) marijuana;​
10007-310.29 (2) tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, except​
10008-310.30that tetrahydrocannabinols do not include any material, compound, mixture, or preparation​
10009-310​Article 8 Sec. 2.​
10010-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 311.1that qualifies as industrial hemp as defined in section 18K.02, subdivision 3; synthetic​
10011-311.2equivalents of the substances contained in the cannabis plant or in the resinous extractives​
10012-311.3of the plant; or synthetic substances with similar chemical structure and pharmacological​
10013-311.4activity to those substances contained in the plant or resinous extract, including but not​
10014-311.5limited to 1 cis or trans tetrahydrocannabinol, 6 cis or trans tetrahydrocannabinol, and 3,4​
10015-311.6cis or trans tetrahydrocannabinol.​
10016-311.7 EFFECTIVE DATE.This section is effective the day following final enactment.​
10017-311.8 ARTICLE 9​
10018-311.9 APPROPRIATIONS​
10019-311.10Section 1. APPROPRIATIONS.​
10020-311.11 The sums shown in the columns marked "Appropriations" are appropriated to the agencies​
10021-311.12and for the purposes of this act. The appropriations are from the general fund, or another​
10022-311.13named fund, and are available for the fiscal years indicated for each purpose. The figures​
10023-311.14"2024" and "2025" used in this article mean that the appropriations listed under them are​
10024-311.15available for the fiscal year ending June 30, 2024, or June 30, 2025, respectively. "The first​
10025-311.16year" is fiscal year 2024. "The second year" is fiscal year 2025. "The biennium" is fiscal​
10026-311.17years 2024 and 2025.​
10027-311.18 APPROPRIATIONS​
10028-311.19 Available for the Year​
10029-311.20 Ending June 30​
10030-2025​311.21 2024​
10031-411,000​$​411,000​$​311.22Sec. 2. AGRICULTURE​
10032-311.23The base for this appropriation is $338,000 in​
10033-311.24fiscal year 2026 and each fiscal year thereafter.​
10034-358,000​$​358,000​$​311.25Sec. 3. ATTORNEY GENERAL​
10035-311.26The base for this appropriation is $358,000 in​
10036-311.27fiscal years 2026, 2027, and 2028. The base​
10037-311.28for this appropriation is $0 in fiscal year 2029.​
10038-5,356,000​$​5,871,000​$​311.29Sec. 4. CANNABIS EXPUNGEMENT BOARD​
10039-17,953,000​$​21,614,000​$​
10040-311.30Sec. 5. OFFICE OF CANNABIS​
10041-311.31MANAGEMENT​
10042-311​Article 9 Sec. 5.​
10043-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 312.1The base for this appropriation is $35,587,000​
10044-312.2in fiscal year 2026 and $38,144,000 in fiscal​
10045-312.3year 2027.​
10046-312.4$1,000,000 the second year is for cannabis​
10047-312.5industry community renewal grants under​
10048-312.6Minnesota Statutes, section 342.70. Of these​
10049-312.7amounts, up to three percent may be used for​
10050-312.8administrative expenses. The base for this​
10051-312.9appropriation is $15,000,000 in fiscal year​
10052-312.102026 and each fiscal year thereafter.​
10053-312.11$1,000,000 each year is for transfer to the​
10054-312.12CanGrow revolving loan account established​
10055-312.13under Minnesota Statutes, section 342.73,​
10056-312.14subdivision 4. Of these amounts, up to three​
10057-312.15percent may be used for administrative​
10058-312.16expenses.​
10059-1,093,000​$​527,000​$​312.17Sec. 6. COMMERCE​
10060-312.18The base for this appropriation is $1,341,000​
10061-312.19in fiscal year 2026 and $1,520,000 in fiscal​
10062-312.20year 2027.​
10063-312.21$82,000 each year is to establish appropriate​
10064-312.22energy standards.​
10065-312.23$445,000 the first year and $1,011,000 the​
10066-312.24second year are for scale and packaging​
10067-312.25inspections. The base for this appropriation is​
10068-312.26$1,259,000 in fiscal year 2026 and $1,438,000​
10069-312.27in fiscal year 2027.​
10070-1,500,000​$​1,500,000​$​312.28Sec. 7. DISTRICT COURT​
10071-312.29This appropriation is to support treatment​
10072-312.30courts. The base for this appropriation is​
10073-312.31$2,500,000 in fiscal year 2026 and each fiscal​
10074-312.32year thereafter.​
10075-120,000​$​180,000​$​312.33Sec. 8. EDUCATION​
10076-312​Article 9 Sec. 8.​
10077-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 6,000,000​$​6,000,000​$​
10078-313.1Sec. 9. EMPLOYMENT AND ECONOMIC​
10079-313.2DEVELOPMENT​
10080-313.3(a) For the CanStartup, CanNavigate, and​
10081-313.4CanTrain programs. Any unencumbered​
10082-313.5balances remaining in the first year do not​
10083-313.6cancel but are available for the second year.​
10084-313.7(b) $3,000,000 each year is for transfer to the​
10085-313.8CanStartup revolving loan account established​
10086-313.9under Minnesota Statutes, section 116J.659,​
10087-313.10subdivision 3.​
10088-313.11(c) $1,000,000 each year is for the​
10089-313.12CanNavigate program established under​
10090-313.13Minnesota Statutes, section 116J.6595.​
10091-313.14(d) $2,000,000 each year is for the CanTrain​
10092-313.15program established under Minnesota Statutes,​
10093-313.16section 116L.90.​
10094-313.17(e) Of these amounts, up to four percent may​
10095-313.18be used for administrative expenses.​
10096-313.19Sec. 10. HEALTH​
10097-20,252,000​$​3,300,000​$​313.20Subdivision 1.Total Appropriation​
10098-313.21The base for this appropriation is $19,064,000​
10099-313.22in fiscal year 2026 and each fiscal year​
10100-313.23thereafter.​
10101-313.24The amounts that may be spent for each​
10102-313.25purpose are specified in the following​
10103-313.26subdivisions.​
10104-5,000,000​-0-​313.27Subd. 2.Youth Education​
10105-313.28For grants under Minnesota Statutes, section​
10106-313.29144.197, subdivision 1.​
10107-2,000,000​-0-​
10108-313.30Subd. 3.Education Grants for Pregnant or​
10109-313.31Breastfeeding Individuals​
10110-313.32For grants under Minnesota Statutes, section​
10111-313.33144.197, subdivision 2.​
10112-313​Article 9 Sec. 10.​
10113-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 10,000,000​-0-​314.1Subd. 4.Local and Tribal Health Departments​
10114-314.2For grants under Minnesota Statutes, section​
10115-314.3144.197, subdivision 4.​
10116-493,000​493,000​
10117-314.4Subd. 5.Cannabis Data Collection and Biennial​
10118-314.5Reports​
10119-314.6For reports under Minnesota Statutes, section​
10120-314.7144.196.​
10121-71,000​71,000​
10122-314.8Subd. 6.Administration for Expungement​
10123-314.9Orders​
10124-314.10For administration related to orders issued by​
10125-314.11the Cannabis Expungement Board. The base​
10126-314.12for this appropriation is $71,000 in fiscal year​
10127-314.132026, $71,000 in fiscal year 2027, $71,000 in​
10128-314.14fiscal year 2028, $71,000 in fiscal year 2029,​
10129-314.15and $0 in fiscal year 2030.​
10130-810,000​910,000​
10131-314.16Subd. 7.Grants to the Minnesota Poison Control​
10132-314.17System​
10133-314.18For grants under Minnesota Statutes, section​
10134-314.19145.93.​
10135-1,107,000​1,107,000​
10136-314.20Subd. 8.Temporary Regulation of Edible​
10137-314.21Products Extracted from Hemp​
10138-314.22For temporary regulation under the health​
10139-314.23enforcement consolidation act of edible​
10140-314.24products extracted from hemp. This is a​
10141-314.25onetime appropriation.​
10142-771,000​719,000​314.26Subd. 9.Testing.​
10143-314.27For testing of edible cannabinoid products.​
10144-314.28The base for this appropriation is $690,000 in​
10145-314.29fiscal year 2026 and each fiscal year thereafter.​
10146-1,360,000​$​1,506,000​$​314.30Sec. 11. HUMAN SERVICES​
10147-314.31Central Office Administration​
10148-314.32For the Office of Inspector General to process​
10149-314.33additional background studies and for the​
10150-314​Article 9 Sec. 11.​
10151-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 315.1behavioral health, deaf and hard-of-hearing,​
10152-315.2and housing division to provide data required​
10153-315.3under Minnesota Statutes, section 342.04, and​
10154-315.4the consultation requirements under Minnesota​
10155-315.5Statutes, section 342.72.​
10156-123,000​$​116,000​$​315.6Sec. 12. LABOR AND INDUSTRY​
10157--0-​$​338,000​$​315.7Sec. 13. NATURAL RESOURCES​
10158-70,000​$​140,000​$​315.8Sec. 14. POLLUTION CONTROL AGENCY​
10159-315.9Sec. 15. PUBLIC SAFETY​
10160-11,964,000​$​18,422,000​$​315.10Subdivision 1.Total Appropriation​
10161-315.11The base for this appropriation is $10,847,000​
10162-315.12in fiscal year 2026 and each fiscal year​
10163-315.13thereafter. The amounts that may be spent for​
10164-315.14each purpose are specified in the following​
10165-315.15subdivisions.​
10166--0-​760,000​315.16Subd. 2.Administration​
10167-315.17$760,000 the first year is for a public​
10168-315.18information campaign relating to automatic​
10169-315.19expungement of cannabis-related crimes. This​
10170-315.20appropriation is available until June 30, 2025.​
10171-3,629,000​-0-​315.21Subd. 3.Bureau of Criminal Apprehension​
10172-6,117,000​11,485,000​315.22Subd. 4.Office of Traffic and Safety​
10173-315.23(a) The base for this appropriation is​
10174-315.24$5,000,000 in fiscal year 2026 and each fiscal​
10175-315.25year thereafter.​
10176-315.26(b) $10,000,000 the first year and $5,000,000​
10177-315.27the second year are for the drug evaluation​
10178-315.28and classification program for drug recognition​
10179-315.29evaluator training; additional phlebotomists;​
10180-315.30drug recognition training for peace officers,​
10181-315.31as defined in Minnesota Statutes, section​
10182-315.32626.84, subdivision 1, paragraph (c); and​
10183-315​Article 9 Sec. 15.​
10184-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 316.1required continuing education training for drug​
10185-316.2recognition experts. The commissioner must​
10186-316.3make reasonable efforts to reflect the​
10187-316.4geographic diversity of the state in making​
10188-316.5expenditures under this appropriation.​
10189-316.6(c) $1,485,000 the first year and $1,117,000​
10190-316.7the second year are for a roadside testing pilot​
10191-316.8project. These are onetime appropriations.​
10192--0-​20,000​316.9Subd. 5.Office of Justice Programs​
10193-316.10For a grant to Hennepin County to produce​
10194-316.11the High Intensity Drug Trafficking Area​
10195-316.12report in article 6, section 72.​
10196-2,218,000​6,157,000​316.13Subd. 6.State Patrol​
10197-316.14This appropriation is from the trunk highway​
10198-316.15fund.​
10199-3,931,000​$​4,559,000​$​316.16Sec. 16. REVENUE​
10200-316.17The base for this appropriation is $3,896,000​
10201-316.18in fiscal year 2026 and $3,897,000 in fiscal​
10202-316.19year 2027.​
10203-545,000​$​545,000​$​316.20Sec. 17. SUPREME COURT​
10204-316.21These are onetime appropriations.​
10205-2,600,000​$​2,600,000​$​316.22Sec. 18. UNIVERSITY OF MINNESOTA​
10206-316.23(a) The base for this appropriation is​
10207-316.24$3,250,000 in fiscal year 2026 and each fiscal​
10208-316.25year thereafter.​
10209-316.26(b) $2,500,000 each year is to establish a​
10210-316.27Center for Cannabis Research within the​
10211-316.28School of Public Health. The center must​
10212-316.29investigate the effects of cannabis use on​
10213-316.30health and research other topics related to​
10214-316.31cannabis, including but not limited to​
10215-316.32prevention and treatment of substance use​
10216-316​Article 9 Sec. 18.​
10217-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 317.1disorders, equity issues, education, and​
10218-317.2decriminalization.​
10219-317.3(c) $100,000 each year is for grants for​
10220-317.4cannabis genetics and agronomy research and​
10221-317.5for the creation and maintenance of a​
10222-317.6University of Minnesota Extension position​
10223-317.7and a postdoctoral position. The base for this​
10224-317.8appropriation is $750,000 in fiscal year 2026​
10225-317.9and each fiscal year thereafter. In awarding​
10226-317.10grants under this paragraph, the University of​
10227-317.11Minnesota must give priority to applications​
10228-317.12by researchers who are eligible to be social​
10229-317.13equity applicants as defined in Minnesota​
10230-317.14Statutes, section 342.17.​
10231-317.15Sec. 19. APPROPRIATION AND BASE REDUCTIONS.​
10232-317.16 (a) The commissioner of management and budget must reduce general fund appropriations​
10233-317.17to the commissioner of corrections by $165,000 in fiscal year 2024 and $368,000 in fiscal​
10234-317.18year 2025. The commissioner must reduce the base for general fund appropriations to the​
10235-317.19commissioner of corrections by $460,000 in fiscal year 2026 and $503,000 in fiscal year​
10236-317.202027.​
10237-317.21 (b) The commissioner of management and budget must reduce general fund appropriations​
10238-317.22to the commissioner of health by $260,000 in fiscal year 2025 for the administration of the​
10239-317.23medical cannabis program. The commissioner must reduce the base for general fund​
10240-317.24appropriations to the commissioner of health by $781,000 in fiscal year 2026 and each fiscal​
10241-317.25year thereafter.​
10242-317.26 (c) The commissioner of management and budget must reduce state government special​
10243-317.27revenue fund appropriations to the commissioner of health by $1,141,000 in fiscal year​
10244-317.282025 for the administration of the medical cannabis program. The commissioner must reduce​
10245-317.29the base for state government special revenue fund appropriations to the commissioner of​
10246-317.30health by $3,424,000 in fiscal year 2026 and each fiscal year thereafter.​
10247-317.31Sec. 20. TRANSFERS.​
10248-317.32 (a) $1,000,000 in fiscal year 2024 and $1,000,000 in fiscal year 2025 are transferred​
10249-317.33from the general fund to the dual training account in the special revenue fund under​
10250-317​Article 9 Sec. 20.​
10251-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 318.1Minnesota Statutes, section 136A.246, subdivision 10, for grants to employers in the legal​
10252-318.2cannabis industry. The base for this transfer is $1,000,000 in fiscal year 2026 and each fiscal​
10253-318.3year thereafter. The commissioner may use up to six percent of the amount transferred for​
10254-318.4administrative costs. The commissioner shall give priority to applications from employers​
10255-318.5who are, or who are training employees who are, eligible to be social equity applicants​
10256-318.6under Minnesota Statutes, section 342.17. After June 30, 2025, any unencumbered balance​
10257-318.7from this transfer may be used for grants to any eligible employer under Minnesota Statutes,​
10258-318.8section 136A.246.​
10259-318.9 (b) $5,500,000 in fiscal year 2024 and $5,500,000 in fiscal year 2025 are transferred​
10260-318.10from the general fund to the substance use treatment, recovery, and prevention grant account​
10261-318.11established under Minnesota Statutes, section 342.72. The base for this transfer is $5,500,000​
10262-318.12in fiscal year 2026 and each fiscal year thereafter.​
10263-318.13Sec. 21. OFFICE OF CANNABIS MANAGEMENT; IMPLEMENTATION.​
10264-318.14 (a) $3,000,000 in fiscal year 2023 is appropriated from the general fund to the​
10265-318.15commissioner of agriculture for the planning, research, analysis, and other efforts needed​
10266-318.16to establish the Office of Cannabis Management and transition programs, authorities, and​
10267-318.17responsibilities contained in Minnesota Statutes, chapter 342, to that office. This is a onetime​
10268-318.18appropriation and is available until June 30, 2025.​
10269-318.19 (b) Upon the effective date of this act, the commissioner of agriculture may exercise all​
10270-318.20authorities and responsibilities granted to the Office of Cannabis Management under​
10271-318.21Minnesota Statutes, chapter 342, that are necessary to establish the Office of Cannabis​
10272-318.22Management and transition programs, authorities, and responsibilities to that office.​
10273-318.23 (c) On or after January 1, 2024, and at such time that the Office of Cannabis Management​
10274-318.24is able to fulfill the powers and duties enumerated in Minnesota Statutes, section 342.02,​
10275-318.25subdivision 2, the commissioner of agriculture may transfer all or some Minnesota Statutes,​
10276-318.26chapter 342, programs, authorities, and responsibilities to the Office of Cannabis​
10277-318.27Management. Upon such transfer, existing contracts, obligations, and funds managed by​
10278-318.28the commissioner of agriculture that are necessary to administer the transferred programs,​
10279-318.29authorities, or responsibilities shall be transferred to the Office of Cannabis Management.​
10280-318.30 (d) To the extent practicable, the commissioner of agriculture and the Office of Cannabis​
10281-318.31Management must comply with Minnesota Statutes, chapter 16C. The commissioner of​
10282-318.32administration may waive the application of any provision of Minnesota Statutes, chapter​
10283-318.3316C, on a case-by-case basis, if the commissioner of agriculture or the Office of Cannabis​
10284-318.34Management demonstrates that full compliance with Minnesota Statutes, chapter 16C, would​
10285-318​Article 9 Sec. 21.​
10286-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​ 319.1be impractical given the effective date or other deadlines established by this act. This​
10287-319.2exemption expires July 1, 2025.​
10288-319.3 EFFECTIVE DATE.This section is effective the day following final enactment.​
10289-319.4Sec. 22. APPROPRIATION; DEPARTMENT OF PUBLIC SAFETY; BUREAU OF​
10290-319.5CRIMINAL APPREHENSION.​
10291-319.6 $6,656,000 in fiscal year 2023 is appropriated from the general fund to the commissioner​
10292-319.7of public safety for the Bureau of Criminal Apprehension to identify and provide records​
10293-319.8of convictions for certain offenses involving the possession of cannabis that may be eligible​
10294-319.9for expungement and resentencing; for forensic science services including additional staff,​
10295-319.10equipment, and supplies; and for the investigation of diversion crimes. This is a onetime​
10296-319.11appropriation and is available until June 30, 2025.​
10297-319.12 EFFECTIVE DATE.This section is effective the day following final enactment.​
10298-319​Article 9 Sec. 22.​
10299-REVISOR BD H0100-12​HF100 TWELFTH ENGROSSMENT​
6097+187.27Sec. 21. Minnesota Statutes 2022, section 152.11, subdivision 2, is amended to read:​
6098+187.28 Subd. 2. Prescription requirements for Schedule III or IV controlled substances.(a)​
6099+187.29Except as provided in paragraph (b), no person may dispense a controlled substance included​
6100+187.30in Schedule III or IV of section 152.02 without a prescription issued, as permitted under​
6101+187.31subdivision 1, by a doctor of medicine, a doctor of osteopathic medicine licensed to practice​
6102+187​Article 4 Sec. 21.​
6103+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 188.1medicine, a doctor of dental surgery, a doctor of dental medicine, a doctor of podiatry, a​
6104+188.2doctor of optometry limited to Schedule IV, or a doctor of veterinary medicine, lawfully​
6105+188.3licensed to prescribe in this state or from a practitioner licensed to prescribe controlled​
6106+188.4substances by the state in which the prescription is issued, and having a current federal drug​
6107+188.5enforcement administration registration number. Such prescription may not be dispensed​
6108+188.6or refilled except with the documented consent of the prescriber, and in no event more than​
6109+188.7six months after the date on which such prescription was issued and no such prescription​
6110+188.8may be refilled more than five times.​
6111+188.9 (b) This subdivision does not apply to cannabis plants, cannabis flower, cannabis products,​
6112+188.10or hemp-derived consumer products sold or transferred in compliance with chapter 342.​
6113+188.11Sec. 22. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6114+188.12to read:​
6115+188.13 Subd. 3a.Artificially derived cannabinoid."Artificially derived cannabinoid" has the​
6116+188.14meaning given in section 342.01, subdivision 6.​
6117+188.15Sec. 23. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6118+188.16to read:​
6119+188.17 Subd. 3b.Cannabis flower."Cannabis flower" has the meaning given in section 342.01,​
6120+188.18subdivision 15.​
6121+188.19Sec. 24. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6122+188.20to read:​
6123+188.21 Subd. 3c.Cannabis product."Cannabis product" has the meaning given in section​
6124+188.22342.01, subdivision 19.​
6125+188.23Sec. 25. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6126+188.24to read:​
6127+188.25 Subd. 10a.Hemp-derived consumer product."Hemp-derived consumer product" has​
6128+188.26the meaning given in section 342.01, subdivision 35.​
6129+188.27Sec. 26. Minnesota Statutes 2022, section 169A.03, is amended by adding a subdivision​
6130+188.28to read:​
6131+188.29 Subd. 11b.Lower-potency hemp edible."Lower-potency hemp edible" has the meaning​
6132+188.30given in section 342.01, subdivision 48.​
6133+188​Article 4 Sec. 26.​
6134+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 189.1Sec. 27. Minnesota Statutes 2022, section 169A.20, subdivision 1, is amended to read:​
6135+189.2 Subdivision 1.Driving while impaired crime; motor vehicle.It is a crime for any​
6136+189.3person to drive, operate, or be in physical control of any motor vehicle, as defined in section​
6137+189.4169A.03, subdivision 15, within this state or on any boundary water of this state when:​
6138+189.5 (1) the person is under the influence of alcohol;​
6139+189.6 (2) the person is under the influence of a controlled substance;​
6140+189.7 (3) the person is under the influence of an intoxicating substance and the person knows​
6141+189.8or has reason to know that the substance has the capacity to cause impairment;​
6142+189.9 (4) the person is under the influence of a combination of any two or more of the elements​
6143+189.10named in clauses (1) to (3) or (8);​
6144+189.11 (5) the person's alcohol concentration at the time, or as measured within two hours of​
6145+189.12the time, of driving, operating, or being in physical control of the motor vehicle is 0.08 or​
6146+189.13more;​
6147+189.14 (6) the vehicle is a commercial motor vehicle and the person's alcohol concentration at​
6148+189.15the time, or as measured within two hours of the time, of driving, operating, or being in​
6149+189.16physical control of the commercial motor vehicle is 0.04 or more; or​
6150+189.17 (7) the person's body contains any amount of a controlled substance listed in Schedule​
6151+189.18I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6152+189.19lower-potency hemp edible, a hemp-derived consumer product, an artificially derived​
6153+189.20cannabinoid, or tetrahydrocannabinols; or​
6154+189.21 (8) the person is under the influence of cannabis flower, a cannabis product, a​
6155+189.22lower-potency hemp edible, a hemp-derived consumer product, an artificially derived​
6156+189.23cannabinoid, or tetrahydrocannabinols.​
6157+189.24Sec. 28. Minnesota Statutes 2022, section 169A.31, subdivision 1, is amended to read:​
6158+189.25 Subdivision 1.Crime described.It is a crime for any person to drive, operate, or be in​
6159+189.26physical control of any class of school bus or Head Start bus within this state when there is​
6160+189.27physical evidence present in the person's body of the consumption of any alcohol, cannabis​
6161+189.28flower, a cannabis product, an artificially derived cannabinoid, or tetrahydrocannabinols.​
6162+189.29Sec. 29. [169A.36] OPEN PACKAGE LAW.​
6163+189.30 Subdivision 1.Definitions.As used in this section:​
6164+189​Article 4 Sec. 29.​
6165+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 190.1 (1) "motor vehicle" does not include motorboats in operation or off-road recreational​
6166+190.2vehicles except while operated on a roadway or shoulder of a roadway that is not part of a​
6167+190.3grant-in-aid trail or trail designated for that vehicle by the commissioner of natural resources;​
6168+190.4and​
6169+190.5 (2) "possession" means either that the person had actual possession of the package or​
6170+190.6that the person consciously exercised dominion and control over the package.​
6171+190.7 Subd. 2.Use; crime described.It is a crime for a person to use cannabis flower, a​
6172+190.8cannabis product, a lower-potency hemp edible, a hemp-derived consumer product, or any​
6173+190.9other product containing an artificially derived cannabinoid in a motor vehicle when the​
6174+190.10vehicle is on a street or highway.​
6175+190.11 Subd. 3.Possession; crime described.It is a crime for a person to have in possession,​
6176+190.12while in a private motor vehicle on a street or highway, any cannabis flower, a cannabis​
6177+190.13product, a lower-potency hemp edible, a hemp-derived consumer product, or any other​
6178+190.14product containing an artificially derived cannabinoid that:​
6179+190.15 (1) is in packaging or another container that does not comply with the relevant packaging​
6180+190.16requirements in chapter 152 or 342;​
6181+190.17 (2) has been removed from the packaging in which it was sold;​
6182+190.18 (3) is in packaging that has been opened or the seal has been broken; or​
6183+190.19 (4) is in packaging of which the contents have been partially removed.​
6184+190.20 Subd. 4.Liability of nonpresent owner; crime described.It is a crime for the owner​
6185+190.21of any private motor vehicle or the driver, if the owner is not present in the motor vehicle,​
6186+190.22to keep or allow to be kept in a motor vehicle when the vehicle is on a street or highway​
6187+190.23any cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6188+190.24consumer product, or any other product containing an artificially derived cannabinoid that:​
6189+190.25 (1) is in packaging or another container that does not comply with the relevant packaging​
6190+190.26requirements in chapter 152 or 342;​
6191+190.27 (2) has been removed from the packaging in which it was sold;​
6192+190.28 (3) is in packaging that has been opened or the seal has been broken; or​
6193+190.29 (4) is in packaging of which the contents have been partially removed.​
6194+190.30 Subd. 5.Criminal penalty.A person who violates subdivision 2, 3, or 4 is guilty of a​
6195+190.31misdemeanor.​
6196+190​Article 4 Sec. 29.​
6197+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 191.1 Subd. 6.Exceptions.(a) This section does not prohibit the possession or consumption​
6198+191.2of cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6199+191.3consumer product, or any other product containing an artificially derived cannabinoid by​
6200+191.4passengers in:​
6201+191.5 (1) a bus that is operated by a motor carrier of passengers as defined in section 221.012,​
6202+191.6subdivision 26;​
6203+191.7 (2) a vehicle that is operated for commercial purposes in a manner similar to a bicycle​
6204+191.8as defined in section 169.011, subdivision 4, with five or more passengers who provide​
6205+191.9pedal power to the drive train of the vehicle; or​
6206+191.10 (3) a vehicle providing limousine service as defined in section 221.84, subdivision 1.​
6207+191.11 (b) Subdivisions 3 and 4 do not apply to: (1) a package that is in the trunk of the vehicle​
6208+191.12if the vehicle is equipped with a trunk; or (2) a package that is in another area of the vehicle​
6209+191.13not normally occupied by the driver and passengers if the vehicle is not equipped with a​
6210+191.14trunk. A utility compartment or glove compartment is deemed to be within the area occupied​
6211+191.15by the driver and passengers.​
6212+191.16Sec. 30. Minnesota Statutes 2022, section 169A.51, subdivision 1, is amended to read:​
6213+191.17 Subdivision 1.Implied consent; conditions; election of test.(a) Any person who drives,​
6214+191.18operates, or is in physical control of a motor vehicle within this state or on any boundary​
6215+191.19water of this state consents, subject to the provisions of sections 169A.50 to 169A.53 (implied​
6216+191.20consent law), and section 169A.20 (driving while impaired), to a chemical test of that​
6217+191.21person's blood, breath, or urine for the purpose of determining the presence of alcohol,; a​
6218+191.22controlled substance or its metabolite,; cannabis flower, a cannabis product, a lower-potency​
6219+191.23hemp edible, a hemp-derived consumer product, artificially derived cannabinoids, or​
6220+191.24tetrahydrocannabinols; or an intoxicating substance. The test must be administered at the​
6221+191.25direction of a peace officer.​
6222+191.26 (b) The test may be required of a person when an officer has probable cause to believe​
6223+191.27the person was driving, operating, or in physical control of a motor vehicle in violation of​
6224+191.28section 169A.20 (driving while impaired), and one of the following conditions exist:​
6225+191.29 (1) the person has been lawfully placed under arrest for violation of section 169A.20 or​
6226+191.30an ordinance in conformity with it;​
6227+191.31 (2) the person has been involved in a motor vehicle accident or collision resulting in​
6228+191.32property damage, personal injury, or death;​
6229+191​Article 4 Sec. 30.​
6230+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 192.1 (3) the person has refused to take the screening test provided for by section 169A.41​
6231+192.2(preliminary screening test); or​
6232+192.3 (4) the screening test was administered and indicated an alcohol concentration of 0.08​
6233+192.4or more.​
6234+192.5 (c) The test may also be required of a person when an officer has probable cause to​
6235+192.6believe the person was driving, operating, or in physical control of a commercial motor​
6236+192.7vehicle with the presence of any alcohol.​
6237+192.8Sec. 31. Minnesota Statutes 2022, section 169A.51, subdivision 4, is amended to read:​
6238+192.9 Subd. 4.Requirement of urine or blood test.A blood or urine test may be required​
6239+192.10pursuant to a search warrant under sections 626.04 to 626.18 even after a breath test has​
6240+192.11been administered if there is probable cause to believe that:​
6241+192.12 (1) there is impairment by a controlled substance or; an intoxicating substance; or​
6242+192.13cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived consumer​
6243+192.14product, artificially derived cannabinoids, or tetrahydrocannabinols that is not subject to​
6244+192.15testing by a breath test;​
6245+192.16 (2) a controlled substance listed in Schedule I or II or its metabolite, other than marijuana​
6246+192.17cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived consumer​
6247+192.18product, artificially derived cannabinoids, or tetrahydrocannabinols, is present in the person's​
6248+192.19body; or​
6249+192.20 (3) the person is unconscious or incapacitated to the point that the peace officer providing​
6250+192.21a breath test advisory, administering a breath test, or serving the search warrant has a​
6251+192.22good-faith belief that the person is mentally or physically unable to comprehend the breath​
6252+192.23test advisory or otherwise voluntarily submit to chemical tests.​
6253+192.24 Action may be taken against a person who refuses to take a blood test under this​
6254+192.25subdivision only if a urine test was offered and action may be taken against a person who​
6255+192.26refuses to take a urine test only if a blood test was offered. This limitation does not apply​
6256+192.27to an unconscious person under the circumstances described in clause (3).​
6257+192​Article 4 Sec. 31.​
6258+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 193.1Sec. 32. Minnesota Statutes 2022, section 169A.72, is amended to read:​
6259+193.2 169A.72 DRIVER EDUCATION PROGRAMS.​
6260+193.3 Driver training courses offered through the public schools and driver training courses​
6261+193.4offered by private or commercial schools or institutes shall include instruction which must​
6262+193.5encompass at least:​
6263+193.6 (1) information on the effects of consumption of beverage alcohol products and the use​
6264+193.7of illegal drugs, cannabis flower, cannabis products, lower-potency hemp edibles,​
6265+193.8hemp-derived consumer products, artificially derived cannabinoids, tetrahydrocannabinol​
6266+193.9derived from any source, prescription drugs, and nonprescription drugs on the ability of a​
6267+193.10person to operate a motor vehicle;​
6268+193.11 (2) the hazards of driving while under the influence of alcohol, a controlled substance,​
6269+193.12or drugs an intoxicating substance; and​
6270+193.13 (3) the legal penalties and financial consequences resulting from violations of laws​
6271+193.14prohibiting the operation of a motor vehicle while under the influence of alcohol, a controlled​
6272+193.15substance, or drugs an intoxicating substance.​
6273+193.16Sec. 33. Minnesota Statutes 2022, section 244.05, subdivision 2, is amended to read:​
6274+193.17 Subd. 2.Rules.(a) The commissioner of corrections shall adopt by rule standards and​
6275+193.18procedures for the establishment of conditions of release and the revocation of supervised​
6276+193.19or conditional release, and shall specify the period of revocation for each violation of release.​
6277+193.20Procedures for the revocation of release shall provide due process of law for the inmate.​
6278+193.21 (b) The commissioner may prohibit an inmate placed on parole, supervised release, or​
6279+193.22conditional release from using adult-use cannabis flower as defined in section 342.01,​
6280+193.23subdivision 3, or adult-use cannabis products as defined in section 342.01, subdivision 3,​
6281+193.24hemp-derived consumer products as defined in section 342.01, subdivision 35, or​
6282+193.25lower-potency hemp edibles as defined in section 342.01, subdivision 48, if the inmate​
6283+193.26undergoes a chemical use assessment and abstinence is consistent with a recommended​
6284+193.27level of care for the defendant in accordance with the criteria in rules adopted by the​
6285+193.28commissioner of human services under section 254A.03, subdivision 3.​
6286+193.29 (c) The commissioner of corrections shall not prohibit an inmate placed on parole,​
6287+193.30supervised release, or conditional release from participating in the registry program as​
6288+193.31defined in section 342.01, subdivision 61, as a condition of release or revoke a patient's​
6289+193.32parole, supervised release, or conditional release or otherwise sanction a patient on parole,​
6290+193​Article 4 Sec. 33.​
6291+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 194.1supervised release, or conditional release solely for participating in the registry program or​
6292+194.2for a positive drug test for cannabis components or metabolites.​
6293+194.3 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to supervised​
6294+194.4release granted on or after that date.​
6295+194.5Sec. 34. Minnesota Statutes 2022, section 609.2112, subdivision 1, is amended to read:​
6296+194.6 Subdivision 1.Criminal vehicular homicide.(a) Except as provided in paragraph (b),​
6297+194.7a person is guilty of criminal vehicular homicide and may be sentenced to imprisonment​
6298+194.8for not more than ten years or to payment of a fine of not more than $20,000, or both, if the​
6299+194.9person causes the death of a human being not constituting murder or manslaughter as a​
6300+194.10result of operating a motor vehicle:​
6301+194.11 (1) in a grossly negligent manner;​
6302+194.12 (2) in a negligent manner while under the influence of:​
6303+194.13 (i) alcohol;​
6304+194.14 (ii) a controlled substance; or​
6305+194.15 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6306+194.16consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6307+194.17 (iii) (iv) any combination of those elements;​
6308+194.18 (3) while having an alcohol concentration of 0.08 or more;​
6309+194.19 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6310+194.20of the time of driving;​
6311+194.21 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6312+194.22person knows or has reason to know that the substance has the capacity to cause impairment;​
6313+194.23 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6314+194.24I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6315+194.25lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6316+194.26cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6317+194.27 (7) where the driver who causes the collision leaves the scene of the collision in violation​
6318+194.28of section 169.09, subdivision 1 or 6; or​
6319+194.29 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6320+194.30citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6321+194​Article 4 Sec. 34.​
6322+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 195.1knowledge that remedial action was not taken, the driver had reason to know that the defect​
6323+195.2created a present danger to others, and the death was caused by the defective maintenance.​
6324+195.3 (b) If a person is sentenced under paragraph (a) for a violation under paragraph (a),​
6325+195.4clauses (2) to (6), occurring within ten years of a qualified prior driving offense, the statutory​
6326+195.5maximum sentence of imprisonment is 15 years.​
6327+195.6Sec. 35. Minnesota Statutes 2022, section 609.2113, subdivision 1, is amended to read:​
6328+195.7 Subdivision 1.Great bodily harm.A person is guilty of criminal vehicular operation​
6329+195.8resulting in great bodily harm and may be sentenced to imprisonment for not more than five​
6330+195.9years or to payment of a fine of not more than $10,000, or both, if the person causes great​
6331+195.10bodily harm to another not constituting attempted murder or assault as a result of operating​
6332+195.11a motor vehicle:​
6333+195.12 (1) in a grossly negligent manner;​
6334+195.13 (2) in a negligent manner while under the influence of:​
6335+195.14 (i) alcohol;​
6336+195.15 (ii) a controlled substance; or​
6337+195.16 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6338+195.17consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6339+195.18 (iii) (iv) any combination of those elements;​
6340+195.19 (3) while having an alcohol concentration of 0.08 or more;​
6341+195.20 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6342+195.21of the time of driving;​
6343+195.22 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6344+195.23person knows or has reason to know that the substance has the capacity to cause impairment;​
6345+195.24 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6346+195.25I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6347+195.26lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6348+195.27cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6349+195.28 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6350+195.29of section 169.09, subdivision 1 or 6; or​
6351+195.30 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6352+195.31citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6353+195​Article 4 Sec. 35.​
6354+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 196.1knowledge that remedial action was not taken, the driver had reason to know that the defect​
6355+196.2created a present danger to others, and the injury was caused by the defective maintenance.​
6356+196.3Sec. 36. Minnesota Statutes 2022, section 609.2113, subdivision 2, is amended to read:​
6357+196.4 Subd. 2.Substantial bodily harm.A person is guilty of criminal vehicular operation​
6358+196.5resulting in substantial bodily harm and may be sentenced to imprisonment for not more​
6359+196.6than three years or to payment of a fine of not more than $10,000, or both, if the person​
6360+196.7causes substantial bodily harm to another as a result of operating a motor vehicle:​
6361+196.8 (1) in a grossly negligent manner;​
6362+196.9 (2) in a negligent manner while under the influence of:​
6363+196.10 (i) alcohol;​
6364+196.11 (ii) a controlled substance; or​
6365+196.12 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6366+196.13consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6367+196.14 (iii) (iv) any combination of those elements;​
6368+196.15 (3) while having an alcohol concentration of 0.08 or more;​
6369+196.16 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6370+196.17of the time of driving;​
6371+196.18 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6372+196.19person knows or has reason to know that the substance has the capacity to cause impairment;​
6373+196.20 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6374+196.21I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6375+196.22lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6376+196.23cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6377+196.24 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6378+196.25of section 169.09, subdivision 1 or 6; or​
6379+196.26 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6380+196.27citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6381+196.28knowledge that remedial action was not taken, the driver had reason to know that the defect​
6382+196.29created a present danger to others, and the injury was caused by the defective maintenance.​
6383+196​Article 4 Sec. 36.​
6384+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 197.1Sec. 37. Minnesota Statutes 2022, section 609.2113, subdivision 3, is amended to read:​
6385+197.2 Subd. 3.Bodily harm.A person is guilty of criminal vehicular operation resulting in​
6386+197.3bodily harm and may be sentenced to imprisonment for not more than one year or to payment​
6387+197.4of a fine of not more than $3,000, or both, if the person causes bodily harm to another as a​
6388+197.5result of operating a motor vehicle:​
6389+197.6 (1) in a grossly negligent manner;​
6390+197.7 (2) in a negligent manner while under the influence of:​
6391+197.8 (i) alcohol;​
6392+197.9 (ii) a controlled substance; or​
6393+197.10 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6394+197.11consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6395+197.12 (iii) (iv) any combination of those elements;​
6396+197.13 (3) while having an alcohol concentration of 0.08 or more;​
6397+197.14 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6398+197.15of the time of driving;​
6399+197.16 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6400+197.17person knows or has reason to know that the substance has the capacity to cause impairment;​
6401+197.18 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6402+197.19I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6403+197.20lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6404+197.21cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6405+197.22 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6406+197.23of section 169.09, subdivision 1 or 6; or​
6407+197.24 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6408+197.25citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6409+197.26knowledge that remedial action was not taken, the driver had reason to know that the defect​
6410+197.27created a present danger to others, and the injury was caused by the defective maintenance.​
6411+197.28Sec. 38. Minnesota Statutes 2022, section 609.2114, subdivision 1, is amended to read:​
6412+197.29 Subdivision 1.Death to an unborn child.(a) Except as provided in paragraph (b), a​
6413+197.30person is guilty of criminal vehicular operation resulting in death to an unborn child and​
6414+197.31may be sentenced to imprisonment for not more than ten years or to payment of a fine of​
6415+197​Article 4 Sec. 38.​
6416+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 198.1not more than $20,000, or both, if the person causes the death of an unborn child as a result​
6417+198.2of operating a motor vehicle:​
6418+198.3 (1) in a grossly negligent manner;​
6419+198.4 (2) in a negligent manner while under the influence of:​
6420+198.5 (i) alcohol;​
6421+198.6 (ii) a controlled substance; or​
6422+198.7 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6423+198.8consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6424+198.9 (iii) (iv) any combination of those elements;​
6425+198.10 (3) while having an alcohol concentration of 0.08 or more;​
6426+198.11 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6427+198.12of the time of driving;​
6428+198.13 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6429+198.14person knows or has reason to know that the substance has the capacity to cause impairment;​
6430+198.15 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6431+198.16I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6432+198.17lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6433+198.18cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6434+198.19 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6435+198.20of section 169.09, subdivision 1 or 6; or​
6436+198.21 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6437+198.22citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6438+198.23knowledge that remedial action was not taken, the driver had reason to know that the defect​
6439+198.24created a present danger to others, and the injury was caused by the defective maintenance.​
6440+198.25 (b) If a person is sentenced under paragraph (a) for a violation under paragraph (a),​
6441+198.26clauses (2) to (6), occurring within ten years of a qualified prior driving offense, the statutory​
6442+198.27maximum sentence of imprisonment is 15 years.​
6443+198.28Sec. 39. Minnesota Statutes 2022, section 609.2114, subdivision 2, is amended to read:​
6444+198.29 Subd. 2.Injury to an unborn child.A person is guilty of criminal vehicular operation​
6445+198.30resulting in injury to an unborn child and may be sentenced to imprisonment for not more​
6446+198.31than five years or to payment of a fine of not more than $10,000, or both, if the person​
6447+198​Article 4 Sec. 39.​
6448+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 199.1causes the great bodily harm to an unborn child subsequently born alive as a result of​
6449+199.2operating a motor vehicle:​
6450+199.3 (1) in a grossly negligent manner;​
6451+199.4 (2) in a negligent manner while under the influence of:​
6452+199.5 (i) alcohol;​
6453+199.6 (ii) a controlled substance; or​
6454+199.7 (iii) cannabis flower, a cannabis product, a lower-potency hemp edible, a hemp-derived​
6455+199.8consumer product, artificially derived cannabinoids, or tetrahydrocannabinols; or​
6456+199.9 (iii) (iv) any combination of those elements;​
6457+199.10 (3) while having an alcohol concentration of 0.08 or more;​
6458+199.11 (4) while having an alcohol concentration of 0.08 or more, as measured within two hours​
6459+199.12of the time of driving;​
6460+199.13 (5) in a negligent manner while under the influence of an intoxicating substance and the​
6461+199.14person knows or has reason to know that the substance has the capacity to cause impairment;​
6462+199.15 (6) in a negligent manner while any amount of a controlled substance listed in Schedule​
6463+199.16I or II, or its metabolite, other than marijuana cannabis flower, a cannabis product, a​
6464+199.17lower-potency hemp edible, a hemp-derived consumer product, artificially derived​
6465+199.18cannabinoids, or tetrahydrocannabinols, is present in the person's body;​
6466+199.19 (7) where the driver who causes the accident leaves the scene of the accident in violation​
6467+199.20of section 169.09, subdivision 1 or 6; or​
6468+199.21 (8) where the driver had actual knowledge that a peace officer had previously issued a​
6469+199.22citation or warning that the motor vehicle was defectively maintained, the driver had actual​
6470+199.23knowledge that remedial action was not taken, the driver had reason to know that the defect​
6471+199.24created a present danger to others, and the injury was caused by the defective maintenance.​
6472+199.25Sec. 40. Minnesota Statutes 2022, section 609.5311, subdivision 1, is amended to read:​
6473+199.26 Subdivision 1.Controlled substances.All controlled substances that were manufactured,​
6474+199.27distributed, dispensed, or acquired in violation of chapter 152 or 342 are subject to forfeiture​
6475+199.28under this section, except as provided in subdivision 3 and section 609.5316.​
6476+199.29 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to violations​
6477+199.30committed on or after that date.​
6478+199​Article 4 Sec. 40.​
6479+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 200.1Sec. 41. Minnesota Statutes 2022, section 609.5314, subdivision 1, is amended to read:​
6480+200.2 Subdivision 1.Property subject to administrative forfeiture.(a) The following are​
6481+200.3subject to administrative forfeiture under this section:​
6482+200.4 (1) all money totaling $1,500 or more, precious metals, and precious stones that there​
6483+200.5is probable cause to believe represent the proceeds of a controlled substance offense;​
6484+200.6 (2) all money found in proximity to controlled substances when there is probable cause​
6485+200.7to believe that the money was exchanged for the purchase of a controlled substance;​
6486+200.8 (3) all conveyance devices containing controlled substances with a retail value of $100​
6487+200.9or more if there is probable cause to believe that the conveyance device was used in the​
6488+200.10transportation or exchange of a controlled substance intended for distribution or sale; and​
6489+200.11 (4) all firearms, ammunition, and firearm accessories found:​
6490+200.12 (i) in a conveyance device used or intended for use to commit or facilitate the commission​
6491+200.13of a felony offense involving a controlled substance;​
6492+200.14 (ii) on or in proximity to a person from whom a felony amount of controlled substance​
6493+200.15is seized; or​
6494+200.16 (iii) on the premises where a controlled substance is seized and in proximity to the​
6495+200.17controlled substance, if possession or sale of the controlled substance would be a felony​
6496+200.18under chapter 152.​
6497+200.19 (b) The Department of Corrections Fugitive Apprehension Unit shall not seize items​
6498+200.20listed in paragraph (a), clauses (3) and (4), for the purposes of forfeiture.​
6499+200.21 (c) Money is the property of an appropriate agency and may be seized and recovered by​
6500+200.22the appropriate agency if:​
6501+200.23 (1) the money is used by an appropriate agency, or furnished to a person operating on​
6502+200.24behalf of an appropriate agency, to purchase or attempt to purchase a controlled substance;​
6503+200.25and​
6504+200.26 (2) the appropriate agency records the serial number or otherwise marks the money for​
6505+200.27identification.​
6506+200.28 (d) As used in this section, "money" means United States currency and coin; the currency​
6507+200.29and coin of a foreign country; a bank check, cashier's check, or traveler's check; a prepaid​
6508+200.30credit card; cryptocurrency; or a money order.​
6509+200​Article 4 Sec. 41.​
6510+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 201.1 (e) As used in this section, "controlled substance" does not include cannabis flower as​
6511+201.2defined in section 342.01, subdivision 15, cannabis products as defined in section 342.01,​
6512+201.3subdivision 19, hemp-derived consumer products as defined in section 342.01, subdivision​
6513+201.435, or lower-potency hemp edibles as defined in section 342.01, subdivision 48.​
6514+201.5 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6515+201.6committed on or after that date.​
6516+201.7Sec. 42. Minnesota Statutes 2022, section 609.5316, subdivision 2, is amended to read:​
6517+201.8 Subd. 2.Controlled substances.(a) Controlled substances listed in Schedule I that are​
6518+201.9possessed, transferred, sold, or offered for sale in violation of chapter 152 or 342, are​
6519+201.10contraband and must be seized and summarily forfeited. Controlled substances listed in​
6520+201.11Schedule I that are seized or come into the possession of peace officers, the owners of which​
6521+201.12are unknown, are contraband and must be summarily forfeited.​
6522+201.13 (b) Species of plants from which controlled substances in Schedules I and II may be​
6523+201.14derived that have been planted or cultivated in violation of chapter 152 or of which the​
6524+201.15owners or cultivators are unknown, or that are wild growths, may be seized and summarily​
6525+201.16forfeited to the state. The appropriate agency or its authorized agent may seize the plants if​
6526+201.17the person in occupancy or in control of land or premises where the plants are growing or​
6527+201.18being stored fails to produce an appropriate registration or proof that the person is the holder​
6528+201.19of appropriate registration.​
6529+201.20 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6530+201.21committed on or after that date.​
6531+201.22Sec. 43. ORAL FLUID PRELIMINARY TESTING; PILOT PROJECT​
6532+201.23AUTHORIZED.​
6533+201.24 (a) The commissioner of public safety is authorized to design, plan, and implement a​
6534+201.25pilot project intended to determine the efficacy of oral fluid roadside testing to determine​
6535+201.26the presence of a controlled substance or intoxicating substance by trained law enforcement​
6536+201.27personnel. The project is further intended to gain a better assessment of the prevalence of​
6537+201.28drug-impaired drivers on Minnesota roads and to evaluate and validate the appropriate​
6538+201.29device that could be authorized for use.​
6539+201.30 (b) The results of this preliminary oral fluid test must not be used in any court action.​
6540+201.31 (c) Following the screening test, additional tests may be required of the driver pursuant​
6541+201.32to Minnesota Statutes, section 169A.51 (chemical tests for intoxication).​
6542+201​Article 4 Sec. 43.​
6543+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 202.1 EFFECTIVE DATE.This section is effective August 1, 2023, and expires July 31,​
6544+202.22025.​
6545+202.3 ARTICLE 5​
6546+202.4 EXPUNGEMENT​
6547+202.5Section 1. Minnesota Statutes 2022, section 609A.01, is amended to read:​
6548+202.6 609A.01 EXPUNGEMENT OF CRIMINAL RECORDS.​
6549+202.7 This chapter provides the grounds and procedures for expungement of criminal records​
6550+202.8under section 13.82; 152.18, subdivision 1; 299C.11, where a petition is authorized under​
6551+202.9section 609A.02, subdivision 3; expungement is automatic under section 609A.05;​
6552+202.10expungement is considered by a panel under section 609A.06; or other applicable law. The​
6553+202.11remedy available is limited to a court order sealing the records and prohibiting the disclosure​
6554+202.12of their existence or their opening except under court order or statutory authority. Nothing​
6555+202.13in this chapter authorizes the destruction of records or their return to the subject of the​
6556+202.14records.​
6557+202.15 EFFECTIVE DATE.This section is effective August 1, 2023.​
6558+202.16Sec. 2. Minnesota Statutes 2022, section 609A.03, subdivision 5, is amended to read:​
6559+202.17 Subd. 5.Nature of remedy; standard.(a) Except as otherwise provided by paragraph​
6560+202.18(b), expungement of a criminal record under this section is an extraordinary remedy to be​
6561+202.19granted only upon clear and convincing evidence that it would yield a benefit to the petitioner​
6562+202.20commensurate with the disadvantages to the public and public safety of:​
6563+202.21 (1) sealing the record; and​
6564+202.22 (2) burdening the court and public authorities to issue, enforce, and monitor an​
6565+202.23expungement order.​
6566+202.24 (b) Except as otherwise provided by this paragraph, if the petitioner is petitioning for​
6567+202.25the sealing of a criminal record under section 609A.02, subdivision 3, paragraph (a), clause​
6568+202.26(1) or (2), the court shall grant the petition to seal the record unless the agency or jurisdiction​
6569+202.27whose records would be affected establishes by clear and convincing evidence that the​
6570+202.28interests of the public and public safety outweigh the disadvantages to the petitioner of not​
6571+202.29sealing the record.​
6572+202.30 (c) In making a determination under this subdivision, the court shall consider:​
6573+202.31 (1) the nature and severity of the underlying crime, the record of which would be sealed;​
6574+202​Article 5 Sec. 2.​
6575+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 203.1 (2) the risk, if any, the petitioner poses to individuals or society;​
6576+203.2 (3) the length of time since the crime occurred;​
6577+203.3 (4) the steps taken by the petitioner toward rehabilitation following the crime;​
6578+203.4 (5) aggravating or mitigating factors relating to the underlying crime, including the​
6579+203.5petitioner's level of participation and context and circumstances of the underlying crime;​
6580+203.6 (6) the reasons for the expungement, including the petitioner's attempts to obtain​
6581+203.7employment, housing, or other necessities;​
6582+203.8 (7) the petitioner's criminal record;​
6583+203.9 (8) the petitioner's record of employment and community involvement;​
6584+203.10 (9) the recommendations of interested law enforcement, prosecutorial, and corrections​
6585+203.11officials;​
6586+203.12 (10) the recommendations of victims or whether victims of the underlying crime were​
6587+203.13minors;​
6588+203.14 (11) the amount, if any, of restitution outstanding, past efforts made by the petitioner​
6589+203.15toward payment, and the measures in place to help ensure completion of restitution payment​
6590+203.16after expungement of the record if granted; and​
6591+203.17 (12) other factors deemed relevant by the court.​
6592+203.18 (d) Notwithstanding section 13.82, 13.87, or any other law to the contrary, if the court​
6593+203.19issues an expungement order it may require that the criminal record be sealed, the existence​
6594+203.20of the record not be revealed, and the record not be opened except as required under​
6595+203.21subdivision 7. Records must not be destroyed or returned to the subject of the record.​
6596+203.22 (e) Information relating to a criminal history record of an employee, former employee,​
6597+203.23or tenant that has been expunged before the occurrence of the act giving rise to the civil​
6598+203.24action may not be introduced as evidence in a civil action against a private employer or​
6599+203.25landlord or its employees or agents that is based on the conduct of the employee, former​
6600+203.26employee, or tenant.​
6601+203.27 EFFECTIVE DATE.This section is effective August 1, 2023, and applies to crimes​
6602+203.28committed on or after that date.​
6603+203.29Sec. 3. Minnesota Statutes 2022, section 609A.03, subdivision 9, is amended to read:​
6604+203.30 Subd. 9.Stay of order; appeal.An expungement order issued under this section shall​
6605+203.31be stayed automatically for 60 days after the order is filed and, if the order is appealed,​
6606+203​Article 5 Sec. 3.​
6607+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 204.1during the appeal period. A person or an agency or jurisdiction whose records would be​
6608+204.2affected by the order may appeal the order within 60 days of service of notice of filing of​
6609+204.3the order. An agency or jurisdiction or its officials or employees need not file a cost bond​
6610+204.4or supersedeas bond in order to further stay the proceedings or file an appeal.​
6611+204.5 EFFECTIVE DATE.This section is effective August 1, 2023.​
6612+204.6Sec. 4. [609A.05] AUTOMATIC EXPUNGEMENT OF CERTAIN CANNABIS​
6613+204.7OFFENSES.​
6614+204.8 Subdivision 1.Eligibility; dismissal, exoneration, or conviction of nonfelony cannabis​
6615+204.9offenses.(a) A person is eligible for an order of expungement:​
6616+204.10 (1) upon the dismissal and discharge of proceedings against a person under section​
6617+204.11152.18, subdivision 1, for violation of section 152.024, 152.025, or 152.027 for possession​
6618+204.12of marijuana or tetrahydrocannabinols;​
6619+204.13 (2) if the person was convicted of or received a stayed sentence for a violation of section​
6620+204.14152.027, subdivision 3 or 4;​
6621+204.15 (3) if the person was arrested for possession of marijuana or tetrahydrocannabinols and​
6622+204.16all charges were dismissed prior to a determination of probable cause for charges under​
6623+204.17section 152.021, subdivision 2, paragraph (a), clause (6); 152.022, subdivision 2, paragraph​
6624+204.18(a), clause (6); 152.023, subdivision 2, paragraph (a), clause (5); 152.024, subdivision 2,​
6625+204.19clause (2); 152.025, subdivision 2, clause (1); or 152.027, subdivision 3 or 4; or​
6626+204.20 (4) if all pending actions or proceedings involving the possession of marijuana or​
6627+204.21tetrahydrocannabinols were resolved in favor of the person for charges under section 152.021,​
6628+204.22subdivision 2, paragraph (a), clause (6); 152.022, subdivision 2, paragraph (a), clause (6);​
6629+204.23152.023, subdivision 2, paragraph (a), clause (5); 152.024, subdivision 2, clause (2); 152.025,​
6630+204.24subdivision 2, clause (1); or 152.027, subdivision 3 or 4.​
6631+204.25 (b) For purposes of this section:​
6632+204.26 (1) a verdict of not guilty by reason of mental illness is not a resolution in favor of the​
6633+204.27person; and​
6634+204.28 (2) an action or proceeding is resolved in favor of the person if the person received an​
6635+204.29order under section 590.11 determining that the person is eligible for compensation based​
6636+204.30on exoneration.​
6637+204​Article 5 Sec. 4.​
6638+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 205.1 Subd. 2.Bureau of Criminal Apprehension to identify eligible individuals.(a) The​
6639+205.2Bureau of Criminal Apprehension shall identify records that qualify for an order of​
6640+205.3expungement pursuant to subdivision 1.​
6641+205.4 (b) The Bureau of Criminal Apprehension shall notify the judicial branch of:​
6642+205.5 (1) the name and date of birth of an individual whose record is eligible for an order of​
6643+205.6expungement; and​
6644+205.7 (2) the case number of the eligible record.​
6645+205.8 (c) The Bureau of Criminal Apprehension shall grant an expungement to each qualifying​
6646+205.9person whose records the bureau possesses and shall seal the bureau's records without​
6647+205.10requiring an application, petition, or motion. The bureau shall seal records related to an​
6648+205.11expungement within 60 days after the bureau sent notice of the expungement to the judicial​
6649+205.12branch pursuant to paragraph (b) unless an order of the judicial branch prohibits sealing the​
6650+205.13records or additional information establishes that the records are not eligible for expungement.​
6651+205.14 (d) Nonpublic criminal records maintained by the bureau and subject to a grant of​
6652+205.15expungement relief must display a notation stating "expungement relief granted pursuant​
6653+205.16to section 609A.05."​
6654+205.17 (e) The bureau shall inform each arresting or citing law enforcement agency with records​
6655+205.18affected by the grant of expungement relief issued pursuant to paragraph (c) that expungement​
6656+205.19has been granted. The bureau shall notify each arresting or citing law enforcement agency​
6657+205.20of an expungement within 60 days after the bureau sent notice of the expungement to the​
6658+205.21judicial branch. The bureau may notify each law enforcement agency using electronic means.​
6659+205.22Upon receiving notification of an expungement, a law enforcement agency shall seal all​
6660+205.23records related to the expungement, including the records of the person's arrest, indictment,​
6661+205.24trial, verdict, and dismissal or discharge of the case.​
6662+205.25 (f) The Bureau of Criminal Apprehension shall make a reasonable and good faith effort​
6663+205.26to notify any person whose record qualifies for an order of expungement or a grant of​
6664+205.27expungement that the offense qualifies and notice is being sent to the judicial branch. Notice​
6665+205.28sent pursuant to this paragraph shall inform the person that, following the order of​
6666+205.29expungement, any records of an arrest, conviction, or incarceration should not appear on​
6667+205.30any background check or study performed in Minnesota. Notice must also clearly state that​
6668+205.31an order of expungement or a grant of expungement may not change a person's immigration​
6669+205.32status and any person with questions about the effect on the person's immigration status​
6670+205.33should consult with an immigration attorney.​
6671+205​Article 5 Sec. 4.​
6672+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 206.1 (g) On a schedule and in a manner established by the commissioner of human services,​
6673+206.2the bureau shall send the commissioner of human services a list identifying the name and​
6674+206.3case number or, if no case number is available, the citation number of each person who​
6675+206.4received a grant of expungement.​
6676+206.5 (h) Data on a person whose offense has been expunged under this subdivision, including​
6677+206.6any notice sent pursuant to paragraph (e), (f), or (g), are private data on individuals as defined​
6678+206.7in section 13.02, subdivision 12.​
6679+206.8 Subd. 3.Order of expungement.(a) Upon receiving notice that an offense qualifies​
6680+206.9for expungement, or upon entering an order dismissing charges prior to a determination of​
6681+206.10probable cause, the court shall issue an order vacating the conviction, if any, discharging​
6682+206.11the person from any form of supervision, dismissing the proceedings against that person,​
6683+206.12and sealing all records relating to an arrest, indictment or information, trial, verdict, or​
6684+206.13dismissal and discharge for an offense described in subdivision 1.​
6685+206.14 (b) Section 609A.03, subdivision 6, applies to an order issued under this section sealing​
6686+206.15the record of proceedings under section 152.18.​
6687+206.16 (c) The limitations under section 609A.03, subdivision 7a, paragraph (b), do not apply​
6688+206.17to an order issued under this section.​
6689+206.18 (d) The court administrator shall send a copy of an expungement order issued under this​
6690+206.19section to each agency and jurisdiction whose records are affected by the terms of the order​
6691+206.20and send a letter to the last known address of the person whose offense has been expunged​
6692+206.21identifying each agency to which the order was sent. The courts shall not order the​
6693+206.22Department of Health or Human Services to seal records under this section.​
6694+206.23 (e) In consultation with the commissioner of human services, the court shall establish a​
6695+206.24schedule on which the court shall provide the commissioner of human services and the​
6696+206.25Professional Educator Licensing and Standards Board a list identifying the name and case​
6697+206.26number or if no case number is available, the citation number of each person who received​
6698+206.27an expungement order issued under this section.​
6699+206.28 (f) Data on the person whose offense has been expunged contained in a letter or other​
6700+206.29notification sent under this subdivision are private data on individuals as defined in section​
6701+206.3013.02.​
6702+206.31 Subd. 4.Report.The Bureau of Criminal Apprehension shall issue a report to the​
6703+206.32legislative committees and divisions with jurisdiction over public safety policy and finance​
6704+206.33upon completion of the work required under subdivision 2. The report shall contain summary​
6705+206​Article 5 Sec. 4.​
6706+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 207.1data and must include the total number of expungements granted by the Bureau of Criminal​
6707+207.2Apprehension.​
6708+207.3 EFFECTIVE DATE.This section is effective August 1, 2023.​
6709+207.4Sec. 5. [609A.06] EXPUNGEMENT AND RESENTENCING OF FELONY​
6710+207.5CANNABIS OFFENSES.​
6711+207.6 Subdivision 1.Cannabis Expungement Board.(a) The Cannabis Expungement Board​
6712+207.7is created with the powers and duties established by law.​
6713+207.8 (b) The Cannabis Expungement Board is composed of the following members:​
6714+207.9 (1) the chief justice of the supreme court or a designee;​
6715+207.10 (2) the attorney general or a designee;​
6716+207.11 (3) one public defender, appointed by the governor upon recommendation of the state​
6717+207.12public defender;​
6718+207.13 (4) the commissioner of one department of the state government as defined in section​
6719+207.1415.01, appointed by the governor; and​
6720+207.15 (5) one public member with experience as an advocate for victim's rights, appointed by​
6721+207.16the governor.​
6722+207.17 (c) The Cannabis Expungement Board shall have the following powers and duties:​
6723+207.18 (1) to obtain and review the records, including but not limited to all matters, files,​
6724+207.19documents, and papers incident to the arrest, indictment, information, trial, appeal, or​
6725+207.20dismissal and discharge, which relate to a charge for possession of a controlled substance;​
6726+207.21 (2) to determine whether a person committed an act involving the possession of cannabis​
6727+207.22flower or cannabinoid products that would either be a lesser offense or no longer be a crime​
6728+207.23after August 1, 2023;​
6729+207.24 (3) to determine whether a person's conviction should be vacated, charges should be​
6730+207.25dismissed, and records should be expunged, or whether the person should be resentenced​
6731+207.26to a lesser offense; and​
6732+207.27 (4) to notify the judicial branch of individuals eligible for an expungement or resentencing​
6733+207.28to a lesser offense.​
6734+207.29 (d) The Cannabis Expungement Board shall complete the board's work by June 30, 2028.​
6735+207​Article 5 Sec. 5.​
6736+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 208.1 Subd. 2.Eligibility; possession of cannabis.(a) A person is eligible for an expungement​
6737+208.2or resentencing to a lesser offense if:​
6738+208.3 (1) the person was convicted of, or adjudication was stayed for, a violation of any of the​
6739+208.4following involving the possession of marijuana or tetrahydrocannabinols:​
6740+208.5 (i) section 152.021, subdivision 2, clause (6);​
6741+208.6 (ii) section 152.022, subdivision 2, clause (6);​
6742+208.7 (iii) section 152.023, subdivision 2, clause (5); or​
6743+208.8 (iv) section 152.025, subdivision 2, clause (1).​
6744+208.9 (2) the offense did not involve a dangerous weapon, the intentional infliction of bodily​
6745+208.10harm on another, an attempt to inflict bodily harm on another, or an act committed with the​
6746+208.11intent to cause fear in another of immediate bodily harm or death;​
6747+208.12 (3) the act on which the charge was based would either be a lesser offense or no longer​
6748+208.13be a crime after August 1, 2023; and​
6749+208.14 (4) the person did not appeal the sentence, any appeal was denied, or the deadline to file​
6750+208.15an appeal has expired.​
6751+208.16 (b) For purposes of this subdivision, a "lesser offense" means a nonfelony offense if the​
6752+208.17person was charged with a felony.​
6753+208.18 Subd. 3.Bureau of Criminal Apprehension to identify eligible records.(a) The​
6754+208.19Bureau of Criminal Apprehension shall identify convictions and sentences where adjudication​
6755+208.20was stayed that qualify for review under subdivision 2, paragraph (a), clause (1).​
6756+208.21 (b) The Bureau of Criminal Apprehension shall notify the Cannabis Expungement Board​
6757+208.22of:​
6758+208.23 (1) the name and date of birth of a person whose record is eligible for review; and​
6759+208.24 (2) the case number of the eligible conviction or stay of adjudication.​
6760+208.25 Subd. 4.Access to records.The Cannabis Expungement Board shall have free access​
6761+208.26to records, including but not limited to all matters, files, documents, and papers incident to​
6762+208.27the arrest, indictment, information, trial, appeal, or dismissal and discharge that relate to a​
6763+208.28charge and conviction or stay of adjudication for possession of a controlled substance held​
6764+208.29by law enforcement agencies, prosecuting authorities, and court administrators. The Cannabis​
6765+208.30Expungement Board may issue subpoenas for and compel the production of books, records,​
6766+208.31accounts, documents, and papers. If any person fails or refuses to produce any books, records,​
6767+208​Article 5 Sec. 5.​
6768+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 209.1accounts, documents, or papers material in the matter under consideration after having been​
6769+209.2lawfully required by order or subpoena, any judge of the district court in any county of the​
6770+209.3state where the order or subpoena was made returnable, on application of the commissioner​
6771+209.4of management and budget or commissioner of administration, as the case may be, shall​
6772+209.5compel obedience or punish disobedience as for contempt, as in the case of disobedience​
6773+209.6of a similar order or subpoena issued by such court.​
6774+209.7 Subd. 5.Meetings; anonymous identifier.(a) The Cannabis Expungement Board shall​
6775+209.8hold meetings at least monthly and shall hold a meeting whenever the board takes formal​
6776+209.9action on a review of a conviction or stay of adjudication for an offense involving the​
6777+209.10possession of marijuana or tetrahydrocannabinols. All board meetings shall be open to the​
6778+209.11public and subject to chapter 13D.​
6779+209.12 (b) Any victim of a crime being reviewed and any law enforcement agency may submit​
6780+209.13an oral or written statement at the meeting, giving a recommendation on whether a person's​
6781+209.14record should be expunged or the person should be resentenced to a lesser offense. The​
6782+209.15board must consider the victim's and the law enforcement agency's statement when making​
6783+209.16the board's decision.​
6784+209.17 (c) Section 13D.05 governs the board's treatment of not public data, as defined by section​
6785+209.1813.02, subdivision 8a, discussed at open meetings of the board. Notwithstanding section​
6786+209.1913.03, subdivision 11, the board shall assign an anonymous, unique identifier to each victim​
6787+209.20of a crime and person whose conviction or stay of adjudication the board reviews. The​
6788+209.21identifier shall be used in any discussion in a meeting open to the public and on any records​
6789+209.22available to the public to protect the identity of the person whose records are being​
6790+209.23considered.​
6791+209.24 Subd. 6.Review and determination.(a) The Cannabis Expungement Board shall review​
6792+209.25all available records to determine whether the conviction or stay of adjudication is eligible​
6793+209.26for an expungement or resentencing to a lesser offense. An expungement under this section​
6794+209.27is presumed to be in the public interest unless there is clear and convincing evidence that​
6795+209.28an expungement or resentencing to a lesser offense would create a risk to public safety.​
6796+209.29 (b) If the Cannabis Expungement Board determines that an expungement is in the public​
6797+209.30interest, the board shall determine whether a person's conviction should be vacated and​
6798+209.31charges should be dismissed.​
6799+209.32 (c) If the Cannabis Expungement Board determines that an expungement is in the public​
6800+209.33interest, the board shall determine whether the limitations under section 609A.03, subdivision​
6801+209.345a, apply.​
6802+209​Article 5 Sec. 5.​
6803+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 210.1 (d) If the Cannabis Expungement Board determines that an expungement is in the public​
6804+210.2interest, the board shall determine whether the limitations under section 609A.03, subdivision​
6805+210.37a, paragraph (b), clause (5), apply.​
6806+210.4 (e) If the Cannabis Expungement Board determines that an expungement is not in the​
6807+210.5public interest, the board shall determine whether the person is eligible for resentencing to​
6808+210.6a lesser offense.​
6809+210.7 (f) In making a determination under this subdivision, the Cannabis Expungement Board​
6810+210.8shall consider:​
6811+210.9 (1) the nature and severity of the underlying crime, including but not limited to the total​
6812+210.10amount of marijuana or tetrahydrocannabinols possessed by the person and whether the​
6813+210.11offense involved a dangerous weapon, the intentional infliction of bodily harm on another,​
6814+210.12an attempt to inflict bodily harm on another, or an act committed with the intent to cause​
6815+210.13fear in another of immediate bodily harm or death;​
6816+210.14 (2) whether an expungement or resentencing the person a lesser offense would increase​
6817+210.15the risk, if any, the person poses to other individuals or society;​
6818+210.16 (3) if the person is under sentence, whether an expungement or resentencing to a lesser​
6819+210.17offense would result in the release of the person and whether release earlier than the date​
6820+210.18that the person would be released under the sentence currently being served would present​
6821+210.19a danger to the public or would be compatible with the welfare of society;​
6822+210.20 (4) aggravating or mitigating factors relating to the underlying crime, including the​
6823+210.21person's level of participation and the context and circumstances of the underlying crime;​
6824+210.22 (5) statements from victims and law enforcement, if any;​
6825+210.23 (6) if an expungement or resentencing the person to a lesser offense is considered,​
6826+210.24whether there is good cause to restore the person's right to possess firearms and ammunition;​
6827+210.25 (7) if an expungement is considered, whether an expunged record of a conviction or stay​
6828+210.26of adjudication may be opened for purposes of a background check required under section​
6829+210.27122A.18, subdivision 8; and​
6830+210.28 (8) other factors deemed relevant by the Cannabis Expungement Board.​
6831+210.29 (g) In making a determination under this subdivision, the Cannabis Expungement Board​
6832+210.30shall not consider the impact the expungement would have on the offender based on any​
6833+210.31records held by the Department of Health or Human Services.​
6834+210.32 (h) The affirmative vote of three members is required for action taken at any meeting.​
6835+210​Article 5 Sec. 5.​
6836+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 211.1 Subd. 7.Annual report.Until the board completes its work, the board shall issue a​
6837+211.2report by January 15 of each year to the legislative committees and divisions with jurisdiction​
6838+211.3over public safety policy and finance upon completion of the work required under subdivision​
6839+211.42. The report shall contain summary data and must include:​
6840+211.5 (1) the total number of cases reviewed in the previous year;​
6841+211.6 (2) the total number of cases in which the board determined that an expungement is in​
6842+211.7the public interest;​
6843+211.8 (3) the total number of cases in which the board determined that resentencing to a lesser​
6844+211.9offense is appropriate, the original sentence in those cases, and the lesser offense​
6845+211.10recommended by the board;​
6846+211.11 (4) the total number of cases in which the board determined that no change to the original​
6847+211.12sentence was appropriate; and​
6848+211.13 (5) the total number of cases remaining to be reviewed.​
6849+211.14 Subd. 8.Notice to judicial branch and offenders.(a) The Cannabis Expungement​
6850+211.15Board shall identify any conviction or stay of adjudication that qualifies for an order of​
6851+211.16expungement or resentencing to a lesser offense and notify the judicial branch of:​
6852+211.17 (1) the name and date of birth of a person whose conviction or stay of adjudication is​
6853+211.18eligible for an order of expungement or resentencing to a lesser offense;​
6854+211.19 (2) the case number of the eligible conviction or stay of adjudication;​
6855+211.20 (3) whether the person is eligible for an expungement;​
6856+211.21 (4) if the person is eligible for an expungement, whether the person's conviction should​
6857+211.22be vacated and charges should be dismissed;​
6858+211.23 (5) if the person is eligible for an expungement, whether there is good cause to restore​
6859+211.24the offender's right to possess firearms and ammunition;​
6860+211.25 (6) if the person is eligible for an expungement, whether the limitations under section​
6861+211.26609A.03, subdivision 7a, paragraph (b), clause (5), apply; and​
6862+211.27 (7) if the person is eligible for resentencing to a lesser offense, the lesser sentence to be​
6863+211.28imposed.​
6864+211.29 (b) The Cannabis Expungement Board shall make a reasonable and good faith effort to​
6865+211.30notify any person whose conviction or stay of adjudication qualifies for an order of​
6866+211.31expungement that the offense qualifies and notice is being sent to the judicial branch. Notice​
6867+211​Article 5 Sec. 5.​
6868+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 212.1sent pursuant to this paragraph shall inform the person that, following the order of​
6869+212.2expungement, any records of an arrest, conviction, or incarceration should not appear on​
6870+212.3any background check or study.​
6871+212.4 Subd. 9.Data classification.All data collected, created, received, maintained, or​
6872+212.5disseminated by the Cannabis Expungement Board in which each victim of a crime and​
6873+212.6person whose conviction or stay of adjudication that the Cannabis Expungement Board​
6874+212.7reviews is or can be identified as the subject of the data is classified as private data on​
6875+212.8individuals, as defined by section 13.02, subdivision 12.​
6876+212.9 Subd. 10.Order of expungement.(a) Upon receiving notice that an offense qualifies​
6877+212.10for expungement, the court shall issue an order sealing all records relating to an arrest,​
6878+212.11indictment or information, trial, verdict, or dismissal and discharge for an offense described​
6879+212.12in subdivision 1. The courts shall not order the Department of Health or Human Services​
6880+212.13to seal records under this section. If the Cannabis Expungement Board determined that the​
6881+212.14person's conviction should be vacated and charges should be dismissed, the order shall​
6882+212.15vacate and dismiss the charges.​
6883+212.16 (b) If the Cannabis Expungement Board determined that there is good cause to restore​
6884+212.17the person's right to possess firearms and ammunition, the court shall issue an order pursuant​
6885+212.18to section 609.165, subdivision 1d.​
6886+212.19 (c) If the Cannabis Expungement Board determined that an expunged record of a​
6887+212.20conviction or stay of adjudication may not be opened for purposes of a background check​
6888+212.21required under section 122A.18, subdivision 8, the court shall direct the order specifically​
6889+212.22to the Professional Educator Licensing and Standards Board.​
6890+212.23 (d) The court administrator shall send a copy of an expungement order issued under this​
6891+212.24section to each agency and jurisdiction whose records are affected by the terms of the order​
6892+212.25and send a letter to the last known address of the person whose offense has been expunged​
6893+212.26identifying each agency to which the order was sent.​
6894+212.27 (e) Data on the person whose offense has been expunged in a letter sent under this​
6895+212.28subdivision are private data on individuals as defined in section 13.02.​
6896+212.29 Subd. 11.Resentencing.(a) If the Cannabis Expungement Board determined that a​
6897+212.30person is eligible for resentencing to a lesser offense and the person is currently under​
6898+212.31sentence, the court shall proceed as if the appellate court directed a reduction of the conviction​
6899+212.32to an offense of lesser degree pursuant to rule 28.02, subdivision 12 of the Rules of Criminal​
6900+212.33Procedure.​
6901+212​Article 5 Sec. 5.​
6902+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 213.1 (b) If the Cannabis Expungement Board determined that a person is eligible for​
6903+213.2resentencing to a lesser offense and the person completed or has been discharged from the​
6904+213.3sentence, the court may issue an order amending the conviction to an offense of lesser degree​
6905+213.4without holding a hearing.​
6906+213.5 (c) If the Cannabis Expungement Board determined that there is good cause to restore​
6907+213.6the person's right to possess firearms and ammunition, the court shall, as necessary, issue​
6908+213.7an order pursuant to section 609.165, subdivision 1d.​
6909+213.8 EFFECTIVE DATE.This section is effective August 1, 2023.​
6910+213.9 ARTICLE 6​
6911+213.10 MISCELLANEOUS PROVISIONS​
6912+213.11Section 1. [3.9224] MEDICAL CANNABIS; COMPACTS TO BE NEGOTIATED.​
6913+213.12 Subdivision 1.Definitions.(a) As used in this section, the following terms have the​
6914+213.13meanings given.​
6915+213.14 (b) "Indian Tribe" means a Tribe, band, nation, or other federally recognized group or​
6916+213.15community of Indians located within the geographical boundaries of the state of Minnesota.​
6917+213.16 (c) "Medical cannabinoid product" has the meaning given in section 342.01, subdivision​
6918+213.1750.​
6919+213.18 (d) "Medical cannabis flower" has the meaning given in section 342.01, subdivision 52.​
6920+213.19 Subd. 2.Negotiations authorized.Following a public hearing, the governor or the​
6921+213.20governor's designated representatives are authorized to negotiate in good faith a compact​
6922+213.21with an Indian Tribe regulating medical cannabis flower and medical cannabinoid products.​
6923+213.22The attorney general is the legal counsel for the governor or the governor's representatives​
6924+213.23in regard to negotiating a compact under this section. If the governor appoints designees to​
6925+213.24negotiate under this subdivision, the designees must include at least two members of the​
6926+213.25senate and two members of the house of representatives, two of whom must be the chairs​
6927+213.26of the senate and house of representatives standing committees with jurisdiction over health​
6928+213.27policy.​
6929+213.28 Subd. 3.Terms of compact; rights of parties.(a) A compact agreed to under this​
6930+213.29section may address any issues related to medical cannabis flower and medical cannabinoid​
6931+213.30products that affect the interests of both the state and Indian Tribe or otherwise have an​
6932+213.31impact on Tribal-state relations. At a minimum, a compact agreed to on behalf of the state​
6933+213.32under this section must address:​
6934+213​Article 6 Section 1.​
6935+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 214.1 (1) the enforcement of criminal and civil laws;​
6936+214.2 (2) the regulation of the commercial production, processing, sale or distribution, and​
6937+214.3possession of medical cannabis flower and medical cannabinoid products;​
6938+214.4 (3) medical and pharmaceutical research involving medical cannabis flower and medical​
6939+214.5cannabinoid products;​
6940+214.6 (4) the taxation of medical cannabis flower and medical cannabinoid products, including​
6941+214.7establishing an appropriate amount and method of revenue sharing;​
6942+214.8 (5) the immunities of an Indian Tribe or preemption of state law regarding the production,​
6943+214.9processing, or sale or distribution of medical cannabis flower and medical cannabinoid​
6944+214.10products; and​
6945+214.11 (6) the method of resolution for disputes involving the compact, including the use of​
6946+214.12mediation or other alternative dispute resolution processes and procedures.​
6947+214.13 (b) In addressing the issues identified under paragraph (a), the governor or the governor's​
6948+214.14designated representatives shall only enter into agreements that:​
6949+214.15 (1) provide for the preservation of public health and safety;​
6950+214.16 (2) ensure the security of production, processing, retail, and research facilities on Tribal​
6951+214.17land; and​
6952+214.18 (3) establish provisions regulating business involving medical cannabis flower and​
6953+214.19medical cannabinoid products that pass between Tribal land and non-Tribal land in the state.​
6954+214.20 Subd. 4.Assessments and charges.Notwithstanding any law to the contrary, any​
6955+214.21compact agreed to under this section shall establish all taxes, fees, assessments, and other​
6956+214.22charges related to the production, processing, sale or distribution, and possession of medical​
6957+214.23cannabis flower and medical cannabinoid products.​
6958+214.24 Subd. 5.Civil and criminal immunities.The following acts, when performed by a​
6959+214.25validly licensed medical cannabis retailer or an employee of a medical cannabis retailer​
6960+214.26operated by an Indian Tribe pursuant to a compact entered into under this section, do not​
6961+214.27constitute a criminal or civil offense under state law:​
6962+214.28 (1) the cultivation of cannabis flower, as defined in section 342.01, subdivision 15;​
6963+214.29 (2) the possession, purchase, and receipt of medical cannabis flower and medical​
6964+214.30cannabinoid products that are properly packaged and labeled as authorized under a compact​
6965+214.31entered into pursuant to this section; and​
6966+214​Article 6 Section 1.​
6967+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 215.1 (3) the delivery, distribution, and sale of medical cannabis flower and medical cannabinoid​
6968+215.2products as authorized under a compact entered into pursuant to this section and that takes​
6969+215.3place on the premises of a medical cannabis retailer on Tribal land to any person 21 years​
6970+215.4of age or older.​
6971+215.5 Subd. 6.Publication; report.(a) The governor shall post any compact entered into​
6972+215.6under this section on a publicly accessible website.​
6973+215.7 (b) The governor, the attorney general, and the governor's designated representatives​
6974+215.8shall report to the legislative committees having jurisdiction over health, taxation, and​
6975+215.9commerce annually. This report shall contain information on compacts negotiated and an​
6976+215.10outline of prospective negotiations.​
6977+215.11Sec. 2. [3.9228] ADULT-USE CANNABIS; COMPACTS TO BE NEGOTIATED.​
6978+215.12 Subdivision 1.Definitions.(a) As used in this section, the following terms have the​
6979+215.13meanings given.​
6980+215.14 (b) "Adult-use cannabis flower" has the meaning given in section 342.01, subdivision​
6981+215.154.​
6982+215.16 (c) "Adult-use cannabinoid product" has the meaning given in section 342.01, subdivision​
6983+215.172.​
6984+215.18 (d) "Cannabis business" means a cannabis cultivator, manufacturer, retailer, wholesaler,​
6985+215.19transporter, testing facility, microbusiness, event organizer, delivery service, or lower​
6986+215.20potency edible retailer.​
6987+215.21 (e) "Cannabinoid product" has the meaning given in section 342.01, subdivision 12.​
6988+215.22 (f) "Minnesota Tribal governments" means the federally recognized Indian Tribes located​
6989+215.23in Minnesota including:​
6990+215.24 (1) Bois Forte Band;​
6991+215.25 (2) Fond Du Lac Band;​
6992+215.26 (3) Grand Portage Band;​
6993+215.27 (4) Leech Lake Band;​
6994+215.28 (5) Mille Lacs Band;​
6995+215.29 (6) White Earth Band;​
6996+215.30 (7) Red Lake Nation;​
6997+215​Article 6 Sec. 2.​
6998+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 216.1 (8) Lower Sioux Indian Community;​
6999+216.2 (9) Prairie Island Indian Community;​
7000+216.3 (10) Shakopee Mdewakanton Sioux Community; and​
7001+216.4 (11) Upper Sioux Indian Community.​
7002+216.5 (g) "Tribal cannabis business" means a cannabis business licensed by a Minnesota Tribal​
7003+216.6government, including the business categories identified in paragraph (d) as well as any​
7004+216.7others that may be provided under the law of a Minnesota Tribal government.​
7005+216.8 (h) "Tribally regulated land" means:​
7006+216.9 (1) all land held in trust by the United States for the benefit of a Minnesota Tribal​
7007+216.10government;​
7008+216.11 (2) all land held by a Minnesota Tribal government in restricted fee status; and​
7009+216.12 (3) all land within the exterior boundaries of the reservation of a Minnesota Tribal​
7010+216.13government that is subject to the civil regulatory jurisdiction of the Tribal government. For​
7011+216.14the purposes of this section, land that is subject to the civil regulatory jurisdiction of the​
7012+216.15Tribal government includes:​
7013+216.16 (i) fee land held by the Tribe, entities organized under Tribal law, or individual Indians;​
7014+216.17and​
7015+216.18 (ii) land held by non-Indian entities or individuals who consent to the civil regulation​
7016+216.19of the Tribal government or are otherwise subject to such regulation under federal law.​
7017+216.20 Subd. 2.Acknowledgment and purpose; negotiations authorized.(a) The state of​
7018+216.21Minnesota acknowledges the sovereign right of Minnesota Tribal governments to regulate​
7019+216.22Tribal cannabis businesses and address other matters of cannabis regulation related to the​
7020+216.23internal affairs of Minnesota Tribal governments without regard to whether such Tribal​
7021+216.24government has entered a compact authorized by this section. The purpose of this section​
7022+216.25is to provide for the negotiation of compacts to proactively address jurisdictional issues​
7023+216.26related to the regulation of adult-use cannabis. The legislature finds that these agreements​
7024+216.27will facilitate and promote a cooperative and mutually beneficial relationship between the​
7025+216.28state and the Tribes regarding the legalization of cannabis. Such cooperative agreements​
7026+216.29will enhance public health and safety, ensure a lawful and well-regulated cannabis market,​
7027+216.30encourage economic development, and provide fiscal benefits to both Indian Tribes and the​
7028+216.31state.​
7029+216​Article 6 Sec. 2.​
7030+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 217.1 (b) The governor shall negotiate in good faith, and has the authority to execute and bind​
7031+217.2the state to, a compact with any Minnesota Tribal government wishing to enter into such​
7032+217.3compact regulating adult-use cannabis flower and adult-use cannabinoid products.​
7033+217.4 (c) This subdivision shall be effective upon enactment.​
7034+217.5 Subd. 3.Terms of compact; rights of parties.(a) A compact agreed to under this​
7035+217.6section may address any issues related to the adult-use cannabis industry including adult-use​
7036+217.7cannabis flower, adult-use cannabinoid products, extracts, concentrates, and artificially​
7037+217.8derived cannabinoids that affect the interest of both the state and Minnesota Tribal​
7038+217.9government or otherwise have an impact on Tribal-state relations. Indian Tribes are not​
7039+217.10required to enter into compacts pursuant to this section in order to regulate or engage in​
7040+217.11cannabis businesses or activities on reservation lands or participate as a licensee in the state's​
7041+217.12legal cannabis market.​
7042+217.13 (b) The state shall not, as a condition for entering into a compact under this section:​
7043+217.14 (1) require any Minnesota Tribal government to waive any right, privilege, or immunity​
7044+217.15based on their status as independent sovereigns;​
7045+217.16 (2) require that any revenue generated by cannabis businesses licensed by a Minnesota​
7046+217.17Tribal government be subject to any state cannabis gross receipt taxes imposed under section​
7047+217.18295.81 or state and local sales or use taxes on sales of cannabis;​
7048+217.19 (3) require any taxes collected by Minnesota Tribal governments to be shared in any​
7049+217.20manner with the state or any subdivisions thereof;​
7050+217.21 (4) require a Minnesota Tribal government to consent to state licensing of cannabis​
7051+217.22businesses on the Tribally regulated land of the Minnesota Tribal government; or​
7052+217.23 (5) require any cannabis business licensed by a Minnesota Tribal government pursuant​
7053+217.24to a compact agreed to under this section to comply with specific state regulations on Tribally​
7054+217.25regulated land.​
7055+217.26 (c) Notwithstanding any law to the contrary, the state shall not impose, attempt to impose,​
7056+217.27and shall not require or attempt to require any Indian Tribe to impose, any taxes, fees,​
7057+217.28assessments, and other charges related to the production, processing, sale, purchase,​
7058+217.29distribution, or possession of adult-use cannabis flower and adult-use cannabinoid products​
7059+217.30on Minnesota Tribal governments, or their members, on a reservation or Tribally regulated​
7060+217.31land.​
7061+217.32 (d) Compacts agreed to under this section may allow an exemption from any otherwise​
7062+217.33applicable tax for sales to a Minnesota Tribal government, a Tribal cannabis business, or​
7063+217​Article 6 Sec. 2.​
7064+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 218.1Tribal members, of cannabis flower and adult use cannabinoid products grown, produced,​
7065+218.2or processed as provided for in said compacts, or for activities, to the extent they are not​
7066+218.3already exempt under state or federal law from the state cannabis gross receipt tax under​
7067+218.4section 295.81 or state and local sales or use taxes on sales of cannabis.​
7068+218.5 (e) This subdivision shall be effective upon enactment.​
7069+218.6 Subd. 4.Tax agreements.(a) For any cannabis business owned by a Minnesota Tribal​
7070+218.7government or its instrumentalities that is operated outside of Tribally regulated land, under​
7071+218.8a state-issued license, the collection and administration of taxes on such business may be​
7072+218.9governed through an agreement to be entered under section 270C.19.​
7073+218.10 (b) Any compact that provides for the voluntary sharing of tax or fee revenue among a​
7074+218.11Minnesota Tribal government and the state or a local government may provide that such​
7075+218.12sharing be carried out through an agreement to be entered under section 270C.19.​
7076+218.13 Subd. 5.Civil and criminal immunities.(a) The following acts, when performed by a​
7077+218.14licensed Tribal cannabis business or an employee in the course of their employment for a​
7078+218.15Tribal cannabis business, pursuant to a compact entered into under this section, do not​
7079+218.16constitute a criminal or civil offense under state law:​
7080+218.17 (1) the cultivation of cannabis flower, and the extraction, processing, or manufacture of​
7081+218.18adult-use cannabinoid and artificially derived cannabinoid products, extracts, or concentrates,​
7082+218.19as those terms are defined in section 342.01;​
7083+218.20 (2) the possession, purchase, and receipt of adult-use cannabis seed, flower, and adult-use​
7084+218.21cannabinoid products that are properly packaged and labeled as authorized under a compact​
7085+218.22entered into pursuant to this section, and the sale, delivery, transport, or distribution of such​
7086+218.23products to a licensed cannabis business; and​
7087+218.24 (3) the delivery, distribution, and sale of adult-use cannabis seed, flower, and adult-use​
7088+218.25cannabinoid products as authorized under a compact entered into pursuant to this section​
7089+218.26and that takes place on, or originates from, the premises of a Tribal cannabis business on​
7090+218.27Tribally regulated land, to any person 21 years of age or older.​
7091+218.28 (b) The following acts, when performed by a patron of a licensed Tribal cannabis business​
7092+218.29do not constitute a criminal or civil offense under state law: the purchase, possession, or​
7093+218.30receipt of adult-use cannabis seed, flower, and adult-use cannabinoid products as authorized​
7094+218.31under a compact entered into pursuant to this section.​
7095+218.32 (c) Actions by a Tribal cannabis business, a Tribal member, employee, or agent of a​
7096+218.33Minnesota Tribal government or Tribal cannabis business on Tribally regulated land pursuant​
7097+218​Article 6 Sec. 2.​
7098+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 219.1to Tribal laws governing cannabis, or a compact entered into under this section, do not​
7099+219.2constitute a criminal or civil offense under state law.​
7100+219.3 (d) The following acts, when performed by a state-licensed cannabis business, or an​
7101+219.4employee of such business, and which would be permitted under the terms of the applicable​
7102+219.5cannabis business license if undertaken with another state-licensed cannabis business, are​
7103+219.6permitted under the state license conditions when undertaken with a Tribal cannabis business​
7104+219.7and do not constitute a criminal or civil offense under state law: the possession, purchase,​
7105+219.8wholesale and retail sale, delivery, transport, distribution, and receipt of adult-use cannabis,​
7106+219.9seed, flower, and adult-use cannabinoid products that are properly packaged and labeled as​
7107+219.10authorized under a compact entered into pursuant to this section.​
7108+219.11 (e) The following acts, when performed by a Minnesota Tribal government, a Tribal​
7109+219.12cannabis business licensed by such Tribal government, or an employee of such Tribal​
7110+219.13government or Tribal cannabis business, regardless of whether the Minnesota Tribal​
7111+219.14government issuing such license has compacted with the state under this section, do not​
7112+219.15constitute a criminal or civil offense under state law: purchase, sale, receipt, or delivery​
7113+219.16(including delivery that involves transit through the state, outside a reservation), from or to​
7114+219.17another Minnesota Tribal government or cannabis business licensed by such government.​
7115+219.18 (f) Notwithstanding any other provision of law, a state-licensed cannabis testing facility​
7116+219.19may provide cannabis testing services to a Tribal cannabis business, and the possession or​
7117+219.20transport of cannabis flower or cannabinoid products for such purpose by a Tribal cannabis​
7118+219.21business shall not constitute a criminal or civil offense under state law.​
7119+219.22 (g) This subdivision shall be effective upon enactment.​
7120+219.23 Subd. 6.Publication.The governor shall post any compact entered into under this section​
7121+219.24on a publicly accessible website.​
7122+219.25Sec. 3. Minnesota Statutes 2022, section 13.411, is amended by adding a subdivision to​
7123+219.26read:​
7124+219.27 Subd. 12.Cannabis businesses.Data submitted to the Office of Cannabis Management​
7125+219.28for a cannabis business license or a hemp business license and data relating to investigations​
7126+219.29and disciplinary proceedings involving cannabis businesses and hemp businesses licensed​
7127+219.30by the Office of Cannabis Management are classified under section 342.20.​
7128+219​Article 6 Sec. 3.​
7129+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 220.1Sec. 4. Minnesota Statutes 2022, section 13.871, is amended by adding a subdivision to​
7130+220.2read:​
7131+220.3 Subd. 15.Cannabis Expungement Board records.Data collected, created, received,​
7132+220.4maintained, or disseminated by the Cannabis Expungement Board are classified under​
7133+220.5section 609A.06, subdivision 8.​
7134+220.6Sec. 5. Minnesota Statutes 2022, section 34A.01, subdivision 4, is amended to read:​
7135+220.7 Subd. 4.Food."Food" means every ingredient used for, entering into the consumption​
7136+220.8of, or used or intended for use in the preparation of food, drink, confectionery, or condiment​
7137+220.9for humans or other animals, whether simple, mixed, or compound; and articles used as​
7138+220.10components of these ingredients, except that edible cannabinoid cannabis products, as​
7139+220.11defined in section 151.72, subdivision 1, paragraph (c) 342.01, subdivision 29, lower-potency​
7140+220.12hemp edibles as defined in section 342.01, subdivision 48, and hemp-derived consumer​
7141+220.13products, as defined in section 342.01, subdivision 35, that are intended to be eaten or​
7142+220.14consumed as a beverage are not food.​
7143+220.15 EFFECTIVE DATE.This section is effective July 1, 2024.​
7144+220.16Sec. 6. [120B.215] EDUCATION ON CANNABIS USE AND SUBSTANCE USE.​
7145+220.17 Subdivision 1.Model program.The commissioner of education, in consultation with​
7146+220.18the commissioners of health and human services, local district and school health education​
7147+220.19specialists, and other qualified experts, shall identify one or more model programs that may​
7148+220.20be used to educate middle school and high school students on the health effects on children​
7149+220.21and adolescents of cannabis use and substance use, including but not limited to the use of​
7150+220.22fentanyl or mixtures containing fentanyl, consistent with local standards as required in​
7151+220.23section 120B.021, subdivision 1, paragraph (a), clause (6), for elementary and secondary​
7152+220.24school students. The commissioner must publish a list of model programs that include​
7153+220.25written materials, curriculum resources, and training for instructors by June 1, 2025. A​
7154+220.26model program identified by the commissioner must be medically accurate, age and​
7155+220.27developmentally appropriate, culturally inclusive, and grounded in science, and must address:​
7156+220.28 (1) the physical and mental health effects of cannabis use and substance use by children​
7157+220.29and adolescents, including effects on the developing brains of children and adolescents;​
7158+220.30 (2) unsafe or unhealthy behaviors associated with cannabis use and substance use;​
7159+220.31 (3) signs of substance use disorders;​
7160+220.32 (4) treatment options; and​
7161+220​Article 6 Sec. 6.​
7162+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 221.1 (5) healthy coping strategies for children and adolescents.​
7163+221.2 Subd. 2.School programs.(a) Starting in the 2026-2027 school year, a school district​
7164+221.3or charter school must implement a comprehensive education program on cannabis use and​
7165+221.4substance use, including but not limited to the use of fentanyl or mixtures containing fentanyl,​
7166+221.5for students in middle school and high school. The program must include instruction on the​
7167+221.6topics listed in subdivision 1 and must:​
7168+221.7 (1) respect community values and encourage students to communicate with parents,​
7169+221.8guardians, and other trusted adults about cannabis use and substance use, including but not​
7170+221.9limited to the use of fentanyl or mixtures containing fentanyl; and​
7171+221.10 (2) refer students to local resources where students may obtain medically accurate​
7172+221.11information about cannabis use and substance use, including but not limited to the use of​
7173+221.12fentanyl or mixtures containing fentanyl, and treatment for a substance use disorder.​
7174+221.13 (b) District efforts to develop, implement, or improve instruction or curriculum as a​
7175+221.14result of the provisions of this section must be consistent with sections 120B.10 and 120B.11.​
7176+221.15 Subd. 3.Parental review.Notwithstanding any law to the contrary, each school district​
7177+221.16shall have a procedure for a parent, a guardian, or an adult student 18 years of age or older​
7178+221.17to review the content of the instructional materials to be provided to a minor child or to an​
7179+221.18adult student pursuant to this section. The district or charter school must allow a parent or​
7180+221.19adult student to opt out of instruction under this section with no academic or other penalty​
7181+221.20for the student and must inform parents and adult students of this right to opt out.​
7182+221.21 Subd. 4.Youth council.A school district or charter school may establish one or more​
7183+221.22youth councils in which student members of the council receive education and training on​
7184+221.23cannabis use and substance use, including but not limited to the use of fentanyl or mixtures​
7185+221.24containing fentanyl, and provide peer-to-peer education on these topics.​
7186+221.25Sec. 7. [144.196] CANNABIS DATA COLLECTION AND BIENNIAL REPORTS.​
7187+221.26 Subdivision 1.General.The commissioner of health shall engage in research and data​
7188+221.27collection activities to measure the prevalence of cannabis flower use and the use of cannabis​
7189+221.28products, lower-potency hemp edibles, and hemp-derived consumer products in the state​
7190+221.29by persons under 21 years of age and by persons 21 years of age or older. In order to collect​
7191+221.30data, the commissioner may modify existing data collection tools used by the department​
7192+221.31or other state agencies or may establish one or more new data collection tools.​
7193+221.32 Subd. 2.Statewide assessment; baseline data; updates.(a) The commissioner shall​
7194+221.33conduct a statewide assessment to establish a baseline for the prevalence of cannabis flower​
7195+221​Article 6 Sec. 7.​
7196+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 222.1use and the use of cannabis products, lower-potency hemp edibles, and hemp-derived​
7197+222.2consumer products in the state broken out by:​
7198+222.3 (1) the current age of the customer;​
7199+222.4 (2) the age at which the customer began consuming cannabis flower, cannabis products,​
7200+222.5lower-potency hemp edibles, or hemp-derived consumer products;​
7201+222.6 (3) whether the customer consumes cannabis flower, cannabis products, lower-potency​
7202+222.7hemp edibles, or hemp-derived consumer products, and by type of product that the customer​
7203+222.8consumes, if applicable;​
7204+222.9 (4) the amount of cannabis flower, cannabis product, lower-potency hemp edible, or​
7205+222.10hemp-derived consumer product typically consumed at one time;​
7206+222.11 (5) the typical frequency of consumption; and​
7207+222.12 (6) other criteria specified by the commissioner.​
7208+222.13 (b) The initial assessment must be completed by July 1, 2024. The commissioner shall​
7209+222.14collect updated data under this subdivision at least every two years thereafter.​
7210+222.15 Subd. 3.Reports.Beginning January 1, 2025, and every two years thereafter, the​
7211+222.16commissioner shall issue a public report on the prevalence of cannabis flower use and the​
7212+222.17use of cannabis products, lower-potency hemp edibles, and hemp-derived consumer products​
7213+222.18in the state by persons under age 21 and by persons age 21 or older. The report may include​
7214+222.19recommendations from the commissioner for changes to this chapter that would discourage​
7215+222.20or prevent personal use of cannabis flower, cannabis products, lower-potency hemp edibles,​
7216+222.21or hemp-derived consumer products by persons under age 21, that would discourage personal​
7217+222.22use of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived​
7218+222.23consumer products by pregnant or breastfeeding women, that would prevent access to​
7219+222.24cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
7220+222.25products by young children, or that would otherwise promote public health.​
7221+222.26Sec. 8. [144.197] CANNABIS EDUCATION PROGRAMS.​
7222+222.27 Subdivision 1.Youth education.The commissioner of health, in collaboration with​
7223+222.28local health departments, shall conduct a long-term, coordinated education program to raise​
7224+222.29public awareness about and address the top three adverse health effects, as determined by​
7225+222.30the commissioner, associated with the use of cannabis flower, cannabis products,​
7226+222.31lower-potency hemp edibles, or hemp-derived consumer products by persons under age 21.​
7227+222.32In conducting this education program, the commissioner shall engage and consult with​
7228+222​Article 6 Sec. 8.​
7229+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 223.1youth around the state on program content and on methods to effectively disseminate program​
7230+223.2information to youth around the state.​
7231+223.3 Subd. 2.Education for pregnant and breastfeeding women; women who may become​
7232+223.4pregnant.The commissioner of health shall conduct a long-term, coordinated program to​
7233+223.5educate pregnant women, breastfeeding women, and women who may become pregnant on​
7234+223.6the adverse health effects of prenatal exposure to cannabis flower, cannabis products,​
7235+223.7lower-potency hemp edibles, or hemp-derived consumer products and on the adverse health​
7236+223.8effects experienced by infants and children who are exposed to cannabis flower, cannabis​
7237+223.9products, lower-potency hemp edibles, or hemp-derived consumer products in breast milk,​
7238+223.10from secondhand smoke, or by ingesting cannabinoid products. This education program​
7239+223.11must also educate women on what constitutes a substance use disorder, signs of a substance​
7240+223.12use disorder, and treatment options for persons with a substance use disorder.​
7241+223.13 Subd. 3.Home visiting programs.The commissioner of health shall provide training,​
7242+223.14technical assistance, and education materials to local public health home visiting programs​
7243+223.15and Tribal home visiting programs regarding the safe and unsafe use of cannabis flower,​
7244+223.16cannabis products, lower-potency hemp edibles, or hemp-derived consumer products in​
7245+223.17homes with infants and young children. Training, technical assistance, and education​
7246+223.18materials shall address substance use, the signs of a substance use disorder, treatment options​
7247+223.19for persons with a substance use disorder, the dangers of driving under the influence of​
7248+223.20cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
7249+223.21products, how to safely consume cannabis flower, cannabis products, lower-potency hemp​
7250+223.22edibles, or hemp-derived consumer products in homes with infants and young children, and​
7251+223.23how to prevent infants and young children from being exposed to cannabis flower, cannabis​
7252+223.24products, lower-potency hemp edibles, or hemp-derived consumer products by ingesting​
7253+223.25cannabinoid products or through secondhand smoke.​
7254+223.26 Subd. 4.Local and Tribal health departments.The commissioner of health shall​
7255+223.27distribute grants to local health departments and Tribal health departments for these​
7256+223.28departments to create and disseminate educational materials on cannabis flower, cannabis​
7257+223.29products, lower-potency hemp edibles, and hemp-derived consumer products and to provide​
7258+223.30safe use and prevention training, education, technical assistance, and community engagement​
7259+223.31regarding cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived​
7260+223.32consumer products.​
7261+223​Article 6 Sec. 8.​
7262+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 224.1Sec. 9. Minnesota Statutes 2022, section 144.99, subdivision 1, is amended to read:​
7263+224.2 Subdivision 1.Remedies available.The provisions of chapters 103I and 157 and sections​
7264+224.3115.71 to 115.77; 144.12, subdivision 1, paragraphs (1), (2), (5), (6), (10), (12), (13), (14),​
7265+224.4and (15); 144.1201 to 144.1204; 144.121; 144.1215; 144.1222; 144.35; 144.381 to 144.385;​
7266+224.5144.411 to 144.417; 144.495; 144.71 to 144.74; 144.9501 to 144.9512; 144.97 to 144.98;​
7267+224.6144.992; 152.22 to 152.37; 326.70 to 326.785; 327.10 to 327.131; and 327.14 to 327.28​
7268+224.7and all rules, orders, stipulation agreements, settlements, compliance agreements, licenses,​
7269+224.8registrations, certificates, and permits adopted or issued by the department or under any​
7270+224.9other law now in force or later enacted for the preservation of public health may, in addition​
7271+224.10to provisions in other statutes, be enforced under this section.​
7272+224.11 EFFECTIVE DATE.This section is effective January 1, 2024.​
7273+224.12Sec. 10. Minnesota Statutes 2022, section 144A.4791, subdivision 14, is amended to read:​
7274+224.13 Subd. 14.Application of other law.Home care providers may exercise the authority​
7275+224.14and are subject to the protections in section 152.34 342.51, subdivision 2.​
7276+224.15Sec. 11. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7277+224.16read:​
7278+224.17 Subd. 5d.Indian lands."Indian lands" means all lands within the limits of any Indian​
7279+224.18reservation within the boundaries of Minnesota and any lands within the boundaries of​
7280+224.19Minnesota, title to which are either held in trust by the United States or over which an Indian​
7281+224.20Tribe exercises governmental power.​
7282+224.21Sec. 12. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7283+224.22read:​
7284+224.23 Subd. 15.Tribal medical cannabis board."Tribal medical cannabis board" means an​
7285+224.24agency established by each federally recognized Tribal government and duly authorized by​
7286+224.25that Tribe's governing body to perform regulatory oversight and monitor compliance with​
7287+224.26a Tribal medical cannabis program and applicable regulations.​
7288+224.27Sec. 13. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7289+224.28read:​
7290+224.29 Subd. 16.Tribal medical cannabis program."Tribal medical cannabis program" means​
7291+224.30a program established by a federally recognized Tribal government within the boundaries​
7292+224​Article 6 Sec. 13.​
7293+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 225.1of Minnesota regarding the commercial production, processing, sale or distribution, and​
7294+225.2possession of medical cannabis and medical cannabis products.​
7295+225.3Sec. 14. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7296+225.4read:​
7297+225.5 Subd. 17.Tribal medical cannabis program manufacturer."Tribal medical cannabis​
7298+225.6program manufacturer" means an entity designated by a Tribal medical cannabis board​
7299+225.7within the boundaries of Minnesota or a federally recognized Tribal government within the​
7300+225.8boundaries of Minnesota to engage in production, processing, and sale or distribution of​
7301+225.9medical cannabis and medical cannabis products under that Tribe's Tribal medical cannabis​
7302+225.10program.​
7303+225.11Sec. 15. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to​
7304+225.12read:​
7305+225.13 Subd. 18.Tribal medical cannabis program patient."Tribal medical cannabis program​
7306+225.14patient" means a person who possesses a valid registration verification card or equivalent​
7307+225.15document that is issued under the laws or regulations of a Tribal nation within the boundaries​
7308+225.16of Minnesota and that verifies that the person is enrolled in or authorized to participate in​
7309+225.17that Tribal nation's Tribal medical cannabis program.​
7310+225.18Sec. 16. Minnesota Statutes 2022, section 152.29, subdivision 4, is amended to read:​
7311+225.19 Subd. 4.Report.(a) Each manufacturer shall report to the commissioner on a monthly​
7312+225.20basis the following information on each individual patient for the month prior to the report:​
7313+225.21 (1) the amount and dosages of medical cannabis distributed;​
7314+225.22 (2) the chemical composition of the medical cannabis; and​
7315+225.23 (3) the tracking number assigned to any medical cannabis distributed.​
7316+225.24 (b) For transactions involving Tribal medical cannabis program patients, each​
7317+225.25manufacturer shall report to the commissioner on a weekly basis the following information​
7318+225.26on each individual Tribal medical cannabis program patient for the week prior to the report:​
7319+225.27 (1) the name of the Tribal medical cannabis program in which the Tribal medical cannabis​
7320+225.28program patient is enrolled;​
7321+225.29 (2) the amount and dosages of medical cannabis distributed;​
7322+225.30 (3) the chemical composition of the medical cannabis distributed; and​
7323+225​Article 6 Sec. 16.​
7324+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 226.1 (4) the tracking number assigned to the medical cannabis distributed.​
7325+226.2Sec. 17. Minnesota Statutes 2022, section 152.29, is amended by adding a subdivision to​
7326+226.3read:​
7327+226.4 Subd. 5.Distribution to Tribal medical cannabis program patient.(a) A manufacturer​
7328+226.5may distribute medical cannabis in accordance with subdivisions 1 to 4 to a Tribal medical​
7329+226.6cannabis program patient.​
7330+226.7 (b) Prior to distribution, the Tribal medical cannabis program patient must provide to​
7331+226.8the manufacturer:​
7332+226.9 (1) a valid medical cannabis registration verification card or equivalent document issued​
7333+226.10by a Tribal medical cannabis program that indicates that the Tribal medical cannabis program​
7334+226.11patient is authorized to use medical cannabis on Indian lands over which the Tribe has​
7335+226.12jurisdiction; and​
7336+226.13 (2) a valid photographic identification card issued by the Tribal medical cannabis​
7337+226.14program, a valid driver's license, or a valid state identification card.​
7338+226.15 (c) A manufacturer shall distribute medical cannabis to a Tribal medical cannabis program​
7339+226.16patient only in a form allowed under section 152.22, subdivision 6.​
7340+226.17Sec. 18. [152.291] TRIBAL MEDICAL CANNABIS PROGRAM MANUFACTURER​
7341+226.18TRANSPORTATION.​
7342+226.19 (a) A Tribal medical cannabis program manufacturer may transport medical cannabis​
7343+226.20to testing laboratories in the state and to other Indian lands.​
7344+226.21 (b) A Tribal medical cannabis program manufacturer must staff a motor vehicle used to​
7345+226.22transport medical cannabis with at least two employees of the manufacturer. Each employee​
7346+226.23in the transport vehicle must carry identification specifying that the employee is an employee​
7347+226.24of the manufacturer, and one employee in the transport vehicle must carry a detailed​
7348+226.25transportation manifest that includes the place and time of departure, the address of the​
7349+226.26destination, and a description and count of the medical cannabis being transported.​
7350+226.27Sec. 19. Minnesota Statutes 2022, section 152.30, is amended to read:​
7351+226.28 152.30 PATIENT DUTIES.​
7352+226.29 (a) A patient shall apply to the commissioner for enrollment in the registry program by​
7353+226.30submitting an application as required in section 152.27 and an annual registration fee as​
7354+226.31determined under section 152.35.​
7355+226​Article 6 Sec. 19.​
7356+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 227.1 (b) As a condition of continued enrollment, patients shall agree to:​
7357+227.2 (1) continue to receive regularly scheduled treatment for their qualifying medical​
7358+227.3condition from their health care practitioner; and​
7359+227.4 (2) report changes in their qualifying medical condition to their health care practitioner.​
7360+227.5 (c) A patient shall only receive medical cannabis from a registered manufacturer or​
7361+227.6Tribal medical cannabis program but is not required to receive medical cannabis products​
7362+227.7from only a registered manufacturer or Tribal medical cannabis program.​
7363+227.8Sec. 20. Minnesota Statutes 2022, section 152.32, is amended to read:​
7364+227.9 152.32 PROTECTIONS FOR REGISTRY PROGRAM OR TRIBAL MEDICAL​
7365+227.10CANNABIS PROGRAM PARTICIPATION.​
7366+227.11 Subdivision 1.Presumption.(a) There is a presumption that a patient enrolled in the​
7367+227.12registry program under sections 152.22 to 152.37 or a Tribal medical cannabis program​
7368+227.13patient is engaged in the authorized use of medical cannabis.​
7369+227.14 (b) The presumption may be rebutted by evidence that:​
7370+227.15 (1) a patient's conduct related to use of medical cannabis was not for the purpose of​
7371+227.16treating or alleviating the patient's qualifying medical condition or symptoms associated​
7372+227.17with the patient's qualifying medical condition.; or​
7373+227.18 (2) a Tribal medical cannabis program patient's use of medical cannabis was not for a​
7374+227.19purpose authorized by the Tribal medical cannabis program.​
7375+227.20 Subd. 2.Criminal and civil protections.(a) Subject to section 152.23, the following​
7376+227.21are not violations under this chapter:​
7377+227.22 (1) use or possession of medical cannabis or medical cannabis products by a patient​
7378+227.23enrolled in the registry program, or; possession by a registered designated caregiver or the​
7379+227.24parent, legal guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed​
7380+227.25on the registry verification; or use or possession of medical cannabis or medical cannabis​
7381+227.26products by a Tribal medical cannabis program patient;​
7382+227.27 (2) possession, dosage determination, or sale of medical cannabis or medical cannabis​
7383+227.28products by a medical cannabis manufacturer, employees of a manufacturer, a Tribal medical​
7384+227.29cannabis program manufacturer, employees of a Tribal medical cannabis program​
7385+227.30manufacturer, a laboratory conducting testing on medical cannabis, or employees of the​
7386+227.31laboratory; and​
7387+227​Article 6 Sec. 20.​
7388+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 228.1 (3) possession of medical cannabis or medical cannabis products by any person while​
7389+228.2carrying out the duties required under sections 152.22 to 152.37.​
7390+228.3 (b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and​
7391+228.4associated property is not subject to forfeiture under sections 609.531 to 609.5316.​
7392+228.5 (c) The commissioner, members of a Tribal medical cannabis board, the commissioner's​
7393+228.6or Tribal medical cannabis board's staff, the commissioner's or Tribal medical cannabis​
7394+228.7board's agents or contractors, and any health care practitioner are not subject to any civil or​
7395+228.8disciplinary penalties by the Board of Medical Practice, the Board of Nursing, or by any​
7396+228.9business, occupational, or professional licensing board or entity, solely for the participation​
7397+228.10in the registry program under sections 152.22 to 152.37 or in a Tribal medical cannabis​
7398+228.11program. A pharmacist licensed under chapter 151 is not subject to any civil or disciplinary​
7399+228.12penalties by the Board of Pharmacy when acting in accordance with the provisions of​
7400+228.13sections 152.22 to 152.37. Nothing in this section affects a professional licensing board​
7401+228.14from taking action in response to violations of any other section of law.​
7402+228.15 (d) Notwithstanding any law to the contrary, the commissioner, the governor of​
7403+228.16Minnesota, or an employee of any state agency may not be held civilly or criminally liable​
7404+228.17for any injury, loss of property, personal injury, or death caused by any act or omission​
7405+228.18while acting within the scope of office or employment under sections 152.22 to 152.37.​
7406+228.19 (e) Federal, state, and local law enforcement authorities are prohibited from accessing​
7407+228.20the patient registry under sections 152.22 to 152.37 except when acting pursuant to a valid​
7408+228.21search warrant.​
7409+228.22 (f) Notwithstanding any law to the contrary, neither the commissioner nor a public​
7410+228.23employee may release data or information about an individual contained in any report,​
7411+228.24document, or registry created under sections 152.22 to 152.37 or any information obtained​
7412+228.25about a patient participating in the program, except as provided in sections 152.22 to 152.37.​
7413+228.26 (g) No information contained in a report, document, or registry or obtained from a patient​
7414+228.27under sections 152.22 to 152.37 or from a Tribal medical cannabis program patient may be​
7415+228.28admitted as evidence in a criminal proceeding unless independently obtained or in connection​
7416+228.29with a proceeding involving a violation of sections 152.22 to 152.37.​
7417+228.30 (h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty​
7418+228.31of a gross misdemeanor.​
7419+228.32 (i) An attorney may not be subject to disciplinary action by the Minnesota Supreme​
7420+228.33Court, a Tribal court, or the professional responsibility board for providing legal assistance​
7421+228​Article 6 Sec. 20.​
7422+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 229.1to prospective or registered manufacturers or others related to activity that is no longer​
7423+229.2subject to criminal penalties under state law pursuant to sections 152.22 to 152.37, or for​
7424+229.3providing legal assistance to a Tribal medical cannabis program or a Tribal medical cannabis​
7425+229.4program manufacturer.​
7426+229.5 (j) Possession of a registry verification or application for enrollment in the program by​
7427+229.6a person entitled to possess or apply for enrollment in the registry program does The​
7428+229.7following do not constitute probable cause or reasonable suspicion, nor and shall it not be​
7429+229.8used to support a search of the person or property of the person possessing or applying for​
7430+229.9the registry verification or equivalent, or otherwise subject the person or property of the​
7431+229.10person to inspection by any governmental agency.:​
7432+229.11 (1) possession of a registry verification or application for enrollment in the registry​
7433+229.12program by a person entitled to possess a registry verification or apply for enrollment in​
7434+229.13the registry program; or​
7435+229.14 (2) possession of a verification or equivalent issued by a Tribal medical cannabis program​
7436+229.15or application for enrollment in a Tribal medical cannabis program by a person entitled to​
7437+229.16possess such a verification or application.​
7438+229.17 Subd. 3.Discrimination prohibited.(a) No school or landlord may refuse to enroll or​
7439+229.18lease to and may not otherwise penalize a person solely for the person's status as a patient​
7440+229.19enrolled in the registry program under sections 152.22 to 152.37 or for the person's status​
7441+229.20as a Tribal medical cannabis program patient, unless failing to do so would violate federal​
7442+229.21law or regulations or cause the school or landlord to lose a monetary or licensing-related​
7443+229.22benefit under federal law or regulations.​
7444+229.23 (b) For the purposes of medical care, including organ transplants, a registry program​
7445+229.24enrollee's use of medical cannabis under sections 152.22 to 152.37, or a Tribal medical​
7446+229.25cannabis program patient's use of medical cannabis as authorized by the Tribal medical​
7447+229.26cannabis program, is considered the equivalent of the authorized use of any other medication​
7448+229.27used at the discretion of a physician, advanced practice registered nurse, or physician assistant​
7449+229.28and does not constitute the use of an illicit substance or otherwise disqualify a patient from​
7450+229.29needed medical care.​
7451+229.30 (c) Unless a failure to do so would violate federal law or regulations or cause an employer​
7452+229.31to lose a monetary or licensing-related benefit under federal law or regulations, an employer​
7453+229.32may not discriminate against a person in hiring, termination, or any term or condition of​
7454+229.33employment, or otherwise penalize a person, if the discrimination is based upon either any​
7455+229.34of the following:​
7456+229​Article 6 Sec. 20.​
7457+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 230.1 (1) the person's status as a patient enrolled in the registry program under sections 152.22​
7458+230.2to 152.37; or​
7459+230.3 (2) the person's status as a Tribal medical cannabis program patient; or​
7460+230.4 (2) (3) a patient's positive drug test for cannabis components or metabolites, unless the​
7461+230.5patient used, possessed, or was impaired by medical cannabis on the premises of the place​
7462+230.6of employment or during the hours of employment.​
7463+230.7 (d) An employee who is required to undergo employer drug testing pursuant to section​
7464+230.8181.953 may present verification of enrollment in the patient registry or of enrollment in a​
7465+230.9Tribal medical cannabis program as part of the employee's explanation under section 181.953,​
7466+230.10subdivision 6.​
7467+230.11 (e) A person shall not be denied custody of a minor child or visitation rights or parenting​
7468+230.12time with a minor child solely based on the person's status as a patient enrolled in the registry​
7469+230.13program under sections 152.22 to 152.37, or on the person's status as a Tribal medical​
7470+230.14cannabis program patient. There shall be no presumption of neglect or child endangerment​
7471+230.15for conduct allowed under sections 152.22 to 152.37 or under a Tribal medical cannabis​
7472+230.16program, unless the person's behavior is such that it creates an unreasonable danger to the​
7473+230.17safety of the minor as established by clear and convincing evidence.​
7474+230.18Sec. 21. Minnesota Statutes 2022, section 152.33, subdivision 1, is amended to read:​
7475+230.19 Subdivision 1.Intentional diversion; criminal penalty.In addition to any other​
7476+230.20applicable penalty in law, a manufacturer or an agent of a manufacturer who intentionally​
7477+230.21transfers medical cannabis to a person other than another registered manufacturer, a patient,​
7478+230.22a Tribal medical cannabis program patient, a registered designated caregiver or, if listed on​
7479+230.23the registry verification, a parent, legal guardian, or spouse of a patient is guilty of a felony​
7480+230.24punishable by imprisonment for not more than two years or by payment of a fine of not​
7481+230.25more than $3,000, or both. A person convicted under this subdivision may not continue to​
7482+230.26be affiliated with the manufacturer and is disqualified from further participation under​
7483+230.27sections 152.22 to 152.37.​
7484+230.28Sec. 22. Minnesota Statutes 2022, section 175.45, subdivision 1, is amended to read:​
7485+230.29 Subdivision 1.Duties; goal.The commissioner of labor and industry shall convene​
7486+230.30industry representatives, identify occupational competency standards, and provide technical​
7487+230.31assistance to develop dual-training programs. The competency standards shall be identified​
7488+230.32for employment in occupations in advanced manufacturing, health care services, information​
7489+230​Article 6 Sec. 22.​
7490+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 231.1technology, and agriculture, and the legal cannabis industry. Competency standards are not​
7491+231.2rules and are exempt from the rulemaking provisions of chapter 14, and the provisions in​
7492+231.3section 14.386 concerning exempt rules do not apply.​
7493+231.4Sec. 23. Minnesota Statutes 2022, section 181.938, subdivision 2, is amended to read:​
7494+231.5 Subd. 2.Prohibited practice.(a) An employer may not refuse to hire a job applicant​
7495+231.6or discipline or discharge an employee because the applicant or employee engages in or has​
7496+231.7engaged in the use or enjoyment of lawful consumable products, if the use or enjoyment​
7497+231.8takes place off the premises of the employer during nonworking hours. For purposes of this​
7498+231.9section, "lawful consumable products" means products whose use or enjoyment is lawful​
7499+231.10and which are consumed during use or enjoyment, and includes food, alcoholic or​
7500+231.11nonalcoholic beverages, and tobacco, cannabis flower, as defined in section 342.01,​
7501+231.12subdivision 15, cannabis products, as defined in section 342.01, subdivision 19,​
7502+231.13lower-potency hemp edibles as defined in section 342.01, subdivision 48, and hemp-derived​
7503+231.14consumer products as defined in section 342.01, subdivision 35.​
7504+231.15 (b) Cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived​
7505+231.16consumer products are lawful consumable products for the purpose of Minnesota law,​
7506+231.17regardless of whether federal or other state law considers cannabis use, possession,​
7507+231.18impairment, sale, or transfer to be unlawful. Nothing in this section shall be construed to​
7508+231.19limit an employer's ability to discipline or discharge an employee for cannabis flower,​
7509+231.20cannabis product, lower-potency hemp edible, or hemp-derived consumer product use,​
7510+231.21possession, impairment, sale, or transfer during working hours, on work premises, or while​
7511+231.22operating an employer's vehicle, machinery, or equipment, or if a failure to do so would​
7512+231.23violate federal or state law or regulations or cause an employer to lose a monetary or​
7513+231.24licensing-related benefit under federal law or regulations.​
7514+231.25Sec. 24. Minnesota Statutes 2022, section 181.950, subdivision 2, is amended to read:​
7515+231.26 Subd. 2.Confirmatory test; confirmatory retest."Confirmatory test" and "confirmatory​
7516+231.27retest" mean a drug or alcohol test or cannabis test that uses a method of analysis allowed​
7517+231.28under one of the programs listed in section 181.953, subdivision 1.​
7518+231.29Sec. 25. Minnesota Statutes 2022, section 181.950, subdivision 4, is amended to read:​
7519+231.30 Subd. 4.Drug."Drug" means a controlled substance as defined in section 152.01,​
7520+231.31subdivision 4, but does not include marijuana, tetrahydrocannabinols, cannabis flower as​
7521+231.32defined in section 342.01, subdivision 15, cannabis products as defined in section 342.01,​
7522+231​Article 6 Sec. 25.​
7523+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 232.1subdivision 19, lower-potency hemp edibles as defined in section 342.01, subdivision 48,​
7524+232.2and hemp-derived consumer products as defined in section 342.01, subdivision 35.​
7525+232.3Sec. 26. Minnesota Statutes 2022, section 181.950, subdivision 5, is amended to read:​
7526+232.4 Subd. 5.Drug and alcohol testing."Drug and alcohol testing," "drug or alcohol testing,"​
7527+232.5and "drug or alcohol test" mean analysis of a body component sample according to the​
7528+232.6standards established under one of the programs listed in section 181.953, subdivision 1,​
7529+232.7for the purpose of measuring the presence or absence of drugs, alcohol, or their metabolites​
7530+232.8in the sample tested. "Drug and alcohol testing," "drug or alcohol testing," and "drug or​
7531+232.9alcohol test" do not include cannabis or cannabis testing, unless stated otherwise.​
7532+232.10Sec. 27. Minnesota Statutes 2022, section 181.950, is amended by adding a subdivision​
7533+232.11to read:​
7534+232.12 Subd. 5a.Cannabis testing."Cannabis testing" means the analysis of a body component​
7535+232.13sample according to the standards established under one of the programs listed in section​
7536+232.14181.953, subdivision 1, for the purpose of measuring the presence or absence of cannabis​
7537+232.15flower, as defined in section 342.01, subdivision 15, cannabis products, as defined in section​
7538+232.16342.01, subdivision 19, lower-potency hemp edibles as defined in section 342.01, subdivision​
7539+232.1748, hemp-derived consumer products as defined in section 342.01, subdivision 35, or cannabis​
7540+232.18metabolites in the sample tested. The definitions in this section apply to cannabis testing​
7541+232.19unless stated otherwise.​
7542+232.20Sec. 28. Minnesota Statutes 2022, section 181.950, subdivision 8, is amended to read:​
7543+232.21 Subd. 8.Initial screening test."Initial screening test" means a drug or alcohol test or​
7544+232.22cannabis test which uses a method of analysis under one of the programs listed in section​
7545+232.23181.953, subdivision 1.​
7546+232.24Sec. 29. Minnesota Statutes 2022, section 181.950, subdivision 13, is amended to read:​
7547+232.25 Subd. 13.Safety-sensitive position."Safety-sensitive position" means a job, including​
7548+232.26any supervisory or management position, in which an impairment caused by drug or, alcohol,​
7549+232.27or cannabis usage would threaten the health or safety of any person.​
7550+232.28Sec. 30. Minnesota Statutes 2022, section 181.951, subdivision 4, is amended to read:​
7551+232.29 Subd. 4.Random testing.An employer may request or require employees to undergo​
7552+232.30cannabis testing or drug and alcohol testing on a random selection basis only if (1) they are​
7553+232​Article 6 Sec. 30.​
7554+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 233.1employed in safety-sensitive positions, or (2) they are employed as professional athletes if​
7555+233.2the professional athlete is subject to a collective bargaining agreement permitting random​
7556+233.3testing but only to the extent consistent with the collective bargaining agreement.​
7557+233.4Sec. 31. Minnesota Statutes 2022, section 181.951, subdivision 5, is amended to read:​
7558+233.5 Subd. 5.Reasonable suspicion testing.An employer may request or require an employee​
7559+233.6to undergo cannabis testing and drug and alcohol testing if the employer has a reasonable​
7560+233.7suspicion that the employee:​
7561+233.8 (1) is under the influence of drugs or alcohol;​
7562+233.9 (2) has violated the employer's written work rules prohibiting the use, possession, sale,​
7563+233.10or transfer of drugs or alcohol, cannabis flower, cannabis products, lower-potency hemp​
7564+233.11edibles, or hemp-derived consumer products while the employee is working or while the​
7565+233.12employee is on the employer's premises or operating the employer's vehicle, machinery, or​
7566+233.13equipment, provided the work rules are in writing and contained in the employer's written​
7567+233.14cannabis testing or drug and alcohol testing policy;​
7568+233.15 (3) has sustained a personal injury, as that term is defined in section 176.011, subdivision​
7569+233.1616, or has caused another employee to sustain a personal injury; or​
7570+233.17 (4) has caused a work-related accident or was operating or helping to operate machinery,​
7571+233.18equipment, or vehicles involved in a work-related accident.​
7572+233.19Sec. 32. Minnesota Statutes 2022, section 181.951, subdivision 6, is amended to read:​
7573+233.20 Subd. 6.Treatment program testing.An employer may request or require an employee​
7574+233.21to undergo cannabis testing and drug and alcohol testing if the employee has been referred​
7575+233.22by the employer for substance use disorder treatment or evaluation or is participating in a​
7576+233.23substance use disorder treatment program under an employee benefit plan, in which case​
7577+233.24the employee may be requested or required to undergo cannabis testing and drug or alcohol​
7578+233.25testing without prior notice during the evaluation or treatment period and for a period of up​
7579+233.26to two years following completion of any prescribed substance use disorder treatment​
7580+233.27program.​
7581+233.28Sec. 33. Minnesota Statutes 2022, section 181.951, is amended by adding a subdivision​
7582+233.29to read:​
7583+233.30 Subd. 8.Limitations on cannabis testing.(a) An employer must not request or require​
7584+233.31a job applicant to undergo cannabis testing solely for the purpose of determining the presence​
7585+233​Article 6 Sec. 33.​
7586+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 234.1or absence of cannabis as a condition of employment unless otherwise required by state or​
7587+234.2federal law.​
7588+234.3 (b) Unless otherwise required by state or federal law, an employer must not refuse to​
7589+234.4hire a job applicant solely because the job applicant submits to a cannabis test or a drug and​
7590+234.5alcohol test authorized by this section and the results of the test indicate the presence of​
7591+234.6cannabis.​
7592+234.7 (c) An employer must not request or require an employee or job applicant to undergo​
7593+234.8cannabis testing on an arbitrary or capricious basis.​
7594+234.9 (d) Cannabis testing authorized under paragraph (d) must comply with the safeguards​
7595+234.10for testing employees provided in sections 181.953 and 181.954.​
7596+234.11Sec. 34. Minnesota Statutes 2022, section 181.951, is amended by adding a subdivision​
7597+234.12to read:​
7598+234.13 Subd. 9.Cannabis testing exceptions.For the following positions, cannabis and its​
7599+234.14metabolites are considered a drug and subject to the drug and alcohol testing provisions in​
7600+234.15sections 181.950 to 181.957:​
7601+234.16 (1) a safety-sensitive position, as defined in section 181.950, subdivision 13;​
7602+234.17 (2) a peace officer position, as defined in section 626.84, subdivision 1;​
7603+234.18 (3) a firefighter position, as defined in section 299N.01, subdivision 3;​
7604+234.19 (4) a position requiring face-to-face care, training, education, supervision, counseling,​
7605+234.20consultation, or medical assistance to:​
7606+234.21 (i) children;​
7607+234.22 (ii) vulnerable adults, as defined in section 626.5572, subdivision 21; or​
7608+234.23 (iii) patients who receive health care services from a provider for the treatment,​
7609+234.24examination, or emergency care of a medical, psychiatric, or mental condition;​
7610+234.25 (5) a position requiring a commercial driver's license or requiring an employee to operate​
7611+234.26a motor vehicle for which state or federal law requires drug or alcohol testing of a job​
7612+234.27applicant or an employee;​
7613+234.28 (6) a position of employment funded by a federal grant; or​
7614+234.29 (7) any other position for which state or federal law requires testing of a job applicant​
7615+234.30or an employee for cannabis.​
7616+234​Article 6 Sec. 34.​
7617+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 235.1Sec. 35. Minnesota Statutes 2022, section 181.952, is amended by adding a subdivision​
7618+235.2to read:​
7619+235.3 Subd. 3.Cannabis policy.(a) Unless otherwise provided by state or federal law, an​
7620+235.4employer is not required to permit or accommodate cannabis flower, cannabis product,​
7621+235.5lower-potency hemp edible, or hemp-derived consumer product use, possession, impairment,​
7622+235.6sale, or transfer while an employee is working or while an employee is on the employer's​
7623+235.7premises or operating the employer's vehicle, machinery, or equipment.​
7624+235.8 (b) An employer may enact and enforce written work rules prohibiting cannabis flower,​
7625+235.9cannabis product, lower-potency hemp edible, and hemp-derived consumer product use,​
7626+235.10possession, impairment, sale, or transfer while an employee, is working or while an employee​
7627+235.11is on the employer's premises or operating the employer's vehicle, machinery, or equipment​
7628+235.12in a written policy that contains the minimum information required by this section.​
7629+235.13Sec. 36. Minnesota Statutes 2022, section 181.953, is amended to read:​
7630+235.14 181.953 RELIABILITY AND FAIRNESS SAFEGUARDS.​
7631+235.15 Subdivision 1.Use of licensed, accredited, or certified laboratory required.(a) An​
7632+235.16employer who requests or requires an employee or job applicant to undergo drug or alcohol​
7633+235.17testing or cannabis testing shall use the services of a testing laboratory that meets one of​
7634+235.18the following criteria for drug testing:​
7635+235.19 (1) is certified by the National Institute on Drug Abuse as meeting the mandatory​
7636+235.20guidelines published at 53 Federal Register 11970 to 11989, April 11, 1988;​
7637+235.21 (2) is accredited by the College of American Pathologists, 325 Waukegan Road,​
7638+235.22Northfield, Illinois, 60093-2750, under the forensic urine drug testing laboratory program;​
7639+235.23or​
7640+235.24 (3) is licensed to test for drugs by the state of New York, Department of Health, under​
7641+235.25Public Health Law, article 5, title V, and rules adopted under that law.​
7642+235.26 (b) For alcohol testing, the laboratory must either be:​
7643+235.27 (1) licensed to test for drugs and alcohol by the state of New York, Department of Health,​
7644+235.28under Public Health Law, article 5, title V, and the rules adopted under that law; or​
7645+235.29 (2) accredited by the College of American Pathologists, 325 Waukegan Road, Northfield,​
7646+235.30Illinois, 60093-2750, in the laboratory accreditation program.​
7647+235.31 Subd. 3.Laboratory testing, reporting, and sample retention requirements.A testing​
7648+235.32laboratory that is not certified by the National Institute on Drug Abuse according to​
7649+235​Article 6 Sec. 36.​
7650+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 236.1subdivision 1 shall follow the chain-of-custody procedures prescribed for employers in​
7651+236.2subdivision 5. A testing laboratory shall conduct a confirmatory test on all samples that​
7652+236.3produced a positive test result on an initial screening test. A laboratory shall disclose to the​
7653+236.4employer a written test result report for each sample tested within three working days after​
7654+236.5a negative test result on an initial screening test or, when the initial screening test produced​
7655+236.6a positive test result, within three working days after a confirmatory test. A test report must​
7656+236.7indicate the drugs, alcohol, or drug or alcohol metabolites, or cannabis or cannabis​
7657+236.8metabolites tested for and whether the test produced negative or positive test results. A​
7658+236.9laboratory shall retain and properly store for at least six months all samples that produced​
7659+236.10a positive test result.​
7660+236.11 Subd. 4.Prohibitions on employers.An employer may not conduct drug or alcohol​
7661+236.12testing or cannabis testing of its own employees and job applicants using a testing laboratory​
7662+236.13owned and operated by the employer; except that, one agency of the state may test the​
7663+236.14employees of another agency of the state. Except as provided in subdivision 9, an employer​
7664+236.15may not request or require an employee or job applicant to contribute to, or pay the cost of,​
7665+236.16drug or alcohol testing or cannabis testing under sections 181.950 to 181.954.​
7666+236.17 Subd. 5.Employer chain-of-custody procedures.An employer shall establish its own​
7667+236.18reliable chain-of-custody procedures to ensure proper record keeping, handling, labeling,​
7668+236.19and identification of the samples to be tested. The procedures must require the following:​
7669+236.20 (1) possession of a sample must be traceable to the employee from whom the sample is​
7670+236.21collected, from the time the sample is collected through the time the sample is delivered to​
7671+236.22the laboratory;​
7672+236.23 (2) the sample must always be in the possession of, must always be in view of, or must​
7673+236.24be placed in a secured area by a person authorized to handle the sample;​
7674+236.25 (3) a sample must be accompanied by a written chain-of-custody record; and​
7675+236.26 (4) individuals relinquishing or accepting possession of the sample must record the time​
7676+236.27the possession of the sample was transferred and must sign and date the chain-of-custody​
7677+236.28record at the time of transfer.​
7678+236.29 Subd. 6.Rights of employees and job applicants.(a) Before requesting an employee​
7679+236.30or job applicant to undergo drug or alcohol testing or requesting cannabis testing, an employer​
7680+236.31shall provide the employee or job applicant with a form, developed by the employer, on​
7681+236.32which to acknowledge that the employee or job applicant has seen the employer's drug and​
7682+236.33alcohol testing or cannabis testing policy.​
7683+236​Article 6 Sec. 36.​
7684+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 237.1 (b) If an employee or job applicant tests positive for drug use, the employee must be​
7685+237.2given written notice of the right to explain the positive test and the employer may request​
7686+237.3that the employee or job applicant indicate any over-the-counter or prescription medication​
7687+237.4that the individual is currently taking or has recently taken and any other information relevant​
7688+237.5to the reliability of, or explanation for, a positive test result.​
7689+237.6 (c) Within three working days after notice of a positive test result on a confirmatory test,​
7690+237.7the employee or job applicant may submit information to the employer, in addition to any​
7691+237.8information already submitted under paragraph (b), to explain that result, or may request a​
7692+237.9confirmatory retest of the original sample at the employee's or job applicant's own expense​
7693+237.10as provided under subdivision 9.​
7694+237.11 Subd. 7.Notice of test results.Within three working days after receipt of a test result​
7695+237.12report from the testing laboratory, an employer shall inform in writing an employee or job​
7696+237.13applicant who has undergone drug or alcohol testing or cannabis testing of (1) a negative​
7697+237.14test result on an initial screening test or of a negative or positive test result on a confirmatory​
7698+237.15test and (2) the right provided in subdivision 8. In the case of a positive test result on a​
7699+237.16confirmatory test, the employer shall also, at the time of this notice, inform the employee​
7700+237.17or job applicant in writing of the rights provided in subdivisions 6, paragraph (b), 9, and​
7701+237.18either subdivision 10 or 11, whichever applies.​
7702+237.19 Subd. 8.Right to test result report.An employee or job applicant has the right to​
7703+237.20request and receive from the employer a copy of the test result report on any drug or alcohol​
7704+237.21test or cannabis test.​
7705+237.22 Subd. 9.Confirmatory retests.An employee or job applicant may request a confirmatory​
7706+237.23retest of the original sample at the employee's or job applicant's own expense after notice​
7707+237.24of a positive test result on a confirmatory test. Within five working days after notice of the​
7708+237.25confirmatory test result, the employee or job applicant shall notify the employer in writing​
7709+237.26of the employee's or job applicant's intention to obtain a confirmatory retest. Within three​
7710+237.27working days after receipt of the notice, the employer shall notify the original testing​
7711+237.28laboratory that the employee or job applicant has requested the laboratory to conduct the​
7712+237.29confirmatory retest or transfer the sample to another laboratory licensed under subdivision​
7713+237.301 to conduct the confirmatory retest. The original testing laboratory shall ensure that the​
7714+237.31chain-of-custody procedures in subdivision 3 are followed during transfer of the sample to​
7715+237.32the other laboratory. The confirmatory retest must use the same drug or, alcohol, or cannabis​
7716+237.33threshold detection levels as used in the original confirmatory test. If the confirmatory retest​
7717+237.34does not confirm the original positive test result, no adverse personnel action based on the​
7718+237.35original confirmatory test may be taken against the employee or job applicant.​
7719+237​Article 6 Sec. 36.​
7720+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 238.1 Subd. 10.Limitations on employee discharge, discipline, or discrimination.(a) An​
7721+238.2employer may not discharge, discipline, discriminate against, or request or require​
7722+238.3rehabilitation of an employee on the basis of a positive test result from an initial screening​
7723+238.4test that has not been verified by a confirmatory test.​
7724+238.5 (b) In addition to the limitation under paragraph (a), an employer may not discharge an​
7725+238.6employee for whom a positive test result on a confirmatory test was the first such result for​
7726+238.7the employee on a drug or alcohol test or cannabis test requested by the employer unless​
7727+238.8the following conditions have been met:​
7728+238.9 (1) the employer has first given the employee an opportunity to participate in, at the​
7729+238.10employee's own expense or pursuant to coverage under an employee benefit plan, either a​
7730+238.11drug or, alcohol, or cannabis counseling or rehabilitation program, whichever is more​
7731+238.12appropriate, as determined by the employer after consultation with a certified chemical use​
7732+238.13counselor or a physician trained in the diagnosis and treatment of substance use disorder;​
7733+238.14and​
7734+238.15 (2) the employee has either refused to participate in the counseling or rehabilitation​
7735+238.16program or has failed to successfully complete the program, as evidenced by withdrawal​
7736+238.17from the program before its completion or by a positive test result on a confirmatory test​
7737+238.18after completion of the program.​
7738+238.19 (c) Notwithstanding paragraph (a), an employer may temporarily suspend the tested​
7739+238.20employee or transfer that employee to another position at the same rate of pay pending the​
7740+238.21outcome of the confirmatory test and, if requested, the confirmatory retest, provided the​
7741+238.22employer believes that it is reasonably necessary to protect the health or safety of the​
7742+238.23employee, coemployees, or the public. An employee who has been suspended without pay​
7743+238.24must be reinstated with back pay if the outcome of the confirmatory test or requested​
7744+238.25confirmatory retest is negative.​
7745+238.26 (d) An employer may not discharge, discipline, discriminate against, or request or require​
7746+238.27rehabilitation of an employee on the basis of medical history information revealed to the​
7747+238.28employer pursuant to subdivision 6 unless the employee was under an affirmative duty to​
7748+238.29provide the information before, upon, or after hire.​
7749+238.30 (e) An employee must be given access to information in the employee's personnel file​
7750+238.31relating to positive test result reports and other information acquired in the drug and alcohol​
7751+238.32testing process or cannabis testing process and conclusions drawn from and actions taken​
7752+238.33based on the reports or other acquired information.​
7753+238​Article 6 Sec. 36.​
7754+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 239.1 Subd. 10a.Additional limitations for cannabis.An employer may discipline, discharge,​
7755+239.2or take other adverse personnel action against an employee for cannabis flower, cannabis​
7756+239.3product, lower-potency hemp edible, or hemp-derived consumer product use, possession,​
7757+239.4impairment, sale, or transfer while an employee is working, on the employer's premises, or​
7758+239.5operating the employer's vehicle, machinery, or equipment as follows:​
7759+239.6 (1) if the employee is under the influence of cannabis flower, a cannabis product, a​
7760+239.7lower-potency hemp edible, or a hemp-derived consumer product;​
7761+239.8 (2) if cannabis testing verifies the presence of cannabis flower, a cannabis product, a​
7762+239.9lower-potency hemp edible, or a hemp-derived consumer product following a confirmatory​
7763+239.10test;​
7764+239.11 (3) as provided in the employer's written work rules for cannabis flower, cannabis​
7765+239.12products, lower-potency hemp edibles, or hemp-derived consumer products and cannabis​
7766+239.13testing, provided that the rules are in writing and in a written policy that contains the​
7767+239.14minimum information required by section 181.952; or​
7768+239.15 (4) as otherwise authorized or required under state or federal law or regulations, or if a​
7769+239.16failure to do so would cause an employer to lose a monetary or licensing-related benefit​
7770+239.17under federal law or regulations.​
7771+239.18 Subd. 11.Limitation on withdrawal of job offer.If a job applicant has received a job​
7772+239.19offer made contingent on the applicant passing drug and alcohol testing, the employer may​
7773+239.20not withdraw the offer based on a positive test result from an initial screening test that has​
7774+239.21not been verified by a confirmatory test.​
7775+239.22Sec. 37. Minnesota Statutes 2022, section 181.954, is amended to read:​
7776+239.23 181.954 PRIVACY, CONFIDENTIALITY, AND PRIVILEGE SAFEGUARDS.​
7777+239.24 Subdivision 1.Privacy limitations.A laboratory may only disclose to the employer test​
7778+239.25result data regarding the presence or absence of drugs, alcohol, or their metabolites in a​
7779+239.26sample tested.​
7780+239.27 Subd. 2.Confidentiality limitations.Test result reports and other information acquired​
7781+239.28in the drug or alcohol testing or cannabis testing process are, with respect to private sector​
7782+239.29employees and job applicants, private and confidential information, and, with respect to​
7783+239.30public sector employees and job applicants, private data on individuals as that phrase is​
7784+239.31defined in chapter 13, and may not be disclosed by an employer or laboratory to another​
7785+239.32employer or to a third-party individual, governmental agency, or private organization without​
7786+239.33the written consent of the employee or job applicant tested.​
7787+239​Article 6 Sec. 37.​
7788+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 240.1 Subd. 3.Exceptions to privacy and confidentiality disclosure​
7789+240.2limitations.Notwithstanding subdivisions 1 and 2, evidence of a positive test result on a​
7790+240.3confirmatory test may be: (1) used in an arbitration proceeding pursuant to a collective​
7791+240.4bargaining agreement, an administrative hearing under chapter 43A or other applicable state​
7792+240.5or local law, or a judicial proceeding, provided that information is relevant to the hearing​
7793+240.6or proceeding; (2) disclosed to any federal agency or other unit of the United States​
7794+240.7government as required under federal law, regulation, or order, or in accordance with​
7795+240.8compliance requirements of a federal government contract; and (3) disclosed to a substance​
7796+240.9abuse treatment facility for the purpose of evaluation or treatment of the employee.​
7797+240.10 Subd. 4.Privilege.Positive test results from an employer drug or alcohol testing or​
7798+240.11cannabis testing program may not be used as evidence in a criminal action against the​
7799+240.12employee or job applicant tested.​
7800+240.13Sec. 38. Minnesota Statutes 2022, section 181.955, is amended to read:​
7801+240.14 181.955 CONSTRUCTION.​
7802+240.15 Subdivision 1.Freedom to collectively bargain.Sections 181.950 to 181.954 shall not​
7803+240.16be construed to limit the parties to a collective bargaining agreement from bargaining and​
7804+240.17agreeing with respect to a drug and alcohol testing or a cannabis testing policy that meets​
7805+240.18or exceeds, and does not otherwise conflict with, the minimum standards and requirements​
7806+240.19for employee protection provided in those sections.​
7807+240.20 Subd. 2.Employee protections under existing collective bargaining​
7808+240.21agreements.Sections 181.950 to 181.954 shall not be construed to interfere with or diminish​
7809+240.22any employee protections relating to drug and alcohol testing or cannabis testing already​
7810+240.23provided under collective bargaining agreements in effect on the effective date of those​
7811+240.24sections that exceed the minimum standards and requirements for employee protection​
7812+240.25provided in those sections.​
7813+240.26 Subd. 3.Professional athletes.Sections 181.950 to 181.954 shall not be construed to​
7814+240.27interfere with the operation of a drug and alcohol testing or cannabis testing program if:​
7815+240.28 (1) the drug and alcohol testing program is permitted under a contract between the​
7816+240.29employer and employees; and​
7817+240.30 (2) the covered employees are employed as professional athletes.​
7818+240.31 Upon request of the commissioner of labor and industry, the exclusive representative​
7819+240.32of the employees and the employer shall certify to the commissioner of labor and industry​
7820+240.33that the drug and alcohol testing or cannabis testing program permitted under the contract​
7821+240​Article 6 Sec. 38.​
7822+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 241.1should operate without interference from the sections specified in this subdivision. This​
7823+241.2subdivision must not be construed to create an exemption from controlled substance crimes​
7824+241.3in chapter 152.​
7825+241.4Sec. 39. Minnesota Statutes 2022, section 181.957, subdivision 1, is amended to read:​
7826+241.5 Subdivision 1.Excluded employees and job applicants.Except as provided under​
7827+241.6subdivision 2, the employee and job applicant protections provided under sections 181.950​
7828+241.7to 181.956 do not apply to employees and job applicants where the specific work performed​
7829+241.8requires those employees and job applicants to be subject to drug and alcohol testing or​
7830+241.9cannabis testing pursuant to:​
7831+241.10 (1) federal regulations that specifically preempt state regulation of drug and alcohol​
7832+241.11testing or cannabis testing with respect to those employees and job applicants;​
7833+241.12 (2) federal regulations or requirements necessary to operate federally regulated facilities;​
7834+241.13 (3) federal contracts where the drug and alcohol testing or cannabis testing is conducted​
7835+241.14for security, safety, or protection of sensitive or proprietary data; or​
7836+241.15 (4) state agency rules that adopt federal regulations applicable to the interstate component​
7837+241.16of a federally regulated industry, and the adoption of those rules is for the purpose of​
7838+241.17conforming the nonfederally regulated intrastate component of the industry to identical​
7839+241.18regulation.​
7840+241.19Sec. 40. Minnesota Statutes 2022, section 245C.08, subdivision 1, is amended to read:​
7841+241.20 Subdivision 1.Background studies conducted by Department of Human Services.(a)​
7842+241.21For a background study conducted by the Department of Human Services, the commissioner​
7843+241.22shall review:​
7844+241.23 (1) information related to names of substantiated perpetrators of maltreatment of​
7845+241.24vulnerable adults that has been received by the commissioner as required under section​
7846+241.25626.557, subdivision 9c, paragraph (j);​
7847+241.26 (2) the commissioner's records relating to the maltreatment of minors in licensed​
7848+241.27programs, and from findings of maltreatment of minors as indicated through the social​
7849+241.28service information system;​
7850+241.29 (3) information from juvenile courts as required in subdivision 4 for individuals listed​
7851+241.30in section 245C.03, subdivision 1, paragraph (a), when there is reasonable cause;​
7852+241​Article 6 Sec. 40.​
7853+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 242.1 (4) information from the Bureau of Criminal Apprehension, including information​
7854+242.2regarding a background study subject's registration in Minnesota as a predatory offender​
7855+242.3under section 243.166;​
7856+242.4 (5) except as provided in clause (6), information received as a result of submission of​
7857+242.5fingerprints for a national criminal history record check, as defined in section 245C.02,​
7858+242.6subdivision 13c, when the commissioner has reasonable cause for a national criminal history​
7859+242.7record check as defined under section 245C.02, subdivision 15a, or as required under section​
7860+242.8144.057, subdivision 1, clause (2);​
7861+242.9 (6) for a background study related to a child foster family setting application for licensure,​
7862+242.10foster residence settings, children's residential facilities, a transfer of permanent legal and​
7863+242.11physical custody of a child under sections 260C.503 to 260C.515, or adoptions, and for a​
7864+242.12background study required for family child care, certified license-exempt child care, child​
7865+242.13care centers, and legal nonlicensed child care authorized under chapter 119B, the​
7866+242.14commissioner shall also review:​
7867+242.15 (i) information from the child abuse and neglect registry for any state in which the​
7868+242.16background study subject has resided for the past five years;​
7869+242.17 (ii) when the background study subject is 18 years of age or older, or a minor under​
7870+242.18section 245C.05, subdivision 5a, paragraph (c), information received following submission​
7871+242.19of fingerprints for a national criminal history record check; and​
7872+242.20 (iii) when the background study subject is 18 years of age or older or a minor under​
7873+242.21section 245C.05, subdivision 5a, paragraph (d), for licensed family child care, certified​
7874+242.22license-exempt child care, licensed child care centers, and legal nonlicensed child care​
7875+242.23authorized under chapter 119B, information obtained using non-fingerprint-based data​
7876+242.24including information from the criminal and sex offender registries for any state in which​
7877+242.25the background study subject resided for the past five years and information from the national​
7878+242.26crime information database and the national sex offender registry; and​
7879+242.27 (7) for a background study required for family child care, certified license-exempt child​
7880+242.28care centers, licensed child care centers, and legal nonlicensed child care authorized under​
7881+242.29chapter 119B, the background study shall also include, to the extent practicable, a name​
7882+242.30and date-of-birth search of the National Sex Offender Public website.​
7883+242.31 (b) Except as otherwise provided in this paragraph, notwithstanding expungement by a​
7884+242.32court, the commissioner may consider information obtained under paragraph (a), clauses​
7885+242.33(3) and (4), unless the commissioner received notice of the petition for expungement and​
7886+242.34the court order for expungement is directed specifically to the commissioner. The​
7887+242​Article 6 Sec. 40.​
7888+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 243.1commissioner may not consider information obtained under paragraph (a), clauses (3) and​
7889+243.2(4), or from any other source that identifies a violation of chapter 152 without determining​
7890+243.3if the offense involved the possession of marijuana or tetrahydrocannabinol and, if so,​
7891+243.4whether the person received a grant of expungement or order of expungement, or the person​
7892+243.5was resentenced to a lesser offense. If the person received a grant of expungement or order​
7893+243.6of expungement, the commissioner may not consider information related to that violation​
7894+243.7but may consider any other relevant information arising out of the same incident.​
7895+243.8 (c) The commissioner shall also review criminal case information received according​
7896+243.9to section 245C.04, subdivision 4a, from the Minnesota court information system that relates​
7897+243.10to individuals who have already been studied under this chapter and who remain affiliated​
7898+243.11with the agency that initiated the background study.​
7899+243.12 (d) When the commissioner has reasonable cause to believe that the identity of a​
7900+243.13background study subject is uncertain, the commissioner may require the subject to provide​
7901+243.14a set of classifiable fingerprints for purposes of completing a fingerprint-based record check​
7902+243.15with the Bureau of Criminal Apprehension. Fingerprints collected under this paragraph​
7903+243.16shall not be saved by the commissioner after they have been used to verify the identity of​
7904+243.17the background study subject against the particular criminal record in question.​
7905+243.18 (e) The commissioner may inform the entity that initiated a background study under​
7906+243.19NETStudy 2.0 of the status of processing of the subject's fingerprints.​
7907+243.20Sec. 41. Minnesota Statutes 2022, section 256.01, subdivision 18c, is amended to read:​
7908+243.21 Subd. 18c.Drug convictions.(a) The state court administrator shall provide a report​
7909+243.22every six months by electronic means to the commissioner of human services, including​
7910+243.23the name, address, date of birth, and, if available, driver's license or state identification card​
7911+243.24number, date of the sentence, effective date of the sentence, and county in which the​
7912+243.25conviction occurred, of each person convicted of a felony under chapter 152, except for​
7913+243.26convictions under section 152.0263 or 152.0264, during the previous six months.​
7914+243.27 (b) The commissioner shall determine whether the individuals who are the subject of​
7915+243.28the data reported under paragraph (a) are receiving public assistance under chapter 256D​
7916+243.29or 256J, and if the an individual is receiving assistance under chapter 256D or 256J, the​
7917+243.30commissioner shall instruct the county to proceed under section 256D.024 or 256J.26,​
7918+243.31whichever is applicable, for this individual.​
7919+243​Article 6 Sec. 41.​
7920+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 244.1 (c) The commissioner shall not retain any data received under paragraph (a) or (d) that​
7921+244.2does not relate to an individual receiving publicly funded assistance under chapter 256D or​
7922+244.3256J.​
7923+244.4 (d) In addition to the routine data transfer under paragraph (a), the state court​
7924+244.5administrator shall provide a onetime report of the data fields under paragraph (a) for​
7925+244.6individuals with a felony drug conviction under chapter 152 dated from July 1, 1997, until​
7926+244.7the date of the data transfer. The commissioner shall perform the tasks identified under​
7927+244.8paragraph (b) related to this data and shall retain the data according to paragraph (c).​
7928+244.9Sec. 42. Minnesota Statutes 2022, section 256B.0625, subdivision 13d, is amended to​
7929+244.10read:​
7930+244.11 Subd. 13d.Drug formulary.(a) The commissioner shall establish a drug formulary. Its​
7931+244.12establishment and publication shall not be subject to the requirements of the Administrative​
7932+244.13Procedure Act, but the Formulary Committee shall review and comment on the formulary​
7933+244.14contents.​
7934+244.15 (b) The formulary shall not include:​
7935+244.16 (1) drugs, active pharmaceutical ingredients, or products for which there is no federal​
7936+244.17funding;​
7937+244.18 (2) over-the-counter drugs, except as provided in subdivision 13;​
7938+244.19 (3) drugs or active pharmaceutical ingredients when used for the treatment of impotence​
7939+244.20or erectile dysfunction;​
7940+244.21 (4) drugs or active pharmaceutical ingredients for which medical value has not been​
7941+244.22established;​
7942+244.23 (5) drugs from manufacturers who have not signed a rebate agreement with the​
7943+244.24Department of Health and Human Services pursuant to section 1927 of title XIX of the​
7944+244.25Social Security Act; and​
7945+244.26 (6) medical cannabis flower as defined in section 152.22, subdivision 6 342.01,​
7946+244.27subdivision 52, or medical cannabinoid products as defined in section 342.01, subdivision​
7947+244.2850.​
7948+244.29 (c) If a single-source drug used by at least two percent of the fee-for-service medical​
7949+244.30assistance recipients is removed from the formulary due to the failure of the manufacturer​
7950+244.31to sign a rebate agreement with the Department of Health and Human Services, the​
7951+244.32commissioner shall notify prescribing practitioners within 30 days of receiving notification​
7952+244​Article 6 Sec. 42.​
7953+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 245.1from the Centers for Medicare and Medicaid Services (CMS) that a rebate agreement was​
7954+245.2not signed.​
7955+245.3Sec. 43. Minnesota Statutes 2022, section 256D.024, subdivision 1, is amended to read:​
7956+245.4 Subdivision 1.Person convicted of drug offenses.(a) If an applicant or recipient has​
7957+245.5been convicted of a drug offense after July 1, 1997, except for convictions related to cannabis,​
7958+245.6marijuana, or tetrahydrocannabinols, the assistance unit is ineligible for benefits under this​
7959+245.7chapter until five years after the applicant has completed terms of the court-ordered sentence,​
7960+245.8unless the person is participating in a drug treatment program, has successfully completed​
7961+245.9a drug treatment program, or has been assessed by the county and determined not to be in​
7962+245.10need of a drug treatment program. Persons subject to the limitations of this subdivision who​
7963+245.11become eligible for assistance under this chapter shall be subject to random drug testing as​
7964+245.12a condition of continued eligibility and shall lose eligibility for benefits for five years​
7965+245.13beginning the month following:​
7966+245.14 (1) any positive test result for an illegal controlled substance under chapter 152; or​
7967+245.15 (2) discharge of sentence after conviction for another drug felony.​
7968+245.16 (b) For the purposes of this subdivision, "drug offense" means a conviction that occurred​
7969+245.17after July 1, 1997, of sections 152.021 to 152.025, 152.0261, 152.0262, or 152.096. Drug​
7970+245.18offense also means a conviction in another jurisdiction of the possession, use, or distribution​
7971+245.19of a controlled substance, or conspiracy to commit any of these offenses, if the offense​
7972+245.20occurred after July 1, 1997, and the conviction is a felony offense in that jurisdiction, or in​
7973+245.21the case of New Jersey, a high misdemeanor for a crime that would be a felony if committed​
7974+245.22in Minnesota.​
7975+245.23Sec. 44. Minnesota Statutes 2022, section 256D.024, subdivision 3, is amended to read:​
7976+245.24 Subd. 3.Fleeing felons.An individual who is fleeing to avoid prosecution, or custody,​
7977+245.25or confinement after conviction for a crime that is a felony under the laws of the jurisdiction​
7978+245.26from which the individual flees, or in the case of New Jersey, is a high misdemeanor, would​
7979+245.27be a felony if committed in Minnesota, is ineligible to receive benefits under this chapter.​
7980+245.28Sec. 45. Minnesota Statutes 2022, section 256J.26, subdivision 1, is amended to read:​
7981+245.29 Subdivision 1.Person convicted of drug offenses.(a) An individual who has been​
7982+245.30convicted of a felony level drug offense committed during the previous ten years from the​
7983+245.31date of application or recertification, except for convictions related to cannabis, marijuana,​
7984+245.32or tetrahydrocannabinols, is subject to the following:​
7985+245​Article 6 Sec. 45.​
7986+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 246.1 (1) Benefits for the entire assistance unit must be paid in vendor form for shelter and​
7987+246.2utilities during any time the applicant is part of the assistance unit.​
7988+246.3 (2) The convicted applicant or participant shall be subject to random drug testing as a​
7989+246.4condition of continued eligibility and following any positive test for an illegal controlled​
7990+246.5substance under chapter 152 is subject to the following sanctions:​
7991+246.6 (i) for failing a drug test the first time, the residual amount of the participant's grant after​
7992+246.7making vendor payments for shelter and utility costs, if any, must be reduced by an amount​
7993+246.8equal to 30 percent of the MFIP standard of need for an assistance unit of the same size.​
7994+246.9When a sanction under this subdivision is in effect, the job counselor must attempt to meet​
7995+246.10with the person face-to-face. During the face-to-face meeting, the job counselor must explain​
7996+246.11the consequences of a subsequent drug test failure and inform the participant of the right to​
7997+246.12appeal the sanction under section 256J.40. If a face-to-face meeting is not possible, the​
7998+246.13county agency must send the participant a notice of adverse action as provided in section​
7999+246.14256J.31, subdivisions 4 and 5, and must include the information required in the face-to-face​
8000+246.15meeting; or​
8001+246.16 (ii) for failing a drug test two times, the participant is permanently disqualified from​
8002+246.17receiving MFIP assistance, both the cash and food portions. The assistance unit's MFIP​
8003+246.18grant must be reduced by the amount which would have otherwise been made available to​
8004+246.19the disqualified participant. Disqualification under this item does not make a participant​
8005+246.20ineligible for the Supplemental Nutrition Assistance Program (SNAP). Before a​
8006+246.21disqualification under this provision is imposed, the job counselor must attempt to meet​
8007+246.22with the participant face-to-face. During the face-to-face meeting, the job counselor must​
8008+246.23identify other resources that may be available to the participant to meet the needs of the​
8009+246.24family and inform the participant of the right to appeal the disqualification under section​
8010+246.25256J.40. If a face-to-face meeting is not possible, the county agency must send the participant​
8011+246.26a notice of adverse action as provided in section 256J.31, subdivisions 4 and 5, and must​
8012+246.27include the information required in the face-to-face meeting.​
8013+246.28 (3) A participant who fails a drug test the first time and is under a sanction due to other​
8014+246.29MFIP program requirements is considered to have more than one occurrence of​
8015+246.30noncompliance and is subject to the applicable level of sanction as specified under section​
8016+246.31256J.46, subdivision 1, paragraph (d).​
8017+246.32 (b) Applicants requesting only SNAP benefits or participants receiving only SNAP​
8018+246.33benefits, who have been convicted of a drug offense that occurred after July 1, 1997, except​
8019+246.34for convictions related to cannabis, marijuana, or tetrahydrocannabinols, may, if otherwise​
8020+246​Article 6 Sec. 45.​
8021+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 247.1eligible, receive SNAP benefits if the convicted applicant or participant is subject to random​
8022+247.2drug testing as a condition of continued eligibility. Following a positive test for an illegal​
8023+247.3controlled substance under chapter 152, the applicant is subject to the following sanctions:​
8024+247.4 (1) for failing a drug test the first time, SNAP benefits shall be reduced by an amount​
8025+247.5equal to 30 percent of the applicable SNAP benefit allotment. When a sanction under this​
8026+247.6clause is in effect, a job counselor must attempt to meet with the person face-to-face. During​
8027+247.7the face-to-face meeting, a job counselor must explain the consequences of a subsequent​
8028+247.8drug test failure and inform the participant of the right to appeal the sanction under section​
8029+247.9256J.40. If a face-to-face meeting is not possible, a county agency must send the participant​
8030+247.10a notice of adverse action as provided in section 256J.31, subdivisions 4 and 5, and must​
8031+247.11include the information required in the face-to-face meeting; and​
8032+247.12 (2) for failing a drug test two times, the participant is permanently disqualified from​
8033+247.13receiving SNAP benefits. Before a disqualification under this provision is imposed, a job​
8034+247.14counselor must attempt to meet with the participant face-to-face. During the face-to-face​
8035+247.15meeting, the job counselor must identify other resources that may be available to the​
8036+247.16participant to meet the needs of the family and inform the participant of the right to appeal​
8037+247.17the disqualification under section 256J.40. If a face-to-face meeting is not possible, a county​
8038+247.18agency must send the participant a notice of adverse action as provided in section 256J.31,​
8039+247.19subdivisions 4 and 5, and must include the information required in the face-to-face meeting.​
8040+247.20 (c) For the purposes of this subdivision, "drug offense" means an offense that occurred​
8041+247.21during the previous ten years from the date of application or recertification of sections​
8042+247.22152.021 to 152.025, 152.0261, 152.0262, 152.096, or 152.137. Drug offense also means a​
8043+247.23conviction in another jurisdiction of the possession, use, or distribution of a controlled​
8044+247.24substance, or conspiracy to commit any of these offenses, if the offense occurred during​
8045+247.25the previous ten years from the date of application or recertification and the conviction is​
8046+247.26a felony offense in that jurisdiction, or in the case of New Jersey, a high misdemeanor for​
8047+247.27a crime that would be a felony if committed in Minnesota.​
8048+247.28Sec. 46. Minnesota Statutes 2022, section 256J.26, subdivision 3, is amended to read:​
8049+247.29 Subd. 3.Fleeing felons.An individual who is fleeing to avoid prosecution, or custody,​
8050+247.30or confinement after conviction for a crime that is a felony under the laws of the jurisdiction​
8051+247.31from which the individual flees, or in the case of New Jersey, is a high misdemeanor, would​
8052+247.32be a felony if committed in Minnesota, is disqualified from receiving MFIP.​
8053+247​Article 6 Sec. 46.​
8054+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 248.1Sec. 47. [340A.4022] RETAIL LICENSE NOT PROHIBITED; LOWER-POTENCY​
8055+248.2HEMP EDIBLES.​
8056+248.3 (a) Nothing in this chapter:​
8057+248.4 (1) prohibits the issuance of a retail license or permit to a person also holding a hemp​
8058+248.5business license authorizing the manufacture or retail sale of lower-potency hemp edibles;​
8059+248.6 (2) allows any agreement between a licensing authority and retail license or permit holder​
8060+248.7that prohibits the license or permit holder from also holding a lower-potency hemp edible​
8061+248.8manufacturer or retailer license; or​
8062+248.9 (3) allows the revocation or suspension of a retail license or permit, or the imposition​
8063+248.10of a penalty on a retail license or permit holder, due to the retail license or permit holder​
8064+248.11also holding a lower-potency hemp edible manufacturer or retailer license.​
8065+248.12 (b) For purposes of this section, "hemp business license authorizing manufacture or​
8066+248.13retail sale of lower-potency hemp edibles" means a license issued by the Office of Cannabis​
8067+248.14Management pursuant to sections 342.43 to 342.46.​
8068+248.15Sec. 48. Minnesota Statutes 2022, section 340A.412, subdivision 14, is amended to read:​
8069+248.16 Subd. 14.Exclusive liquor stores.(a) Except as otherwise provided in this subdivision,​
8070+248.17an exclusive liquor store may sell only the following items:​
8071+248.18 (1) alcoholic beverages;​
8072+248.19 (2) tobacco products;​
8073+248.20 (3) ice;​
8074+248.21 (4) beverages, either liquid or powder, specifically designated for mixing with intoxicating​
8075+248.22liquor;​
8076+248.23 (5) soft drinks;​
8077+248.24 (6) liqueur-filled candies;​
8078+248.25 (7) food products that contain more than one-half of one percent alcohol by volume;​
8079+248.26 (8) cork extraction devices;​
8080+248.27 (9) books and videos on the use of alcoholic beverages;​
8081+248.28 (10) magazines and other publications published primarily for information and education​
8082+248.29on alcoholic beverages;​
8083+248.30 (11) multiple-use bags designed to carry purchased items;​
8084+248​Article 6 Sec. 48.​
8085+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 249.1 (12) devices designed to ensure safe storage and monitoring of alcohol in the home, to​
8086+249.2prevent access by underage drinkers;​
8087+249.3 (13) home brewing equipment;​
8088+249.4 (14) clothing marked with the specific name, brand, or identifying logo of the exclusive​
8089+249.5liquor store, and bearing no other name, brand, or identifying logo;​
8090+249.6 (15) citrus fruit; and​
8091+249.7 (16) glassware.;​
8092+249.8 (17) lower-potency hemp edibles as defined in section 342.01, subdivision 48; and​
8093+249.9 (18) products that detect the presence of fentanyl or a fentanyl analog.​
8094+249.10 (b) An exclusive liquor store that has an on-sale, or combination on-sale and off-sale​
8095+249.11license may sell food for on-premise consumption when authorized by the municipality​
8096+249.12issuing the license.​
8097+249.13 (c) An exclusive liquor store may offer live or recorded entertainment.​
8098+249.14 EFFECTIVE DATE.This section is effective July 1, 2024.​
8099+249.15Sec. 49. Minnesota Statutes 2022, section 484.014, subdivision 3, is amended to read:​
8100+249.16 Subd. 3.Mandatory expungement.(a) The court shall order expungement of an eviction​
8101+249.17case commenced solely on the grounds provided in section 504B.285, subdivision 1, clause​
8102+249.18(1), if the court finds that the defendant occupied real property that was subject to contract​
8103+249.19for deed cancellation or mortgage foreclosure and:​
8104+249.20 (1) the time for contract cancellation or foreclosure redemption has expired and the​
8105+249.21defendant vacated the property prior to commencement of the eviction action; or​
8106+249.22 (2) the defendant was a tenant during the contract cancellation or foreclosure redemption​
8107+249.23period and did not receive a notice under section 504B.285, subdivision 1a, 1b, or 1c, to​
8108+249.24vacate on a date prior to commencement of the eviction case.​
8109+249.25 (b) If a tenant brings a motion for the expungement of an eviction, the court shall order​
8110+249.26the expungement of an eviction case that was commenced on the grounds of a violation of​
8111+249.27section 504B.171 or any other claim of breach regardless of when the original eviction was​
8112+249.28ordered, if the tenant could receive an automatic expungement under section 609A.05, or​
8113+249.29if the breach was based solely on the possession of marijuana or tetrahydrocannabinols.​
8114+249​Article 6 Sec. 49.​
8115+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 250.1Sec. 50. Minnesota Statutes 2022, section 504B.171, subdivision 1, is amended to read:​
8116+250.2 Subdivision 1.Terms of covenant.(a) In every lease or license of residential premises,​
8117+250.3whether in writing or parol, the landlord or licensor and the tenant or licensee covenant that:​
8118+250.4 (1) neither will:​
8119+250.5 (i) unlawfully allow controlled substances in those premises or in the common area and​
8120+250.6curtilage of the premises in violation of any criminal provision of chapter 152;​
8121+250.7 (ii) allow prostitution or prostitution-related activity as defined in section 617.80,​
8122+250.8subdivision 4, to occur on the premises or in the common area and curtilage of the premises;​
8123+250.9 (iii) allow the unlawful use or possession of a firearm in violation of section 609.66,​
8124+250.10subdivision 1a, 609.67, or 624.713, on the premises or in the common area and curtilage of​
8125+250.11the premises; or​
8126+250.12 (iv) allow stolen property or property obtained by robbery in those premises or in the​
8127+250.13common area and curtilage of the premises; and​
8128+250.14 (2) the common area and curtilage of the premises will not be used by either the landlord​
8129+250.15or licensor or the tenant or licensee or others acting under the control of either to manufacture,​
8130+250.16sell, give away, barter, deliver, exchange, distribute, purchase, or possess a controlled​
8131+250.17substance in violation of any criminal provision of chapter 152. The covenant is not violated​
8132+250.18when a person other than the landlord or licensor or the tenant or licensee possesses or​
8133+250.19allows controlled substances in the premises, common area, or curtilage, unless the landlord​
8134+250.20or licensor or the tenant or licensee knew or had reason to know of that activity.​
8135+250.21 (b) In every lease or license of residential premises, whether in writing or parol, the​
8136+250.22tenant or licensee covenant that the tenant or licensee will not commit an act enumerated​
8137+250.23under section 504B.206, subdivision 1, paragraph (a), against a tenant or licensee or any​
8138+250.24authorized occupant.​
8139+250.25 (c) A landlord cannot prohibit a tenant from legally possessing, and a tenant cannot​
8140+250.26waive the right to legally possess, any cannabis products, lower-potency hemp edibles, or​
8141+250.27hemp-derived consumer products, or using any cannabinoid product or hemp-derived​
8142+250.28consumer product, other than consumption by combustion or vaporization of the product​
8143+250.29and inhalation of smoke, aerosol, or vapor from the product.​
8144+250​Article 6 Sec. 50.​
8145+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 251.1Sec. 51. [504B.1715] COVENANTS; SOBER HOMES.​
8146+251.2 A sober housing program for people with substance use disorders may prohibit people​
8147+251.3in the program from the possession and use of cannabis flower, cannabis products,​
8148+251.4lower-potency hemp edibles, or hemp-derived consumer products.​
8149+251.5Sec. 52. Minnesota Statutes 2022, section 609B.425, subdivision 2, is amended to read:​
8150+251.6 Subd. 2.Benefit eligibility.(a) A person convicted of a drug offense after July 1, 1997,​
8151+251.7except for convictions related to cannabis, marijuana, or tetrahydrocannabinols, is ineligible​
8152+251.8for general assistance benefits and Supplemental Security Income under chapter 256D until:​
8153+251.9 (1) five years after completing the terms of a court-ordered sentence; or​
8154+251.10 (2) unless the person is participating in a drug treatment program, has successfully​
8155+251.11completed a program, or has been determined not to be in need of a drug treatment program.​
8156+251.12 (b) A person who becomes eligible for assistance under chapter 256D is subject to​
8157+251.13random drug testing and shall lose eligibility for benefits for five years beginning the month​
8158+251.14following:​
8159+251.15 (1) any positive test for an illegal controlled substance under chapter 152; or​
8160+251.16 (2) discharge of sentence for conviction of another drug felony.​
8161+251.17 (c) Parole violators and fleeing felons are ineligible for benefits and persons fraudulently​
8162+251.18misrepresenting eligibility are also ineligible to receive benefits for ten years.​
8163+251.19Sec. 53. Minnesota Statutes 2022, section 609B.435, subdivision 2, is amended to read:​
8164+251.20 Subd. 2.Drug offenders; random testing; sanctions.A person who is an applicant for​
8165+251.21benefits from the Minnesota family investment program or MFIP, the vehicle for temporary​
8166+251.22assistance for needy families or TANF, and who has been convicted of a drug offense,​
8167+251.23except for convictions related to cannabis, marijuana, or tetrahydrocannabinols, shall be​
8168+251.24subject to certain conditions, including random drug testing, in order to receive MFIP​
8169+251.25benefits. Following any positive test for a controlled substance under chapter 152, the​
8170+251.26convicted applicant or participant is subject to the following sanctions:​
8171+251.27 (1) a first time drug test failure results in a reduction of benefits in an amount equal to​
8172+251.2830 percent of the MFIP standard of need; and​
8173+251.29 (2) a second time drug test failure results in permanent disqualification from receiving​
8174+251.30MFIP assistance.​
8175+251​Article 6 Sec. 53.​
8176+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 252.1A similar disqualification sequence occurs if the applicant is receiving Supplemental Nutrition​
8177+252.2Assistance Program (SNAP) benefits.​
8178+252.3Sec. 54. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8179+252.4to read:​
8180+252.5 Subd. 13.Adult-use cannabis flower."Adult-use cannabis flower" has the meaning​
8181+252.6given in section 342.01, subdivision 3.​
8182+252.7Sec. 55. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8183+252.8to read:​
8184+252.9 Subd. 14.Adult-use cannabinoid product."Adult-use cannabis product" has the​
8185+252.10meaning given in section 342.01, subdivision 4.​
8186+252.11Sec. 56. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8187+252.12to read:​
8188+252.13 Subd. 15.Medical cannabis flower."Medical cannabis flower" has the meaning given​
8189+252.14in section 342.01, subdivision 52.​
8190+252.15Sec. 57. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8191+252.16to read:​
8192+252.17 Subd. 16.Medical cannabinoid product."Medical cannabinoid product" has the​
8193+252.18meaning given in section 342.01, subdivision 50.​
8194+252.19Sec. 58. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8195+252.20to read:​
8196+252.21 Subd. 17.Patient."Patient" has the meaning given in section 342.01, subdivision 57.​
8197+252.22Sec. 59. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8198+252.23to read:​
8199+252.24 Subd. 18.Qualifying medical condition."Qualifying medical condition" has the meaning​
8200+252.25given in section 342.01, subdivision 59.​
8201+252​Article 6 Sec. 59.​
8202+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 253.1Sec. 60. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8203+253.2to read:​
8204+253.3 Subd. 19.Registry or registry program."Registry" or "registry program" has the​
8205+253.4meaning given in section 342.01, subdivision 61.​
8206+253.5Sec. 61. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8207+253.6to read:​
8208+253.7 Subd. 20.Hemp-derived consumer product."Hemp-derived consumer product" has​
8209+253.8the meaning given in section 342.01, subdivision 35.​
8210+253.9Sec. 62. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision​
8211+253.10to read:​
8212+253.11 Subd. 21.Lower-potency hemp edible."Lower-potency hemp edible" has the meaning​
8213+253.12given in section 342.01, subdivision 48.​
8214+253.13Sec. 63. Minnesota Statutes 2022, section 624.713, subdivision 1, is amended to read:​
8215+253.14 Subdivision 1.Ineligible persons.The following persons shall not be entitled to possess​
8216+253.15ammunition or a pistol or semiautomatic military-style assault weapon or, except for clause​
8217+253.16(1), any other firearm:​
8218+253.17 (1) a person under the age of 18 years except that a person under 18 may possess​
8219+253.18ammunition designed for use in a firearm that the person may lawfully possess and may​
8220+253.19carry or possess a pistol or semiautomatic military-style assault weapon (i) in the actual​
8221+253.20presence or under the direct supervision of the person's parent or guardian, (ii) for the​
8222+253.21purpose of military drill under the auspices of a legally recognized military organization​
8223+253.22and under competent supervision, (iii) for the purpose of instruction, competition, or target​
8224+253.23practice on a firing range approved by the chief of police or county sheriff in whose​
8225+253.24jurisdiction the range is located and under direct supervision; or (iv) if the person has​
8226+253.25successfully completed a course designed to teach marksmanship and safety with a pistol​
8227+253.26or semiautomatic military-style assault weapon and approved by the commissioner of natural​
8228+253.27resources;​
8229+253.28 (2) except as otherwise provided in clause (9), a person who has been convicted of, or​
8230+253.29adjudicated delinquent or convicted as an extended jurisdiction juvenile for committing, in​
8231+253.30this state or elsewhere, a crime of violence. For purposes of this section, crime of violence​
8232+253.31includes crimes in other states or jurisdictions which would have been crimes of violence​
8233+253.32as herein defined if they had been committed in this state;​
8234+253​Article 6 Sec. 63.​
8235+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 254.1 (3) a person who is or has ever been committed in Minnesota or elsewhere by a judicial​
8236+254.2determination that the person is mentally ill, developmentally disabled, or mentally ill and​
8237+254.3dangerous to the public, as defined in section 253B.02, to a treatment facility, or who has​
8238+254.4ever been found incompetent to stand trial or not guilty by reason of mental illness, unless​
8239+254.5the person's ability to possess a firearm and ammunition has been restored under subdivision​
8240+254.64;​
8241+254.7 (4) a person who has been convicted in Minnesota or elsewhere of a misdemeanor or​
8242+254.8gross misdemeanor violation of chapter 152, unless three years have elapsed since the date​
8243+254.9of conviction and, during that time, the person has not been convicted of any other such​
8244+254.10violation of chapter 152 or a similar law of another state; or a person who is or has ever​
8245+254.11been committed by a judicial determination for treatment for the habitual use of a controlled​
8246+254.12substance or marijuana, as defined in sections 152.01 and 152.02, unless the person's ability​
8247+254.13to possess a firearm and ammunition has been restored under subdivision 4;​
8248+254.14 (5) a person who has been committed to a treatment facility in Minnesota or elsewhere​
8249+254.15by a judicial determination that the person is chemically dependent as defined in section​
8250+254.16253B.02, unless the person has completed treatment or the person's ability to possess a​
8251+254.17firearm and ammunition has been restored under subdivision 4. Property rights may not be​
8252+254.18abated but access may be restricted by the courts;​
8253+254.19 (6) a peace officer who is informally admitted to a treatment facility pursuant to section​
8254+254.20253B.04 for chemical dependency, unless the officer possesses a certificate from the head​
8255+254.21of the treatment facility discharging or provisionally discharging the officer from the​
8256+254.22treatment facility. Property rights may not be abated but access may be restricted by the​
8257+254.23courts;​
8258+254.24 (7) a person, including a person under the jurisdiction of the juvenile court, who has​
8259+254.25been charged with committing a crime of violence and has been placed in a pretrial diversion​
8260+254.26program by the court before disposition, until the person has completed the diversion program​
8261+254.27and the charge of committing the crime of violence has been dismissed;​
8262+254.28 (8) except as otherwise provided in clause (9), a person who has been convicted in​
8263+254.29another state of committing an offense similar to the offense described in section 609.224,​
8264+254.30subdivision 3, against a family or household member or section 609.2242, subdivision 3,​
8265+254.31unless three years have elapsed since the date of conviction and, during that time, the person​
8266+254.32has not been convicted of any other violation of section 609.224, subdivision 3, or 609.2242,​
8267+254.33subdivision 3, or a similar law of another state;​
8268+254​Article 6 Sec. 63.​
8269+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 255.1 (9) a person who has been convicted in this state or elsewhere of assaulting a family or​
8270+255.2household member and who was found by the court to have used a firearm in any way​
8271+255.3during commission of the assault is prohibited from possessing any type of firearm or​
8272+255.4ammunition for the period determined by the sentencing court;​
8273+255.5 (10) a person who:​
8274+255.6 (i) has been convicted in any court of a crime punishable by imprisonment for a term​
8275+255.7exceeding one year;​
8276+255.8 (ii) is a fugitive from justice as a result of having fled from any state to avoid prosecution​
8277+255.9for a crime or to avoid giving testimony in any criminal proceeding;​
8278+255.10 (iii) is an unlawful user of any controlled substance as defined in chapter 152. The use​
8279+255.11of medical cannabis flower or medical cannabinoid products by a patient enrolled in the​
8280+255.12registry program or the use of adult-use cannabis flower, adult-use cannabis products,​
8281+255.13lower-potency hemp edibles, or hemp-derived consumer products by a person 21 years of​
8282+255.14age or older does not constitute the unlawful use of a controlled substance under this item;​
8283+255.15 (iv) has been judicially committed to a treatment facility in Minnesota or elsewhere as​
8284+255.16a person who is mentally ill, developmentally disabled, or mentally ill and dangerous to the​
8285+255.17public, as defined in section 253B.02;​
8286+255.18 (v) is an alien who is illegally or unlawfully in the United States;​
8287+255.19 (vi) has been discharged from the armed forces of the United States under dishonorable​
8288+255.20conditions;​
8289+255.21 (vii) has renounced the person's citizenship having been a citizen of the United States;​
8290+255.22or​
8291+255.23 (viii) is disqualified from possessing a firearm under United States Code, title 18, section​
8292+255.24922(g)(8) or (9), as amended through March 1, 2014;​
8293+255.25 (11) a person who has been convicted of the following offenses at the gross misdemeanor​
8294+255.26level, unless three years have elapsed since the date of conviction and, during that time, the​
8295+255.27person has not been convicted of any other violation of these sections: section 609.229​
8296+255.28(crimes committed for the benefit of a gang); 609.2231, subdivision 4 (assaults motivated​
8297+255.29by bias); 609.255 (false imprisonment); 609.378 (neglect or endangerment of a child);​
8298+255.30609.582, subdivision 4 (burglary in the fourth degree); 609.665 (setting a spring gun); 609.71​
8299+255.31(riot); or 609.749 (harassment or stalking). For purposes of this paragraph, the specified​
8300+255.32gross misdemeanor convictions include crimes committed in other states or jurisdictions​
8301+255.33which would have been gross misdemeanors if conviction occurred in this state;​
8302+255​Article 6 Sec. 63.​
8303+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 256.1 (12) a person who has been convicted of a violation of section 609.224 if the court​
8304+256.2determined that the assault was against a family or household member in accordance with​
8305+256.3section 609.2242, subdivision 3 (domestic assault), unless three years have elapsed since​
8306+256.4the date of conviction and, during that time, the person has not been convicted of another​
8307+256.5violation of section 609.224 or a violation of a section listed in clause (11); or​
8308+256.6 (13) a person who is subject to an order for protection as described in section 260C.201,​
8309+256.7subdivision 3, paragraph (d), or 518B.01, subdivision 6, paragraph (g).​
8310+256.8 A person who issues a certificate pursuant to this section in good faith is not liable for​
8311+256.9damages resulting or arising from the actions or misconduct with a firearm or ammunition​
8312+256.10committed by the individual who is the subject of the certificate.​
8313+256.11 The prohibition in this subdivision relating to the possession of firearms other than​
8314+256.12pistols and semiautomatic military-style assault weapons does not apply retroactively to​
8315+256.13persons who are prohibited from possessing a pistol or semiautomatic military-style assault​
8316+256.14weapon under this subdivision before August 1, 1994.​
8317+256.15 The lifetime prohibition on possessing, receiving, shipping, or transporting firearms and​
8318+256.16ammunition for persons convicted or adjudicated delinquent of a crime of violence in clause​
8319+256.17(2), applies only to offenders who are discharged from sentence or court supervision for a​
8320+256.18crime of violence on or after August 1, 1993.​
8321+256.19 Participation as a patient in the registry program or use of adult-use cannabis flower,​
8322+256.20adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
8323+256.21products by a person 21 years of age or older does not disqualify the person from possessing​
8324+256.22firearms and ammunition under this section.​
8325+256.23 For purposes of this section, "judicial determination" means a court proceeding pursuant​
8326+256.24to sections 253B.07 to 253B.09 or a comparable law from another state.​
8327+256.25Sec. 64. Minnesota Statutes 2022, section 624.714, subdivision 6, is amended to read:​
8328+256.26 Subd. 6.Granting and denial of permits.(a) The sheriff must, within 30 days after the​
8329+256.27date of receipt of the application packet described in subdivision 3:​
8330+256.28 (1) issue the permit to carry;​
8331+256.29 (2) deny the application for a permit to carry solely on the grounds that the applicant​
8332+256.30failed to qualify under the criteria described in subdivision 2, paragraph (b); or​
8333+256.31 (3) deny the application on the grounds that there exists a substantial likelihood that the​
8334+256.32applicant is a danger to self or the public if authorized to carry a pistol under a permit.​
8335+256​Article 6 Sec. 64.​
8336+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 257.1 (b) Failure of the sheriff to notify the applicant of the denial of the application within​
8337+257.230 days after the date of receipt of the application packet constitutes issuance of the permit​
8338+257.3to carry and the sheriff must promptly fulfill the requirements under paragraph (c). To deny​
8339+257.4the application, the sheriff must provide the applicant with written notification and the​
8340+257.5specific factual basis justifying the denial under paragraph (a), clause (2) or (3), including​
8341+257.6the source of the factual basis. The sheriff must inform the applicant of the applicant's right​
8342+257.7to submit, within 20 business days, any additional documentation relating to the propriety​
8343+257.8of the denial. Upon receiving any additional documentation, the sheriff must reconsider the​
8344+257.9denial and inform the applicant within 15 business days of the result of the reconsideration.​
8345+257.10Any denial after reconsideration must be in the same form and substance as the original​
8346+257.11denial and must specifically address any continued deficiencies in light of the additional​
8347+257.12documentation submitted by the applicant. The applicant must be informed of the right to​
8348+257.13seek de novo review of the denial as provided in subdivision 12.​
8349+257.14 (c) Upon issuing a permit to carry, the sheriff must provide a laminated permit card to​
8350+257.15the applicant by first class mail unless personal delivery has been made. Within five business​
8351+257.16days, the sheriff must submit the information specified in subdivision 7, paragraph (a), to​
8352+257.17the commissioner for inclusion solely in the database required under subdivision 15,​
8353+257.18paragraph (a). The sheriff must transmit the information in a manner and format prescribed​
8354+257.19by the commissioner.​
8355+257.20 (d) Within five business days of learning that a permit to carry has been suspended or​
8356+257.21revoked, the sheriff must submit information to the commissioner regarding the suspension​
8357+257.22or revocation for inclusion solely in the databases required or permitted under subdivision​
8358+257.2315.​
8359+257.24 (e) Notwithstanding paragraphs (a) and (b), the sheriff may suspend the application​
8360+257.25process if a charge is pending against the applicant that, if resulting in conviction, will​
8361+257.26prohibit the applicant from possessing a firearm.​
8362+257.27 (f) A sheriff shall not deny an application for a permit to carry solely because the applicant​
8363+257.28is a patient enrolled in the registry program and uses medical cannabis flower or medical​
8364+257.29cannabinoid products for a qualifying medical condition or because the person is 21 years​
8365+257.30of age or older and uses adult-use cannabis flower, adult-use cannabis products,​
8366+257.31lower-potency hemp edibles, or hemp-derived consumer products.​
8367+257.32Sec. 65. Minnesota Statutes 2022, section 624.7142, subdivision 1, is amended to read:​
8368+257.33 Subdivision 1.Acts prohibited.A person may not carry a pistol on or about the person's​
8369+257.34clothes or person in a public place:​
8370+257​Article 6 Sec. 65.​
8371+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 258.1 (1) when the person is under the influence of a controlled substance, as defined in section​
8372+258.2152.01, subdivision 4;​
8373+258.3 (2) when the person is under the influence of a combination of any two or more of the​
8374+258.4elements named in clauses (1) and (4);​
8375+258.5 (3) when the person is under the influence of an intoxicating substance as defined in​
8376+258.6section 169A.03, subdivision 11a, and the person knows or has reason to know that the​
8377+258.7substance has the capacity to cause impairment;​
8378+258.8 (4) when the person is under the influence of alcohol;​
8379+258.9 (5) when the person's alcohol concentration is 0.10 or more; or​
8380+258.10 (6) when the person's alcohol concentration is less than 0.10, but more than 0.04.; or​
8381+258.11 (7) when the person is enrolled as a patient in the registry program, uses medical cannabis​
8382+258.12flower or medical cannabinoid products, and knows or has reason to know that the medical​
8383+258.13cannabis flower or medical cannabinoid products used by the person has the capacity to​
8384+258.14cause impairment.​
8385+258.15Sec. 66. Minnesota Statutes 2022, section 624.7151, is amended to read:​
8386+258.16 624.7151 STANDARDIZED FORMS.​
8387+258.17 By December 1, 1992, the commissioner shall adopt statewide standards governing the​
8388+258.18form and contents, as required by sections 624.7131 to 624.714, of every application for a​
8389+258.19pistol transferee permit, pistol transferee permit, report of transfer of a pistol, application​
8390+258.20for a permit to carry a pistol, and permit to carry a pistol that is granted or renewed on or​
8391+258.21after January 1, 1993.​
8392+258.22 Every application for a pistol transferee permit, pistol transferee permit, report of transfer​
8393+258.23of a pistol, application for a permit to carry a pistol, and permit to carry a pistol that is​
8394+258.24received, granted, or renewed by a police chief or county sheriff on or after January 1, 1993,​
8395+258.25must meet the statewide standards adopted by the commissioner. Notwithstanding the​
8396+258.26previous sentence, neither failure of the Department of Public Safety to adopt standards nor​
8397+258.27failure of the police chief or county sheriff to meet them shall delay the timely processing​
8398+258.28of applications nor invalidate permits issued on other forms meeting the requirements of​
8399+258.29sections 624.7131 to 624.714.​
8400+258.30 Any form used for the purpose of approving or disapproving a person from purchasing,​
8401+258.31owning, possessing, or carrying a firearm that inquires about the applicant's use of controlled​
8402+258.32substances shall specifically authorize a patient in the registry program to refrain from​
8403+258​Article 6 Sec. 66.​
8404+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 259.1reporting the use of medical cannabis flower and medical cannabinoid products and shall​
8405+259.2specifically authorize a person 21 years of age or older from refraining from reporting the​
8406+259.3use of adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles,​
8407+259.4or hemp-derived consumer products.​
8408+259.5Sec. 67. [624.7152] LAWFUL CANNABIS USERS.​
8409+259.6 (a) A person may not be denied the right to purchase, own, possess, or carry a firearm​
8410+259.7solely on the basis that the person is a patient in the registry program.​
8411+259.8 (b) A person may not be denied the right to purchase, own, possess, or carry a firearm​
8412+259.9solely on the basis that the person is 21 years of age or older and uses adult-use cannabis​
8413+259.10flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
8414+259.11products.​
8415+259.12 (c) A state or local agency may not access a database containing the identities of patients​
8416+259.13in the registry program to obtain information for the purpose of approving or disapproving​
8417+259.14a person from purchasing, owning, possessing, or carrying a firearm.​
8418+259.15 (d) A state or local agency may not use information gathered from a database containing​
8419+259.16the identities of patients in the registry program to obtain information for the purpose of​
8420+259.17approving or disapproving a person from purchasing, owning, possessing, or carrying a​
8421+259.18firearm.​
8422+259.19 (e) A state or local agency may not inquire about a person's status as a patient in the​
8423+259.20registry program for the purpose of approving or disapproving the person from purchasing,​
8424+259.21owning, possessing, or carrying a firearm.​
8425+259.22 (f) A state or local agency may not inquire about the use of adult-use cannabis flower,​
8426+259.23adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer​
8427+259.24products by a person 21 years of age or older for the purpose of approving or disapproving​
8428+259.25the person from purchasing, owning, possessing, or carrying a firearm.​
8429+259.26Sec. 68. REPEALER.​
8430+259.27 (a) Minnesota Statutes 2022, sections 152.22, subdivisions 1, 2, 3, 4, 5, 5a, 5b, 6, 7, 8,​
8431+259.289, 10, 11, 12, 13, and 14; 152.23; 152.24; 152.25, subdivisions 1, 1a, 1b, 1c, 2, 3, and 4;​
8432+259.29152.26; 152.261; 152.27, subdivisions 1, 2, 3, 4, 5, 6, and 7; 152.28, subdivisions 1, 2, and​
8433+259.303; 152.29, subdivisions 1, 2, 3, 3a, and 4; 152.30; 152.31; 152.32, subdivisions 1, 2, and 3;​
8434+259.31152.33, subdivisions 1, 1a, 2, 3, 4, 5, and 6; 152.34; 152.35; 152.36, subdivisions 1, 1a, 2,​
8435+259.323, 4, and 5; and 152.37, are repealed.​
8436+259​Article 6 Sec. 68.​
8437+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 260.1 (b) Minnesota Statutes 2022, section 152.027, subdivisions 3 and 4, are repealed.​
8438+260.2 (c) Minnesota Statutes 2022, section 152.21, is repealed.​
8439+260.3 EFFECTIVE DATE.Paragraph (a) is effective January 1, 2024. Paragraph (b) is​
8440+260.4effective August 1, 2023. Paragraph (c) is effective July 1, 2023.​
8441+260.5 ARTICLE 7​
8442+260.6 TEMPORARY REGULATION OF CERTAIN PRODUCTS​
8443+260.7Section 1. Minnesota Statutes 2022, section 34A.01, subdivision 4, is amended to read:​
8444+260.8 Subd. 4.Food."Food" means every ingredient used for, entering into the consumption​
8445+260.9of, or used or intended for use in the preparation of food, drink, confectionery, or condiment​
8446+260.10for humans or other animals, whether simple, mixed, or compound; and articles used as​
8447+260.11components of these ingredients, except that edible cannabinoid products, as defined in​
8448+260.12section 151.72, subdivision 1, paragraph (c) (f), are not food.​
8449+260.13 EFFECTIVE DATE.This section is effective the day following final enactment.​
8450+260.14Sec. 2. Minnesota Statutes 2022, section 151.72, is amended to read:​
8451+260.15 151.72 SALE OF CERTAIN CANNABINOID PRODUCTS.​
8452+260.16 Subdivision 1.Definitions.(a) For the purposes of this section, the following terms have​
8453+260.17the meanings given.​
8454+260.18 (a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant​
8455+260.19or hemp plant parts whose chemical makeup is changed after extraction to create a different​
8456+260.20cannabinoid or other chemical compound by applying a catalyst other than heat or light.​
8457+260.21Artificially derived cannabinoid includes but is not limited to any tetrahydrocannabinol​
8458+260.22created from cannabidiol.​
8459+260.23 (b) "Batch" means a specific quantity of a specific product containing cannabinoids​
8460+260.24derived from hemp, including an edible cannabinoid product, that is manufactured at the​
8461+260.25same time and using the same methods, equipment, and ingredients that is uniform and​
8462+260.26intended to meet specifications for identity, strength, purity, and composition, and that is​
8463+260.27manufactured, packaged, and labeled according to a single batch production record executed​
8464+260.28and documented during the same cycle of manufacture and produced by a continuous​
8465+260.29process.​
8466+260.30 (b) (c) "Certified hemp" means hemp plants that have been tested and found to meet the​
8467+260.31requirements of chapter 18K and the rules adopted thereunder.​
8468+260​Article 7 Sec. 2.​
8469+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 261.1 (d) "Commissioner" means the commissioner of health.​
8470+261.2 (e) "Distributor" means a person who sells, arranges a sale, or delivers a product​
8471+261.3containing cannabinoids derived from hemp, including an edible cannabinoid product, that​
8472+261.4the person did not manufacture to a retail establishment for sale to consumers. Distributor​
8473+261.5does not include a common carrier used only to complete delivery to a retailer.​
8474+261.6 (c) (f) "Edible cannabinoid product" means any product that is intended to be eaten or​
8475+261.7consumed as a beverage by humans, contains a cannabinoid in combination with food​
8476+261.8ingredients, and is not a drug.​
8477+261.9 (d) (g) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision​
8478+261.103.​
8479+261.11 (e) (h) "Label" has the meaning given in section 151.01, subdivision 18.​
8480+261.12 (f) (i) "Labeling" means all labels and other written, printed, or graphic matter that are:​
8481+261.13 (1) affixed to the immediate container in which a product regulated under this section​
8482+261.14is sold;​
8483+261.15 (2) provided, in any manner, with the immediate container, including but not limited to​
8484+261.16outer containers, wrappers, package inserts, brochures, or pamphlets; or​
8485+261.17 (3) provided on that portion of a manufacturer's website that is linked by a scannable​
8486+261.18barcode or matrix barcode.​
8487+261.19 (g) (j) "Matrix barcode" means a code that stores data in a two-dimensional array of​
8488+261.20geometrically shaped dark and light cells capable of being read by the camera on a​
8489+261.21smartphone or other mobile device.​
8490+261.22 (h) (k) "Nonintoxicating cannabinoid" means substances extracted from certified hemp​
8491+261.23plants that do not produce intoxicating effects when consumed by any route of administration.​
8492+261.24 (l) "Synthetic cannabinoid" means a substance with a similar chemical structure and​
8493+261.25pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp​
8494+261.26plants, or hemp plant parts and is instead created or produced by chemical or biochemical​
8495+261.27synthesis.​
8496+261.28 Subd. 2.Scope.(a) This section applies to the sale of any product that contains​
8497+261.29cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended​
8498+261.30for human or animal consumption by any route of administration.​
8499+261.31 (b) This section does not apply to any product dispensed by a registered medical cannabis​
8500+261.32manufacturer pursuant to sections 152.22 to 152.37.​
8501+261​Article 7 Sec. 2.​
8502+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 262.1 (c) The board commissioner must have no authority over food products, as defined in​
8503+262.2section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from​
8504+262.3hemp.​
8505+262.4 Subd. 3.Sale of cannabinoids derived from hemp.(a) Notwithstanding any other​
8506+262.5section of this chapter, a product containing nonintoxicating cannabinoids, including an​
8507+262.6edible cannabinoid product, may be sold for human or animal consumption only if all of​
8508+262.7the requirements of this section are met, provided that a product sold for human or animal​
8509+262.8consumption does not contain more than 0.3 percent of any tetrahydrocannabinol and an​
8510+262.9edible cannabinoid product does not contain an amount of any tetrahydrocannabinol that​
8511+262.10exceeds the limits established in subdivision 5a, paragraph (f).​
8512+262.11 (b) No other substance extracted or otherwise derived from hemp may be sold for human​
8513+262.12consumption if the substance is intended:​
8514+262.13 (1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention​
8515+262.14of disease in humans or other animals; or​
8516+262.15 (2) to affect the structure or any function of the bodies of humans or other animals.​
8517+262.16 (c) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise​
8518+262.17derived from hemp may be sold to any individual who is under the age of 21.​
8519+262.18 (d) Products that meet the requirements of this section are not controlled substances​
8520+262.19under section 152.02.​
8521+262.20 Subd. 4.Testing requirements.(a) A manufacturer of a product regulated under this​
8522+262.21section must submit representative samples of each batch of the product to an independent,​
8523+262.22accredited laboratory in order to certify that the product complies with the standards adopted​
8524+262.23by the board on or before July 1, 2023, or the standards adopted by the commissioner.​
8525+262.24Testing must be consistent with generally accepted industry standards for herbal and botanical​
8526+262.25substances, and, at a minimum, the testing must confirm that the product:​
8527+262.26 (1) contains the amount or percentage of cannabinoids that is stated on the label of the​
8528+262.27product;​
8529+262.28 (2) does not contain more than trace amounts of any mold, residual solvents or other​
8530+262.29catalysts, pesticides, fertilizers, or heavy metals; and​
8531+262.30 (3) does not contain more than 0.3 percent of any tetrahydrocannabinol.​
8532+262.31 (b) A manufacturer of a product regulated under this section must disclose all known​
8533+262.32information regarding pesticides, fertilizers, solvents, or other foreign materials applied to​
8534+262​Article 7 Sec. 2.​
8535+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 263.1industrial hemp or added to industrial hemp during any production or processing stages of​
8536+263.2any batch from which a representative sample has been sent for testing, including any​
8537+263.3catalysts used to create artificially derived cannabinoids. Disclosure must be made to the​
8538+263.4laboratory performing testing or sampling and, upon request, to the commissioner. Disclosure​
8539+263.5must include all information known to the licensee regardless of whether the application or​
8540+263.6addition was made intentionally or accidentally, or by the manufacturer or any other person.​
8541+263.7 (b) (c) Upon the request of the board commissioner, the manufacturer of the product​
8542+263.8must provide the board commissioner with the results of the testing required in this section.​
8543+263.9 (d) The commissioner may determine that any testing laboratory that does not operate​
8544+263.10formal management systems under the International Organization for Standardization is not​
8545+263.11an accredited laboratory and require that a representative sample of a batch of the product​
8546+263.12be retested by a testing laboratory that meets this requirement.​
8547+263.13 (c) (e) Testing of the hemp from which the nonintoxicating cannabinoid was derived,​
8548+263.14or possession of a certificate of analysis for such hemp, does not meet the testing requirements​
8549+263.15of this section.​
8550+263.16 Subd. 5.Labeling requirements.(a) A product regulated under this section must bear​
8551+263.17a label that contains, at a minimum:​
8552+263.18 (1) the name, location, contact phone number, and website of the manufacturer of the​
8553+263.19product;​
8554+263.20 (2) the name and address of the independent, accredited laboratory used by the​
8555+263.21manufacturer to test the product; and​
8556+263.22 (3) the batch number; and​
8557+263.23 (3) (4) an accurate statement of the amount or percentage of cannabinoids found in each​
8558+263.24unit of the product meant to be consumed.​
8559+263.25 (b) The information in paragraph (a) may be provided on an outer package if the​
8560+263.26immediate container that holds the product is too small to contain all of the information.​
8561+263.27 (c) The information required in paragraph (a) may be provided through the use of a​
8562+263.28scannable barcode or matrix barcode that links to a page on the manufacturer's website if​
8563+263.29that page contains all of the information required by this subdivision.​
8564+263.30 (d) The label must also include a statement stating that the product does not claim to​
8565+263.31diagnose, treat, cure, or prevent any disease and has not been evaluated or approved by the​
8566+263.32United States Food and Drug Administration (FDA) unless the product has been so approved.​
8567+263​Article 7 Sec. 2.​
8568+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 264.1 (e) The information required by this subdivision must be prominently and conspicuously​
8569+264.2placed on the label or displayed on the website in terms that can be easily read and understood​
8570+264.3by the consumer.​
8571+264.4 (f) The labeling must not contain any claim that the product may be used or is effective​
8572+264.5for the prevention, treatment, or cure of a disease or that it may be used to alter the structure​
8573+264.6or function of human or animal bodies, unless the claim has been approved by the FDA.​
8574+264.7 Subd. 5a.Additional requirements for edible cannabinoid products.(a) In addition​
8575+264.8to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid​
8576+264.9must meet the requirements of this subdivision.​
8577+264.10 (b) An edible cannabinoid product must not:​
8578+264.11 (1) bear the likeness or contain cartoon-like characteristics of a real or fictional person,​
8579+264.12animal, or fruit that appeals to children;​
8580+264.13 (2) be modeled after a brand of products primarily consumed by or marketed to children;​
8581+264.14 (3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a​
8582+264.15commercially available candy or snack food item;​
8583+264.16 (4) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved​
8584+264.17by the United States Food and Drug Administration for use in food;​
8585+264.18 (5) be packaged in a way that resembles the trademarked, characteristic, or​
8586+264.19product-specialized packaging of any commercially available food product; or​
8587+264.20 (6) be packaged in a container that includes a statement, artwork, or design that could​
8588+264.21reasonably mislead any person to believe that the package contains anything other than an​
8589+264.22edible cannabinoid product.​
8590+264.23 (c) An edible cannabinoid product must be prepackaged in packaging or a container that​
8591+264.24is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is​
8592+264.25child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The​
8593+264.26requirement that packaging be child-resistant does not apply to an edible cannabinoid product​
8594+264.27that is intended to be consumed as a beverage and which contains no more than a trace​
8595+264.28amount of any tetrahydrocannabinol total of 0.25 milligrams of all tetrahydrocannabinols.​
8596+264.29 (d) If an edible cannabinoid product is intended for more than a single use or contains​
8597+264.30multiple servings, each serving must be indicated by scoring, wrapping, or other indicators​
8598+264.31designating the individual serving size that appear on the edible cannabinoid product.​
8599+264​Article 7 Sec. 2.​
8600+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 265.1 (e) A label containing at least the following information must be affixed to the packaging​
8601+265.2or container of all edible cannabinoid products sold to consumers:​
8602+265.3 (1) the serving size;​
8603+265.4 (2) the cannabinoid profile per serving and in total;​
8604+265.5 (3) a list of ingredients, including identification of any major food allergens declared​
8605+265.6by name; and​
8606+265.7 (4) the following statement: "Keep this product out of reach of children."​
8607+265.8 (f) An edible cannabinoid product must not contain more than five milligrams of any​
8608+265.9tetrahydrocannabinol in a single serving, or more than a total of 50 milligrams of any​
8609+265.10tetrahydrocannabinol per package.​
8610+265.11 (g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9​
8611+265.12tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an​
8612+265.13artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing​
8613+265.14any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and​
8614+265.15HHC, unless the commissioner authorizes use of the artificially derived cannabinoid in​
8615+265.16edible cannabinoid products. Edible cannabinoid products are prohibited from containing​
8616+265.17synthetic cannabinoids.​
8617+265.18 Subd. 5b.Registration; prohibitions.(a) On or before October 1, 2023, every person​
8618+265.19selling edible cannabinoid products to consumers must apply for registration with the​
8619+265.20commissioner in a form and manner established by the commissioner. After October 1,​
8620+265.212023, the sale of edible cannabinoid products by a person that is not registered is prohibited.​
8621+265.22 (b) The commissioner shall approve completed registration applications unless the​
8622+265.23applicant is operating in violation of this section or the commissioner reasonably believes​
8623+265.24that the applicant will operate in violation of this section.​
8624+265.25 (c) The commissioner shall not charge a fee for registration under this subdivision.​
8625+265.26 (d) A registered retailer shall not:​
8626+265.27 (1) permit the on-site consumption of edible cannabinoid products; or​
8627+265.28 (2) provide free samples of edible cannabinoid products, except that a retailer may​
8628+265.29provide a single package of an edible cannabinoid product with the purchase of a childproof​
8629+265.30packaging container or other device designed to ensure the safe storage and monitoring of​
8630+265.31edible cannabinoid products in the home to prevent access by individuals under 21 years​
8631+265.32of age.​
8632+265​Article 7 Sec. 2.​
8633+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 266.1 Subd. 5c.Age verification.(a) Prior to initiating a sale of an edible cannabinoid product,​
8634+266.2an employee of a retailer must verify that the customer is at least 21 years of age.​
8635+266.3 (b) Proof of age may be established only by one of the following:​
8636+266.4 (1) a valid driver's license or identification card issued by Minnesota, another state, or​
8637+266.5a province of Canada and including the photograph and date of birth of the licensed person;​
8638+266.6 (2) a valid Tribal identification card as defined in section 171.072, paragraph (b);​
8639+266.7 (3) a valid passport issued by the United States;​
8640+266.8 (4) a valid instructional permit issued under section 171.05 to a person of legal age to​
8641+266.9purchase edible cannabinoid products, which includes a photograph and the date of birth​
8642+266.10of the person issued the permit; or​
8643+266.11 (5) in the case of a foreign national, by a valid passport.​
8644+266.12 (c) A registered retailer may seize a form of identification listed under paragraph (b) if​
8645+266.13the registered retailer has reasonable grounds to believe that the form of identification has​
8646+266.14been altered or falsified or is being used to violate any law. A registered retailer that seizes​
8647+266.15a form of identification as authorized under this paragraph must deliver it to a law​
8648+266.16enforcement agency within 24 hours of seizing it.​
8649+266.17 Subd. 6.Noncompliant products; enforcement.(a) A product regulated under this​
8650+266.18section, including an edible cannabinoid product, shall be considered an adulterated drug​
8651+266.19a noncompliant product if the product is offered for sale in this state or if the product is​
8652+266.20manufactured, imported, distributed, or stored with the intent to be offered for sale in this​
8653+266.21state in violation of any provision of this section, including but not limited to if:​
8654+266.22 (1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;​
8655+266.23 (2) it has been produced, prepared, packed, or held under unsanitary conditions where​
8656+266.24it may have been rendered injurious to health, or where it may have been contaminated with​
8657+266.25filth;​
8658+266.26 (3) its container is composed, in whole or in part, of any poisonous or deleterious​
8659+266.27substance that may render the contents injurious to health;​
8660+266.28 (4) it contains any food additives, color additives, or excipients that have been found by​
8661+266.29the FDA to be unsafe for human or animal consumption;​
8662+266.30 (5) it contains an amount or percentage of nonintoxicating cannabinoids that is different​
8663+266.31than the amount or percentage stated on the label;​
8664+266​Article 7 Sec. 2.​
8665+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 267.1 (6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is​
8666+267.2an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits​
8667+267.3established in subdivision 5a, paragraph (f); or​
8668+267.4 (7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers,​
8669+267.5or heavy metals.​
8670+267.6 (b) A product regulated under this section shall be considered a misbranded drug​
8671+267.7noncompliant product if the product's labeling is false or misleading in any manner or in​
8672+267.8violation of the requirements of this section.​
8673+267.9 (c) The board's authority to issue cease and desist orders under section 151.06; to embargo​
8674+267.10adulterated and misbranded drugs under section 151.38; and to seek injunctive relief under​
8675+267.11section 214.11, extends to any commissioner may assume that any product regulated under​
8676+267.12this section that is present in the state, other than a product lawfully possessed for personal​
8677+267.13use, has been manufactured, imported, distributed, or stored with the intent to be offered​
8678+267.14for sale in this state if a product of the same type and brand was sold in the state on or after​
8679+267.15July 1, 2023, or if the product is in the possession of a person who has sold any product in​
8680+267.16violation of this section.​
8681+267.17 (d) The commissioner may enforce this section, including enforcement against a​
8682+267.18manufacturer or distributor of a product regulated under this section, under sections 144.989​
8683+267.19to 144.993.​
8684+267.20 (e) The commissioner may enter into an interagency agreement with the Office of​
8685+267.21Cannabis Management to perform inspections and take other enforcement actions on behalf​
8686+267.22of the commissioner.​
8687+267.23 Subd. 7.Violations; criminal penalties.(a) Notwithstanding section 144.99, subdivision​
8688+267.2411, a person who does any of the following regarding a product regulated under this section​
8689+267.25is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than​
8690+267.26one year or to payment of a fine of not more than $3,000, or both:​
8691+267.27 (1) knowingly alters or otherwise falsifies testing results;​
8692+267.28 (2) intentionally alters or falsifies any information required to be included on the label​
8693+267.29of an edible cannabinoid product; or​
8694+267.30 (3) intentionally makes a false material statement to the commissioner.​
8695+267.31 (b) Notwithstanding section 144.99, subdivision 11, a person who does any of the​
8696+267.32following on the premises of a registered retailer or another business that sells retail goods​
8697+267​Article 7 Sec. 2.​
8698+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 268.1to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for​
8699+268.2not more than one year or to payment of a fine of not more than $3,000, or both:​
8700+268.3 (1) sells an edible cannabinoid product knowing that the product does not comply with​
8701+268.4the limits on the amount or types of cannabinoids that a product may contain;​
8702+268.5 (2) sells an edible cannabinoid product knowing that the product does not comply with​
8703+268.6the applicable testing, packaging, or labeling requirements; or​
8704+268.7 (3) sells an edible cannabinoid product to a person under the age of 21, except that it is​
8705+268.8an affirmative defense to a charge under this clause if the defendant proves by a​
8706+268.9preponderance of the evidence that the defendant reasonably and in good faith relied on​
8707+268.10proof of age as described in subdivision 5c.​
8708+268.11 EFFECTIVE DATE.This section is effective the day following final enactment.​
8709+268.12Sec. 3. Minnesota Statutes 2022, section 340A.412, subdivision 14, is amended to read:​
8710+268.13 Subd. 14.Exclusive liquor stores.(a) Except as otherwise provided in this subdivision,​
8711+268.14an exclusive liquor store may sell only the following items:​
8712+268.15 (1) alcoholic beverages;​
8713+268.16 (2) tobacco products;​
8714+268.17 (3) ice;​
8715+268.18 (4) beverages, either liquid or powder, specifically designated for mixing with intoxicating​
8716+268.19liquor;​
8717+268.20 (5) soft drinks;​
8718+268.21 (6) liqueur-filled candies;​
8719+268.22 (7) food products that contain more than one-half of one percent alcohol by volume;​
8720+268.23 (8) cork extraction devices;​
8721+268.24 (9) books and videos on the use of alcoholic beverages;​
8722+268.25 (10) magazines and other publications published primarily for information and education​
8723+268.26on alcoholic beverages;​
8724+268.27 (11) multiple-use bags designed to carry purchased items;​
8725+268.28 (12) devices designed to ensure safe storage and monitoring of alcohol in the home, to​
8726+268.29prevent access by underage drinkers;​
8727+268​Article 7 Sec. 3.​
8728+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 269.1 (13) home brewing equipment;​
8729+269.2 (14) clothing marked with the specific name, brand, or identifying logo of the exclusive​
8730+269.3liquor store, and bearing no other name, brand, or identifying logo;​
8731+269.4 (15) citrus fruit; and​
8732+269.5 (16) glassware.;​
8733+269.6 (17) edible cannabinoid products as defined in section 151.72, subdivision 1, paragraph​
8734+269.7(f); and​
8735+269.8 (18) products that detect the presence of fentanyl or a fentanyl analog.​
8736+269.9 (b) An exclusive liquor store that has an on-sale, or combination on-sale and off-sale​
8737+269.10license may sell food for on-premise consumption when authorized by the municipality​
8738+269.11issuing the license.​
8739+269.12 (c) An exclusive liquor store may offer live or recorded entertainment.​
8740+269.13 EFFECTIVE DATE.This section is effective the day following final enactment.​
8741+269.14Sec. 4. EDIBLE CANNABINOID PRODUCTS; ENFORCEMENT .​
8742+269.15 (a) The Department of Health shall enforce the provisions of Minnesota Statutes, section​
8743+269.16151.72, and all rules, orders, stipulation agreements, settlements, compliance agreements,​
8744+269.17and registrations related to that section adopted or issued by the Office of Medical Cannabis​
8745+269.18or the Department of Health pursuant to the Health Enforcement Consolidation Act of 1993​
8746+269.19contained in Minnesota Statutes, sections 144.989 to 144.993. The commissioner of health​
8747+269.20may assign enforcement responsibilities to the Office of Medical Cannabis.​
8748+269.21 (b) The enforcement authority under paragraph (a) shall transfer to the Office of Cannabis​
8749+269.22Management at any such time that the powers and duties of the Department of Health with​
8750+269.23respect to the medical cannabis program under Minnesota Statutes, sections 152.22 to​
8751+269.24152.37, are transferred to the Office of Cannabis Management. The director of the Office​
8752+269.25of Cannabis Management may assign enforcement responsibilities to the Division of Medical​
8753+269.26Cannabis.​
8754+269.27 (c) This section shall expire on July 1, 2024.​
8755+269.28 EFFECTIVE DATE.This section is effective the day following final enactment.​
8756+269.29Sec. 5. REPEALER.​
8757+269.30 Minnesota Statutes 2022, section 151.72, is repealed.​
8758+269​Article 7 Sec. 5.​
8759+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 270.1 EFFECTIVE DATE.This section is effective July 1, 2024.​
8760+270.2 ARTICLE 8​
8761+270.3 SCHEDULING OF MARIJUANA​
8762+270.4Section 1. Minnesota Statutes 2022, section 152.02, subdivision 2, is amended to read:​
8763+270.5 Subd. 2.Schedule I.(a) Schedule I consists of the substances listed in this subdivision.​
8764+270.6 (b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the​
8765+270.7following substances, including their analogs, isomers, esters, ethers, salts, and salts of​
8766+270.8isomers, esters, and ethers, whenever the existence of the analogs, isomers, esters, ethers,​
8767+270.9and salts is possible:​
8768+270.10 (1) acetylmethadol;​
8769+270.11 (2) allylprodine;​
8770+270.12 (3) alphacetylmethadol (except levo-alphacetylmethadol, also known as levomethadyl​
8771+270.13acetate);​
8772+270.14 (4) alphameprodine;​
8773+270.15 (5) alphamethadol;​
8774+270.16 (6) alpha-methylfentanyl benzethidine;​
8775+270.17 (7) betacetylmethadol;​
8776+270.18 (8) betameprodine;​
8777+270.19 (9) betamethadol;​
8778+270.20 (10) betaprodine;​
8779+270.21 (11) clonitazene;​
8780+270.22 (12) dextromoramide;​
8781+270.23 (13) diampromide;​
8782+270.24 (14) diethyliambutene;​
8783+270.25 (15) difenoxin;​
8784+270.26 (16) dimenoxadol;​
8785+270.27 (17) dimepheptanol;​
8786+270.28 (18) dimethyliambutene;​
8787+270​Article 8 Section 1.​
8788+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 271.1 (19) dioxaphetyl butyrate;​
8789+271.2 (20) dipipanone;​
8790+271.3 (21) ethylmethylthiambutene;​
8791+271.4 (22) etonitazene;​
8792+271.5 (23) etoxeridine;​
8793+271.6 (24) furethidine;​
8794+271.7 (25) hydroxypethidine;​
8795+271.8 (26) ketobemidone;​
8796+271.9 (27) levomoramide;​
8797+271.10 (28) levophenacylmorphan;​
8798+271.11 (29) 3-methylfentanyl;​
8799+271.12 (30) acetyl-alpha-methylfentanyl;​
8800+271.13 (31) alpha-methylthiofentanyl;​
8801+271.14 (32) benzylfentanyl beta-hydroxyfentanyl;​
8802+271.15 (33) beta-hydroxy-3-methylfentanyl;​
8803+271.16 (34) 3-methylthiofentanyl;​
8804+271.17 (35) thenylfentanyl;​
8805+271.18 (36) thiofentanyl;​
8806+271.19 (37) para-fluorofentanyl;​
8807+271.20 (38) morpheridine;​
8808+271.21 (39) 1-methyl-4-phenyl-4-propionoxypiperidine;​
8809+271.22 (40) noracymethadol;​
8810+271.23 (41) norlevorphanol;​
8811+271.24 (42) normethadone;​
8812+271.25 (43) norpipanone;​
8813+271.26 (44) 1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine (PEPAP);​
8814+271.27 (45) phenadoxone;​
8815+271​Article 8 Section 1.​
8816+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 272.1 (46) phenampromide;​
8817+272.2 (47) phenomorphan;​
8818+272.3 (48) phenoperidine;​
8819+272.4 (49) piritramide;​
8820+272.5 (50) proheptazine;​
8821+272.6 (51) properidine;​
8822+272.7 (52) propiram;​
8823+272.8 (53) racemoramide;​
8824+272.9 (54) tilidine;​
8825+272.10 (55) trimeperidine;​
8826+272.11 (56) N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide (acetyl fentanyl);​
8827+272.12 (57) 3,4-dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-​
8828+272.13methylbenzamide(U47700);​
8829+272.14 (58) N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide(furanylfentanyl);​
8830+272.15 (59) 4-(4-bromophenyl)-4-dimethylamino-1-phenethylcyclohexanol (bromadol);​
8831+272.16 (60) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (Cyclopropryl​
8832+272.17fentanyl);​
8833+272.18 (61) N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) (butyryl fentanyl);​
8834+272.19 (62) 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) (MT-45);​
8835+272.20 (63) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl​
8836+272.21fentanyl);​
8837+272.22 (64) N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl);​
8838+272.23 (65) N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl);​
8839+272.24 (66) N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide​
8840+272.25(para-chloroisobutyryl fentanyl);​
8841+272.26 (67) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl​
8842+272.27fentanyl);​
8843+272.28 (68) N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide​
8844+272.29(para-methoxybutyryl fentanyl);​
8845+272​Article 8 Section 1.​
8846+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 273.1 (69) N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil);​
8847+273.2 (70) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl​
8848+273.3fentanyl or para-fluoroisobutyryl fentanyl);​
8849+273.4 (71) N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl or​
8850+273.5acryloylfentanyl);​
8851+273.6 (72) 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (methoxyacetyl​
8852+273.7fentanyl);​
8853+273.8 (73) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (ortho-fluorofentanyl​
8854+273.9or 2-fluorofentanyl);​
8855+273.10 (74) N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide​
8856+273.11(tetrahydrofuranyl fentanyl); and​
8857+273.12 (75) Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers,​
8858+273.13esters and ethers, meaning any substance not otherwise listed under another federal​
8859+273.14Administration Controlled Substance Code Number or not otherwise listed in this section,​
8860+273.15and for which no exemption or approval is in effect under section 505 of the Federal Food,​
8861+273.16Drug, and Cosmetic Act, United States Code , title 21, section 355, that is structurally related​
8862+273.17to fentanyl by one or more of the following modifications:​
8863+273.18 (i) replacement of the phenyl portion of the phenethyl group by any monocycle, whether​
8864+273.19or not further substituted in or on the monocycle;​
8865+273.20 (ii) substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo,​
8866+273.21haloalkyl, amino, or nitro groups;​
8867+273.22 (iii) substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether,​
8868+273.23hydroxyl, halo, haloalkyl, amino, or nitro groups;​
8869+273.24 (iv) replacement of the aniline ring with any aromatic monocycle whether or not further​
8870+273.25substituted in or on the aromatic monocycle; or​
8871+273.26 (v) replacement of the N-propionyl group by another acyl group.​
8872+273.27 (c) Opium derivatives. Any of the following substances, their analogs, salts, isomers,​
8873+273.28and salts of isomers, unless specifically excepted or unless listed in another schedule,​
8874+273.29whenever the existence of the analogs, salts, isomers, and salts of isomers is possible:​
8875+273.30 (1) acetorphine;​
8876+273.31 (2) acetyldihydrocodeine;​
8877+273​Article 8 Section 1.​
8878+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 274.1 (3) benzylmorphine;​
8879+274.2 (4) codeine methylbromide;​
8880+274.3 (5) codeine-n-oxide;​
8881+274.4 (6) cyprenorphine;​
8882+274.5 (7) desomorphine;​
8883+274.6 (8) dihydromorphine;​
8884+274.7 (9) drotebanol;​
8885+274.8 (10) etorphine;​
8886+274.9 (11) heroin;​
8887+274.10 (12) hydromorphinol;​
8888+274.11 (13) methyldesorphine;​
8889+274.12 (14) methyldihydromorphine;​
8890+274.13 (15) morphine methylbromide;​
8891+274.14 (16) morphine methylsulfonate;​
8892+274.15 (17) morphine-n-oxide;​
8893+274.16 (18) myrophine;​
8894+274.17 (19) nicocodeine;​
8895+274.18 (20) nicomorphine;​
8896+274.19 (21) normorphine;​
8897+274.20 (22) pholcodine; and​
8898+274.21 (23) thebacon.​
8899+274.22 (d) Hallucinogens. Any material, compound, mixture or preparation which contains any​
8900+274.23quantity of the following substances, their analogs, salts, isomers (whether optical, positional,​
8901+274.24or geometric), and salts of isomers, unless specifically excepted or unless listed in another​
8902+274.25schedule, whenever the existence of the analogs, salts, isomers, and salts of isomers is​
8903+274.26possible:​
8904+274.27 (1) methylenedioxy amphetamine;​
8905+274.28 (2) methylenedioxymethamphetamine;​
8906+274​Article 8 Section 1.​
8907+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 275.1 (3) methylenedioxy-N-ethylamphetamine (MDEA);​
8908+275.2 (4) n-hydroxy-methylenedioxyamphetamine;​
8909+275.3 (5) 4-bromo-2,5-dimethoxyamphetamine (DOB);​
8910+275.4 (6) 2,5-dimethoxyamphetamine (2,5-DMA);​
8911+275.5 (7) 4-methoxyamphetamine;​
8912+275.6 (8) 5-methoxy-3, 4-methylenedioxyamphetamine;​
8913+275.7 (9) alpha-ethyltryptamine;​
8914+275.8 (10) bufotenine;​
8915+275.9 (11) diethyltryptamine;​
8916+275.10 (12) dimethyltryptamine;​
8917+275.11 (13) 3,4,5-trimethoxyamphetamine;​
8918+275.12 (14) 4-methyl-2, 5-dimethoxyamphetamine (DOM);​
8919+275.13 (15) ibogaine;​
8920+275.14 (16) lysergic acid diethylamide (LSD);​
8921+275.15 (17) mescaline;​
8922+275.16 (18) parahexyl;​
8923+275.17 (19) N-ethyl-3-piperidyl benzilate;​
8924+275.18 (20) N-methyl-3-piperidyl benzilate;​
8925+275.19 (21) psilocybin;​
8926+275.20 (22) psilocyn;​
8927+275.21 (23) tenocyclidine (TPCP or TCP);​
8928+275.22 (24) N-ethyl-1-phenyl-cyclohexylamine (PCE);​
8929+275.23 (25) 1-(1-phenylcyclohexyl) pyrrolidine (PCPy);​
8930+275.24 (26) 1-[1-(2-thienyl)cyclohexyl]-pyrrolidine (TCPy);​
8931+275.25 (27) 4-chloro-2,5-dimethoxyamphetamine (DOC);​
8932+275.26 (28) 4-ethyl-2,5-dimethoxyamphetamine (DOET);​
8933+275.27 (29) 4-iodo-2,5-dimethoxyamphetamine (DOI);​
8934+275​Article 8 Section 1.​
8935+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 276.1 (30) 4-bromo-2,5-dimethoxyphenethylamine (2C-B);​
8936+276.2 (31) 4-chloro-2,5-dimethoxyphenethylamine (2C-C);​
8937+276.3 (32) 4-methyl-2,5-dimethoxyphenethylamine (2C-D);​
8938+276.4 (33) 4-ethyl-2,5-dimethoxyphenethylamine (2C-E);​
8939+276.5 (34) 4-iodo-2,5-dimethoxyphenethylamine (2C-I);​
8940+276.6 (35) 4-propyl-2,5-dimethoxyphenethylamine (2C-P);​
8941+276.7 (36) 4-isopropylthio-2,5-dimethoxyphenethylamine (2C-T-4);​
8942+276.8 (37) 4-propylthio-2,5-dimethoxyphenethylamine (2C-T-7);​
8943+276.9 (38) 2-(8-bromo-2,3,6,7-tetrahydrofuro [2,3-f][1]benzofuran-4-yl)ethanamine​
8944+276.10(2-CB-FLY);​
8945+276.11 (39) bromo-benzodifuranyl-isopropylamine (Bromo-DragonFLY);​
8946+276.12 (40) alpha-methyltryptamine (AMT);​
8947+276.13 (41) N,N-diisopropyltryptamine (DiPT);​
8948+276.14 (42) 4-acetoxy-N,N-dimethyltryptamine (4-AcO-DMT);​
8949+276.15 (43) 4-acetoxy-N,N-diethyltryptamine (4-AcO-DET);​
8950+276.16 (44) 4-hydroxy-N-methyl-N-propyltryptamine (4-HO-MPT);​
8951+276.17 (45) 4-hydroxy-N,N-dipropyltryptamine (4-HO-DPT);​
8952+276.18 (46) 4-hydroxy-N,N-diallyltryptamine (4-HO-DALT);​
8953+276.19 (47) 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT);​
8954+276.20 (48) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT);​
8955+276.21 (49) 5-methoxy-α-methyltryptamine (5-MeO-AMT);​
8956+276.22 (50) 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT);​
8957+276.23 (51) 5-methylthio-N,N-dimethyltryptamine (5-MeS-DMT);​
8958+276.24 (52) 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT);​
8959+276.25 (53) 5-methoxy-α-ethyltryptamine (5-MeO-AET);​
8960+276.26 (54) 5-methoxy-N,N-dipropyltryptamine (5-MeO-DPT);​
8961+276.27 (55) 5-methoxy-N,N-diethyltryptamine (5-MeO-DET);​
8962+276​Article 8 Section 1.​
8963+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 277.1 (56) 5-methoxy-N,N-diallyltryptamine (5-MeO-DALT);​
8964+277.2 (57) methoxetamine (MXE);​
8965+277.3 (58) 5-iodo-2-aminoindane (5-IAI);​
8966+277.4 (59) 5,6-methylenedioxy-2-aminoindane (MDAI);​
8967+277.5 (60) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe);​
8968+277.6 (61) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe);​
8969+277.7 (62) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe);​
8970+277.8 (63) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);​
8971+277.9 (64) 2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine (2C-T-2);​
8972+277.10 (65) N,N-Dipropyltryptamine (DPT);​
8973+277.11 (66) 3-[1-(Piperidin-1-yl)cyclohexyl]phenol (3-HO-PCP);​
8974+277.12 (67) N-ethyl-1-(3-methoxyphenyl)cyclohexanamine (3-MeO-PCE);​
8975+277.13 (68) 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo);​
8976+277.14 (69) 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine (methoxydine, 4-MeO-PCP);​
8977+277.15 (70) 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexan-1-one (N-Ethylnorketamine,​
8978+277.16ethketamine, NENK);​
8979+277.17 (71) methylenedioxy-N,N-dimethylamphetamine (MDDMA);​
8980+277.18 (72) 3-(2-Ethyl(methyl)aminoethyl)-1H-indol-4-yl (4-AcO-MET); and​
8981+277.19 (73) 2-Phenyl-2-(methylamino)cyclohexanone (deschloroketamine).​
8982+277.20 (e) Peyote. All parts of the plant presently classified botanically as Lophophora williamsii​
8983+277.21Lemaire, whether growing or not, the seeds thereof, any extract from any part of the plant,​
8984+277.22and every compound, manufacture, salts, derivative, mixture, or preparation of the plant,​
8985+277.23its seeds or extracts. The listing of peyote as a controlled substance in Schedule I does not​
8986+277.24apply to the nondrug use of peyote in bona fide religious ceremonies of the American Indian​
8987+277.25Church, and members of the American Indian Church are exempt from registration. Any​
8988+277.26person who manufactures peyote for or distributes peyote to the American Indian Church,​
8989+277.27however, is required to obtain federal registration annually and to comply with all other​
8990+277.28requirements of law.​
8991+277.29 (f) Central nervous system depressants. Unless specifically excepted or unless listed in​
8992+277.30another schedule, any material compound, mixture, or preparation which contains any​
8993+277​Article 8 Section 1.​
8994+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 278.1quantity of the following substances, their analogs, salts, isomers, and salts of isomers​
8995+278.2whenever the existence of the analogs, salts, isomers, and salts of isomers is possible:​
8996+278.3 (1) mecloqualone;​
8997+278.4 (2) methaqualone;​
8998+278.5 (3) gamma-hydroxybutyric acid (GHB), including its esters and ethers;​
8999+278.6 (4) flunitrazepam;​
9000+278.7 (5) 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexanone (2-MeO-2-deschloroketamine,​
9001+278.8methoxyketamine);​
9002+278.9 (6) tianeptine;​
9003+278.10 (7) clonazolam;​
9004+278.11 (8) etizolam;​
9005+278.12 (9) flubromazolam; and​
9006+278.13 (10) flubromazepam.​
9007+278.14 (g) Stimulants. Unless specifically excepted or unless listed in another schedule, any​
9008+278.15material compound, mixture, or preparation which contains any quantity of the following​
9009+278.16substances, their analogs, salts, isomers, and salts of isomers whenever the existence of the​
9010+278.17analogs, salts, isomers, and salts of isomers is possible:​
9011+278.18 (1) aminorex;​
9012+278.19 (2) cathinone;​
9013+278.20 (3) fenethylline;​
9014+278.21 (4) methcathinone;​
9015+278.22 (5) methylaminorex;​
9016+278.23 (6) N,N-dimethylamphetamine;​
9017+278.24 (7) N-benzylpiperazine (BZP);​
9018+278.25 (8) methylmethcathinone (mephedrone);​
9019+278.26 (9) 3,4-methylenedioxy-N-methylcathinone (methylone);​
9020+278.27 (10) methoxymethcathinone (methedrone);​
9021+278.28 (11) methylenedioxypyrovalerone (MDPV);​
9022+278​Article 8 Section 1.​
9023+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 279.1 (12) 3-fluoro-N-methylcathinone (3-FMC);​
9024+279.2 (13) methylethcathinone (MEC);​
9025+279.3 (14) 1-benzofuran-6-ylpropan-2-amine (6-APB);​
9026+279.4 (15) dimethylmethcathinone (DMMC);​
9027+279.5 (16) fluoroamphetamine;​
9028+279.6 (17) fluoromethamphetamine;​
9029+279.7 (18) α-methylaminobutyrophenone (MABP or buphedrone);​
9030+279.8 (19) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone);​
9031+279.9 (20) 2-(methylamino)-1-(4-methylphenyl)butan-1-one (4-MEMABP or BZ-6378);​
9032+279.10 (21) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl) pentan-1-one (naphthylpyrovalerone or​
9033+279.11naphyrone);​
9034+279.12 (22) (alpha-pyrrolidinopentiophenone (alpha-PVP);​
9035+279.13 (23) (RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-hexanone (4-Me-PHP or MPHP);​
9036+279.14 (24) 2-(1-pyrrolidinyl)-hexanophenone (Alpha-PHP);​
9037+279.15 (25) 4-methyl-N-ethylcathinone (4-MEC);​
9038+279.16 (26) 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP);​
9039+279.17 (27) 2-(methylamino)-1-phenylpentan-1-one (pentedrone);​
9040+279.18 (28) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone);​
9041+279.19 (29) 4-fluoro-N-methylcathinone (4-FMC);​
9042+279.20 (30) 3,4-methylenedioxy-N-ethylcathinone (ethylone);​
9043+279.21 (31) alpha-pyrrolidinobutiophenone (α-PBP);​
9044+279.22 (32) 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB);​
9045+279.23 (33) 1-phenyl-2-(1-pyrrolidinyl)-1-heptanone (PV8);​
9046+279.24 (34) 6-(2-Aminopropyl)-2,3-dihydrobenzofuran (6-APDB);​
9047+279.25 (35) 4-methyl-alpha-ethylaminopentiophenone (4-MEAPP);​
9048+279.26 (36) 4'-chloro-alpha-pyrrolidinopropiophenone (4'-chloro-PPP);​
9049+279.27 (37) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one (dibutylone, bk-DMBDB);​
9050+279​Article 8 Section 1.​
9051+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 280.1 (38) 1-(3-chlorophenyl) piperazine (meta-chlorophenylpiperazine or mCPP);​
9052+280.2 (39) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one (N-ethylpentylone, ephylone);​
9053+280.3and​
9054+280.4 (40) any other substance, except bupropion or compounds listed under a different​
9055+280.5schedule, that is structurally derived from 2-aminopropan-1-one by substitution at the​
9056+280.61-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the​
9057+280.7compound is further modified in any of the following ways:​
9058+280.8 (i) by substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy,​
9059+280.9haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring​
9060+280.10system by one or more other univalent substituents;​
9061+280.11 (ii) by substitution at the 3-position with an acyclic alkyl substituent;​
9062+280.12 (iii) by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or​
9063+280.13methoxybenzyl groups; or​
9064+280.14 (iv) by inclusion of the 2-amino nitrogen atom in a cyclic structure.​
9065+280.15 (h) Marijuana, tetrahydrocannabinols, and synthetic cannabinoids. Unless specifically​
9066+280.16excepted or unless listed in another schedule, any natural or synthetic material, compound,​
9067+280.17mixture, or preparation that contains any quantity of the following substances, their analogs,​
9068+280.18isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence​
9069+280.19of the isomers, esters, ethers, or salts is possible:​
9070+280.20 (1) marijuana;​
9071+280.21 (2) tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, except​
9072+280.22that tetrahydrocannabinols do not include any material, compound, mixture, or preparation​
9073+280.23that qualifies as industrial hemp as defined in section 18K.02, subdivision 3; synthetic​
9074+280.24equivalents of the substances contained in the cannabis plant or in the resinous extractives​
9075+280.25of the plant; or synthetic substances with similar chemical structure and pharmacological​
9076+280.26activity to those substances contained in the plant or resinous extract, including, but not​
9077+280.27limited to, 1 cis or trans tetrahydrocannabinol, 6 cis or trans tetrahydrocannabinol, and 3,4​
9078+280.28cis or trans tetrahydrocannabinol;​
9079+280.29 (3) (h) Synthetic cannabinoids, including the following substances:​
9080+280.30 (i) (1) Naphthoylindoles, which are any compounds containing a 3-(1-napthoyl)indole​
9081+280.31structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl,​
9082+280.32alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or​
9083+280​Article 8 Section 1.​
9084+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 281.12-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any​
9085+281.2extent and whether or not substituted in the naphthyl ring to any extent. Examples of​
9086+281.3naphthoylindoles include, but are not limited to:​
9087+281.4 (A) (i) 1-Pentyl-3-(1-naphthoyl)indole (JWH-018 and AM-678);​
9088+281.5 (B) (ii) 1-Butyl-3-(1-naphthoyl)indole (JWH-073);​
9089+281.6 (C) (iii) 1-Pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081);​
9090+281.7 (D) (iv) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);​
9091+281.8 (E) (v) 1-Propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015);​
9092+281.9 (F) (vi) 1-Hexyl-3-(1-naphthoyl)indole (JWH-019);​
9093+281.10 (G) (vii) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);​
9094+281.11 (H) (viii) 1-Pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210);​
9095+281.12 (I) (ix) 1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);​
9096+281.13 (J) (x) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201).​
9097+281.14 (ii) (2) Napthylmethylindoles, which are any compounds containing a​
9098+281.151H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the​
9099+281.16indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,​
9100+281.171-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further​
9101+281.18substituted in the indole ring to any extent and whether or not substituted in the naphthyl​
9102+281.19ring to any extent. Examples of naphthylmethylindoles include, but are not limited to:​
9103+281.20 (A) (i) 1-Pentyl-1H-indol-3-yl-(1-naphthyl)methane (JWH-175);​
9104+281.21 (B) (ii) 1-Pentyl-1H-indol-3-yl-(4-methyl-1-naphthyl)methane (JWH-184).​
9105+281.22 (iii) (3) Naphthoylpyrroles, which are any compounds containing a 3-(1-naphthoyl)pyrrole​
9106+281.23structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl,​
9107+281.24alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or​
9108+281.252-(4-morpholinyl)ethyl group whether or not further substituted in the pyrrole ring to any​
9109+281.26extent, whether or not substituted in the naphthyl ring to any extent. Examples of​
9110+281.27naphthoylpyrroles include, but are not limited to,​
9111+281.28(5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone (JWH-307).​
9112+281.29 (iv) (4) Naphthylmethylindenes, which are any compounds containing a​
9113+281.30naphthylideneindene structure with substitution at the 3-position of the indene ring by an​
9114+281.31alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,​
9115+281​Article 8 Section 1.​
9116+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 282.11-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not further​
9117+282.2substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring​
9118+282.3to any extent. Examples of naphthylemethylindenes include, but are not limited to,​
9119+282.4E-1-[1-(1-naphthalenylmethylene)-1H-inden-3-yl]pentane (JWH-176).​
9120+282.5 (v) (5) Phenylacetylindoles, which are any compounds containing a 3-phenylacetylindole​
9121+282.6structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl,​
9122+282.7alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or​
9123+282.82-(4-morpholinyl)ethyl group whether or not further substituted in the indole ring to any​
9124+282.9extent, whether or not substituted in the phenyl ring to any extent. Examples of​
9125+282.10phenylacetylindoles include, but are not limited to:​
9126+282.11 (A) (i) 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole (RCS-8);​
9127+282.12 (B) (ii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);​
9128+282.13 (C) (iii) 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251);​
9129+282.14 (D) (iv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).​
9130+282.15 (vi) (6) Cyclohexylphenols, which are compounds containing a​
9131+282.162-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic​
9132+282.17ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,​
9133+282.181-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not substituted​
9134+282.19in the cyclohexyl ring to any extent. Examples of cyclohexylphenols include, but are not​
9135+282.20limited to:​
9136+282.21 (A) (i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497);​
9137+282.22 (B) (ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol​
9138+282.23(Cannabicyclohexanol or CP 47,497 C8 homologue);​
9139+282.24 (C) (iii) 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]​
9140+282.25-phenol (CP 55,940).​
9141+282.26 (vii) (7) Benzoylindoles, which are any compounds containing a 3-(benzoyl)indole​
9142+282.27structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl,​
9143+282.28alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or​
9144+282.292-(4-morpholinyl)ethyl group whether or not further substituted in the indole ring to any​
9145+282.30extent and whether or not substituted in the phenyl ring to any extent. Examples of​
9146+282.31benzoylindoles include, but are not limited to:​
9147+282.32 (A) (i) 1-Pentyl-3-(4-methoxybenzoyl)indole (RCS-4);​
9148+282​Article 8 Section 1.​
9149+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 283.1 (B) (ii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694);​
9150+283.2 (C) (iii) (4-methoxyphenyl-[2-methyl-1-(2-(4-morpholinyl)ethyl)indol-3-yl]methanone​
9151+283.3(WIN 48,098 or Pravadoline).​
9152+283.4 (viii) (8) Others specifically named:​
9153+283.5 (A) (i) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)​
9154+283.6-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (HU-210);​
9155+283.7 (B) (ii) (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)​
9156+283.8-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Dexanabinol or HU-211);​
9157+283.9 (C) (iii) 2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]​
9158+283.10-1,4-benzoxazin-6-yl-1-naphthalenylmethanone (WIN 55,212-2);​
9159+283.11 (D) (iv) (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144);​
9160+283.12 (E) (v) (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone​
9161+283.13(XLR-11);​
9162+283.14 (F) (vi) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide​
9163+283.15(AKB-48(APINACA));​
9164+283.16 (G) (vii) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide​
9165+283.17(5-Fluoro-AKB-48);​
9166+283.18 (H) (viii) 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22);​
9167+283.19 (I) (ix) 8-quinolinyl ester-1-(5-fluoropentyl)-1H-indole-3-carboxylic acid (5-Fluoro​
9168+283.20PB-22);​
9169+283.21 (J) (x) N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole- 3-carboxamide​
9170+283.22(AB-PINACA);​
9171+283.23 (K) (xi) N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-​
9172+283.241H-indazole-3-carboxamide (AB-FUBINACA);​
9173+283.25 (L) (xii) N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-​
9174+283.26indazole-3-carboxamide(AB-CHMINACA);​
9175+283.27 (M) (xiii) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-​
9176+283.28methylbutanoate (5-fluoro-AMB);​
9177+283.29 (N) (xiv) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl) methanone (THJ-2201);​
9178+283​Article 8 Section 1.​
9179+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 284.1 (O) (xv) (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone)​
9180+284.2(FUBIMINA);​
9181+284.3 (P) (xvi) (7-methoxy-1-(2-morpholinoethyl)-N-((1S,2S,4R)-1,3,3-trimethylbicyclo​
9182+284.4[2.2.1]heptan-2-yl)-1H-indole-3-carboxamide (MN-25 or UR-12);​
9183+284.5 (Q) (xvii) (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)​
9184+284.6-1H-indole-3-carboxamide (5-fluoro-ABICA);​
9185+284.7 (R) (xviii) N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)​
9186+284.8-1H-indole-3-carboxamide;​
9187+284.9 (S) (xix) N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)​
9188+284.10-1H-indazole-3-carboxamide;​
9189+284.11 (T) (xx) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)​
9190+284.12-3,3-dimethylbutanoate;​
9191+284.13 (U) (xxi) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1​
9192+284.14H-indazole-3-carboxamide (MAB-CHMINACA);​
9193+284.15 (V) (xxii)​
9194+284.16N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-pentyl-1H-indazole-3-carboxamide​
9195+284.17(ADB-PINACA);​
9196+284.18 (W) (xxiii) methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate (FUB-AMB);​
9197+284.19 (X) (xxiv)​
9198+284.20N-[(1S)-2-amino-2-oxo-1-(phenylmethyl)ethyl]-1-(cyclohexylmethyl)-1H-Indazole-​
9199+284.213-carboxamide. (APP-CHMINACA);​
9200+284.22 (Y) (xxv) quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FUB-PB-22); and​
9201+284.23 (Z) (xxvi) methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]valinate​
9202+284.24(MMB-CHMICA).​
9203+284.25 (ix) (9) Additional substances specifically named:​
9204+284.26 (A) (i) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1​
9205+284.27H-pyrrolo[2,3-B]pyridine-3-carboxamide (5F-CUMYL-P7AICA);​
9206+284.28 (B) (ii) 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1 H-indazole-3-carboxamide​
9207+284.29(4-CN-Cumyl-Butinaca);​
9208+284.30 (C) (iii) naphthalen-1-yl-1-(5-fluoropentyl)-1-H-indole-3-carboxylate (NM2201;​
9209+284.31CBL2201);​
9210+284​Article 8 Section 1.​
9211+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 285.1 (D) (iv) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1​
9212+285.2H-indazole-3-carboxamide (5F-ABPINACA);​
9213+285.3 (E) (v) methyl-2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate​
9214+285.4(MDMB CHMICA);​
9215+285.5 (F) (vi) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate​
9216+285.6(5F-ADB; 5F-MDMB-PINACA); and​
9217+285.7 (G) (vii) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)​
9218+285.81H-indazole-3-carboxamide (ADB-FUBINACA).​
9219+285.9 (i) A controlled substance analog, to the extent that it is implicitly or explicitly intended​
9220+285.10for human consumption.​
9221+285.11 EFFECTIVE DATE.This section is effective the day following final enactment.​
9222+285.12Sec. 2. Minnesota Statutes 2022, section 152.02, subdivision 4, is amended to read:​
9223+285.13 Subd. 4.Schedule III.(a) Schedule III consists of the substances listed in this subdivision.​
9224+285.14 (b) Stimulants. Unless specifically excepted or unless listed in another schedule, any​
9225+285.15material, compound, mixture, or preparation which contains any quantity of the following​
9226+285.16substances having a potential for abuse associated with a stimulant effect on the central​
9227+285.17nervous system, including its salts, isomers, and salts of such isomers whenever the existence​
9228+285.18of such salts, isomers, and salts of isomers is possible within the specific chemical​
9229+285.19designation:​
9230+285.20 (1) benzphetamine;​
9231+285.21 (2) chlorphentermine;​
9232+285.22 (3) clortermine;​
9233+285.23 (4) phendimetrazine.​
9234+285.24 (c) Depressants. Unless specifically excepted or unless listed in another schedule, any​
9235+285.25material, compound, mixture, or preparation which contains any quantity of the following​
9236+285.26substances having a potential for abuse associated with a depressant effect on the central​
9237+285.27nervous system:​
9238+285.28 (1) any compound, mixture, or preparation containing amobarbital, secobarbital,​
9239+285.29pentobarbital or any salt thereof and one or more other active medicinal ingredients which​
9240+285.30are not listed in any schedule;​
9241+285​Article 8 Sec. 2.​
9242+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 286.1 (2) any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or​
9243+286.2any salt of any of these drugs and approved by the food and drug administration for marketing​
9244+286.3only as a suppository;​
9245+286.4 (3) any substance which contains any quantity of a derivative of barbituric acid, or any​
9246+286.5salt of a derivative of barbituric acid, except those substances which are specifically listed​
9247+286.6in other schedules;​
9248+286.7 (4) any drug product containing gamma hydroxybutyric acid, including its salts, isomers,​
9249+286.8and salts of isomers, for which an application is approved under section 505 of the federal​
9250+286.9Food, Drug, and Cosmetic Act;​
9251+286.10 (5) any of the following substances:​
9252+286.11 (i) chlorhexadol;​
9253+286.12 (ii) ketamine, its salts, isomers and salts of isomers;​
9254+286.13 (iii) lysergic acid;​
9255+286.14 (iv) lysergic acid amide;​
9256+286.15 (v) methyprylon;​
9257+286.16 (vi) sulfondiethylmethane;​
9258+286.17 (vii) sulfonenthylmethane;​
9259+286.18 (viii) sulfonmethane;​
9260+286.19 (ix) tiletamine and zolazepam and any salt thereof;​
9261+286.20 (x) embutramide;​
9262+286.21 (xi) Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-Dihydropyridin-3-yl)​
9263+286.22benzonitrile].​
9264+286.23 (d) Nalorphine.​
9265+286.24 (e) Narcotic drugs. Unless specifically excepted or unless listed in another schedule,​
9266+286.25any material, compound, mixture, or preparation containing any of the following narcotic​
9267+286.26drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities​
9268+286.27as follows:​
9269+286.28 (1) not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams​
9270+286.29per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;​
9271+286​Article 8 Sec. 2.​
9272+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 287.1 (2) not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams​
9273+287.2per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic​
9274+287.3amounts;​
9275+287.4 (3) not more than 1.80 grams of dihydrocodeine per 100 milliliters or not more than 90​
9276+287.5milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized​
9277+287.6therapeutic amounts;​
9278+287.7 (4) not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than​
9279+287.815 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized​
9280+287.9therapeutic amounts;​
9281+287.10 (5) not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not​
9282+287.11more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients​
9283+287.12in recognized therapeutic amounts;​
9284+287.13 (6) not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with​
9285+287.14one or more active, nonnarcotic ingredients in recognized therapeutic amounts.​
9286+287.15 (f) Anabolic steroids, human growth hormone, and chorionic gonadotropin.​
9287+287.16 (1) Anabolic steroids, for purposes of this subdivision, means any drug or hormonal​
9288+287.17substance, chemically and pharmacologically related to testosterone, other than estrogens,​
9289+287.18progestins, corticosteroids, and dehydroepiandrosterone, and includes:​
9290+287.19 (i) 3[beta],17[beta]-dihydroxy-5[alpha]-androstane;​
9291+287.20 (ii) 3[alpha],17[beta]-dihydroxy-5[alpha]-androstane;​
9292+287.21 (iii) androstanedione (5[alpha]-androstan-3,17-dione);​
9293+287.22 (iv) 1-androstenediol (3[beta],17[beta]-dihydroxy-5[alpha]-androst-l-ene;​
9294+287.23 (v) 3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene);​
9295+287.24 (vi) 4-androstenediol (3[beta],17[beta]-dihydroxy-androst-4-ene);​
9296+287.25 (vii) 5-androstenediol (3[beta],17[beta]-dihydroxy-androst-5-ene);​
9297+287.26 (viii) 1-androstenedione (5[alpha]-androst-1-en-3,17-dione);​
9298+287.27 (ix) 4-androstenedione (androst-4-en-3,17-dione);​
9299+287.28 (x) 5-androstenedione (androst-5-en-3,17-dione);​
9300+287.29 (xi) bolasterone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);​
9301+287.30 (xii) boldenone (17[beta]-hydroxyandrost-1,4-diene-3-one);​
9302+287​Article 8 Sec. 2.​
9303+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 288.1 (xiii) boldione (androsta-1,4-diene-3,17-dione);​
9304+288.2 (xiv) calusterone (7[beta],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);​
9305+288.3 (xv) clostebol (4-chloro-17[beta]-hydroxyandrost-4-en-3-one);​
9306+288.4 (xvi) dehydrochloromethyltestosterone​
9307+288.5(4-chloro-17[beta]-hydroxy-17[alpha]-methylandrost-1,4-dien-3-one);​
9308+288.6 (xvii) desoxymethyltestosterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[beta]-ol);​
9309+288.7 (xviii) [delta]1-dihydrotestosterone- (17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);​
9310+288.8 (xix) 4-dihydrotestosterone (17[beta]-hydroxy-androstan-3-one);​
9311+288.9 (xx) drostanolone (17[beta]hydroxy-2[alpha]-methyl-5[alpha]-androstan-3-one);​
9312+288.10 (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]-hydroxyestr-4-ene);​
9313+288.11 (xxii) fluoxymesterone​
9314+288.12(9-fluoro-17[alpha]-methyl-11[beta],17[beta]-dihydroxyandrost-4-en-3-one);​
9315+288.13 (xxiii) formebolone​
9316+288.14(2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-1,4-dien-3-one);​
9317+288.15 (xxiv) furazabol​
9318+288.16(17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan)13[beta]-ethyl-17[beta]​
9319+288.17-hydroxygon-4-en-3-one;​
9320+288.18 (xxv) 4-hydroxytestosterone (4,17[beta]-dihydroxyandrost-4-en-3-one);​
9321+288.19 (xxvi) 4-hydroxy-19-nortestosterone (4,17[beta]-dihydroxyestr-4-en-3-one);​
9322+288.20 (xxvii) mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one);​
9323+288.21 (xxviii) mesterolone (1[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one);​
9324+288.22 (xxix) methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-dien-3-one);​
9325+288.23 (xxx) methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene);​
9326+288.24 (xxxi) methasterone (2 alpha-17 alpha-dimethyl-5 alpha-androstan-17beta-ol-3-one);​
9327+288.25 (xxxii) methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);​
9328+288.26 (xxxiii) 17[alpha]-methyl-3[beta],17[beta]-dihydroxy-5[alpha]-androstane;​
9329+288.27 (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5[alpha]-androstane;​
9330+288.28 (xxxv) 17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene;​
9331+288​Article 8 Sec. 2.​
9332+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 289.1 (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone​
9333+289.2(17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one);​
9334+289.3 (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one);​
9335+289.4 (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9-11-trien-3-one);​
9336+289.5 (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]-hydroxyandrost-4-en-3-one);​
9337+289.6 (xl) mibolerone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyestr-4-en-3-one);​
9338+289.7 (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone​
9339+289.8(17[beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one);​
9340+289.9 (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one);​
9341+289.10 (xliii) 19-nor-4-androstenediol (3[beta],17[beta]-dihydroxyestr-4-ene;​
9342+289.11 (xliv) 3[alpha],17[beta]-dihydroxyestr-4-ene); 19-nor-5-androstenediol​
9343+289.12(3[beta],17[beta]-dihydroxyestr-5-ene;​
9344+289.13 (xlv) 3[alpha],17[beta]-dihydroxyestr-5-ene);​
9345+289.14 (xlvi) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);​
9346+289.15 (xlvii) 19-nor-5-androstenedione (estr-5-en-3,17-dione);​
9347+289.16 (xlviii) norbolethone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4-en-3-one);​
9348+289.17 (xlix) norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3-one);​
9349+289.18 (l) norethandrolone (17[alpha]-ethyl-17[beta]-hydroxyestr-4-en-3-one);​
9350+289.19 (li) normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one);​
9351+289.20 (lii) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-5[alpha]-androstan-3-one);​
9352+289.21 (liii) oxymesterone (17[alpha]-methyl-4,17[beta]-dihydroxyandrost-4-en-3-one);​
9353+289.22 (liv) oxymetholone​
9354+289.23(17[alpha]-methyl-2-hydroxymethylene-17[beta]-hydroxy-5[alpha]-androstan-3-one);​
9355+289.24 (lv) prostanozol (17 beta-hydroxy-5 alpha-androstano[3,2-C]pryazole;​
9356+289.25 (lvi) stanozolol​
9357+289.26(17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androst-2-eno[3,2-c]-pyrazole);​
9358+289.27 (lvii) stenbolone (17[beta]-hydroxy-2-methyl-5[alpha]-androst-1-en-3-one);​
9359+289.28 (lviii) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);​
9360+289​Article 8 Sec. 2.​
9361+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 290.1 (lix) testosterone (17[beta]-hydroxyandrost-4-en-3-one);​
9362+290.2 (lx) tetrahydrogestrinone​
9363+290.3(13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4,9,11-trien-3-one);​
9364+290.4 (lxi) trenbolone (17[beta]-hydroxyestr-4,9,11-trien-3-one);​
9365+290.5 (lxii) any salt, ester, or ether of a drug or substance described in this paragraph.​
9366+290.6Anabolic steroids are not included if they are: (A) expressly intended for administration​
9367+290.7through implants to cattle or other nonhuman species; and (B) approved by the United States​
9368+290.8Food and Drug Administration for that use;​
9369+290.9 (2) Human growth hormones.​
9370+290.10 (3) Chorionic gonadotropin, except that a product containing chorionic gonadotropin is​
9371+290.11not included if it is:​
9372+290.12 (i) expressly intended for administration to cattle or other nonhuman species; and​
9373+290.13 (ii) approved by the United States Food and Drug Administration for that use.​
9374+290.14 (g) Hallucinogenic substances. Dronabinol (synthetic) in sesame oil and encapsulated​
9375+290.15in a soft gelatin capsule in a United States Food and Drug Administration approved product.​
9376+290.16 (h) Any material, compound, mixture, or preparation containing the following narcotic​
9377+290.17drug or its salt: buprenorphine.​
9378+290.18 (i) Marijuana, tetrahydrocannabinols, and synthetic cannabinoids. Unless specifically​
9379+290.19excepted or unless listed in another schedule, any natural or synthetic material, compound,​
9380+290.20mixture, or preparation that contains any quantity of the following substances, their analogs,​
9381+290.21isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence​
9382+290.22of the isomers, esters, ethers, or salts is possible:​
9383+290.23 (1) marijuana;​
9384+290.24 (2) tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, except​
9385+290.25that tetrahydrocannabinols do not include any material, compound, mixture, or preparation​
9386+290.26that qualifies as industrial hemp as defined in section 18K.02, subdivision 3; synthetic​
9387+290.27equivalents of the substances contained in the cannabis plant or in the resinous extractives​
9388+290.28of the plant; or synthetic substances with similar chemical structure and pharmacological​
9389+290.29activity to those substances contained in the plant or resinous extract, including but not​
9390+290.30limited to 1 cis or trans tetrahydrocannabinol, 6 cis or trans tetrahydrocannabinol, and 3,4​
9391+290.31cis or trans tetrahydrocannabinol.​
9392+290​Article 8 Sec. 2.​
9393+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 291.1 EFFECTIVE DATE.This section is effective the day following final enactment.​
9394+291.2 ARTICLE 9​
9395+291.3 IMPLEMENTATION; APPROPRIATIONS; TRANSFER​
9396+291.4Section 1. OFFICE OF CANNABIS MANAGEMENT; IMPLEMENTATION.​
9397+291.5 (a) $3,000,000 in fiscal year 2023 is appropriated from the general fund to the​
9398+291.6commissioner of agriculture for the planning, research, analysis, and other efforts needed​
9399+291.7to establish the Office of Cannabis Management and transition programs, authorities, and​
9400+291.8responsibilities contained in Minnesota Statutes, chapter 342, to that office. This is a onetime​
9401+291.9appropriation and is available until June 30, 2025.​
9402+291.10 (b) Upon the effective date of this act, the commissioner of agriculture may exercise all​
9403+291.11authorities and responsibilities granted to the Office of Cannabis Management under​
9404+291.12Minnesota Statutes, chapter 342, that are necessary to establish the Office of Cannabis​
9405+291.13Management and transition programs, authorities, and responsibilities to that office.​
9406+291.14 (c) On or after January 1, 2024, and at such time the Office of Cannabis Management​
9407+291.15is able to fulfill the powers and duties enumerated in Minnesota Statutes, section 342.02,​
9408+291.16subdivision 2, the commissioner of agriculture may transfer all or some Minnesota Statutes,​
9409+291.17chapter 342, programs, authorities, and responsibilities to the Office of Cannabis​
9410+291.18Management. Upon such transfer, existing contracts, obligations, and funds managed by​
9411+291.19the commissioner of agriculture that are necessary to administer the transferred programs,​
9412+291.20authorities, or responsibilities shall be transferred to the Office of Cannabis Management.​
9413+291.21 (d) To the extent necessary to establish the Office of Cannabis Management and fulfill​
9414+291.22the powers and duties enumerated in Minnesota Statutes, section 342.02, the commissioner​
9415+291.23of agriculture and the Office of Cannabis Management are exempt from the requirements​
9416+291.24of Minnesota Statutes, section 16A.15, subdivision 3, and chapter 16C, and any other state​
9417+291.25procurement laws, rules, and procedures. This exemption expires on July 1, 2025.​
9418+291.26 EFFECTIVE DATE.This section is effective the day following final enactment.​
9419+291.27Sec. 2. APPROPRIATIONS; TRANSFER.​
9420+291.28 Subdivision 1.Office of Cannabis Management.(a) $20,814,000 in fiscal year 2024​
9421+291.29and $17,260,000 in fiscal year 2025 are appropriated from the general fund to the Office​
9422+291.30of Cannabis Management for purposes of this act. The base for this appropriation is​
9423+291.31$31,787,000 in fiscal year 2026 and $42,344,00 in fiscal year 2027.​
9424+291​Article 9 Sec. 2.​
9425+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 292.1 (b) Of the base established in paragraph (a), $12,000,000 in fiscal year 2026 and​
9426+292.2$20,000,000 in fiscal year 2027 are for cannabis industry community renewal grants. Of​
9427+292.3these amounts, up to three percent may be used for administrative expenses.​
9428+292.4 (c) Of the base established in paragraph (a), $1,000,000 in fiscal year 2026 and $1,000,000​
9429+292.5in fiscal year 2027 are for grants issued pursuant to Minnesota Statutes, section 342.73, to​
9430+292.6eligible organizations to help farmers navigate the regulatory structure of the legal cannabis​
9431+292.7industry and to nonprofit corporations to fund loans to farmers for expansion into the legal​
9432+292.8cannabis industry. Of these amounts, up to three percent may be used for administrative​
9433+292.9expenses.​
9434+292.10 Subd. 2.Substance use treatment, recovery, and prevention grant account;​
9435+292.11transfer.Money for substance use treatment, recovery, and prevention is transferred from​
9436+292.12the general fund to the substance use treatment, recovery, and prevention grant account​
9437+292.13established under Minnesota Statutes, section 342.72. The transfer is $4,000,000 in fiscal​
9438+292.14years 2024 and 2025. The base for this transfer is $12,000,000 in fiscal year 2026 and​
9439+292.15$16,000,000 in fiscal year 2027.​
9440+292.16 Subd. 3.Office of Cannabis Management; extension and research grants.(a) $100,000​
9441+292.17in fiscal year 2024 and $100,000 in fiscal year 2025 are appropriated from the general fund​
9442+292.18to the Office of Cannabis Management for grants to the University of Minnesota for cannabis​
9443+292.19genetics and agronomy research. The base for this appropriation is $750,000 in fiscal year​
9444+292.202026 and beyond.​
9445+292.21 (b) Projects involving cannabis genetics and agronomy research that are not currently​
9446+292.22receiving financial support from the University of Minnesota are eligible for grants under​
9447+292.23this section. Grant money must be used for the creation and maintenance of a University of​
9448+292.24Minnesota Extension position and a postdoctoral position.​
9449+292.25 (c) In awarding grants, the Office of Cannabis Management must give priority to​
9450+292.26applications by researchers who would be eligible to be social equity applicants as defined​
9451+292.27in Minnesota Statutes, section 342.16.​
9452+292.28 Subd. 4.Department of Agriculture.$411,000 in fiscal year 2024 and $411,000 in​
9453+292.29fiscal year 2025 are appropriated from the general fund to the commissioner of agriculture​
9454+292.30to provide consultation services and assist the Office of Cannabis Management with licensing,​
9455+292.31inspection, enforcement, laboratory services, surveillance of retail sales, outreach, and grants​
9456+292.32to farmers, and to perform other duties as required by this act. The base for this appropriation​
9457+292.33is $338,000 in fiscal year 2026 and beyond.​
9458+292​Article 9 Sec. 2.​
9459+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 293.1 Subd. 5.Attorney General.$358,000 in fiscal year 2024 and $358,000 in fiscal year​
9460+293.22025 are appropriated from the general fund to the attorney general for costs associated​
9461+293.3with the Cannabis Expungement Board, including but not limited to reviewing records,​
9462+293.4conducting interviews, drafting subpoenas, moving the court for orders to compel, and​
9463+293.5drafting memoranda. The base in fiscal year 2029 and thereafter is $0.​
9464+293.6 Subd. 6.Cannabis Expungement Board.$4,880,000 in fiscal year 2024 and $4,687,000​
9465+293.7in fiscal year 2025 are appropriated from the general fund to the Cannabis Expungement​
9466+293.8Board for staffing and other expenses related to reviewing criminal convictions and issuing​
9467+293.9decisions related to expungement and resentencing. The base for this appropriation is​
9468+293.10$4,687,000 in fiscal years 2026, 2027, and 2028. The base in fiscal year 2029 and thereafter​
9469+293.11is $0.​
9470+293.12 Subd. 7.Department of Commerce.$527,000 in fiscal year 2024 and $1,093,000 in​
9471+293.13fiscal year 2025 are appropriated from the general fund to the commissioner of commerce​
9472+293.14for the purposes of this act. The base for this appropriation is $1,341,000 in fiscal year 2026​
9473+293.15and $1,520,000 in fiscal year 2027.​
9474+293.16 Subd. 8.Department of Corrections.An appropriation to the commissioner of​
9475+293.17corrections for correctional institutions is reduced by $165,000 in fiscal year 2024 and​
9476+293.18$368,000 in fiscal year 2025. The base for this appropriation is reduced by $460,000 in​
9477+293.19fiscal year 2026 and $503,000 in fiscal year 2027.​
9478+293.20 Subd. 9.Department of Education.$180,000 in fiscal year 2024 and $120,000 in fiscal​
9479+293.21year 2025 are appropriated from the general fund to the commissioner of education for the​
9480+293.22purposes of this act.​
9481+293.23 Subd. 10.Department of Employment and Economic Development.(a) $10,400,000​
9482+293.24in fiscal year 2024 and $6,700,000 in fiscal year 2025 are appropriated from the general​
9483+293.25fund to the commissioner of employment and economic development for the CanStartup,​
9484+293.26CanNavigate, and CanTrain programs. Any unencumbered balances remaining in the first​
9485+293.27year do not cancel but are available for the second year.​
9486+293.28 (b) Of the amount appropriated under paragraph (a), $4,000,000 in fiscal year 2024 and​
9487+293.29$2,619,000 in fiscal year 2025 are for the CanStartup program.​
9488+293.30 (c) Of the amount appropriated under paragraph (a), $2,000,000 in fiscal year 2024 and​
9489+293.31$1,884,000 in fiscal year 2025 are for the CanNavigate program.​
9490+293.32 (d) Of the amount appropriated under paragraph (a), $4,400,000 in fiscal year 2024 and​
9491+293.33$2,197,000 in fiscal year 2025 are for the CanTrain program.​
9492+293​Article 9 Sec. 2.​
9493+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 294.1 (e) Of these amounts, up to four percent may be used for administrative expenses.​
9494+294.2 Subd. 11.Department of Health.(a) $9,680,000 in fiscal year 2024 and $18,186,000​
9495+294.3in fiscal year 2025 are appropriated from the general fund to the commissioner of health​
9496+294.4for the purposes of this act.​
9497+294.5 (b) Of the amount appropriated under paragraph (a), $1,674,000 in fiscal year 2024 and​
9498+294.6$1,674,000 in fiscal year 2025 are for education for women who are pregnant, breastfeeding,​
9499+294.7or who may become pregnant. Of this amount, $1,000,000 each year is for media campaign​
9500+294.8contracts. The base for this appropriation is $3,174,000 in fiscal year 2026 and thereafter.​
9501+294.9Of the amounts appropriated in fiscal year 2026 and thereafter, $2,500,000 is for media​
9502+294.10campaign contracts.​
9503+294.11 (c) Of the amount appropriated under paragraph (a), $330,000 in fiscal year 2024 and​
9504+294.12$277,000 in fiscal year 2025 are for data collection and reports. The base for this​
9505+294.13appropriation is $227,000 in fiscal year 2026 and $277,000 in fiscal year 2027.​
9506+294.14 (d) Of the amount appropriated under paragraph (a), $719,000 in fiscal year 2024 and​
9507+294.15$771,000 in fiscal year 2025 are for testing required by this act. The base for this​
9508+294.16appropriation is $690,000 in fiscal year 2026 and thereafter.​
9509+294.17 (e) Of the amount appropriated under paragraph (a), $2,998,000 in fiscal year 2024 and​
9510+294.18$2,998,000 in fiscal year 2025 are for education for youth. Of this amount, $1,000,000 each​
9511+294.19year is for statewide youth awareness campaign contracts. The base for this appropriation​
9512+294.20is $4,498,000 in fiscal year 2026 and thereafter. Of the amounts in fiscal year 2026 and​
9513+294.21thereafter, $2,500,000 is for media campaign contracts.​
9514+294.22 (f) Of the amount appropriated under paragraph (a), $9,000,000 in fiscal year 2025 is​
9515+294.23for grants to local health departments for: (1) creation and dissemination of educational​
9516+294.24materials on cannabis flower, cannabis products, lower-potency hemp edibles, and​
9517+294.25hemp-derived consumer products; and (2) community education, technical assistance, and​
9518+294.26outreach on prevention and safe use regarding cannabis flower, cannabis products,​
9519+294.27lower-potency hemp edibles, and hemp-derived consumer products. The commissioner shall​
9520+294.28distribute these grants according to a contract with the Local Public Health Association of​
9521+294.29Minnesota. Of the appropriations in this paragraph, the commissioner may withhold up to​
9522+294.30ten percent for grant administration and technical assistance to local health departments.​
9523+294.31 (g) Of the amount appropriated under paragraph (a), $1,000,000 in fiscal year 2025 is​
9524+294.32for grants to Tribal health departments for: (1) creation and dissemination of educational​
9525+294.33materials on cannabis flower, cannabis products, lower-potency hemp edibles, and​
9526+294.34hemp-derived consumer products; and (2) community education, technical assistance, and​
9527+294​Article 9 Sec. 2.​
9528+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 295.1outreach on prevention and safe use regarding cannabis flower, cannabis products,​
9529+295.2lower-potency hemp edibles, and hemp-derived consumer products. Of the appropriations​
9530+295.3in this paragraph, the commissioner may withhold up to ten percent for grant administration​
9531+295.4and technical assistance to Tribal health departments.​
9532+295.5 Subd. 12.Department of Health; Minnesota Poison Control System.$910,000 in​
9533+295.6fiscal year 2024 and $810,000 in fiscal year 2025 are appropriated from the general fund​
9534+295.7to the commissioner of health to support the Poison Control System and award or supplement​
9535+295.8grants pursuant to Minnesota Statutes, section 145.93.​
9536+295.9 Subd. 13.Department of Human Services.(a) $1,566,000 in fiscal year 2024 and​
9537+295.10$1,420,000 in fiscal year 2025 are appropriated from the general fund to the commissioner​
9538+295.11of human services for the purposes of this act. The base for this appropriation is $1,420,000​
9539+295.12in fiscal years 2026, 2027, and 2028. The base in fiscal year 2029 and thereafter is $225,000.​
9540+295.13 (b) Of the amount appropriated under paragraph (a), $1,043,000 in fiscal year 2024 and​
9541+295.14$1,195,000 in fiscal year 2025 are for the Background Studies Legal Division. The base for​
9542+295.15this appropriation is $1,195,000 in fiscal years 2026, 2027, and 2028. The base in fiscal​
9543+295.16year 2029 and thereafter is $0.​
9544+295.17 (c) Of the amount appropriated under paragraph (a), $322,000 in fiscal year 2024 is for​
9545+295.18technology system changes. This is a onetime appropriation.​
9546+295.19 (d) Of the amount appropriated under paragraph (a), $201,000 in fiscal year 2024 and​
9547+295.20$225,000 in fiscal year 2025 are for costs associated with the Substance Use Disorder​
9548+295.21Advisory Council.​
9549+295.22 Subd. 14.Department of Labor and Industry.$116,000 in fiscal year 2024 and​
9550+295.23$123,000 in fiscal year 2025 are appropriated from the general fund to the commissioner​
9551+295.24of labor and industry to identify occupational competency standards and provide technical​
9552+295.25assistance for developing dual-training programs under Minnesota Statutes, section 175.45,​
9553+295.26for the legal cannabis industry.​
9554+295.27 Subd. 15.Department of Natural Resources.$338,000 in fiscal year 2024 is​
9555+295.28appropriated from the general fund to the commissioner of natural resources for the purposes​
9556+295.29of this act. This is a onetime appropriation.​
9557+295.30 Subd. 16.Office of Higher Education.$1,000,000 in fiscal year 2024 and $1,000,000​
9558+295.31in fiscal year 2025 are appropriated from the general fund to the commissioner of higher​
9559+295.32education for transfer to the dual training account in the special revenue fund under Minnesota​
9560+295.33Statutes, section 136A.246, subdivision 10, for grants to employers in the legal cannabis​
9561+295​Article 9 Sec. 2.​
9562+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 296.1industry. The commissioner shall give priority to applications from employers who are, or​
9563+296.2who are training employees who are, eligible to be social equity applicants under Minnesota​
9564+296.3Statutes, section 342.16. After June 30, 2025, any unencumbered balance from this​
9565+296.4appropriation may be used for grants to any eligible employer under Minnesota Statutes,​
9566+296.5section 136A.246.​
9567+296.6 Subd. 17.Pollution Control Agency.(a) $140,000 in fiscal year 2024 and $70,000 in​
9568+296.7fiscal year 2025 are appropriated from the general fund to the commissioner of the Pollution​
9569+296.8Control Agency for the purposes of this act.​
9570+296.9 (b) Of the amount appropriated under paragraph (a), $70,000 in fiscal year 2024 is for​
9571+296.10wastewater staff. This is a onetime appropriation.​
9572+296.11 (c) Of the amount appropriated under paragraph (a), $70,000 in fiscal year 2024 and​
9573+296.12$70,000 in fiscal year 2025 are for small business assistance staff.​
9574+296.13 Subd. 18.Department of Public Safety; Bureau of Criminal Apprehension.(a)​
9575+296.14$7,945,000 in fiscal year 2024 and $4,543,000 in fiscal year 2025 are appropriated from​
9576+296.15the general fund to the commissioner of public safety for use by the Bureau of Criminal​
9577+296.16Apprehension. The base for this appropriation is $3,551,000 in fiscal years 2026, 2027, and​
9578+296.172028. The base in fiscal year 2029 and thereafter is $1,495,000.​
9579+296.18 (b) Of the amount appropriated under paragraph (a), $992,000 in fiscal year 2024 and​
9580+296.19$992,000 in fiscal year 2025 are for expenses related to identifying and providing records​
9581+296.20of convictions for certain offenses involving the possession of cannabis that may be eligible​
9582+296.21for expungement and resentencing. The base for this appropriation is $992,000 in fiscal​
9583+296.22years 2026, 2027, and 2028. The base in fiscal year 2029 and thereafter is $0.​
9584+296.23 (c) Of the amount appropriated under paragraph (a), $1,766,000 in fiscal year 2024 and​
9585+296.24$1,240,000 in fiscal year 2025 are for forensic science services including additional staff,​
9586+296.25equipment, and supplies.​
9587+296.26 (d) Of the amount appropriated under paragraph (a), $255,000 in fiscal year 2024 and​
9588+296.27$255,000 in fiscal year 2025 are for investigation of diversion crimes.​
9589+296.28 Subd. 19.Department of Public Safety; Office of Traffic Safety.(a) $1,620,000 in​
9590+296.29fiscal year 2024 and $1,117,000 in fiscal year 2025 are appropriated from the general fund​
9591+296.30to the commissioner of public safety for use by the Office of Traffic Safety.​
9592+296.31 (b) Of the amount appropriated under paragraph (a), $125,000 in fiscal year 2024 and​
9593+296.32$125,000 in fiscal year 2025 are for a statewide impaired driving coordinator with a specific​
9594+296.33focus on cannabis and other drug driving issues.​
9595+296​Article 9 Sec. 2.​
9596+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 297.1 (c) Of the amount appropriated under paragraph (a), $1,495,000 in fiscal year 2024 and​
9597+297.2$992,000 in fiscal year 2025 are to support oral fluid roadside testing.​
9598+297.3 Subd. 20.Department of Public Safety; State Patrol.$6,157,000 in fiscal year 2024​
9599+297.4and $2,218,000 in fiscal year 2025 are appropriated from the trunk highway fund to the​
9600+297.5commissioner of public safety for use by the Minnesota State Patrol for the purposes of this​
9601+297.6act, including but not limited to replacing drug detection canines, providing accident​
9602+297.7reconstruction services, identifying and investigating incidents and offenses that involve​
9603+297.8driving under the influence, and sealing expunged records.​
9604+297.9 Subd. 21.Department of Public Safety; State Patrol.$10,000,000 in fiscal year 2024​
9605+297.10and $5,000,000 in fiscal year 2025 are appropriated from the general fund to the Minnesota​
9606+297.11State Patrol for its drug evaluation and classification program for drug recognition evaluator​
9607+297.12training; additional phlebotomists; drug recognition training for peace officers, as defined​
9608+297.13in Minnesota Statutes, section 626.84, subdivision 1, paragraph (c); and required continuing​
9609+297.14education training for drug recognition experts.​
9610+297.15 Subd. 22.Department of Revenue.$3,709,000 in fiscal year 2024 and $3,145,000 in​
9611+297.16fiscal year 2025 are appropriated from the general fund to the commissioner of revenue for​
9612+297.17the purposes of this act. The base for this appropriation is $3,157,000 in fiscal year 2026​
9613+297.18and beyond.​
9614+297.19 Subd. 23.Supreme court.$545,000 in fiscal year 2024 and $545,000 in fiscal year​
9615+297.202025 are appropriated from the general fund to the supreme court for reviewing records and​
9616+297.21issuing orders related to the expungement or resentencing of certain cannabis offenses. The​
9617+297.22base for this appropriation is $0 in fiscal year 2026 and thereafter.​
9618+297.23 ARTICLE 10​
9619+297.24 GRANTS MANAGEMENT​
9620+297.25Section 1. FINANCIAL REVIEW OF NONPROFIT GRANT RECIPIENTS​
9621+297.26REQUIRED.​
9622+297.27 Subdivision 1.Financial review required.(a) Before awarding a competitive,​
9623+297.28legislatively named, single-source, or sole-source grant to a nonprofit organization under​
9624+297.29this act, the grantor must require the applicant to submit financial information sufficient for​
9625+297.30the grantor to document and assess the applicant's current financial standing and management.​
9626+297.31Items of significant concern must be addressed with the applicant and resolved to the​
9627+297.32satisfaction of the grantor before a grant is awarded. The grantor must document the material​
9628+297.33requested and reviewed; whether the applicant had a significant operating deficit, a deficit​
9629+297​Article 10 Section 1.​
9630+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 298.1in unrestricted net assets, or insufficient internal controls; whether and how the applicant​
9631+298.2resolved the grantor's concerns; and the grantor's final decision. This documentation must​
9632+298.3be maintained in the grantor's files.​
9633+298.4 (b) At a minimum, the grantor must require each applicant to provide the following​
9634+298.5information:​
9635+298.6 (1) the applicant's most recent Form 990, Form 990-EZ, or Form 990-N filed with the​
9636+298.7Internal Revenue Service. If the applicant has not been in existence long enough or is not​
9637+298.8required to file Form 990, Form 990-EZ, or Form 990-N, the applicant must demonstrate​
9638+298.9to the grantor that the applicant is exempt and must instead submit documentation of internal​
9639+298.10controls and the applicant's most recent financial statement prepared in accordance with​
9640+298.11generally accepted accounting principles and approved by the applicant's board of directors​
9641+298.12or trustees, or if there is no such board, by the applicant's managing group;​
9642+298.13 (2) evidence of registration and good standing with the secretary of state under Minnesota​
9643+298.14Statutes, chapter 317A, or other applicable law;​
9644+298.15 (3) unless exempt under Minnesota Statutes, section 309.515, evidence of registration​
9645+298.16and good standing with the attorney general under Minnesota Statutes, chapter 309; and​
9646+298.17 (4) if required under Minnesota Statutes, section 309.53, subdivision 3, the applicant's​
9647+298.18most recent audited financial statement prepared in accordance with generally accepted​
9648+298.19accounting principles.​
9649+298.20 Subd. 2.Authority to postpone or forgo; reporting required.(a) Notwithstanding​
9650+298.21any contrary provision in this act, a grantor that identifies an area of significant concern​
9651+298.22regarding the financial standing or management of a legislatively named applicant may​
9652+298.23postpone or forgo awarding the grant.​
9653+298.24 (b) No later than 30 days after a grantor exercises the authority provided under paragraph​
9654+298.25(a), the grantor must report to the chairs and ranking minority members of the legislative​
9655+298.26committees with jurisdiction over the grantor's operating budget. The report must identify​
9656+298.27the legislatively named applicant and the grantor's reason for postponing or forgoing the​
9657+298.28grant.​
9658+298.29 Subd. 3.Authority to award subject to additional assistance and oversight.A grantor​
9659+298.30that identifies an area of significant concern regarding an applicant's financial standing or​
9660+298.31management may award a grant to the applicant if the grantor provides or the grantee​
9661+298.32otherwise obtains additional technical assistance, as needed, and the grantor imposes​
9662+298.33additional requirements in the grant agreement. Additional requirements may include but​
9663+298​Article 10 Section 1.​
9664+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 299.1are not limited to enhanced monitoring, additional reporting, or other reasonable requirements​
9665+299.2imposed by the grantor to protect the interests of the state.​
9666+299.3 Subd. 4.Relation to other law and policy.The requirements in this section are in​
9667+299.4addition to any other requirements imposed by law; the commissioner of administration​
9668+299.5under Minnesota Statutes, sections 16B.97 and 16B.98; or agency policy.​
9669+299​Article 10 Section 1.​
9670+REVISOR BD H0100-11​HF100 ELEVENTH ENGROSSMENT​ 151.72 SALE OF CERTAIN CANNABINOID PRODUCTS.​
9671+Subdivision 1.Definitions.(a) For the purposes of this section, the following terms have the​
9672+meanings given.​
9673+(b) "Certified hemp" means hemp plants that have been tested and found to meet the requirements​
9674+of chapter 18K and the rules adopted thereunder.​
9675+(c) "Edible cannabinoid product" means any product that is intended to be eaten or consumed​
9676+as a beverage by humans, contains a cannabinoid in combination with food ingredients, and is not​
9677+a drug.​
9678+(d) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision 3.​
9679+(e) "Label" has the meaning given in section 151.01, subdivision 18.​
9680+(f) "Labeling" means all labels and other written, printed, or graphic matter that are:​
9681+(1) affixed to the immediate container in which a product regulated under this section is sold;​
9682+(2) provided, in any manner, with the immediate container, including but not limited to outer​
9683+containers, wrappers, package inserts, brochures, or pamphlets; or​
9684+(3) provided on that portion of a manufacturer's website that is linked by a scannable barcode​
9685+or matrix barcode.​
9686+(g) "Matrix barcode" means a code that stores data in a two-dimensional array of geometrically​
9687+shaped dark and light cells capable of being read by the camera on a smartphone or other mobile​
9688+device.​
9689+(h) "Nonintoxicating cannabinoid" means substances extracted from certified hemp plants that​
9690+do not produce intoxicating effects when consumed by any route of administration.​
9691+Subd. 2.Scope.(a) This section applies to the sale of any product that contains cannabinoids​
9692+extracted from hemp and that is an edible cannabinoid product or is intended for human or animal​
9693+consumption by any route of administration.​
9694+(b) This section does not apply to any product dispensed by a registered medical cannabis​
9695+manufacturer pursuant to sections 152.22 to 152.37.​
9696+(c) The board must have no authority over food products, as defined in section 34A.01,​
9697+subdivision 4, that do not contain cannabinoids extracted or derived from hemp.​
9698+Subd. 3.Sale of cannabinoids derived from hemp.(a) Notwithstanding any other section of​
9699+this chapter, a product containing nonintoxicating cannabinoids, including an edible cannabinoid​
9700+product, may be sold for human or animal consumption only if all of the requirements of this section​
9701+are met, provided that a product sold for human or animal consumption does not contain more than​
9702+0.3 percent of any tetrahydrocannabinol and an edible cannabinoid product does not contain an​
9703+amount of any tetrahydrocannabinol that exceeds the limits established in subdivision 5a, paragraph​
9704+(f).​
9705+(b) No other substance extracted or otherwise derived from hemp may be sold for human​
9706+consumption if the substance is intended:​
9707+(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention of​
9708+disease in humans or other animals; or​
9709+(2) to affect the structure or any function of the bodies of humans or other animals.​
9710+(c) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise​
9711+derived from hemp may be sold to any individual who is under the age of 21.​
9712+(d) Products that meet the requirements of this section are not controlled substances under​
9713+section 152.02.​
9714+Subd. 4.Testing requirements.(a) A manufacturer of a product regulated under this section​
9715+must submit representative samples of the product to an independent, accredited laboratory in order​
9716+to certify that the product complies with the standards adopted by the board. Testing must be​
9717+consistent with generally accepted industry standards for herbal and botanical substances, and, at​
9718+a minimum, the testing must confirm that the product:​
9719+(1) contains the amount or percentage of cannabinoids that is stated on the label of the product;​
9720+1R​
9721+APPENDIX​
9722+Repealed Minnesota Statutes: H0100-11​ (2) does not contain more than trace amounts of any mold, residual solvents, pesticides, fertilizers,​
9723+or heavy metals; and​
9724+(3) does not contain more than 0.3 percent of any tetrahydrocannabinol.​
9725+(b) Upon the request of the board, the manufacturer of the product must provide the board with​
9726+the results of the testing required in this section.​
9727+(c) Testing of the hemp from which the nonintoxicating cannabinoid was derived, or possession​
9728+of a certificate of analysis for such hemp, does not meet the testing requirements of this section.​
9729+Subd. 5.Labeling requirements.(a) A product regulated under this section must bear a label​
9730+that contains, at a minimum:​
9731+(1) the name, location, contact phone number, and website of the manufacturer of the product;​
9732+(2) the name and address of the independent, accredited laboratory used by the manufacturer​
9733+to test the product; and​
9734+(3) an accurate statement of the amount or percentage of cannabinoids found in each unit of the​
9735+product meant to be consumed.​
9736+(b) The information in paragraph (a) may be provided on an outer package if the immediate​
9737+container that holds the product is too small to contain all of the information.​
9738+(c) The information required in paragraph (a) may be provided through the use of a scannable​
9739+barcode or matrix barcode that links to a page on the manufacturer's website if that page contains​
9740+all of the information required by this subdivision.​
9741+(d) The label must also include a statement stating that the product does not claim to diagnose,​
9742+treat, cure, or prevent any disease and has not been evaluated or approved by the United States​
9743+Food and Drug Administration (FDA) unless the product has been so approved.​
9744+(e) The information required by this subdivision must be prominently and conspicuously placed​
9745+on the label or displayed on the website in terms that can be easily read and understood by the​
9746+consumer.​
9747+(f) The labeling must not contain any claim that the product may be used or is effective for the​
9748+prevention, treatment, or cure of a disease or that it may be used to alter the structure or function​
9749+of human or animal bodies, unless the claim has been approved by the FDA.​
9750+Subd. 5a.Additional requirements for edible cannabinoid products.(a) In addition to the​
9751+testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid must meet the​
9752+requirements of this subdivision.​
9753+(b) An edible cannabinoid product must not:​
9754+(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, animal,​
9755+or fruit that appeals to children;​
9756+(2) be modeled after a brand of products primarily consumed by or marketed to children;​
9757+(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a​
9758+commercially available candy or snack food item;​
9759+(4) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved by the​
9760+United States Food and Drug Administration for use in food;​
9761+(5) be packaged in a way that resembles the trademarked, characteristic, or product-specialized​
9762+packaging of any commercially available food product; or​
9763+(6) be packaged in a container that includes a statement, artwork, or design that could reasonably​
9764+mislead any person to believe that the package contains anything other than an edible cannabinoid​
9765+product.​
9766+(c) An edible cannabinoid product must be prepackaged in packaging or a container that is​
9767+child-resistant, tamper-evident, and opaque or placed in packaging or a container that is​
9768+child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The requirement​
9769+that packaging be child-resistant does not apply to an edible cannabinoid product that is intended​
9770+to be consumed as a beverage and which contains no more than a trace amount of any​
9771+tetrahydrocannabinol.​
9772+2R​
9773+APPENDIX​
9774+Repealed Minnesota Statutes: H0100-11​ (d) If an edible cannabinoid product is intended for more than a single use or contains multiple​
9775+servings, each serving must be indicated by scoring, wrapping, or other indicators designating the​
9776+individual serving size.​
9777+(e) A label containing at least the following information must be affixed to the packaging or​
9778+container of all edible cannabinoid products sold to consumers:​
9779+(1) the serving size;​
9780+(2) the cannabinoid profile per serving and in total;​
9781+(3) a list of ingredients, including identification of any major food allergens declared by name;​
9782+and​
9783+(4) the following statement: "Keep this product out of reach of children."​
9784+(f) An edible cannabinoid product must not contain more than five milligrams of any​
9785+tetrahydrocannabinol in a single serving, or more than a total of 50 milligrams of any​
9786+tetrahydrocannabinol per package.​
9787+Subd. 6.Enforcement.(a) A product regulated under this section, including an edible​
9788+cannabinoid product, shall be considered an adulterated drug if:​
9789+(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;​
9790+(2) it has been produced, prepared, packed, or held under unsanitary conditions where it may​
9791+have been rendered injurious to health, or where it may have been contaminated with filth;​
9792+(3) its container is composed, in whole or in part, of any poisonous or deleterious substance​
9793+that may render the contents injurious to health;​
9794+(4) it contains any food additives, color additives, or excipients that have been found by the​
9795+FDA to be unsafe for human or animal consumption;​
9796+(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different than​
9797+the amount or percentage stated on the label;​
9798+(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is an edible​
9799+cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits established in​
9800+subdivision 5a, paragraph (f); or​
9801+(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers, or​
9802+heavy metals.​
9803+(b) A product regulated under this section shall be considered a misbranded drug if the product's​
9804+labeling is false or misleading in any manner or in violation of the requirements of this section.​
9805+(c) The board's authority to issue cease and desist orders under section 151.06; to embargo​
9806+adulterated and misbranded drugs under section 151.38; and to seek injunctive relief under section​
9807+214.11, extends to any violation of this section.​
9808+152.027 OTHER CONTROLLED SUBSTANCE OFFENSES.​
9809+Subd. 3.Possession of marijuana in a motor vehicle.A person is guilty of a misdemeanor if​
9810+the person is the owner of a private motor vehicle, or is the driver of the motor vehicle if the owner​
9811+is not present, and possesses on the person, or knowingly keeps or allows to be kept within the area​
9812+of the vehicle normally occupied by the driver or passengers, more than 1.4 grams of marijuana.​
9813+This area of the vehicle does not include the trunk of the motor vehicle if the vehicle is equipped​
9814+with a trunk, or another area of the vehicle not normally occupied by the driver or passengers if the​
9815+vehicle is not equipped with a trunk. A utility or glove compartment is deemed to be within the​
9816+area occupied by the driver and passengers.​
9817+Subd. 4.Possession or sale of small amounts of marijuana.(a) A person who unlawfully​
9818+sells a small amount of marijuana for no remuneration, or who unlawfully possesses a small amount​
9819+of marijuana is guilty of a petty misdemeanor and shall be required to participate in a drug education​
9820+program unless the court enters a written finding that a drug education program is inappropriate.​
9821+The program must be approved by an area mental health board with a curriculum approved by the​
9822+state alcohol and drug abuse authority.​
9823+(b) A person convicted of an unlawful sale under paragraph (a) who is subsequently convicted​
9824+of an unlawful sale under paragraph (a) within two years is guilty of a misdemeanor and shall be​
9825+3R​
9826+APPENDIX​
9827+Repealed Minnesota Statutes: H0100-11​ required to participate in a chemical dependency evaluation and treatment if so indicated by the​
9828+evaluation.​
9829+(c) A person who is convicted of a petty misdemeanor under paragraph (a) who willfully and​
9830+intentionally fails to comply with the sentence imposed, is guilty of a misdemeanor. Compliance​
9831+with the terms of the sentence imposed before conviction under this paragraph is an absolute defense.​
9832+152.21 THC THERAPEUTIC RESEARCH ACT.​
9833+Subdivision 1.Findings and purpose.The legislature finds that scientific literature indicates​
9834+promise for delta-9-tetrahydro-cannabinol (THC), the active component of marijuana, in alleviating​
9835+certain side effects of cancer chemotherapy under strictly controlled medical circumstances.​
9836+The legislature also finds that further research and strictly controlled experimentation regarding​
9837+the therapeutic use of THC is necessary and desirable. The intent of this section is to establish an​
9838+extensive research program to investigate and report on the therapeutic effects of THC under strictly​
9839+controlled circumstances in compliance with all federal laws and regulations promulgated by the​
9840+federal Food and Drug Administration, the National Institute on Drug Abuse and the Drug​
9841+Enforcement Administration. The intent of the legislature is to allow this research program the​
9842+greatest possible access to qualified cancer patients residing in Minnesota who meet protocol​
9843+requirements. The establishment of this research program is not intended in any manner whatsoever​
9844+to condone or promote the illicit recreational use of marijuana.​
9845+Subd. 2.Definitions.For purposes of this section, the following terms shall have the meanings​
9846+given.​
9847+(a) "Commissioner" means the commissioner of health.​
9848+(b) "Marijuana" means marijuana as defined in section 152.01, subdivision 9, and​
9849+delta-9-tetrahydro-cannabinol (THC), tetrahydrocannabinols or a chemical derivative of​
9850+tetrahydrocannabinols, and all species of the genus Cannabis.​
9851+(c) "Principal investigator" means the individual responsible for the medical and scientific​
9852+aspects of the research, development of protocol, and contacting and qualifying the clinical​
9853+investigators in the state.​
9854+(d) "Clinical investigators" means those individuals who conduct the clinical trials.​
9855+(e) "Sponsor" means that individual or organization who, acting on behalf of the state, has the​
9856+total responsibility for the state program.​
9857+Subd. 3.Research grant.The commissioner of health shall grant funds to the principal​
9858+investigator selected by the commissioner pursuant to subdivision 4 for the purpose of conducting​
9859+a research program under a protocol approved by the FDA regarding the therapeutic use of oral​
9860+THC and other dosage forms, if available, according to the guidelines and requirements of the​
9861+federal Food and Drug Administration, the Drug Enforcement Administration and the National​
9862+Institute on Drug Abuse. The commissioner shall ensure that the research principal investigator​
9863+complies with the requirements of subdivision 5. The commissioner may designate the principal​
9864+investigator as the sponsor.​
9865+Subd. 4.Principal investigator.Within three months of April 25, 1980, the commissioner​
9866+shall, in consultation with a representative chosen by the state Board of Pharmacy and a representative​
9867+chosen by the state Board of Medical Examiners, select a person or research organization to be the​
9868+principal investigator of the research program.​
9869+Subd. 5.Duties.The principal investigator shall:​
9870+(1) apply to the Food and Drug Administration for a notice of "Claimed Investigational​
9871+Exemption for a New Drug (IND)" pursuant to the Federal Food, Drug and Cosmetic Act, United​
9872+States Code, title 21, section 301, et seq., and shall comply with all applicable laws and regulations​
9873+of the federal Food and Drug Administration, the Drug Enforcement Administration, and the National​
9874+Institute on Drug Abuse in establishing the program;​
9875+(2) notify every oncologist in the state of the program, explain the purposes and requirements​
9876+of the program to them, provide on request each of them with a copy of the approved protocol which​
9877+shall include summaries of current papers in medical journals reporting on research concerning the​
9878+safety, efficacy and appropriate use of THC in alleviating the nausea and emetic effects of cancer​
9879+chemotherapy, and provide on request each of them with a bibliography of other articles published​
9880+in medical journals;​
9881+4R​
9882+APPENDIX​
9883+Repealed Minnesota Statutes: H0100-11​ (3) allow each oncologist (clinical investigator) in the state who meets or agrees to meet all​
9884+applicable federal requirements for investigational new drug research and who so requests to be​
9885+included in the research program as a clinical investigator to conduct the clinical trials;​
9886+(4) provide explanatory information and assistance to each clinical investigator in understanding​
9887+the nature of therapeutic use of THC within program requirements, including the informed consent​
9888+document contained in the protocol, informing and counseling patients involved in the program​
9889+regarding the appropriate use and the effects of therapeutic use of THC;​
9890+(5) apply to contract with the National Institute on Drug Abuse for receipt of dosage forms of​
9891+THC, fully characterized as to contents and delivery to the human system, pursuant to regulations​
9892+promulgated by the National Institute on Drug Abuse, and the federal Food and Drug Administration.​
9893+The principal investigator shall ensure delivery of the THC dosages to clinical investigators as​
9894+needed for participation in the program;​
9895+(6) conduct the research program in compliance with federal laws and regulations promulgated​
9896+by the federal Food and Drug Administration, the Drug Enforcement Administration, the National​
9897+Institute on Drug Abuse, and the purposes and provisions of this section;​
9898+(7) submit periodic reports as determined by the commissioner on the numbers of oncologists​
9899+and patients involved in the program and the results of the program;​
9900+(8) submit reports on intermediate or final research results, as appropriate, to the major scientific​
9901+journals in the United States; and​
9902+(9) otherwise comply with the provisions of this section.​
9903+Subd. 6.Exemption from criminal sanctions.For the purposes of this section, the following​
9904+are not violations under this chapter:​
9905+(1) use or possession of THC, or both, by a patient in the research program;​
9906+(2) possession, prescribing use of, administering, or dispensing THC, or any combination of​
9907+these actions, by the principal investigator or by any clinical investigator; and​
9908+(3) possession or distribution of THC, or both, by a pharmacy registered to handle Schedule I​
9909+substances which stores THC on behalf of the principal investigator or a clinical investigator.​
9910+THC obtained and distributed pursuant to this section is not subject to forfeiture under sections​
9911+609.531 to 609.5316.​
9912+For the purposes of this section, THC is removed from Schedule I contained in section 152.02,​
9913+subdivision 2, and inserted in Schedule II contained in section 152.02, subdivision 3.​
9914+Subd. 7.Citation.This section may be cited as the "THC Therapeutic Research Act."​
9915+152.22 DEFINITIONS.​
9916+Subdivision 1.Applicability.For purposes of sections 152.22 to 152.37, the terms defined in​
9917+this section have the meanings given them.​
9918+Subd. 2.Commissioner."Commissioner" means the commissioner of health.​
9919+Subd. 3.Disqualifying felony offense."Disqualifying felony offense" means a violation of a​
9920+state or federal controlled substance law that is a felony under Minnesota law, or would be a felony​
9921+if committed in Minnesota, regardless of the sentence imposed, unless the commissioner determines​
9922+that the person's conviction was for the medical use of cannabis or assisting with the medical use​
9923+of cannabis.​
9924+Subd. 4.Health care practitioner."Health care practitioner" means a Minnesota licensed​
9925+doctor of medicine, a Minnesota licensed physician assistant, or a Minnesota licensed advanced​
9926+practice registered nurse who has the primary responsibility for the care and treatment of the​
9927+qualifying medical condition of a person diagnosed with a qualifying medical condition.​
9928+Subd. 5.Health records."Health records" means health records as defined in section 144.291,​
9929+subdivision 2, paragraph (c).​
9930+Subd. 5a.Hemp."Hemp" has the meaning given to industrial hemp in section 18K.02,​
9931+subdivision 3.​
9932+Subd. 5b.Hemp grower."Hemp grower" means a person licensed by the commissioner of​
9933+agriculture under chapter 18K to grow hemp for commercial purposes.​
9934+5R​
9935+APPENDIX​
9936+Repealed Minnesota Statutes: H0100-11​ Subd. 6.Medical cannabis.(a) "Medical cannabis" means any species of the genus cannabis​
9937+plant, or any mixture or preparation of them, including whole plant extracts and resins, and is​
9938+delivered in the form of:​
9939+(1) liquid, including, but not limited to, oil;​
9940+(2) pill;​
9941+(3) vaporized delivery method with use of liquid or oil;​
9942+(4) combustion with use of dried raw cannabis; or​
9943+(5) any other method approved by the commissioner.​
9944+(b) This definition includes any part of the genus cannabis plant prior to being processed into​
9945+a form allowed under paragraph (a), that is possessed by a person while that person is engaged in​
9946+employment duties necessary to carry out a requirement under sections 152.22 to 152.37 for a​
9947+registered manufacturer or a laboratory under contract with a registered manufacturer. This definition​
9948+also includes any hemp acquired by a manufacturer by a hemp grower as permitted under section​
9949+152.29, subdivision 1, paragraph (b).​
9950+Subd. 7.Medical cannabis manufacturer."Medical cannabis manufacturer" or "manufacturer"​
9951+means an entity registered by the commissioner to cultivate, acquire, manufacture, possess, prepare,​
9952+transfer, transport, supply, or dispense medical cannabis, delivery devices, or related supplies and​
9953+educational materials.​
9954+Subd. 8.Medical cannabis product."Medical cannabis product" means any delivery device​
9955+or related supplies and educational materials used in the administration of medical cannabis for a​
9956+patient with a qualifying medical condition enrolled in the registry program.​
9957+Subd. 9.Patient."Patient" means a Minnesota resident who has been diagnosed with a qualifying​
9958+medical condition by a health care practitioner and who has otherwise met any other requirements​
9959+for patients under sections 152.22 to 152.37 to participate in the registry program under sections​
9960+152.22 to 152.37.​
9961+Subd. 10.Patient registry number."Patient registry number" means a unique identification​
9962+number assigned by the commissioner to a patient enrolled in the registry program.​
9963+Subd. 11.Registered designated caregiver."Registered designated caregiver" means a person​
9964+who:​
9965+(1) is at least 18 years old;​
9966+(2) does not have a conviction for a disqualifying felony offense;​
9967+(3) has been approved by the commissioner to assist a patient who requires assistance in​
9968+administering medical cannabis or obtaining medical cannabis from a distribution facility; and​
9969+(4) is authorized by the commissioner to assist the patient with the use of medical cannabis.​
9970+Subd. 12.Registry program."Registry program" means the patient registry established in​
9971+sections 152.22 to 152.37.​
9972+Subd. 13.Registry verification."Registry verification" means the verification provided by the​
9973+commissioner that a patient is enrolled in the registry program and that includes the patient's name,​
9974+registry number, and, if applicable, the name of the patient's registered designated caregiver or​
9975+parent, legal guardian, or spouse.​
9976+Subd. 14.Qualifying medical condition."Qualifying medical condition" means a diagnosis​
9977+of any of the following conditions:​
9978+(1) cancer, if the underlying condition or treatment produces one or more of the following:​
9979+(i) severe or chronic pain;​
9980+(ii) nausea or severe vomiting; or​
9981+(iii) cachexia or severe wasting;​
9982+(2) glaucoma;​
9983+(3) human immunodeficiency virus or acquired immune deficiency syndrome;​
9984+6R​
9985+APPENDIX​
9986+Repealed Minnesota Statutes: H0100-11​ (4) Tourette's syndrome;​
9987+(5) amyotrophic lateral sclerosis;​
9988+(6) seizures, including those characteristic of epilepsy;​
9989+(7) severe and persistent muscle spasms, including those characteristic of multiple sclerosis;​
9990+(8) inflammatory bowel disease, including Crohn's disease;​
9991+(9) terminal illness, with a probable life expectancy of under one year, if the illness or its​
9992+treatment produces one or more of the following:​
9993+(i) severe or chronic pain;​
9994+(ii) nausea or severe vomiting; or​
9995+(iii) cachexia or severe wasting; or​
9996+(10) any other medical condition or its treatment approved by the commissioner.​
9997+152.23 LIMITATIONS.​
9998+(a) Nothing in sections 152.22 to 152.37 permits any person to engage in and does not prevent​
9999+the imposition of any civil, criminal, or other penalties for:​
10000+(1) undertaking any task under the influence of medical cannabis that would constitute negligence​
10001+or professional malpractice;​
10002+(2) possessing or engaging in the use of medical cannabis:​
10003+(i) on a school bus or van;​
10004+(ii) on the grounds of any preschool or primary or secondary school;​
10005+(iii) in any correctional facility; or​
10006+(iv) on the grounds of any child care facility or home day care;​
10007+(3) vaporizing or combusting medical cannabis pursuant to section 152.22, subdivision 6:​
10008+(i) on any form of public transportation;​
10009+(ii) where the vapor would be inhaled by a nonpatient minor child or where the smoke would​
10010+be inhaled by a minor child; or​
10011+(iii) in any public place, including any indoor or outdoor area used by or open to the general​
10012+public or a place of employment as defined under section 144.413, subdivision 1b; and​
10013+(4) operating, navigating, or being in actual physical control of any motor vehicle, aircraft, train,​
10014+or motorboat, or working on transportation property, equipment, or facilities while under the​
10015+influence of medical cannabis.​
10016+(b) Nothing in sections 152.22 to 152.37 require the medical assistance and MinnesotaCare​
10017+programs to reimburse an enrollee or a provider for costs associated with the medical use of cannabis.​
10018+Medical assistance and MinnesotaCare shall continue to provide coverage for all services related​
10019+to treatment of an enrollee's qualifying medical condition if the service is covered under chapter​
10020+256B or 256L.​
10021+152.24 FEDERALLY APPROVED CLINICAL TRIALS.​
10022+The commissioner may prohibit enrollment of a patient in the registry program if the patient is​
10023+simultaneously enrolled in a federally approved clinical trial for the treatment of a qualifying medical​
10024+condition with medical cannabis. The commissioner shall provide information to all patients enrolled​
10025+in the registry program on the existence of federally approved clinical trials for the treatment of the​
10026+patient's qualifying medical condition with medical cannabis as an alternative to enrollment in the​
10027+patient registry program.​
10028+152.25 COMMISSIONER DUTIES.​
10029+Subdivision 1.Medical cannabis manufacturer registration.(a) The commissioner shall​
10030+register two in-state manufacturers for the production of all medical cannabis within the state. A​
10031+registration agreement between the commissioner and a manufacturer is nontransferable. The​
10032+commissioner shall register new manufacturers or reregister the existing manufacturers by December​
10033+7R​
10034+APPENDIX​
10035+Repealed Minnesota Statutes: H0100-11​ 1 every two years, using the factors described in this subdivision. The commissioner shall accept​
10036+applications after December 1, 2014, if one of the manufacturers registered before December 1,​
10037+2014, ceases to be registered as a manufacturer. The commissioner's determination that no​
10038+manufacturer exists to fulfill the duties under sections 152.22 to 152.37 is subject to judicial review​
10039+in Ramsey County District Court. Data submitted during the application process are private data​
10040+on individuals or nonpublic data as defined in section 13.02 until the manufacturer is registered​
10041+under this section. Data on a manufacturer that is registered are public data, unless the data are trade​
10042+secret or security information under section 13.37.​
10043+(b) As a condition for registration, a manufacturer must agree to:​
10044+(1) begin supplying medical cannabis to patients by July 1, 2015; and​
10045+(2) comply with all requirements under sections 152.22 to 152.37.​
10046+(c) The commissioner shall consider the following factors when determining which manufacturer​
10047+to register:​
10048+(1) the technical expertise of the manufacturer in cultivating medical cannabis and converting​
10049+the medical cannabis into an acceptable delivery method under section 152.22, subdivision 6;​
10050+(2) the qualifications of the manufacturer's employees;​
10051+(3) the long-term financial stability of the manufacturer;​
10052+(4) the ability to provide appropriate security measures on the premises of the manufacturer;​
10053+(5) whether the manufacturer has demonstrated an ability to meet the medical cannabis production​
10054+needs required by sections 152.22 to 152.37; and​
10055+(6) the manufacturer's projection and ongoing assessment of fees on patients with a qualifying​
10056+medical condition.​
10057+(d) If an officer, director, or controlling person of the manufacturer pleads or is found guilty of​
10058+intentionally diverting medical cannabis to a person other than allowed by law under section 152.33,​
10059+subdivision 1, the commissioner may decide not to renew the registration of the manufacturer,​
10060+provided the violation occurred while the person was an officer, director, or controlling person of​
10061+the manufacturer.​
10062+(e) The commissioner shall require each medical cannabis manufacturer to contract with an​
10063+independent laboratory to test medical cannabis produced by the manufacturer. The commissioner​
10064+shall approve the laboratory chosen by each manufacturer and require that the laboratory report​
10065+testing results to the manufacturer in a manner determined by the commissioner.​
10066+Subd. 1a.Revocation or nonrenewal of a medical cannabis manufacturer registration.If​
10067+the commissioner intends to revoke or not renew a registration issued under this section, the​
10068+commissioner must first notify in writing the manufacturer against whom the action is to be taken​
10069+and provide the manufacturer with an opportunity to request a hearing under the contested case​
10070+provisions of chapter 14. If the manufacturer does not request a hearing by notifying the​
10071+commissioner in writing within 20 days after receipt of the notice of proposed action, the​
10072+commissioner may proceed with the action without a hearing. For revocations, the registration of​
10073+a manufacturer is considered revoked on the date specified in the commissioner's written notice of​
10074+revocation.​
10075+Subd. 1b.Temporary suspension proceedings.The commissioner may institute proceedings​
10076+to temporarily suspend the registration of a medical cannabis manufacturer for a period of up to 90​
10077+days by notifying the manufacturer in writing if any action by an employee, agent, officer, director,​
10078+or controlling person of the manufacturer:​
10079+(1) violates any of the requirements of sections 152.21 to 152.37 or the rules adopted thereunder;​
10080+(2) permits, aids, or abets the commission of any violation of state law at the manufacturer's​
10081+location for cultivation, harvesting, manufacturing, packaging, and processing or at any site for​
10082+distribution of medical cannabis;​
10083+(3) performs any act contrary to the welfare of a registered patient or registered designated​
10084+caregiver; or​
10085+(4) obtains, or attempts to obtain, a registration by fraudulent means or misrepresentation.​
10086+8R​
10087+APPENDIX​
10088+Repealed Minnesota Statutes: H0100-11​ Subd. 1c.Notice to patients.Upon the revocation or nonrenewal of a manufacturer's registration​
10089+under subdivision 1a or implementation of an enforcement action under subdivision 1b that may​
10090+affect the ability of a registered patient, registered designated caregiver, or a registered patient's​
10091+parent, legal guardian, or spouse to obtain medical cannabis from the manufacturer subject to the​
10092+enforcement action, the commissioner shall notify in writing each registered patient and the patient's​
10093+registered designated caregiver or registered patient's parent, legal guardian, or spouse about the​
10094+outcome of the proceeding and information regarding alternative registered manufacturers. This​
10095+notice must be provided two or more business days prior to the effective date of the revocation,​
10096+nonrenewal, or other enforcement action.​
10097+Subd. 2.Range of compounds and dosages; report.The commissioner shall review and​
10098+publicly report the existing medical and scientific literature regarding the range of recommended​
10099+dosages for each qualifying condition and the range of chemical compositions of any plant of the​
10100+genus cannabis that will likely be medically beneficial for each of the qualifying medical conditions.​
10101+The commissioner shall make this information available to patients with qualifying medical​
10102+conditions beginning December 1, 2014, and update the information annually. The commissioner​
10103+may consult with the independent laboratory under contract with the manufacturer or other experts​
10104+in reporting the range of recommended dosages for each qualifying medical condition, the range​
10105+of chemical compositions that will likely be medically beneficial, and any risks of noncannabis​
10106+drug interactions. The commissioner shall consult with each manufacturer on an annual basis on​
10107+medical cannabis offered by the manufacturer. The list of medical cannabis offered by a manufacturer​
10108+shall be published on the Department of Health website.​
10109+Subd. 3.Deadlines.The commissioner shall adopt rules necessary for the manufacturer to begin​
10110+distribution of medical cannabis to patients under the registry program by July 1, 2015, and have​
10111+notice of proposed rules published in the State Register prior to January 1, 2015.​
10112+Subd. 4.Reports.(a) The commissioner shall provide regular updates to the task force on​
10113+medical cannabis therapeutic research and to the chairs and ranking minority members of the​
10114+legislative committees with jurisdiction over health and human services, public safety, judiciary,​
10115+and civil law regarding: (1) any changes in federal law or regulatory restrictions regarding the use​
10116+of medical cannabis or hemp; and (2) the market demand and supply in this state for products made​
10117+from hemp that can be used for medicinal purposes.​
10118+(b) The commissioner may submit medical research based on the data collected under sections​
10119+152.22 to 152.37 to any federal agency with regulatory or enforcement authority over medical​
10120+cannabis to demonstrate the effectiveness of medical cannabis for treating a qualifying medical​
10121+condition.​
10122+152.26 RULEMAKING.​
10123+(a) The commissioner may adopt rules to implement sections 152.22 to 152.37. Rules for which​
10124+notice is published in the State Register before January 1, 2015, may be adopted using the process​
10125+in section 14.389.​
10126+(b) The commissioner may adopt or amend rules, using the procedure in section 14.386,​
10127+paragraph (a), to implement the addition of dried raw cannabis as an allowable form of medical​
10128+cannabis under section 152.22, subdivision 6, paragraph (a), clause (4). Section 14.386, paragraph​
10129+(b), does not apply to these rules.​
10130+152.261 RULES; ADVERSE INCIDENTS.​
10131+(a) The commissioner of health shall adopt rules to establish requirements for reporting incidents​
10132+when individuals who are not authorized to possess medical cannabis under sections 152.22 to​
10133+152.37 are found in possession of medical cannabis. The rules must identify professionals required​
10134+to report, the information they are required to report, and actions the reporter must take to secure​
10135+the medical cannabis.​
10136+(b) The commissioner of health shall adopt rules to establish requirements for law enforcement​
10137+officials and health care professionals to report incidents involving an overdose of medical cannabis​
10138+to the commissioner of health.​
10139+(c) Rules must include the method by which the commissioner will collect and tabulate reports​
10140+of unauthorized possession and overdose.​
10141+152.27 PATIENT REGISTRY PROGRAM ESTABLISHED.​
10142+Subdivision 1.Patient registry program; establishment.(a) The commissioner shall establish​
10143+a patient registry program to evaluate data on patient demographics, effective treatment options,​
10144+9R​
10145+APPENDIX​
10146+Repealed Minnesota Statutes: H0100-11​ clinical outcomes, and quality-of-life outcomes for the purpose of reporting on the benefits, risks,​
10147+and outcomes regarding patients with a qualifying medical condition engaged in the therapeutic​
10148+use of medical cannabis.​
10149+(b) The establishment of the registry program shall not be construed or interpreted to condone​
10150+or promote the illicit recreational use of marijuana.​
10151+Subd. 2.Commissioner duties.(a) The commissioner shall:​
10152+(1) give notice of the program to health care practitioners in the state who are eligible to serve​
10153+as health care practitioners and explain the purposes and requirements of the program;​
10154+(2) allow each health care practitioner who meets or agrees to meet the program's requirements​
10155+and who requests to participate, to be included in the registry program to collect data for the patient​
10156+registry;​
10157+(3) provide explanatory information and assistance to each health care practitioner in​
10158+understanding the nature of therapeutic use of medical cannabis within program requirements;​
10159+(4) create and provide a certification to be used by a health care practitioner for the practitioner​
10160+to certify whether a patient has been diagnosed with a qualifying medical condition and include in​
10161+the certification an option for the practitioner to certify whether the patient, in the health care​
10162+practitioner's medical opinion, is developmentally or physically disabled and, as a result of that​
10163+disability, the patient requires assistance in administering medical cannabis or obtaining medical​
10164+cannabis from a distribution facility;​
10165+(5) supervise the participation of the health care practitioner in conducting patient treatment​
10166+and health records reporting in a manner that ensures stringent security and record-keeping​
10167+requirements and that prevents the unauthorized release of private data on individuals as defined​
10168+by section 13.02;​
10169+(6) develop safety criteria for patients with a qualifying medical condition as a requirement of​
10170+the patient's participation in the program, to prevent the patient from undertaking any task under​
10171+the influence of medical cannabis that would constitute negligence or professional malpractice on​
10172+the part of the patient; and​
10173+(7) conduct research and studies based on data from health records submitted to the registry​
10174+program and submit reports on intermediate or final research results to the legislature and major​
10175+scientific journals. The commissioner may contract with a third party to complete the requirements​
10176+of this clause. Any reports submitted must comply with section 152.28, subdivision 2.​
10177+(b) The commissioner may add a delivery method under section 152.22, subdivision 6, or add,​
10178+remove, or modify a qualifying medical condition under section 152.22, subdivision 14, upon a​
10179+petition from a member of the public or the task force on medical cannabis therapeutic research or​
10180+as directed by law. The commissioner shall evaluate all petitions to add a qualifying medical​
10181+condition or to remove or modify an existing qualifying medical condition submitted by the task​
10182+force on medical cannabis therapeutic research or as directed by law and may make the addition,​
10183+removal, or modification if the commissioner determines the addition, removal, or modification is​
10184+warranted based on the best available evidence and research. If the commissioner wishes to add a​
10185+delivery method under section 152.22, subdivision 6, or add or remove a qualifying medical condition​
10186+under section 152.22, subdivision 14, the commissioner must notify the chairs and ranking minority​
10187+members of the legislative policy committees having jurisdiction over health and public safety of​
10188+the addition or removal and the reasons for its addition or removal, including any written comments​
10189+received by the commissioner from the public and any guidance received from the task force on​
10190+medical cannabis research, by January 15 of the year in which the commissioner wishes to make​
10191+the change. The change shall be effective on August 1 of that year, unless the legislature by law​
10192+provides otherwise.​
10193+Subd. 3.Patient application.(a) The commissioner shall develop a patient application for​
10194+enrollment into the registry program. The application shall be available to the patient and given to​
10195+health care practitioners in the state who are eligible to serve as health care practitioners. The​
10196+application must include:​
10197+(1) the name, mailing address, and date of birth of the patient;​
10198+(2) the name, mailing address, and telephone number of the patient's health care practitioner;​
10199+10R​
10200+APPENDIX​
10201+Repealed Minnesota Statutes: H0100-11​ (3) the name, mailing address, and date of birth of the patient's designated caregiver, if any, or​
10202+the patient's parent, legal guardian, or spouse if the parent, legal guardian, or spouse will be acting​
10203+as a caregiver;​
10204+(4) a copy of the certification from the patient's health care practitioner that is dated within 90​
10205+days prior to submitting the application that certifies that the patient has been diagnosed with a​
10206+qualifying medical condition; and​
10207+(5) all other signed affidavits and enrollment forms required by the commissioner under sections​
10208+152.22 to 152.37, including, but not limited to, the disclosure form required under paragraph (c).​
10209+(b) The commissioner shall require a patient to resubmit a copy of the certification from the​
10210+patient's health care practitioner on a yearly basis and shall require that the recertification be dated​
10211+within 90 days of submission.​
10212+(c) The commissioner shall develop a disclosure form and require, as a condition of enrollment,​
10213+all patients to sign a copy of the disclosure. The disclosure must include:​
10214+(1) a statement that, notwithstanding any law to the contrary, the commissioner, or an employee​
10215+of any state agency, may not be held civilly or criminally liable for any injury, loss of property,​
10216+personal injury, or death caused by any act or omission while acting within the scope of office or​
10217+employment under sections 152.22 to 152.37; and​
10218+(2) the patient's acknowledgment that enrollment in the patient registry program is conditional​
10219+on the patient's agreement to meet all of the requirements of sections 152.22 to 152.37.​
10220+Subd. 4.Registered designated caregiver.(a) The commissioner shall register a designated​
10221+caregiver for a patient if the patient requires assistance in administering medical cannabis or obtaining​
10222+medical cannabis from a distribution facility and the caregiver has agreed, in writing, to be the​
10223+patient's designated caregiver. As a condition of registration as a designated caregiver, the​
10224+commissioner shall require the person to:​
10225+(1) be at least 18 years of age;​
10226+(2) agree to only possess the patient's medical cannabis for purposes of assisting the patient;​
10227+and​
10228+(3) agree that if the application is approved, the person will not be a registered designated​
10229+caregiver for more than six registered patients at one time. Patients who reside in the same residence​
10230+shall count as one patient.​
10231+(b) The commissioner shall conduct a criminal background check on the designated caregiver​
10232+prior to registration to ensure that the person does not have a conviction for a disqualifying felony​
10233+offense. Any cost of the background check shall be paid by the person seeking registration as a​
10234+designated caregiver. A designated caregiver must have the criminal background check renewed​
10235+every two years.​
10236+(c) Nothing in sections 152.22 to 152.37 shall be construed to prevent a person registered as a​
10237+designated caregiver from also being enrolled in the registry program as a patient and possessing​
10238+and using medical cannabis as a patient.​
10239+Subd. 5.Parents, legal guardians, and spouses.A parent, legal guardian, or spouse of a patient​
10240+may act as the caregiver to the patient without having to register as a designated caregiver. The​
10241+parent, legal guardian, or spouse shall follow all of the requirements of parents, legal guardians,​
10242+and spouses listed in sections 152.22 to 152.37. Nothing in sections 152.22 to 152.37 limits any​
10243+legal authority a parent, legal guardian, or spouse may have for the patient under any other law.​
10244+Subd. 6.Patient enrollment.(a) After receipt of a patient's application, application fees, and​
10245+signed disclosure, the commissioner shall enroll the patient in the registry program and issue the​
10246+patient and patient's registered designated caregiver or parent, legal guardian, or spouse, if applicable,​
10247+a registry verification. The commissioner shall approve or deny a patient's application for​
10248+participation in the registry program within 30 days after the commissioner receives the patient's​
10249+application and application fee. The commissioner may approve applications up to 60 days after​
10250+the receipt of a patient's application and application fees until January 1, 2016. A patient's enrollment​
10251+in the registry program shall only be denied if the patient:​
10252+(1) does not have certification from a health care practitioner that the patient has been diagnosed​
10253+with a qualifying medical condition;​
10254+11R​
10255+APPENDIX​
10256+Repealed Minnesota Statutes: H0100-11​ (2) has not signed and returned the disclosure form required under subdivision 3, paragraph (c),​
10257+to the commissioner;​
10258+(3) does not provide the information required;​
10259+(4) has previously been removed from the registry program for violations of section 152.30 or​
10260+152.33; or​
10261+(5) provides false information.​
10262+(b) The commissioner shall give written notice to a patient of the reason for denying enrollment​
10263+in the registry program.​
10264+(c) Denial of enrollment into the registry program is considered a final decision of the​
10265+commissioner and is subject to judicial review under the Administrative Procedure Act pursuant​
10266+to chapter 14.​
10267+(d) A patient's enrollment in the registry program may only be revoked upon the death of the​
10268+patient or if a patient violates a requirement under section 152.30 or 152.33.​
10269+(e) The commissioner shall develop a registry verification to provide to the patient, the health​
10270+care practitioner identified in the patient's application, and to the manufacturer. The registry​
10271+verification shall include:​
10272+(1) the patient's name and date of birth;​
10273+(2) the patient registry number assigned to the patient; and​
10274+(3) the name and date of birth of the patient's registered designated caregiver, if any, or the​
10275+name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or spouse will​
10276+be acting as a caregiver.​
10277+Subd. 7.Notice requirements.Patients and registered designated caregivers shall notify the​
10278+commissioner of any address or name change within 30 days of the change having occurred. A​
10279+patient or registered designated caregiver is subject to a $100 fine for failure to notify the​
10280+commissioner of the change.​
10281+152.28 HEALTH CARE PRACTITIONER DUTIES.​
10282+Subdivision 1.Health care practitioner duties.(a) Prior to a patient's enrollment in the registry​
10283+program, a health care practitioner shall:​
10284+(1) determine, in the health care practitioner's medical judgment, whether a patient suffers from​
10285+a qualifying medical condition, and, if so determined, provide the patient with a certification of that​
10286+diagnosis;​
10287+(2) advise patients, registered designated caregivers, and parents, legal guardians, or spouses​
10288+who are acting as caregivers of the existence of any nonprofit patient support groups or organizations;​
10289+(3) provide explanatory information from the commissioner to patients with qualifying medical​
10290+conditions, including disclosure to all patients about the experimental nature of therapeutic use of​
10291+medical cannabis; the possible risks, benefits, and side effects of the proposed treatment; the​
10292+application and other materials from the commissioner; and provide patients with the Tennessen​
10293+warning as required by section 13.04, subdivision 2; and​
10294+(4) agree to continue treatment of the patient's qualifying medical condition and report medical​
10295+findings to the commissioner.​
10296+(b) Upon notification from the commissioner of the patient's enrollment in the registry program,​
10297+the health care practitioner shall:​
10298+(1) participate in the patient registry reporting system under the guidance and supervision of​
10299+the commissioner;​
10300+(2) report health records of the patient throughout the ongoing treatment of the patient to the​
10301+commissioner in a manner determined by the commissioner and in accordance with subdivision 2;​
10302+(3) determine, on a yearly basis, if the patient continues to suffer from a qualifying medical​
10303+condition and, if so, issue the patient a new certification of that diagnosis; and​
10304+(4) otherwise comply with all requirements developed by the commissioner.​
10305+12R​
10306+APPENDIX​
10307+Repealed Minnesota Statutes: H0100-11​ (c) A health care practitioner may conduct a patient assessment to issue a recertification as​
10308+required under paragraph (b), clause (3), via telehealth, as defined in section 62A.673, subdivision​
10309+2.​
10310+(d) Nothing in this section requires a health care practitioner to participate in the registry program.​
10311+Subd. 2.Data.Data collected on patients by a health care practitioner and reported to the patient​
10312+registry are health records under section 144.291, and are private data on individuals under section​
10313+13.02, but may be used or reported in an aggregated, nonidentifiable form as part of a scientific,​
10314+peer-reviewed publication of research conducted under section 152.25 or in the creation of summary​
10315+data, as defined in section 13.02, subdivision 19.​
10316+Subd. 3.Advertising restrictions.(a) A health care practitioner shall not publish or cause to​
10317+be published any advertisement that:​
10318+(1) contains false or misleading statements about medical cannabis or about the medical cannabis​
10319+registry program;​
10320+(2) uses colloquial terms to refer to medical cannabis, such as pot, weed, or grass;​
10321+(3) states or implies the health care practitioner is endorsed by the Department of Health or by​
10322+the medical cannabis registry program;​
10323+(4) includes images of cannabis in its plant or leaf form or of cannabis-smoking paraphernalia;​
10324+or​
10325+(5) contains medical symbols that could reasonably be confused with symbols of established​
10326+medical associations or groups.​
10327+(b) A health care practitioner found by the commissioner to have violated this subdivision is​
10328+prohibited from certifying that patients have a qualifying medical condition for purposes of patient​
10329+participation in the registry program. The commissioner's decision that a health care practitioner​
10330+has violated this subdivision is a final decision of the commissioner and is not subject to the contested​
10331+case procedures in chapter 14.​
10332+152.29 MANUFACTURER OF MEDICAL CANNABIS DUTIES.​
10333+Subdivision 1.Manufacturer; requirements.(a) A manufacturer may operate eight distribution​
10334+facilities, which may include the manufacturer's single location for cultivation, harvesting,​
10335+manufacturing, packaging, and processing but is not required to include that location. The​
10336+commissioner shall designate the geographical service areas to be served by each manufacturer​
10337+based on geographical need throughout the state to improve patient access. A manufacturer shall​
10338+not have more than two distribution facilities in each geographical service area assigned to the​
10339+manufacturer by the commissioner. A manufacturer shall operate only one location where all​
10340+cultivation, harvesting, manufacturing, packaging, and processing of medical cannabis shall be​
10341+conducted. This location may be one of the manufacturer's distribution facility sites. The additional​
10342+distribution facilities may dispense medical cannabis and medical cannabis products but may not​
10343+contain any medical cannabis in a form other than those forms allowed under section 152.22,​
10344+subdivision 6, and the manufacturer shall not conduct any cultivation, harvesting, manufacturing,​
10345+packaging, or processing at the other distribution facility sites. Any distribution facility operated​
10346+by the manufacturer is subject to all of the requirements applying to the manufacturer under sections​
10347+152.22 to 152.37, including, but not limited to, security and distribution requirements.​
10348+(b) A manufacturer may acquire hemp grown in this state from a hemp grower, and may acquire​
10349+hemp products produced by a hemp processor. A manufacturer may manufacture or process hemp​
10350+and hemp products into an allowable form of medical cannabis under section 152.22, subdivision​
10351+6. Hemp and hemp products acquired by a manufacturer under this paragraph are subject to the​
10352+same quality control program, security and testing requirements, and other requirements that apply​
10353+to medical cannabis under sections 152.22 to 152.37 and Minnesota Rules, chapter 4770.​
10354+(c) A medical cannabis manufacturer shall contract with a laboratory approved by the​
10355+commissioner, subject to any additional requirements set by the commissioner, for purposes of​
10356+testing medical cannabis manufactured or hemp or hemp products acquired by the medical cannabis​
10357+manufacturer as to content, contamination, and consistency to verify the medical cannabis meets​
10358+the requirements of section 152.22, subdivision 6. The cost of laboratory testing shall be paid by​
10359+the manufacturer.​
10360+(d) The operating documents of a manufacturer must include:​
10361+13R​
10362+APPENDIX​
10363+Repealed Minnesota Statutes: H0100-11​ (1) procedures for the oversight of the manufacturer and procedures to ensure accurate record​
10364+keeping;​
10365+(2) procedures for the implementation of appropriate security measures to deter and prevent the​
10366+theft of medical cannabis and unauthorized entrance into areas containing medical cannabis; and​
10367+(3) procedures for the delivery and transportation of hemp between hemp growers and​
10368+manufacturers and for the delivery and transportation of hemp products between hemp processors​
10369+and manufacturers.​
10370+(e) A manufacturer shall implement security requirements, including requirements for the​
10371+delivery and transportation of hemp and hemp products, protection of each location by a fully​
10372+operational security alarm system, facility access controls, perimeter intrusion detection systems,​
10373+and a personnel identification system.​
10374+(f) A manufacturer shall not share office space with, refer patients to a health care practitioner,​
10375+or have any financial relationship with a health care practitioner.​
10376+(g) A manufacturer shall not permit any person to consume medical cannabis on the property​
10377+of the manufacturer.​
10378+(h) A manufacturer is subject to reasonable inspection by the commissioner.​
10379+(i) For purposes of sections 152.22 to 152.37, a medical cannabis manufacturer is not subject​
10380+to the Board of Pharmacy licensure or regulatory requirements under chapter 151.​
10381+(j) A medical cannabis manufacturer may not employ any person who is under 21 years of age​
10382+or who has been convicted of a disqualifying felony offense. An employee of a medical cannabis​
10383+manufacturer must submit a completed criminal history records check consent form, a full set of​
10384+classifiable fingerprints, and the required fees for submission to the Bureau of Criminal Apprehension​
10385+before an employee may begin working with the manufacturer. The bureau must conduct a Minnesota​
10386+criminal history records check and the superintendent is authorized to exchange the fingerprints​
10387+with the Federal Bureau of Investigation to obtain the applicant's national criminal history record​
10388+information. The bureau shall return the results of the Minnesota and federal criminal history records​
10389+checks to the commissioner.​
10390+(k) A manufacturer may not operate in any location, whether for distribution or cultivation,​
10391+harvesting, manufacturing, packaging, or processing, within 1,000 feet of a public or private school​
10392+existing before the date of the manufacturer's registration with the commissioner.​
10393+(l) A manufacturer shall comply with reasonable restrictions set by the commissioner relating​
10394+to signage, marketing, display, and advertising of medical cannabis.​
10395+(m) Before a manufacturer acquires hemp from a hemp grower or hemp products from a hemp​
10396+processor, the manufacturer must verify that the hemp grower or hemp processor has a valid license​
10397+issued by the commissioner of agriculture under chapter 18K.​
10398+(n) Until a state-centralized, seed-to-sale system is implemented that can track a specific medical​
10399+cannabis plant from cultivation through testing and point of sale, the commissioner shall conduct​
10400+at least one unannounced inspection per year of each manufacturer that includes inspection of:​
10401+(1) business operations;​
10402+(2) physical locations of the manufacturer's manufacturing facility and distribution facilities;​
10403+(3) financial information and inventory documentation, including laboratory testing results; and​
10404+(4) physical and electronic security alarm systems.​
10405+Subd. 2.Manufacturer; production.(a) A manufacturer of medical cannabis shall provide a​
10406+reliable and ongoing supply of all medical cannabis needed for the registry program through​
10407+cultivation by the manufacturer and through the purchase of hemp from hemp growers.​
10408+(b) All cultivation, harvesting, manufacturing, packaging, and processing of medical cannabis​
10409+must take place in an enclosed, locked facility at a physical address provided to the commissioner​
10410+during the registration process.​
10411+(c) A manufacturer must process and prepare any medical cannabis plant material or hemp plant​
10412+material into a form allowable under section 152.22, subdivision 6, prior to distribution of any​
10413+medical cannabis.​
10414+14R​
10415+APPENDIX​
10416+Repealed Minnesota Statutes: H0100-11​ Subd. 3.Manufacturer; distribution.(a) A manufacturer shall require that employees licensed​
10417+as pharmacists pursuant to chapter 151 be the only employees to give final approval for the​
10418+distribution of medical cannabis to a patient. A manufacturer may transport medical cannabis or​
10419+medical cannabis products that have been cultivated, harvested, manufactured, packaged, and​
10420+processed by that manufacturer to another registered manufacturer for the other manufacturer to​
10421+distribute.​
10422+(b) A manufacturer may distribute medical cannabis products, whether or not the products have​
10423+been manufactured by that manufacturer.​
10424+(c) Prior to distribution of any medical cannabis, the manufacturer shall:​
10425+(1) verify that the manufacturer has received the registry verification from the commissioner​
10426+for that individual patient;​
10427+(2) verify that the person requesting the distribution of medical cannabis is the patient, the​
10428+patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse listed in​
10429+the registry verification using the procedures described in section 152.11, subdivision 2d;​
10430+(3) assign a tracking number to any medical cannabis distributed from the manufacturer;​
10431+(4) ensure that any employee of the manufacturer licensed as a pharmacist pursuant to chapter​
10432+151 has consulted with the patient to determine the proper dosage for the individual patient after​
10433+reviewing the ranges of chemical compositions of the medical cannabis and the ranges of proper​
10434+dosages reported by the commissioner. For purposes of this clause, a consultation may be conducted​
10435+remotely by secure videoconference, telephone, or other remote means, so long as the employee​
10436+providing the consultation is able to confirm the identity of the patient and the consultation adheres​
10437+to patient privacy requirements that apply to health care services delivered through telehealth. A​
10438+pharmacist consultation under this clause is not required when a manufacturer is distributing medical​
10439+cannabis to a patient according to a patient-specific dosage plan established with that manufacturer​
10440+and is not modifying the dosage or product being distributed under that plan and the medical cannabis​
10441+is distributed by a pharmacy technician;​
10442+(5) properly package medical cannabis in compliance with the United States Poison Prevention​
10443+Packing Act regarding child-resistant packaging and exemptions for packaging for elderly patients,​
10444+and label distributed medical cannabis with a list of all active ingredients and individually identifying​
10445+information, including:​
10446+(i) the patient's name and date of birth;​
10447+(ii) the name and date of birth of the patient's registered designated caregiver or, if listed on the​
10448+registry verification, the name of the patient's parent or legal guardian, if applicable;​
10449+(iii) the patient's registry identification number;​
10450+(iv) the chemical composition of the medical cannabis; and​
10451+(v) the dosage; and​
10452+(6) ensure that the medical cannabis distributed contains a maximum of a 90-day supply of the​
10453+dosage determined for that patient.​
10454+(d) A manufacturer shall require any employee of the manufacturer who is transporting medical​
10455+cannabis or medical cannabis products to a distribution facility or to another registered manufacturer​
10456+to carry identification showing that the person is an employee of the manufacturer.​
10457+(e) A manufacturer shall distribute medical cannabis in dried raw cannabis form only to a patient​
10458+age 21 or older, or to the registered designated caregiver, parent, legal guardian, or spouse of a​
10459+patient age 21 or older.​
10460+Subd. 3a.Transportation of medical cannabis; staffing.(a) A medical cannabis manufacturer​
10461+may staff a transport motor vehicle with only one employee if the medical cannabis manufacturer​
10462+is transporting medical cannabis to either a certified laboratory for the purpose of testing or a facility​
10463+for the purpose of disposal. If the medical cannabis manufacturer is transporting medical cannabis​
10464+for any other purpose or destination, the transport motor vehicle must be staffed with a minimum​
10465+of two employees as required by rules adopted by the commissioner.​
10466+(b) Notwithstanding paragraph (a), a medical cannabis manufacturer that is only transporting​
10467+hemp for any purpose may staff the transport motor vehicle with only one employee.​
10468+15R​
10469+APPENDIX​
10470+Repealed Minnesota Statutes: H0100-11​ Subd. 4.Report.Each manufacturer shall report to the commissioner on a monthly basis the​
10471+following information on each individual patient for the month prior to the report:​
10472+(1) the amount and dosages of medical cannabis distributed;​
10473+(2) the chemical composition of the medical cannabis; and​
10474+(3) the tracking number assigned to any medical cannabis distributed.​
10475+152.30 PATIENT DUTIES.​
10476+(a) A patient shall apply to the commissioner for enrollment in the registry program by submitting​
10477+an application as required in section 152.27 and an annual registration fee as determined under​
10478+section 152.35.​
10479+(b) As a condition of continued enrollment, patients shall agree to:​
10480+(1) continue to receive regularly scheduled treatment for their qualifying medical condition​
10481+from their health care practitioner; and​
10482+(2) report changes in their qualifying medical condition to their health care practitioner.​
10483+(c) A patient shall only receive medical cannabis from a registered manufacturer but is not​
10484+required to receive medical cannabis products from only a registered manufacturer.​
10485+152.31 DATA PRACTICES.​
10486+(a) Government data in patient files maintained by the commissioner and the health care​
10487+practitioner, and data submitted to or by a medical cannabis manufacturer, are private data on​
10488+individuals, as defined in section 13.02, subdivision 12, or nonpublic data, as defined in section​
10489+13.02, subdivision 9, but may be used for purposes of complying with chapter 13 and complying​
10490+with a request from the legislative auditor or the state auditor in the performance of official duties.​
10491+The provisions of section 13.05, subdivision 11, apply to a registration agreement entered between​
10492+the commissioner and a medical cannabis manufacturer under section 152.25.​
10493+(b) Not public data maintained by the commissioner may not be used for any purpose not​
10494+provided for in sections 152.22 to 152.37, and may not be combined or linked in any manner with​
10495+any other list, dataset, or database.​
10496+(c) The commissioner may execute data sharing arrangements with the commissioner of​
10497+agriculture to verify licensing, inspection, and compliance information related to hemp growers​
10498+and hemp processors under chapter 18K.​
10499+152.32 PROTECTIONS FOR REGISTRY PROGRAM PARTICIPATION.​
10500+Subdivision 1.Presumption.(a) There is a presumption that a patient enrolled in the registry​
10501+program under sections 152.22 to 152.37 is engaged in the authorized use of medical cannabis.​
10502+(b) The presumption may be rebutted by evidence that conduct related to use of medical cannabis​
10503+was not for the purpose of treating or alleviating the patient's qualifying medical condition or​
10504+symptoms associated with the patient's qualifying medical condition.​
10505+Subd. 2.Criminal and civil protections.(a) Subject to section 152.23, the following are not​
10506+violations under this chapter:​
10507+(1) use or possession of medical cannabis or medical cannabis products by a patient enrolled​
10508+in the registry program, or possession by a registered designated caregiver or the parent, legal​
10509+guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed on the registry​
10510+verification;​
10511+(2) possession, dosage determination, or sale of medical cannabis or medical cannabis products​
10512+by a medical cannabis manufacturer, employees of a manufacturer, a laboratory conducting testing​
10513+on medical cannabis, or employees of the laboratory; and​
10514+(3) possession of medical cannabis or medical cannabis products by any person while carrying​
10515+out the duties required under sections 152.22 to 152.37.​
10516+(b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and​
10517+associated property is not subject to forfeiture under sections 609.531 to 609.5316.​
10518+(c) The commissioner, the commissioner's staff, the commissioner's agents or contractors, and​
10519+any health care practitioner are not subject to any civil or disciplinary penalties by the Board of​
10520+16R​
10521+APPENDIX​
10522+Repealed Minnesota Statutes: H0100-11​ Medical Practice, the Board of Nursing, or by any business, occupational, or professional licensing​
10523+board or entity, solely for the participation in the registry program under sections 152.22 to 152.37.​
10524+A pharmacist licensed under chapter 151 is not subject to any civil or disciplinary penalties by the​
10525+Board of Pharmacy when acting in accordance with the provisions of sections 152.22 to 152.37.​
10526+Nothing in this section affects a professional licensing board from taking action in response to​
10527+violations of any other section of law.​
10528+(d) Notwithstanding any law to the contrary, the commissioner, the governor of Minnesota, or​
10529+an employee of any state agency may not be held civilly or criminally liable for any injury, loss of​
10530+property, personal injury, or death caused by any act or omission while acting within the scope of​
10531+office or employment under sections 152.22 to 152.37.​
10532+(e) Federal, state, and local law enforcement authorities are prohibited from accessing the patient​
10533+registry under sections 152.22 to 152.37 except when acting pursuant to a valid search warrant.​
10534+(f) Notwithstanding any law to the contrary, neither the commissioner nor a public employee​
10535+may release data or information about an individual contained in any report, document, or registry​
10536+created under sections 152.22 to 152.37 or any information obtained about a patient participating​
10537+in the program, except as provided in sections 152.22 to 152.37.​
10538+(g) No information contained in a report, document, or registry or obtained from a patient under​
10539+sections 152.22 to 152.37 may be admitted as evidence in a criminal proceeding unless independently​
10540+obtained or in connection with a proceeding involving a violation of sections 152.22 to 152.37.​
10541+(h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty of a​
10542+gross misdemeanor.​
10543+(i) An attorney may not be subject to disciplinary action by the Minnesota Supreme Court or​
10544+professional responsibility board for providing legal assistance to prospective or registered​
10545+manufacturers or others related to activity that is no longer subject to criminal penalties under state​
10546+law pursuant to sections 152.22 to 152.37.​
10547+(j) Possession of a registry verification or application for enrollment in the program by a person​
10548+entitled to possess or apply for enrollment in the registry program does not constitute probable​
10549+cause or reasonable suspicion, nor shall it be used to support a search of the person or property of​
10550+the person possessing or applying for the registry verification, or otherwise subject the person or​
10551+property of the person to inspection by any governmental agency.​
10552+Subd. 3.Discrimination prohibited.(a) No school or landlord may refuse to enroll or lease to​
10553+and may not otherwise penalize a person solely for the person's status as a patient enrolled in the​
10554+registry program under sections 152.22 to 152.37, unless failing to do so would violate federal law​
10555+or regulations or cause the school or landlord to lose a monetary or licensing-related benefit under​
10556+federal law or regulations.​
10557+(b) For the purposes of medical care, including organ transplants, a registry program enrollee's​
10558+use of medical cannabis under sections 152.22 to 152.37 is considered the equivalent of the authorized​
10559+use of any other medication used at the discretion of a physician, advanced practice registered nurse,​
10560+or physician assistant and does not constitute the use of an illicit substance or otherwise disqualify​
10561+a patient from needed medical care.​
10562+(c) Unless a failure to do so would violate federal law or regulations or cause an employer to​
10563+lose a monetary or licensing-related benefit under federal law or regulations, an employer may not​
10564+discriminate against a person in hiring, termination, or any term or condition of employment, or​
10565+otherwise penalize a person, if the discrimination is based upon either of the following:​
10566+(1) the person's status as a patient enrolled in the registry program under sections 152.22 to​
10567+152.37; or​
10568+(2) a patient's positive drug test for cannabis components or metabolites, unless the patient used,​
10569+possessed, or was impaired by medical cannabis on the premises of the place of employment or​
10570+during the hours of employment.​
10571+(d) An employee who is required to undergo employer drug testing pursuant to section 181.953​
10572+may present verification of enrollment in the patient registry as part of the employee's explanation​
10573+under section 181.953, subdivision 6.​
10574+(e) A person shall not be denied custody of a minor child or visitation rights or parenting time​
10575+with a minor child solely based on the person's status as a patient enrolled in the registry program​
10576+under sections 152.22 to 152.37. There shall be no presumption of neglect or child endangerment​
10577+17R​
10578+APPENDIX​
10579+Repealed Minnesota Statutes: H0100-11​ for conduct allowed under sections 152.22 to 152.37, unless the person's behavior is such that it​
10580+creates an unreasonable danger to the safety of the minor as established by clear and convincing​
10581+evidence.​
10582+152.33 VIOLATIONS.​
10583+Subdivision 1.Intentional diversion; criminal penalty.In addition to any other applicable​
10584+penalty in law, a manufacturer or an agent of a manufacturer who intentionally transfers medical​
10585+cannabis to a person other than another registered manufacturer, a patient, a registered designated​
10586+caregiver or, if listed on the registry verification, a parent, legal guardian, or spouse of a patient is​
10587+guilty of a felony punishable by imprisonment for not more than two years or by payment of a fine​
10588+of not more than $3,000, or both. A person convicted under this subdivision may not continue to​
10589+be affiliated with the manufacturer and is disqualified from further participation under sections​
10590+152.22 to 152.37.​
10591+Subd. 1a.Intentional diversion outside the state; penalties.(a) In addition to any other​
10592+applicable penalty in law, the commissioner may levy a fine of $250,000 against a manufacturer​
10593+and may immediately initiate proceedings to revoke the manufacturer's registration, using the​
10594+procedure in section 152.25, if:​
10595+(1) an officer, director, or controlling person of the manufacturer pleads or is found guilty under​
10596+subdivision 1 of intentionally transferring medical cannabis, while the person was an officer, director,​
10597+or controlling person of the manufacturer, to a person other than allowed by law; and​
10598+(2) in intentionally transferring medical cannabis to a person other than allowed by law, the​
10599+officer, director, or controlling person transported or directed the transport of medical cannabis​
10600+outside of Minnesota.​
10601+(b) All fines collected under this subdivision shall be deposited in the state government special​
10602+revenue fund.​
10603+Subd. 2.Diversion by patient, registered designated caregiver, parent, legal guardian, or​
10604+patient's spouse; criminal penalty.In addition to any other applicable penalty in law, a patient,​
10605+registered designated caregiver or, if listed on the registry verification, a parent, legal guardian, or​
10606+spouse of a patient who intentionally sells or otherwise transfers medical cannabis to a person other​
10607+than a patient, designated registered caregiver or, if listed on the registry verification, a parent, legal​
10608+guardian, or spouse of a patient is guilty of a felony punishable by imprisonment for not more than​
10609+two years or by payment of a fine of not more than $3,000, or both.​
10610+Subd. 3.False statement; criminal penalty.A person who intentionally makes a false statement​
10611+to a law enforcement official about any fact or circumstance relating to the medical use of cannabis​
10612+to avoid arrest or prosecution is guilty of a misdemeanor punishable by imprisonment for not more​
10613+than 90 days or by payment of a fine of not more than $1,000, or both. The penalty is in addition​
10614+to any other penalties that may apply for making a false statement or for the possession, cultivation,​
10615+or sale of cannabis not protected by sections 152.22 to 152.37. If a person convicted of violating​
10616+this subdivision is a patient or a registered designated caregiver, the person is disqualified from​
10617+further participation under sections 152.22 to 152.37.​
10618+Subd. 4.Submission of false records; criminal penalty.A person who knowingly submits​
10619+false records or documentation required by the commissioner to register as a manufacturer of medical​
10620+cannabis under sections 152.22 to 152.37 is guilty of a felony and may be sentenced to imprisonment​
10621+for not more than two years or by payment of a fine of not more than $3,000, or both.​
10622+Subd. 5.Violation by health care practitioner; criminal penalty.A health care practitioner​
10623+who knowingly refers patients to a manufacturer or to a designated caregiver, who advertises as a​
10624+manufacturer, or who issues certifications while holding a financial interest in a manufacturer is​
10625+guilty of a misdemeanor and may be sentenced to imprisonment for not more than 90 days or by​
10626+payment of a fine of not more than $1,000, or both.​
10627+Subd. 6.Other violations; civil penalty.A manufacturer shall be fined up to $1,000 for any​
10628+violation of sections 152.22 to 152.37, or the regulations issued pursuant to them, where no penalty​
10629+has been specified. This penalty is in addition to any other applicable penalties in law.​
10630+152.34 HEALTH CARE FACILITIES.​
10631+(a) Health care facilities licensed under chapter 144A, hospice providers licensed under chapter​
10632+144A, boarding care homes or supervised living facilities licensed under section 144.50, assisted​
10633+living facilities, facilities owned, controlled, managed, or under common control with hospitals​
10634+licensed under chapter 144, and other health facilities licensed by the commissioner of health, may​
10635+18R​
10636+APPENDIX​
10637+Repealed Minnesota Statutes: H0100-11​ adopt reasonable restrictions on the use of medical cannabis by a patient enrolled in the registry​
10638+program who resides at or is actively receiving treatment or care at the facility. The restrictions​
10639+may include a provision that the facility will not store or maintain the patient's supply of medical​
10640+cannabis, that the facility is not responsible for providing the medical cannabis for patients, and​
10641+that medical cannabis be used only in a place specified by the facility.​
10642+(b) Any employee or agent of a facility listed in this section or a person licensed under chapter​
10643+144E is not subject to violations under this chapter for possession of medical cannabis while carrying​
10644+out employment duties, including providing or supervising care to a registered patient, or distribution​
10645+of medical cannabis to a registered patient who resides at or is actively receiving treatment or care​
10646+at the facility with which the employee or agent is affiliated. Nothing in this section shall require​
10647+the facilities to adopt such restrictions and no facility shall unreasonably limit a patient's access to​
10648+or use of medical cannabis to the extent that use is authorized by the patient under sections 152.22​
10649+to 152.37.​
10650+152.35 FEES; DEPOSIT OF REVENUE.​
10651+(a) The commissioner shall collect an enrollment fee of $200 from patients enrolled under this​
10652+section. If the patient provides evidence of receiving Social Security disability insurance (SSDI),​
10653+Supplemental Security Income (SSI), veterans disability, or railroad disability payments, or being​
10654+enrolled in medical assistance or MinnesotaCare, then the fee shall be $50. For purposes of this​
10655+section:​
10656+(1) a patient is considered to receive SSDI if the patient was receiving SSDI at the time the​
10657+patient was transitioned to retirement benefits by the United States Social Security Administration;​
10658+and​
10659+(2) veterans disability payments include VA dependency and indemnity compensation.​
10660+Unless a patient provides evidence of receiving payments from or participating in one of the programs​
10661+specifically listed in this paragraph, the commissioner of health must collect the $200 enrollment​
10662+fee from a patient to enroll the patient in the registry program. The fees shall be payable annually​
10663+and are due on the anniversary date of the patient's enrollment. The fee amount shall be deposited​
10664+in the state treasury and credited to the state government special revenue fund.​
10665+(b) The commissioner shall collect an application fee of $20,000 from each entity submitting​
10666+an application for registration as a medical cannabis manufacturer. Revenue from the fee shall be​
10667+deposited in the state treasury and credited to the state government special revenue fund.​
10668+(c) The commissioner shall establish and collect an annual fee from a medical cannabis​
10669+manufacturer equal to the cost of regulating and inspecting the manufacturer in that year. Revenue​
10670+from the fee amount shall be deposited in the state treasury and credited to the state government​
10671+special revenue fund.​
10672+(d) A medical cannabis manufacturer may charge patients enrolled in the registry program a​
10673+reasonable fee for costs associated with the operations of the manufacturer. The manufacturer may​
10674+establish a sliding scale of patient fees based upon a patient's household income and may accept​
10675+private donations to reduce patient fees.​
10676+152.36 IMPACT ASSESSMENT OF MEDICAL CANNABIS THERAPEUTIC​
10677+RESEARCH.​
10678+Subdivision 1.Task force on medical cannabis therapeutic research.(a) A 23-member task​
10679+force on medical cannabis therapeutic research is created to conduct an impact assessment of medical​
10680+cannabis therapeutic research. The task force shall consist of the following members:​
10681+(1) two members of the house of representatives, one selected by the speaker of the house, the​
10682+other selected by the minority leader;​
10683+(2) two members of the senate, one selected by the majority leader, the other selected by the​
10684+minority leader;​
10685+(3) four members representing consumers or patients enrolled in the registry program, including​
10686+at least two parents of patients under age 18;​
10687+(4) four members representing health care providers, including one licensed pharmacist;​
10688+(5) four members representing law enforcement, one from the Minnesota Chiefs of Police​
10689+Association, one from the Minnesota Sheriff's Association, one from the Minnesota Police and​
10690+Peace Officers Association, and one from the Minnesota County Attorneys Association;​
10691+19R​
10692+APPENDIX​
10693+Repealed Minnesota Statutes: H0100-11​ (6) four members representing substance use disorder treatment providers; and​
10694+(7) the commissioners of health, human services, and public safety.​
10695+(b) Task force members listed under paragraph (a), clauses (3), (4), (5), and (6), shall be appointed​
10696+by the governor under the appointment process in section 15.0597. Members shall serve on the task​
10697+force at the pleasure of the appointing authority. All members must be appointed by July 15, 2014,​
10698+and the commissioner of health shall convene the first meeting of the task force by August 1, 2014.​
10699+(c) There shall be two cochairs of the task force chosen from the members listed under paragraph​
10700+(a). One cochair shall be selected by the speaker of the house and the other cochair shall be selected​
10701+by the majority leader of the senate. The authority to convene meetings shall alternate between the​
10702+cochairs.​
10703+(d) Members of the task force other than those in paragraph (a), clauses (1), (2), and (7), shall​
10704+receive expenses as provided in section 15.059, subdivision 6.​
10705+Subd. 1a.Administration.The commissioner of health shall provide administrative and technical​
10706+support to the task force.​
10707+Subd. 2.Impact assessment.The task force shall hold hearings to evaluate the impact of the​
10708+use of medical cannabis and hemp and Minnesota's activities involving medical cannabis and hemp,​
10709+including, but not limited to:​
10710+(1) program design and implementation;​
10711+(2) the impact on the health care provider community;​
10712+(3) patient experiences;​
10713+(4) the impact on the incidence of substance abuse;​
10714+(5) access to and quality of medical cannabis, hemp, and medical cannabis products;​
10715+(6) the impact on law enforcement and prosecutions;​
10716+(7) public awareness and perception; and​
10717+(8) any unintended consequences.​
10718+Subd. 3.Cost assessment.By January 15 of each year, beginning January 15, 2015, and ending​
10719+January 15, 2019, the commissioners of state departments impacted by the medical cannabis​
10720+therapeutic research study shall report to the cochairs of the task force on the costs incurred by each​
10721+department on implementing sections 152.22 to 152.37. The reports must compare actual costs to​
10722+the estimated costs of implementing these sections and must be submitted to the task force on​
10723+medical cannabis therapeutic research.​
10724+Subd. 4.Reports to the legislature.(a) The cochairs of the task force shall submit the following​
10725+reports to the chairs and ranking minority members of the legislative committees and divisions with​
10726+jurisdiction over health and human services, public safety, judiciary, and civil law:​
10727+(1) by February 1, 2015, a report on the design and implementation of the registry program;​
10728+and every two years thereafter, a complete impact assessment report; and​
10729+(2) upon receipt of a cost assessment from a commissioner of a state agency, the completed​
10730+cost assessment.​
10731+(b) The task force may make recommendations to the legislature on whether to add or remove​
10732+conditions from the list of qualifying medical conditions.​
10733+Subd. 5.No expiration.The task force on medical cannabis therapeutic research does not expire.​
10734+152.37 FINANCIAL EXAMINATIONS; PRICING REVIEWS.​
10735+Subdivision 1.Financial records.A medical cannabis manufacturer shall maintain detailed​
10736+financial records in a manner and format approved by the commissioner, and shall keep all records​
10737+updated and accessible to the commissioner when requested.​
10738+Subd. 2.Certified annual audit.A medical cannabis manufacturer shall submit the results of​
10739+an annual certified financial audit to the commissioner no later than May 1 of each year for the​
10740+calendar year beginning January 2015. The annual audit shall be conducted by an independent​
10741+certified public accountant and the costs of the audit are the responsibility of the medical cannabis​
10742+manufacturer. Results of the audit shall be provided to the medical cannabis manufacturer and the​
10743+20R​
10744+APPENDIX​
10745+Repealed Minnesota Statutes: H0100-11​ commissioner. The commissioner may also require another audit of the medical cannabis​
10746+manufacturer by a certified public accountant chosen by the commissioner with the costs of the​
10747+audit paid by the medical cannabis manufacturer.​
10748+Subd. 3.Power to examine.(a) The commissioner or designee may examine the business affairs​
10749+and conditions of any medical cannabis manufacturer, including but not limited to a review of the​
10750+financing, budgets, revenues, sales, and pricing.​
10751+(b) An examination may cover the medical cannabis manufacturer's business affairs, practices,​
10752+and conditions including but not limited to a review of the financing, budgets, revenues, sales, and​
10753+pricing. The commissioner shall determine the nature and scope of each examination and in doing​
10754+so shall take into account all available relevant factors concerning the financial and business affairs,​
10755+practices, and conditions of the examinee. The costs incurred by the department in conducting an​
10756+examination shall be paid for by the medical cannabis manufacturer.​
10757+(c) When making an examination under this section, the commissioner may retain attorneys,​
10758+appraisers, independent economists, independent certified public accountants, or other professionals​
10759+and specialists as designees. A certified public accountant retained by the commissioner may not​
10760+be the same certified public accountant providing the certified annual audit in subdivision 2.​
10761+(d) The commissioner shall make a report of an examination conducted under this section and​
10762+provide a copy to the medical cannabis manufacturer. The commissioner shall then post a copy of​
10763+the report on the department's website. All working papers, recorded information, documents, and​
10764+copies produced by, obtained by, or disclosed to the commissioner or any other person in the course​
10765+of an examination, other than the information contained in any commissioner official report, made​
10766+under this section are private data on individuals or nonpublic data, as defined in section 13.02.​
10767+21R​
10768+APPENDIX​
10769+Repealed Minnesota Statutes: H0100-11​